{
    "56c8605b5795f9a73e000014_1": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.1953125,
            "text": "JAK1/2",
            "probability": 0.55419921875
        },
        {
            "start_logit": 9.2578125,
            "end_logit": 8.9765625,
            "text": "JAK1",
            "probability": 0.445556640625
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 9.1953125,
            "text": "2",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -0.7646484375,
            "text": "JAK",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -1.5908203125,
            "end_logit": 9.1953125,
            "text": "1/2",
            "probability": 1.0848045349121094e-05
        },
        {
            "start_logit": -1.5908203125,
            "end_logit": 8.9765625,
            "text": "1",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.19140625,
            "text": "JAK1/",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.9453125,
            "text": "JAK1/2 Inhibitor Baricitinib.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.265625,
            "text": "JAK1/2 Inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.1953125,
            "text": "Alopecia Areata Following Treatment With the JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.4375,
            "text": "JAK1/2 Inhibitor Baricitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.53515625,
            "text": "JAK1/2 Inhibitor Bari",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.9765625,
            "text": "Alopecia Areata Following Treatment With the JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5546875,
            "text": "JAK1/2 Inhibitor Barici",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.1953125,
            "text": "/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.1953125,
            "text": "Reversal of Alopecia Areata Following Treatment With the JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.1953125,
            "text": "the JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.9765625,
            "text": "Reversal of Alopecia Areata Following Treatment With the JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.9765625,
            "text": "the JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5908203125,
            "end_logit": -5.19140625,
            "text": "1/",
            "probability": 0.0
        }
    ],
    "56c8605b5795f9a73e000014_2": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.3203125,
            "text": "JAK1/2",
            "probability": 0.6962890625
        },
        {
            "start_logit": 9.359375,
            "end_logit": 8.5,
            "text": "JAK1",
            "probability": 0.303955078125
        },
        {
            "start_logit": -0.43701171875,
            "end_logit": 9.3203125,
            "text": "2",
            "probability": 3.844499588012695e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.54052734375,
            "text": "JAK",
            "probability": 3.612041473388672e-05
        },
        {
            "start_logit": -2.43359375,
            "end_logit": 9.3203125,
            "text": "1/2",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -2.43359375,
            "end_logit": 8.5,
            "text": "1",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 9.359375,
            "end_logit": -5.80859375,
            "text": "JAK1/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.05859375,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.3203125,
            "text": "patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.29296875,
            "text": "JAK1/2 inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.3203125,
            "text": "/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.3828125,
            "text": "JAK1/2 inhibitor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.4765625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 9.3203125,
            "text": "a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5078125,
            "text": "JAK1/2 inhibitor, to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.3203125,
            "text": "A patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.3203125,
            "text": "clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.3203125,
            "text": "examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.3203125,
            "text": ", a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.3203125,
            "text": "the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c8605b5795f9a73e000014_3": [
        {
            "start_logit": 8.8515625,
            "end_logit": 8.8671875,
            "text": "JAK1",
            "probability": 1.0
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -0.3671875,
            "text": "JAK1 and JAK2",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -2.00390625,
            "text": "JAK",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -2.08984375,
            "end_logit": 8.8671875,
            "text": "1",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.99609375,
            "text": "JAK1 and JAK2, is currently in clinical development for the treatment of rheumatoid arthritis (RA) and other inflammatory disorders.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 8.8671875,
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.1953125,
            "text": "JAK1 and JAK2, is currently in clinical development for the treatment of rheumatoid arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.28515625,
            "text": "JAK1 and JAK2, is currently in clinical development for the treatment of rheumatoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.8671875,
            "text": "small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.31640625,
            "text": "JAK1 and JAK2, is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.8671875,
            "text": "JAKs) with selectivity for JAK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.8671875,
            "text": "for JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.41796875,
            "text": "JAK1 and JAK2, is currently in clinical development for the treatment of rheumatoid arthritis (RA) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.8671875,
            "text": "selectivity for JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.8671875,
            "text": "potent small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.8671875,
            "text": "novel and potent small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.08984375,
            "end_logit": -0.3671875,
            "text": "1 and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -0.3671875,
            "text": "JAK2",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -0.3671875,
            "text": "and JAK2",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -0.3671875,
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.0
        }
    ],
    "56c8605b5795f9a73e000014_4": [
        {
            "start_logit": 9.421875,
            "end_logit": 9.4140625,
            "text": "JAK1/2",
            "probability": 0.66552734375
        },
        {
            "start_logit": 9.421875,
            "end_logit": 8.7265625,
            "text": "JAK1",
            "probability": 0.334716796875
        },
        {
            "start_logit": -0.1871337890625,
            "end_logit": 9.4140625,
            "text": "2",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": 9.421875,
            "end_logit": -0.341064453125,
            "text": "JAK",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 9.4140625,
            "text": "1/2",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 8.7265625,
            "text": "1",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.421875,
            "end_logit": -6.0078125,
            "text": "JAK1/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.09375,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 9.4140625,
            "text": "patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.2421875,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.4140625,
            "text": "/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.3203125,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse model",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.35546875,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.4140625,
            "text": "A patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.4140625,
            "text": "a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.40234375,
            "text": "JAK1/2 inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.41796875,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse model to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.421875,
            "text": "JAK1/2 inhibitor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.4140625,
            "text": "clinical trial to examine the efficacy of baricitinib, a JAK1/2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.4765625,
            "text": "JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were",
            "probability": 5.960464477539063e-08
        }
    ],
    "58de71fa8acda3452900002c_1": [
        {
            "start_logit": 8.6953125,
            "end_logit": 8.5234375,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -2.427734375,
            "text": "IN",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -2.939453125,
            "end_logit": 8.5234375,
            "text": "80",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.375,
            "text": "INO80 promotes homologous recombination",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 8.5234375,
            "text": "O80",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.5234375,
            "text": "by INO80",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -7.25390625,
            "text": "INO",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -7.27734375,
            "text": "INO80 promotes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -7.5390625,
            "text": "INO80 promotes homologous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.5234375,
            "text": "Z by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.5234375,
            "text": "Removal of H2A.Z by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -2.427734375,
            "text": "by IN",
            "probability": 0.0
        },
        {
            "start_logit": -2.939453125,
            "end_logit": -6.375,
            "text": "80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -2.427734375,
            "text": "Z by IN",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.427734375,
            "text": "Removal of H2A.Z by IN",
            "probability": 0.0
        },
        {
            "start_logit": -2.939453125,
            "end_logit": -7.27734375,
            "text": "80 promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.939453125,
            "end_logit": -7.5390625,
            "text": "80 promotes homologous",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -6.375,
            "text": "O80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -6.375,
            "text": "by INO80 promotes homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -7.25390625,
            "text": "O",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_2": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.1875,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 9.1875,
            "text": "80",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.5390625,
            "text": "IN",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.984375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 9.1875,
            "text": "O80",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.6953125,
            "text": "INO80 can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.88671875,
            "text": "INO80 can remove H2A.Z/H2B",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.90234375,
            "text": "INO80 can remove H2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.953125,
            "text": "INO80 can remove H2A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.12109375,
            "text": "INO80 can remove H2A.Z/H2B dimers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.2265625,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.25,
            "text": "INO80 can remove H2A.Z/H2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4375,
            "text": "INO",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.45703125,
            "text": "INO80 can remove H2A.Z",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.46875,
            "text": "INO80 can remove H2A.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.49609375,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.5078125,
            "text": "INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.1875,
            "text": "yeast INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.1875,
            "text": "Budding yeast INO80",
            "probability": 5.960464477539063e-08
        }
    ],
    "58de71fa8acda3452900002c_3": [
        {
            "start_logit": 8.9453125,
            "end_logit": 8.9921875,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -1.921875,
            "text": "IN",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": -2.046875,
            "end_logit": 8.9921875,
            "text": "80",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 8.9921875,
            "text": "O80",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 8.9921875,
            "text": "DNA damage by INO80",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.9921875,
            "text": "by INO80",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.125,
            "text": "INO80.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 8.9921875,
            "text": "that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.30078125,
            "text": "INO",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.9921875,
            "text": "from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.9921875,
            "text": "Here, we show that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.9921875,
            "text": "flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.9921875,
            "text": "we show that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.9921875,
            "text": "show that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.9921875,
            "text": "H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.9921875,
            "text": "removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.9921875,
            "text": "in human cells is indeed rapidly removed from chromatin flanking DNA damage by INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -1.921875,
            "text": "DNA damage by IN",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -1.921875,
            "text": "by IN",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -1.921875,
            "text": "that H2A.Z in human cells is indeed rapidly removed from chromatin flanking DNA damage by IN",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_4": [
        {
            "start_logit": 9.1953125,
            "end_logit": 9.3125,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": -1.322265625,
            "end_logit": 9.3125,
            "text": "80",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.279296875,
            "text": "IN",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.3125,
            "text": "O80",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.72265625,
            "text": "INO",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.0,
            "text": "INO80 in these assays.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.3125,
            "text": "H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.20703125,
            "text": "INO80 in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.3125,
            "text": "as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.3125,
            "text": "HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.3125,
            "text": "ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.36328125,
            "text": "INO80 in these assays",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.375,
            "text": "INO80 in these",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.3125,
            "text": "removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -1.279296875,
            "text": "histone chaperone ANP32E, which is implicated in removing H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as IN",
            "probability": 0.0
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -7.0,
            "text": "80 in these assays.",
            "probability": 0.0
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -7.20703125,
            "text": "80 in",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -1.279296875,
            "text": "H2AZ from chromatin, similarly promotes HR and appears to work on the same pathway as IN",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -1.279296875,
            "text": "as IN",
            "probability": 0.0
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -7.36328125,
            "text": "80 in these assays",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_5": [
        {
            "start_logit": 8.6640625,
            "end_logit": 8.5859375,
            "text": "INO80",
            "probability": 1.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -2.384765625,
            "text": "IN",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": -2.640625,
            "end_logit": 8.5859375,
            "text": "80",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -4.3515625,
            "text": "INO80 and ANP32E",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.5859375,
            "text": "O80",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.43359375,
            "text": "INO80 and ANP32E in promoting homologous recombination",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.484375,
            "text": "INO80 and ANP32",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.9609375,
            "text": "INO80 and ANP32E in promoting homologous recombination.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.203125,
            "text": "INO80 and ANP32E in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.25,
            "text": "INO",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.3203125,
            "text": "INO80 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.5859375,
            "text": "of INO80",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.5859375,
            "text": "function of INO80",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.5859375,
            "text": "from chromatin is the primary function of INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.5859375,
            "text": "primary function of INO80",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.640625,
            "end_logit": -4.3515625,
            "text": "80 and ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -6.43359375,
            "text": "80 and ANP32E in promoting homologous recombination",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -6.484375,
            "text": "80 and ANP32",
            "probability": 0.0
        },
        {
            "start_logit": -5.078125,
            "end_logit": -4.3515625,
            "text": "ANP32E",
            "probability": 0.0
        },
        {
            "start_logit": -2.640625,
            "end_logit": -6.9609375,
            "text": "80 and ANP32E in promoting homologous recombination.",
            "probability": 0.0
        }
    ],
    "58de71fa8acda3452900002c_6": [
        {
            "start_logit": 8.3671875,
            "end_logit": 7.55078125,
            "text": "INO80 complex",
            "probability": 0.994140625
        },
        {
            "start_logit": 8.3671875,
            "end_logit": 2.431640625,
            "text": "INO80",
            "probability": 0.00591278076171875
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -2.888671875,
            "text": "IN",
            "probability": 2.8908252716064453e-05
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -3.3828125,
            "text": "INO80 complex, which removes H2A.Z(Htz1",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -3.75,
            "end_logit": 7.55078125,
            "text": "complex",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.30859375,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.453125,
            "text": "INO80 complex, which removes H2A.Z(Htz1)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.8203125,
            "text": "INO",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.14453125,
            "text": "INO80 complex, which removes H2A.Z(Htz",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.2265625,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.265625,
            "text": "INO80 complex, which removes H2A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.41796875,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes, promotes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.421875,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.44921875,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes, promotes the ectopic deposition of CENP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.484375,
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes, promotes the ectopic deposition of CENP-A(Cse",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 7.55078125,
            "text": ", the INO80 complex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 7.55078125,
            "text": "O80 complex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 7.55078125,
            "text": "the INO80 complex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.55078125,
            "text": "80 complex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.55078125,
            "text": "Instead, the INO80 complex",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58846be0e56acf5176000005_1": [
        {
            "start_logit": 9.328125,
            "end_logit": 9.390625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.328125,
            "end_logit": -1.0234375,
            "text": "essential",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -1.095703125,
            "end_logit": 9.390625,
            "text": "tremor",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.390625,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.28515625,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are not clear.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.33984375,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.35546875,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are not clear",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.40234375,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.390625,
            "text": "Thalamotomy at the ventralis intermedius nucleus has been an effective treatment method for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4296875,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.390625,
            "text": "effective treatment method for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.390625,
            "text": "ventralis intermedius nucleus has been an effective treatment method for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.51953125,
            "text": "essential tremor, but how the brain network changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5234375,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.54296875,
            "text": "essential tremor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.546875,
            "text": "essential tremor, but how the brain network changes immediately responding to this deliberate lesion and then re",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": -1.0234375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.28515625,
            "text": "tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are not clear.",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.33984375,
            "text": "tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.35546875,
            "text": "tremor, but how the brain network changes immediately responding to this deliberate lesion and then reorganizes afterwards are not clear",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_2": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.3359375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -0.79443359375,
            "text": "essential",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -1.2421875,
            "end_logit": 9.3359375,
            "text": "tremor",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.3359375,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.16796875,
            "text": "essential tremor: practices and clinicoradiological outcomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.2265625,
            "text": "essential tremor: practices and clinicoradiological outcomes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.3359375,
            "text": "thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.57421875,
            "text": "essential tremor: practices and clinicoradiological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.3359375,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.5859375,
            "text": "essential tremor:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3359375,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.3359375,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.875,
            "end_logit": -0.79443359375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -0.79443359375,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -0.79443359375,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -0.79443359375,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -0.79443359375,
            "text": "focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.16796875,
            "text": "tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.2265625,
            "text": "tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.57421875,
            "text": "tremor: practices and clinicoradiological",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_3": [
        {
            "start_logit": 9.3671875,
            "end_logit": 9.203125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -0.9052734375,
            "text": "essential",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": 9.203125,
            "text": "tremor",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -3.87109375,
            "text": "essential tremor (ET",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -4.375,
            "text": "essential tremor (ET)",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.0859375,
            "text": "essential tremor (ET) or obsessive-compulsive disorder (OCD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 9.203125,
            "text": "with essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.203125,
            "text": "patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 9.203125,
            "text": "authors report different MRI patterns in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.203125,
            "text": "in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.36328125,
            "text": "essential tremor (ET) or obsessive-compulsive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.203125,
            "text": "report different MRI patterns in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.39453125,
            "text": "essential tremor (ET) or obsessive-compulsive disorder (OCD)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.4453125,
            "text": "essential tremor (ET) or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.51953125,
            "text": "essential tremor (ET) or obsessive-compulsive disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.203125,
            "text": "different MRI patterns in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -3.87109375,
            "text": "tremor (ET",
            "probability": 0.0
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -4.375,
            "text": "tremor (ET)",
            "probability": 0.0
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -0.9052734375,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -6.0859375,
            "text": "tremor (ET) or obsessive-compulsive disorder (OCD",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_4": [
        {
            "start_logit": 9.3359375,
            "end_logit": 9.3125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -0.990234375,
            "text": "essential",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -1.2919921875,
            "end_logit": 9.3125,
            "text": "tremor",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -7.015625,
            "end_logit": 9.3125,
            "text": "neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.3125,
            "text": ", essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.3125,
            "text": "neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.30078125,
            "text": "essential tremor, while measuring magnetoencephalogram",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.3125,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.3125,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.34375,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.3828125,
            "text": "essential tremor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.51171875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.3125,
            "text": "to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.3125,
            "text": "intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.3125,
            "text": "discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.3125,
            "text": "MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.3125,
            "text": "applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.015625,
            "end_logit": -0.990234375,
            "text": "neurologic disorder, essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -0.990234375,
            "text": ", essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.990234375,
            "text": "neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_5": [
        {
            "start_logit": 9.453125,
            "end_logit": 9.40625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -0.65625,
            "text": "essential",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -1.048828125,
            "end_logit": 9.40625,
            "text": "tremor",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 9.40625,
            "text": "with essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.8203125,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.9453125,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.16796875,
            "text": "essential tremor treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.40625,
            "text": "patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.30078125,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.4765625,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.51171875,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.40625,
            "text": "in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.54296875,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo fiber",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.546875,
            "text": "essential tremor treated with MR imaging-guided focused ultrasound: in vivo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.453125,
            "end_logit": -0.65625,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -6.8203125,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging.",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -0.65625,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -6.9453125,
            "text": "tremor treated with MR imaging-guided focused ultrasound: in vivo fiber tracking by using diffusion-tensor MR imaging",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -0.65625,
            "text": "in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -7.16796875,
            "text": "tremor treated",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_6": [
        {
            "start_logit": 9.328125,
            "end_logit": 9.4140625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -1.017578125,
            "end_logit": 9.4140625,
            "text": "tremor",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 9.328125,
            "end_logit": -0.9921875,
            "text": "essential",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 9.4140625,
            "text": "with essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 9.4140625,
            "text": "in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.4140625,
            "text": "patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.4140625,
            "text": "use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.4140625,
            "text": "diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.4140625,
            "text": "To use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.3671875,
            "text": "essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5078125,
            "text": "essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.546875,
            "text": "essential tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.62890625,
            "end_logit": -0.9921875,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -0.9921875,
            "text": "in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -0.9921875,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -0.9921875,
            "text": "use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.017578125,
            "end_logit": -7.3671875,
            "text": "tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -0.9921875,
            "text": "diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -0.9921875,
            "text": "To use diffusion-tensor (DT) magnetic resonance (MR) imaging in patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.017578125,
            "end_logit": -7.5078125,
            "text": "tremor who were treated with transcranial MR imaging-guided focused ultrasound lesion inducement to identify the structural connectivity of the",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_7": [
        {
            "start_logit": 9.3828125,
            "end_logit": 9.203125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -0.8662109375,
            "text": "essential",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": -1.5517578125,
            "end_logit": 9.203125,
            "text": "tremor",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.70703125,
            "text": "essential tremor.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 9.203125,
            "text": "A pilot study of focused ultrasound thalamotomy for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 9.203125,
            "text": "pilot study of focused ultrasound thalamotomy for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 9.203125,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.203125,
            "text": "study of focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -0.8662109375,
            "text": "A pilot study of focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -0.8662109375,
            "text": "pilot study of focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -0.8662109375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.5517578125,
            "end_logit": -6.70703125,
            "text": "tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -0.8662109375,
            "text": "study of focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -5.234375,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.55078125,
            "text": "A pilot study of focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.70703125,
            "text": "A pilot study of focused ultrasound thalamotomy for essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.73046875,
            "text": "A pilot",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.77734375,
            "text": "A pilot study",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -6.55078125,
            "text": "pilot study of focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -6.70703125,
            "text": "pilot study of focused ultrasound thalamotomy for essential tremor.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_8": [
        {
            "start_logit": 9.3359375,
            "end_logit": 9.3828125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -1.005859375,
            "text": "essential",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": 9.3828125,
            "text": "tremor",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.37890625,
            "text": "essential tremor.METHODS: From February 2011 through",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.3828125,
            "text": "This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.3828125,
            "text": "of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.3828125,
            "text": "preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3828125,
            "text": "use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.515625,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.578125,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.578125,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -1.005859375,
            "text": "This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.005859375,
            "text": "of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -1.005859375,
            "text": "preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": -7.37890625,
            "text": "tremor.METHODS: From February 2011 through",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -1.005859375,
            "text": "use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": -7.515625,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label",
            "probability": 0.0
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": -7.578125,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-",
            "probability": 0.0
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": -7.578125,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.359375,
            "text": "essential tremor",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_9": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.3828125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -0.796875,
            "text": "essential",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -1.12109375,
            "end_logit": 9.3828125,
            "text": "tremor",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.3671875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.37890625,
            "text": "essential tremor improved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.3828125,
            "text": ", essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.4921875,
            "text": "essential tremor improved in 15",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3828125,
            "text": "pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.5625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.56640625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.578125,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.59375,
            "text": "essential tremor improved in 15 patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.3828125,
            "text": "CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.3828125,
            "text": ": In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -0.796875,
            "text": ", essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -0.796875,
            "text": "pilot study, essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -0.796875,
            "text": "CONCLUSIONS: In this pilot study, essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -0.796875,
            "text": ": In this pilot study, essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.12109375,
            "end_logit": -7.3671875,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.12109375,
            "end_logit": -7.37890625,
            "text": "tremor improved",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_10": [
        {
            "start_logit": 9.3984375,
            "end_logit": 9.2734375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -0.8349609375,
            "text": "essential",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": 9.2734375,
            "text": "tremor",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.92578125,
            "text": "essential tremor: a proof-of-concept study.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.01953125,
            "text": "essential tremor: a proof-of-concept study",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": 9.2734375,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.19140625,
            "text": "essential tremor:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.359375,
            "text": "essential tremor: a proof-of-concept",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.37109375,
            "text": "essential tremor: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.37890625,
            "text": "essential tremor: a proof-of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.48046875,
            "text": "essential tremor: a proof",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.51953125,
            "text": "essential tremor: a proof-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.2734375,
            "text": "thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.2734375,
            "text": "MR-guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.2734375,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": -0.8349609375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": -6.92578125,
            "text": "tremor: a proof-of-concept study.",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.8349609375,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": -7.01953125,
            "text": "tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -0.8349609375,
            "text": "MR-guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_11": [
        {
            "start_logit": 8.6328125,
            "end_logit": 7.15234375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -2.326171875,
            "text": "essential",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -4.3515625,
            "end_logit": 7.15234375,
            "text": "tremor",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.15234375,
            "text": ". We examined its application to the management of essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.15234375,
            "text": "management of essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 7.15234375,
            "text": "non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.15234375,
            "text": "of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.15234375,
            "text": "focal lesions. We examined its application to the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.15234375,
            "text": "as a non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.15234375,
            "text": "examined its application to the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.15234375,
            "text": "the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.15234375,
            "text": "We examined its application to the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.15234375,
            "text": "precisely placed focal lesions. We examined its application to the management of essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -2.326171875,
            "text": ". We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -2.326171875,
            "text": "management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -2.326171875,
            "text": "non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -2.326171875,
            "text": "of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -2.326171875,
            "text": "focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -2.326171875,
            "text": "as a non-invasive means of generating precisely placed focal lesions. We examined its application to the management of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -2.326171875,
            "text": "examined its application to the management of essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_12": [
        {
            "start_logit": 9.390625,
            "end_logit": 9.28125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.390625,
            "end_logit": -0.84033203125,
            "text": "essential",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -1.3564453125,
            "end_logit": 9.28125,
            "text": "tremor",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.84765625,
            "text": "essential tremor were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 9.28125,
            "text": "Four patients with chronic and medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.28125,
            "text": "patients with chronic and medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.265625,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.2734375,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.30078125,
            "text": "essential tremor were treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.35546875,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.28125,
            "text": "with chronic and medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.4921875,
            "text": "essential tremor were treated with MR-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.53515625,
            "text": "essential tremor were treated with MR-guided focused ultrasound to ablate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.28125,
            "text": "and medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0625,
            "end_logit": -0.84033203125,
            "text": "Four patients with chronic and medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -0.84033203125,
            "text": "patients with chronic and medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -0.84033203125,
            "text": "with chronic and medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.3564453125,
            "end_logit": -6.84765625,
            "text": "tremor were",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -0.84033203125,
            "text": "and medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.3564453125,
            "end_logit": -7.265625,
            "text": "tremor were treated with MR-guided focused ultrasound to ablate tremor-mediating areas of the thalamus.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_13": [
        {
            "start_logit": 9.40625,
            "end_logit": 9.28125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -0.783203125,
            "text": "essential",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -1.3564453125,
            "end_logit": 9.28125,
            "text": "tremor",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.22265625,
            "text": "essential tremor.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.28125,
            "text": ", medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.28125,
            "text": "safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.28125,
            "text": "disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.28125,
            "text": "intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.28125,
            "text": "of disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.28125,
            "text": "management of disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.28125,
            "text": "focal intracranial lesions for the management of disabling, medication-resistant essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -0.783203125,
            "text": ", medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -0.783203125,
            "text": "safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -0.783203125,
            "text": "disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -0.783203125,
            "text": "intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -0.783203125,
            "text": "of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -0.783203125,
            "text": "INTERPRETATION: MR-guided focused ultrasound might be a safe and effective approach to generation of focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -0.783203125,
            "text": "management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -0.783203125,
            "text": "focal intracranial lesions for the management of disabling, medication-resistant essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.3564453125,
            "end_logit": -7.22265625,
            "text": "tremor.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_14": [
        {
            "start_logit": 9.4765625,
            "end_logit": 9.40625,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -0.461669921875,
            "text": "neuropathic",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -1.0087890625,
            "end_logit": 9.40625,
            "text": "pain",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": -5.453125,
            "end_logit": 9.40625,
            "text": "chronic neuropathic pain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.19921875,
            "text": "neuropathic pain.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.40625,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.40625,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.40625,
            "text": ": noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.40625,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.40625,
            "text": "for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.453125,
            "end_logit": -0.461669921875,
            "text": "chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -0.461669921875,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -0.461669921875,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -0.461669921875,
            "text": ": noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -0.461669921875,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -0.461669921875,
            "text": "for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -1.0087890625,
            "end_logit": -7.19921875,
            "text": "pain.",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -7.19921875,
            "text": "chronic neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -7.38671875,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.19921875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_15": [
        {
            "start_logit": 9.484375,
            "end_logit": 9.6171875,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": -0.359130859375,
            "end_logit": 9.6171875,
            "text": "pain",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": 9.484375,
            "end_logit": -0.4794921875,
            "text": "neuropathic",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": 9.484375,
            "end_logit": -4.58203125,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.6171875,
            "text": "chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.6171875,
            "text": "noninvasive central lateral thalamotomies (CLTs) as a treatment for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.2890625,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.30078125,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain, tcMRgFUS CLT was proposed.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.6171875,
            "text": "perform noninvasive central lateral thalamotomies (CLTs) as a treatment for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.6171875,
            "text": "for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.44921875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.51171875,
            "text": "neuropathic pain.METHODS: In 12",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.54296875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.546875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.546875,
            "text": "neuropathic pain.METHODS: In 12 patients suffering",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.58984375,
            "text": "neuropathic pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain, tcMRgF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.359130859375,
            "end_logit": -4.58203125,
            "text": "pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -0.4794921875,
            "text": "chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -0.359130859375,
            "end_logit": -7.2890625,
            "text": "pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -0.359130859375,
            "end_logit": -7.30078125,
            "text": "pain.METHODS: In 12 patients suffering from chronic therapy-resistant neuropathic pain, tcMRgFUS CLT was proposed.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_16": [
        {
            "start_logit": 9.375,
            "end_logit": 9.375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.8896484375,
            "text": "essential",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -1.1357421875,
            "end_logit": 9.375,
            "text": "tremor",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.234375,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.375,
            "text": ", essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.46484375,
            "text": "essential tremor improved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.49609375,
            "text": "essential tremor improved in 15",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.375,
            "text": "=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.375,
            "text": "pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.375,
            "text": ".CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.375,
            "text": "P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.53515625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.375,
            "text": ": In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.375,
            "text": "CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.5625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.375,
            "text": "Quality-of-life scores improved from 37% to 11% (P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.375,
            "text": "(P=0.001).CONCLUSIONS: In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.6015625,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": -0.8896484375,
            "text": ", essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.1357421875,
            "end_logit": -7.234375,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_17": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.2734375,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -0.9453125,
            "text": "Essential",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -1.3935546875,
            "end_logit": 9.2734375,
            "text": "Tremor",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -3.515625,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 9.2734375,
            "text": "Tremor and the Quality of Life in Essential Tremor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.03125,
            "text": "Essential Tremor Questionnaire.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": 9.2734375,
            "text": "for Tremor and the Quality of Life in Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.2734375,
            "text": "in Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.3359375,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.2734375,
            "text": "Clinical Rating Scale for Tremor and the Quality of Life in Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.42578125,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral Vim",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.44921875,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.4609375,
            "text": "Essential Tremor Questionnaire.This is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.47265625,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.4765625,
            "text": "Essential Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor patients treated at the University of Virginia with bilateral Vi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.484375,
            "text": "Essential Tremor Questionnaire",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3935546875,
            "end_logit": -3.515625,
            "text": "Tremor Questionnaire.This is a retrospective study of medication-refractory essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -0.9453125,
            "text": "Tremor and the Quality of Life in Essential",
            "probability": 0.0
        },
        {
            "start_logit": -2.86328125,
            "end_logit": -3.515625,
            "text": "essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -1.7646484375,
            "text": "Tremor",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_18": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.328125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.90966796875,
            "text": "essential",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 9.328125,
            "text": "tremor",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 9.328125,
            "text": ".In this pilot study, essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.35546875,
            "text": "essential tremor improved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.328125,
            "text": ", essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.421875,
            "text": "essential tremor improved in 15",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.328125,
            "text": "=0.001).In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.54296875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.328125,
            "text": "pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.546875,
            "text": "essential tremor improved in 15 patients treated with MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.55078125,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.328125,
            "text": "P=0.001).In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.328125,
            "text": "Quality-of-life scores improved from 37% to 11% (P=0.001).In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.328125,
            "text": "In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.328125,
            "text": "from 37% to 11% (P=0.001).In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.328125,
            "text": "(P=0.001).In this pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -0.90966796875,
            "text": ".In this pilot study, essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -0.90966796875,
            "text": ", essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -0.90966796875,
            "text": "=0.001).In this pilot study, essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_19": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.21875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.92626953125,
            "text": "essential",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": -1.447265625,
            "end_logit": 9.21875,
            "text": "tremor",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 9.21875,
            "text": "neurologic disorder, essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.5,
            "end_logit": 9.21875,
            "text": ", essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 9.21875,
            "text": "neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 9.21875,
            "text": ". To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.01171875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 9.21875,
            "text": "disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.13671875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.20703125,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy beam",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.2265625,
            "text": "essential tremor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.2578125,
            "text": "essential tremor, while measuring magnetoencephalogram",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.265625,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 9.21875,
            "text": "neurologic disorders. To discern the neurophysiologic correlates of its therapeutic effects, we applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 9.21875,
            "text": "to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.32421875,
            "text": "essential tremor, while measuring magnetoencephalogram mu rhythms from the motor cortex. Focused ultrasound sonication destroyed tissues by focusing a high-energy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.21875,
            "text": "applied MRgHIFU to an intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.21875,
            "text": "intractable neurologic disorder, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -0.92626953125,
            "text": "neurologic disorder, essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_20": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.296875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.8935546875,
            "text": "essential",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.27734375,
            "end_logit": 9.296875,
            "text": "tremor",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.921875,
            "text": "essential tremor.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.296875,
            "text": ". This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.33984375,
            "text": "essential tremor.METHODS: From February 2011 through",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.296875,
            "text": "of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.4296875,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.296875,
            "text": "treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.47265625,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.296875,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5,
            "text": "essential tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.90625,
            "end_logit": -0.8935546875,
            "text": ". This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.27734375,
            "end_logit": -6.921875,
            "text": "tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -0.8935546875,
            "text": "of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -0.8935546875,
            "text": "treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -0.8935546875,
            "text": "transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.27734375,
            "end_logit": -7.33984375,
            "text": "tremor.METHODS: From February 2011 through",
            "probability": 0.0
        },
        {
            "start_logit": -1.27734375,
            "end_logit": -7.4296875,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label",
            "probability": 0.0
        },
        {
            "start_logit": -1.27734375,
            "end_logit": -7.47265625,
            "text": "tremor.METHODS: From February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_21": [
        {
            "start_logit": 9.40625,
            "end_logit": 9.390625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -0.80322265625,
            "text": "essential",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": 9.390625,
            "text": "tremor",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.2890625,
            "text": "essential tremor improved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.375,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.390625,
            "text": ", essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.5,
            "text": "essential tremor improved in 15",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.50390625,
            "text": "essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.51953125,
            "text": "essential tremor improved in 15 patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.52734375,
            "text": "essential tremor improved in 15 patients treated with MRI-guided",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.54296875,
            "text": "essential tremor improved in 15 patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.390625,
            "text": "pilot study, essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.61328125,
            "text": "essential tremor improved in 15 patients treated with MRI-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -0.80322265625,
            "text": ", essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.80322265625,
            "text": "pilot study, essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": -7.2890625,
            "text": "tremor improved",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": -7.375,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": -7.5,
            "text": "tremor improved in 15",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": -7.50390625,
            "text": "tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -1.0947265625,
            "end_logit": -7.51953125,
            "text": "tremor improved in 15 patients treated",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_22": [
        {
            "start_logit": 9.40625,
            "end_logit": 9.25,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -0.8125,
            "text": "Essential",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -1.451171875,
            "end_logit": 9.25,
            "text": "Tremor",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.40625,
            "end_logit": -6.6953125,
            "text": "Essential Tremor.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 9.25,
            "text": "for Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.25,
            "text": "A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.25,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.25,
            "text": "Thalamotomy for Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.25,
            "text": "Focused Ultrasound Thalamotomy for Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.046875,
            "end_logit": -0.8125,
            "text": "for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -0.8125,
            "text": "A Randomized Trial of Focused Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.451171875,
            "end_logit": -6.6953125,
            "text": "Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -0.8125,
            "text": "Randomized Trial of Focused Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -0.8125,
            "text": "Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -0.8125,
            "text": "Focused Ultrasound Thalamotomy for Essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.6953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": -6.6953125,
            "text": "for Essential Tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -6.63671875,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -6.6640625,
            "text": "A Randomized Trial of Focused Ultrasound Thalamotomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -6.6953125,
            "text": "A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_23": [
        {
            "start_logit": 9.3984375,
            "end_logit": 9.2734375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -0.8349609375,
            "text": "essential",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": 9.2734375,
            "text": "tremor",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.92578125,
            "text": "essential tremor: a proof-of-concept study.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.01953125,
            "text": "essential tremor: a proof-of-concept study",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": 9.2734375,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.19140625,
            "text": "essential tremor:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.359375,
            "text": "essential tremor: a proof-of-concept",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.37109375,
            "text": "essential tremor: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.37890625,
            "text": "essential tremor: a proof-of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.48046875,
            "text": "essential tremor: a proof",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.51953125,
            "text": "essential tremor: a proof-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.2734375,
            "text": "thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.2734375,
            "text": "MR-guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.2734375,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": -0.8349609375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": -6.92578125,
            "text": "tremor: a proof-of-concept study.",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.8349609375,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": -7.01953125,
            "text": "tremor: a proof-of-concept study",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -0.8349609375,
            "text": "MR-guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_24": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.3359375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -0.79443359375,
            "text": "essential",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -1.2421875,
            "end_logit": 9.3359375,
            "text": "tremor",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.3359375,
            "text": "for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.16796875,
            "text": "essential tremor: practices and clinicoradiological outcomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.2265625,
            "text": "essential tremor: practices and clinicoradiological outcomes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.3359375,
            "text": "thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.57421875,
            "text": "essential tremor: practices and clinicoradiological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.3359375,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.5859375,
            "text": "essential tremor:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3359375,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.3359375,
            "text": "focused ultrasound thalamotomy for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.875,
            "end_logit": -0.79443359375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -0.79443359375,
            "text": "thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -0.79443359375,
            "text": "Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -0.79443359375,
            "text": "magnetic resonance guided focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -0.79443359375,
            "text": "focused ultrasound thalamotomy for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.16796875,
            "text": "tremor: practices and clinicoradiological outcomes",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.2265625,
            "text": "tremor: practices and clinicoradiological outcomes.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2421875,
            "end_logit": -7.57421875,
            "text": "tremor: practices and clinicoradiological",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_25": [
        {
            "start_logit": 9.390625,
            "end_logit": 9.4140625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.390625,
            "end_logit": -0.85205078125,
            "text": "essential",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": -1.03515625,
            "end_logit": 9.4140625,
            "text": "tremor",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 9.4140625,
            "text": "in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.26953125,
            "text": "essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.31640625,
            "text": "essential tremor with bilateral or unilateral DBS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.33203125,
            "text": "essential tremor with bilateral or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.33984375,
            "text": "essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.4140625,
            "text": "quality of life in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.41015625,
            "text": "essential tremor with bilateral or unilateral DBS and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.45703125,
            "text": "essential tremor with bilateral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.4140625,
            "text": "Functional assessment and quality of life in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.5,
            "text": "essential tremor with bilateral or unilateral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.5546875,
            "text": "essential tremor with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.4140625,
            "text": "assessment and quality of life in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -0.85205078125,
            "text": "in essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -0.85205078125,
            "text": "quality of life in essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.03515625,
            "end_logit": -7.26953125,
            "text": "tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.03515625,
            "end_logit": -7.31640625,
            "text": "tremor with bilateral or unilateral DBS",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -0.85205078125,
            "text": "Functional assessment and quality of life in essential",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_26": [
        {
            "start_logit": 9.4765625,
            "end_logit": 9.40625,
            "text": "neuropathic pain",
            "probability": 1.0
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -0.461669921875,
            "text": "neuropathic",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -1.0087890625,
            "end_logit": 9.40625,
            "text": "pain",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": -5.453125,
            "end_logit": 9.40625,
            "text": "chronic neuropathic pain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.19921875,
            "text": "neuropathic pain.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.40625,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.40625,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.40625,
            "text": ": noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.40625,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.40625,
            "text": "for chronic neuropathic pain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.453125,
            "end_logit": -0.461669921875,
            "text": "chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -0.461669921875,
            "text": "Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -0.461669921875,
            "text": "noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -0.461669921875,
            "text": ": noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -0.461669921875,
            "text": "focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -0.461669921875,
            "text": "for chronic neuropathic",
            "probability": 0.0
        },
        {
            "start_logit": -1.0087890625,
            "end_logit": -7.19921875,
            "text": "pain.",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -7.19921875,
            "text": "chronic neuropathic pain.",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -7.38671875,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.19921875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "58846be0e56acf5176000005_27": [
        {
            "start_logit": 9.390625,
            "end_logit": 9.3515625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.390625,
            "end_logit": -0.83740234375,
            "text": "essential",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -1.2158203125,
            "end_logit": 9.3515625,
            "text": "tremor",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 9.3515625,
            "text": "retrospective study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.3515625,
            "text": "study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.3515625,
            "text": "is a retrospective study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.41796875,
            "text": "essential tremor patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.3515625,
            "text": "of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.45703125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS (n = 13",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.3515625,
            "text": "This is a retrospective study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.3515625,
            "text": "a retrospective study of medication-refractory essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.51171875,
            "text": "essential tremor patients treated at the University of Virginia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.54296875,
            "text": "essential tremor patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.55078125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.55078125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS (n = 13)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.578125,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS (n = 57), unilateral Vim DBS (n",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.60546875,
            "text": "essential tremor patients treated at the University of Virginia with bilateral Vim DBS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -0.83740234375,
            "text": "retrospective study of medication-refractory essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -0.83740234375,
            "text": "study of medication-refractory essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -0.83740234375,
            "text": "is a retrospective study of medication-refractory essential",
            "probability": 0.0
        }
    ],
    "515a7ffdd24251bc050000a5_1": [
        {
            "start_logit": 6.71875,
            "end_logit": 5.84375,
            "text": "ERK",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.71875,
            "end_logit": -0.17578125,
            "text": "ERK and JNK",
            "probability": 0.002422332763671875
        },
        {
            "start_logit": -2.318359375,
            "end_logit": 5.84375,
            "text": "inhibited TGF\u03b2-mediated activation of ERK",
            "probability": 0.00011831521987915039
        },
        {
            "start_logit": -3.056640625,
            "end_logit": 5.84375,
            "text": "TGF\u03b2-mediated activation of ERK",
            "probability": 5.6743621826171875e-05
        },
        {
            "start_logit": -4.43359375,
            "end_logit": 5.84375,
            "text": "activation of ERK",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.1875,
            "text": "ERK and JNK, phosphorylation of c-Jun",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.4765625,
            "text": "ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun promoter.",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.66015625,
            "text": "ERK and",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.23046875,
            "text": "ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun promoter",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.2578125,
            "text": "ERK and JNK, phosphorylation of c-Jun, and transactivation of the c-Jun",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.296875,
            "text": "ERK and JNK, phosphorylation of c-Jun, and transactivation",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.31640625,
            "text": "ERK and JNK, phosphorylation",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 5.84375,
            "text": "of ERK",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 5.84375,
            "text": ", knockdown of km23-1 inhibited TGF\u03b2-mediated activation of ERK",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 5.84375,
            "text": "Further, knockdown of km23-1 inhibited TGF\u03b2-mediated activation of ERK",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 5.84375,
            "text": "knockdown of km23-1 inhibited TGF\u03b2-mediated activation of ERK",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.318359375,
            "end_logit": -0.17578125,
            "text": "inhibited TGF\u03b2-mediated activation of ERK and JNK",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.056640625,
            "end_logit": -0.17578125,
            "text": "TGF\u03b2-mediated activation of ERK and JNK",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.43359375,
            "end_logit": -0.17578125,
            "text": "activation of ERK and JNK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.203125,
            "end_logit": -0.17578125,
            "text": "JNK",
            "probability": 0.0
        }
    ],
    "515a7ffdd24251bc050000a5_2": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.578125,
            "text": "RhoA activation",
            "probability": 1.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": 8.578125,
            "text": "decreased RhoA activation",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -2.4765625,
            "end_logit": 8.578125,
            "text": "activation",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -2.513671875,
            "text": "RhoA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.91015625,
            "text": "RhoA activation in Mv1Lu epithelial cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.0546875,
            "text": "RhoA activation in Mv1Lu epithelial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.16796875,
            "text": "RhoA activation in Mv1Lu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.578125,
            "text": "knockdown (KD) of km23-1 decreased RhoA activation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.30859375,
            "text": "RhoA activation in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.32421875,
            "text": "RhoA activation in Mv1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.47265625,
            "text": "RhoA activation in Mv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -2.513671875,
            "text": "decreased RhoA",
            "probability": 0.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -6.91015625,
            "text": "decreased RhoA activation in Mv1Lu epithelial cells",
            "probability": 0.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -7.0546875,
            "text": "decreased RhoA activation in Mv1Lu epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -6.91015625,
            "text": "activation in Mv1Lu epithelial cells",
            "probability": 0.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -7.16796875,
            "text": "decreased RhoA activation in Mv1Lu",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -7.0546875,
            "text": "activation in Mv1Lu epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -7.30859375,
            "text": "decreased RhoA activation in",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -7.16796875,
            "text": "activation in Mv1Lu",
            "probability": 0.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": -7.32421875,
            "text": "decreased RhoA activation in Mv1",
            "probability": 0.0
        }
    ],
    "515a7ffdd24251bc050000a5_3": [
        {
            "start_logit": 7.734375,
            "end_logit": 8.25,
            "text": "inhibition of cell growth",
            "probability": 1.0
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 8.25,
            "text": "growth",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 7.734375,
            "end_logit": -2.537109375,
            "text": "inhibition",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -3.74609375,
            "end_logit": 8.25,
            "text": "small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.453125,
            "end_logit": 8.25,
            "text": "induction of fibronectin expression and inhibition of cell growth",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.25,
            "text": "fibronectin expression and inhibition of cell growth",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 8.25,
            "text": "cell growth",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.0,
            "end_logit": 8.25,
            "text": "TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.32421875,
            "text": "inhibition of cell growth.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.25,
            "text": "using small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.62109375,
            "text": "inhibition of cell",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.25,
            "text": "of fibronectin expression and inhibition of cell growth",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.7421875,
            "text": "inhibition of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.25,
            "text": "Blockade of km23 using small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.25,
            "text": "and inhibition of cell growth",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.25,
            "text": "interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.25,
            "text": "including induction of fibronectin expression and inhibition of cell growth",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.25,
            "text": "key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.74609375,
            "end_logit": -1.203125,
            "text": "small interfering RNAs significantly decreased key TGFbeta responses, including induction of fibronectin expression",
            "probability": 0.0
        },
        {
            "start_logit": -4.453125,
            "end_logit": -1.203125,
            "text": "induction of fibronectin expression",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_1": [
        {
            "start_logit": 9.6640625,
            "end_logit": 9.6171875,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": 0.81640625,
            "text": "uc",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": 9.6171875,
            "text": "454",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -5.93359375,
            "end_logit": 9.6171875,
            "text": ".454",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.32421875,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.3984375,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.4453125,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.453125,
            "text": "uc.454 Inhibited",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.4921875,
            "text": "uc.454 Inhibited Growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.50390625,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.5625,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.6171875,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.62890625,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.6328125,
            "text": "uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.32421875,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.3984375,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small",
            "probability": 0.0
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.4453125,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell",
            "probability": 0.0
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.453125,
            "text": "454 Inhibited",
            "probability": 0.0
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.4921875,
            "text": "454 Inhibited Growth",
            "probability": 0.0
        },
        {
            "start_logit": -0.365478515625,
            "end_logit": -7.50390625,
            "text": "454 Inhibited Growth by Targeting Heat Shock Protein",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_2": [
        {
            "start_logit": 3.03515625,
            "end_logit": 8.8125,
            "text": "uc",
            "probability": 0.5390625
        },
        {
            "start_logit": 3.03515625,
            "end_logit": 8.5078125,
            "text": "uc.454",
            "probability": 0.400634765625
        },
        {
            "start_logit": 0.1761474609375,
            "end_logit": 8.8125,
            "text": "that uc",
            "probability": 0.0311126708984375
        },
        {
            "start_logit": 0.1761474609375,
            "end_logit": 8.5078125,
            "text": "that uc.454",
            "probability": 0.02294921875
        },
        {
            "start_logit": -1.2353515625,
            "end_logit": 8.5078125,
            "text": "454",
            "probability": 0.005580902099609375
        },
        {
            "start_logit": -4.875,
            "end_logit": 8.8125,
            "text": "found that uc",
            "probability": 0.00019848346710205078
        },
        {
            "start_logit": -4.875,
            "end_logit": 8.5078125,
            "text": "found that uc.454",
            "probability": 0.00014638900756835938
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 8.8125,
            "text": ". We found that uc",
            "probability": 9.018182754516602e-05
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 8.8125,
            "text": "We found that uc",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 8.5078125,
            "text": ". We found that uc.454",
            "probability": 6.651878356933594e-05
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 8.5078125,
            "text": "We found that uc.454",
            "probability": 5.0187110900878906e-05
        },
        {
            "start_logit": -6.265625,
            "end_logit": 8.5078125,
            "text": ".454",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 3.03515625,
            "end_logit": -6.7890625,
            "text": "uc.454 was",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.28125,
            "end_logit": -3.998046875,
            "text": "oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": 0.1761474609375,
            "end_logit": -6.7890625,
            "text": "that uc.454 was",
            "probability": 0.0
        },
        {
            "start_logit": -1.2353515625,
            "end_logit": -6.7890625,
            "text": "454 was",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -6.44921875,
            "text": "oncogenes, or tumor suppressors are",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -6.82421875,
            "text": "oncogenes, or tumor suppressors",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -6.90234375,
            "text": "oncogenes, or tumor suppressors are involved in tumorigenesis and cancer",
            "probability": 0.0
        },
        {
            "start_logit": -5.89453125,
            "end_logit": -3.998046875,
            "text": ". Previous studies showed that T-UCRs serve as novel oncogenes",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_3": [
        {
            "start_logit": 4.703125,
            "end_logit": 9.359375,
            "text": "high expression of uc.339",
            "probability": 0.6708984375
        },
        {
            "start_logit": 4.703125,
            "end_logit": 8.3828125,
            "text": "high expression of uc",
            "probability": 0.252685546875
        },
        {
            "start_logit": 1.990234375,
            "end_logit": 9.359375,
            "text": "uc.339",
            "probability": 0.04461669921875
        },
        {
            "start_logit": 1.990234375,
            "end_logit": 8.3828125,
            "text": "uc",
            "probability": 0.0167999267578125
        },
        {
            "start_logit": 0.71923828125,
            "end_logit": 9.359375,
            "text": "339",
            "probability": 0.012481689453125
        },
        {
            "start_logit": -1.328125,
            "end_logit": 9.359375,
            "text": "expression of uc.339",
            "probability": 0.0016126632690429688
        },
        {
            "start_logit": -1.328125,
            "end_logit": 8.3828125,
            "text": "expression of uc",
            "probability": 0.0006070137023925781
        },
        {
            "start_logit": -5.203125,
            "end_logit": 9.359375,
            "text": ".339",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 9.359375,
            "text": "that high expression of uc.339",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 9.359375,
            "text": ". Here we show that high expression of uc.339",
            "probability": 1.6868114471435547e-05
        },
        {
            "start_logit": -6.078125,
            "end_logit": 9.359375,
            "text": "Here we show that high expression of uc.339",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 8.3828125,
            "text": "that high expression of uc",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 8.3828125,
            "text": ". Here we show that high expression of uc",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.3828125,
            "text": "Here we show that high expression of uc",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 4.703125,
            "end_logit": -5.015625,
            "text": "high",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.703125,
            "end_logit": -5.609375,
            "text": "high expression",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.71923828125,
            "end_logit": -2.607421875,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.71923828125,
            "end_logit": -6.421875,
            "text": "339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53 directly",
            "probability": 0.0
        },
        {
            "start_logit": -1.328125,
            "end_logit": -5.609375,
            "text": "expression",
            "probability": 0.0
        },
        {
            "start_logit": -5.203125,
            "end_logit": -2.607421875,
            "text": ".339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients. We provide evidence from cell lines and primary samples that TP53",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_4": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.6640625,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": 9.6640625,
            "text": "339",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -0.50439453125,
            "text": "uc",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 9.6640625,
            "text": ".339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.6640625,
            "text": "role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 9.6640625,
            "text": "key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.6640625,
            "text": "results support a key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.20703125,
            "text": "uc.339 in lung cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.26953125,
            "text": "uc.339 in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.6640625,
            "text": "Our results support a key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.6640625,
            "text": "for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.515625,
            "text": "uc.339 in lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.51953125,
            "text": "uc.339 in lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -0.50439453125,
            "text": "role for uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.20703125,
            "text": "339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.26953125,
            "text": "339 in",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -0.50439453125,
            "text": "key role for uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.515625,
            "text": "339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.51953125,
            "text": "339 in lung",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -0.50439453125,
            "text": "results support a key role for uc",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_5": [
        {
            "start_logit": 9.5546875,
            "end_logit": 9.703125,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": 0.260986328125,
            "text": "uc",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 0.0997314453125,
            "end_logit": 9.703125,
            "text": "339",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 9.703125,
            "text": "high expression of uc.339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 9.703125,
            "text": ".339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.703125,
            "text": "that high expression of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 9.703125,
            "text": "of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 9.703125,
            "text": "expression of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 9.703125,
            "text": "Here we show that high expression of uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.0078125,
            "text": "uc.339 correlates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.703125,
            "text": "show that high expression of uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.3046875,
            "text": "uc.339 correlates with lower survival",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.36328125,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.55078125,
            "text": "uc.339 correlates with lower survival in 210 non-small cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.5546875,
            "text": "uc.339 correlates with lower survival in 210 non-small",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.6015625,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.6640625,
            "text": "uc.339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 0.260986328125,
            "text": "high expression of uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": 0.260986328125,
            "text": "that high expression of uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 0.260986328125,
            "text": "of uc",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_6": [
        {
            "start_logit": 9.609375,
            "end_logit": 9.71875,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": 1.1474609375,
            "text": "uc",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": 0.1419677734375,
            "end_logit": 9.71875,
            "text": "454",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 9.609375,
            "end_logit": -3.640625,
            "text": "uc.454/HSPA12B",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -5.07421875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 9.71875,
            "text": ".454",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.5546875,
            "text": "uc.454/HSPA12B axis further",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.78125,
            "text": "uc.454/HSPA12B axis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96875,
            "end_logit": 9.71875,
            "text": "The uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.87890625,
            "text": "uc.454/HSPA1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.0234375,
            "text": "uc.454/HSPA12B axis furthers our understanding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.04296875,
            "text": "uc.454/HSPA12B axis furthers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.16796875,
            "text": "uc.454/HSPA12B axis furthers our",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.2578125,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.30078125,
            "text": "uc.454/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.32421875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.34765625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.37890625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.40625,
            "text": "uc.454/HSPA12B axis furthers our understanding of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.4296875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e36a901b5b409ea53000005_7": [
        {
            "start_logit": 9.5390625,
            "end_logit": 9.515625,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.5390625,
            "end_logit": 0.04522705078125,
            "text": "uc",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -0.6845703125,
            "end_logit": 9.515625,
            "text": "454",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 9.515625,
            "text": "that uc.454",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 9.515625,
            "text": ".454",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.40234375,
            "text": "uc.454 played",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.796875,
            "text": "uc.454 played a suppressive role in LC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 9.515625,
            "text": "suggested that uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.83203125,
            "text": "uc.454 played a suppressive role",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.91796875,
            "text": "uc.454 played a suppressive role in LC.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.15625,
            "text": "uc.454 played a suppressive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.515625,
            "text": "results suggested that uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.28125,
            "text": "uc.454 played a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.515625,
            "text": "Above results suggested that uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.3984375,
            "text": "uc.454 played a suppressive role in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 0.04522705078125,
            "text": "that uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 0.04522705078125,
            "text": "suggested that uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.6845703125,
            "end_logit": -6.40234375,
            "text": "454 played",
            "probability": 0.0
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 0.04522705078125,
            "text": "results suggested that uc",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 0.04522705078125,
            "text": "Above results suggested that uc",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_8": [
        {
            "start_logit": 9.609375,
            "end_logit": 9.71875,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": 1.1474609375,
            "text": "uc",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": 0.1419677734375,
            "end_logit": 9.71875,
            "text": "454",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 9.609375,
            "end_logit": -3.640625,
            "text": "uc.454/HSPA12B",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -5.07421875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 9.71875,
            "text": ".454",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.5546875,
            "text": "uc.454/HSPA12B axis further",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.78125,
            "text": "uc.454/HSPA12B axis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96875,
            "end_logit": 9.71875,
            "text": "The uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.87890625,
            "text": "uc.454/HSPA1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.0234375,
            "text": "uc.454/HSPA12B axis furthers our understanding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.04296875,
            "text": "uc.454/HSPA12B axis furthers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.16796875,
            "text": "uc.454/HSPA12B axis furthers our",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.2578125,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.30078125,
            "text": "uc.454/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.32421875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.34765625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.37890625,
            "text": "uc.454/HSPA12B axis furthers our understanding of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.40625,
            "text": "uc.454/HSPA12B axis furthers our understanding of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.4296875,
            "text": "uc.454/HSPA12B axis furthers our understanding of the molecular mechanisms involved in tumor apoptosis, which may potentially serve as a therapeutic target",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e36a901b5b409ea53000005_9": [
        {
            "start_logit": 9.5703125,
            "end_logit": 9.5078125,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": 0.658203125,
            "text": "uc",
            "probability": 0.00014317035675048828
        },
        {
            "start_logit": -0.7041015625,
            "end_logit": 9.5078125,
            "text": "454",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": -5.80859375,
            "end_logit": 9.5078125,
            "text": ".454",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 9.5078125,
            "text": "that uc.454",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.24609375,
            "text": "uc.454 was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.5078125,
            "text": "found that uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.328125,
            "text": "uc.454 was downregulated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.390625,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.40234375,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell lines, and the downregulated uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.5078125,
            "text": "We found that uc.454",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.52734375,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.61328125,
            "text": "uc.454 was downregulated in both non-small",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.625,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.6484375,
            "text": "uc.454 was downregulated in both non-small-cell LC (NSCLC) tissues and LC cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.6796875,
            "text": "uc.454 was downregulated in both non-small-cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 0.658203125,
            "text": "that uc",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 0.658203125,
            "text": "found that uc",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 0.658203125,
            "text": "We found that uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.7041015625,
            "end_logit": -7.24609375,
            "text": "454 was",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_10": [
        {
            "start_logit": 9.6640625,
            "end_logit": 9.640625,
            "text": "uc.454",
            "probability": 1.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": 1.1181640625,
            "text": "uc",
            "probability": 0.0001971721649169922
        },
        {
            "start_logit": -0.2227783203125,
            "end_logit": 9.640625,
            "text": "454",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 9.640625,
            "text": "Transfection with uc.454",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 9.640625,
            "text": ".454",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -6.48828125,
            "text": "uc.454 markedly induced apoptosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 9.640625,
            "text": "with uc.454",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.25390625,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.3046875,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.390625,
            "text": "uc.454 markedly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.4453125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.5,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.52734375,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.546875,
            "text": "uc.454 markedly induced apoptosis and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.5703125,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.58984375,
            "text": "uc.454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 1.1181640625,
            "text": "Transfection with uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 1.1181640625,
            "text": "with uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.2227783203125,
            "end_logit": -6.48828125,
            "text": "454 markedly induced apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -0.2227783203125,
            "end_logit": -7.25390625,
            "text": "454 markedly induced apoptosis and inhibited cell proliferation in SPC-A-1 and NCI-H2170 LC cell lines.",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_11": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.6640625,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": 9.6640625,
            "text": "339",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -0.50439453125,
            "text": "uc",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 9.6640625,
            "text": ".339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.6640625,
            "text": "role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 9.6640625,
            "text": "key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.6640625,
            "text": "results support a key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.20703125,
            "text": "uc.339 in lung cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.26953125,
            "text": "uc.339 in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.6640625,
            "text": "Our results support a key role for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.6640625,
            "text": "for uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.515625,
            "text": "uc.339 in lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.51953125,
            "text": "uc.339 in lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -0.50439453125,
            "text": "role for uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.20703125,
            "text": "339 in lung cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.26953125,
            "text": "339 in",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -0.50439453125,
            "text": "key role for uc",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.515625,
            "text": "339 in lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -0.1136474609375,
            "end_logit": -7.51953125,
            "text": "339 in lung",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -0.50439453125,
            "text": "results support a key role for uc",
            "probability": 0.0
        }
    ],
    "5e36a901b5b409ea53000005_12": [
        {
            "start_logit": 9.5546875,
            "end_logit": 9.703125,
            "text": "uc.339",
            "probability": 1.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": 0.260986328125,
            "text": "uc",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 0.0997314453125,
            "end_logit": 9.703125,
            "text": "339",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 9.703125,
            "text": "high expression of uc.339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 9.703125,
            "text": ".339",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.703125,
            "text": "that high expression of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 9.703125,
            "text": "of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 9.703125,
            "text": "expression of uc.339",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 9.703125,
            "text": "Here we show that high expression of uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.0078125,
            "text": "uc.339 correlates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.703125,
            "text": "show that high expression of uc.339",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.3046875,
            "text": "uc.339 correlates with lower survival",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.36328125,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC) patients.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.55078125,
            "text": "uc.339 correlates with lower survival in 210 non-small cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.5546875,
            "text": "uc.339 correlates with lower survival in 210 non-small",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.6015625,
            "text": "uc.339 correlates with lower survival in 210 non-small cell lung cancer (NSCLC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.6640625,
            "text": "uc.339 correlates with lower survival in",
            "probability": 0.0
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 0.260986328125,
            "text": "high expression of uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": 0.260986328125,
            "text": "that high expression of uc",
            "probability": 0.0
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 0.260986328125,
            "text": "of uc",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_1": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.0078125,
            "text": "Lipid Mini-On",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.69580078125,
            "text": "Lipid",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -1.76953125,
            "end_logit": 9.0078125,
            "text": "On",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 9.0078125,
            "text": "Mini-On",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.94921875,
            "text": "Lipid Mini-On: mining and ontology tool",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.0546875,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic data.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.19140625,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis of lipidomic data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.24609375,
            "text": "Lipid Mini",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.28515625,
            "text": "Lipid Mini-On: mining and ontology",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.3046875,
            "text": "Lipid Mini-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.3671875,
            "text": "Lipid Mini-On: mining and ontology tool for enrichment analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.3984375,
            "text": "Lipid Mini-On: mining and ontology tool for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 9.0078125,
            "text": "-On",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -6.94921875,
            "text": "On: mining and ontology tool",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.0546875,
            "text": "On: mining and ontology tool for enrichment analysis of lipidomic data.",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.19140625,
            "text": "On: mining and ontology tool for enrichment analysis of lipidomic data",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.28515625,
            "text": "On: mining and ontology",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.3671875,
            "text": "On: mining and ontology tool for enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.3984375,
            "text": "On: mining and ontology tool for",
            "probability": 0.0
        },
        {
            "start_logit": -6.1796875,
            "end_logit": -6.94921875,
            "text": "Mini-On: mining and ontology tool",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_2": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.328125,
            "text": "Lipid Mini-On",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -0.79541015625,
            "text": "Lipid",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": 9.328125,
            "text": "On",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 9.328125,
            "text": "Mini-On",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.02734375,
            "text": "Lipid Mini-On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data. Lipid Mini-On",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.05078125,
            "text": "Lipid Mini-On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.05078125,
            "text": "Lipid Mini-On, an open-source",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.328125,
            "text": "introduce Lipid Mini-On",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.11328125,
            "text": "Lipid Mini-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.11328125,
            "text": "Lipid Mini-On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.328125,
            "text": "Here we introduce Lipid Mini-On",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.328125,
            "text": "-On",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -0.79541015625,
            "text": "introduce Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -6.96484375,
            "text": "On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data. Lipid Mini-On uses a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -0.79541015625,
            "text": "Here we introduce Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -7.02734375,
            "text": "On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data. Lipid Mini-On",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -7.05078125,
            "text": "On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -7.05078125,
            "text": "On, an open-source",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -7.09765625,
            "text": "On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data. Lipid Mini-On uses a text-mining process",
            "probability": 0.0
        },
        {
            "start_logit": -1.0634765625,
            "end_logit": -7.11328125,
            "text": "On, an open-source tool that performs lipid enrichment analyses and visualizations of lipidomics data.",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_3": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.1484375,
            "text": "lipidr",
            "probability": 1.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": 9.1484375,
            "text": "r",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.673828125,
            "text": "lipid",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.265625,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.26953125,
            "text": "lipidr: A Software Tool",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.2890625,
            "text": "lipidr: A Software Tool for Data Mining",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.3125,
            "text": "lipidr: A Software Tool for Data Mining and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.32421875,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics Datasets",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.40234375,
            "text": "lipidr: A Software Tool for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.40625,
            "text": "lipidr: A Software Tool for Data Mining and Analysis of Lipidomics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.41015625,
            "text": "lipidr: A Software Tool for Data Mining and Analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.265625,
            "text": "r: A Software Tool for Data Mining and Analysis of Lipidomics Datasets.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.26953125,
            "text": "r: A Software Tool",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.2890625,
            "text": "r: A Software Tool for Data Mining",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.3125,
            "text": "r: A Software Tool for Data Mining and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.32421875,
            "text": "r: A Software Tool for Data Mining and Analysis of Lipidomics Datasets",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.40234375,
            "text": "r: A Software Tool for",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.40625,
            "text": "r: A Software Tool for Data Mining and Analysis of Lipidomics",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -7.41015625,
            "text": "r: A Software Tool for Data Mining and Analysis",
            "probability": 0.0
        },
        {
            "start_logit": -7.17578125,
            "end_logit": -7.265625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_4": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.109375,
            "text": "lipidr",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.435546875,
            "text": "lipid",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -1.59765625,
            "end_logit": 9.109375,
            "text": "r",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 9.109375,
            "text": "developed lipidr",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.66796875,
            "text": "lipidr, an open-source R/Bioconductor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.06640625,
            "text": "lipidr, an open-source",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.109375,
            "text": "need, we developed lipidr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.31640625,
            "text": "lipidr, an open-source R/Bioconductor package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -1.435546875,
            "text": "developed lipid",
            "probability": 0.0
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -6.66796875,
            "text": "r, an open-source R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -1.435546875,
            "text": "need, we developed lipid",
            "probability": 0.0
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.06640625,
            "text": "r, an open-source",
            "probability": 0.0
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.31640625,
            "text": "r, an open-source R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -6.23046875,
            "end_logit": -6.31640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -6.66796875,
            "text": "developed lipidr, an open-source R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -7.06640625,
            "text": "developed lipidr, an open-source",
            "probability": 0.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -7.31640625,
            "text": "developed lipidr, an open-source R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -7.109375,
            "end_logit": -6.31640625,
            "text": "ease of use and innovative features of lipidr will allow the lipidomics research community to gain novel detailed insights from lipidomics data.",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -6.31640625,
            "text": "innovative features of lipidr will allow the lipidomics research community to gain novel detailed insights from lipidomics data.",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -6.31640625,
            "text": "that the ease of use and innovative features of lipidr will allow the lipidomics research community to gain novel detailed insights from lipidomics data.",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_5": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.25,
            "text": "LipidMS",
            "probability": 1.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": 9.25,
            "text": "MS",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.46484375,
            "text": "Lipid",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.21484375,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.28515625,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.3125,
            "text": "LipidMS: An R Package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.3828125,
            "text": "LipidMS: An R Package for Lipid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.44921875,
            "text": "LipidMS: An R Package for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4765625,
            "text": "LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4921875,
            "text": "LipidMS: An R",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.49609375,
            "text": "LipidMS:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.53125,
            "text": "LipidMS: An R Package for Lipid Annotation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.21484375,
            "text": "MS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.28515625,
            "text": "MS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.3125,
            "text": "MS: An R Package",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.3828125,
            "text": "MS: An R Package for Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.44921875,
            "text": "MS: An R Package for",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.4765625,
            "text": "MS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.4921875,
            "text": "MS: An R",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -7.49609375,
            "text": "MS:",
            "probability": 0.0
        }
    ],
    "6060838e94d57fd879000042_6": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.421875,
            "text": "LipidMS",
            "probability": 1.0
        },
        {
            "start_logit": -0.93701171875,
            "end_logit": 9.421875,
            "text": "MS",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.4462890625,
            "text": "Lipid",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.421875,
            "text": ". Here, we present LipidMS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.1015625,
            "text": "LipidMS, an R package aimed to confidently identify lipid species in untargeted LC-DIA-MS.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.421875,
            "text": "present LipidMS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.421875,
            "text": "with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.421875,
            "text": "precursor and the product ions combined with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present LipidMS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.41796875,
            "text": "LipidMS, an R package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.93701171875,
            "end_logit": -7.1015625,
            "text": "MS, an R package aimed to confidently identify lipid species in untargeted LC-DIA-MS.",
            "probability": 0.0
        },
        {
            "start_logit": -0.93701171875,
            "end_logit": -7.41796875,
            "text": "MS, an R package",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -1.4462890625,
            "text": ". Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -1.4462890625,
            "text": "present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -1.4462890625,
            "text": "with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -1.4462890625,
            "text": "precursor and the product ions combined with the high dimensionality of DIA data sets hinder accurate feature annotation. Here, we present Lipid",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": -7.0859375,
            "text": ". However, the loss of the link between the precursor and the product ions combined with the high dimensionality of DIA data sets",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.1015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": -7.10546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": -7.125,
            "text": ". However, the loss of the link between the precursor and the product ions combined with the high dimensionality of DIA data sets hinder accurate feature annotation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.1015625,
            "text": ". Here, we present LipidMS, an R package aimed to confidently identify lipid species in untargeted LC-DIA-MS.",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_1": [
        {
            "start_logit": 9.1875,
            "end_logit": 8.9140625,
            "text": "HDAC4",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.3486328125,
            "text": "HDAC",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -2.150390625,
            "end_logit": 8.9140625,
            "text": "4",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -4.296875,
            "text": "HDAC4 and",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.1875,
            "end_logit": -5.2890625,
            "text": "HDAC4 and HDAC5",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.5625,
            "end_logit": 8.9140625,
            "text": ", HDAC4",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.00390625,
            "text": "HDAC4 and HDAC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.9140625,
            "text": "PTHrP targets salt-inducible kinases, HDAC4",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.3671875,
            "text": "HDAC4 and HDAC5,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.9140625,
            "text": "kinases, HDAC4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.9140625,
            "text": "-inducible kinases, HDAC4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.9140625,
            "text": "inducible kinases, HDAC4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.150390625,
            "end_logit": -4.296875,
            "text": "4 and",
            "probability": 0.0
        },
        {
            "start_logit": -2.150390625,
            "end_logit": -5.2890625,
            "text": "4 and HDAC5",
            "probability": 0.0
        },
        {
            "start_logit": -6.5625,
            "end_logit": -1.3486328125,
            "text": ", HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -1.3486328125,
            "text": "PTHrP targets salt-inducible kinases, HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -1.3486328125,
            "text": "kinases, HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.3486328125,
            "text": "-inducible kinases, HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.765625,
            "end_logit": -1.3486328125,
            "text": "inducible kinases, HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -2.150390625,
            "end_logit": -7.00390625,
            "text": "4 and HDAC",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_2": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.078125,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.240234375,
            "text": "SI",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": -1.76171875,
            "end_logit": 9.078125,
            "text": "K1",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -1.994140625,
            "end_logit": 9.078125,
            "text": "AMPK family kinases. SIK1",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 9.078125,
            "text": "subfamily of AMPK family kinases. SIK1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.64453125,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.671875,
            "text": "SIK1 has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.84375,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 9.078125,
            "text": "kinases. SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 9.078125,
            "text": ". SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.9765625,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.01953125,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.0234375,
            "text": "SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SIK2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.078125,
            "text": "of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.078125,
            "text": "kinases (SIKs) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.078125,
            "text": "a subfamily of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.078125,
            "text": "Ks) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.078125,
            "text": "family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.078125,
            "text": "represent a subfamily of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.078125,
            "text": "SIKs) represent a subfamily of AMPK family kinases. SIK1",
            "probability": 5.960464477539063e-08
        }
    ],
    "621b806c3a8413c653000040_3": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.2578125,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": -1.3857421875,
            "end_logit": 9.2578125,
            "text": "K1",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.5556640625,
            "text": "SI",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -4.75,
            "text": "SIK1)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.34765625,
            "end_logit": 9.2578125,
            "text": "Type 1 salt-inducible kinases (SIK1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 9.2578125,
            "text": "(SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.55078125,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 9.2578125,
            "text": "kinases (SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0859375,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.15234375,
            "text": "SIK1) has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.29296875,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.3203125,
            "text": "SIK1) has been shown to act as a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.2578125,
            "text": "salt-inducible kinases (SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.3359375,
            "text": "SIK1) has been shown to act",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.34375,
            "text": "SIK1) has been shown to act as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.2578125,
            "text": "inducible kinases (SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.37109375,
            "text": "SIK1) has been shown to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.2578125,
            "text": "1 salt-inducible kinases (SIK1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.4140625,
            "text": "SIK1) has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. Type 2 SI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3857421875,
            "end_logit": -4.75,
            "text": "K1)",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_4": [
        {
            "start_logit": 8.9765625,
            "end_logit": 9.328125,
            "text": "SIK1",
            "probability": 1.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": 9.328125,
            "text": "K1",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -1.8828125,
            "text": "SI",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.359375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.328125,
            "text": ", SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.5859375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.328125,
            "text": "kinases, SIK1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.0234375,
            "text": "SIK1, SIK2 and SIK3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.328125,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.375,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.453125,
            "text": "SIK1, SIK2 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.47265625,
            "text": "SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.49609375,
            "text": "SIK1, SIK2 and SIK3,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -6.359375,
            "text": "K1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK",
            "probability": 0.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -6.5859375,
            "text": "K1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK)",
            "probability": 0.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -7.0234375,
            "text": "K1, SIK2 and SIK3",
            "probability": 0.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -7.328125,
            "text": "K1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase",
            "probability": 0.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -7.375,
            "text": "K1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (",
            "probability": 0.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -1.8828125,
            "text": ", SI",
            "probability": 0.0
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": -7.453125,
            "text": "K1, SIK2 and",
            "probability": 0.0
        }
    ],
    "621b806c3a8413c653000040_5": [
        {
            "start_logit": 7.74609375,
            "end_logit": 6.1484375,
            "text": "SIK2",
            "probability": 1.0
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -2.2734375,
            "text": "SIK2 and SIK3",
            "probability": 0.0002200603485107422
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -3.33984375,
            "text": "SIK2 and",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -3.70703125,
            "text": "SI",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -5.2890625,
            "text": "SIK2 and SIK3)",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -5.8984375,
            "text": "SIK2 and SIK3) by Na+ stress",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 6.1484375,
            "text": "K2",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.109375,
            "text": "SIK2 and SI",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.2890625,
            "text": "SIK2 and SIK3) by Na",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.34765625,
            "text": "SIK2 and SIK3) by",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 6.1484375,
            "text": "SIKs; SIK2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.421875,
            "end_logit": 6.1484375,
            "text": "; SIK2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 6.1484375,
            "text": "salt-inducible kinases (SIKs; SIK2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 6.1484375,
            "text": "activation of the salt-inducible kinases (SIKs; SIK2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 6.1484375,
            "text": "Ks; SIK2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 6.1484375,
            "text": "kinases (SIKs; SIK2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.1484375,
            "text": "(SIKs; SIK2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.1484375,
            "text": "inducible kinases (SIKs; SIK2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.1484375,
            "text": "the activation of the salt-inducible kinases (SIKs; SIK2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.1484375,
            "text": "the salt-inducible kinases (SIKs; SIK2",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292e661cb411341a000112_1": [
        {
            "start_logit": 6.08984375,
            "end_logit": 5.2578125,
            "text": "duodenum",
            "probability": 0.5400390625
        },
        {
            "start_logit": 4.98046875,
            "end_logit": 5.71484375,
            "text": "pancreatic duct",
            "probability": 0.2822265625
        },
        {
            "start_logit": 4.98046875,
            "end_logit": 5.2578125,
            "text": "pancreatic duct and the duodenum",
            "probability": 0.1781005859375
        },
        {
            "start_logit": -4.546875,
            "end_logit": 5.71484375,
            "text": "duct",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 5.71484375,
            "text": "bile duct, the pancreatic duct",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -4.546875,
            "end_logit": 5.2578125,
            "text": "duct and the duodenum",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 5.2578125,
            "text": "bile duct, the pancreatic duct and the duodenum",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -5.41015625,
            "text": "pancreatic",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.71484375,
            "text": ", the pancreatic duct",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.08984375,
            "end_logit": -7.25,
            "text": "duodenum.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.2578125,
            "text": ", the pancreatic duct and the duodenum",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 5.71484375,
            "text": "the pancreatic duct",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 5.71484375,
            "text": "confluence of the bile duct, the pancreatic duct",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 5.71484375,
            "text": "dynamic structure located strategically at the confluence of the bile duct, the pancreatic duct",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 5.71484375,
            "text": "structure located strategically at the confluence of the bile duct, the pancreatic duct",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 5.2578125,
            "text": "the pancreatic duct and the duodenum",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 5.2578125,
            "text": "the duodenum",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 5.2578125,
            "text": "confluence of the bile duct, the pancreatic duct and the duodenum",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 5.2578125,
            "text": "dynamic structure located strategically at the confluence of the bile duct, the pancreatic duct and the duodenum",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 5.2578125,
            "text": "and the duodenum",
            "probability": 7.748603820800781e-07
        }
    ],
    "60292e661cb411341a000112_2": [
        {
            "start_logit": 8.296875,
            "end_logit": 6.91796875,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -3.900390625,
            "end_logit": 6.91796875,
            "text": "biliary tract and pancreas",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.77734375,
            "text": "pancreas are",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.24609375,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.3671875,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (SO)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4453125,
            "text": "pancreas are associated with disordered motility of the",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4453125,
            "text": "pancreas are associated with disordered motility",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.47265625,
            "text": "pancreas are associated with disordered motility of the sphincter of Oddi (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.484375,
            "text": "pancreas are associated with disordered motility of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.5,
            "text": "pancreas are associated with disordered motility of the sphincter",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.50390625,
            "text": "pancreas are associated with disordered motility of the sphincter of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.53515625,
            "text": "pancreas are associated with disordered",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 6.91796875,
            "text": "tract and pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.91796875,
            "text": "and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.91796875,
            "text": "of the biliary tract and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.91796875,
            "text": "most common functional disorders of the biliary tract and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.91796875,
            "text": "the biliary tract and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.900390625,
            "end_logit": -3.298828125,
            "text": "biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -6.75,
            "end_logit": -3.298828125,
            "text": "tract",
            "probability": 0.0
        },
        {
            "start_logit": -3.900390625,
            "end_logit": -6.77734375,
            "text": "biliary tract and pancreas are",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_3": [
        {
            "start_logit": 8.4296875,
            "end_logit": 7.05078125,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.86328125,
            "text": "duodenum and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.21875,
            "text": "duodenum and the sphincter of Oddi (SO",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.34765625,
            "text": "duodenum and the sphincter of Oddi (SO)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.4296875,
            "text": "duodenum and the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.59765625,
            "text": "duodenum and the sphincter of Oddi (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.6171875,
            "text": "duodenum and the sphincter of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.63671875,
            "text": "duodenum and the sphincter of Oddi (SO). St",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.05078125,
            "text": "neural connections between the duodenum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.05078125,
            "text": "existence of neural connections between the duodenum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.05078125,
            "text": "the duodenum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.86328125,
            "text": "neural connections between the duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.86328125,
            "text": "existence of neural connections between the duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.86328125,
            "text": "the duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.04296875,
            "text": "neural connections",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.04296875,
            "text": "existence of neural connections",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.21875,
            "text": "neural connections between the duodenum and the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.21875,
            "text": "existence of neural connections between the duodenum and the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.21875,
            "text": "the duodenum and the sphincter of Oddi (SO",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.21875,
            "text": "SO",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_4": [
        {
            "start_logit": 8.3359375,
            "end_logit": 9.234375,
            "text": "common bile duct",
            "probability": 1.0
        },
        {
            "start_logit": -1.25,
            "end_logit": 9.234375,
            "text": "duct",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -2.48046875,
            "end_logit": 9.234375,
            "text": "bile duct",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -2.587890625,
            "text": "common",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 9.234375,
            "text": "duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 9.234375,
            "text": "and areas close to the common bile duct",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 9.234375,
            "text": "and the effects of field stimulation were studied separately on areas close to the duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.234375,
            "text": "area I) and areas close to the common bile duct",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 9.234375,
            "text": "effects of field stimulation were studied separately on areas close to the duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.234375,
            "text": "field stimulation were studied separately on areas close to the duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.234375,
            "text": "on areas close to the duodenal papilla (area I) and areas close to the common bile duct",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.5234375,
            "text": "common bile duct (area II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.8125,
            "text": "common bile duct (area",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -7.01953125,
            "text": "common bile duct (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -7.0703125,
            "text": "common bile duct (area II)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.25,
            "end_logit": -6.5234375,
            "text": "duct (area II",
            "probability": 0.0
        },
        {
            "start_logit": -1.25,
            "end_logit": -6.8125,
            "text": "duct (area",
            "probability": 0.0
        },
        {
            "start_logit": -1.25,
            "end_logit": -7.01953125,
            "text": "duct (",
            "probability": 0.0
        },
        {
            "start_logit": -1.25,
            "end_logit": -7.0703125,
            "text": "duct (area II)",
            "probability": 0.0
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -2.587890625,
            "text": "duodenal papilla (area I) and areas close to the common",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_5": [
        {
            "start_logit": 8.15625,
            "end_logit": 7.30078125,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.87890625,
            "text": "duodenum but were rare in the duodenum",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 7.30078125,
            "text": "gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 7.30078125,
            "text": "proximal duodenum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.37109375,
            "text": "duodenum but were rare in the duodenum distal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.45703125,
            "text": "duodenum but were rare in the duodenum distal to",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.48828125,
            "text": "duodenum but were rare in the duodenum distal to the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.52734375,
            "text": "duodenum but were rare in the duodenum distal to the sphincter",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.53125,
            "text": "duodenum but were rare in the duodenum distal to the sphincter of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.58203125,
            "text": "duodenum but were rare in the duodenum distal to the sphincter of Odd",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.59375,
            "text": "duodenum but were",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.30078125,
            "text": "myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.30078125,
            "text": ", labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.30078125,
            "text": "after gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.30078125,
            "text": "to 3 weeks after gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.30078125,
            "text": "weeks after gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.30078125,
            "text": "LTS: Two to 3 weeks after gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.30078125,
            "text": ": Two to 3 weeks after gallbladder injection, labeled nerve cell bodies were found in the myenteric plexus of the proximal duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.30078125,
            "text": "found in the myenteric plexus of the proximal duodenum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.30078125,
            "text": "in the myenteric plexus of the proximal duodenum",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292e661cb411341a000112_6": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.42578125,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": -4.35546875,
            "end_logit": 7.42578125,
            "text": "bile duct and the duodenum",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.42578125,
            "text": "smooth muscle connection between the bile duct and the duodenum",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 7.42578125,
            "text": "the duodenum",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.25390625,
            "text": "duodenum.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.42578125,
            "text": "and the duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.42578125,
            "text": "connection between the bile duct and the duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.42578125,
            "text": "i is the smooth muscle connection between the bile duct and the duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.42578125,
            "text": "is the smooth muscle connection between the bile duct and the duodenum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -3.626953125,
            "text": "bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -3.626953125,
            "text": "smooth muscle connection between the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -6.6484375,
            "text": "bile duct and",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -3.626953125,
            "text": "connection between the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -3.626953125,
            "text": "i is the smooth muscle connection between the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -3.626953125,
            "text": "is the smooth muscle connection between the bile duct",
            "probability": 0.0
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -7.25390625,
            "text": "bile duct and the duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -7.26171875,
            "text": "bile",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -6.6484375,
            "text": "smooth muscle connection between the bile duct and",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -7.19140625,
            "text": "smooth muscle",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -7.21875,
            "text": "smooth muscle connection",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_7": [
        {
            "start_logit": 7.59765625,
            "end_logit": 6.55859375,
            "text": "duodenum",
            "probability": 1.0
        },
        {
            "start_logit": -0.477294921875,
            "end_logit": 6.55859375,
            "text": "pancreatic duct, and duodenum",
            "probability": 0.0003101825714111328
        },
        {
            "start_logit": -4.46875,
            "end_logit": 6.55859375,
            "text": "bile duct, pancreatic duct, and duodenum",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -5.77734375,
            "end_logit": 6.55859375,
            "text": "and duodenum",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.234375,
            "text": "duodenum.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 6.55859375,
            "text": "junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 6.55859375,
            "text": "small smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 6.55859375,
            "text": "smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 6.55859375,
            "text": "duct, and duodenum",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.55859375,
            "text": ", pancreatic duct, and duodenum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.55859375,
            "text": "of the bile duct, pancreatic duct, and duodenum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.55859375,
            "text": "is a small smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.55859375,
            "text": "i is a small smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct, and duodenum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.55859375,
            "text": "the bile duct, pancreatic duct, and duodenum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.477294921875,
            "end_logit": -0.67578125,
            "text": "pancreatic duct",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.46875,
            "end_logit": -0.67578125,
            "text": "bile duct, pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -6.93359375,
            "end_logit": -0.67578125,
            "text": "junction of the bile duct, pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -0.67578125,
            "text": "small smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct",
            "probability": 0.0
        },
        {
            "start_logit": -0.477294921875,
            "end_logit": -7.234375,
            "text": "pancreatic duct, and duodenum.",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -0.67578125,
            "text": "smooth muscle sphincter strategically placed at the junction of the bile duct, pancreatic duct",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_8": [
        {
            "start_logit": 8.1640625,
            "end_logit": 7.37890625,
            "text": "stomach",
            "probability": 1.0
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -3.984375,
            "text": "stomach, duodenum",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -5.61328125,
            "text": "stomach, duodenum and gall-bladder",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.21484375,
            "text": "stomach, duodenum and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.30859375,
            "text": "stomach, duodenum and gall-bladder.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 7.37890625,
            "text": "the stomach",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.37890625,
            "text": "to the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.37890625,
            "text": "The relationship of the sphincter of Oddi to the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.37890625,
            "text": "relationship of the sphincter of Oddi to the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.3671875,
            "end_logit": -3.984375,
            "text": "duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -3.984375,
            "text": ", duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -5.3671875,
            "end_logit": -5.61328125,
            "text": "duodenum and gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -3.984375,
            "text": "the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -3.984375,
            "text": "to the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -3.984375,
            "text": "The relationship of the sphincter of Oddi to the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -3.984375,
            "text": "relationship of the sphincter of Oddi to the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -6.14453125,
            "end_logit": -5.61328125,
            "text": "gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.3671875,
            "end_logit": -7.21484375,
            "text": "duodenum and",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -5.61328125,
            "text": ", duodenum and gall-bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.3671875,
            "end_logit": -7.30859375,
            "text": "duodenum and gall-bladder.",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_9": [
        {
            "start_logit": 8.0078125,
            "end_logit": 7.55859375,
            "text": "stomach",
            "probability": 1.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -4.59375,
            "text": "stomach, duodenum",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.5234375,
            "text": "stomach, duodenum, or upper small bowel",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.3359375,
            "text": "stomach, duodenum, or",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.34765625,
            "text": "stomach, duodenum, or upper small bowel influences the tone of the sphincter of Oddi.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.515625,
            "text": "stomach, duodenum, or upper small bowel influences",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.52734375,
            "text": "stomach, duodenum, or upper small bowel influences the tone",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.59375,
            "text": "stomach, duodenum,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.609375,
            "text": "stomach, duodenum, or upper small bowel influences the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.61328125,
            "text": "stomach, duodenum, or upper small",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.6171875,
            "text": "stomach, duodenum, or upper small bowel influences the tone of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.625,
            "text": "stomach, duodenum, or upper small bowel influences the tone of the sphincter of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.55859375,
            "text": "the stomach",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.55859375,
            "text": "of the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.55859375,
            "text": "Mechanical or electrical stimulation of the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.046875,
            "end_logit": -4.59375,
            "text": "duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -4.59375,
            "text": ", duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -4.59375,
            "text": "the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -4.59375,
            "text": "of the stomach, duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -4.59375,
            "text": "Mechanical or electrical stimulation of the stomach, duodenum",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_10": [
        {
            "start_logit": 8.3046875,
            "end_logit": 6.8828125,
            "text": "stomach",
            "probability": 1.0
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -1.48046875,
            "text": "stomach, descending duodenum",
            "probability": 0.00023424625396728516
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -4.54296875,
            "text": "stomach, descending duodenum, gallbladder",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.3046875,
            "text": "stomach, descending duodenum, gallbladder and sphincter of Oddi.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.41015625,
            "text": "stomach, descending duodenum, gallbladder and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.5234375,
            "text": "stomach, descending duodenum, gallbladder and sphincter",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.52734375,
            "text": "stomach, descending duodenum, gallbladder and sphincter of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 6.8828125,
            "text": "celiac branches of the vagus nerve modulate the interdigestive motor activity in the stomach",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 6.8828125,
            "text": "the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.8828125,
            "text": "vagus nerve modulate the interdigestive motor activity in the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.8828125,
            "text": "results imply that celiac branches of the vagus nerve modulate the interdigestive motor activity in the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.8828125,
            "text": "interdigestive motor activity in the stomach",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.8828125,
            "text": "in the stomach",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.8828125,
            "text": "that celiac branches of the vagus nerve modulate the interdigestive motor activity in the stomach",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.8828125,
            "text": "The results imply that celiac branches of the vagus nerve modulate the interdigestive motor activity in the stomach",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -1.48046875,
            "text": "duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -4.54296875,
            "text": "duodenum, gallbladder",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": -1.48046875,
            "text": "descending duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -6.85546875,
            "end_logit": -1.48046875,
            "text": "celiac branches of the vagus nerve modulate the interdigestive motor activity in the stomach, descending duodenum",
            "probability": 0.0
        },
        {
            "start_logit": -7.125,
            "end_logit": -1.48046875,
            "text": "the stomach, descending duodenum",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_11": [
        {
            "start_logit": 3.724609375,
            "end_logit": 4.83984375,
            "text": "pancreatic duct",
            "probability": 0.92236328125
        },
        {
            "start_logit": 3.724609375,
            "end_logit": 2.1640625,
            "text": "pancreatic duct with the duodenum",
            "probability": 0.06378173828125
        },
        {
            "start_logit": 2.0625,
            "end_logit": 2.1640625,
            "text": "duodenum",
            "probability": 0.01207733154296875
        },
        {
            "start_logit": -2.806640625,
            "end_logit": 4.83984375,
            "text": "bile duct and pancreatic duct",
            "probability": 0.0013446807861328125
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 4.83984375,
            "text": "duct",
            "probability": 0.0001289844512939453
        },
        {
            "start_logit": -2.806640625,
            "end_logit": 2.1640625,
            "text": "bile duct and pancreatic duct with the duodenum",
            "probability": 9.292364120483398e-05
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 4.83984375,
            "text": "junction of the bile duct and pancreatic duct",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 4.83984375,
            "text": "small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct",
            "probability": 2.205371856689453e-05
        },
        {
            "start_logit": 3.724609375,
            "end_logit": -6.13671875,
            "text": "pancreatic",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 4.83984375,
            "text": "and pancreatic duct",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 4.83984375,
            "text": "the bile duct and pancreatic duct",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 4.83984375,
            "text": "of the bile duct and pancreatic duct",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 4.83984375,
            "text": "is a small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 4.83984375,
            "text": "i is a small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct",
            "probability": 1.0848045349121094e-05
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 4.83984375,
            "text": "which is strategically placed at the junction of the bile duct and pancreatic duct",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 2.1640625,
            "text": "duct with the duodenum",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 3.724609375,
            "end_logit": -7.19140625,
            "text": "pancreatic duct with the duodenum.",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 2.1640625,
            "text": "junction of the bile duct and pancreatic duct with the duodenum",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 2.1640625,
            "text": "with the duodenum",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 2.1640625,
            "text": "small sphincter which is strategically placed at the junction of the bile duct and pancreatic duct with the duodenum",
            "probability": 1.5497207641601562e-06
        }
    ],
    "60292e661cb411341a000112_12": [
        {
            "start_logit": 6.01171875,
            "end_logit": 3.84765625,
            "text": "duodenum",
            "probability": 0.9921875
        },
        {
            "start_logit": 1.09375,
            "end_logit": 3.84765625,
            "text": "pancreatic juice into the duodenum",
            "probability": 0.00725555419921875
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -6.31640625,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -6.56640625,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal systems.",
            "probability": 2.9742717742919922e-05
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -6.91015625,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal systems",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -7.0390625,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -7.26171875,
            "text": "duodenum, and equally importantly helps prevent the reflux of duodenal contents into",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -7.3359375,
            "text": "duodenum, and equally importantly helps",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -5.6171875,
            "end_logit": 3.84765625,
            "text": "that the sphincter has a major role in the control of flow of bile and pancreatic juice into the duodenum",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 1.09375,
            "end_logit": -3.83203125,
            "text": "pancreatic",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 3.84765625,
            "text": "control of flow of bile and pancreatic juice into the duodenum",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 3.84765625,
            "text": "sphincter has a major role in the control of flow of bile and pancreatic juice into the duodenum",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 3.84765625,
            "text": "bile and pancreatic juice into the duodenum",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 3.84765625,
            "text": "description that the sphincter has a major role in the control of flow of bile and pancreatic juice into the duodenum",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 3.84765625,
            "text": "into the duodenum",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 3.84765625,
            "text": "flow of bile and pancreatic juice into the duodenum",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 3.84765625,
            "text": "the duodenum",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 1.09375,
            "end_logit": -5.3515625,
            "text": "pancreatic juice",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 1.09375,
            "end_logit": -6.31640625,
            "text": "pancreatic juice into the duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.09375,
            "end_logit": -6.56640625,
            "text": "pancreatic juice into the duodenum, and equally importantly helps prevent the reflux of duodenal contents into the biliary and pancreatic ductal systems.",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292e661cb411341a000112_13": [
        {
            "start_logit": 6.6171875,
            "end_logit": 5.2109375,
            "text": "duodenum",
            "probability": 0.998046875
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": 5.2109375,
            "text": "common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 0.001712799072265625
        },
        {
            "start_logit": -5.20703125,
            "end_logit": 5.2109375,
            "text": "pancreatic duct, and the duodenum",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.31640625,
            "text": "duodenum.",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -5.921875,
            "end_logit": 5.2109375,
            "text": "bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": -1.060546875,
            "text": "common bile duct",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 5.2109375,
            "text": "junction of the common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 5.2109375,
            "text": "CBD), main pancreatic duct, and the duodenum",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 5.2109375,
            "text": "duct, and the duodenum",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 5.2109375,
            "text": "the duodenum",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 5.2109375,
            "text": "main pancreatic duct, and the duodenum",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 5.2109375,
            "text": "and the duodenum",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 5.2109375,
            "text": "duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 5.2109375,
            "text": "the common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 5.2109375,
            "text": "of the common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 5.2109375,
            "text": "at the junction of the common bile duct (CBD), main pancreatic duct, and the duodenum",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": -4.6328125,
            "text": "common bile duct (CBD), main pancreatic duct",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": -5.38671875,
            "text": "common bile duct (CBD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": -5.65625,
            "text": "common bile duct (CBD)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.25146484375,
            "end_logit": -6.84375,
            "text": "common bile duct (",
            "probability": 0.0
        }
    ],
    "60292e661cb411341a000112_14": [
        {
            "start_logit": 6.08984375,
            "end_logit": 5.2578125,
            "text": "duodenum",
            "probability": 0.5400390625
        },
        {
            "start_logit": 4.98046875,
            "end_logit": 5.71484375,
            "text": "pancreatic duct",
            "probability": 0.2822265625
        },
        {
            "start_logit": 4.98046875,
            "end_logit": 5.2578125,
            "text": "pancreatic duct and the duodenum",
            "probability": 0.1781005859375
        },
        {
            "start_logit": -4.546875,
            "end_logit": 5.71484375,
            "text": "duct",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 5.71484375,
            "text": "bile duct, the pancreatic duct",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -4.546875,
            "end_logit": 5.2578125,
            "text": "duct and the duodenum",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 5.2578125,
            "text": "bile duct, the pancreatic duct and the duodenum",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -5.41015625,
            "text": "pancreatic",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.71484375,
            "text": ", the pancreatic duct",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.08984375,
            "end_logit": -7.25,
            "text": "duodenum.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.2578125,
            "text": ", the pancreatic duct and the duodenum",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 5.71484375,
            "text": "the pancreatic duct",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 5.71484375,
            "text": "confluence of the bile duct, the pancreatic duct",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 5.71484375,
            "text": "dynamic structure located strategically at the confluence of the bile duct, the pancreatic duct",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 5.71484375,
            "text": "structure located strategically at the confluence of the bile duct, the pancreatic duct",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 5.2578125,
            "text": "the pancreatic duct and the duodenum",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 5.2578125,
            "text": "the duodenum",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 5.2578125,
            "text": "confluence of the bile duct, the pancreatic duct and the duodenum",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 5.2578125,
            "text": "dynamic structure located strategically at the confluence of the bile duct, the pancreatic duct and the duodenum",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 5.2578125,
            "text": "and the duodenum",
            "probability": 7.748603820800781e-07
        }
    ],
    "60292e661cb411341a000112_15": [
        {
            "start_logit": 8.109375,
            "end_logit": 7.41015625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 7.41015625,
            "text": "biliary tract and pancreas",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.03125,
            "text": "pancreas relates",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.30859375,
            "text": "pancreas relates to the activity of the Sphincter of Oddi.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.40234375,
            "text": "pancreas relates to the activity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.40234375,
            "text": "pancreas relates to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.44921875,
            "text": "pancreas relates to the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.4609375,
            "text": "pancreas relates to the activity of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.4765625,
            "text": "pancreas relates to the activity of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 7.41015625,
            "text": "tract and pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.41015625,
            "text": "of the biliary tract and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.41015625,
            "text": "functional disorder of the biliary tract and pancreas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -5.5703125,
            "text": "biliary tract",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -5.5703125,
            "text": "tract",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.03125,
            "text": "biliary tract and pancreas relates",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.1171875,
            "text": "biliary",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.296875,
            "text": "biliary tract and",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.30859375,
            "text": "biliary tract and pancreas relates to the activity of the Sphincter of Oddi.",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.40234375,
            "text": "biliary tract and pancreas relates to the activity",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.40234375,
            "text": "biliary tract and pancreas relates to",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_1": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.2578125,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": 9.2578125,
            "text": "faecium",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.4287109375,
            "text": "Enterococcus",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.70703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 9.2578125,
            "text": "whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.2578125,
            "text": "antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.18359375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.2578125,
            "text": "of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.2578125,
            "text": "test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.2578125,
            "text": "clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.2578125,
            "text": "study was to test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.2578125,
            "text": "aim of this study was to test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.2578125,
            "text": "The aim of this study was to test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.2578125,
            "text": "this study was to test in the clinic whether antimicrobial diversity affects resistance of Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.5,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.5390625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens in ventilator-associated pneumonia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.55859375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.58203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens in ventilator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.58203125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.6171875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        }
    ],
    "56d2ac03f22319765a000004_2": [
        {
            "start_logit": 9.4296875,
            "end_logit": 9.4296875,
            "text": "Klebsiella pneumoniae",
            "probability": 0.9970703125
        },
        {
            "start_logit": 3.427734375,
            "end_logit": 9.4296875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.002471923828125
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -0.53466796875,
            "text": "Klebsiella",
            "probability": 4.7087669372558594e-05
        },
        {
            "start_logit": -0.8837890625,
            "end_logit": 9.4296875,
            "text": "pneumoniae",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 3.427734375,
            "end_logit": 3.6953125,
            "text": "Enterococcus faecium",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -5.66796875,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 3.427734375,
            "end_logit": -0.53466796875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -6.828125,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9375,
            "end_logit": 9.4296875,
            "text": ", Klebsiella pneumoniae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 9.4296875,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.4296875,
            "text": ", Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.14453125,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.359375,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.41796875,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (ESKAPE) pathogens constitute more than 80% of ventilator-associated pneumonia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.421875,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.4765625,
            "text": "Klebsiella pneumoniae, Acinetobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.4296875,
            "text": "Despite important geographical variations, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.515625,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (ESKAPE) pathogens constitute more than 80% of ventilator-associated pneumonia (VAP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.51953125,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.5546875,
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species (ESKAPE) pathogens constitute more than 80",
            "probability": 5.960464477539063e-08
        }
    ],
    "56d2ac03f22319765a000004_3": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.328125,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.0654296875,
            "text": "Enterococcus",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 9.328125,
            "text": "faecium",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.67578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.328125,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.328125,
            "text": "encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.49609375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.328125,
            "text": "'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.328125,
            "text": "' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.51953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5390625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5859375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. -",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.609375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.64453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.6484375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.65625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": -6.67578125,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_4": [
        {
            "start_logit": 5.921875,
            "end_logit": 6.83203125,
            "text": "A. baumannii",
            "probability": 0.8525390625
        },
        {
            "start_logit": 5.921875,
            "end_logit": 5.01953125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium",
            "probability": 0.13916015625
        },
        {
            "start_logit": 2.80859375,
            "end_logit": 5.01953125,
            "text": "Enterococcus faecium",
            "probability": 0.006214141845703125
        },
        {
            "start_logit": 5.921875,
            "end_logit": 0.1846923828125,
            "text": "A",
            "probability": 0.0011091232299804688
        },
        {
            "start_logit": 5.921875,
            "end_logit": -0.11395263671875,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0008244514465332031
        },
        {
            "start_logit": -3.783203125,
            "end_logit": 6.83203125,
            "text": "baumannii",
            "probability": 5.2094459533691406e-05
        },
        {
            "start_logit": 2.80859375,
            "end_logit": -0.11395263671875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 3.6656856536865234e-05
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 6.83203125,
            "text": ". baumannii",
            "probability": 1.2576580047607422e-05
        },
        {
            "start_logit": -3.783203125,
            "end_logit": 5.01953125,
            "text": "baumannii (the ESKAPE pathogens are Enterococcus faecium",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 6.83203125,
            "text": "include A. baumannii",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 5.01953125,
            "text": ". baumannii (the ESKAPE pathogens are Enterococcus faecium",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.83203125,
            "text": "risk for wound and surgical site infections caused by ESKAPE pathogens, which include A. baumannii",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 6.83203125,
            "text": "surgical site infections caused by ESKAPE pathogens, which include A. baumannii",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 6.83203125,
            "text": "by ESKAPE pathogens, which include A. baumannii",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.83203125,
            "text": "wound and surgical site infections caused by ESKAPE pathogens, which include A. baumannii",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 6.83203125,
            "text": "weeks to months of hospitalization, increasing the risk for wound and surgical site infections caused by ESKAPE pathogens, which include A. baumannii",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.765625,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.78125,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species).",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.78515625,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.80859375,
            "text": "A. baumannii (the ESKAPE pathogens are Enterococcus",
            "probability": 1.0132789611816406e-06
        }
    ],
    "56d2ac03f22319765a000004_5": [
        {
            "start_logit": 9.0390625,
            "end_logit": 9.1796875,
            "text": "Enterococcus faecium",
            "probability": 0.990234375
        },
        {
            "start_logit": 9.0390625,
            "end_logit": 4.55078125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.00971221923828125
        },
        {
            "start_logit": -1.556640625,
            "end_logit": 9.1796875,
            "text": "faecium",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.61328125,
            "text": "Enterococcus",
            "probability": 2.0265579223632812e-05
        },
        {
            "start_logit": 2.8046875,
            "end_logit": 4.55078125,
            "text": "Klebsiella pneumoniae",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -1.556640625,
            "end_logit": 4.55078125,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.94140625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.1796875,
            "text": "' (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.1796875,
            "text": "(Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.30078125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.359375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.3828125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.39453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.1796875,
            "text": "'ESKAPE' (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.45703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) pathogens play",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.46875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.515625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.51953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobact",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.53515625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.5546875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinto",
            "probability": 5.960464477539063e-08
        }
    ],
    "56d2ac03f22319765a000004_6": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.296875,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.2138671875,
            "text": "Enterococcus",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.30078125,
            "end_logit": 9.296875,
            "text": "faecium",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -3.92578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.296875,
            "text": "pathogens (Enterococcus faecium",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.296875,
            "text": "(Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.296875,
            "text": "by the 6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.296875,
            "text": "bacteremias caused by the 6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.296875,
            "text": "Although bacteremias caused by the 6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.296875,
            "text": "6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.37109375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.296875,
            "text": "the 6 ESKAPE pathogens (Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.40234375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.51953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.54296875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.55859375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.63671875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.70703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.7265625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) have recently been highlighted",
            "probability": 5.960464477539063e-08
        }
    ],
    "56d2ac03f22319765a000004_7": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.34375,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.0927734375,
            "text": "Enterococcus",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.1875,
            "end_logit": 9.34375,
            "text": "faecium",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.8359375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.3046875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.34375,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.44921875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.45703125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.34375,
            "text": "encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.46875,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.34375,
            "text": "'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.546875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5859375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.58984375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.34375,
            "text": "' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.6015625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.66796875,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.6796875,
            "text": "Enterococcus faecium, Staphylococcus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1875,
            "end_logit": -6.8359375,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        }
    ],
    "56d2ac03f22319765a000004_8": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.328125,
            "text": "Enterococcus faecium",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.0654296875,
            "text": "Enterococcus",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 9.328125,
            "text": "faecium",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.67578125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.328125,
            "text": "Multidrug resistance among the 'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.328125,
            "text": "encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.49609375,
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.328125,
            "text": "'ESKAPE' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.328125,
            "text": "' organisms - encompassing Enterococcus faecium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.51953125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5390625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5859375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. -",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.609375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.64453125,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. - is of particular concern",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.6484375,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.65625,
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": -6.67578125,
            "text": "faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_1": [
        {
            "start_logit": 8.5546875,
            "end_logit": 8.6875,
            "text": "NHT",
            "probability": 1.0
        },
        {
            "start_logit": 8.5546875,
            "end_logit": 0.341552734375,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.00023603439331054688
        },
        {
            "start_logit": -2.49609375,
            "end_logit": 8.6875,
            "text": "T",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -2.478515625,
            "text": "NH",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.3359375,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C and -D",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 8.6875,
            "text": "that NHT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.96484375,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF-C and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.6875,
            "text": "ur results demonstrate that NHT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.15625,
            "text": "NHT stimulates lymphangiogenesis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.21875,
            "text": "NHT stimulates lymphangiogenesis via upregulation of VEGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.6875,
            "text": "demonstrate that NHT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.6875,
            "text": "results demonstrate that NHT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.33203125,
            "text": "NHT stimulates",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.40234375,
            "text": "NHT stimulates lymphangi",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.41015625,
            "text": "NHT stimulates lymphangiogenesis via",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": 0.341552734375,
            "text": "VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -2.49609375,
            "end_logit": 0.341552734375,
            "text": "T stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 0.341552734375,
            "text": "that NHT stimulates lymphangiogenesis via upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 0.341552734375,
            "text": "upregulation of VEGF-C",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 0.341552734375,
            "text": "C",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_2": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.328125,
            "text": "VEGF-C",
            "probability": 1.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": 9.328125,
            "text": "C",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.2412109375,
            "text": "VEGF",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.328125,
            "text": ", VEGF-C",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 9.328125,
            "text": "-C",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.2109375,
            "text": "VEGF-C and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.75390625,
            "text": "VEGF-C and its receptor VEGF-R3",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.890625,
            "text": "VEGF-C and its receptor VEGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.22265625,
            "text": "VEGF-C and its receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.328125,
            "text": "ogenesis, VEGF-C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.328125,
            "text": "signals for lymphangiogenesis, VEGF-C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.328125,
            "text": "The signals for lymphangiogenesis, VEGF-C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.46875,
            "text": "VEGF-C and its receptor VEGF-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.328125,
            "text": "lymphangiogenesis, VEGF-C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -1.2412109375,
            "text": ", VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -6.2109375,
            "text": "C and",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -6.75390625,
            "text": "C and its receptor VEGF-R3",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -6.890625,
            "text": "C and its receptor VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -7.22265625,
            "text": "C and its receptor",
            "probability": 0.0
        },
        {
            "start_logit": -0.97509765625,
            "end_logit": -7.46875,
            "text": "C and its receptor VEGF-",
            "probability": 0.0
        }
    ],
    "5a89a20ffcd1d6a10c00000e_3": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.375,
            "text": "Vascular endothelial growth factor",
            "probability": 1.0
        },
        {
            "start_logit": -1.1376953125,
            "end_logit": 9.375,
            "text": "factor",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.482421875,
            "text": "Vascular",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -3.068359375,
            "text": "Vascular endothelial growth factor (VEGF",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 9.375,
            "text": "endothelial growth factor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.375,
            "text": "growth factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.65234375,
            "text": "Vascular endothelial growth factor (VEGF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.9375,
            "text": "Vascular endothelial growth factor (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1328125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1484375,
            "text": "Vascular endothelial growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.296875,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.33203125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.36328125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.37890625,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.44921875,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.453125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.46484375,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are both potent candidates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.53125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.55078125,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are both potent candidates for stimulating lymphangiogenesis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.5546875,
            "text": "Vascular endothelial growth factor (VEGF) members VEGF-C and VEGF-D are both",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b52c8822d3005309000001_1": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.2890625,
            "text": "Ascher's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -2.3203125,
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -2.84765625,
            "end_logit": 8.2890625,
            "text": "syndrome",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -3.123046875,
            "text": "Asc",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.9296875,
            "text": "Ascher",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2734375,
            "text": "Ascher's",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.53125,
            "text": "Ascher'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.6953125,
            "text": "Ascher's syndrome associated with iris colob",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.2890625,
            "text": "of Ascher's syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.2890625,
            "text": "case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.2890625,
            "text": "Ascher's syndrome associated with iris col",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.2890625,
            "text": ", this is the first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.2890625,
            "text": "knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.2890625,
            "text": "s syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.2890625,
            "text": "first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.45703125,
            "text": "Ascher's syndrome associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.51953125,
            "text": "Ascher's syndrome associated with iris coloboma,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.5234375,
            "end_logit": -2.3203125,
            "text": "iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -2.84765625,
            "end_logit": -2.3203125,
            "text": "syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -2.5234375,
            "end_logit": -6.6953125,
            "text": "iris colob",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_2": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.7421875,
            "text": "Sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -0.978515625,
            "text": "Sensorineural",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 8.7421875,
            "text": "hearing loss",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 8.7421875,
            "text": "loss",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 1.337890625,
            "end_logit": 3.22265625,
            "text": "WS2",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.21484375,
            "text": "Sensorineural hearing loss (17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.7109375,
            "text": "Sensorineural hearing loss (17/20, 85.0%)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.00390625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.046875,
            "text": "Sensorineural hearing loss (17/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05078125,
            "text": "Sensorineural hearing loss (17/20, 85",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.078125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.10546875,
            "text": "Sensorineural hearing loss (17/20, 85.0",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.18359375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.26953125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3203125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Sensorineural hearing loss (17/20, 85.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.42578125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 3.22265625,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.22265625,
            "text": "2",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_3": [
        {
            "start_logit": 8.765625,
            "end_logit": 8.6171875,
            "text": "Waardenburg Syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.765625,
            "end_logit": -2.2109375,
            "text": "Wa",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -2.45703125,
            "end_logit": 8.6171875,
            "text": "Syndrome",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -3.033203125,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.98828125,
            "text": "Waardenburg",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.125,
            "text": "Waardenburg Syndrome (WS)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.16796875,
            "text": "Waarden",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.49609375,
            "text": "Waardenburg Syndrome (WS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 8.6171875,
            "text": "ardenburg Syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.71875,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.14453125,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss and pigmentary abnormalities",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.25,
            "text": "Waardenburg Syndrome (WS) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.30078125,
            "text": "Waardenburg Syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.31640625,
            "text": "Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss and pigmentary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -3.033203125,
            "text": "Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -3.033203125,
            "text": "hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -6.125,
            "text": "Syndrome (WS)",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -6.49609375,
            "text": "Syndrome (WS",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -6.71875,
            "text": "Syndrome (WS) is an autosomal-dominant",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -3.033203125,
            "text": "sensorineural hearing loss",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_4": [
        {
            "start_logit": 9.0390625,
            "end_logit": 9.2734375,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": 9.2734375,
            "text": "syndrome",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.7392578125,
            "text": "Horn",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 9.2734375,
            "text": "er's syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.21875,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 9.2734375,
            "text": "s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 9.2734375,
            "text": "congenital Horner's syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.2734375,
            "text": "'s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.98046875,
            "text": "Horner's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.16796875,
            "text": "Horner's syndrome and hypochrom",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.1875,
            "text": "Horner's syndrome and hypochromia iridum without anhidro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.20703125,
            "text": "Horner'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.2734375,
            "text": "association of congenital Horner's syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.328125,
            "text": "Horner's syndrome and hypochromia iridum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.359375,
            "text": "Horner's syndrome and hypochromia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.37890625,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway injury early in life",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.390625,
            "text": "Horner's syndrome and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.2734375,
            "text": "The association of congenital Horner's syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.41015625,
            "text": "Horner's syndrome and hypochromia iridum without anhidrosis is highly suggestive of sympathetic pathway injury early in life.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.2734375,
            "text": "of congenital Horner's syndrome",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b52c8822d3005309000001_5": [
        {
            "start_logit": 8.8828125,
            "end_logit": 8.578125,
            "text": "Waardenburg syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -2.02734375,
            "text": "Wa",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -2.572265625,
            "end_logit": 8.578125,
            "text": "syndrome",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -4.12890625,
            "text": "Waardenburg",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -5.3203125,
            "text": "Waardenburg syndrome (WS) consists",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -5.5703125,
            "text": "Waardenburg syndrome (WS)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -5.69921875,
            "text": "Waardenburg syndrome (WS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -5.7734375,
            "text": "Waarden",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.8203125,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.00390625,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.0078125,
            "text": "Waardenburg syndrome (WS) consists of at least two",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 8.578125,
            "text": "ardenburg syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.13671875,
            "text": "Waardenburg syndrome (WS) consists of at least two distinct autosomal dominant hereditary disorders",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 8.578125,
            "text": "The Waardenburg syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.203125,
            "text": "Waardenburg syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.25,
            "text": "Waardenburg syndrome (WS) consists of at",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -5.3203125,
            "text": "syndrome (WS) consists",
            "probability": 0.0
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -5.5703125,
            "text": "syndrome (WS)",
            "probability": 0.0
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -5.69921875,
            "text": "syndrome (WS",
            "probability": 0.0
        },
        {
            "start_logit": -6.83203125,
            "end_logit": -2.02734375,
            "text": "The Wa",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_6": [
        {
            "start_logit": 7.96484375,
            "end_logit": 6.9765625,
            "text": "WS",
            "probability": 0.98095703125
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.018524169921875
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 3.068359375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0003726482391357422
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.24609375,
            "text": "WS Type II",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 6.9765625,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.78125,
            "text": "WS Type",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.9765625,
            "text": "WS Type II.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.9765625,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -4.24609375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 6.9765625,
            "text": "for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.9765625,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.9765625,
            "text": "most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.9765625,
            "text": "um (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.9765625,
            "text": "important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 3.068359375,
            "text": "hearing loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.55859375,
            "text": "Sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.78125,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.03515625,
            "text": "Sensorineural hearing loss (77%)",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.1484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%)",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_7": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.2890625,
            "text": "Ascher's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -2.3203125,
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -2.84765625,
            "end_logit": 8.2890625,
            "text": "syndrome",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -3.123046875,
            "text": "Asc",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.9296875,
            "text": "Ascher",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2734375,
            "text": "Ascher's",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.53125,
            "text": "Ascher'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.6953125,
            "text": "Ascher's syndrome associated with iris colob",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.2890625,
            "text": "of Ascher's syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.2890625,
            "text": "case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.2890625,
            "text": "Ascher's syndrome associated with iris col",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.2890625,
            "text": ", this is the first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.2890625,
            "text": "knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.2890625,
            "text": "s syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.2890625,
            "text": "first reported case of Ascher's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.45703125,
            "text": "Ascher's syndrome associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.51953125,
            "text": "Ascher's syndrome associated with iris coloboma,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.5234375,
            "end_logit": -2.3203125,
            "text": "iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -2.84765625,
            "end_logit": -2.3203125,
            "text": "syndrome associated with iris coloboma",
            "probability": 0.0
        },
        {
            "start_logit": -2.5234375,
            "end_logit": -6.6953125,
            "text": "iris colob",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_8": [
        {
            "start_logit": 7.96484375,
            "end_logit": 6.9765625,
            "text": "WS",
            "probability": 0.98095703125
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.018524169921875
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 3.068359375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0003726482391357422
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.24609375,
            "text": "WS Type II",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 6.9765625,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.78125,
            "text": "WS Type",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.9765625,
            "text": "WS Type II.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.9765625,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -4.24609375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 6.9765625,
            "text": "for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.9765625,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.9765625,
            "text": "most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.9765625,
            "text": "um (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.9765625,
            "text": "important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 3.068359375,
            "text": "hearing loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.55859375,
            "text": "Sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.78125,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.03515625,
            "text": "Sensorineural hearing loss (77%)",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.1484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%)",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_9": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.7421875,
            "text": "Sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -0.978515625,
            "text": "Sensorineural",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 8.7421875,
            "text": "hearing loss",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 8.7421875,
            "text": "loss",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 1.337890625,
            "end_logit": 3.22265625,
            "text": "WS2",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.21484375,
            "text": "Sensorineural hearing loss (17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.7109375,
            "text": "Sensorineural hearing loss (17/20, 85.0%)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.00390625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.046875,
            "text": "Sensorineural hearing loss (17/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05078125,
            "text": "Sensorineural hearing loss (17/20, 85",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.078125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.10546875,
            "text": "Sensorineural hearing loss (17/20, 85.0",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.18359375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.26953125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3203125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Sensorineural hearing loss (17/20, 85.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.42578125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 3.22265625,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.22265625,
            "text": "2",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_10": [
        {
            "start_logit": 9.0234375,
            "end_logit": 9.078125,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.814453125,
            "end_logit": 9.078125,
            "text": "syndrome",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -1.7724609375,
            "text": "Horn",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.28515625,
            "text": "Horner's syndrome due to paravertebral neurilemmoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.31640625,
            "text": "Horner's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 9.078125,
            "text": "er's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 9.078125,
            "text": "and Horner's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.99609375,
            "text": "Horner'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.046875,
            "text": "Horner's syndrome due to paravertebral neurilemm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.078125,
            "text": "s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.203125,
            "text": "Horner's syndrome due to paravertebral neurile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.26171875,
            "text": "Horner's syndrome due to paravertebral neurilemmoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.26171875,
            "text": "Horner",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.078125,
            "text": "'s syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.30078125,
            "text": "Horner's syndrome due to paravertebral neur",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.33203125,
            "text": "Horner's syndrome due to paravertebral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.3359375,
            "text": "Horner's syndrome due",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.078125,
            "text": "Heterochromia iridis and Horner's syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -6.28515625,
            "text": "syndrome due to paravertebral neurilemmoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.625,
            "end_logit": -1.7724609375,
            "text": "and Horn",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_11": [
        {
            "start_logit": 8.78125,
            "end_logit": 8.875,
            "text": "Horner's syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.150390625,
            "end_logit": 8.875,
            "text": "syndrome",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -2.220703125,
            "text": "Horn",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.6015625,
            "text": "Horner's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 8.875,
            "text": "er's syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.69140625,
            "text": "Horner's syndrome is reported",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.71875,
            "text": "Horner's syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.875,
            "text": "s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 8.875,
            "text": "case of heterochromia iridis and Horner's syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.9765625,
            "text": "Horner'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.02734375,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemmoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 8.875,
            "text": "A case of heterochromia iridis and Horner's syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.0625,
            "text": "Horner",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.875,
            "text": "and Horner's syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.1171875,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemmoma.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.875,
            "text": "'s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.3203125,
            "text": "Horner's syndrome is reported in a 7-year old girl with paravertebral neurilemm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.375,
            "text": "Horner's syndrome is reported in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.3828125,
            "text": "Horner's syndrome is reported in a 7-year old girl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.42578125,
            "text": "Horner's syndrome is reported in a 7-year",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b52c8822d3005309000001_12": [
        {
            "start_logit": 8.640625,
            "end_logit": 8.125,
            "text": "Aschers syndrome",
            "probability": 0.994140625
        },
        {
            "start_logit": 8.640625,
            "end_logit": 2.953125,
            "text": "Aschers",
            "probability": 0.00563812255859375
        },
        {
            "start_logit": 8.640625,
            "end_logit": -2.498046875,
            "text": "Asc",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -3.380859375,
            "end_logit": 8.125,
            "text": "syndrome",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 8.640625,
            "end_logit": -4.1171875,
            "text": "Aschers syndrome associated with iris coloboma",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 8.640625,
            "end_logit": -6.65234375,
            "text": "Ascher",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -6.953125,
            "text": "Aschers syndrome associated with iris colob",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.4140625,
            "text": "Aschers syndrome associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.421875,
            "text": "Aschers syndrome associated with iris col",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.50390625,
            "text": "Aschers syndrome associated with iris coloboma,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.5625,
            "text": "Aschers syndrome associated with iris coloboma, heterochromia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.59375,
            "text": "Aschers syndrome associated with iris coloboma, heterochromia iridum, and narrowing of horizontal palpebral fissure and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.640625,
            "end_logit": -7.59765625,
            "text": "Aschers syndrome associated with iris coloboma, heterochromia iridum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.125,
            "text": "s syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.125,
            "text": "hers syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.125,
            "text": "of Aschers syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.125,
            "text": "case of Aschers syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.125,
            "text": ", this is the first reported case of Aschers syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.125,
            "text": "knowledge, this is the first reported case of Aschers syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.125,
            "text": "first reported case of Aschers syndrome",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b52c8822d3005309000001_13": [
        {
            "start_logit": 8.765625,
            "end_logit": 7.9375,
            "text": "Sensorineural hearing loss",
            "probability": 0.87060546875
        },
        {
            "start_logit": 6.71484375,
            "end_logit": 8.0859375,
            "text": "WS2",
            "probability": 0.1295166015625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -1.96484375,
            "text": "Sensorineural",
            "probability": 4.3451786041259766e-05
        },
        {
            "start_logit": -2.923828125,
            "end_logit": 7.9375,
            "text": "hearing loss",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -3.291015625,
            "end_logit": 8.0859375,
            "text": "2",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -3.65625,
            "end_logit": 7.9375,
            "text": "loss",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -4.31640625,
            "text": "WS",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.41796875,
            "text": "Sensorineural hearing loss (17",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.86328125,
            "text": "Sensorineural hearing loss (17/20, 85.0%)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.03515625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.04296875,
            "text": "Sensorineural hearing loss (17/20",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.11328125,
            "text": "Sensorineural hearing loss (17/20, 85",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.1328125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.1640625,
            "text": "Sensorineural hearing loss (17/20, 85.0",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.21484375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.3125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.34765625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.3984375,
            "text": "Sensorineural hearing loss (17/20, 85.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.40234375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.42578125,
            "text": "Sensorineural hearing loss (17/",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58b52c8822d3005309000001_14": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.7421875,
            "text": "Sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -0.978515625,
            "text": "Sensorineural",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 8.7421875,
            "text": "hearing loss",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 8.7421875,
            "text": "loss",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 1.337890625,
            "end_logit": 3.22265625,
            "text": "WS2",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.21484375,
            "text": "Sensorineural hearing loss (17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.7109375,
            "text": "Sensorineural hearing loss (17/20, 85.0%)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.00390625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.046875,
            "text": "Sensorineural hearing loss (17/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05078125,
            "text": "Sensorineural hearing loss (17/20, 85",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.078125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.10546875,
            "text": "Sensorineural hearing loss (17/20, 85.0",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.18359375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.26953125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3203125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Sensorineural hearing loss (17/20, 85.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.42578125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 3.22265625,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.22265625,
            "text": "2",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_15": [
        {
            "start_logit": 7.96484375,
            "end_logit": 6.9765625,
            "text": "WS",
            "probability": 0.98095703125
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 0.018524169921875
        },
        {
            "start_logit": 3.994140625,
            "end_logit": 3.068359375,
            "text": "Sensorineural hearing loss",
            "probability": 0.0003726482391357422
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.24609375,
            "text": "WS Type II",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 6.9765625,
            "text": "hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.78125,
            "text": "WS Type",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.9765625,
            "text": "WS Type II.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.9765625,
            "text": "loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -4.24609375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 6.9765625,
            "text": "for WS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.9765625,
            "text": "and heterochromia iridum (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.9765625,
            "text": "most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.9765625,
            "text": "um (47%) were the two most important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.9765625,
            "text": "important diagnostic indicators for WS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 3.068359375,
            "text": "hearing loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.55859375,
            "text": "Sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.78125,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -6.9765625,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%) were the two most important diagnostic indicators for WS Type II.",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.03515625,
            "text": "Sensorineural hearing loss (77%)",
            "probability": 0.0
        },
        {
            "start_logit": 3.994140625,
            "end_logit": -7.1484375,
            "text": "Sensorineural hearing loss (77%) and heterochromia iridum (47%)",
            "probability": 0.0
        }
    ],
    "58b52c8822d3005309000001_16": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.7421875,
            "text": "Sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -0.978515625,
            "text": "Sensorineural",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 8.7421875,
            "text": "hearing loss",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 8.7421875,
            "text": "loss",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 1.337890625,
            "end_logit": 3.22265625,
            "text": "WS2",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.21484375,
            "text": "Sensorineural hearing loss (17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.7109375,
            "text": "Sensorineural hearing loss (17/20, 85.0%)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.00390625,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.046875,
            "text": "Sensorineural hearing loss (17/20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05078125,
            "text": "Sensorineural hearing loss (17/20, 85",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.078125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.10546875,
            "text": "Sensorineural hearing loss (17/20, 85.0",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.18359375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.26953125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3203125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Sensorineural hearing loss (17/20, 85.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.42578125,
            "text": "Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 3.22265625,
            "text": "and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.22265625,
            "text": "2",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_1": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.390625,
            "text": "MLE4901",
            "probability": 1.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": 9.390625,
            "text": "01",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.34765625,
            "text": "ML",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 9.390625,
            "text": "E4901",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 9.390625,
            "text": "4901",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.14453125,
            "text": "MLE49",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.15234375,
            "text": "MLE4901 at 40 mg twice daily orally for 7 days.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.390625,
            "text": "postmenopausal women were administered the NK3R antagonist MLE4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.390625,
            "text": "administered the NK3R antagonist MLE4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.328125,
            "text": "MLE4901 at 40 mg twice daily orally for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.390625,
            "text": "antagonist MLE4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.39453125,
            "text": "MLE4901 at 40 mg twice daily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.390625,
            "text": "Eleven postmenopausal women were administered the NK3R antagonist MLE4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.4375,
            "text": "MLE4901 at 40 mg twice daily orally",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.390625,
            "text": "NK3R antagonist MLE4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.484375,
            "text": "MLE4901 at 40 mg twice daily orally for 7 days",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.53125,
            "text": "MLE4901 at 40 mg twice daily orally for 7",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -7.15234375,
            "text": "01 at 40 mg twice daily orally for 7 days.",
            "probability": 0.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -7.328125,
            "text": "01 at 40 mg twice daily orally for",
            "probability": 0.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -7.39453125,
            "text": "01 at 40 mg twice daily",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_2": [
        {
            "start_logit": 9.125,
            "end_logit": 9.390625,
            "text": "SB222200",
            "probability": 0.9970703125
        },
        {
            "start_logit": 5.26953125,
            "end_logit": 7.40234375,
            "text": "senktide",
            "probability": 0.0028896331787109375
        },
        {
            "start_logit": -1.0478515625,
            "end_logit": 9.390625,
            "text": "00",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.484375,
            "text": "SB",
            "probability": 1.8894672393798828e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.88671875,
            "text": "SB2222",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.37109375,
            "end_logit": 7.40234375,
            "text": "ide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.25390625,
            "text": "SB22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.421875,
            "text": "SB222200 in the pubertal but not prepubertal monkeys.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 9.390625,
            "text": "2200",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.390625,
            "text": "antagonist SB222200",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.390625,
            "text": "222200",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 7.40234375,
            "text": "ktide",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.40234375,
            "text": "NK3R agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.40234375,
            "text": "agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.40234375,
            "text": ", the NK3R agonist senktide",
            "probability": 0.0
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -5.875,
            "text": "sen",
            "probability": 0.0
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -6.9921875,
            "text": "senktide stimulated GnRH release in a dose-responsive manner in both prepubertal",
            "probability": 0.0
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -7.0078125,
            "text": "senktide stimulated GnRH release in a dose-responsive manner in both prepubertal and pubertal",
            "probability": 0.0
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -7.23046875,
            "text": "senktide stimulated GnRH release in a dose-responsive manner in both prepubertal and pubertal monkeys",
            "probability": 0.0
        },
        {
            "start_logit": -1.0478515625,
            "end_logit": -6.421875,
            "text": "00 in the pubertal but not prepubertal monkeys.",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_3": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.3984375,
            "text": "AZD4901",
            "probability": 1.0
        },
        {
            "start_logit": -1.150390625,
            "end_logit": 9.3984375,
            "text": "1",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0908203125,
            "text": "AZ",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 9.3984375,
            "text": "D4901",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 9.3984375,
            "text": "901",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.734375,
            "text": "AZD490",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.42578125,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.3984375,
            "text": "antagonist AZD4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.46875,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.50390625,
            "text": "AZD4901 40 mg twice daily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.3984375,
            "text": "NK3R antagonist AZD4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5078125,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.515625,
            "text": "AZD4901 40 mg twice daily orally",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.53125,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5390625,
            "text": "AZD4901 40 mg twice daily orally was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.3984375,
            "text": "3R antagonist AZD4901",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5625,
            "text": "AZD4901 40",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5625,
            "text": "AZD4901 40 mg twice daily orally was taken from cycle day 4-6 for 6 days",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.150390625,
            "end_logit": -7.078125,
            "text": "1 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls).",
            "probability": 0.0
        },
        {
            "start_logit": -1.150390625,
            "end_logit": -7.42578125,
            "text": "1 40 mg twice daily orally was taken from cycle day 4-6 for 6 days (n = 10, with 10 no treatment controls",
            "probability": 0.0
        }
    ],
    "5e55046fb761aafe09000004_4": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.359375,
            "text": "ESN364",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.92626953125,
            "text": "ES",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": -1.251953125,
            "end_logit": 9.359375,
            "text": "64",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -5.27734375,
            "end_logit": 9.359375,
            "text": "N364",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 9.359375,
            "text": ", ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.359375,
            "text": "Oral administration of the NK3R antagonist, ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.40234375,
            "text": "ESN364,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.359375,
            "text": "administration of the NK3R antagonist, ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5078125,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin secretion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.55859375,
            "text": "ESN364, suppressed the hypothalamic-pituitary-gonadal axis in healthy volunteers by selective modulation of gonadotropin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.359375,
            "text": "NK3R antagonist, ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.60546875,
            "text": "ESN364, suppressed the hypothalamic-pituitary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.359375,
            "text": "the NK3R antagonist, ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.359375,
            "text": "of the NK3R antagonist, ESN364",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -0.92626953125,
            "text": ", ES",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -0.92626953125,
            "text": "Oral administration of the NK3R antagonist, ES",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -0.92626953125,
            "text": "administration of the NK3R antagonist, ES",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -0.92626953125,
            "text": "NK3R antagonist, ES",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -0.92626953125,
            "text": "the NK3R antagonist, ES",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -0.92626953125,
            "text": "of the NK3R antagonist, ES",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_1": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.5390625,
            "text": "H4K20me3",
            "probability": 1.0
        },
        {
            "start_logit": -0.69970703125,
            "end_logit": 9.5390625,
            "text": "me3",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.9921875,
            "text": "H4",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -5.5078125,
            "text": "H4K20me3, H3K9me3",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -5.8125,
            "text": "H4K20",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.125,
            "end_logit": 9.5390625,
            "text": "0me3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 9.5390625,
            "text": "K20me3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 9.5390625,
            "text": "as H4K20me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.8828125,
            "text": "H4K20me3, H3K9me3, and H3K79me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.5390625,
            "text": "histone methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.5390625,
            "text": "in histone methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.5390625,
            "text": "enriched in histone methylation marks usually found in constitutive heterochromatin, such as H4K20me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.5390625,
            "text": "such as H4K20me3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.31640625,
            "text": "H4K2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.48046875,
            "text": "H4K20me3, H3K9me3, and H3K79",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.515625,
            "text": "H4K20me3, H3K9me3, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.5546875,
            "text": "H4K20me3, H3K9",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.69970703125,
            "end_logit": -5.5078125,
            "text": "me3, H3K9me3",
            "probability": 0.0
        },
        {
            "start_logit": -0.69970703125,
            "end_logit": -6.8828125,
            "text": "me3, H3K9me3, and H3K79me3",
            "probability": 0.0
        },
        {
            "start_logit": -6.921875,
            "end_logit": -0.9921875,
            "text": "as H4",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_2": [
        {
            "start_logit": 9.3515625,
            "end_logit": 9.3046875,
            "text": "H3K9me2",
            "probability": 1.0
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -0.95263671875,
            "text": "H3K",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -1.3056640625,
            "end_logit": 9.3046875,
            "text": "2",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -5.57421875,
            "text": "H3K9me",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 9.3046875,
            "text": "9me2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -6.3125,
            "text": "H3K9me2, H3K27me1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 9.3046875,
            "text": "including H3K9me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 9.3046875,
            "text": "histone modifications associated with heterochromatin, including H3K9me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -6.72265625,
            "text": "H3K9me2, H3K27me",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 9.3046875,
            "text": "me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.3046875,
            "text": "Classical histone modifications associated with heterochromatin, including H3K9me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -6.96484375,
            "text": "H3K9me2,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.2578125,
            "text": "H3K9me2, H3K27me1 and H3K27me2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.28515625,
            "text": "H3K9me2, H3K27",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.32421875,
            "text": "H3K9",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.328125,
            "text": "H3K9me2, H3K27me1 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.4140625,
            "text": "H3K9me2, H3K27me1 and H3K27me2,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.46484375,
            "text": "H3K9me2, H3K27me1 and H3K27me2, were distributed throughout both A and B chromosomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.4765625,
            "text": "H3K9me2, H3K27me1 and H3K27me",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.4375,
            "end_logit": -0.95263671875,
            "text": "including H3K",
            "probability": 0.0
        }
    ],
    "52e0c9a298d0239505000010_3": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.1171875,
            "text": "H3K27me2",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.6279296875,
            "text": "H3K",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": 9.1171875,
            "text": "2",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -4.4296875,
            "text": "H3K27me",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 9.1171875,
            "text": "27me2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.80859375,
            "text": "H3K27",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.1171875,
            "text": ", H3K27me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.1171875,
            "text": "However, H3K27me2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.09765625,
            "text": "H3K27me2 showed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.1171875,
            "text": "me2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.21875,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.2578125,
            "text": "H3K27me2 showed a reduced level on the B chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.28125,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.33203125,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.375,
            "text": "H3K27me2 showed a reduced",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.3828125,
            "text": "H3K27me2 showed a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.43359375,
            "text": "H3K27me2 showed a reduced level on the B",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.44921875,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A chromosomes and was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.45703125,
            "text": "H3K27me2 showed a reduced level on the B chromosome compared with the A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.48828125,
            "text": "H3K27me2 showed a reduced level",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6e5d1d51b80c9423000003_1": [
        {
            "start_logit": 7.87109375,
            "end_logit": 7.7578125,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.46484375,
            "text": "schizophrenia and methamphetamine sensitization",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.84765625,
            "text": "schizophrenia and methamphetamine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.0078125,
            "text": "schizophrenia and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.7578125,
            "text": "to schizophrenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.7578125,
            "text": ", SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.7578125,
            "text": "related genes to schizophrenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.7578125,
            "text": "addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.46484375,
            "text": "to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -6.46484375,
            "text": ", SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.46484375,
            "text": "related genes to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -6.46484375,
            "text": "addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine sensitization",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.84765625,
            "text": "to schizophrenia and methamphetamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.0078125,
            "text": "to schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -6.84765625,
            "text": ", SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.84765625,
            "text": "related genes to schizophrenia and methamphetamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -6.84765625,
            "text": "addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and methamphetamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.0078125,
            "text": ", SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.0078125,
            "text": "related genes to schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.0078125,
            "text": "addition, SNAP25, RAB18, FABP5, ARF5 and LDHA, which are related genes to schizophrenia and",
            "probability": 0.0
        }
    ],
    "5e6e5d1d51b80c9423000003_2": [
        {
            "start_logit": 6.8984375,
            "end_logit": 6.35546875,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -3.484375,
            "text": "schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 6.35546875,
            "text": ", schizophrenia",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -6.41796875,
            "text": "schizophrenia, and attention-deficit",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -6.47265625,
            "text": "schizophrenia, and attention-deficit/hyperactivity",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -7.0703125,
            "text": "schizophrenia,",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 6.35546875,
            "text": "psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -7.1328125,
            "text": "schizophrenia, and attention-deficit/",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.8984375,
            "end_logit": -7.13671875,
            "text": "schizophrenia, and attention-deficit/hyperactivity disorder.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 6.35546875,
            "text": ". Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 6.35546875,
            "text": "bipolar, schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 6.35546875,
            "text": "associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 6.35546875,
            "text": "and a variety of brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 6.35546875,
            "text": "brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.35546875,
            "text": "with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.35546875,
            "text": "variety of brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -3.95703125,
            "end_logit": -3.484375,
            "text": "attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": -3.484375,
            "text": ", schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -5.03125,
            "end_logit": -3.484375,
            "text": "and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -3.484375,
            "text": "psychiatric diseases, such as bipolar, schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.0
        }
    ],
    "5e6e5d1d51b80c9423000003_3": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.703125,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.828125,
            "text": "schizophrenia and ADHD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.9296875,
            "text": "schizophrenia and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.703125,
            "text": "including schizophrenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.703125,
            "text": "psychiatric diseases including schizophrenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.703125,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.828125,
            "text": "including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.828125,
            "text": "psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.9296875,
            "text": "including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.9296875,
            "text": "psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -6.828125,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and ADHD",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -6.9296875,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases including schizophrenia and",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.2734375,
            "text": "psychiatric diseases",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.2734375,
            "text": "synaptic-vesicle fusion machinery, involved in several psychiatric diseases",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.3046875,
            "text": "synaptic-vesicle fusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.46875,
            "text": "synaptic-vesicle fusion machinery, involved",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.50390625,
            "text": "synaptic-vesicle fusion machinery, involved in",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.546875,
            "text": "synaptic-vesicle fusion machinery, involved in several",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.55859375,
            "text": "synaptic-vesicle fusion machinery,",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.5625,
            "text": "synaptic-vesicle",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_1": [
        {
            "start_logit": 5.9921875,
            "end_logit": 2.923828125,
            "text": "fibroblast growth factors",
            "probability": 0.810546875
        },
        {
            "start_logit": 5.9921875,
            "end_logit": 1.4306640625,
            "text": "fibroblast growth factors (FGFs",
            "probability": 0.1822509765625
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -2.474609375,
            "text": "fibroblast growth factors (FGFs)",
            "probability": 0.0036678314208984375
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -3.0234375,
            "text": "fibroblast growth factors (FGF",
            "probability": 0.0021228790283203125
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -4.53125,
            "text": "fibroblast",
            "probability": 0.00047016143798828125
        },
        {
            "start_logit": -0.7138671875,
            "end_logit": 1.4306640625,
            "text": "FGFs",
            "probability": 0.00022363662719726562
        },
        {
            "start_logit": -2.349609375,
            "end_logit": 2.923828125,
            "text": ", fibroblast growth factors",
            "probability": 0.00019276142120361328
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -5.84765625,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF",
            "probability": 0.0001264810562133789
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -6.421875,
            "text": "fibroblast growth factors (",
            "probability": 7.092952728271484e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -6.734375,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR",
            "probability": 5.1915645599365234e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -6.76171875,
            "text": "fibroblast growth factors (FGFs) exec",
            "probability": 5.030632019042969e-05
        },
        {
            "start_logit": -2.349609375,
            "end_logit": 1.4306640625,
            "text": ", fibroblast growth factors (FGFs",
            "probability": 4.3332576751708984e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -7.02734375,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family",
            "probability": 3.8564205169677734e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -7.07421875,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including FGFR1",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -7.07421875,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -7.09765625,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGFR) family, including FGF",
            "probability": 3.62396240234375e-05
        },
        {
            "start_logit": 5.9921875,
            "end_logit": -7.125,
            "text": "fibroblast growth factors (FGFs) execute diverse functions by binding to and activating members of the FGF receptor (FGF",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -0.7138671875,
            "end_logit": -2.474609375,
            "text": "FGFs)",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.171875,
            "end_logit": 2.923828125,
            "text": "factors",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.203125,
            "end_logit": 2.923828125,
            "text": "growth factors",
            "probability": 4.112720489501953e-06
        }
    ],
    "5319abffb166e2b80600002f_2": [
        {
            "start_logit": 8.5078125,
            "end_logit": 8.9453125,
            "text": "TGF-\u03b22",
            "probability": 1.0
        },
        {
            "start_logit": -1.9951171875,
            "end_logit": 8.9453125,
            "text": "\u03b22",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -2.498046875,
            "text": "TGF",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.9453125,
            "text": "Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 8.9453125,
            "text": "-\u03b22",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 8.9453125,
            "text": "ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.9453125,
            "text": "in TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.9453125,
            "text": "K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.9453125,
            "text": ",K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -6.73046875,
            "text": "TGF-\u03b22-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.9453125,
            "text": "of Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.9453125,
            "text": "-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.9453125,
            "text": "ulation of Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.9453125,
            "text": "egulation of Na,K-ATPase \u03b21-subunit in TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -7.42578125,
            "text": "TGF-\u03b22-mediated epithelial-to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -7.42578125,
            "text": "TGF-\u03b22-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -7.4765625,
            "text": "TGF-\u03b22-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -7.484375,
            "text": "TGF-\u03b22-mediated epithelial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -7.51953125,
            "text": "TGF-\u03b22-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.69140625,
            "end_logit": -2.498046875,
            "text": "Na,K-ATPase \u03b21-subunit in TGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_3": [
        {
            "start_logit": 9.0390625,
            "end_logit": 9.0,
            "text": "TGF-\u03b22",
            "probability": 1.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.611328125,
            "text": "TGF",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -1.9599609375,
            "end_logit": 9.0,
            "text": "\u03b22",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 9.0,
            "text": "-\u03b22",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 9.0,
            "text": "growth factors such as TGF-\u03b22",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 9.0,
            "text": "as TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 9.0,
            "text": "cytokines and growth factors such as TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 9.0,
            "text": "vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.984375,
            "text": "TGF-\u03b22.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.0,
            "text": "exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.0,
            "text": "such as TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.0,
            "text": "to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.0,
            "text": "EMT process is mediated via exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.0,
            "text": "via exposure to vitreous cytokines and growth factors such as TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -1.611328125,
            "text": "growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -1.611328125,
            "text": "as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.57421875,
            "end_logit": -1.611328125,
            "text": "cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -1.611328125,
            "text": "vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -1.611328125,
            "text": "exposure to vitreous cytokines and growth factors such as TGF",
            "probability": 0.0
        },
        {
            "start_logit": -1.9599609375,
            "end_logit": -6.984375,
            "text": "\u03b22.",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_4": [
        {
            "start_logit": 9.3828125,
            "end_logit": 9.46875,
            "text": "TGF-\u03b21",
            "probability": 1.0
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -0.73828125,
            "text": "TGF",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -0.83251953125,
            "end_logit": 9.46875,
            "text": "\u03b21",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": -6.171875,
            "end_logit": 9.46875,
            "text": "-\u03b21",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.91796875,
            "text": "TGF-\u03b21-mediated EMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.46875,
            "text": "with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.46875,
            "text": "that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.1875,
            "text": "TGF-\u03b21-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.46875,
            "text": "polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.2578125,
            "text": "TGF-\u03b21-mediated EMT in kidney cells.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.46875,
            "text": "associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.46875,
            "text": "decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.46875,
            "text": "Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.46875,
            "text": "epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF-\u03b21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.83251953125,
            "end_logit": -6.91796875,
            "text": "\u03b21-mediated EMT",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -0.73828125,
            "text": "with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -0.73828125,
            "text": "Na,K-ATPase is required for maintaining a normal polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.73828125,
            "text": "that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        },
        {
            "start_logit": -0.83251953125,
            "end_logit": -7.1875,
            "text": "\u03b21-",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -0.73828125,
            "text": "polarized epithelial phenotype and that decreased Na,K-ATPase function and subunit levels are associated with TGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_5": [
        {
            "start_logit": 8.9140625,
            "end_logit": 9.3203125,
            "text": "TGF-\u03b22",
            "probability": 1.0
        },
        {
            "start_logit": -1.1279296875,
            "end_logit": 9.3203125,
            "text": "\u03b22",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -1.8505859375,
            "text": "TGF",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -4.15625,
            "end_logit": 9.3203125,
            "text": "Na,K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 9.3203125,
            "text": "-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 9.3203125,
            "text": ",K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.3203125,
            "text": "loss of Na,K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -6.43359375,
            "text": "TGF-\u03b22-mediated EMT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.3203125,
            "text": "K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 9.3203125,
            "text": "ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.3203125,
            "text": "of Na,K-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -6.6171875,
            "text": "TGF-\u03b22-mediated EMT in RPE cells.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.3203125,
            "text": "potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.3203125,
            "text": "-ATPase \u03b21 is a potential contributor to TGF-\u03b22",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -6.7578125,
            "text": "TGF-\u03b22-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.3203125,
            "text": "to TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.3203125,
            "text": "contributor to TGF-\u03b22",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.2890625,
            "text": "TGF-\u03b22-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.37109375,
            "text": "TGF-\u03b22-mediated EMT in RPE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.39453125,
            "text": "TGF-\u03b22-mediated EMT in RPE cells",
            "probability": 5.960464477539063e-08
        }
    ],
    "5319abffb166e2b80600002f_6": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.4609375,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -0.7998046875,
            "end_logit": 9.4609375,
            "text": "\u03b2",
            "probability": 4.506111145019531e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.259765625,
            "text": "TGF",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 9.4609375,
            "text": "lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 9.4609375,
            "text": "-\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 9.4609375,
            "text": ", TGF-\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 9.4609375,
            "text": ". In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.6875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.8671875,
            "text": "TGF-\u03b2 elicited EMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.0234375,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology, expression of EMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.4609375,
            "text": "invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.4609375,
            "text": "cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.4609375,
            "text": "cells, TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.4609375,
            "text": "In A549 lung adenocarcinoma cells, TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3125,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process, as confirmed by cell morphology, expression of EMT markers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.32421875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5,
            "text": "TGF-\u03b2 elicited EMT in Smad",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.51171875,
            "text": "TGF-\u03b2 elicited",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.515625,
            "text": "TGF-\u03b2 elicited EMT in Smad-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5546875,
            "text": "TGF-\u03b2 elicited EMT in Smad-dependent manner and TNF-\u03b1 accelerated this process,",
            "probability": 5.960464477539063e-08
        }
    ],
    "5319abffb166e2b80600002f_7": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.5546875,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -0.55615234375,
            "end_logit": 9.5546875,
            "text": "\u03b2",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.0322265625,
            "text": "TGF",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 9.5546875,
            "text": "-\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.5546875,
            "text": "by TGF-\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.74609375,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.96875,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.5546875,
            "text": "genes differentially regulated by TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 9.5546875,
            "text": "differentially regulated by TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.5546875,
            "text": "ed genes differentially regulated by TGF-\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.20703125,
            "text": "TGF-\u03b2 and TNF-\u03b1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.21875,
            "text": "TGF-\u03b2 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.28125,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.37109375,
            "text": "TGF-\u03b2 and TNF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.46875,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.46875,
            "text": "TGF-\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices), suggesting the drastic change in autocrine/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.51171875,
            "text": "TGF-\u03b2 and TNF-\u03b1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.55615234375,
            "end_logit": -6.74609375,
            "text": "\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices",
            "probability": 0.0
        },
        {
            "start_logit": -0.55615234375,
            "end_logit": -6.953125,
            "text": "\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices), suggesting the drastic change in autocrine/paracrine signals",
            "probability": 0.0
        },
        {
            "start_logit": -0.55615234375,
            "end_logit": -6.96875,
            "text": "\u03b2 and TNF-\u03b1, such as cytokines, chemokines, growth factors and ECM (extracellular matrices)",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_8": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.1640625,
            "text": "CCN1",
            "probability": 1.0
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": 9.1640625,
            "text": "N1",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.68359375,
            "text": "CC",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.375,
            "text": "CCN1 regulates",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 9.1640625,
            "text": "that CCN1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.65625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.859375,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.03515625,
            "text": "CCN1 regulates the Sonic Hedgehog",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.1640625,
            "text": "show that CCN1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.09765625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.1640625,
            "text": "Here we show that CCN1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.16015625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.19140625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression and poor prognosis.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.2109375,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.30859375,
            "text": "CCN1 regulates the Sonic Hedgehog (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.3203125,
            "text": "CCN1 regulates the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.33984375,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.34375,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.4140625,
            "text": "CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression and poor prognosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -6.375,
            "text": "N1 regulates",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_9": [
        {
            "start_logit": 8.0546875,
            "end_logit": 7.40625,
            "text": "SHh",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.59423828125,
            "end_logit": 7.40625,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 0.0005745887756347656
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -4.65625,
            "text": "SHh and Notch1",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 7.40625,
            "text": "that targeting CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.51171875,
            "text": "SHh and Notch1) associated with the development of the disease as well as drug resistance.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 7.40625,
            "text": "targeting CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.74609375,
            "text": "SHh and Notch1) associated with the development of the disease as",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.77734375,
            "text": "SHh and Notch1) associated with the development of the disease as well as drug resistance",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.79296875,
            "text": "SHh and Notch1)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.265625,
            "text": "SHh and Notch1) associated with the development of the disease as well",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.30078125,
            "text": "SHh and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.40625,
            "text": ". SHh",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 7.40625,
            "text": "pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 7.40625,
            "text": "treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.40625,
            "text": "new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.59423828125,
            "end_logit": -0.477783203125,
            "text": "CCN1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.40625,
            "text": "since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.40625,
            "text": "with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.59423828125,
            "end_logit": -4.65625,
            "text": "CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1",
            "probability": 0.0
        },
        {
            "start_logit": 0.59423828125,
            "end_logit": -4.91015625,
            "text": "CCN1 can",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_10": [
        {
            "start_logit": 8.984375,
            "end_logit": 9.2109375,
            "text": "GF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": 9.2109375,
            "text": "\u03b2",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.5546875,
            "text": "GF",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -6.25,
            "end_logit": 9.2109375,
            "text": "-\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.11328125,
            "text": "GF-\u03b2-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.2265625,
            "text": "GF-\u03b2-induced epithelial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.29296875,
            "text": "GF-\u03b2-induced epithelial-mesenchymal transition",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.34375,
            "text": "GF-\u03b2-induced epithelial-mesenchymal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.5,
            "text": "GF-\u03b2-induced",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.51953125,
            "text": "GF-\u03b2-induced epithelial-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.11328125,
            "text": "\u03b2-",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.2265625,
            "text": "\u03b2-induced epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.29296875,
            "text": "\u03b2-induced epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.34375,
            "text": "\u03b2-induced epithelial-mesenchymal",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.5,
            "text": "\u03b2-induced",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.51953125,
            "text": "\u03b2-induced epithelial-",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.11328125,
            "text": "-\u03b2-",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.2265625,
            "text": "-\u03b2-induced epithelial",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.29296875,
            "text": "-\u03b2-induced epithelial-mesenchymal transition",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.34375,
            "text": "-\u03b2-induced epithelial-mesenchymal",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_11": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.4140625,
            "text": "TGF-\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": 9.4140625,
            "text": "\u03b2",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.2626953125,
            "text": "TGF",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 9.4140625,
            "text": "cytokine TGF-\u03b2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 9.4140625,
            "text": "-\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.98828125,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a master regulator of the pro-invasive tumor microenvironment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.99609375,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.1171875,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.14453125,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.28125,
            "text": "TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -1.2626953125,
            "text": "cytokine TGF",
            "probability": 0.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": -6.98828125,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a master regulator of the pro-invasive tumor microenvironment.",
            "probability": 0.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": -6.99609375,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out",
            "probability": 0.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": -7.1171875,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands",
            "probability": 0.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": -7.14453125,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as",
            "probability": 0.0
        },
        {
            "start_logit": -0.970703125,
            "end_logit": -7.28125,
            "text": "\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -6.98828125,
            "text": "cytokine TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as a master regulator of the pro-invasive tumor microenvironment.",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -6.99609375,
            "text": "cytokine TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -7.1171875,
            "text": "cytokine TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -7.14453125,
            "text": "cytokine TGF-\u03b2, which is expressed by tumor-infiltrating immune cells, stands out as",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_12": [
        {
            "start_logit": 8.2734375,
            "end_logit": 6.515625,
            "text": "EGF",
            "probability": 0.96533203125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 3.205078125,
            "text": "EGF/bFGF",
            "probability": 0.03515625
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.41796875,
            "text": "EGF/bFGF-induced epithelial",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.53125,
            "text": "EGF/bFGF-induced",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.546875,
            "text": "EGF/bFGF-induced epithelial-mesenchymal",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 6.515625,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.515625,
            "text": "colon cancer cells undergoing EGF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 6.515625,
            "text": "factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.515625,
            "text": "CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 6.515625,
            "text": "ranscription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.515625,
            "text": "-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.515625,
            "text": "in colon cancer cells undergoing EGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.515625,
            "text": "undergoing EGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.515625,
            "text": "ption factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.875,
            "end_logit": 3.205078125,
            "text": "bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 3.205078125,
            "text": "c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 3.205078125,
            "text": "/bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 3.205078125,
            "text": "colon cancer cells undergoing EGF/bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": 3.205078125,
            "text": "factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 3.205078125,
            "text": "CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_13": [
        {
            "start_logit": 7.8984375,
            "end_logit": 7.67578125,
            "text": "EGF",
            "probability": 1.0
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -5.86328125,
            "text": "EGF and/or basic FGF",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.08203125,
            "text": "EGF and/or basic FGF (bFGF",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 7.67578125,
            "text": "with EGF",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.8046875,
            "text": "EGF and/",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 7.67578125,
            "text": "Treatment of HT29 and DLD-1 cells with EGF",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.85546875,
            "text": "EGF and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.85546875,
            "text": "EGF and/or",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.1875,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression resulting in enhanced E-selectin binding activity.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.22265625,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression resulting in enhanced E-selectin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.2265625,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression resulting in enhanced E-selectin binding activity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.234375,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression resulting in enhanced E-selectin binding",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.34375,
            "text": "EGF and/or basic FGF (bFGF)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.359375,
            "text": "EGF and/or basic FGF (bFGF) induced EMT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.39453125,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.43359375,
            "text": "EGF and/or basic FGF (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.453125,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression resulting",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.48828125,
            "text": "EGF and/or basic FGF (bFGF) induced EMT and significantly increased sLe(x/a) expression",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.67578125,
            "text": "HT29 and DLD-1 cells with EGF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.67578125,
            "text": "cells with EGF",
            "probability": 2.384185791015625e-07
        }
    ],
    "5319abffb166e2b80600002f_14": [
        {
            "start_logit": 8.1171875,
            "end_logit": 7.14453125,
            "text": "EGF",
            "probability": 1.0
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": 7.14453125,
            "text": "cell migration induced by IGF-I or EGF",
            "probability": 0.00011593103408813477
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -4.51171875,
            "text": "EGF stimulation",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -4.73046875,
            "end_logit": 7.14453125,
            "text": "IGF-I or EGF",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.2109375,
            "text": "EGF stimulation.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 7.14453125,
            "text": "enhanced cell migration induced by IGF-I or EGF",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.37890625,
            "text": "EGF stimulation. The phenotypic effects of Akt1 down-regulation were accompanied by enhanced extracellular signal-related kinase (ERK) activation",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.38671875,
            "text": "EGF stimulation. The phenotypic effects of Akt1 down-regulation were accompanied by enhanced extracellular signal-related kinase (ERK",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.48046875,
            "text": "EGF stimulation. The phenotypic effects of Akt1 down",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.74609375,
            "text": "EGF stimulation. The phenotypic effects of Akt1 down-regulation",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.0234375,
            "text": "EGF stimulation. The phenotypic effects of Akt1",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 7.14453125,
            "text": "by IGF-I or EGF",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 7.14453125,
            "text": "or EGF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.14453125,
            "text": "and enhanced cell migration induced by IGF-I or EGF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": -1.912109375,
            "text": "cell migration",
            "probability": 0.0
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": -4.51171875,
            "text": "cell migration induced by IGF-I or EGF stimulation",
            "probability": 0.0
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": -4.83984375,
            "text": "cell migration induced by IGF-I",
            "probability": 0.0
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": -6.2109375,
            "text": "cell migration induced by IGF-I or EGF stimulation.",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -1.912109375,
            "text": "enhanced cell migration",
            "probability": 0.0
        },
        {
            "start_logit": -0.9462890625,
            "end_logit": -6.48046875,
            "text": "cell migration induced by IGF-I or EGF stimulation. The phenotypic effects of Akt1 down",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_15": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.2890625,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.0205078125,
            "text": "IGF",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 9.2890625,
            "text": "II",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 9.2890625,
            "text": "-II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.19921875,
            "text": "IGF-II induces rapid beta-catenin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.24609375,
            "text": "IGF-II induces rapid beta-catenin relocation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.28125,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34375,
            "text": "IGF-II induces rapid beta-catenin rel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34765625,
            "text": "IGF-II induces",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.37890625,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3984375,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4375,
            "text": "IGF-II induces rapid beta-catenin relocation to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.49609375,
            "text": "IGF-II induces rapid beta-catenin relocation to the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.53125,
            "text": "IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.19921875,
            "text": "II induces rapid beta-catenin",
            "probability": 0.0
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.24609375,
            "text": "II induces rapid beta-catenin relocation",
            "probability": 0.0
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.28125,
            "text": "II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme",
            "probability": 0.0
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.34375,
            "text": "II induces rapid beta-catenin rel",
            "probability": 0.0
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.34765625,
            "text": "II induces",
            "probability": 0.0
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": -7.37890625,
            "text": "II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_16": [
        {
            "start_logit": 9.25,
            "end_logit": 9.234375,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.123046875,
            "text": "IGF",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": 9.234375,
            "text": "II",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 9.234375,
            "text": "-II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 9.234375,
            "text": ") IGF-II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.24609375,
            "text": "IGF-II induces",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.234375,
            "text": "1) IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.234375,
            "text": "that (1) IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.234375,
            "text": "(1) IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.4375,
            "text": "IGF-II induces a rapid epithelium",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51953125,
            "text": "IGF-II induces a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.55078125,
            "text": "IGF-II induces a rapid epithelium to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.58203125,
            "text": "IGF-II induces a rapid epithelium to mesenchymal transition",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -1.123046875,
            "text": ") IGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -1.123046875,
            "text": "1) IGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -1.123046875,
            "text": "that (1) IGF",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -1.123046875,
            "text": "(1) IGF",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.24609375,
            "text": "II induces",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.4375,
            "text": "II induces a rapid epithelium",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.51953125,
            "text": "II induces a",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_17": [
        {
            "start_logit": 9.375,
            "end_logit": 9.40625,
            "text": "IGF-II",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.81591796875,
            "text": "IGF",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -1.044921875,
            "end_logit": 9.40625,
            "text": "II",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -6.21875,
            "end_logit": 9.40625,
            "text": "-II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.046875,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell-cell adhesion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.046875,
            "text": "IGF-II and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.046875,
            "text": "IGF-II and E-cadherin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.23046875,
            "text": "IGF-II and E-cadherin/beta-catenin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 9.40625,
            "text": "given case of IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.40625,
            "text": "case of IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.34765625,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.40625,
            "text": "of IGF-II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.421875,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.44921875,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.4765625,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.4921875,
            "text": "IGF-II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell-cell",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.49609375,
            "text": "IGF-II and E-cadherin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.5078125,
            "text": "IGF-II and E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.044921875,
            "end_logit": -6.94921875,
            "text": "II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell-cell adhesion during EMT",
            "probability": 0.0
        },
        {
            "start_logit": -1.044921875,
            "end_logit": -7.046875,
            "text": "II and E-cadherin/beta-catenin complex, this study reveals the backbone of a cascade connecting growth factor signaling with cell-cell adhesion",
            "probability": 0.0
        }
    ],
    "5319abffb166e2b80600002f_18": [
        {
            "start_logit": 5.67578125,
            "end_logit": 8.078125,
            "text": "FGF-1",
            "probability": 1.0
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -0.33349609375,
            "text": "FGF-1 and EGF",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": -3.154296875,
            "end_logit": 8.078125,
            "text": "1",
            "probability": 0.00014650821685791016
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.078125,
            "text": "NBT-II rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 8.078125,
            "text": "-1",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.046875,
            "end_logit": 8.078125,
            "text": "to FGF-1",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.078125,
            "text": "rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -5.26171875,
            "text": "FGF",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -0.80322265625,
            "end_logit": -0.33349609375,
            "text": "EGF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.12109375,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to-mesenchyme transition (EMT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.21484375,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.27734375,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to-mesenchyme transition (EMT) when",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.3046875,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.3828125,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to-mesenchyme transition",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.4140625,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.67578125,
            "end_logit": -7.41796875,
            "text": "FGF-1 and EGF, entering mitosis at cell confluency while undergoing an epithelium-to-mesenchyme transition (EMT) when cultured",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.154296875,
            "end_logit": -0.33349609375,
            "text": "1 and EGF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -0.33349609375,
            "text": "NBT-II rat carcinoma cell line exhibits two mutually exclusive responses to FGF-1 and EGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -0.33349609375,
            "text": "-1 and EGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -0.33349609375,
            "text": "and EGF",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_1": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.109375,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.412109375,
            "text": "ExT",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": 9.109375,
            "text": "DB",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -6.296875,
            "end_logit": 9.109375,
            "text": "opoDB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.37109375,
            "text": "ExTopoDB: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.38671875,
            "text": "ExTopoDB: a database of experimentally derived topological models",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.39453125,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.40625,
            "text": "ExTopoDB:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.4453125,
            "text": "ExTopoDB: a database of experimentally derived topological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.49609375,
            "text": "ExTopoDB: a database of experimentally derived topological models of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.51953125,
            "text": "ExTopoDB: a database of experimentally derived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.54296875,
            "text": "ExTopoDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.56640625,
            "text": "ExTopoDB: a database of experimentally",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.37109375,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.38671875,
            "text": "DB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.39453125,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.40625,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.4453125,
            "text": "DB: a database of experimentally derived topological",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.49609375,
            "text": "DB: a database of experimentally derived topological models of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -7.51953125,
            "text": "DB: a database of experimentally derived",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_2": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.21875,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.310546875,
            "text": "ExT",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.58984375,
            "end_logit": 9.21875,
            "text": "DB",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 9.21875,
            "text": "opoDB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0234375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.21484375,
            "text": "ExTopoDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.38671875,
            "text": "ExTopoDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.40625,
            "text": "ExTopoDB is a publicly accessible",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.43359375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.51171875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the literature that report",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.51171875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the literature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.52734375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the literature that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.53515625,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.0234375,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.21484375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.38671875,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.40625,
            "text": "DB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.43359375,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.51171875,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the literature that report",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.51171875,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins. It contains information collected from studies in the literature",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_3": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.1328125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.46875,
            "text": "TMP",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": 9.1328125,
            "text": "DB",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.3203125,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.33984375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.37109375,
            "text": "TMPDB: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.46484375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.48046875,
            "text": "TMPDB:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.49609375,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.55078125,
            "text": "TMPDB: a database of experimentally-characterized",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.56640625,
            "text": "TMPDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.58203125,
            "text": "TMPDB: a database of experimentally-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.59375,
            "text": "TMPDB: a database of experimentally",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.3203125,
            "text": "DB: a database of experimentally-characterized transmembrane topologi",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.33984375,
            "text": "DB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.37109375,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.46484375,
            "text": "DB: a database of experimentally-characterized transmembrane topolo",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.48046875,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.49609375,
            "text": "DB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -7.55078125,
            "text": "DB: a database of experimentally-characterized",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_4": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.2890625,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": 9.2890625,
            "text": "DB",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.419921875,
            "text": "TMP",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.5078125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.5234375,
            "text": "TMPDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.52734375,
            "text": "TMPDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.5078125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.5234375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.52734375,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -7.13671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -7.51171875,
            "text": ". The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -7.51953125,
            "text": ". The TM topologies in TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -7.51953125,
            "text": ". The TM topologies in TMPDB were determined experimentally by means of X-ray",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.13671875,
            "text": ", and 9 alpha-helical sequences with short pore-forming helices buried in the membrane.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -7.13671875,
            "text": "membrane.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.32421875,
            "text": ". TMPDB",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -7.51171875,
            "text": "subsets are freely available at the following web site: http://bioinfo.si.hirosaki-u.ac",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -7.53125,
            "text": "subsets are freely available at the following web site: http:/",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.484375,
            "text": "following web site: http://bioinfo.si.hirosaki-u.ac.jp/~TMPDB/",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.5,
            "text": "following web site: http://bioinfo.si.hirosaki-u.ac.jp/~TMP",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_5": [
        {
            "start_logit": 9.25,
            "end_logit": 9.28125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.28125,
            "text": "ExT",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -1.482421875,
            "end_logit": 9.28125,
            "text": "DB",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 9.28125,
            "text": "opoDB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.00390625,
            "text": "ExTopoDB provides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.30078125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u0436\u2534-helical transmembrane proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.40234375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.453125,
            "text": "ExTopoDB provides an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.28125,
            "text": "and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.49609375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.5,
            "text": "ExTopoDB provides an up to date",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.5,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u0436\u2534-helical transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51171875,
            "text": "ExTopo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51171875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51171875,
            "text": "ExTopoDB provides an up to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51171875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.5234375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.52734375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u0436\u2534",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.28125,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.482421875,
            "end_logit": -7.00390625,
            "text": "DB provides",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_6": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.203125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.513671875,
            "text": "TMP",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": 9.203125,
            "text": "DB",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.22265625,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.265625,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.30078125,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.375,
            "text": "TMPDB: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.4453125,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.51953125,
            "text": "TMPDB: a database of experimentally-characterized transmembrane topo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.52734375,
            "text": "TMPDB:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5703125,
            "text": "TMPDB: a database of experimentally-characterized",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.59375,
            "text": "TMPDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.22265625,
            "text": "DB: a database of experimentally-characterized transmembrane topologies.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.265625,
            "text": "DB: a database of experimentally-characterized transmembrane topologies",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.30078125,
            "text": "DB: a database of experimentally-characterized transmembrane topologi",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.375,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.4453125,
            "text": "DB: a database of experimentally-characterized transmembrane topolo",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.51953125,
            "text": "DB: a database of experimentally-characterized transmembrane topo",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.52734375,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6005859375,
            "end_logit": -7.5703125,
            "text": "DB: a database of experimentally-characterized",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_7": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.21875,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.486328125,
            "text": "TMP",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": -1.572265625,
            "end_logit": 9.21875,
            "text": "DB",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.30078125,
            "text": "TMPDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.31640625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.3359375,
            "text": "TMPDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.41015625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.42578125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.48828125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.53515625,
            "text": "TMPDB is a database of experimentally-characterized",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.56640625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.56640625,
            "text": "TMPDB is a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.30078125,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.31640625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies.",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.3359375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.41015625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologi",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.42578125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.48828125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topolo",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.53515625,
            "text": "DB is a database of experimentally-characterized",
            "probability": 0.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": -7.56640625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_8": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.3515625,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": 9.3515625,
            "text": "DB",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.5693359375,
            "text": "TMP",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.3515625,
            "text": "in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.2265625,
            "text": "TMPDB were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.3515625,
            "text": "TM topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.37109375,
            "text": "TMPDB were determined experimentally by means of X-ray",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.37890625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.40234375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.40625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.43359375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.3515625,
            "text": "topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.4609375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.48828125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.2265625,
            "text": "DB were",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.37109375,
            "text": "DB were determined experimentally by means of X-ray",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.37890625,
            "text": "DB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.40234375,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.40625,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.43359375,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_9": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.2578125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.294921875,
            "text": "ExT",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -1.537109375,
            "end_logit": 9.2578125,
            "text": "DB",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": 9.2578125,
            "text": "opoDB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.0390625,
            "text": "ExTopoDB provides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.34375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.453125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.4921875,
            "text": "ExTopoDB provides an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.2578125,
            "text": "and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.515625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.515625,
            "text": "ExTopoDB provides an up to date",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.52734375,
            "text": "ExTopoDB provides an up to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.54296875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.546875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.56640625,
            "text": "ExTopo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.56640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.56640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.2578125,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.2578125,
            "text": "function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.537109375,
            "end_logit": -7.0390625,
            "text": "DB provides",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_10": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.25,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.2978515625,
            "text": "ExT",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -1.552734375,
            "end_logit": 9.25,
            "text": "DB",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 9.25,
            "text": "opoDB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.08203125,
            "text": "ExTopoDB provides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.328125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \ufffd-helical transmembrane proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.47265625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.25,
            "text": "and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.50390625,
            "text": "ExTopoDB provides an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.51171875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.51953125,
            "text": "ExTopoDB provides an up to date",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5234375,
            "text": "ExTopoDB provides an up to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.55859375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.55859375,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \ufffd-helical transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5625,
            "text": "ExTopo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.25,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.25,
            "text": "function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -7.08203125,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -1.2978515625,
            "text": "and ExT",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -7.328125,
            "text": "DB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \ufffd-helical transmembrane proteins.",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_11": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.2421875,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": 9.2421875,
            "text": "DB",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5908203125,
            "text": "ExT",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 9.2421875,
            "text": "opoDB",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.12109375,
            "text": "ExTopoDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.23828125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.33203125,
            "text": "ExTopoDB is a publicly accessible",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.359375,
            "text": "ExTopoDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.2421875,
            "text": ": ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.45703125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.484375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.51171875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.2421875,
            "text": "UNLABELLED: ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.57421875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.58203125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.59375,
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -7.12109375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -7.23828125,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -7.33203125,
            "text": "DB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -7.359375,
            "text": "DB is a",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_12": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.3515625,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": 9.3515625,
            "text": "DB",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.5693359375,
            "text": "TMP",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.3515625,
            "text": "in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.2265625,
            "text": "TMPDB were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.3515625,
            "text": "TM topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.37109375,
            "text": "TMPDB were determined experimentally by means of X-ray",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.37890625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.40234375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.40625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.43359375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.3515625,
            "text": "topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.4609375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.48828125,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.2265625,
            "text": "DB were",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.37109375,
            "text": "DB were determined experimentally by means of X-ray",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.37890625,
            "text": "DB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.40234375,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.40625,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.43359375,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_13": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.0703125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.53125,
            "text": "ExT",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.966796875,
            "end_logit": 9.0703125,
            "text": "DB",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 9.0703125,
            "text": "opoDB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.11328125,
            "text": "ExTopoDB provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.47265625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.5234375,
            "text": "ExTopoDB provides an up to date",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.52734375,
            "text": "ExTopoDB provides an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.54296875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.546875,
            "text": "ExTopoDB provides an up to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.56640625,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.57421875,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies of \u03b1-helical transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.578125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of experimentally determined topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.58203125,
            "text": "ExTopoDB provides an up to date, complete and comprehensive dataset of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.0703125,
            "text": "and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.0703125,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExTopoDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.966796875,
            "end_logit": -7.11328125,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -1.53125,
            "text": "and ExT",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -1.53125,
            "text": "Transmembrane protein topology is highly important in order to understand their function and ExT",
            "probability": 0.0
        },
        {
            "start_logit": -1.966796875,
            "end_logit": -7.47265625,
            "text": "DB provides an up to date, complete and comprehensive dataset of experimentally determined topologi",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_14": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.3203125,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.30078125,
            "end_logit": 9.3203125,
            "text": "DB",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.6005859375,
            "text": "TMP",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.21875,
            "text": "TMPDB were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.3203125,
            "text": "in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.375,
            "text": "TMPDB were determined experimentally by means of X-ray",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.3984375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4140625,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4296875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.3203125,
            "text": "topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.44921875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.46484375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.3203125,
            "text": "TM topologies in TMPDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.51171875,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.52734375,
            "text": "TMPDB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.30078125,
            "end_logit": -7.21875,
            "text": "DB were",
            "probability": 0.0
        },
        {
            "start_logit": -1.30078125,
            "end_logit": -7.375,
            "text": "DB were determined experimentally by means of X-ray",
            "probability": 0.0
        },
        {
            "start_logit": -1.30078125,
            "end_logit": -7.3984375,
            "text": "DB were determined experimentally by means of X-ray crystallography",
            "probability": 0.0
        },
        {
            "start_logit": -1.30078125,
            "end_logit": -7.4140625,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility",
            "probability": 0.0
        },
        {
            "start_logit": -1.30078125,
            "end_logit": -7.4296875,
            "text": "DB were determined experimentally by means of X-ray crystallography, NMR, gene fusion technique, substituted cysteine accessibility method, N-linked glycosylation",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_15": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.140625,
            "text": "TMPDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.4814453125,
            "text": "TMP",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.76171875,
            "end_logit": 9.140625,
            "text": "DB",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.30859375,
            "text": "TMPDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.32421875,
            "text": "TMPDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.4375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.48828125,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.515625,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topolo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.52734375,
            "text": "TMPDB is a database of experimentally-characterized",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.54296875,
            "text": "TMPDB is a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.58203125,
            "text": "TMPDB is a database of experimentally-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.5859375,
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.30859375,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.32421875,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.4375,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologi",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.48828125,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.515625,
            "text": "DB is a database of experimentally-characterized transmembrane (TM) topolo",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.52734375,
            "text": "DB is a database of experimentally-characterized",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.54296875,
            "text": "DB is a database of",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.58203125,
            "text": "DB is a database of experimentally-",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_16": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.234375,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3115234375,
            "text": "ExT",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -1.591796875,
            "end_logit": 9.234375,
            "text": "DB",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": 9.234375,
            "text": "opoDB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.9765625,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.34375,
            "text": "ExTopoDB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3515625,
            "text": "ExTopoDB: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3828125,
            "text": "ExTopoDB: a database of experimentally derived topological models",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.42578125,
            "text": "ExTopoDB:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.44921875,
            "text": "ExTopoDB: a database of experimentally derived topological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5234375,
            "text": "ExTopoDB: a database of experimentally derived topological models of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.53125,
            "text": "ExTopoDB: a database of experimentally derived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5625,
            "text": "ExTopoDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.57421875,
            "text": "ExTopoDB: a database of experimentally",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -6.9765625,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -7.34375,
            "text": "DB: a database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -7.3515625,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -7.3828125,
            "text": "DB: a database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -7.42578125,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": -7.44921875,
            "text": "DB: a database of experimentally derived topological",
            "probability": 0.0
        }
    ],
    "55414a763f2354b713000003_17": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.0703125,
            "text": "ExTopoDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.443359375,
            "text": "ExT",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": 9.0703125,
            "text": "DB",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": -6.203125,
            "end_logit": 9.0703125,
            "text": "opoDB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.24609375,
            "text": "ExTopoDB is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.34375,
            "text": "ExTopoDB is a publicly accessible",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.34765625,
            "text": "ExTopoDB is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.4296875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.47265625,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.53125,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.54296875,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.55078125,
            "text": "ExTopoDB is a publicly accessible database",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.55859375,
            "text": "ExTopoDB is a publicly accessible database of experimentally derived topological models of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.578125,
            "text": "ExTopoDB is a publicly accessible database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.24609375,
            "text": "DB is",
            "probability": 0.0
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.34375,
            "text": "DB is a publicly accessible",
            "probability": 0.0
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.34765625,
            "text": "DB is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.4296875,
            "text": "DB is a publicly accessible database of experimentally derived topological models",
            "probability": 0.0
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.47265625,
            "text": "DB is a publicly accessible database of experimentally derived topological models of transmembrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.9833984375,
            "end_logit": -7.53125,
            "text": "DB is a publicly accessible database of experimentally derived topological",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_1": [
        {
            "start_logit": 4.9140625,
            "end_logit": 6.30859375,
            "text": "kidney",
            "probability": 0.9970703125
        },
        {
            "start_logit": -1.0498046875,
            "end_logit": 6.30859375,
            "text": "renal cells/kidney",
            "probability": 0.0025691986083984375
        },
        {
            "start_logit": -3.18359375,
            "end_logit": 6.30859375,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": 4.9140625,
            "end_logit": -4.0390625,
            "text": "kidney tissues",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 6.30859375,
            "text": "present study explored the relevance of the aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": -6.765625,
            "end_logit": 6.30859375,
            "text": "study explored the relevance of the aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.30859375,
            "text": "has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.30859375,
            "text": "anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.30859375,
            "text": "relevance of the aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.30859375,
            "text": ", which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.30859375,
            "text": "murine renal cells/kidney",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.30859375,
            "text": "explored the relevance of the aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.30859375,
            "text": "\u2011aging activity and is highly expressed in murine renal cells/kidney",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -1.0498046875,
            "end_logit": -4.0390625,
            "text": "renal cells/kidney tissues",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0498046875,
            "end_logit": -4.18359375,
            "text": "renal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0498046875,
            "end_logit": -5.53515625,
            "text": "renal cells",
            "probability": 0.0
        },
        {
            "start_logit": -3.18359375,
            "end_logit": -4.0390625,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells/kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": -3.18359375,
            "end_logit": -4.18359375,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal",
            "probability": 0.0
        },
        {
            "start_logit": -1.0498046875,
            "end_logit": -7.125,
            "text": "renal cells/",
            "probability": 0.0
        },
        {
            "start_logit": -3.18359375,
            "end_logit": -5.53515625,
            "text": "aging suppressor, Klotho, which has anti\u2011aging activity and is highly expressed in murine renal cells",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_2": [
        {
            "start_logit": 8.3671875,
            "end_logit": 6.578125,
            "text": "Renal",
            "probability": 1.0
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -5.44921875,
            "text": "Renal expression of klotho is diminished in polycystic kidney",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.0234375,
            "text": "Renal expression",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -4.6875,
            "end_logit": 6.578125,
            "text": "growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.68359375,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.890625,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (PKD",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.0234375,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (PK",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.12890625,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (PKD)",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.24609375,
            "text": "Renal expression of klotho is diminished",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.265625,
            "text": "Renal expression of klotho",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.265625,
            "text": "Renal expression of klotho is diminished in polycystic kidney disease (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.3203125,
            "text": "Renal expression of klotho is diminished in",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.578125,
            "text": ". Renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 6.578125,
            "text": "(TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 6.578125,
            "text": "factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 6.578125,
            "text": "TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 6.578125,
            "text": "insulin-like growth factor (IGF). Renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 6.578125,
            "text": "\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.578125,
            "text": "ing growth factor-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.578125,
            "text": "-\u03b2 (TGF-\u03b2) and insulin-like growth factor (IGF). Renal",
            "probability": 1.7881393432617188e-07
        }
    ],
    "6060996394d57fd879000045_3": [
        {
            "start_logit": 7.98828125,
            "end_logit": 7.44921875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -6.75390625,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 7.44921875,
            "text": "\u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -6.8203125,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.16015625,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.25,
            "text": "kidney, and deletion of the Klotho gene in mice",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.3203125,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.33203125,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.34765625,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease (CKD).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.35546875,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of chronic kidney disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.4609375,
            "text": "kidney, and deletion of the Klotho gene in mice causes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.46484375,
            "text": "kidney, and deletion of the Klotho gene in mice causes a phenotype strikingly similar to that of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.44921875,
            "text": "antiaging membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.44921875,
            "text": "fortuitously discovered antiaging membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.44921875,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.44921875,
            "text": "Klotho (Klotho) is highly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.44921875,
            "text": "membrane protein \u03b1Klotho (Klotho) is highly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.44921875,
            "text": "highly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.44921875,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.26171875,
            "end_logit": -6.578125,
            "text": "\u03b1Klotho",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_4": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.3828125,
            "text": "heart",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.56640625,
            "text": "heart against ischaemia-reperfusion injury",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 7.3828125,
            "text": "High-intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.0390625,
            "text": "heart against ischaemia-reperfusion injury.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.2109375,
            "text": "heart against ischaemia-reperfusion",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.37109375,
            "text": "heart against",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.41796875,
            "text": "heart against ischaemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.49609375,
            "text": "heart against ischaemia-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.3828125,
            "text": "myocardial levels of Klotho and protects the heart",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.3828125,
            "text": "protects the heart",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.3828125,
            "text": "the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.3828125,
            "text": "interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.3828125,
            "text": "-intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.3828125,
            "text": "intensity interval training increases myocardial levels of Klotho and protects the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.3828125,
            "text": "levels of Klotho and protects the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -6.56640625,
            "text": "High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -6.8203125,
            "text": "High-intensity interval training",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -7.0390625,
            "text": "High-intensity interval training increases myocardial levels of Klotho and protects the heart against ischaemia-reperfusion injury.",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -7.15625,
            "text": "High-intensity interval training increases myocardial levels of Klotho and",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -7.17578125,
            "text": "High-intensity interval training increases myocardial",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_5": [
        {
            "start_logit": 2.73828125,
            "end_logit": 6.390625,
            "text": "cerebellum",
            "probability": 0.9990234375
        },
        {
            "start_logit": -4.9296875,
            "end_logit": 6.390625,
            "text": "Purkinje cells of the cerebellum",
            "probability": 0.00046896934509277344
        },
        {
            "start_logit": -6.296875,
            "end_logit": 6.390625,
            "text": "anti-aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 0.0001195073127746582
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 6.390625,
            "text": "the cerebellum",
            "probability": 5.0187110900878906e-05
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 6.390625,
            "text": "of the cerebellum",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.390625,
            "text": "an anti-aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 3.314018249511719e-05
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.390625,
            "text": "in Purkinje cells of the cerebellum",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 6.390625,
            "text": "is an anti-aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.390625,
            "text": "aging protein expressed in Purkinje cells of the cerebellum",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.390625,
            "text": "cells of the cerebellum",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.390625,
            "text": "protein expressed in Purkinje cells of the cerebellum",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 2.73828125,
            "end_logit": -6.96875,
            "text": "cerebellum.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -4.9296875,
            "end_logit": -5.875,
            "text": "Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": -4.9296875,
            "end_logit": -6.6796875,
            "text": "Purkinje",
            "probability": 0.0
        },
        {
            "start_logit": -4.9296875,
            "end_logit": -6.96875,
            "text": "Purkinje cells of the cerebellum.",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -5.73828125,
            "text": "anti-aging",
            "probability": 0.0
        },
        {
            "start_logit": -4.9296875,
            "end_logit": -7.2265625,
            "text": "Purkinje cells of",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -5.875,
            "text": "anti-aging protein expressed in Purkinje cells",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -6.6796875,
            "text": "anti-aging protein expressed in Purkinje",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -6.96875,
            "text": "anti-aging protein expressed in Purkinje cells of the cerebellum.",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_6": [
        {
            "start_logit": 7.58984375,
            "end_logit": 7.63671875,
            "text": "lens",
            "probability": 1.0
        },
        {
            "start_logit": -7.0,
            "end_logit": 7.63671875,
            "text": "tissues including the lens",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.63671875,
            "text": "the lens",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.63671875,
            "text": "limited tissues including the lens",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.31640625,
            "text": "lens.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.63671875,
            "text": "including the lens",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.63671875,
            "text": "in limited tissues including the lens",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.0546875,
            "text": "tissues",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.0546875,
            "text": "limited tissues",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.31640625,
            "text": "tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -7.31640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.390625,
            "text": "tissues including",
            "probability": 0.0
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -7.31640625,
            "text": "the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.31640625,
            "text": "limited tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.390625,
            "text": "limited tissues including",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.0546875,
            "text": "in limited tissues",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.31640625,
            "text": "including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.390625,
            "text": "including",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.31640625,
            "text": "in limited tissues including the lens.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.390625,
            "text": "in limited tissues including",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_7": [
        {
            "start_logit": 7.73828125,
            "end_logit": 7.6953125,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.57421875,
            "text": "brain may",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.06640625,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.09765625,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.2265625,
            "text": "brain may lead",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.26171875,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.6953125,
            "text": "in the brain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.37109375,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.6953125,
            "text": "Thus, upregulating Klotho in the brain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.390625,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.3984375,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.45703125,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.6953125,
            "text": "the brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.46484375,
            "text": "brain may lead to novel therapeutics to people suffering or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.484375,
            "text": "brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.6953125,
            "text": "upregulating Klotho in the brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -6.57421875,
            "text": "in the brain may",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -6.57421875,
            "text": "Thus, upregulating Klotho in the brain may",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -6.57421875,
            "text": "the brain may",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.57421875,
            "text": "upregulating Klotho in the brain may",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_8": [
        {
            "start_logit": 8.671875,
            "end_logit": 6.4765625,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.03125,
            "text": "kidneys, parathyroid glands",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.0390625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.40625,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.46875,
            "text": "kidneys, parathyroid glands, and choroid plexus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.54296875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.55078125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and released",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.57421875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.60546875,
            "text": "kidneys, parathyroid glands, and choroid plexus of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.60546875,
            "text": "kidneys,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.60546875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.60546875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.4765625,
            "text": "the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.4765625,
            "text": "single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 6.4765625,
            "text": ", a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.4765625,
            "text": "in the kidneys",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.4765625,
            "text": "a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.4765625,
            "text": ": Klotho, a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.4765625,
            "text": "-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.03125,
            "text": "parathyroid glands",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_9": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.7109375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.3203125,
            "text": "kidney, parathyroid gland, and choroid plexus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.6484375,
            "text": "kidney, parathyroid gland",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.33984375,
            "text": "kidney, parathyroid gland,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.34375,
            "text": "kidney, parathyroid gland, and choroid",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.7109375,
            "text": "in kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.39453125,
            "text": "kidney, parathyroid gland, and choroid plexus.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.7109375,
            "text": "transmembrane protein expressed primarily in kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.58203125,
            "text": "kidney, parathyroid gland, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.6328125,
            "text": "kidney, parathyroid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.7109375,
            "text": "Klotho is a transmembrane protein expressed primarily in kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -6.3203125,
            "text": "parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -6.3203125,
            "text": "choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.3203125,
            "text": "in kidney, parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -6.6484375,
            "text": "parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.3203125,
            "text": "transmembrane protein expressed primarily in kidney, parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -6.3203125,
            "text": "and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.3203125,
            "text": ", parathyroid gland, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.6484375,
            "text": "in kidney, parathyroid gland",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.3203125,
            "text": "Klotho is a transmembrane protein expressed primarily in kidney, parathyroid gland, and choroid plexus",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_10": [
        {
            "start_logit": 8.234375,
            "end_logit": 7.265625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.36328125,
            "text": "kidney tubules",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.27734375,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and osteoporesis, features common to patients with chronic renal",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.37890625,
            "text": "kidney tubules; the mutant mice",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.421875,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and osteoporesis, features common to patients with chronic renal failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.42578125,
            "text": "kidney tubules; the mutant mice have shortened life span",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.50390625,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and osteoporesis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5859375,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6015625,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and osteoporesis, features common",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.65625,
            "text": "kidney tubules; the mutant mice have shortened life span, arteriosclerosis, anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.265625,
            "text": "antiaging gene with restricted organ distribution, is mainly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.265625,
            "text": "the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.265625,
            "text": ", an antiaging gene with restricted organ distribution, is mainly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.265625,
            "text": "an antiaging gene with restricted organ distribution, is mainly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.265625,
            "text": "restricted organ distribution, is mainly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.36328125,
            "text": "antiaging gene with restricted organ distribution, is mainly expressed in the kidney tubules",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -6.36328125,
            "text": "the kidney tubules",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -6.36328125,
            "text": ", an antiaging gene with restricted organ distribution, is mainly expressed in the kidney tubules",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.36328125,
            "text": "an antiaging gene with restricted organ distribution, is mainly expressed in the kidney tubules",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_11": [
        {
            "start_logit": 7.56640625,
            "end_logit": 6.56640625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -3.435546875,
            "end_logit": 6.56640625,
            "text": "parathyroid glands, kidney",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -5.05859375,
            "text": "kidney, and choroid plexus, counteracts aging",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.1328125,
            "text": "kidney, and choroid plexus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.4375,
            "text": "kidney, and choroid",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.484375,
            "text": "kidney, and choroid plexus, counteracts aging and increases the life span",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.52734375,
            "text": "kidney, and choroid plexus, counteracts aging and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.54296875,
            "text": "kidney, and choroid plexus, counteracts aging and increases the life span. Accor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.5703125,
            "text": "kidney, and choroid plexus,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.5859375,
            "text": "kidney, and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 6.56640625,
            "text": ", kidney",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 6.56640625,
            "text": "membrane protein mainly expressed in parathyroid glands, kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.56640625,
            "text": "in parathyroid glands, kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.56640625,
            "text": ", a membrane protein mainly expressed in parathyroid glands, kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.56640625,
            "text": "a membrane protein mainly expressed in parathyroid glands, kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.435546875,
            "end_logit": -3.306640625,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -3.435546875,
            "end_logit": -5.05859375,
            "text": "parathyroid glands, kidney, and choroid plexus, counteracts aging",
            "probability": 0.0
        },
        {
            "start_logit": -3.435546875,
            "end_logit": -7.1328125,
            "text": "parathyroid glands, kidney, and choroid plexus",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -3.306640625,
            "text": "membrane protein mainly expressed in parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -3.306640625,
            "text": "in parathyroid glands",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_12": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.828125,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.8203125,
            "text": "kidney, is required for the inhibitory effect of FGF23",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.06640625,
            "text": "kidney, is required for the inhibitory effect of FGF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.14453125,
            "text": "kidney, is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.171875,
            "text": "kidney, is required",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.1875,
            "text": "kidney,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.31640625,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.32421875,
            "text": "kidney, is required for the inhibitory effect of FGF23 on",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.51171875,
            "text": "kidney, is required for the inhibitory effect",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.53125,
            "text": "kidney, is required for the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.53515625,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1,25(OH)2D3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.5546875,
            "text": "kidney, is required for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.828125,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.828125,
            "text": "protein expressed mainly in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.59765625,
            "text": "kidney, is required for the inhibitory effect of FGF23 on renal 1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.59765625,
            "text": "kidney, is required for the inhibitory effect of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.828125,
            "text": ", a protein expressed mainly in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.828125,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.8203125,
            "text": "inhibitory effect of FGF23",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -6.8203125,
            "text": "FGF23",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_13": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.4609375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.09765625,
            "text": "kidney in the distal but not in the proximal tubule",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.27734375,
            "text": "kidney in",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.4609375,
            "text": "FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.3671875,
            "text": "kidney in the distal but not in the proximal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4375,
            "text": "kidney in the distal but not",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4609375,
            "text": "kidney in the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.47265625,
            "text": "kidney in the distal but not in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.51171875,
            "text": "kidney in the distal but not in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.52734375,
            "text": "kidney in the distal but not in the proximal tubule. The mech",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5703125,
            "text": "kidney in the distal but",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 7.4609375,
            "text": "FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.4609375,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.4609375,
            "text": "ing of FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.4609375,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.4609375,
            "text": "of FGF23 to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.4609375,
            "text": "a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.4609375,
            "text": "to a FGF receptor requires a protein named Klotho that is expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -6.73828125,
            "text": "FGF23",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -6.83203125,
            "text": "FGF23 to a FGF receptor",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_14": [
        {
            "start_logit": 7.7421875,
            "end_logit": 7.50390625,
            "text": "kidney",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.529296875,
            "end_logit": 7.50390625,
            "text": "brain and kidney",
            "probability": 0.001987457275390625
        },
        {
            "start_logit": 1.529296875,
            "end_logit": 0.70849609375,
            "text": "brain",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 7.50390625,
            "text": "lotho, an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 7.50390625,
            "text": "anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.50390625,
            "text": "and kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.50390625,
            "text": "the brain and kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.50390625,
            "text": "in the brain and kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 0.70849609375,
            "text": "lotho, an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 0.70849609375,
            "text": "anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": 1.529296875,
            "end_logit": -7.45703125,
            "text": "brain and",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 0.70849609375,
            "text": "the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 0.70849609375,
            "text": "in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -6.11328125,
            "text": "lotho",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -6.1171875,
            "text": "lotho, an anti-aging",
            "probability": 0.0
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -6.1171875,
            "text": "anti-aging",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -6.89453125,
            "text": "lotho, an anti-aging gene",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -6.93359375,
            "text": "lot",
            "probability": 0.0
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -6.89453125,
            "text": "anti-aging gene",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -7.3671875,
            "text": "lotho, an anti-aging gene,",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_15": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.5390625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.0703125,
            "text": "kidney, where it acts",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.16015625,
            "text": "kidney, where it acts as a permissive co-receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.171875,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor 23",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.2734375,
            "text": "kidney,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.30859375,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor 23.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.40625,
            "text": "kidney, where it acts as",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.4140625,
            "text": "kidney, where it acts as a permissive co-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.4453125,
            "text": "kidney, where it acts as a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.46875,
            "text": "kidney, where it acts as a permissive co-receptor for",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.55859375,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast Growth Factor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.5625,
            "text": "kidney, where it acts as a permissive co-receptor for Fibroblast",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.59375,
            "text": "kidney, where it acts as a permissive co",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.5390625,
            "text": "membrane-bound protein predominantly expressed in the kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.5390625,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.5390625,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.5390625,
            "text": "is a membrane-bound protein predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.5390625,
            "text": "a membrane-bound protein predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -7.171875,
            "text": "Fibroblast Growth Factor 23",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -7.30859375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_16": [
        {
            "start_logit": 3.45703125,
            "end_logit": 3.703125,
            "text": "kidney",
            "probability": 0.77734375
        },
        {
            "start_logit": 2.015625,
            "end_logit": 3.703125,
            "text": "inner ear and in the distal convoluted tubule of the kidney",
            "probability": 0.1839599609375
        },
        {
            "start_logit": 2.015625,
            "end_logit": 2.1171875,
            "text": "inner ear",
            "probability": 0.03765869140625
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -4.640625,
            "text": "kidney, likely serving a common function in the two organs, i.e., modulating ion transport",
            "probability": 0.00018489360809326172
        },
        {
            "start_logit": -5.28125,
            "end_logit": 3.703125,
            "text": "stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 0.0001251697540283203
        },
        {
            "start_logit": -5.28125,
            "end_logit": 2.1171875,
            "text": "stria vascularis and spiral ligament of the inner ear",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -6.66796875,
            "text": "kidney, likely serving a common function in the two organs",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -6.67578125,
            "text": "kidney, likely serving a common function in the two organs, i.e., modulating ion",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 3.703125,
            "text": "distal convoluted tubule of the kidney",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 3.703125,
            "text": "ear and in the distal convoluted tubule of the kidney",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -7.28125,
            "end_logit": 3.703125,
            "text": "of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 3.703125,
            "text": "spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -7.171875,
            "text": "kidney, likely serving a common function in the two organs, i.e",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -7.18359375,
            "text": "kidney, likely serving a common function in the two organs, i.e., modulating ion transport.",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -7.453125,
            "end_logit": 3.703125,
            "text": "in the stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 3.703125,
            "text": "convoluted tubule of the kidney",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 3.703125,
            "text": "ia vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 3.703125,
            "text": "the stria vascularis and spiral ligament of the inner ear and in the distal convoluted tubule of the kidney",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 2.015625,
            "end_logit": -6.66796875,
            "text": "inner ear and in the distal convoluted tubule of the kidney, likely serving a common function in the two organs",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 2.1171875,
            "text": "ear",
            "probability": 4.470348358154297e-06
        }
    ],
    "6060996394d57fd879000045_17": [
        {
            "start_logit": 8.21875,
            "end_logit": 7.23046875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.0703125,
            "text": "kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.140625,
            "text": "kidney, parathyroid glands",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.31640625,
            "text": "kidney, parathyroid glands and choroid plexus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.375,
            "text": "kidney, parathyroid glands and choroid plexus of the brain.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5234375,
            "text": "kidney, parathyroid glands and choroid",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5625,
            "text": "kidney, parathyroid glands and choroid plexus of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.57421875,
            "text": "kidney, parathyroid glands and choroid plexus of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.23046875,
            "text": "antiaging protein of Klotho is a transmembrane protein mainly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.23046875,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.23046875,
            "text": "transmembrane protein mainly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.23046875,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.23046875,
            "text": "The antiaging protein of Klotho is a transmembrane protein mainly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.23046875,
            "text": "a transmembrane protein mainly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.0703125,
            "text": "antiaging protein of Klotho is a transmembrane protein mainly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.0703125,
            "text": "the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -6.0703125,
            "text": "parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.0703125,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.0703125,
            "text": "transmembrane protein mainly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.0703125,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_18": [
        {
            "start_logit": 8.0078125,
            "end_logit": 7.390625,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -5.66015625,
            "text": "kidney and choroid plexus of the brain",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.95703125,
            "text": "kidney and choroid plexus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.328125,
            "text": "kidney and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.33984375,
            "text": "kidney and choroid plexus of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.45703125,
            "text": "kidney and choroid plexus of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.390625,
            "text": "hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.390625,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.390625,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.390625,
            "text": ", encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.390625,
            "text": "primarily expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 7.390625,
            "text": ": The hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.390625,
            "text": "BACKGROUND: The hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -5.66015625,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -5.66015625,
            "text": "hormone klotho, encoded by the gene klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -5.66015625,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -5.66015625,
            "text": "the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -5.66015625,
            "text": "in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -5.66015625,
            "text": ", encoded by the gene klotho, is primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -5.66015625,
            "text": "primarily expressed in the kidney and choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_19": [
        {
            "start_logit": 7.734375,
            "end_logit": 7.80859375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -5.7734375,
            "text": "kidney and expressed in a limited number of other organs, including the brain",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.51171875,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in choroid plexus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 7.80859375,
            "text": "in kidney",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.06640625,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in choroid",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.25,
            "text": "kidney and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.36328125,
            "text": "kidney and expressed in a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.38671875,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in choroid plexus.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.453125,
            "text": "kidney and expressed in a limited number of other organs, including the brain,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.4921875,
            "text": "kidney and expressed in a limited number",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.50390625,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.5078125,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.51171875,
            "text": "kidney and expressed in a limited number of other organs, including",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.52734375,
            "text": "kidney and expressed in a limited number of other organs,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.5390625,
            "text": "kidney and expressed in a limited number of other organs, including the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.54296875,
            "text": "kidney and expressed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.54296875,
            "text": "kidney and expressed in a limited number of other organs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.5546875,
            "text": "kidney and expressed in a limited number of other organs, including the brain, where klotho levels are highest in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -5.7734375,
            "text": "in kidney and expressed in a limited number of other organs, including the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -5.7734375,
            "text": "brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_20": [
        {
            "start_logit": 8.5859375,
            "end_logit": 6.578125,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.0546875,
            "text": "kidneys, parathyroid glands",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.05859375,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.4453125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.47265625,
            "text": "kidneys, parathyroid glands, and choroid plexus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.51953125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.57421875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and released",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.578125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.60546875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.60546875,
            "text": "kidneys, parathyroid glands, and choroid plexus of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.609375,
            "text": "kidneys,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.61328125,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can be cleaved and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.6171875,
            "text": "kidneys, parathyroid glands, and choroid plexus of the brain, has a short cytoplasmic tail and a long extracellular domain, which can",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.578125,
            "text": "the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.578125,
            "text": "single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.578125,
            "text": ", a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": "in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.578125,
            "text": "a single-pass transmembrane protein primarily expressed in the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.0546875,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.05859375,
            "text": "parathyroid glands, and choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_21": [
        {
            "start_logit": 5.0390625,
            "end_logit": 4.52734375,
            "text": "kidney",
            "probability": 0.89453125
        },
        {
            "start_logit": 2.259765625,
            "end_logit": 4.52734375,
            "text": "parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 0.05584716796875
        },
        {
            "start_logit": 2.259765625,
            "end_logit": 4.41796875,
            "text": "parathyroid gland",
            "probability": 0.050048828125
        },
        {
            "start_logit": -5.328125,
            "end_logit": 4.52734375,
            "text": "gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": -5.328125,
            "end_logit": 4.41796875,
            "text": "gland",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -7.15234375,
            "text": "kidney.",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -6.671875,
            "end_logit": 4.52734375,
            "text": "FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 4.52734375,
            "text": "in the parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 4.52734375,
            "text": "where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 4.52734375,
            "text": "the parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 4.52734375,
            "text": "in kidney",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 4.52734375,
            "text": "expressed in the parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 4.41796875,
            "text": "in the parathyroid gland",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 4.41796875,
            "text": "the parathyroid gland",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 4.52734375,
            "text": "is expressed in the parathyroid gland, where FGF-23 decreases parathyroid hormone expression and secretion, further suppressing vitamin D synthesis in kidney",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 4.41796875,
            "text": "expressed in the parathyroid gland",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 4.52734375,
            "text": ", further suppressing vitamin D synthesis in kidney",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 4.41796875,
            "text": "is expressed in the parathyroid gland",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 2.259765625,
            "end_logit": -6.578125,
            "text": "parathyroid gland, where FGF-23",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 2.259765625,
            "end_logit": -6.73828125,
            "text": "parathyroid",
            "probability": 7.152557373046875e-07
        }
    ],
    "6060996394d57fd879000045_22": [
        {
            "start_logit": 8.015625,
            "end_logit": 7.19140625,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -1.6083984375,
            "text": "brain parenchyma from early postnatal development",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": 8.015625,
            "end_logit": -3.916015625,
            "text": "brain parenchyma from early postnatal development into adulthood",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": 8.015625,
            "end_logit": -4.5078125,
            "text": "brain parenchyma",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 8.015625,
            "end_logit": -6.1875,
            "text": "brain parenchyma from early postnatal",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.015625,
            "end_logit": -6.6015625,
            "text": "brain parenchyma from early postnatal development into",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.015625,
            "end_logit": -6.7265625,
            "text": "brain parenchyma from",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -6.8359375,
            "text": "brain parenchyma from early postnatal development into adulthood.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.19140625,
            "text": "in rat brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.19140625,
            "text": "rat brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.19140625,
            "text": "Expression of klotho mRNA and protein in rat brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.19140625,
            "text": "mRNA and protein in rat brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.19140625,
            "text": "of klotho mRNA and protein in rat brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": -1.6083984375,
            "text": "early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -1.6083984375,
            "text": "from early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -1.6083984375,
            "text": "in rat brain parenchyma from early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -1.6083984375,
            "text": "rat brain parenchyma from early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -1.6083984375,
            "text": "development",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -1.6083984375,
            "text": "Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -1.6083984375,
            "text": "postnatal development",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_23": [
        {
            "start_logit": 7.875,
            "end_logit": 6.171875,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -4.09375,
            "text": "brain parenchyma",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -4.83984375,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across postnatal development",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -5.515625,
            "text": "brain parenchyma, and no data is available as",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.2734375,
            "text": "brain parenchyma, and no data is available",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.87890625,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across postnatal development.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.90625,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.96875,
            "text": "brain parenchyma, and no data",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.9921875,
            "text": "brain parenchyma, and no data is",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.0,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across postnatal",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.12109375,
            "text": "brain parenchyma, and no data is available as to",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.21484375,
            "text": "brain parenchyma, and no data is available as to whether klotho levels change across",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.34765625,
            "text": "brain parenchyma, and no data is available as to whether",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.3984375,
            "text": "brain parenchyma,",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.171875,
            "text": "within the brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.171875,
            "text": "Reports vary on where klotho is expressed within the brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.171875,
            "text": "where klotho is expressed within the brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -4.09375,
            "text": "within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -4.09375,
            "text": "Reports vary on where klotho is expressed within the brain parenchyma",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -4.09375,
            "text": "where klotho is expressed within the brain parenchyma",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_24": [
        {
            "start_logit": 7.578125,
            "end_logit": 6.7734375,
            "text": "brain",
            "probability": 1.0
        },
        {
            "start_logit": 7.578125,
            "end_logit": -7.0234375,
            "text": "brain.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.7734375,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely throughout the brain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.7734375,
            "text": "the brain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.7734375,
            "text": "mRNA results, with klotho protein expressed widely throughout the brain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.7734375,
            "text": "with klotho protein expressed widely throughout the brain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.7734375,
            "text": "throughout the brain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.7734375,
            "text": "the mRNA results, with klotho protein expressed widely throughout the brain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.0234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.71484375,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.8125,
            "text": "Immunohistochemistry",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.8203125,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -6.71484375,
            "text": "mRNA",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.9296875,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -6.8203125,
            "text": "mRNA results, with klotho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.98046875,
            "text": "Immunohistochemistry revealed a protein expression pattern",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.8203125,
            "text": "with klotho protein expressed",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.0234375,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely throughout the brain.",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.0390625,
            "text": "Immunohistochemistry revealed a protein expression pattern similar to the mRNA results, with klotho protein expressed widely",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -6.9296875,
            "text": "mRNA results",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_25": [
        {
            "start_logit": 7.109375,
            "end_logit": 7.58984375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": 7.58984375,
            "text": "brain and kidney",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.58984375,
            "text": "anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.58984375,
            "text": "and kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.58984375,
            "text": "the brain and kidney",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.58984375,
            "text": "an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.58984375,
            "text": "in the brain and kidney",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.58984375,
            "text": ", an anti-aging gene, is mainly expressed in the brain and kidney",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.28125,
            "text": "kidney.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 7.58984375,
            "text": "mainly expressed in the brain and kidney",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -1.9599609375,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -1.9599609375,
            "text": "anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.9599609375,
            "text": "the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -1.9599609375,
            "text": "an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -7.28125,
            "text": "brain and kidney.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -1.9599609375,
            "text": "in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -1.9599609375,
            "text": ", an anti-aging gene, is mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -1.9599609375,
            "text": "mainly expressed in the brain",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -6.4296875,
            "text": "anti-aging",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -7.05859375,
            "text": "anti-aging gene",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_26": [
        {
            "start_logit": 8.359375,
            "end_logit": 7.0078125,
            "text": "kidney",
            "probability": 0.955078125
        },
        {
            "start_logit": 5.25,
            "end_logit": 7.0078125,
            "text": "brain, kidney",
            "probability": 0.042633056640625
        },
        {
            "start_logit": 5.25,
            "end_logit": 3.904296875,
            "text": "brain",
            "probability": 0.0019168853759765625
        },
        {
            "start_logit": 8.359375,
            "end_logit": -6.51171875,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid gland",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.359375,
            "end_logit": -6.94921875,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.33984375,
            "text": "kidney, reproductive organs, pituitary gland, and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.43359375,
            "text": "kidney, reproductive organs, pituitary gland",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.44140625,
            "text": "kidney, reproductive organs, pituitary gland,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.45703125,
            "text": "kidney, reproductive organs, pituitary gland, and parathyroid gland.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.50390625,
            "text": "kidney, reproductive organs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.59375,
            "text": "kidney, reproductive organs, pituitary",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.0078125,
            "text": ", kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.0078125,
            "text": "in brain, kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.0078125,
            "text": "however, is expressed only in brain, kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.0078125,
            "text": ", however, is expressed only in brain, kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.25,
            "end_logit": -6.51171875,
            "text": "brain, kidney, reproductive organs, pituitary gland, and parathyroid gland",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.25,
            "end_logit": -6.94921875,
            "text": "brain, kidney, reproductive organs, pituitary gland, and parathyroid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.25,
            "end_logit": -7.33984375,
            "text": "brain, kidney, reproductive organs, pituitary gland, and",
            "probability": 0.0
        },
        {
            "start_logit": 5.25,
            "end_logit": -7.43359375,
            "text": "brain, kidney, reproductive organs, pituitary gland",
            "probability": 0.0
        },
        {
            "start_logit": 5.25,
            "end_logit": -7.44140625,
            "text": "brain, kidney, reproductive organs, pituitary gland,",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_27": [
        {
            "start_logit": 8.0859375,
            "end_logit": 7.3828125,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.05078125,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.453125,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.1640625,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine, and ovaries",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.1953125,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.28515625,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine, and ovaries.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.37890625,
            "text": "kidney, while RT-PCR detected",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.3828125,
            "text": "kidney, while RT-PCR detected low levels of expression also",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.4140625,
            "text": "kidney, while RT-PCR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.421875,
            "text": "kidney, while RT-PCR detected low levels of expression",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.42578125,
            "text": "kidney, while RT-PCR detected low levels of expression also in the brain, lung, intestine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.3828125,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.3828125,
            "text": "single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.3828125,
            "text": "rat klotho cDNA probe identified a single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.3828125,
            "text": "Northern blot analysis using the rat klotho cDNA probe identified a single transcript of 5.2 kb in size expressed predominantly in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.3828125,
            "text": "in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -6.05078125,
            "text": "lung",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -6.05078125,
            "text": "brain, lung",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -6.453125,
            "text": "brain",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -7.1640625,
            "text": "lung, intestine, and ovaries",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_28": [
        {
            "start_logit": 4.359375,
            "end_logit": 6.59765625,
            "text": "choroid plexus",
            "probability": 0.95703125
        },
        {
            "start_logit": 1.240234375,
            "end_logit": 6.59765625,
            "text": "brain, Klotho proteins were localized at choroid plexus",
            "probability": 0.042388916015625
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 6.59765625,
            "text": "plexus",
            "probability": 8.64267349243164e-05
        },
        {
            "start_logit": 1.240234375,
            "end_logit": -0.0355224609375,
            "text": "brain",
            "probability": 5.5789947509765625e-05
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 6.59765625,
            "text": "at choroid plexus",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 6.59765625,
            "text": "In brain, Klotho proteins were localized at choroid plexus",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 6.59765625,
            "text": "localized at choroid plexus",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.59765625,
            "text": ", Klotho proteins were localized at choroid plexus",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.59765625,
            "text": "were localized at choroid plexus",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.59765625,
            "text": "proteins were localized at choroid plexus",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -6.4609375,
            "text": "choroid",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -6.8203125,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of ependym",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -6.83984375,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of ependymal cells",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -6.8984375,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.13671875,
            "text": "choroid plexus,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.16796875,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of ependymal",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.1953125,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma membrane of ependymal cells.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.26171875,
            "text": "choroid plexus, where the proteins were",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.30859375,
            "text": "choroid plexus, where the proteins were dominantly localized at the apical plasma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 4.359375,
            "end_logit": -7.3828125,
            "text": "choroid plexus, where the proteins were dominantly localized",
            "probability": 7.748603820800781e-07
        }
    ],
    "6060996394d57fd879000045_29": [
        {
            "start_logit": 8.71875,
            "end_logit": 6.31640625,
            "text": "kidneys",
            "probability": 1.0
        },
        {
            "start_logit": 8.71875,
            "end_logit": -5.03125,
            "text": "kidneys and brain",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -5.359375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.953125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.09765625,
            "text": "kidneys and",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.30078125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver, which was in contrast to previous reports.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.359375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver, which was in contrast to previous reports",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.39453125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.4609375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.5,
            "text": "kidneys and brain, other tissues primarily expressed",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.52734375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-kl",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.53125,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver, which was in contrast",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.53515625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.54296875,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver, which",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.54296875,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including liver, which was in contrast to previous",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.56640625,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-klotho, including",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.5859375,
            "text": "kidneys and brain, other tissues primarily expressed the shorter-form \u03b1-kloth",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.31640625,
            "text": "the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.31640625,
            "text": "that, except for the kidneys",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.31640625,
            "text": ", except for the kidneys",
            "probability": 1.1920928955078125e-07
        }
    ],
    "6060996394d57fd879000045_30": [
        {
            "start_logit": 8.1328125,
            "end_logit": 7.36328125,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.09765625,
            "text": "kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.1171875,
            "text": "kidney, parathyroid glands",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.1875,
            "text": "kidney, parathyroid glands and choroid plexus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.31640625,
            "text": "kidney, parathyroid glands and choroid plexus of the brain.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.41015625,
            "text": "kidney, parathyroid glands and choroid plexus of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.46484375,
            "text": "kidney, parathyroid glands and choroid plexus of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.515625,
            "text": "kidney, parathyroid glands and choroid",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.61328125,
            "text": "kidney,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.6171875,
            "text": "kidney, parathyroid glands and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 7.36328125,
            "text": "anti-aging protein predominantly expressed in the kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.36328125,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.36328125,
            "text": "an anti-aging protein predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.36328125,
            "text": "in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.36328125,
            "text": "is an anti-aging protein predominantly expressed in the kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -6.09765625,
            "text": "anti-aging protein predominantly expressed in the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -6.09765625,
            "text": "choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -6.09765625,
            "text": "parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.09765625,
            "text": "the kidney, parathyroid glands and choroid plexus of the brain",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.09765625,
            "text": "and choroid plexus of the brain",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_31": [
        {
            "start_logit": 6.98828125,
            "end_logit": 7.65234375,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": -3.28515625,
            "end_logit": 7.65234375,
            "text": "distal tubule cells of the kidney",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -3.806640625,
            "text": "kidney, choroid plexus in the brain, and the main cells of the parathyroid gland",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 7.65234375,
            "text": "the kidney",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.65234375,
            "text": "calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 7.65234375,
            "text": "tubule cells of the kidney",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 7.65234375,
            "text": "as distal tubule cells of the kidney",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.65234375,
            "text": "tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.65234375,
            "text": "gene is expressed principally in the important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.65234375,
            "text": "important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.65234375,
            "text": "Furthermore, the klotho gene is expressed principally in the important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.65234375,
            "text": "in the important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.65234375,
            "text": ", the klotho gene is expressed principally in the important tissues for calcium homeostasis such as distal tubule cells of the kidney",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.1015625,
            "text": "kidney, choroid plexus in the brain",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.1171875,
            "text": "kidney, choroid plexus in the brain, and the main cells of the parathyroid gland.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.17578125,
            "text": "kidney, choroid plexus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.375,
            "text": "kidney, choroid plexus in the brain, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.42578125,
            "text": "kidney, choroid plexus in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.4609375,
            "text": "kidney, choroid",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.28515625,
            "end_logit": -3.806640625,
            "text": "distal tubule cells of the kidney, choroid plexus in the brain, and the main cells of the parathyroid gland",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_32": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.57421875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.8984375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.140625,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.15625,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure (CRF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.27734375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.30078125,
            "text": "kidney and the expression level of klotho RNA was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.30859375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure (CRF) patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.33984375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure (CRF) patients.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.34375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.390625,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of chronic renal failure (CRF)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.390625,
            "text": "kidney and the expression level of klotho RNA was shown",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.3984375,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly reduced in the kidneys of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.4453125,
            "text": "kidney and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.45703125,
            "text": "kidney and the expression level of klotho RNA was shown to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.51171875,
            "text": "kidney and the expression level of klotho RNA was shown to be greatly",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.57421875,
            "text": "the kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.57421875,
            "text": "in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.57421875,
            "text": "The klotho gene is predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.57421875,
            "text": "klotho gene is predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.57421875,
            "text": "gene is predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        }
    ],
    "6060996394d57fd879000045_33": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.5546875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.63671875,
            "text": "kidney is",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.85546875,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus metabolism",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.94140625,
            "text": "kidney is a fundamental regulator of aging and calcium",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.98046875,
            "text": "kidney is a fundamental regulator of aging",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.23046875,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus metabolism.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.26171875,
            "text": "kidney is a fundamental regulator of aging and calcium/phosphorus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.31640625,
            "text": "kidney is a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.39453125,
            "text": "kidney is a fundamental regulator of aging and calcium/",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.46484375,
            "text": "kidney is a fundamental regulator of aging and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.5546875,
            "text": "gene predominantly expressed in the kidney",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.5546875,
            "text": "the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5546875,
            "text": "klotho gene: a gene predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.5546875,
            "text": "a gene predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.5546875,
            "text": "gene: a gene predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.5546875,
            "text": "The klotho gene: a gene predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.5546875,
            "text": "otho gene: a gene predominantly expressed in the kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": -6.63671875,
            "text": "gene predominantly expressed in the kidney is",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -6.63671875,
            "text": "the kidney is",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -6.85546875,
            "text": "gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism",
            "probability": 0.0
        }
    ],
    "6060996394d57fd879000045_34": [
        {
            "start_logit": 8.25,
            "end_logit": 6.94921875,
            "text": "kidney",
            "probability": 1.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": 6.94921875,
            "text": "brain and kidney",
            "probability": 0.0004639625549316406
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.51953125,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.83984375,
            "text": "kidney tissues",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.2109375,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.2890625,
            "text": "kidney tissues were",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.40234375,
            "text": "kidney tissues were examined",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.52734375,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.546875,
            "text": "kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -0.1292724609375,
            "text": "brain",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.94921875,
            "text": "and kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.94921875,
            "text": "in rat brain and kidney",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.94921875,
            "text": "rat brain and kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.94921875,
            "text": "mRNA and protein expression levels in rat brain and kidney",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -5.51953125,
            "text": "brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting",
            "probability": 0.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -5.83984375,
            "text": "brain and kidney tissues",
            "probability": 0.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -7.2109375,
            "text": "brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively.",
            "probability": 0.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -7.2890625,
            "text": "brain and kidney tissues were",
            "probability": 0.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -7.40234375,
            "text": "brain and kidney tissues were examined",
            "probability": 0.0
        },
        {
            "start_logit": 0.57958984375,
            "end_logit": -7.52734375,
            "text": "brain and kidney tissues were examined using reverse transcription-quantitative polymerase chain reaction and western blotting, respectively",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_1": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3984375,
            "text": "telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": -1.1416015625,
            "end_logit": 9.3984375,
            "text": "s",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2529296875,
            "text": "telangiectasia",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.89453125,
            "text": "telangiectasias, erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.3984375,
            "text": "(telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2421875,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.3984375,
            "text": "I (telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.42578125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.51953125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.58203125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.58984375,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.61328125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6328125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6640625,
            "text": "telangiectasias, erythrocyt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6875,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perineph",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6953125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting) syndrome is a newly described",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.703125,
            "text": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gamm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1416015625,
            "end_logit": -6.89453125,
            "text": "s, erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.1416015625,
            "end_logit": -7.2421875,
            "text": "s, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -1.2529296875,
            "text": "(telangiectasia",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_2": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.40625,
            "text": "telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": 9.40625,
            "text": "s",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.2646484375,
            "text": "telangiectasia",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.16015625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.328125,
            "end_logit": 9.40625,
            "text": "(telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.40625,
            "text": "syndrome (telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.48046875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5390625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.55859375,
            "text": "telangiectasias, elevated erythropoietin level and erythrocyt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5625,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.57421875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.609375,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.64453125,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.6484375,
            "text": "telangiectasias, elevated erythropoietin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.66796875,
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.115234375,
            "end_logit": -7.16015625,
            "text": "s, elevated erythropoietin level and erythrocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": -7.48046875,
            "text": "s, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -1.2646484375,
            "text": "(telangiectasia",
            "probability": 0.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": -7.5390625,
            "text": "s, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting)",
            "probability": 0.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": -7.55859375,
            "text": "s, elevated erythropoietin level and erythrocyt",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_3": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.3125,
            "text": "Telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": -1.3662109375,
            "end_logit": 9.3125,
            "text": "s",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.4140625,
            "text": "Telangiectasia",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.3125,
            "text": ": Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.3125,
            "text": "constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.3125,
            "text": "characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.3125,
            "text": "hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.36328125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.3125,
            "text": ", and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.3125,
            "text": "by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.3125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.44140625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.515625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.578125,
            "text": "Telangiectasias, Erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.6015625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66015625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.6640625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perineph",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6b7daa7c78d6947100002b_4": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.296875,
            "text": "teleangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": -1.427734375,
            "end_logit": 9.296875,
            "text": "s",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.681640625,
            "text": "tele",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 9.296875,
            "text": "angiectasias",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.296875,
            "text": "asias",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.296875,
            "text": "by teleangiectasias",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.8828125,
            "text": "teleangiectasia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.0,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.1640625,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26171875,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.3203125,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.5,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.5234375,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.5703125,
            "text": "teleangiectasias, elevated erythropoietin and erythrocyt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.5703125,
            "text": "teleangiectasias, elevated erythropoietin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.59765625,
            "text": "teleangiectasias,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.6015625,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.60546875,
            "text": "teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perineph",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.427734375,
            "end_logit": -7.0,
            "text": "s, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.0
        },
        {
            "start_logit": -1.427734375,
            "end_logit": -7.1640625,
            "text": "s, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting.",
            "probability": 0.0
        }
    ],
    "5c6b7daa7c78d6947100002b_5": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.3125,
            "text": "Telangiectasias",
            "probability": 1.0
        },
        {
            "start_logit": -1.3662109375,
            "end_logit": 9.3125,
            "text": "s",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.4140625,
            "text": "Telangiectasia",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.3125,
            "text": ": Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.3125,
            "text": "constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.3125,
            "text": "characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.3125,
            "text": "hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.36328125,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.3125,
            "text": ", and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.3125,
            "text": "by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.3125,
            "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.44140625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.515625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.578125,
            "text": "Telangiectasias, Erythrocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.6015625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66015625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.6640625,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.66796875,
            "text": "Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perineph",
            "probability": 5.960464477539063e-08
        }
    ],
    "551adceb622b194345000018_1": [
        {
            "start_logit": 8.0078125,
            "end_logit": 7.5625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.0546875,
            "text": "age, blood pressure, clinical features, duration and diabetes",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.34765625,
            "text": "age, blood pressure, clinical features, duration and diabetes (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.5625,
            "text": "of age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.4765625,
            "text": "age, blood pressure, clinical features",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.4921875,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.50390625,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.5625,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.5625,
            "text": "age, blood pressure, clinical features,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.5703125,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.58203125,
            "text": "age, blood pressure, clinical features, duration and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2)) scoring by non-stroke specialists referring patients to a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.67578125,
            "text": "age, blood pressure, clinical features, duration and diabetes (ABCD(2))",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.5625,
            "text": "'accuracy' of age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.5625,
            "text": "The 'accuracy' of age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -6.0546875,
            "text": "diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -6.0546875,
            "text": "blood pressure, clinical features, duration and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -6.0546875,
            "text": "of age, blood pressure, clinical features, duration and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -6.0546875,
            "text": ", blood pressure, clinical features, duration and diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -6.0546875,
            "text": "'accuracy' of age, blood pressure, clinical features, duration and diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_2": [
        {
            "start_logit": 8.453125,
            "end_logit": 6.91015625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.453125,
            "end_logit": -5.125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 8.453125,
            "end_logit": -6.45703125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.3046875,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.34765625,
            "text": "age, blood pressure, clinical features, duration of symptoms",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.36328125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.85546875,
            "end_logit": 6.91015625,
            "text": "an age",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.44140625,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.49609375,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.55859375,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4 and the absence of high risk",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.57421875,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4 and the absence of high risk features",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 6.91015625,
            "text": "on an age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 6.91015625,
            "text": "low risk was based on an age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.91015625,
            "text": "Classification of low risk was based on an age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.85546875,
            "end_logit": -5.125,
            "text": "an age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -5.125,
            "text": "<4",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -5.125,
            "text": "on an age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -5.125,
            "text": "diabetes (ABCD2) score <4",
            "probability": 0.0
        },
        {
            "start_logit": -7.109375,
            "end_logit": -5.125,
            "text": "blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -5.125,
            "text": "low risk was based on an age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score <4",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_3": [
        {
            "start_logit": 8.796875,
            "end_logit": 6.34765625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.86328125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.42578125,
            "text": "age, blood pressure, clinical features and duration of symptoms",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.38671875,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.421875,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.484375,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes (",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 6.34765625,
            "text": "[age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.34765625,
            "text": "compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 6.34765625,
            "text": "clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 6.34765625,
            "text": "to compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.34765625,
            "text": "very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.34765625,
            "text": "predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -5.6015625,
            "text": "brain infarction",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -6.4296875,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.171875,
            "text": "brain infarction on imaging",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.3359375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (ABCD3",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.40234375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.40625,
            "text": "brain infarction on",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.4609375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.50390625,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (ABC",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_4": [
        {
            "start_logit": 8.515625,
            "end_logit": 6.734375,
            "text": "age",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.515625,
            "end_logit": -0.5439453125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes",
            "probability": 0.000690460205078125
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.3828125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.51171875,
            "text": "age, blood pressure, clinical features, duration of symptoms",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.55859375,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after TIA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.61328125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.6171875,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.6640625,
            "text": "age, blood pressure, clinical features",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.67578125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after TIA, and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.72265625,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.73828125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.7421875,
            "text": "age, blood pressure",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.7578125,
            "text": "age, blood pressure, clinical features, duration of symptoms and diabetes (ABCD2) score, a validated risk prediction model for stroke after",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 6.734375,
            "text": "association of the age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 6.734375,
            "text": "the age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 6.734375,
            "text": "examined the association of the age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 6.734375,
            "text": "of the age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.734375,
            "text": "the association of the age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.734375,
            "text": "We examined the association of the age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.216796875,
            "end_logit": -0.5439453125,
            "text": "diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_5": [
        {
            "start_logit": 8.1171875,
            "end_logit": 7.44921875,
            "text": "Age",
            "probability": 1.0
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -5.87890625,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.5234375,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.55859375,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.5859375,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.6015625,
            "text": "Age, Blood pressure, Clinical features",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.60546875,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.6953125,
            "text": "Age, Blood pressure, Clinical",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.74609375,
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack who are at high risk for",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.44921875,
            "text": "(Age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.44921875,
            "text": "ABCD2 score (Age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -5.87890625,
            "text": "Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -5.87890625,
            "text": "(Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -5.87890625,
            "text": "Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -5.87890625,
            "text": "Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -5.87890625,
            "text": "and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -5.87890625,
            "text": ", Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -5.87890625,
            "text": ", Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -5.87890625,
            "text": "ABCD2 score (Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -5.87890625,
            "text": "Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_6": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.66015625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.93359375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.66015625,
            "text": "incorporating age",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.109375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.66015625,
            "text": "risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.66015625,
            "text": "by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.53515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.66015625,
            "text": "predicted by scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.66015625,
            "text": "The risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.5625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.66015625,
            "text": "scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.58203125,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.59375,
            "text": "age, blood pressure, clinical",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.6015625,
            "text": "age, blood pressure, clinical features",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.61328125,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.63671875,
            "text": "age, blood pressure, clinical features, duration (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.6484375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.66015625,
            "text": "stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 1.7881393432617188e-07
        }
    ],
    "551adceb622b194345000018_7": [
        {
            "start_logit": 8.3515625,
            "end_logit": 7.046875,
            "text": "age",
            "probability": 0.984375
        },
        {
            "start_logit": 8.3515625,
            "end_logit": 2.84765625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension",
            "probability": 0.01483917236328125
        },
        {
            "start_logit": 3.11328125,
            "end_logit": 2.84765625,
            "text": "hypertension",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -5.9609375,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -6.53125,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.3046875,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.359375,
            "text": "age, blood pressure, clinical symptoms",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.44140625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.44140625,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.59375,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.62109375,
            "text": "age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension and acute hyperglycemia in addition",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.046875,
            "text": "the age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.046875,
            "text": "Modifications to the age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.11328125,
            "end_logit": -5.9609375,
            "text": "hypertension and acute hyperglycemia",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": 2.84765625,
            "text": "history of hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 3.11328125,
            "end_logit": -6.51953125,
            "text": "hypertension and acute hyperglycemia in addition to acute blood pressure (BP) elevation and history of diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 2.84765625,
            "text": "the age, blood pressure, clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": 2.84765625,
            "text": "incorporate history of hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 2.84765625,
            "text": "clinical symptoms, duration of symptoms, and diabetes (ABCD2) score, which incorporate history of hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 3.11328125,
            "end_logit": -7.40625,
            "text": "hypertension and acute hyperglycemia in addition to acute blood pressure (BP) elevation and history of diabetes, have been proposed to increase the predictive value",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_8": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.55859375,
            "text": "Age",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.23828125,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.3203125,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk of stroke.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.45703125,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4609375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5390625,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5546875,
            "text": "Age, Blood pressure, Clinical features, Duration",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.57421875,
            "text": "Age, Blood pressure, Clinical features",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.58984375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.59375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.62890625,
            "text": "Age, Blood pressure, Clinical",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.68359375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and magnetic resonance imaging abnormalities help to identify patients at high risk of stroke",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.68359375,
            "text": "Age, Blood pressure, Clinical features, Duration, Diabetes) score and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.703125,
            "text": "Age, Blood pressure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.55859375,
            "text": "(Age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.23828125,
            "text": "Blood pressure, Clinical features, Duration, Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.23828125,
            "text": "Clinical features, Duration, Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -6.23828125,
            "text": "(Age, Blood pressure, Clinical features, Duration, Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.23828125,
            "text": "Duration, Diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.23828125,
            "text": ", Blood pressure, Clinical features, Duration, Diabetes",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_9": [
        {
            "start_logit": 8.21875,
            "end_logit": 7.21875,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.29296875,
            "text": "age [> or",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.21875,
            "text": "(age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.21875,
            "text": "We prospectively calculated the ABCD(2) score (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.21875,
            "text": "calculated the ABCD(2) score (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.21875,
            "text": ") score (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": -5.96875,
            "text": "duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -6.09765625,
            "text": "duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -6.75390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -5.96875,
            "text": ", other symptom: 0]; duration of symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.09765625,
            "text": "<10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.75390625,
            "text": "consecutive TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -6.75390625,
            "text": "3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.75390625,
            "text": "in consecutive TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -6.75390625,
            "text": "in 3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -6.75390625,
            "text": "patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.75390625,
            "text": "TIA patients hospitalized in 3 tertiary care neurology departments across 2 different racial populations (white and Asian).",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -7.33203125,
            "text": "duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -7.35546875,
            "text": "duration of symptoms [ <10 minutes: 0, 10-59 minutes: 1, > or = 60 minutes: 2]; diabetes mellitus",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -7.1328125,
            "text": "1 point]; blood pressure [systolic >140 mm Hg or diastolic >90 mm Hg: 1[; clinical features [unilateral weakness",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_10": [
        {
            "start_logit": 9.296875,
            "end_logit": 4.1484375,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -4.6796875,
            "text": "age over 60 years",
            "probability": 0.00014650821685791016
        },
        {
            "start_logit": 9.296875,
            "end_logit": -5.796875,
            "text": "age over 60",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.30859375,
            "text": "age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.48046875,
            "text": "age over",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.84375,
            "text": "age over 60 years [1 point]: B blood pressure",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.17578125,
            "text": "age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features, including unilateral weakness",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.21484375,
            "text": "age over 60 years [1 point]: B blood pressure > 140",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 4.1484375,
            "text": "A age",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 4.1484375,
            "text": "(A age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 4.1484375,
            "text": "Early stroke risk is especially high in TIA patients with a high ABCD2 score of 4 or more (A age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 4.1484375,
            "text": "4 or more (A age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 4.1484375,
            "text": "in TIA patients with a high ABCD2 score of 4 or more (A age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 4.1484375,
            "text": "more (A age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -4.6796875,
            "text": "A age over 60 years",
            "probability": 0.0
        },
        {
            "start_logit": -5.484375,
            "end_logit": -5.109375,
            "text": "ischemic lesions on diffusion weighted image, > 50% carotid stenosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -5.796875,
            "text": "A age over 60",
            "probability": 0.0
        },
        {
            "start_logit": -5.484375,
            "end_logit": -5.5625,
            "text": "ischemic lesions",
            "probability": 0.0
        },
        {
            "start_logit": -4.94140625,
            "end_logit": -6.30859375,
            "text": "A age over 60 years [1 point]: B blood pressure > 140/90 mmHg [1 point]: C Clinical features",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -4.6796875,
            "text": "(A age over 60 years",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_11": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.4140625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.3515625,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance] [C",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.44140625,
            "text": "age [A], blood pressure [B], clinical",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.47265625,
            "text": "age [",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.50390625,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance] [C], transient ischemic attack duration [",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.53515625,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance] [",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.546875,
            "text": "age [A], blood pressure [B",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.546875,
            "text": "age [A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.55859375,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.57421875,
            "text": "age [A], blood pressure [B], clinical features [weakness/speech disturbance]",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 7.4140625,
            "text": ", in admitted patients with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.4140625,
            "text": ", the accuracy of the ABCD(2) (age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.4140625,
            "text": ") (age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.4140625,
            "text": "in admitted patients with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.4140625,
            "text": "evaluate, in admitted patients with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.4140625,
            "text": "We evaluate, in admitted patients with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.4140625,
            "text": "patients with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.4140625,
            "text": "the accuracy of the ABCD(2) (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.4140625,
            "text": "with transient ischemic attack, the accuracy of the ABCD(2) (age",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.4140625,
            "text": "accuracy of the ABCD(2) (age",
            "probability": 1.7881393432617188e-07
        }
    ],
    "551adceb622b194345000018_12": [
        {
            "start_logit": 8.796875,
            "end_logit": 6.34765625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.86328125,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.42578125,
            "text": "age, blood pressure, clinical features and duration of symptoms",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.38671875,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.421875,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.484375,
            "text": "age, blood pressure, clinical features and duration of symptoms (ABCD) score, ABCD and diabetes (",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 6.34765625,
            "text": "[age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.34765625,
            "text": "compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 6.34765625,
            "text": "clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 6.34765625,
            "text": "to compare the very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.34765625,
            "text": "very early predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.34765625,
            "text": "predictive accuracy of the most relevant clinical scores [age",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -5.6015625,
            "text": "brain infarction",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -6.4296875,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.171875,
            "text": "brain infarction on imaging",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.3359375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (ABCD3",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.40234375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.40625,
            "text": "brain infarction on",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.4609375,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.50390625,
            "text": "brain infarction on imaging score, ABCD2 and brain infarction on imaging score, ABCD and prior TIA within 1 week of the index event (ABC",
            "probability": 0.0
        }
    ],
    "551adceb622b194345000018_13": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.63671875,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 7.90625,
            "end_logit": -5.83984375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.63671875,
            "text": "incorporating age",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.109375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score).",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 7.63671875,
            "text": "risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 7.63671875,
            "text": "by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 7.63671875,
            "text": "The risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.53515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.5625,
            "text": "age, blood pressure, clinical features",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.59765625,
            "text": "age, blood pressure, clinical",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.609375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.63671875,
            "text": "predicted by scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.63671875,
            "text": "scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.65234375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.65625,
            "text": "age, blood pressure, clinical features,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.65625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.68359375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score",
            "probability": 2.384185791015625e-07
        }
    ],
    "551adceb622b194345000018_14": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.66015625,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.93359375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.66015625,
            "text": "incorporating age",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.109375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.66015625,
            "text": "risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.66015625,
            "text": "by scores incorporating age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.53515625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.66015625,
            "text": "predicted by scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.66015625,
            "text": "The risk of stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.5625,
            "text": "age, blood pressure, clinical features, duration (ABCD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.66015625,
            "text": "scores incorporating age",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.58203125,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.59375,
            "text": "age, blood pressure, clinical",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.6015625,
            "text": "age, blood pressure, clinical features",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.61328125,
            "text": "age, blood pressure, clinical features, duration",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.62890625,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.63671875,
            "text": "age, blood pressure, clinical features, duration (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.6484375,
            "text": "age, blood pressure, clinical features, duration (ABCD-score), and diabetes (ABCD2-score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.66015625,
            "text": "stroke after a transient ischaemic attack (TIA) can be predicted by scores incorporating age",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c6585287c78d69471000004_1": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.4453125,
            "text": "acute myeloid leukemia",
            "probability": 1.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": 9.4453125,
            "text": "leukemia",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.115234375,
            "text": "acute",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 9.4453125,
            "text": "myeloid leukemia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.65625,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.10546875,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mast",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.4453125,
            "text": "for acute myeloid leukemia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.33203125,
            "text": "acute myeloid leukemia with activating FLT3 mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.44140625,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.4453125,
            "text": "Food and Drug Administration (FDA) and the European Medical Agency (EMA) for acute myeloid leukemia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.50390625,
            "text": "acute myeloid leukemia with activating FLT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.546875,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (ASM), systemic mastocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.578125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.58203125,
            "text": "acute myeloid leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -6.65625,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis",
            "probability": 0.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -7.10546875,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mast",
            "probability": 0.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -7.33203125,
            "text": "leukemia with activating FLT3 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -7.44140625,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as",
            "probability": 0.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -7.50390625,
            "text": "leukemia with activating FLT3",
            "probability": 0.0
        },
        {
            "start_logit": -0.8408203125,
            "end_logit": -7.546875,
            "text": "leukemia with activating FLT3 mutations in combination with intensive induction and consolidation therapy as well as aggressive systemic mastocytosis (ASM), systemic mastocytosis",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_1": [
        {
            "start_logit": 8.421875,
            "end_logit": 8.8984375,
            "text": "regulates transcription",
            "probability": 1.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": 8.8984375,
            "text": "transcription",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.421875,
            "end_logit": -2.1015625,
            "text": "regulates",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 8.421875,
            "end_logit": -2.125,
            "text": "regulates transcription, translation",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 8.421875,
            "end_logit": -5.4765625,
            "text": "regulates transcription, translation, splicing",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 8.8984375,
            "text": ". Being present in key regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.19921875,
            "text": "regulates transcription, translation, splicing, etc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.8984375,
            "text": "telomere, G-Quadruplex structure regulates transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.8984375,
            "text": "structure regulates transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.8984375,
            "text": ", G-Quadruplex structure regulates transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.8984375,
            "text": "RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.8984375,
            "text": "regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.83203125,
            "text": "regulates transcription, translation, splicing, etc.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.8984375,
            "text": "Being present in key regulatory regions of oncogenes, RNAs and telomere, G-Quadruplex structure regulates transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.1484375,
            "text": "regulates transcription,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -2.125,
            "text": "transcription, translation",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -5.4765625,
            "text": "transcription, translation, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -6.19921875,
            "text": "transcription, translation, splicing, etc",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -6.83203125,
            "text": "transcription, translation, splicing, etc.",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -7.1484375,
            "text": "transcription,",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_2": [
        {
            "start_logit": -2.59375,
            "end_logit": -1.69140625,
            "text": "biological events",
            "probability": 0.34619140625
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -0.6435546875,
            "text": "5'-TTAGGG-3'/5'-UUAGGG-3' repeats and those in gene regulatory regions",
            "probability": 0.279296875
        },
        {
            "start_logit": -5.34375,
            "end_logit": -0.6435546875,
            "text": "gene regulatory regions",
            "probability": 0.06304931640625
        },
        {
            "start_logit": -2.59375,
            "end_logit": -3.697265625,
            "text": "biological events, including replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer",
            "probability": 0.046661376953125
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -0.6435546875,
            "text": "in gene regulatory regions",
            "probability": 0.039306640625
        },
        {
            "start_logit": -2.78125,
            "end_logit": -3.697265625,
            "text": "cancer",
            "probability": 0.0386962890625
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.6435546875,
            "text": "telomeric 5'-TTAGGG-3'/5'-UUAGGG-3' repeats and those in gene regulatory regions",
            "probability": 0.0294342041015625
        },
        {
            "start_logit": -5.34375,
            "end_logit": -1.69140625,
            "text": "gene regulatory regions. G4s regulate various biological events",
            "probability": 0.022125244140625
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -3.244140625,
            "text": "5'-TTAGGG-3'/5'-UUAGGG-3' repeats",
            "probability": 0.0207061767578125
        },
        {
            "start_logit": -6.6875,
            "end_logit": -0.6435546875,
            "text": "repeats and those in gene regulatory regions",
            "probability": 0.016448974609375
        },
        {
            "start_logit": -2.59375,
            "end_logit": -4.7734375,
            "text": "biological events, including replication, transcription, and translation",
            "probability": 0.0158843994140625
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -1.69140625,
            "text": "in gene regulatory regions. G4s regulate various biological events",
            "probability": 0.0137939453125
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -0.6435546875,
            "text": "those in gene regulatory regions",
            "probability": 0.012908935546875
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -0.6435546875,
            "text": "' repeats and those in gene regulatory regions",
            "probability": 0.01180267333984375
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -1.69140625,
            "text": "G4s regulate various biological events",
            "probability": 0.0103759765625
        },
        {
            "start_logit": -6.3671875,
            "end_logit": -1.69140625,
            "text": "regulate various biological events",
            "probability": 0.00792694091796875
        },
        {
            "start_logit": -6.40625,
            "end_logit": -1.69140625,
            "text": ". G4s regulate various biological events",
            "probability": 0.007678985595703125
        },
        {
            "start_logit": -2.59375,
            "end_logit": -5.69140625,
            "text": "biological events, including replication",
            "probability": 0.006366729736328125
        },
        {
            "start_logit": -2.59375,
            "end_logit": -5.78515625,
            "text": "biological events, including replication, transcription",
            "probability": 0.005794525146484375
        },
        {
            "start_logit": -6.6875,
            "end_logit": -1.69140625,
            "text": "repeats and those in gene regulatory regions. G4s regulate various biological events",
            "probability": 0.005794525146484375
        }
    ],
    "6220ce4c3a8413c653000068_3": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.0546875,
            "text": "translational suppression",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.72216796875,
            "text": "translational",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -1.56640625,
            "end_logit": 9.0546875,
            "text": "suppression",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -4.6796875,
            "text": "translational suppression, splicing",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -5.24609375,
            "text": "translational suppression, splicing etc",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.5234375,
            "text": "translational suppression, splicing etc.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 9.0546875,
            "text": "as translational suppression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.0546875,
            "text": "RNA G-quadruplexes such as translational suppression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.41796875,
            "text": "translational suppression,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.0546875,
            "text": "functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.0546875,
            "text": "plausible functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.0546875,
            "text": ", the plausible functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.0546875,
            "text": "Further, the plausible functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.0546875,
            "text": "the plausible functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.56640625,
            "end_logit": -4.6796875,
            "text": "suppression, splicing",
            "probability": 0.0
        },
        {
            "start_logit": -1.56640625,
            "end_logit": -5.24609375,
            "text": "suppression, splicing etc",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -0.72216796875,
            "text": "as translational",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -0.72216796875,
            "text": "RNA G-quadruplexes such as translational",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -0.72216796875,
            "text": "functions of RNA G-quadruplexes such as translational",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -0.72216796875,
            "text": "plausible functions of RNA G-quadruplexes such as translational",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_4": [
        {
            "start_logit": 8.109375,
            "end_logit": 6.6953125,
            "text": "inhibition of telomerase",
            "probability": 1.0
        },
        {
            "start_logit": 8.109375,
            "end_logit": -3.193359375,
            "text": "inhibition",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 8.109375,
            "end_logit": -4.0703125,
            "text": "inhibition of telomerase and",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -4.6875,
            "end_logit": 6.6953125,
            "text": "telomerase",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.35546875,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development, particularly for novel anticancer therapies.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.52734375,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development, particularly for novel anticancer",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.6484375,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.7265625,
            "text": "inhibition of telomerase and the regulation of gene transcription",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.89453125,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.93359375,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development, particularly for novel anticancer therapies",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.0,
            "text": "inhibition of telomerase and the regulation of gene",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.06640625,
            "text": "inhibition of",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.1328125,
            "text": "inhibition of telomerase and the regulation of",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.22265625,
            "text": "inhibition of telomerase and the",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.234375,
            "text": "inhibition of telomerase and the regulation of gene transcription and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.8515625,
            "end_logit": 6.6953125,
            "text": "biological functions, including inhibition of telomerase",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.3671875,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.375,
            "text": "inhibition of telomerase and the regulation of gene transcription and translation, and have become an active target for drug development, particularly",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 6.6953125,
            "text": "of telomerase",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 6.6953125,
            "text": "including inhibition of telomerase",
            "probability": 2.980232238769531e-07
        }
    ],
    "6220ce4c3a8413c653000068_5": [
        {
            "start_logit": 0.2890625,
            "end_logit": -1.85546875,
            "text": "transcription",
            "probability": 0.73193359375
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -3.775390625,
            "text": "transcription, translation, regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 0.1072998046875
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -4.28125,
            "text": "transcription, translation, regulation of telomere length",
            "probability": 0.064697265625
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -4.32421875,
            "text": "transcription, translation",
            "probability": 0.06201171875
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -6.58203125,
            "text": "transcription, translation, regulation of telomere length, and formation of telomeric heterochromatin.",
            "probability": 0.0064849853515625
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -6.96484375,
            "text": "transcription,",
            "probability": 0.004421234130859375
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -7.03125,
            "text": "transcription, translation, regulation of telomere",
            "probability": 0.004138946533203125
        },
        {
            "start_logit": -4.96484375,
            "end_logit": -1.85546875,
            "text": "as transcription",
            "probability": 0.003826141357421875
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -7.15234375,
            "text": "transcription, translation, regulation of telomere length, and formation",
            "probability": 0.003665924072265625
        },
        {
            "start_logit": 0.2890625,
            "end_logit": -7.33203125,
            "text": "transcription, translation, regulation of telomere length,",
            "probability": 0.003063201904296875
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -1.85546875,
            "text": "processes such as transcription",
            "probability": 0.0022830963134765625
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -1.85546875,
            "text": "RNA G-quadruplexes have important roles in various processes such as transcription",
            "probability": 0.002056121826171875
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -3.775390625,
            "text": "regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 0.000789642333984375
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -1.85546875,
            "text": "important roles in various processes such as transcription",
            "probability": 0.0006008148193359375
        },
        {
            "start_logit": -6.84375,
            "end_logit": -1.85546875,
            "text": "various processes such as transcription",
            "probability": 0.0005822181701660156
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -1.85546875,
            "text": "Growing evidence indicates that RNA G-quadruplexes have important roles in various processes such as transcription",
            "probability": 0.0005731582641601562
        },
        {
            "start_logit": -4.96484375,
            "end_logit": -3.775390625,
            "text": "as transcription, translation, regulation of telomere length, and formation of telomeric heterochromatin",
            "probability": 0.0005598068237304688
        },
        {
            "start_logit": -6.984375,
            "end_logit": -1.85546875,
            "text": "that RNA G-quadruplexes have important roles in various processes such as transcription",
            "probability": 0.0005059242248535156
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -4.28125,
            "text": "regulation of telomere length",
            "probability": 0.0004749298095703125
        },
        {
            "start_logit": -4.96484375,
            "end_logit": -4.28125,
            "text": "as transcription, translation, regulation of telomere length",
            "probability": 0.0003368854522705078
        }
    ],
    "6220ce4c3a8413c653000068_6": [
        {
            "start_logit": 9.390625,
            "end_logit": 9.1640625,
            "text": "translational suppression",
            "probability": 1.0
        },
        {
            "start_logit": 9.390625,
            "end_logit": -0.7373046875,
            "text": "translational",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -1.501953125,
            "end_logit": 9.1640625,
            "text": "suppression",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -5.90234375,
            "text": "translational suppression, splicing etc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.0625,
            "text": "translational suppression, splicing",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.69140625,
            "text": "translational suppression, splicing etc. are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.703125,
            "text": "translational suppression, splicing etc. are discussed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 9.1640625,
            "text": "as translational suppression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.11328125,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope for an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.12109375,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.3125,
            "text": "translational suppression, splicing etc. are discussed in brief, suggesting scope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.4140625,
            "text": "translational suppression,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.4296875,
            "text": "translational suppression, splicing etc. are discussed in brief",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.48828125,
            "text": "translational suppression, splicing etc. are discussed in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.1640625,
            "text": "RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.1640625,
            "text": "functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.1640625,
            "text": "plausible functions of RNA G-quadruplexes such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.1640625,
            "text": "such as translational suppression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.52734375,
            "end_logit": -0.7373046875,
            "text": "as translational",
            "probability": 0.0
        },
        {
            "start_logit": -1.501953125,
            "end_logit": -5.90234375,
            "text": "suppression, splicing etc",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_7": [
        {
            "start_logit": 7.359375,
            "end_logit": 3.9609375,
            "text": "DNA replication",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.359375,
            "end_logit": -3.720703125,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability and cancer",
            "probability": 0.000461578369140625
        },
        {
            "start_logit": 7.359375,
            "end_logit": -3.884765625,
            "text": "DNA",
            "probability": 0.0003917217254638672
        },
        {
            "start_logit": 7.359375,
            "end_logit": -4.65234375,
            "text": "DNA replication, transcription",
            "probability": 0.00018227100372314453
        },
        {
            "start_logit": 7.359375,
            "end_logit": -4.85546875,
            "text": "DNA replication, transcription, and translation",
            "probability": 0.000148773193359375
        },
        {
            "start_logit": 7.359375,
            "end_logit": -6.3046875,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability",
            "probability": 3.4749507904052734e-05
        },
        {
            "start_logit": 7.359375,
            "end_logit": -6.44140625,
            "text": "DNA replication,",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 7.359375,
            "end_logit": -6.57421875,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability and cancer.",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 7.359375,
            "end_logit": -7.2265625,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 7.359375,
            "end_logit": -7.234375,
            "text": "DNA replication, transcription, and translation, while aberrant G-quadruplex formation",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 3.9609375,
            "text": "regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 3.9609375,
            "text": "as DNA replication",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -5.8125,
            "end_logit": 3.9609375,
            "text": "biological processes such as DNA replication",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 3.9609375,
            "text": "processes such as DNA replication",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 3.9609375,
            "text": "replication",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 3.9609375,
            "text": "important regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 3.9609375,
            "text": "fundamental biological processes such as DNA replication",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 3.9609375,
            "text": "that G-quadruplexes serve important regulatory roles in fundamental biological processes such as DNA replication",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -2.87890625,
            "text": "regulatory roles",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -3.720703125,
            "text": "regulatory roles in fundamental biological processes such as DNA replication, transcription, and translation, while aberrant G-quadruplex formation is linked to genome instability and cancer",
            "probability": 0.0
        }
    ],
    "6220ce4c3a8413c653000068_8": [
        {
            "start_logit": 3.513671875,
            "end_logit": 3.14453125,
            "text": "pre-mRNA processing (splicing and polyadenylation",
            "probability": 0.8857421875
        },
        {
            "start_logit": 1.408203125,
            "end_logit": 3.14453125,
            "text": "regulators of pre-mRNA processing (splicing and polyadenylation",
            "probability": 0.1082763671875
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -3.064453125,
            "text": "pre-mRNA processing (splicing and polyadenylation)",
            "probability": 0.0017862319946289062
        },
        {
            "start_logit": -2.935546875,
            "end_logit": 3.14453125,
            "text": "(splicing and polyadenylation",
            "probability": 0.0014066696166992188
        },
        {
            "start_logit": -3.283203125,
            "end_logit": 3.14453125,
            "text": "splicing and polyadenylation",
            "probability": 0.0009899139404296875
        },
        {
            "start_logit": 1.408203125,
            "end_logit": -3.064453125,
            "text": "regulators of pre-mRNA processing (splicing and polyadenylation)",
            "probability": 0.00021731853485107422
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -5.3984375,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover, mRNA targeting and translation",
            "probability": 0.00017333030700683594
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -5.62109375,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover",
            "probability": 0.00013828277587890625
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 3.14453125,
            "text": "processing (splicing and polyadenylation",
            "probability": 0.00012385845184326172
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -5.75390625,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover, mRNA targeting and translation.",
            "probability": 0.00012099742889404297
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -5.9921875,
            "text": "pre-mRNA processing",
            "probability": 9.572505950927734e-05
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -6.18359375,
            "text": "pre-mRNA processing (splicing and polyaden",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -6.25390625,
            "text": "pre-mRNA processing (splicing and",
            "probability": 7.337331771850586e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": 3.14453125,
            "text": "of pre-mRNA processing (splicing and polyadenylation",
            "probability": 5.942583084106445e-05
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -6.67578125,
            "text": "pre",
            "probability": 4.8160552978515625e-05
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 3.14453125,
            "text": "mRNA processing (splicing and polyadenylation",
            "probability": 4.738569259643555e-05
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -6.7265625,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA turnover, mRNA targeting",
            "probability": 4.595518112182617e-05
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 3.14453125,
            "text": "ylation",
            "probability": 3.898143768310547e-05
        },
        {
            "start_logit": 3.513671875,
            "end_logit": -6.921875,
            "text": "pre-mRNA processing (splicing and polyadenylation), RNA",
            "probability": 3.7789344787597656e-05
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 3.14453125,
            "text": "important regulators of pre-mRNA processing (splicing and polyadenylation",
            "probability": 3.409385681152344e-05
        }
    ],
    "6220ce4c3a8413c653000068_9": [
        {
            "start_logit": 8.125,
            "end_logit": 6.82421875,
            "text": "inhibition of transcription",
            "probability": 0.9912109375
        },
        {
            "start_logit": 8.125,
            "end_logit": 1.66015625,
            "text": "inhibition of transcription, translation",
            "probability": 0.00562286376953125
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.91015625,
            "text": "inhibition of transcription, translation, and DNA replication",
            "probability": 0.0026569366455078125
        },
        {
            "start_logit": 8.125,
            "end_logit": -2.84765625,
            "text": "inhibition",
            "probability": 6.246566772460938e-05
        },
        {
            "start_logit": -3.07421875,
            "end_logit": 6.82421875,
            "text": "transcription",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -4.75,
            "end_logit": 6.82421875,
            "text": "biological functions, such as the inhibition of transcription",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.4140625,
            "text": "inhibition of transcription,",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.5390625,
            "text": "inhibition of transcription, translation, and DNA replication.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.69921875,
            "text": "inhibition of transcription, translation, and",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.171875,
            "text": "inhibition of",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 6.82421875,
            "text": "different conformations of G-quadruplexes have certain influences on their biological functions, such as the inhibition of transcription",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 6.82421875,
            "text": "the inhibition of transcription",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 6.82421875,
            "text": "of transcription",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.82421875,
            "text": "as the inhibition of transcription",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 6.82421875,
            "text": "conformations of G-quadruplexes have certain influences on their biological functions, such as the inhibition of transcription",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 6.82421875,
            "text": "influences on their biological functions, such as the inhibition of transcription",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 6.82421875,
            "text": "such as the inhibition of transcription",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.07421875,
            "end_logit": 1.66015625,
            "text": "transcription, translation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.07421875,
            "end_logit": 0.91015625,
            "text": "transcription, translation, and DNA replication",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.67578125,
            "end_logit": 0.91015625,
            "text": "DNA replication",
            "probability": 0.0
        }
    ],
    "5ad303970340b9f05800001a_1": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.6015625,
            "text": "inflammation",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.8515625,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.19921875,
            "text": "inflammation, oxidative stress",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 7.6015625,
            "text": "to inflammation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.39453125,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.40625,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.6015625,
            "text": "Growth differentiation factor 15 (GDF-15) is expressed and secreted in response to inflammation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.5859375,
            "text": "inflammation, oxidative",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.625,
            "text": "inflammation, oxidative stress, hypoxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.65234375,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.6796875,
            "text": "inflammation, oxidative stress, hypoxia, telomere erosion, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.70703125,
            "text": "inflammation, oxidative stress, hypoxia, telomere",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.6015625,
            "text": "response to inflammation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.6015625,
            "text": "in response to inflammation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -6.8515625,
            "text": "to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -6.8515625,
            "text": "Growth differentiation factor 15 (GDF-15) is expressed and secreted in response to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.19921875,
            "text": "to inflammation, oxidative stress",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.39453125,
            "text": "to inflammation, oxidative stress, hypoxia, telomere erosion",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.40625,
            "text": "to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene activation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.8515625,
            "text": ", telomere erosion, and oncogene activation",
            "probability": 0.0
        }
    ],
    "5ad303970340b9f05800001a_2": [
        {
            "start_logit": 3.30078125,
            "end_logit": 7.7109375,
            "text": "tissue injury",
            "probability": 0.9970703125
        },
        {
            "start_logit": -2.77734375,
            "end_logit": 7.7109375,
            "text": "injury",
            "probability": 0.002277374267578125
        },
        {
            "start_logit": -4.96875,
            "end_logit": 7.7109375,
            "text": "response to tissue injury",
            "probability": 0.0002543926239013672
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 7.7109375,
            "text": "to tissue injury",
            "probability": 8.32676887512207e-05
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 7.7109375,
            "text": "in response to tissue injury",
            "probability": 4.601478576660156e-05
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.7109375,
            "text": "induced in response to tissue injury",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.7109375,
            "text": "may be induced in response to tissue injury",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.7109375,
            "text": "that is widely expressed and may be induced in response to tissue injury",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.7109375,
            "text": "TGF-\u03b2cytokine superfamily that is widely expressed and may be induced in response to tissue injury",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 3.30078125,
            "end_logit": -5.4921875,
            "text": "tissue",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 3.30078125,
            "end_logit": -7.02734375,
            "text": "tissue injury.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.77734375,
            "end_logit": -7.02734375,
            "text": "injury.",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -5.4921875,
            "text": "response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -5.4921875,
            "text": "to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -7.02734375,
            "text": "response to tissue injury.",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -6.859375,
            "text": "Growth differentiation",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -5.4921875,
            "text": "in response to tissue",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -7.12109375,
            "text": "Growth differentiation factor",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -7.17578125,
            "text": "Growth differentiation factor-15",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -7.2578125,
            "text": "Growth differentiation factor-15 (",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_1": [
        {
            "start_logit": 1.34375,
            "end_logit": -1.6455078125,
            "text": "transposons",
            "probability": 0.43212890625
        },
        {
            "start_logit": -0.5634765625,
            "end_logit": 0.1868896484375,
            "text": "Alu",
            "probability": 0.401123046875
        },
        {
            "start_logit": -1.6025390625,
            "end_logit": 0.1868896484375,
            "text": "Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.1417236328125
        },
        {
            "start_logit": 1.34375,
            "end_logit": -6.20703125,
            "text": "transposons and retrotransposons). Despite their abundance, only a small fraction of them are currently active in our genome (Long Interspersed",
            "probability": 0.00450897216796875
        },
        {
            "start_logit": 1.34375,
            "end_logit": -6.61328125,
            "text": "transposons and retrotransposons",
            "probability": 0.003002166748046875
        },
        {
            "start_logit": -5.60546875,
            "end_logit": 0.1868896484375,
            "text": ", Alu",
            "probability": 0.002590179443359375
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.0625,
            "text": "transposons and",
            "probability": 0.0019168853759765625
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.12890625,
            "text": "transposons and retrotransposons). Despite their abundance, only a small fraction of them are currently active in our genome (Long Interspersed Element",
            "probability": 0.00179290771484375
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.171875,
            "text": "transposons and retrotransposons).",
            "probability": 0.0017175674438476562
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.265625,
            "text": "transposons and retrotransposons). Despite their abundance, only a small fraction of them are currently active in our genome (Long Intersp",
            "probability": 0.00156402587890625
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.37890625,
            "text": "transposons and retrotransposons). Despite their abundance, only a",
            "probability": 0.0013971328735351562
        },
        {
            "start_logit": -6.296875,
            "end_logit": 0.1868896484375,
            "text": "genome (Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.0012969970703125
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 0.1868896484375,
            "text": "(Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.0012044906616210938
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 0.1868896484375,
            "text": "), Alu",
            "probability": 0.0007443428039550781
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 0.1868896484375,
            "text": "1), Alu",
            "probability": 0.000644683837890625
        },
        {
            "start_logit": -7.0625,
            "end_logit": 0.1868896484375,
            "text": "1 (LINE-1), Alu",
            "probability": 0.0006031990051269531
        },
        {
            "start_logit": -1.6025390625,
            "end_logit": -5.34765625,
            "text": "Long Interspersed Element-1 (LINE-1)",
            "probability": 0.0005598068237304688
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 0.1868896484375,
            "text": "LINE-1), Alu",
            "probability": 0.0005598068237304688
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 0.1868896484375,
            "text": "small fraction of them are currently active in our genome (Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.0004940032958984375
        },
        {
            "start_logit": -0.5634765625,
            "end_logit": -7.0859375,
            "text": "Alu, and SVA elements",
            "probability": 0.00027823448181152344
        }
    ],
    "517843638ed59a060a000036_2": [
        {
            "start_logit": 8.828125,
            "end_logit": 6.3984375,
            "text": "Alu",
            "probability": 1.0
        },
        {
            "start_logit": 8.828125,
            "end_logit": -5.890625,
            "text": "Alu, L1",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.859375,
            "text": "Alu, L1, and SVA",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.890625,
            "text": "Alu, L1, and SVA families",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.4140625,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.48828125,
            "text": "Alu, L1, and SV",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.4921875,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity/",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.5,
            "text": "Alu, L1, and SVA families,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.5234375,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a unique and important class of human genomic diversity/polymorphism",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.5234375,
            "text": "Alu, L1, and SVA families, are",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.546875,
            "text": "Alu, L1, and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.5859375,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.60546875,
            "text": "Alu, L1, and SVA families, are still active, their recent and ongoing propagation generates",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.61328125,
            "text": "Alu, L1, and SVA families, are still active",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.62890625,
            "text": "Alu, L1, and SVA families, are still active, their recent and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.6328125,
            "text": "Alu, L1, and SVA families, are still active, their",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 6.3984375,
            "text": "retrotransposons, particularly members of the Alu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 6.3984375,
            "text": "types of retrotransposons, particularly members of the Alu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.3984375,
            "text": "of the Alu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.3984375,
            "text": "the Alu",
            "probability": 5.960464477539063e-08
        }
    ],
    "517843638ed59a060a000036_3": [
        {
            "start_logit": 9.328125,
            "end_logit": 5.14453125,
            "text": "Alu",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.328125,
            "end_logit": -1.91796875,
            "text": "Alu elements",
            "probability": 0.0008592605590820312
        },
        {
            "start_logit": 9.328125,
            "end_logit": -6.86328125,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.1328125,
            "text": "Alu elements are the most successful SINEs",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.2109375,
            "text": "Alu elements are the most successful SINEs (Short INterspersed",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.26171875,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements)",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.31640625,
            "text": "Alu elements are",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.42578125,
            "text": "Alu elements are the most successful SIN",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5078125,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,000",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.515625,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5234375,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.54296875,
            "text": "Alu elements are the",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5703125,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.57421875,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.578125,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.58984375,
            "text": "Alu elements are the most successful SINEs (Short INterspersed Elements) in primate genomes and have reached more than 1,",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.59375,
            "text": "Alu elements are the most successful SINEs (",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -1.91796875,
            "text": "elements",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -6.86328125,
            "text": "Short INterspersed Elements",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -7.2109375,
            "text": "Short INterspersed",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_4": [
        {
            "start_logit": 8.3828125,
            "end_logit": 6.9765625,
            "text": "Alu",
            "probability": 1.0
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -3.763671875,
            "text": "Alu represent",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -5.078125,
            "text": "Alu represent the most prolific human LINE and SINE",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -5.27734375,
            "text": "Alu represent the most prolific human LINE",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -4.953125,
            "end_logit": 6.9765625,
            "text": "and Alu",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -6.6328125,
            "text": "Alu represent the most prolific human LINE and SINE families",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.01171875,
            "text": "Alu represent the most prolific human LINE and SINE families, respectively.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.1640625,
            "text": "Alu represent the most prolific human LINE and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.29296875,
            "text": "Alu represent the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.3203125,
            "text": "Alu represent the most prolific human LINE and SINE families, respectively",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.41796875,
            "text": "Alu represent the most prolific human LINE and SINE families,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.421875,
            "text": "Alu represent the most prolific human LINE and SIN",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.421875,
            "text": "Alu represent the most prolific",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.44140625,
            "text": "Alu represent the most prolif",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 6.9765625,
            "text": "1 and Alu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.953125,
            "end_logit": -3.763671875,
            "text": "and Alu represent",
            "probability": 0.0
        },
        {
            "start_logit": -4.953125,
            "end_logit": -5.078125,
            "text": "and Alu represent the most prolific human LINE and SINE",
            "probability": 0.0
        },
        {
            "start_logit": -4.953125,
            "end_logit": -5.27734375,
            "text": "and Alu represent the most prolific human LINE",
            "probability": 0.0
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -5.078125,
            "text": "LINE and SINE",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -3.763671875,
            "text": "1 and Alu represent",
            "probability": 0.0
        }
    ],
    "517843638ed59a060a000036_5": [
        {
            "start_logit": 9.390625,
            "end_logit": 3.95703125,
            "text": "Alu elements",
            "probability": 0.87744140625
        },
        {
            "start_logit": 9.390625,
            "end_logit": 1.9853515625,
            "text": "Alu",
            "probability": 0.12255859375
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.41796875,
            "text": "Alu elements are able to retropose",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.625,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood",
            "probability": 2.2351741790771484e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.734375,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.953125,
            "text": "Alu elements are able",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.0078125,
            "text": "Alu elements are",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.015625,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity",
            "probability": 1.5139579772949219e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.1328125,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are poorly understood.",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.23828125,
            "text": "Alu elements are able to retropo",
            "probability": 1.2159347534179688e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.24609375,
            "text": "Alu elements are able to retro",
            "probability": 1.1980533599853516e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.34375,
            "text": "Alu elements are able to retropose, and the factors determining their retroposition capacity are",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.3671875,
            "text": "Alu elements are able to",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.48046875,
            "text": "Alu elements are able to retropose,",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.4921875,
            "text": "Alu elements are able to retropose, and the factors",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 3.95703125,
            "text": "elements",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 3.95703125,
            "text": "few Alu elements",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 3.95703125,
            "text": "Only a few Alu elements",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 1.9853515625,
            "text": "few Alu",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": 1.9853515625,
            "text": "Only a few Alu",
            "probability": 0.0
        }
    ],
    "5aae6a86fcf456587200000e_1": [
        {
            "start_logit": 0.5263671875,
            "end_logit": -3.298828125,
            "text": "short-wave UVC",
            "probability": 0.52978515625
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -4.71484375,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB",
            "probability": 0.1287841796875
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -5.50390625,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 0.05853271484375
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -5.609375,
            "text": "short-wave UVC (200-280 nm",
            "probability": 0.05267333984375
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -5.64453125,
            "text": "short-wave UVC (200-280 nm)",
            "probability": 0.05084228515625
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -5.86328125,
            "text": "short-wave",
            "probability": 0.04083251953125
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -5.91015625,
            "text": "short-wave UVC (",
            "probability": 0.03900146484375
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -6.76171875,
            "text": "short-wave UV",
            "probability": 0.016632080078125
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -6.9921875,
            "text": "short-wave UVC (200",
            "probability": 0.01320648193359375
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.02734375,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280-320 nm)",
            "probability": 0.01275634765625
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.1171875,
            "text": "short-wave UVC (200-280",
            "probability": 0.01165771484375
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.3125,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280-320 nm), and long-wave UVA (",
            "probability": 0.00959014892578125
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.31640625,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280-320",
            "probability": 0.009552001953125
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.3203125,
            "text": "short-wave UVC (200-",
            "probability": 0.00951385498046875
        },
        {
            "start_logit": 0.5263671875,
            "end_logit": -7.3203125,
            "text": "short-wave UVC (200-280 nm), medium-wave UVB (280",
            "probability": 0.00951385498046875
        },
        {
            "start_logit": -3.083984375,
            "end_logit": -4.71484375,
            "text": "UVB",
            "probability": 0.00348663330078125
        },
        {
            "start_logit": -3.083984375,
            "end_logit": -5.50390625,
            "text": "UVB (280-320 nm), and long-wave UVA",
            "probability": 0.0015840530395507812
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -3.298828125,
            "text": "UVC",
            "probability": 0.0011587142944335938
        },
        {
            "start_logit": -3.083984375,
            "end_logit": -6.578125,
            "text": "UVB (280-320 nm), and long-wave UVA (320-400 nm).",
            "probability": 0.0005388259887695312
        },
        {
            "start_logit": -3.083984375,
            "end_logit": -7.02734375,
            "text": "UVB (280-320 nm)",
            "probability": 0.0003452301025390625
        }
    ],
    "5aae6a86fcf456587200000e_2": [
        {
            "start_logit": 0.09027099609375,
            "end_logit": -3.625,
            "text": "short-wave UVC",
            "probability": 0.43017578125
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -4.34765625,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB",
            "probability": 0.2088623046875
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -5.5234375,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA",
            "probability": 0.064453125
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -5.73828125,
            "text": "short-wave",
            "probability": 0.052001953125
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -5.9140625,
            "text": "short-wave UVC (200-280 nm)",
            "probability": 0.043609619140625
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -6.0234375,
            "text": "short-wave UVC (200-280 nm",
            "probability": 0.039093017578125
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -6.03125,
            "text": "short-wave UVC (",
            "probability": 0.038787841796875
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -6.71484375,
            "text": "short-wave UV",
            "probability": 0.0195770263671875
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.0859375,
            "text": "short-wave UVC (200",
            "probability": 0.01351165771484375
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.21875,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm)",
            "probability": 0.01183319091796875
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.2265625,
            "text": "short-wave UVC (200-280",
            "probability": 0.01174163818359375
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.23828125,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave",
            "probability": 0.01160430908203125
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.31640625,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA (",
            "probability": 0.0107269287109375
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.33984375,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320 nm), and long-wave UVA (320",
            "probability": 0.01047515869140625
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.3671875,
            "text": "short-wave UVC (200-",
            "probability": 0.01019287109375
        },
        {
            "start_logit": 0.09027099609375,
            "end_logit": -7.39453125,
            "text": "short-wave UVC (200-280 nm), mid-wave UVB (280-320",
            "probability": 0.009918212890625
        },
        {
            "start_logit": -3.013671875,
            "end_logit": -4.34765625,
            "text": "UVB",
            "probability": 0.00939178466796875
        },
        {
            "start_logit": -3.013671875,
            "end_logit": -5.5234375,
            "text": "UVB (280-320 nm), and long-wave UVA",
            "probability": 0.002887725830078125
        },
        {
            "start_logit": -6.140625,
            "end_logit": -3.625,
            "text": "UVC",
            "probability": 0.00084686279296875
        },
        {
            "start_logit": -3.013671875,
            "end_logit": -7.21875,
            "text": "UVB (280-320 nm)",
            "probability": 0.000530242919921875
        }
    ],
    "5709e4b2cf1c32585100001c_1": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.546875,
            "text": "DVL-1",
            "probability": 1.0
        },
        {
            "start_logit": -0.65625,
            "end_logit": 9.546875,
            "text": "1",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.2646484375,
            "text": "DV",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -5.921875,
            "end_logit": 9.546875,
            "text": "L-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -5.9140625,
            "text": "DVL-1 and DVL-3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.08984375,
            "text": "DVL-1 and DVL-3 genes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 9.546875,
            "text": "-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.375,
            "text": "DVL-1 and DVL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 9.546875,
            "text": "study, we explore the cause of HSCR by studying the expression of DVL-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.7109375,
            "text": "DVL-1 and DV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.75,
            "text": "DVL-1 and DVL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.546875,
            "text": "of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.546875,
            "text": "studying the expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.83984375,
            "text": "DVL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.546875,
            "text": "this study, we explore the cause of HSCR by studying the expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.546875,
            "text": "explore the cause of HSCR by studying the expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.546875,
            "text": "expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.546875,
            "text": "we explore the cause of HSCR by studying the expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.546875,
            "text": "the expression of DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.21875,
            "text": "DVL-",
            "probability": 5.960464477539063e-08
        }
    ],
    "5709e4b2cf1c32585100001c_2": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.53125,
            "text": "DVL-1",
            "probability": 1.0
        },
        {
            "start_logit": -0.54052734375,
            "end_logit": 9.53125,
            "text": "1",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.4296875,
            "text": "DV",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -5.82421875,
            "text": "DVL",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -5.91015625,
            "text": "DVL-1 and DVL-3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 9.53125,
            "text": "as DVL-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.53125,
            "text": "L-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 9.53125,
            "text": ". We have isolated and characterized cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.328125,
            "text": "DVL-1 and DVL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.421875,
            "text": "DVL-1 and DV",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 9.53125,
            "text": "-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 9.53125,
            "text": "dsh-homologous genes, designated as DVL-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 9.53125,
            "text": "segmentation and neuroblast specification. We have isolated and characterized cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.72265625,
            "text": "DVL-1 and DVL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.53125,
            "text": "neuroblast specification. We have isolated and characterized cDNA clones from two different human dsh-homologous genes, designated as DVL-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.76171875,
            "text": "DVL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.94921875,
            "text": "DVL-1 and DVL-3.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.54052734375,
            "end_logit": -5.91015625,
            "text": "1 and DVL-3",
            "probability": 0.0
        },
        {
            "start_logit": -0.54052734375,
            "end_logit": -6.328125,
            "text": "1 and DVL",
            "probability": 0.0
        },
        {
            "start_logit": -0.54052734375,
            "end_logit": -6.421875,
            "text": "1 and DV",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_3": [
        {
            "start_logit": 3.83984375,
            "end_logit": 7.36328125,
            "text": "Dvl-1",
            "probability": 0.9970703125
        },
        {
            "start_logit": -2.947265625,
            "end_logit": 7.36328125,
            "text": "1",
            "probability": 0.0011234283447265625
        },
        {
            "start_logit": -3.005859375,
            "end_logit": 7.36328125,
            "text": "dishevelled gene (Dvl-1",
            "probability": 0.0010633468627929688
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 7.36328125,
            "text": "gene (Dvl-1",
            "probability": 0.00022113323211669922
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -1.9326171875,
            "text": "Dvl",
            "probability": 9.149312973022461e-05
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 7.36328125,
            "text": "(Dvl-1",
            "probability": 5.632638931274414e-05
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 7.36328125,
            "text": "mouse dishevelled gene (Dvl-1",
            "probability": 4.744529724121094e-05
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 7.36328125,
            "text": "protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.36328125,
            "text": ". The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl-1",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.36328125,
            "text": "evelled gene (Dvl-1",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -5.69921875,
            "text": "Dv",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -6.45703125,
            "text": "Dvl-1) shares 50% identity",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -6.5,
            "text": "Dvl-1)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -6.515625,
            "text": "Dvl-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 3.83984375,
            "end_logit": -6.66015625,
            "text": "Dvl-1) shares 50% identity (65% similarity) with dsh.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -3.005859375,
            "end_logit": -1.9326171875,
            "text": "dishevelled gene (Dvl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.57421875,
            "end_logit": -1.9326171875,
            "text": "gene (Dvl",
            "probability": 0.0
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -1.9326171875,
            "text": "mouse homolog of the Drosophila dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl",
            "probability": 0.0
        },
        {
            "start_logit": -3.005859375,
            "end_logit": -4.0625,
            "text": "dishevelled",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -1.9326171875,
            "text": "homolog of the Drosophila dsh segment polarity gene. The 695-amino-acid protein encoded by the mouse dishevelled gene (Dvl",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_4": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.4296875,
            "text": "Dvl-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": 9.4296875,
            "text": "1",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.119140625,
            "text": "Dv",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -5.90625,
            "end_logit": 9.4296875,
            "text": "l-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 9.4296875,
            "text": "-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.984375,
            "text": "Dvl-1 gene on chromosome 1p36",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.28515625,
            "text": "Dvl-1 gene",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.30859375,
            "text": "Dvl-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.31640625,
            "text": "Dvl-1 gene on chromosome 1p36 belongs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.33984375,
            "text": "Dvl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.39453125,
            "text": "Dvl-1 gene on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.4296875,
            "text": "The Dvl-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.4296875,
            "text": "Dvl-1 gene on chromosome 1p36 belongs to a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -6.984375,
            "text": "1 gene on chromosome 1p36",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -7.28515625,
            "text": "1 gene",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -7.31640625,
            "text": "1 gene on chromosome 1p36 belongs",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -7.39453125,
            "text": "1 gene on",
            "probability": 0.0
        },
        {
            "start_logit": -1.0283203125,
            "end_logit": -7.4296875,
            "text": "1 gene on chromosome 1p36 belongs to a",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -1.119140625,
            "text": "The Dv",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.984375,
            "text": "l-1 gene on chromosome 1p36",
            "probability": 0.0
        }
    ],
    "5709e4b2cf1c32585100001c_5": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.375,
            "text": "Dvl-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.103515625,
            "end_logit": 9.375,
            "text": "1",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.5283203125,
            "text": "Dv",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -2.462890625,
            "end_logit": 9.375,
            "text": "Dishevelled-1 (Dvl-1",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -4.9140625,
            "text": "Dvl-1)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 9.375,
            "text": "l-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.375,
            "text": "(Dvl-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.4453125,
            "text": "Dvl-1) and Dishevelled",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 9.375,
            "text": "-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.375,
            "text": "evelled-1 (Dvl-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 9.375,
            "text": "that the mouse Dishevelled-1 (Dvl-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 9.375,
            "text": "mouse Dishevelled-1 (Dvl-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.90234375,
            "text": "Dvl-1) and Dishevelled-2 genes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.90625,
            "text": "Dvl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.375,
            "text": "led-1 (Dvl-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.984375,
            "text": "Dvl-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.375,
            "text": "1 (Dvl-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.04296875,
            "text": "Dvl-1) and Dishevelled-2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.375,
            "text": "-1 (Dvl-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.375,
            "text": "the mouse Dishevelled-1 (Dvl-1",
            "probability": 5.960464477539063e-08
        }
    ],
    "516c3960298dcd4e51000073_1": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.3125,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.939453125,
            "text": "DNMT",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -1.32421875,
            "end_logit": 9.3125,
            "text": "1",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -5.03125,
            "text": "DNMT1 and DNMT3a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 9.3125,
            "text": "DNMTs, DNMT1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.75390625,
            "text": "DNMT1 and DNMT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.84765625,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic neurons",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.89453125,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.91796875,
            "text": "DNMT1 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.3125,
            "text": ", DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.0390625,
            "text": "DNMT1 and DNMT3a are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.1328125,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmito",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.18359375,
            "text": "DNMT1 and DNMT3a are most highly expressed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.35546875,
            "text": "DNMT1 and DNMT3a are most highly expressed in postmitotic neurons.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.4375,
            "text": "DNMT1 and DNMT3a are most highly expressed in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.3125,
            "text": "Of the DNMTs, DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.3125,
            "text": "the DNMTs, DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5,
            "text": "DNMT1 and DNMT3a are most highly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.3125,
            "text": "s, DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5390625,
            "text": "DNMT1 and DNMT3a are most highly expressed in postm",
            "probability": 5.960464477539063e-08
        }
    ],
    "516c3960298dcd4e51000073_2": [
        {
            "start_logit": 9.375,
            "end_logit": 9.4140625,
            "text": "DNMT3",
            "probability": 1.0
        },
        {
            "start_logit": -0.7890625,
            "end_logit": 9.4140625,
            "text": "3",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.7900390625,
            "text": "DNMT",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.80859375,
            "text": "DNMT3 family proteins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.9140625,
            "text": "DNMT3 family",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.4140625,
            "text": "DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.4140625,
            "text": "oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.42578125,
            "text": "DNMT3 family proteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.4140625,
            "text": "with the expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.4140625,
            "text": "the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.4140625,
            "text": "of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.4140625,
            "text": "expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.4140625,
            "text": "Bovine DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.4140625,
            "text": "an oocyte size-specific manner, which are coordinated with the expression of the DNMT3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.7890625,
            "end_logit": -6.80859375,
            "text": "3 family proteins",
            "probability": 0.0
        },
        {
            "start_logit": -0.7890625,
            "end_logit": -6.9140625,
            "text": "3 family",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -0.7900390625,
            "text": "DNA methylation imprints are established in an oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -0.7900390625,
            "text": "oocyte size-specific manner, which are coordinated with the expression of the DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -0.7890625,
            "end_logit": -7.42578125,
            "text": "3 family proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -0.7900390625,
            "text": "with the expression of the DNMT",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_3": [
        {
            "start_logit": 9.3828125,
            "end_logit": 9.2578125,
            "text": "Dnmt2",
            "probability": 1.0
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -0.76611328125,
            "text": "Dnmt",
            "probability": 4.4345855712890625e-05
        },
        {
            "start_logit": -1.4091796875,
            "end_logit": 9.2578125,
            "text": "2",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -5.9453125,
            "text": "Dnmt2 proteins",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.21484375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.8671875,
            "text": "Dnmt2 proteins are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.96484375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.2109375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have been a subject of controversy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.27734375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have been a subject of controversy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.328125,
            "text": "Dnmt2 proteins are the most conserved members of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.34765625,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.34765625,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have been a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.359375,
            "text": "Dnmt2 proteins are the most conserved members of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.3671875,
            "text": "Dnmt2 proteins are the most conserved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.42578125,
            "text": "Dnmt2 proteins are the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.43359375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.45703125,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.46875,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.484375,
            "text": "Dnmt2 proteins are the most conserved members of the DNA methyltransferase enzyme family, but their substrate specificity and biological functions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4091796875,
            "end_logit": -5.9453125,
            "text": "2 proteins",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_4": [
        {
            "start_logit": 3.029296875,
            "end_logit": 3.25,
            "text": "Dnmt1",
            "probability": 0.94189453125
        },
        {
            "start_logit": 0.1658935546875,
            "end_logit": 3.25,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 0.053680419921875
        },
        {
            "start_logit": 0.1658935546875,
            "end_logit": -0.010345458984375,
            "text": "Dnmt3a",
            "probability": 0.0020618438720703125
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 3.25,
            "text": "while Dnmt1",
            "probability": 0.00067138671875
        },
        {
            "start_logit": -4.890625,
            "end_logit": 3.25,
            "text": ", Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 0.00034165382385253906
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -5.06640625,
            "text": "Dnmt1 maintains methylation patterns after DNA replication",
            "probability": 0.0002294778823852539
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -5.76953125,
            "text": "Dnmt1 maintains methylation patterns after DNA replication. The maintenance function of Dnmt1",
            "probability": 0.00011360645294189453
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 3.25,
            "text": "Dnmts), Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 6.783008575439453e-05
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 3.25,
            "text": "DNA methyltransferases (Dnmts), Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 5.239248275756836e-05
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -6.66015625,
            "text": "Dnmt",
            "probability": 4.661083221435547e-05
        },
        {
            "start_logit": -6.921875,
            "end_logit": 3.25,
            "text": "family of DNA methyltransferases (Dnmts), Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 4.482269287109375e-05
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 3.25,
            "text": "1",
            "probability": 4.023313522338867e-05
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -6.84765625,
            "text": "Dnmt1 maintains methylation patterns after DNA replication. The maintenance function of Dnmt1 is regulated by its large regulatory N-terminal",
            "probability": 3.8623809814453125e-05
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -6.91796875,
            "text": "Dnmt1 maintains methylation patterns after DNA replication.",
            "probability": 3.600120544433594e-05
        },
        {
            "start_logit": 3.029296875,
            "end_logit": -6.953125,
            "text": "Dnmt1 maintains methylation patterns",
            "probability": 3.4928321838378906e-05
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 3.25,
            "text": "methyltransferases (Dnmts), Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 3.0338764190673828e-05
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 3.25,
            "text": "Within the family of DNA methyltransferases (Dnmts), Dnmt3a and 3b establish methylation marks during early development, while Dnmt1",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 0.1658935546875,
            "end_logit": -5.06640625,
            "text": "Dnmt3a and 3b establish methylation marks during early development, while Dnmt1 maintains methylation patterns after DNA replication",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -4.890625,
            "end_logit": -0.010345458984375,
            "text": ", Dnmt3a",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": 0.1658935546875,
            "end_logit": -5.71875,
            "text": "Dnmt3a and",
            "probability": 6.794929504394531e-06
        }
    ],
    "516c3960298dcd4e51000073_5": [
        {
            "start_logit": 9.390625,
            "end_logit": 9.3359375,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 9.390625,
            "end_logit": -0.8359375,
            "text": "DNMT",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": -1.248046875,
            "end_logit": 9.3359375,
            "text": "1",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 9.390625,
            "end_logit": -6.8984375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.16796875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.265625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.35546875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.3984375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.41015625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.421875,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC2.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.43359375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.47265625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.484375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.49609375,
            "text": "DNMT1 is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.51953125,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding to HDAC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.52734375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development, and mediating transcriptional repression by direct binding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.52734375,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.53125,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.390625,
            "end_logit": -7.53515625,
            "text": "DNMT1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.248046875,
            "end_logit": -6.8984375,
            "text": "1 is a widely expressed DNA methyltransferase maintaining methylation patterns in development",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_6": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.3359375,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.93408203125,
            "text": "DNMT",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -1.2822265625,
            "end_logit": 9.3359375,
            "text": "1",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 9.3359375,
            "text": "DNA methyltransferase DNMT1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.65234375,
            "text": "DNMT1 causes a widespread loss of imprinting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.125,
            "text": "DNMT1 causes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.2734375,
            "text": "DNMT1 causes a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.296875,
            "text": "DNMT1 causes a widespread loss of imprinting.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.328125,
            "text": "DNMT1 causes a widespread loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.41796875,
            "text": "DNMT1 causes a widespread loss of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.3359375,
            "text": "methyltransferase DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.3359375,
            "text": "for imprinting; a reduction in the DNA methyltransferase DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.3359375,
            "text": "This methylation is critical for imprinting; a reduction in the DNA methyltransferase DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.3359375,
            "text": "methylation is critical for imprinting; a reduction in the DNA methyltransferase DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.3359375,
            "text": "imprinting; a reduction in the DNA methyltransferase DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.1328125,
            "end_logit": -0.93408203125,
            "text": "DNA methyltransferase DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -1.2822265625,
            "end_logit": -6.65234375,
            "text": "1 causes a widespread loss of imprinting",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -0.93408203125,
            "text": "methyltransferase DNMT",
            "probability": 0.0
        },
        {
            "start_logit": -1.2822265625,
            "end_logit": -7.125,
            "text": "1 causes",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -0.93408203125,
            "text": "for imprinting; a reduction in the DNA methyltransferase DNMT",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_7": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.4296875,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": -1.013671875,
            "end_logit": 9.4296875,
            "text": "1",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.1220703125,
            "text": "DNMT",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -4.78125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethylation",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -5.84375,
            "text": "DNMT1 and DNMT3B",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.2578125,
            "text": "DNMT1 and DNMT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 9.4296875,
            "text": "that DNMT1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.53125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethyl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.734375,
            "text": "DNMT1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.0546875,
            "text": "DNMT1 and DNMT3B regulate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.4296875,
            "text": "results suggest that DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.23828125,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.25,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.3046875,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by regulating histone dimethylation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.4296875,
            "text": "suggest that DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.359375,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.4453125,
            "text": "DNMT1 and DNMT3B regulate BAG-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.44921875,
            "text": "DNMT1 and DNMT3B regulate BAG-1 expression via insulator protein DNA-binding and chromatin dynamics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.45703125,
            "text": "DNMT1 and DNMT3B regulate BAG",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.4296875,
            "text": "These results suggest that DNMT1",
            "probability": 5.960464477539063e-08
        }
    ],
    "516c3960298dcd4e51000073_8": [
        {
            "start_logit": 9.375,
            "end_logit": 9.34375,
            "text": "DNMT1",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.87353515625,
            "text": "DNMT",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -1.2509765625,
            "end_logit": 9.34375,
            "text": "1",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -5.5078125,
            "text": "DNMT1)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 9.34375,
            "text": "DNA methyltransferase 1 (DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.28515625,
            "text": "DNMT1) has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.34375,
            "text": "methyltransferase 1 (DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.375,
            "text": "DNMT1) has been reported",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.390625,
            "text": "DNMT1) has been reported to interact with a wide variety of factors and to contain intrinsic transcriptional repressor activity.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.4296875,
            "text": "DNMT1) has been reported to interact with a wide variety of factors and to contain intrinsic transcriptional repressor activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.34375,
            "text": "(DNMT1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.46484375,
            "text": "DNMT1) has been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.5078125,
            "text": "DNMT1) has been reported to interact with a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.515625,
            "text": "DNMT1) has been reported to interact with a wide variety of factors and to contain intrinsic transcriptional repressor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.53515625,
            "text": "DNMT1) has been reported to interact with a wide variety of factors and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.5390625,
            "text": "DNMT1) has been reported to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.56640625,
            "text": "DNMT1) has been reported to interact with a wide variety of factors and to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.56640625,
            "text": "DNMT1) has been reported to interact with a wide variety of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.5703125,
            "text": "DNMT1) has been reported to interact with a wide variety",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.34375,
            "text": "1 (DNMT1",
            "probability": 5.960464477539063e-08
        }
    ],
    "516c3960298dcd4e51000073_9": [
        {
            "start_logit": 6.03125,
            "end_logit": 6.96484375,
            "text": "DNMT1",
            "probability": 0.998046875
        },
        {
            "start_logit": -0.290283203125,
            "end_logit": 6.96484375,
            "text": "DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 0.0017881393432617188
        },
        {
            "start_logit": -3.763671875,
            "end_logit": 6.96484375,
            "text": "enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 5.549192428588867e-05
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 6.96484375,
            "text": "1",
            "probability": 2.4080276489257812e-05
        },
        {
            "start_logit": 6.03125,
            "end_logit": -5.14453125,
            "text": "DNMT",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.96484375,
            "text": ", the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.96484375,
            "text": "de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 6.96484375,
            "text": "DNMT3B and the maintenance enzyme DNMT1",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 6.96484375,
            "text": "DNA methyltransferases (DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 6.96484375,
            "text": "enzyme DNMT1",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.96484375,
            "text": "DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.96484375,
            "text": "maintenance enzyme DNMT1",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.96484375,
            "text": "the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.96484375,
            "text": "combined catalytic actions of three DNA methyltransferases (DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.96484375,
            "text": "three DNA methyltransferases (DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.96484375,
            "text": "novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -0.290283203125,
            "end_logit": -0.262939453125,
            "text": "DNMT3A",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.03125,
            "end_logit": -6.83984375,
            "text": "DNMT1.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -3.763671875,
            "end_logit": -0.262939453125,
            "text": "enzymes DNMT3A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.290283203125,
            "end_logit": -4.84375,
            "text": "DNMT3A and DNMT3B",
            "probability": 0.0
        }
    ],
    "516c3960298dcd4e51000073_10": [
        {
            "start_logit": 8.1640625,
            "end_logit": 6.87890625,
            "text": "H1",
            "probability": 0.97265625
        },
        {
            "start_logit": 8.1640625,
            "end_logit": 3.326171875,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.027801513671875
        },
        {
            "start_logit": 1.7978515625,
            "end_logit": 3.326171875,
            "text": "DNMT1",
            "probability": 4.774332046508789e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -5.40234375,
            "text": "H1 subtypes",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.3515625,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1 and DNMT3B",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.71484375,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1 and DNMT",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.9609375,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1 and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.98046875,
            "text": "H1 subtypes interact",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.15625,
            "text": "H1 subtypes interact with DNA methyltransferases DNMT1 and DNMT3B.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.40625,
            "text": "H1 subtypes interact with DNA methyltransferase",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 6.87890625,
            "text": ", murine H1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.87890625,
            "text": "Some, but not all, murine H1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.87890625,
            "text": "murine H1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.87890625,
            "text": ", but not all, murine H1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.87890625,
            "text": "but not all, murine H1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 3.326171875,
            "text": "s DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 3.326171875,
            "text": "1",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 3.326171875,
            "text": "DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 3.326171875,
            "text": ", murine H1 subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 3.326171875,
            "text": "Some, but not all, murine H1 subtypes interact with DNA methyltransferases DNMT1",
            "probability": 0.0
        }
    ],
    "55031628e9bde69634000024_1": [
        {
            "start_logit": 6.1328125,
            "end_logit": 3.45703125,
            "text": "pheochromocytoma",
            "probability": 1.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": 3.45703125,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 0.00014650821685791016
        },
        {
            "start_logit": 6.1328125,
            "end_logit": -6.61328125,
            "text": "pheochromocytoma, and paraganglioma",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 6.1328125,
            "end_logit": -7.453125,
            "text": "pheochromocytoma, and paragangli",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 3.45703125,
            "text": ", pheochromocytoma",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.078125,
            "end_logit": 3.45703125,
            "text": "thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 3.45703125,
            "text": "tumors, pheochromocytoma",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 3.45703125,
            "text": ". In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 3.45703125,
            "text": "thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 3.45703125,
            "text": "as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -3.3984375,
            "text": "medullary thyroid carcinoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -6.61328125,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.0
        },
        {
            "start_logit": -6.078125,
            "end_logit": -3.3984375,
            "text": "thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -3.3984375,
            "text": "pheochromocytoma-paraganglioma syndrome, and familial nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.52734375,
            "end_logit": -3.3984375,
            "text": ". In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.60546875,
            "end_logit": -3.3984375,
            "text": ", pheochromocytoma-paraganglioma syndrome, and familial nonmedullary thyroid carcinoma. In addition, several individual neuroendocrine tumors are described, such as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -3.3984375,
            "text": "thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.41015625,
            "text": "medullary thyroid",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.453125,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paragangli",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -3.3984375,
            "text": "as medullary thyroid carcinoma",
            "probability": 0.0
        }
    ],
    "55031628e9bde69634000024_2": [
        {
            "start_logit": 8.40625,
            "end_logit": 6.890625,
            "text": "pheochromocytoma",
            "probability": 1.0
        },
        {
            "start_logit": -2.93359375,
            "end_logit": 6.890625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.29296875,
            "text": "pheochromocytoma, and paraganglioma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.6875,
            "text": "pheochromocytoma, and paragangli",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.7109375,
            "text": "pheochromocytoma, and paraganglioma, emphasizing specific histopathologic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.73046875,
            "text": "pheochromocytoma, and paraganglioma, emphasizing specific histopathologic characteristics",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 6.890625,
            "text": "thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 6.890625,
            "text": ", pheochromocytoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 6.890625,
            "text": "tumors, pheochromocytoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 6.890625,
            "text": "as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.890625,
            "text": "neuroendocrine tumors are described, such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 6.890625,
            "text": "gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.890625,
            "text": "such as medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.93359375,
            "end_logit": -3.296875,
            "text": "medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -3.296875,
            "text": "thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -2.93359375,
            "end_logit": -7.29296875,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paraganglioma",
            "probability": 0.0
        },
        {
            "start_logit": -2.93359375,
            "end_logit": -7.42578125,
            "text": "medullary thyroid",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -3.296875,
            "text": "as medullary thyroid carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": -2.93359375,
            "end_logit": -7.66015625,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic",
            "probability": 0.0
        },
        {
            "start_logit": -2.93359375,
            "end_logit": -7.6875,
            "text": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma, and paragangli",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_1": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.078125,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.2734375,
            "text": "is",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -1.931640625,
            "end_logit": 9.078125,
            "text": "ylline",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": -5.609375,
            "end_logit": 9.078125,
            "text": "tradefylline",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 9.078125,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.83203125,
            "text": "istradefylline, improve motor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.90234375,
            "text": "istradefylline, improve motor function",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 9.078125,
            "text": "as istradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.078125,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.015625,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.28125,
            "text": "istradef",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.33984375,
            "text": "istradefylline,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.36328125,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.41796875,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.421875,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.4921875,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.5,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.5234375,
            "text": "istradefylline, improve motor function in PD, but their effect on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.5390625,
            "text": "istradefylline, improve motor function in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.546875,
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment",
            "probability": 5.960464477539063e-08
        }
    ],
    "54fc9b236ad7dcbc12000005_2": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.15625,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.4013671875,
            "text": "is",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -1.732421875,
            "end_logit": 9.15625,
            "text": "ylline",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 9.15625,
            "text": "tradefylline",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.0703125,
            "text": "istradefylline and preladenant",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 9.15625,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 9.15625,
            "text": "Both istradefylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.58203125,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.15625,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.95703125,
            "text": "istradefylline and preladen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.984375,
            "text": "istradefylline and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.98828125,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time in PD patients with motor fluctuations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.046875,
            "text": "istradefylline and pre",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.0703125,
            "text": "istradef",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.1640625,
            "text": "istradefylline and prela",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.28515625,
            "text": "istradefylline and preladenant have demonstrated moderate efficacy in reducing off time in PD patients with motor fluctuations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.37890625,
            "text": "istradefylline and preladenant have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.732421875,
            "end_logit": -6.0703125,
            "text": "ylline and preladenant",
            "probability": 0.0
        },
        {
            "start_logit": -6.4921875,
            "end_logit": -1.4013671875,
            "text": "Both is",
            "probability": 0.0
        },
        {
            "start_logit": -1.732421875,
            "end_logit": -6.58203125,
            "text": "ylline and preladenant have demonstrated moderate efficacy in reducing off time",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_3": [
        {
            "start_logit": 7.7578125,
            "end_logit": 6.92578125,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 0.580078125
        },
        {
            "start_logit": 7.7578125,
            "end_logit": 6.33984375,
            "text": "caffeine",
            "probability": 0.3203125
        },
        {
            "start_logit": 6.00390625,
            "end_logit": 6.92578125,
            "text": "istradefylline",
            "probability": 0.09991455078125
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -5.5,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as is",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 6.92578125,
            "text": "ylline",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -6.37890625,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istrade",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -6.43359375,
            "text": "caffeine can",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -6.86328125,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline reduces OFF time and dyskinesia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 6.92578125,
            "text": "that caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.09765625,
            "text": "caffeine can improve the motor deficits",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 6.92578125,
            "text": "tradefylline",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.1640625,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradef",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.1796875,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline reduces OFF time",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.23828125,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline reduces",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.00390625,
            "end_logit": -5.5,
            "text": "is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.37890625,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline reduces OFF time and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.3984375,
            "text": "caffeine can improve the motor deficits of PD and that adenosine A2A receptor antagonists such as istradefylline reduces OFF time and dyskinesia associated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.40625,
            "text": "caffeine can improve the motor deficits of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 6.33984375,
            "text": "that caffeine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.92578125,
            "text": "that adenosine A2A receptor antagonists such as istradefylline",
            "probability": 1.7881393432617188e-07
        }
    ],
    "54fc9b236ad7dcbc12000005_4": [
        {
            "start_logit": 8.7890625,
            "end_logit": 8.9296875,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": 8.9296875,
            "text": "ylline",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.099609375,
            "text": "Is",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -5.94921875,
            "text": "Istradefylline (KW-6002",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 8.9296875,
            "text": "tradefylline",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.19140625,
            "text": "Istradefylline (KW-600",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 8.9296875,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.67578125,
            "text": "Istradefylline (KW-6002)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.89453125,
            "text": "Istradefylline (KW-6002) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 8.9296875,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.078125,
            "text": "Istradef",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.1015625,
            "text": "Istradefylline (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.26953125,
            "text": "Istradefylline (KW-6002) is the first of several adenosine A2A receptor antagonists in development",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.26953125,
            "text": "Istradefylline (KW-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -5.94921875,
            "text": "ylline (KW-6002",
            "probability": 0.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -6.19140625,
            "text": "ylline (KW-600",
            "probability": 0.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -6.37890625,
            "text": "ylline (KW-6002) is the first of several adenosine A2A receptor antagonists in development for PD to advance to phase III clinical trials.",
            "probability": 0.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -6.67578125,
            "text": "ylline (KW-6002)",
            "probability": 0.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -6.89453125,
            "text": "ylline (KW-6002) is",
            "probability": 0.0
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -7.1015625,
            "text": "ylline (",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_5": [
        {
            "start_logit": 8.6796875,
            "end_logit": 8.859375,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": 8.859375,
            "text": "ylline",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -2.029296875,
            "text": "is",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -2.822265625,
            "end_logit": 8.859375,
            "text": "fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -4.953125,
            "text": "istrade",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 8.859375,
            "text": "alpha2 adrenergic receptor antagonists (eg, fipamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.625,
            "text": "istradefylline)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.640625,
            "text": "istradefylline), AMPA receptor antagonists (eg, talampane",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.72265625,
            "text": "istradefylline), AMPA receptor antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.734375,
            "text": "istradefylline), AMPA receptor antagonists (eg, talampanel",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.859375,
            "text": "fylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.7578125,
            "text": "istradefylline), AMPA receptor antagonists (eg, talampanel), neuronal synchronization modulators",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 8.859375,
            "text": "adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.859375,
            "text": ", adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.859375,
            "text": ", istradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.859375,
            "text": "pamezole), adenosine A2A receptor antagonists (eg, istradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.859375,
            "text": "tradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.822265625,
            "end_logit": -2.029296875,
            "text": "fipamezole), adenosine A2A receptor antagonists (eg, is",
            "probability": 0.0
        },
        {
            "start_logit": -2.822265625,
            "end_logit": -2.826171875,
            "text": "fipamezole",
            "probability": 0.0
        },
        {
            "start_logit": -5.1484375,
            "end_logit": -2.029296875,
            "text": "alpha2 adrenergic receptor antagonists (eg, fipamezole), adenosine A2A receptor antagonists (eg, is",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_6": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.0625,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.6240234375,
            "text": "is",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.92578125,
            "end_logit": 9.0625,
            "text": "ylline",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 9.0625,
            "text": "tradefylline",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 9.0625,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.0625,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.44140625,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.453125,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.453125,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.45703125,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.46484375,
            "text": "istradef",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.46484375,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks in a double-blind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.0625,
            "text": "of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.484375,
            "text": "istradefylline, a selective adenosine A2A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.515625,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.5234375,
            "text": "istradefylline, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.5234375,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.52734375,
            "text": "istradefylline,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.0625,
            "text": "efficacy and safety of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.5390625,
            "text": "istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa",
            "probability": 5.960464477539063e-08
        }
    ],
    "54fc9b236ad7dcbc12000005_7": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.25,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3291015625,
            "text": "Is",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": 9.25,
            "text": "ylline",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -5.80859375,
            "end_logit": 9.25,
            "text": "tradefylline",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 9.25,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 9.25,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.1015625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinsons disease.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.30859375,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3125,
            "text": "Istradef",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.36328125,
            "text": "Istradefylline, a novel adenosine A2A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.37109375,
            "text": "Istradefylline, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.44140625,
            "text": "Istradefylline, a novel adenosine A2A receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.48046875,
            "text": "Istradefylline, a novel adenosine A2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.48828125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.53125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": -7.1015625,
            "text": "ylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinsons disease.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": -7.30859375,
            "text": "ylline, a novel adenosine A2A receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": -7.36328125,
            "text": "ylline, a novel adenosine A2A",
            "probability": 0.0
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": -7.37109375,
            "text": "ylline, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.5263671875,
            "end_logit": -7.44140625,
            "text": "ylline, a novel adenosine A2A receptor",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_8": [
        {
            "start_logit": 9.1953125,
            "end_logit": 9.25,
            "text": "Istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.353515625,
            "text": "Is",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.51953125,
            "end_logit": 9.25,
            "text": "ylline",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 9.25,
            "text": "tradefylline",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 9.25,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 9.25,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.11328125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.3203125,
            "text": "Istradef",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.34765625,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.359375,
            "text": "Istradefylline, a novel adenosine A2A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.3671875,
            "text": "Istradefylline, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.44921875,
            "text": "Istradefylline, a novel adenosine A2A receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.47265625,
            "text": "Istradefylline, a novel adenosine A2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.5078125,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist, for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.52734375,
            "text": "Istradefylline, a novel adenosine A2A receptor antagonist,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.51953125,
            "end_logit": -7.11328125,
            "text": "ylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease.",
            "probability": 0.0
        },
        {
            "start_logit": -1.51953125,
            "end_logit": -7.34765625,
            "text": "ylline, a novel adenosine A2A receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -1.51953125,
            "end_logit": -7.359375,
            "text": "ylline, a novel adenosine A2A",
            "probability": 0.0
        },
        {
            "start_logit": -1.51953125,
            "end_logit": -7.3671875,
            "text": "ylline, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.51953125,
            "end_logit": -7.44921875,
            "text": "ylline, a novel adenosine A2A receptor",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_9": [
        {
            "start_logit": 8.734375,
            "end_logit": 8.2109375,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -2.302734375,
            "text": "is",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -3.427734375,
            "end_logit": 8.2109375,
            "text": "ylline",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.2109375,
            "text": "tradefylline",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.21484375,
            "text": "istradef",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.2109375,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.2109375,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.2109375,
            "text": "author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.2109375,
            "text": "the author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.2109375,
            "text": "potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.2109375,
            "text": "role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.2109375,
            "text": "evaluation of istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.921875,
            "end_logit": -2.302734375,
            "text": "article, the author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -2.302734375,
            "text": "author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -2.302734375,
            "text": "this article, the author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -2.302734375,
            "text": "the author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -2.302734375,
            "text": "potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -2.302734375,
            "text": "role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -2.302734375,
            "text": "evaluation of is",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -2.302734375,
            "text": "In this article, the author discusses the potential role of A2A adenosine receptor antagonists in the treatment of Parkinson's disease through the evaluation of is",
            "probability": 0.0
        }
    ],
    "54fc9b236ad7dcbc12000005_10": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.015625,
            "text": "istradefylline",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.443359375,
            "text": "is",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -2.052734375,
            "end_logit": 9.015625,
            "text": "ylline",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": -5.99609375,
            "end_logit": 9.015625,
            "text": "tradefylline",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.6640625,
            "text": "istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 9.015625,
            "text": "defylline",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 9.015625,
            "text": "fylline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.31640625,
            "text": "istradef",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.359375,
            "text": "istradefylline for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.015625,
            "text": "antagonist istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.45703125,
            "text": "istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.515625,
            "text": "istrade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.015625,
            "text": "adenosine antagonist istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.015625,
            "text": "Suitability of the adenosine antagonist istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.015625,
            "text": "of the adenosine antagonist istradefylline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -1.443359375,
            "text": "antagonist is",
            "probability": 0.0
        },
        {
            "start_logit": -2.052734375,
            "end_logit": -6.6640625,
            "text": "ylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -1.443359375,
            "text": "adenosine antagonist is",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -1.443359375,
            "text": "Suitability of the adenosine antagonist is",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -1.443359375,
            "text": "of the adenosine antagonist is",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_1": [
        {
            "start_logit": 7.296875,
            "end_logit": 8.1953125,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -5.55078125,
            "end_logit": 8.1953125,
            "text": "endocrine pancreas",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 8.1953125,
            "text": "pituitary glands and the endocrine pancreas",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.625,
            "end_logit": 8.1953125,
            "text": "parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 8.1953125,
            "text": "development of hyperplastic or neoplastic changes in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.1953125,
            "text": "in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.1953125,
            "text": "and pituitary glands and the endocrine pancreas",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.1953125,
            "text": "glands and the endocrine pancreas",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.1953125,
            "text": "hyperplastic or neoplastic changes in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1953125,
            "text": "of hyperplastic or neoplastic changes in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1953125,
            "text": "neoplastic changes in the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.22265625,
            "text": "pancreas, along with numerous other characteristic tumors and features.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.46484375,
            "text": "pancreas, along with numerous other characteristic tumors and features",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.5,
            "text": "pancreas, along",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.59375,
            "text": "pancreas, along with numerous other characteristic tumors and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.6171875,
            "text": "pancreas,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.62109375,
            "text": "pancreas, along with numerous other",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -5.95703125,
            "text": "pituitary glands",
            "probability": 0.0
        },
        {
            "start_logit": -6.625,
            "end_logit": -5.95703125,
            "text": "parathyroid and pituitary glands",
            "probability": 0.0
        },
        {
            "start_logit": -5.55078125,
            "end_logit": -7.22265625,
            "text": "endocrine pancreas, along with numerous other characteristic tumors and features.",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_2": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.4765625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": -4.64453125,
            "end_logit": 7.4765625,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -5.25,
            "text": "pancreas and pituitary",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -4.95703125,
            "end_logit": 7.4765625,
            "text": "neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 7.4765625,
            "text": "adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.13671875,
            "text": "pancreas and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.16796875,
            "text": "pancreas and pituitary.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.4765625,
            "text": "and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.4765625,
            "text": "and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.4765625,
            "text": "occurrence of parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.4765625,
            "text": "of parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.4765625,
            "text": "tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.4765625,
            "text": "combined occurrence of parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.4765625,
            "text": "the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.4765625,
            "text": "of the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.4765625,
            "text": "by the combined occurrence of parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.25,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs) of the pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -4.95703125,
            "end_logit": -5.25,
            "text": "neuroendocrine tumors (NETs) of the pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.81640625,
            "text": "parathyroid and adrenocortical tumors, and neuroendocrine tumors (NETs)",
            "probability": 0.0
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.83984375,
            "text": "parathyroid and adrenocortical tumors",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_3": [
        {
            "start_logit": 8.0234375,
            "end_logit": 7.625,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.89453125,
            "text": "pancreas, the pituitary gland, and the parathyroid glands",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.0,
            "text": "pancreas, the pituitary gland, and the parathyroid",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.296875,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows high penetrance.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.31640625,
            "text": "pancreas, the pituitary gland",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.48046875,
            "text": "pancreas, the pituitary gland, and the parathyroid glands-areas where MEN 1 shows high penetrance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.5078125,
            "text": "pancreas, the pituitary gland, and the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.53125,
            "text": "pancreas, the pituitary gland, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.53515625,
            "text": "pancreas, the pituitary gland,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.5625,
            "text": "pancreas, the pituitary",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.57421875,
            "text": "pancreas,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.625,
            "text": "endocrine pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.625,
            "text": "potential role of miRNAs in the endocrine pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.625,
            "text": "We address the potential role of miRNAs in the endocrine pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.625,
            "text": "address the potential role of miRNAs in the endocrine pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.89453125,
            "text": "pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.89453125,
            "text": "parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.89453125,
            "text": "endocrine pancreas, the pituitary gland, and the parathyroid glands",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -7.296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.0,
            "text": "pituitary gland, and the parathyroid",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_4": [
        {
            "start_logit": 7.5859375,
            "end_logit": 8.046875,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -5.6484375,
            "text": "pancreas and pituitary",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.640625,
            "end_logit": 8.046875,
            "text": "hyperparathyroidism, tumors of endocrine pancreas",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.046875,
            "text": "endocrine pancreas",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.046875,
            "text": ", tumors of endocrine pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.046875,
            "text": "tumors of endocrine pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.046875,
            "text": "include hyperparathyroidism, tumors of endocrine pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.203125,
            "text": "pancreas and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.34375,
            "text": "pancreas and pituitary.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.640625,
            "end_logit": -5.38671875,
            "text": "hyperparathyroidism",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -5.6484375,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -5.6484375,
            "text": "pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -5.6484375,
            "text": "endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -5.38671875,
            "text": "include hyperparathyroidism",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -5.6484375,
            "text": ", tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -5.6484375,
            "text": "tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -5.6484375,
            "text": "include hyperparathyroidism, tumors of endocrine pancreas and pituitary",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -7.203125,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -7.34375,
            "text": "hyperparathyroidism, tumors of endocrine pancreas and pituitary.",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -7.34375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "51477de5d24251bc05000020_5": [
        {
            "start_logit": 5.5703125,
            "end_logit": 5.375,
            "text": "pancreas",
            "probability": 0.998046875
        },
        {
            "start_logit": -0.52490234375,
            "end_logit": 5.375,
            "text": "parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 0.0022525787353515625
        },
        {
            "start_logit": -0.52490234375,
            "end_logit": 0.1290283203125,
            "text": "parathyroid glands",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -6.375,
            "end_logit": 5.375,
            "text": "endocrine pancreas",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -6.90625,
            "text": "pancreas, and the neuroendocrine cell system of the gut",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -6.9921875,
            "text": "pancreas, and the neuroendocrine cell system of the gut.",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 5.375,
            "text": "proliferation of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 5.375,
            "text": "the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.1875,
            "text": "pancreas, and the neuroendocrine cell system",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.015625,
            "end_logit": 5.375,
            "text": "anterior pituitary gland, the endocrine pancreas",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 5.375,
            "text": "nodular proliferation of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.37109375,
            "text": "pancreas, and the neuroendocrine cell",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 5.375,
            "text": "tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.43359375,
            "text": "pancreas, and the neuroendocrine cell system of the",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.453125,
            "text": "pancreas,",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.46875,
            "text": "pancreas, and the neuroendocrine cell system of",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.5234375,
            "text": "pancreas, and the",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.5703125,
            "end_logit": -7.5390625,
            "text": "pancreas, and",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 5.375,
            "text": "of the parathyroid glands and tumors of the anterior pituitary gland, the endocrine pancreas",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 5.375,
            "text": ", the endocrine pancreas",
            "probability": 2.384185791015625e-06
        }
    ],
    "51477de5d24251bc05000020_6": [
        {
            "start_logit": 3.94921875,
            "end_logit": 6.015625,
            "text": "parathyroid glands",
            "probability": 1.0
        },
        {
            "start_logit": -4.26953125,
            "end_logit": 6.015625,
            "text": "glands",
            "probability": 0.0002696514129638672
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -3.6875,
            "text": "parathyroid glands, pancreatic islet cells",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 6.015625,
            "text": "of the parathyroid glands",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 6.015625,
            "text": "multiple tumors, typically of the parathyroid glands",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 6.015625,
            "text": "the parathyroid glands",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.015625,
            "text": "combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.015625,
            "text": "tumors, typically of the parathyroid glands",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.015625,
            "text": "typically of the parathyroid glands",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.015625,
            "text": "occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 1.1920928955078125e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.015625,
            "text": "by the combined occurrence of multiple tumors, typically of the parathyroid glands",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -5.98828125,
            "text": "parathyroid",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -6.265625,
            "text": "parathyroid glands, pancreatic islet cells, and anterior pituitary gland",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -6.40625,
            "text": "parathyroid glands, pancreatic islet",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -6.96875,
            "text": "parathyroid glands, pancreatic islet cells, and anterior pituitary",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -7.1953125,
            "text": "parathyroid glands, pancreatic islet cells, and anterior pituitary gland.",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -7.3203125,
            "text": "parathyroid glands, pancreatic",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -7.5,
            "text": "parathyroid glands, pancreatic islet cells, and anterior",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 3.94921875,
            "end_logit": -7.6328125,
            "text": "parathyroid glands, pancreatic islet cells, and",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.35546875,
            "end_logit": -3.6875,
            "text": "pancreatic islet cells",
            "probability": 5.960464477539063e-08
        }
    ],
    "51477de5d24251bc05000020_7": [
        {
            "start_logit": 8.3515625,
            "end_logit": 7.15234375,
            "text": "pancreas",
            "probability": 1.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -2.8671875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -4.453125,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angiofibromas",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -6.93359375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angiofibrom",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -6.99609375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipo",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 7.15234375,
            "text": "endocrine tumors of the parathyroid and pituitary glands, pancreas",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.19921875,
            "text": "pancreas, and duodenum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.234375,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.29296875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.3046875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angiofibromas.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.3046875,
            "text": "pancreas, and duodenum.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.33203125,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angiofi",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.4296875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.4296875,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.48828125,
            "text": "pancreas, and duodenum. Less frequently occurring tumors associated with MEN1 include non-endocrine tumors such as lipomas and angio",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.15234375,
            "text": "pituitary glands, pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 7.15234375,
            "text": ", pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 7.15234375,
            "text": "parathyroid and pituitary glands, pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 7.15234375,
            "text": "glands, pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.15234375,
            "text": "and pituitary glands, pancreas",
            "probability": 1.7881393432617188e-07
        }
    ],
    "51477de5d24251bc05000020_8": [
        {
            "start_logit": 7.96484375,
            "end_logit": 6.26953125,
            "text": "pancreas",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.8408203125,
            "end_logit": 6.26953125,
            "text": "parathyroid glands and the pancreas",
            "probability": 0.0021839141845703125
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 6.26953125,
            "text": "neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": 1.8408203125,
            "end_logit": 1.724609375,
            "text": "parathyroid glands",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.47265625,
            "text": "pancreas and a hepatic neuroendocrine tumor",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.90234375,
            "text": "pancreas and a hepatic neuroendocrine tumor metastasis, as predicted by Knudson's \"two hit\" hypothesis.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.953125,
            "text": "pancreas and a hepatic neuroendocrine tumor metastasis",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.42578125,
            "text": "pancreas and",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.48046875,
            "text": "pancreas and a hepatic neuroendocrine tumor metastasis, as predicted",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 6.26953125,
            "text": "the pancreas",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 1.724609375,
            "text": "neuroendocrine tumors involving the parathyroid glands",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 6.26953125,
            "text": "multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 6.26953125,
            "text": "in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 6.26953125,
            "text": "glands and the pancreas",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.26953125,
            "text": "and the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.26953125,
            "text": "the parathyroid glands and the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.26953125,
            "text": "involving the parathyroid glands and the pancreas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.26953125,
            "text": ", and deletions of the MEN1 gene were consistently detected in multiple neuroendocrine tumors involving the parathyroid glands and the pancreas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.8408203125,
            "end_logit": -6.47265625,
            "text": "parathyroid glands and the pancreas and a hepatic neuroendocrine tumor",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": 1.724609375,
            "text": "multiple neuroendocrine tumors involving the parathyroid glands",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_1": [
        {
            "start_logit": 8.25,
            "end_logit": 7.3515625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.02734375,
            "text": "thrombocytopenia, fever",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.94921875,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental status",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.29296875,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental status.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.5546875,
            "text": "thrombocytopenia, fever, elevated creatinine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.58203125,
            "text": "thrombocytopenia, fever, elevated creatinine, and altered mental",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.3515625,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.3515625,
            "text": "patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.3515625,
            "text": "Our patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.3515625,
            "text": "with the classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.3515625,
            "text": "classic pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.3515625,
            "text": ": anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.3515625,
            "text": "pentad of TTP symptoms: anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -6.02734375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -6.02734375,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -6.02734375,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.02734375,
            "text": "patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.02734375,
            "text": "Our patient presented with the classic pentad of TTP symptoms: anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.02734375,
            "text": "with the classic pentad of TTP symptoms: anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.02734375,
            "text": "classic pentad of TTP symptoms: anemia, thrombocytopenia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_2": [
        {
            "start_logit": 8.3203125,
            "end_logit": 7.25,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": 7.25,
            "text": "fever, thrombocytopenia",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.2421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.38671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.59765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.25,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.25,
            "text": "characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.25,
            "text": "of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.25,
            "text": "by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.25,
            "text": "typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.25,
            "text": "(TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -3.314453125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -3.314453125,
            "text": "characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -3.314453125,
            "text": "of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -3.314453125,
            "text": "by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -7.2421875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -3.314453125,
            "text": "typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_3": [
        {
            "start_logit": 8.1796875,
            "end_logit": 7.45703125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -5.15234375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.37109375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are seen only in 40 percent of the patients.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.48046875,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.484375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.55078125,
            "text": "thrombocytopenia, neurological dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.55078125,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are seen only in 40",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.59765625,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are seen only",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.65234375,
            "text": "thrombocytopenia, neurological dysfunction, kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.65234375,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, neurological dysfunction, kidney dysfunction and fever are seen",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.45703125,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.45703125,
            "text": "microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.45703125,
            "text": "Nonetheless, the classical pentad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.45703125,
            "text": ", the classical pentad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.45703125,
            "text": "pentad of microangiopathic hemolytic anemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -5.15234375,
            "text": ", thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -5.15234375,
            "text": "microangiopathic hemolytic anemia (MAHA), thrombocytopenia, neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -5.15234375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -5.15234375,
            "text": ", neurological dysfunction, kidney dysfunction and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_4": [
        {
            "start_logit": 8.0703125,
            "end_logit": 7.56640625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -6.828125,
            "text": "thrombocytopenia, hemolysis, fever",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.2421875,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.3828125,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthrombi formation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.515625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.56640625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.578125,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.6171875,
            "text": "thrombocytopenia, hemolysis, fever, renal injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.62109375,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthromb",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.640625,
            "text": "thrombocytopenia, hemolysis, fever, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthr",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.65234375,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthrombi formation in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.66015625,
            "text": "thrombocytopenia, hemolysis, fever, renal injury and neurological deficits, yet the patient may present with any atypical symptom related to microthrombi",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.56640625,
            "text": "of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.56640625,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.828125,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.828125,
            "text": "of thrombocytopenia, hemolysis, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -6.828125,
            "text": "pentad of thrombocytopenia, hemolysis, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.828125,
            "text": "fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_5": [
        {
            "start_logit": 8.1484375,
            "end_logit": 7.4921875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.19140625,
            "text": "thrombocytopenia, fever",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.93359375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.26171875,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.53125,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, fever, altered mental status",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.4921875,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.4921875,
            "text": "illness with disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.19140625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -6.19140625,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.93359375,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -7.26171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -6.93359375,
            "text": ", fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.93359375,
            "text": "acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.26171875,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -6.93359375,
            "text": "kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.2890625,
            "text": "illness with disseminated platelet-rich thromboses of small vessels",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.2890625,
            "text": ", life-threatening illness with disseminated platelet-rich thromboses of small vessels",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.53125,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.3984375,
            "text": "illness with disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_6": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.734375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.1796875,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.3359375,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.28515625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.58203125,
            "text": "thrombocytopenia, neurological symptoms, renal impairment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.734375,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.734375,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.671875,
            "text": "thrombocytopenia, neurological symptoms, renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.734375,
            "text": ", rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.734375,
            "text": "distinct, rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.734375,
            "text": "potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.734375,
            "text": "onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.734375,
            "text": "rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.734375,
            "text": "acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -6.1796875,
            "text": "fevers",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -6.3359375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.1796875,
            "text": ", thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.1796875,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -6.1796875,
            "text": ", neurological symptoms, renal impairment and fevers",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_7": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.69140625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.04296875,
            "text": "thrombocytopenia, fever",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.39453125,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.45703125,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.69140625,
            "text": "patient was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5625,
            "text": "thrombocytopenia, fever neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.61328125,
            "text": "thrombocytopenia, fever neurologic, and renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.69140625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.69140625,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.7265625,
            "text": "thrombocytopenia, fever neurologic, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.69140625,
            "text": "clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.69140625,
            "text": "diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.69140625,
            "text": "The patient was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.69140625,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.69140625,
            "text": "pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.69140625,
            "text": ") following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.69140625,
            "text": ": microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.69140625,
            "text": "d of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.69140625,
            "text": "(TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.04296875,
            "text": "patient was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_8": [
        {
            "start_logit": 8.125,
            "end_logit": 7.4453125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -3.37890625,
            "end_logit": 7.4453125,
            "text": "fever, thrombocytopenia",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.0390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.23046875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.6171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.6171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.4453125,
            "text": "of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.4453125,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.4453125,
            "text": "disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.4453125,
            "text": "with the pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.4453125,
            "text": "that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.4453125,
            "text": "(TTP) is a disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -3.04296875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -7.0390625,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -3.04296875,
            "text": "of fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -7.23046875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -3.04296875,
            "text": "disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -3.04296875,
            "text": "with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -3.04296875,
            "text": "that presents classically with the pentad of fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_9": [
        {
            "start_logit": 8.2265625,
            "end_logit": 7.33203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": 7.33203125,
            "text": "fever, thrombocytopenia",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.34765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.35546875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40234375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.484375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66796875,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 7.33203125,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.33203125,
            "text": "of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.33203125,
            "text": "characterized by the pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.33203125,
            "text": "pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.33203125,
            "text": "by the pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -1.4609375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -7.34765625,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -7.35546875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal dysfunction.",
            "probability": 0.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -7.40234375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms, and renal",
            "probability": 0.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -7.4609375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurologic symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -1.1123046875,
            "end_logit": -7.484375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_10": [
        {
            "start_logit": 8.3203125,
            "end_logit": 7.25,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": 7.25,
            "text": "fever, thrombocytopenia",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.2421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.38671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.59765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.25,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.25,
            "text": "characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.25,
            "text": "of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.25,
            "text": "by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.25,
            "text": "typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.25,
            "text": "(TTP) is typically characterized by the symptomatic pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -3.314453125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -3.314453125,
            "text": "characterized by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -3.314453125,
            "text": "of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -3.314453125,
            "text": "by the symptomatic pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -7.2421875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, and renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -3.314453125,
            "text": "typically characterized by the symptomatic pentad of fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_11": [
        {
            "start_logit": 7.3984375,
            "end_logit": 7.1796875,
            "text": "fever",
            "probability": 1.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 7.1796875,
            "text": "hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 7.1796875,
            "text": "multisystem disorder characterized by a pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.1796875,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.0078125,
            "text": "fever.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 7.1796875,
            "text": ", microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 7.1796875,
            "text": "microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.1796875,
            "text": "and fever",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.1796875,
            "text": "renal dysfunction, neurological signs and fever",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.1796875,
            "text": "opathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.1796875,
            "text": "of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.1796875,
            "text": "pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.1796875,
            "text": ", renal dysfunction, neurological signs and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.1796875,
            "text": "a multisystem disorder characterized by a pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia, renal dysfunction, neurological signs and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.1796875,
            "text": "neurological signs and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -5.77734375,
            "text": "hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -5.77734375,
            "text": "multisystem disorder characterized by a pentad consisting of thrombocytopenic, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -5.77734375,
            "text": "thrombocytopenic, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -5.77734375,
            "text": ", microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -5.77734375,
            "text": "microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_12": [
        {
            "start_logit": 8.09375,
            "end_logit": 7.55859375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.09375,
            "end_logit": -5.875,
            "text": "thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.39453125,
            "text": "thrombocytopenia, neurological symptoms, renal involvement, and fever.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.46875,
            "text": "thrombocytopenia, neurological symptoms, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.5,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.515625,
            "text": "thrombocytopenia, neurological symptoms, renal involvement",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.55859375,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.55859375,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.55859375,
            "text": "characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.55859375,
            "text": "Clinical thrombotic thrombocytopenic purpura (TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.55859375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.55859375,
            "text": "by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -5.875,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -5.875,
            "text": ", thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -5.875,
            "text": ", neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -5.875,
            "text": "neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -5.875,
            "text": "characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -5.875,
            "text": "Clinical thrombotic thrombocytopenic purpura (TTP) is characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -5.875,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -5.875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, renal involvement, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_13": [
        {
            "start_logit": 7.9609375,
            "end_logit": 7.71484375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -6.0234375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.3984375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.5234375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.58203125,
            "text": "thrombocytopenia, haemolytic anaemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.59765625,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.625,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purp",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpu",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.703125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.7109375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.7109375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.7421875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.75,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.71484375,
            "text": "of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.71484375,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.71484375,
            "text": ": The pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.0234375,
            "text": "mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_14": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.703125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.54296875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.44921875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.51953125,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.546875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpur",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.55078125,
            "text": "thrombocytopenia, hemolytic anemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.6015625,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purp",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, hemolytic anemia, mild renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.7109375,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.71875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.71875,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.7265625,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.734375,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and fever, classically characterizes the syndrome of thrombotic thrombocytopenic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.703125,
            "text": "of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.74609375,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic signs, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.75390625,
            "text": "thrombocytopenia, hemolytic anemia, mild renal dysfunction,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.703125,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.703125,
            "text": ": The pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.703125,
            "text": "d of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.703125,
            "text": "BACKGROUND: The pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60274aca1cb411341a0000e3_15": [
        {
            "start_logit": 8.15625,
            "end_logit": 7.3203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": 7.3203125,
            "text": "fever, thrombocytopenia",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.16015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.546875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.65234375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.3203125,
            "text": "of fever, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.3203125,
            "text": ", thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.3203125,
            "text": "disorder of blood coagulation that presents classically with the pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.3203125,
            "text": "with the pentad of fever, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.59375,
            "end_logit": -3.853515625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -3.853515625,
            "text": "of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -3.853515625,
            "text": "disorder of blood coagulation that presents classically with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -3.853515625,
            "text": "with the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -7.16015625,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status changes",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -7.546875,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal dysfunction and mental status",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -7.609375,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": -7.625,
            "text": "fever, thrombocytopenia, microangiopathic hemolytic anemia, renal",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_16": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.6484375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": 7.6484375,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.6484375,
            "text": "and thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.6484375,
            "text": "neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.6484375,
            "text": "pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.6484375,
            "text": "renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.6484375,
            "text": ", neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.6484375,
            "text": "characterized by the pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.6484375,
            "text": ", and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.6484375,
            "text": "botic thrombocytopenic purpura has classically been characterized by the pentad of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.6484375,
            "text": "of fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.6484375,
            "text": "microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction, and thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -4.86328125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -4.86328125,
            "text": "pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -4.86328125,
            "text": "characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -4.86328125,
            "text": "botic thrombocytopenic purpura has classically been characterized by the pentad of fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -4.86328125,
            "text": "of fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.38671875,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal dysfunction",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.4765625,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms, renal",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.5859375,
            "text": "fever, microangiopathic hemolytic anemia, neurologic symptoms",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_17": [
        {
            "start_logit": 8.125,
            "end_logit": 7.515625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.125,
            "end_logit": -5.9296875,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.5234375,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.546875,
            "text": "thrombocytopenia, renal failure",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.640625,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, renal failure, fluctuating neurologic signs, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.515625,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.515625,
            "text": "syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.515625,
            "text": "microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.515625,
            "text": "(TTP) is a syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.515625,
            "text": "clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": -5.9296875,
            "text": ", thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -5.9296875,
            "text": "syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -5.9296875,
            "text": "microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -5.9296875,
            "text": ", renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -5.9296875,
            "text": "clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -7.1640625,
            "text": "syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.1640625,
            "text": "microangiopathic haemolytic anaemia (MAHA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.1640625,
            "text": "(TTP) is a syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA)",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_18": [
        {
            "start_logit": 8.25,
            "end_logit": 7.3359375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.69921875,
            "text": "thrombocytopenia, fever",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.31640625,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.60546875,
            "text": "thrombocytopenia, fever, hemiparesis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.6171875,
            "text": "thrombocytopenia, fever, hemiparesis and hematuria)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.69140625,
            "text": "thrombocytopenia, fever,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.3359375,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.3359375,
            "text": "pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.3359375,
            "text": "disease presenting with a pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.3359375,
            "text": "anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.3359375,
            "text": "with a pentad of signs and symptoms (anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.69921875,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.69921875,
            "text": "pentad of signs and symptoms (anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.69921875,
            "text": "disease presenting with a pentad of signs and symptoms (anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -6.69921875,
            "text": "anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -6.69921875,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.69921875,
            "text": "with a pentad of signs and symptoms (anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.140625,
            "text": "hrombotic thrombocytopenic purpura was first described in 1924 by Moschowitz as a disease presenting with a pentad of signs and symptoms (anemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -7.140625,
            "text": "pentad of signs and symptoms (anemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.140625,
            "text": "disease presenting with a pentad of signs and symptoms (anemia",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_19": [
        {
            "start_logit": 8.0234375,
            "end_logit": 7.6484375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.34765625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.97265625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment and fevers",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.55078125,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.59765625,
            "text": "thrombocytopenia, neurological symptoms, renal impairment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.69921875,
            "text": "thrombocytopenia, neurological symptoms, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.6484375,
            "text": ", rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.6484375,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.6484375,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.6484375,
            "text": "distinct, rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.6484375,
            "text": "rare but potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.6484375,
            "text": "potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.6484375,
            "text": "entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.6484375,
            "text": "onset haemolytic anaemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -6.34765625,
            "text": "pentad of acute onset haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -6.34765625,
            "text": ", thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -6.34765625,
            "text": ", neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -6.34765625,
            "text": "potentially life-threatening entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -6.34765625,
            "text": "entity that classically but not invariably presents with a pentad of acute onset haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -6.34765625,
            "text": "onset haemolytic anaemia, thrombocytopenia, neurological symptoms, renal impairment and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_20": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.765625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.1796875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.34375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.38671875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological disturbances",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.44140625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.4609375,
            "text": "thrombocytopenia, Coombs-negative",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.48828125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.48828125,
            "text": "thrombocytopenia, Coombs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.61328125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal abnormalities and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.68359375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, fever, renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.765625,
            "text": "of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.1796875,
            "text": "Coombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.34375,
            "text": "Coombs-negative hemolytic anemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.38671875,
            "text": "Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological disturbances",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -7.1796875,
            "text": "ombs-negative hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.44140625,
            "text": "Coombs-negative hemolytic anemia, fever, renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.4609375,
            "text": "Coombs-negative",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.1796875,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.48828125,
            "text": "Coombs-negative hemolytic anemia, fever, renal abnormalities and neurological",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.48828125,
            "text": "Coombs",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_21": [
        {
            "start_logit": 8.0546875,
            "end_logit": 7.61328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.13671875,
            "text": "thrombocytopenia, fever",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.41796875,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.48828125,
            "text": "thrombocytopenia, fever neurologic, and renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.5703125,
            "text": "thrombocytopenia, fever neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.5703125,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities. Magnetic reso",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.7109375,
            "text": "thrombocytopenia, fever neurologic, and renal abnormalities. Magnetic res",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.61328125,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.61328125,
            "text": "clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.61328125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.61328125,
            "text": "t was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.61328125,
            "text": "diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.61328125,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.61328125,
            "text": "d of clinical features: microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": -7.13671875,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.13671875,
            "text": "clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.13671875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.13671875,
            "text": "t was diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.13671875,
            "text": "diagnosed thrombotic thrombocytopenic purpura (TTP) following pentad of clinical features: microangiopathic hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.13671875,
            "text": "hemolytic anemia, thrombocytopenia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_22": [
        {
            "start_logit": 8.015625,
            "end_logit": 7.59765625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -6.40625,
            "end_logit": 7.59765625,
            "text": "fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.109375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior to therapy.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.49609375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior to therapy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.54296875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.5546875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.578125,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10% prior to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less than 10%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.60546875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.6171875,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.62109375,
            "text": "thrombocytopenia, and evidence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level was found to be less",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, and evidence of red cell fragmentation and his ADAMTS13 level",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.59765625,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.59765625,
            "text": "except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.59765625,
            "text": "for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.59765625,
            "text": "he presented with most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.59765625,
            "text": "fact that he presented with most components of the TTP pentad (except for fever), which included altered mental status, acute kidney injury, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60274aca1cb411341a0000e3_23": [
        {
            "start_logit": 8.1484375,
            "end_logit": 7.4921875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.19140625,
            "text": "thrombocytopenia, fever",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.93359375,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.26171875,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.53125,
            "text": "thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, fever, altered mental status",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.4921875,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.4921875,
            "text": "illness with disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.19140625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -6.19140625,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.93359375,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -7.26171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -6.93359375,
            "text": ", fever, altered mental status, and acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -6.93359375,
            "text": "acute kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.26171875,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney injury.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -6.93359375,
            "text": "kidney injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.2890625,
            "text": "illness with disseminated platelet-rich thromboses of small vessels",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.2890625,
            "text": ", life-threatening illness with disseminated platelet-rich thromboses of small vessels",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.53125,
            "text": ", thrombocytopenia, fever, altered mental status, and acute kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.3984375,
            "text": "illness with disseminated platelet-rich thromboses of small vessels that variably presents with the classic clinical \"pentad\" of microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_24": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.76953125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.2109375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.28125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.34765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.40625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.41015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.76953125,
            "text": "rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.54296875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.76953125,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.6015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.68359375,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.69140625,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.76953125,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.76953125,
            "text": "is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.76953125,
            "text": ") is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.76953125,
            "text": "(TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.76953125,
            "text": "a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.34765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.2109375,
            "text": "rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_25": [
        {
            "start_logit": 7.48046875,
            "end_logit": 7.8203125,
            "text": "fever",
            "probability": 1.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.8203125,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 7.8203125,
            "text": "and fever",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.8203125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.8203125,
            "text": "clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.8203125,
            "text": ", thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.8203125,
            "text": "pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.8203125,
            "text": "It is characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.8203125,
            "text": ", and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.8203125,
            "text": "of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.8203125,
            "text": "characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.8203125,
            "text": "including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.8203125,
            "text": ", neurologic and renal abnormalities, and fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.203125,
            "text": "fever.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": -6.81640625,
            "text": "thrombocytopenic purpura",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.203125,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities, and fever.",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.4296875,
            "text": "thrombocytopenic",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.5,
            "text": "thrombocytopenic purpura, neurologic and renal",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.5,
            "text": "thrombocytopenic purpura, neurologic and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -6.81640625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenic purpura",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_26": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.6953125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -5.65625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.3125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.3828125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.46875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.50390625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.70703125,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.6953125,
            "text": "clinical pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.6953125,
            "text": "is a multi-systemic disorder characterized by a clinical pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.6953125,
            "text": "It is a multi-systemic disorder characterized by a clinical pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -5.65625,
            "text": "microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -5.65625,
            "text": "neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -5.65625,
            "text": "clinical pentad of thrombocytopenia, microangiopathic hemolytic anemia, diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -5.65625,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -5.65625,
            "text": "decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -5.65625,
            "text": ", and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -5.65625,
            "text": "nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -5.65625,
            "text": ", diffuse and nonfocal neurologic symptoms, decreased renal function, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_27": [
        {
            "start_logit": 8.1796875,
            "end_logit": 7.4375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": 7.4375,
            "text": "fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.0703125,
            "text": "thrombocytopenia and a haemolytic anaemia--the pentad of features seen in TTP.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.1875,
            "text": "thrombocytopenia and a haemolytic anaemia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.375,
            "text": "thrombocytopenia and a haemolytic anaemia--the pentad of features seen in TTP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.51171875,
            "text": "thrombocytopenia and a haemolytic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia and a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.4375,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.4375,
            "text": "seizures, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.4375,
            "text": "a fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.4375,
            "text": ", seizures, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.4375,
            "text": "develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.4375,
            "text": "Initially presenting a fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.4375,
            "text": "presenting a fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -3.73828125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -3.73828125,
            "text": "a fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -3.73828125,
            "text": "Initially presenting a fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -3.73828125,
            "text": "presenting a fever",
            "probability": 0.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -6.7578125,
            "text": "fever and systemic upset she progressed to develop dialysis dependent acute renal failure, seizures",
            "probability": 0.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -6.9921875,
            "text": "fever and systemic upset she progressed to develop dialysis dependent acute renal failure",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_28": [
        {
            "start_logit": 7.82421875,
            "end_logit": 7.859375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.03515625,
            "text": "thrombocytopenia, hemolytic anemia, fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.3828125,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and renal disease.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.40625,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.859375,
            "text": "pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.48828125,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and renal disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.859375,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.515625,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic abnormalities, and renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.859375,
            "text": "d of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.5625,
            "text": "thrombocytopenia, hemolytic anemia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.859375,
            "text": "(TTP) consists of the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, hemolytic anemia, fever, neurologic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.3828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.03515625,
            "text": "pentad of thrombocytopenia, hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.03515625,
            "text": "hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.03515625,
            "text": "of thrombocytopenia, hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.03515625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.03515625,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.03515625,
            "text": ", hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.03515625,
            "text": "d of thrombocytopenia, hemolytic anemia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_29": [
        {
            "start_logit": 7.77734375,
            "end_logit": 7.89453125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -6.41796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.89453125,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.3671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.89453125,
            "text": "clinical syndrome defined by the pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.89453125,
            "text": "pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.89453125,
            "text": "d of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.40625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.89453125,
            "text": "is a clinical syndrome defined by the pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.48828125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.671875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.41796875,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -6.41796875,
            "text": "of thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.41796875,
            "text": "clinical syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.41796875,
            "text": "microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.41796875,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.41796875,
            "text": "d of thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_30": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.80078125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -5.359375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.26953125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.41796875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpura (TTP).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.45703125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.5390625,
            "text": "thrombocytopenia, haemolytic anaemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.80078125,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.5703125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.80078125,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.65625,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.80078125,
            "text": "d of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.66796875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.70703125,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic purpura (TTP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.7109375,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.73046875,
            "text": "thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever, classically characterizes the syndrome of thrombotic thrombocytopenic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": -5.359375,
            "text": "haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -5.359375,
            "text": "mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -5.359375,
            "text": "of thrombocytopenia, haemolytic anaemia, mild renal dysfunction, neurological signs and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_31": [
        {
            "start_logit": 8.109375,
            "end_logit": 7.5390625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.109375,
            "end_logit": -5.77734375,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.27734375,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.38671875,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and fever.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.5078125,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, neurologic symptoms, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, neurologic symptoms, renal insufficiency, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.5390625,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.5390625,
            "text": "characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.5390625,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.5390625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.5390625,
            "text": "(TTP) is characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.5390625,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -5.77734375,
            "text": "neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -5.77734375,
            "text": ", neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -5.77734375,
            "text": ", thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -5.77734375,
            "text": "characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -5.77734375,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -5.77734375,
            "text": ", renal insufficiency, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -5.77734375,
            "text": "and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_32": [
        {
            "start_logit": 7.859375,
            "end_logit": 7.8203125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.21875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.26171875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.32421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.42578125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.43359375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.8203125,
            "text": "pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.8203125,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.578125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.8203125,
            "text": "It is characterized by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.8203125,
            "text": "characterized by the pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.6484375,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.6796875,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.6796875,
            "text": "thrombocytopenia,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.43359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.21875,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -7.21875,
            "text": "of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.21875,
            "text": "microangiopathic hemolytic anemia, neurological symptoms, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.26171875,
            "text": "pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -7.26171875,
            "text": "of thrombocytopenia, microangiopathic hemolytic anemia, neurological symptoms, fever, and renal abnormalities",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_33": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.68359375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.36328125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.40234375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.43359375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.4921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and renal damage)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.5234375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms, fever and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6796875,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.69921875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic signs and symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.68359375,
            "text": "(thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.68359375,
            "text": "rare disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.68359375,
            "text": "diagnostic pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.68359375,
            "text": "disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.68359375,
            "text": ", clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.68359375,
            "text": "pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.68359375,
            "text": "(TTP) is a rare disorder of unknown etiology, clinically characterized by a diagnostic pentad (thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -7.36328125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_34": [
        {
            "start_logit": 8.1171875,
            "end_logit": 7.5390625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -4.73046875,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.3671875,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and fever.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.51953125,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia, renal abnormalities, neurologic signs and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.6015625,
            "text": "thrombocytopenia, renal abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.5390625,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.5390625,
            "text": "pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.5390625,
            "text": "clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.5390625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.5390625,
            "text": "d of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5390625,
            "text": "characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.5390625,
            "text": "of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.5390625,
            "text": "by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -4.73046875,
            "text": ", thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -4.73046875,
            "text": "pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -4.73046875,
            "text": "clinical findings, including microangiopathic hemolytic anemia, thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -4.73046875,
            "text": ", renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -4.73046875,
            "text": ", neurologic signs and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -4.73046875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, renal abnormalities, neurologic signs and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_35": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.74609375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -5.39453125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.2265625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.296875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs and symptoms.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.40625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs and symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.4453125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.74609375,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.49609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.74609375,
            "text": "While the pentad of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.6015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.62109375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.74609375,
            "text": "pentad of thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.65625,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.66015625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few patients present with all signs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities characterize the clinical presentation of TTP, few",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60274aca1cb411341a0000e3_36": [
        {
            "start_logit": 8.34375,
            "end_logit": 7.24609375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.4296875,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.4140625,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.4296875,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.43359375,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.55078125,
            "text": "thrombocytopenia, neurologic symptoms, renal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.625,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 7.24609375,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.24609375,
            "text": ". The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.24609375,
            "text": "classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.24609375,
            "text": "(microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.24609375,
            "text": "pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.24609375,
            "text": "no cases of congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.24609375,
            "text": "of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.24609375,
            "text": "The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.24609375,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -6.4296875,
            "text": ", thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -6.4296875,
            "text": ". The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.4296875,
            "text": "neurologic symptoms, renal dysfunction and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_37": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.6875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.984375,
            "end_logit": -6.234375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.3046875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.37109375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.4453125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5859375,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.60546875,
            "text": "thrombocytopenia, microangiopathic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.6328125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.640625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.6875,
            "text": ": thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.6875,
            "text": "pentad: thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.6875,
            "text": "life-threatening disease, characterized by Moschcowitz's pentad: thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.6875,
            "text": "d: thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.234375,
            "text": "microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.234375,
            "text": ": thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -6.234375,
            "text": "pentad: thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -6.234375,
            "text": "d: thrombocytopenia, microangiopathic hemolytic anemia, fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -6.234375,
            "text": ", fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -6.234375,
            "text": "fluctuating neurological signs, renal failure, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_38": [
        {
            "start_logit": 7.3828125,
            "end_logit": 8.2421875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": 8.2421875,
            "text": "severe thrombocytopenia",
            "probability": 0.00019109249114990234
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.2421875,
            "text": ": severe thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.2421875,
            "text": "1 This case presented with the pentad of thrombotic thrombocytopenic purpura: severe thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.2421875,
            "text": "pentad of thrombotic thrombocytopenic purpura: severe thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.2421875,
            "text": "with the pentad of thrombotic thrombocytopenic purpura: severe thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.2421875,
            "text": "d of thrombotic thrombocytopenic purpura: severe thrombocytopenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.30078125,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.53515625,
            "text": "thrombocytopenia (platelets 9",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.546875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20-110",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.56640625,
            "text": "thrombocytopenia (platelets 9 \u00d7",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.60546875,
            "text": "thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": -6.96875,
            "text": "severe",
            "probability": 0.0
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": -7.30078125,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L)",
            "probability": 0.0
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": -7.4765625,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245",
            "probability": 0.0
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": -7.53515625,
            "text": "severe thrombocytopenia (platelets 9",
            "probability": 0.0
        },
        {
            "start_logit": -1.1787109375,
            "end_logit": -7.546875,
            "text": "severe thrombocytopenia (platelets 9 \u00d7 109/L), microangiopathic haemolytic anaemia (reticular count 245 \u00d7 109/L (20-110",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_39": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.55078125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.1796875,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.33984375,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure, and fever.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.4921875,
            "text": "thrombocytopenia, neurologic abnormalities, renal failure",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.5859375,
            "text": "thrombocytopenia, neurologic abnormalities, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.58984375,
            "text": "thrombocytopenia, neurologic abnormalities",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.55078125,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.55078125,
            "text": "; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.55078125,
            "text": "(52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.55078125,
            "text": "All 31 patients had diagnostic criteria for TTP; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.55078125,
            "text": "pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.55078125,
            "text": "patients had diagnostic criteria for TTP; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.55078125,
            "text": "had diagnostic criteria for TTP; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.55078125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.55078125,
            "text": "had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.55078125,
            "text": "\"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.1796875,
            "text": ", thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -6.1796875,
            "text": "; 16 (52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -6.1796875,
            "text": "(52%) had the complete \"pentad\" of microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.1796875,
            "text": ", neurologic abnormalities, renal failure, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_40": [
        {
            "start_logit": 7.99609375,
            "end_logit": 7.6796875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.1015625,
            "text": "thrombocytopenia, renal dysfunction, fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.375,
            "text": "thrombocytopenia, renal dysfunction, fever, and a fluctuating neurologic syndrome.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.41796875,
            "text": "thrombocytopenia, renal dysfunction, fever, and a fluctuating neurologic syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.5078125,
            "text": "thrombocytopenia, renal dysfunction",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, renal dysfunction, fever, and a fluctuating neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.6796875,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.6796875,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.6796875,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.6796875,
            "text": "uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.6796875,
            "text": "disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.6796875,
            "text": "(TTP) is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.6796875,
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.6796875,
            "text": "an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.6796875,
            "text": "is an uncommon disorder characterized by a pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -7.1015625,
            "text": ", thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.1015625,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.1015625,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, renal dysfunction, fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_41": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.6328125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.19921875,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.36328125,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal if left untreated.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal if left untreated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.62890625,
            "text": "thrombocytopenia, neurological symptoms, renal injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.66015625,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that is invariably fatal if left",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.671875,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.67578125,
            "text": "thrombocytopenia, neurological symptoms, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.6953125,
            "text": "thrombocytopenia, neurological symptoms, renal injury, and fever that",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.6328125,
            "text": "rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.6328125,
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.6328125,
            "text": "Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.6328125,
            "text": ": Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.6328125,
            "text": "pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.6328125,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.6328125,
            "text": "BACKGROUND: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.6328125,
            "text": "a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.6328125,
            "text": "is a rare hematological emergency characterized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60274aca1cb411341a0000e3_42": [
        {
            "start_logit": 8.2890625,
            "end_logit": 7.30078125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -3.9921875,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.359375,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities, and fever.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.45703125,
            "text": "thrombocytopenia, renal disease, neurologic abnormalities",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.62109375,
            "text": "thrombocytopenia, renal disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.671875,
            "text": "thrombocytopenia, renal disease, neurologic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.30078125,
            "text": ", thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.30078125,
            "text": "pentad of anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.30078125,
            "text": "anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.30078125,
            "text": "Diagnosis of TTP is usually made on the basis of the pentad of anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.30078125,
            "text": "d of anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.30078125,
            "text": "of anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.30078125,
            "text": "of TTP is usually made on the basis of the pentad of anemia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -3.9921875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.9921875,
            "text": ", thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -3.9921875,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -3.9921875,
            "text": "pentad of anemia, thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -3.9921875,
            "text": "anemia, thrombocytopenia, renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -3.9921875,
            "text": ", renal disease, neurologic abnormalities, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -3.9921875,
            "text": ", neurologic abnormalities, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_43": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.73828125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -5.50390625,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.3515625,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.42578125,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.73828125,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.55859375,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.640625,
            "text": "thrombocytopenia, micro-angiopathic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.66015625,
            "text": "thrombocytopenia, micro-angiopathic hemolytic anemia, renal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.6875,
            "text": "thrombocytopenia, micro-angiopath",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.73828125,
            "text": "., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.73828125,
            "text": "intensive care unit; having classical pentad of thrombocytopenic purpura, i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.73828125,
            "text": ", i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.73828125,
            "text": ".e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.73828125,
            "text": "i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.73828125,
            "text": "he was referred to our intensive care unit; having classical pentad of thrombocytopenic purpura, i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.73828125,
            "text": "having classical pentad of thrombocytopenic purpura, i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.73828125,
            "text": "; having classical pentad of thrombocytopenic purpura, i.e., thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -5.50390625,
            "text": ", thrombocytopenia, micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -5.50390625,
            "text": "micro-angiopathic hemolytic anemia, renal failure, encephalopathy, and fever",
            "probability": 0.0
        }
    ],
    "60274aca1cb411341a0000e3_44": [
        {
            "start_logit": 7.34375,
            "end_logit": 8.265625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 8.265625,
            "text": ". It is characterized by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.265625,
            "text": ": fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.265625,
            "text": "fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.265625,
            "text": "pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.265625,
            "text": "clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.265625,
            "text": "characterized by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.265625,
            "text": "by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.265625,
            "text": "and thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.265625,
            "text": "young adults. It is characterized by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia and thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.34375,
            "end_logit": -7.3359375,
            "text": "thrombocytopenia.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -6.7421875,
            "text": ". It is characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.7421875,
            "text": ": fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -6.7421875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -6.7421875,
            "text": "pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -6.7421875,
            "text": "clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.7421875,
            "text": "characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.7421875,
            "text": "uncommon disorder which usually occurs in young adults. It is characterized by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.7421875,
            "text": "by a pentad of clinical findings: fever",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.265625,
            "text": ". It is characterized by a pentad of clinical findings: fever, neurological abnormalities, renal dysfunction, microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "606a23c694d57fd87900004d_1": [
        {
            "start_logit": 7.66015625,
            "end_logit": 7.44140625,
            "text": "CYP2C9",
            "probability": 1.0
        },
        {
            "start_logit": -1.51171875,
            "end_logit": 7.44140625,
            "text": "VKORC1 and CYP2C9",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": -5.0625,
            "end_logit": 7.44140625,
            "text": "(VKORC1 and CYP2C9",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -6.45703125,
            "text": "CYP2C9) plus clinical information or only clinical information.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 7.44140625,
            "text": "ORC1 and CYP2C9",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.44140625,
            "text": "and CYP2C9",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.06640625,
            "text": "CYP2C9) plus clinical information or",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.20703125,
            "text": "CYP2C9)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.44140625,
            "text": "genetic (VKORC1 and CYP2C9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.44140625,
            "text": "an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.44140625,
            "text": "by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.44140625,
            "text": "adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.44140625,
            "text": "507 adults were randomized to receive initial dosing as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.51953125,
            "text": "CYP2C9) plus clinical information",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.5546875,
            "text": "CYP2C9) plus clinical information or only clinical information",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.44140625,
            "text": "as determined by an algorithm containing genetic (VKORC1 and CYP2C9",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.51171875,
            "end_logit": -3.07421875,
            "text": "VKORC1",
            "probability": 0.0
        },
        {
            "start_logit": -1.51171875,
            "end_logit": -6.45703125,
            "text": "VKORC1 and CYP2C9) plus clinical information or only clinical information.",
            "probability": 0.0
        },
        {
            "start_logit": -5.0625,
            "end_logit": -3.07421875,
            "text": "(VKORC1",
            "probability": 0.0
        },
        {
            "start_logit": -1.51171875,
            "end_logit": -7.06640625,
            "text": "VKORC1 and CYP2C9) plus clinical information or",
            "probability": 0.0
        }
    ],
    "620c01ae3a8413c653000005_1": [
        {
            "start_logit": 7.79296875,
            "end_logit": 7.7265625,
            "text": "CYP1A2",
            "probability": 1.0
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -4.9375,
            "text": "CYP1A2 and CYP3A",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 7.7265625,
            "text": "expression of CYP1A2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 7.7265625,
            "text": "as the expression of CYP1A2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 7.7265625,
            "text": "of CYP1A2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.2265625,
            "text": "CYP1A2 and CYP3A.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.2734375,
            "text": "CYP1A2 and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.7265625,
            "text": "hepatic CYP content as well as the expression of CYP1A2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.7265625,
            "text": "well as the expression of CYP1A2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.7265625,
            "text": "as well as the expression of CYP1A2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.7265625,
            "text": "the expression of CYP1A2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.7265625,
            "text": "total hepatic CYP content as well as the expression of CYP1A2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.7265625,
            "text": "decreased total hepatic CYP content as well as the expression of CYP1A2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.7265625,
            "text": "that pomegranate juice consumption decreased total hepatic CYP content as well as the expression of CYP1A2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -4.9375,
            "text": "expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -4.9375,
            "text": "as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -4.9375,
            "text": "of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -4.9375,
            "text": "hepatic CYP content as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -4.9375,
            "text": "well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -4.9375,
            "text": "as well as the expression of CYP1A2 and CYP3A",
            "probability": 0.0
        }
    ],
    "5c6e146a7c78d6947100004c_1": [
        {
            "start_logit": 8.921875,
            "end_logit": 8.9375,
            "text": "glecaprevir",
            "probability": 1.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -2.021484375,
            "text": "gle",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -2.232421875,
            "end_logit": 8.9375,
            "text": "vir",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 8.9375,
            "text": "caprevir",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.9375,
            "text": "revir",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.76953125,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.87109375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrentas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.9375,
            "text": ") glecaprevir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.08203125,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pi",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.9375,
            "text": "PI) glecaprevir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.13671875,
            "text": "glecaprevir and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.1953125,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.25390625,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.296875,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.296875,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecapre",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.30859375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.33984375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.359375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.359375,
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibre",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.39453125,
            "text": "glecapre",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e146a7c78d6947100004c_2": [
        {
            "start_logit": 8.84375,
            "end_logit": 9.1953125,
            "text": "glecaprevir",
            "probability": 1.0
        },
        {
            "start_logit": -1.6142578125,
            "end_logit": 9.1953125,
            "text": "vir",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -2.140625,
            "text": "gle",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -5.5859375,
            "text": "glecaprevir/pibrentasvir",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 9.1953125,
            "text": "caprevir",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.609375,
            "end_logit": 9.1953125,
            "text": "and glecaprevir",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.44921875,
            "text": "glecapre",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.1953125,
            "text": "revir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.1953125,
            "text": "; and glecaprevir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.1953125,
            "text": "delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.1953125,
            "text": "; delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.9453125,
            "text": "glecaprevir/pibrentas",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.06640625,
            "text": "glecaprevir/pibrentasvir (Mavyret) for chronic HCV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.1953125,
            "text": "visualization of malignant tissue during surgery; delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.09375,
            "text": "glecaprevir/pi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.1953125,
            "text": "the visualization of malignant tissue during surgery; delafloxacin (Baxdela) for certain acute bacterial skin infections; and glecaprevir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.1953125,
            "text": "acute bacterial skin infections; and glecaprevir",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.13671875,
            "text": "glecaprevir/pibrentasvir (Mavyret) for chronic HCV infection.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.16796875,
            "text": "glecaprevir/pibrent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.33203125,
            "text": "glecaprevir/",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c561da707647bbc4b00000f_1": [
        {
            "start_logit": -5.04296875,
            "end_logit": -4.203125,
            "text": "mutations that were not considered in past studies",
            "probability": 0.159423828125
        },
        {
            "start_logit": -5.65625,
            "end_logit": -4.203125,
            "text": "Human Genome Variation Society. By doing so, we cover several important types of mutations that were not considered in past studies",
            "probability": 0.08660888671875
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.83984375,
            "text": "mutations that were not",
            "probability": 0.08465576171875
        },
        {
            "start_logit": -5.78515625,
            "end_logit": -4.203125,
            "text": "studies",
            "probability": 0.07647705078125
        },
        {
            "start_logit": -5.46875,
            "end_logit": -4.6484375,
            "text": "biomedical literature",
            "probability": 0.06695556640625
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -4.203125,
            "text": ". By doing so, we cover several important types of mutations that were not considered in past studies",
            "probability": 0.0501708984375
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -4.6484375,
            "text": "mutation extraction from biomedical literature",
            "probability": 0.048614501953125
        },
        {
            "start_logit": -5.65625,
            "end_logit": -4.83984375,
            "text": "Human Genome Variation Society. By doing so, we cover several important types of mutations that were not",
            "probability": 0.045684814453125
        },
        {
            "start_logit": -6.296875,
            "end_logit": -4.203125,
            "text": "past studies",
            "probability": 0.045684814453125
        },
        {
            "start_logit": -6.375,
            "end_logit": -4.203125,
            "text": "types of mutations that were not considered in past studies",
            "probability": 0.042236328125
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -5.60546875,
            "text": "mutations that were not considered in past studies.",
            "probability": 0.03936767578125
        },
        {
            "start_logit": -6.18359375,
            "end_logit": -4.6484375,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.03289794921875
        },
        {
            "start_logit": -5.65625,
            "end_logit": -5.234375,
            "text": "Human Genome Variation Society",
            "probability": 0.0308990478515625
        },
        {
            "start_logit": -6.72265625,
            "end_logit": -4.203125,
            "text": "important types of mutations that were not considered in past studies",
            "probability": 0.0299530029296875
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -5.8984375,
            "text": "mutations that were not considered in past studies. Using a novel CRF label model",
            "probability": 0.02947998046875
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -5.91015625,
            "text": "mutations that were not considered",
            "probability": 0.0290374755859375
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -5.984375,
            "text": "mutations that were",
            "probability": 0.02685546875
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -4.83984375,
            "text": ". By doing so, we cover several important types of mutations that were not",
            "probability": 0.026641845703125
        },
        {
            "start_logit": -5.46875,
            "end_logit": -5.59765625,
            "text": "biomedical literature.",
            "probability": 0.0260162353515625
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -6.16015625,
            "text": "mutations",
            "probability": 0.022613525390625
        }
    ],
    "5c561da707647bbc4b00000f_2": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.234375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.314453125,
            "text": "tm",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -1.5556640625,
            "end_logit": 9.234375,
            "text": "r",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -5.7265625,
            "text": "tmVar 2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.234375,
            "text": "Var",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.59765625,
            "text": "tmVar 2.0: integrating genomic variant information from literature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.74609375,
            "text": "tmVar 2.0: integrating genomic variant information",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.90234375,
            "text": "tmVar 2.0",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.92578125,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.19140625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.2265625,
            "text": "tmVar 2.0: integrating genomic variant information from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.3125,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.3515625,
            "text": "tmVar 2.0: integrating genomic variant information from literature with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.359375,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.44921875,
            "text": "tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5556640625,
            "end_logit": -5.7265625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -1.5556640625,
            "end_logit": -6.59765625,
            "text": "r 2.0: integrating genomic variant information from literature",
            "probability": 0.0
        },
        {
            "start_logit": -1.5556640625,
            "end_logit": -6.625,
            "text": "r 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5556640625,
            "end_logit": -6.74609375,
            "text": "r 2.0: integrating genomic variant information",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_3": [
        {
            "start_logit": 9.0,
            "end_logit": 8.8671875,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.7744140625,
            "text": "tm",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -2.302734375,
            "end_logit": 8.8671875,
            "text": "r",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.33203125,
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.9453125,
            "text": "tmVar: a text mining approach for extracting sequence variants in biomedical literature.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.50390625,
            "text": "tmVar: a text mining",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.94921875,
            "text": "tmVar: a text mining approach",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.859375,
            "text": "tmVar:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.8671875,
            "text": "Var",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.9296875,
            "text": "tmVar: a text mining approach for extracting sequence variants",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.0234375,
            "text": "tmVar: a text mining approach for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.07421875,
            "text": "tmVar: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -4.33203125,
            "text": "r: a text mining approach for extracting sequence variants in biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -4.9453125,
            "text": "r: a text mining approach for extracting sequence variants in biomedical literature.",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -5.50390625,
            "text": "r: a text mining",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -5.94921875,
            "text": "r: a text mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -6.859375,
            "text": "r:",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -6.9296875,
            "text": "r: a text mining approach for extracting sequence variants",
            "probability": 0.0
        },
        {
            "start_logit": -4.9609375,
            "end_logit": -4.33203125,
            "text": "text mining approach for extracting sequence variants in biomedical literature",
            "probability": 0.0
        },
        {
            "start_logit": -2.302734375,
            "end_logit": -7.0234375,
            "text": "r: a text mining approach for",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_4": [
        {
            "start_logit": 1.169921875,
            "end_logit": 4.33203125,
            "text": "tmVar",
            "probability": 0.9970703125
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 4.33203125,
            "text": "r",
            "probability": 0.0006628036499023438
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 4.33203125,
            "text": "The tmVar",
            "probability": 0.0003895759582519531
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 4.33203125,
            "text": ": The tmVar",
            "probability": 0.0003819465637207031
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -3.6875,
            "text": "tmVar 2.0 source code",
            "probability": 0.0003292560577392578
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 4.33203125,
            "text": "that the combined information can greatly assist human efforts in evaluating/prioritizing variants in genomic research.Availability and implementation: The tmVar",
            "probability": 0.00030922889709472656
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 4.33203125,
            "text": "text mining and that the combined information can greatly assist human efforts in evaluating/prioritizing variants in genomic research.Availability and implementation: The tmVar",
            "probability": 0.0002818107604980469
        },
        {
            "start_logit": -7.09375,
            "end_logit": 4.33203125,
            "text": "Var",
            "probability": 0.00025653839111328125
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -5.74609375,
            "text": "tmVar 2",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -6.3671875,
            "text": "tmVar 2.0",
            "probability": 2.2590160369873047e-05
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -6.70703125,
            "text": "tmVar 2.0 source code and",
            "probability": 1.5974044799804688e-05
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -7.02734375,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": 1.169921875,
            "end_logit": -7.0625,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -4.55078125,
            "text": "databases",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -3.546875,
            "end_logit": -3.6875,
            "text": "source code",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -5.6875,
            "text": "databases.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -6.53125,
            "text": "databases. Our results suggest that databases can be significantly enriched by text mining",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -6.89453125,
            "text": "databases. Our results suggest that databases can be significantly enriched by text mining and that the combined information can",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -6.94140625,
            "text": "databases. Our results suggest that databases can",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.1484375,
            "end_logit": -3.6875,
            "text": "r 2.0 source code",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c561da707647bbc4b00000f_5": [
        {
            "start_logit": 5.80078125,
            "end_logit": 5.58203125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.109375,
            "text": "tm",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -5.15625,
            "end_logit": 5.58203125,
            "text": "r",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.5,
            "text": "tmVar, a text-mining",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.828125,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.94140625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -6.73828125,
            "text": "tmVar, a text-mining approach",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 5.58203125,
            "text": "Var",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -6.921875,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 5.58203125,
            "text": "report tmVar",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.01953125,
            "text": "tmVar, a",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.09765625,
            "text": "tmVar,",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.1875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.28515625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.31640625,
            "text": "tmVar, a text-mining approach based",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 5.58203125,
            "text": "we report tmVar",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -5.5,
            "text": "text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.5,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -5.828125,
            "text": "text-mining approach based on conditional random field (CRF)",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.828125,
            "text": "r, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_6": [
        {
            "start_logit": -3.345703125,
            "end_logit": -3.279296875,
            "text": "mutation extraction from biomedical literature",
            "probability": 0.46240234375
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -3.279296875,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.1107177734375
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -5.04296875,
            "text": "mutation extraction",
            "probability": 0.0791015625
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -5.078125,
            "text": "mutation extraction from biomedical literature.",
            "probability": 0.07666015625
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -3.279296875,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0472412109375
        },
        {
            "start_logit": -5.87890625,
            "end_logit": -3.279296875,
            "text": "biomedical literature",
            "probability": 0.03680419921875
        },
        {
            "start_logit": -6.2421875,
            "end_logit": -3.279296875,
            "text": "results suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0254974365234375
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -3.279296875,
            "text": "suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0232086181640625
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.04296875,
            "text": "that tmVar is a high-performance method for mutation extraction",
            "probability": 0.0189361572265625
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.078125,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.018218994140625
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -3.279296875,
            "text": "These results suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.017242431640625
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -3.279296875,
            "text": "from biomedical literature",
            "probability": 0.01386260986328125
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.484375,
            "text": "that tmVar",
            "probability": 0.0121307373046875
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -3.279296875,
            "text": "Var is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0119476318359375
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -7.17578125,
            "text": "mutation",
            "probability": 0.00937652587890625
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -3.279296875,
            "text": "high-performance method for mutation extraction from biomedical literature",
            "probability": 0.00908660888671875
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -5.04296875,
            "text": "tmVar is a high-performance method for mutation extraction",
            "probability": 0.00807952880859375
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -5.078125,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.00783538818359375
        },
        {
            "start_logit": -5.87890625,
            "end_logit": -5.078125,
            "text": "biomedical literature.",
            "probability": 0.006099700927734375
        },
        {
            "start_logit": -5.984375,
            "end_logit": -5.078125,
            "text": ".",
            "probability": 0.00547027587890625
        }
    ],
    "5c561da707647bbc4b00000f_7": [
        {
            "start_logit": 4.734375,
            "end_logit": 4.375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 4.734375,
            "end_logit": -4.8828125,
            "text": "tmVar software",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -4.96484375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.2578125,
            "text": "tm",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.54296875,
            "text": "tmVar software and its corpus of 500 manually cur",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.87109375,
            "text": "tmVar software and",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 4.375,
            "text": "r",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.09765625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 4.375,
            "text": "Var",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.140625,
            "text": "tmVar software and its corpus of 500 manually curated",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.15625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.171875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.1875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.2890625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.29296875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 4.375,
            "text": "AVAILABILITY tmVar",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -4.96484375,
            "text": "manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -6.54296875,
            "text": "manually cur",
            "probability": 0.0
        },
        {
            "start_logit": -5.12890625,
            "end_logit": -5.5625,
            "text": "pub/tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -7.09765625,
            "text": "manually curated abstracts are",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_8": [
        {
            "start_logit": 8.984375,
            "end_logit": 8.9609375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.7109375,
            "text": "tm",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -2.001953125,
            "end_logit": 8.9609375,
            "text": "r",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -3.5546875,
            "text": "tmVar 2.0 source code",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 8.984375,
            "end_logit": -4.9765625,
            "text": "tmVar 2.0",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -5.1015625,
            "text": "tmVar 2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.9609375,
            "text": "Var",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.71875,
            "text": "tmVar 2.0 source code and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.80859375,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 8.9609375,
            "text": "implementation The tmVar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.9609375,
            "text": "The tmVar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.0078125,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.015625,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.265625,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.37890625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.38671875,
            "text": "tmVar 2.0 source code and corpus are freely available at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -3.5546875,
            "text": "r 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -4.9765625,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -5.1015625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -4.203125,
            "end_logit": -3.5546875,
            "text": "source code",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_9": [
        {
            "start_logit": 5.80078125,
            "end_logit": 5.58203125,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.109375,
            "text": "tm",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -5.15625,
            "end_logit": 5.58203125,
            "text": "r",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.5,
            "text": "tmVar, a text-mining",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.828125,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -5.94140625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -6.73828125,
            "text": "tmVar, a text-mining approach",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 5.58203125,
            "text": "Var",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -6.921875,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 5.58203125,
            "text": "report tmVar",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.01953125,
            "text": "tmVar, a",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.09765625,
            "text": "tmVar,",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.1875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.28515625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for extracting a",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.80078125,
            "end_logit": -7.31640625,
            "text": "tmVar, a text-mining approach based",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 5.58203125,
            "text": "we report tmVar",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -5.5,
            "text": "text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.5,
            "text": "r, a text-mining",
            "probability": 0.0
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -5.828125,
            "text": "text-mining approach based on conditional random field (CRF)",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.828125,
            "text": "r, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_10": [
        {
            "start_logit": 4.734375,
            "end_logit": 4.375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 4.734375,
            "end_logit": -4.8828125,
            "text": "tmVar software",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -4.96484375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.2578125,
            "text": "tm",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.54296875,
            "text": "tmVar software and its corpus of 500 manually cur",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -6.87109375,
            "text": "tmVar software and",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 4.375,
            "text": "r",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.09765625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 4.375,
            "text": "Var",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.140625,
            "text": "tmVar software and its corpus of 500 manually curated",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.15625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.171875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.1875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.2890625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": 4.734375,
            "end_logit": -7.29296875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 4.375,
            "text": "AVAILABILITY tmVar",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -4.96484375,
            "text": "manually curated abstracts",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -6.54296875,
            "text": "manually cur",
            "probability": 0.0
        },
        {
            "start_logit": -5.12890625,
            "end_logit": -5.5625,
            "text": "pub/tmVar",
            "probability": 0.0
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -7.09765625,
            "text": "manually curated abstracts are",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_11": [
        {
            "start_logit": 8.984375,
            "end_logit": 8.9609375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.7109375,
            "text": "tm",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -2.001953125,
            "end_logit": 8.9609375,
            "text": "r",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -3.5546875,
            "text": "tmVar 2.0 source code",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 8.984375,
            "end_logit": -4.9765625,
            "text": "tmVar 2.0",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -5.1015625,
            "text": "tmVar 2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.9609375,
            "text": "Var",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.71875,
            "text": "tmVar 2.0 source code and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.80859375,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 8.9609375,
            "text": "implementation The tmVar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.9609375,
            "text": "The tmVar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.0078125,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.015625,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.265625,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.37890625,
            "text": "tmVar 2.0 source code and corpus are freely available at https://www.ncbi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.38671875,
            "text": "tmVar 2.0 source code and corpus are freely available at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -3.5546875,
            "text": "r 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -4.9765625,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -2.001953125,
            "end_logit": -5.1015625,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -4.203125,
            "end_logit": -3.5546875,
            "text": "source code",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_12": [
        {
            "start_logit": 3.732421875,
            "end_logit": 2.90625,
            "text": "tmVar",
            "probability": 0.998046875
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -4.625,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF",
            "probability": 0.0005350112915039062
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -4.87890625,
            "text": "tmVar, a text-mining",
            "probability": 0.0004134178161621094
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -5.90234375,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF)",
            "probability": 0.00014865398406982422
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -6.52734375,
            "text": "tm",
            "probability": 7.95125961303711e-05
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -6.9375,
            "text": "tmVar, a text-mining approach",
            "probability": 5.2928924560546875e-05
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -6.94921875,
            "text": "tmVar, a text-mining approach based on conditional random field",
            "probability": 5.21540641784668e-05
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -6.95703125,
            "text": "tmVar, a text-mining approach based on conditional random field (CRF) for",
            "probability": 5.173683166503906e-05
        },
        {
            "start_logit": 3.732421875,
            "end_logit": -7.1484375,
            "text": "tmVar, a text-mining approach based on conditional random field (",
            "probability": 4.291534423828125e-05
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 2.90625,
            "text": "report tmVar",
            "probability": 2.950429916381836e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 2.90625,
            "text": "r",
            "probability": 2.9265880584716797e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 2.90625,
            "text": "Var",
            "probability": 2.8789043426513672e-05
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 2.90625,
            "text": "kinds of mutations with high accuracy.<br><b>RESULTS</b>: Here, we report tmVar",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -4.625,
            "text": "text-mining approach based on conditional random field (CRF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -4.87890625,
            "text": "text-mining",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -5.90234375,
            "text": "text-mining approach based on conditional random field (CRF)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -6.9375,
            "text": "text-mining approach",
            "probability": 0.0
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -6.94921875,
            "text": "text-mining approach based on conditional random field",
            "probability": 0.0
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -6.95703125,
            "text": "text-mining approach based on conditional random field (CRF) for",
            "probability": 0.0
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -7.08984375,
            "text": "text-mining approach based on conditional random field (CRF) for extracting a wide range of sequence variants described at protein, DNA and RNA levels",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_13": [
        {
            "start_logit": -0.5517578125,
            "end_logit": 0.377197265625,
            "text": "tmVar",
            "probability": 0.96533203125
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 0.377197265625,
            "text": "biomedical literature.<br><b>AVAILABILITY</b>: tmVar",
            "probability": 0.007396697998046875
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -4.58984375,
            "text": "tmVar software",
            "probability": 0.00673675537109375
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 0.377197265625,
            "text": ": tmVar",
            "probability": 0.00506591796875
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 0.377197265625,
            "text": "mutation extraction from biomedical literature.<br><b>AVAILABILITY</b>: tmVar",
            "probability": 0.00406646728515625
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -5.3828125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 0.003047943115234375
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 0.377197265625,
            "text": "Var",
            "probability": 0.001434326171875
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 0.377197265625,
            "text": "from biomedical literature.<br><b>AVAILABILITY</b>: tmVar",
            "probability": 0.0012407302856445312
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -6.48046875,
            "text": "tmVar software and its corpus of 500 manually cur",
            "probability": 0.0010166168212890625
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -6.6796875,
            "text": "tmVar software and its corpus of 500 manually curated",
            "probability": 0.0008335113525390625
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -6.7109375,
            "text": "tmVar software and",
            "probability": 0.0008077621459960938
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -6.84375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available",
            "probability": 0.0007071495056152344
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -6.921875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are",
            "probability": 0.0006537437438964844
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -7.0234375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0005908012390136719
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -7.04296875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download",
            "probability": 0.0005793571472167969
        },
        {
            "start_logit": -0.5517578125,
            "end_logit": -7.11328125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0005402565002441406
        },
        {
            "start_logit": -5.42578125,
            "end_logit": -3.73046875,
            "text": "biomedical literature",
            "probability": 0.00012105703353881836
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -3.73046875,
            "text": "mutation extraction from biomedical literature",
            "probability": 6.681680679321289e-05
        },
        {
            "start_logit": -6.12890625,
            "end_logit": -3.73046875,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 5.990266799926758e-05
        },
        {
            "start_logit": -5.42578125,
            "end_logit": -4.58984375,
            "text": "biomedical literature.<br><b>AVAILABILITY</b>: tmVar software",
            "probability": 5.120038986206055e-05
        }
    ],
    "5c561da707647bbc4b00000f_14": [
        {
            "start_logit": 5.5,
            "end_logit": 6.37890625,
            "text": "tmVar",
            "probability": 0.990234375
        },
        {
            "start_logit": 5.5,
            "end_logit": 1.486328125,
            "text": "tmVar 2.0",
            "probability": 0.007442474365234375
        },
        {
            "start_logit": 5.5,
            "end_logit": 0.05029296875,
            "text": "tmVar 2.0 source code",
            "probability": 0.0017747879028320312
        },
        {
            "start_logit": 5.5,
            "end_logit": -2.677734375,
            "text": "tmVar 2",
            "probability": 0.0001156926155090332
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 6.37890625,
            "text": "r",
            "probability": 3.49879264831543e-05
        },
        {
            "start_logit": 0.26123046875,
            "end_logit": 0.05029296875,
            "text": "source code",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 5.5,
            "end_logit": -5.21875,
            "text": "tm",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 6.37890625,
            "text": "The tmVar",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 6.37890625,
            "text": "Var",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.37890625,
            "text": ": The tmVar",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 5.5,
            "end_logit": -6.33203125,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 5.5,
            "end_logit": -6.50390625,
            "text": "tmVar 2.0 source code and",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.5,
            "end_logit": -6.859375,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.5,
            "end_logit": -6.9140625,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 1.486328125,
            "text": "r 2.0",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 1.486328125,
            "text": "0",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.05029296875,
            "text": "r 2.0 source code",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 0.05029296875,
            "text": "0 source code",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 1.486328125,
            "text": "The tmVar 2.0",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4619140625,
            "end_logit": -3.939453125,
            "text": "databases",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c561da707647bbc4b00000f_15": [
        {
            "start_logit": 1.9736328125,
            "end_logit": 0.0736083984375,
            "text": "tmVar",
            "probability": 0.97900390625
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -4.58203125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts",
            "probability": 0.00930023193359375
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -5.546875,
            "text": "tmVar software",
            "probability": 0.003543853759765625
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -6.78125,
            "text": "tmVar software and",
            "probability": 0.0010318756103515625
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -6.79296875,
            "text": "tmVar software and its corpus of 500 manually cur",
            "probability": 0.0010194778442382812
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -6.9765625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are",
            "probability": 0.0008487701416015625
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.12109375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available",
            "probability": 0.0007343292236328125
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.15234375,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download",
            "probability": 0.0007119178771972656
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.20703125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi",
            "probability": 0.0006742477416992188
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.2265625,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for",
            "probability": 0.0006608963012695312
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.26171875,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http:/",
            "probability": 0.0006380081176757812
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.26953125,
            "text": "tmVar software and its corpus of 500 manually curated abstracts are available for download at http://www.ncbi.",
            "probability": 0.0006327629089355469
        },
        {
            "start_logit": 1.9736328125,
            "end_logit": -7.2890625,
            "text": "tmVar software and its corpus of",
            "probability": 0.0006208419799804688
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 0.0736083984375,
            "text": "Var",
            "probability": 0.0001246929168701172
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -4.58203125,
            "text": "manually curated abstracts",
            "probability": 5.40614128112793e-05
        },
        {
            "start_logit": -5.12890625,
            "end_logit": -4.625,
            "text": "pub/tmVar",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -6.79296875,
            "text": "manually cur",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -6.9765625,
            "text": "manually curated abstracts are",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.12109375,
            "text": "manually curated abstracts are available",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.15234375,
            "text": "manually curated abstracts are available for download",
            "probability": 4.172325134277344e-06
        }
    ],
    "5c561da707647bbc4b00000f_16": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.34375,
            "text": "tmVar",
            "probability": 1.0
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": 9.34375,
            "text": "r",
            "probability": 3.0934810638427734e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.4765625,
            "text": "tm",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -3.53515625,
            "text": "tmVar 2.0 source code",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.4296875,
            "text": "tmVar 2",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.8125,
            "text": "tmVar 2.0",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.34375,
            "text": "Var",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.734375,
            "text": "tmVar 2.0 source code and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.9921875,
            "text": "tmVar 2.0 source code and corpus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.34375,
            "text": "The tmVar",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0703125,
            "text": "tmVar 2.0 source code and corpus are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.09765625,
            "text": "tmVar 2.0 source code and corpus are freely available",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2734375,
            "text": "tmVar 2.0 source code and corpus are freely available at https:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.359375,
            "text": "tmVar 2.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": -3.53515625,
            "text": "r 2.0 source code",
            "probability": 0.0
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": -4.4296875,
            "text": "r 2",
            "probability": 0.0
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": -5.8125,
            "text": "r 2.0",
            "probability": 0.0
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -3.53515625,
            "text": "source code",
            "probability": 0.0
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": -6.734375,
            "text": "r 2.0 source code and",
            "probability": 0.0
        },
        {
            "start_logit": -1.2587890625,
            "end_logit": -6.9921875,
            "text": "r 2.0 source code and corpus",
            "probability": 0.0
        }
    ],
    "5c561da707647bbc4b00000f_17": [
        {
            "start_logit": -3.345703125,
            "end_logit": -3.279296875,
            "text": "mutation extraction from biomedical literature",
            "probability": 0.46240234375
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -3.279296875,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.1107177734375
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -5.04296875,
            "text": "mutation extraction",
            "probability": 0.0791015625
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -5.078125,
            "text": "mutation extraction from biomedical literature.",
            "probability": 0.07666015625
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -3.279296875,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0472412109375
        },
        {
            "start_logit": -5.87890625,
            "end_logit": -3.279296875,
            "text": "biomedical literature",
            "probability": 0.03680419921875
        },
        {
            "start_logit": -6.2421875,
            "end_logit": -3.279296875,
            "text": "results suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0254974365234375
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -3.279296875,
            "text": "suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0232086181640625
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.04296875,
            "text": "that tmVar is a high-performance method for mutation extraction",
            "probability": 0.0189361572265625
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.078125,
            "text": "that tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.018218994140625
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -3.279296875,
            "text": "These results suggest that tmVar is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.017242431640625
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -3.279296875,
            "text": "from biomedical literature",
            "probability": 0.01386260986328125
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -5.484375,
            "text": "that tmVar",
            "probability": 0.0121307373046875
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -3.279296875,
            "text": "Var is a high-performance method for mutation extraction from biomedical literature",
            "probability": 0.0119476318359375
        },
        {
            "start_logit": -3.345703125,
            "end_logit": -7.17578125,
            "text": "mutation",
            "probability": 0.00937652587890625
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -3.279296875,
            "text": "high-performance method for mutation extraction from biomedical literature",
            "probability": 0.00908660888671875
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -5.04296875,
            "text": "tmVar is a high-performance method for mutation extraction",
            "probability": 0.00807952880859375
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -5.078125,
            "text": "tmVar is a high-performance method for mutation extraction from biomedical literature.",
            "probability": 0.00783538818359375
        },
        {
            "start_logit": -5.87890625,
            "end_logit": -5.078125,
            "text": "biomedical literature.",
            "probability": 0.006099700927734375
        },
        {
            "start_logit": -5.984375,
            "end_logit": -5.078125,
            "text": ".",
            "probability": 0.00547027587890625
        }
    ],
    "5a736f0c3b9d13c708000007_1": [
        {
            "start_logit": 4.140625,
            "end_logit": 2.3515625,
            "text": "mean corpuscular volume",
            "probability": 0.6640625
        },
        {
            "start_logit": 4.140625,
            "end_logit": 1.5556640625,
            "text": "mean corpuscular volume (MCV)",
            "probability": 0.29931640625
        },
        {
            "start_logit": 4.140625,
            "end_logit": -1.330078125,
            "text": "mean corpuscular volume (MCV",
            "probability": 0.0167236328125
        },
        {
            "start_logit": 0.2369384765625,
            "end_logit": 2.3515625,
            "text": "ratio of the mean corpuscular volume",
            "probability": 0.0133819580078125
        },
        {
            "start_logit": 0.2369384765625,
            "end_logit": 1.5556640625,
            "text": "ratio of the mean corpuscular volume (MCV)",
            "probability": 0.00604248046875
        },
        {
            "start_logit": 0.2369384765625,
            "end_logit": -1.330078125,
            "text": "ratio of the mean corpuscular volume (MCV",
            "probability": 0.0003368854522705078
        },
        {
            "start_logit": -4.796875,
            "end_logit": 2.3515625,
            "text": "The ratio of the mean corpuscular volume",
            "probability": 8.726119995117188e-05
        },
        {
            "start_logit": 4.140625,
            "end_logit": -6.65625,
            "text": "mean corpuscular volume (MCV) and",
            "probability": 8.130073547363281e-05
        },
        {
            "start_logit": 4.140625,
            "end_logit": -6.66796875,
            "text": "mean",
            "probability": 8.064508438110352e-05
        },
        {
            "start_logit": 4.140625,
            "end_logit": -6.70703125,
            "text": "mean corpuscular volume (MCV) and red blood cell count (RBC) can be automatically calculated with any of the newer hematology analyzers",
            "probability": 7.700920104980469e-05
        },
        {
            "start_logit": -4.796875,
            "end_logit": 1.5556640625,
            "text": "The ratio of the mean corpuscular volume (MCV)",
            "probability": 3.927946090698242e-05
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.5556640625,
            "text": "MCV)",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 2.3515625,
            "text": "volume",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": -6.265625,
            "end_logit": 2.3515625,
            "text": "the mean corpuscular volume",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -6.125,
            "end_logit": 1.5556640625,
            "text": "(MCV)",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 1.5556640625,
            "text": "volume (MCV)",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -6.265625,
            "end_logit": 1.5556640625,
            "text": "the mean corpuscular volume (MCV)",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -4.796875,
            "end_logit": -1.330078125,
            "text": "The ratio of the mean corpuscular volume (MCV",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -4.953125,
            "end_logit": -1.330078125,
            "text": "MCV",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 0.2369384765625,
            "end_logit": -6.65625,
            "text": "ratio of the mean corpuscular volume (MCV) and",
            "probability": 1.6689300537109375e-06
        }
    ],
    "515db70c298dcd4e51000017_1": [
        {
            "start_logit": 7.58203125,
            "end_logit": 8.0,
            "text": "rash",
            "probability": 1.0
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.83203125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.0,
            "text": "skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.0,
            "text": "antiepileptic drugs, skin reactions to gabapentin are considered uncommon. In adults, reported prevalence of rash",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.0,
            "text": ". In adults, reported prevalence of rash",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.0,
            "text": "of rash",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.0,
            "text": "prevalence of rash",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.0,
            "text": ", reported prevalence of rash",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.30078125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash in 0",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.37109375,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.4140625,
            "text": "rash possibly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.51953125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study reported gabapentin treatment failure as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.55078125,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.5546875,
            "text": "rash possibly related to gabapentin range from 1% to 10",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.55859375,
            "text": "rash possibly related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.5625,
            "text": "rash possibly related to gabapentin range from 1% to 10%. A postmarketing surveillance study",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": -4.67578125,
            "text": "rash",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -4.67578125,
            "text": ". The product monograph does not mention rash",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -4.67578125,
            "text": "mention rash",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -5.83203125,
            "text": "postmarketing surveillance study reported gabapentin treatment failure as a consequence of rash",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_2": [
        {
            "start_logit": 3.73828125,
            "end_logit": 3.416015625,
            "text": "drowsiness",
            "probability": 0.91650390625
        },
        {
            "start_logit": 3.73828125,
            "end_logit": 0.7900390625,
            "text": "drowsiness/sedation",
            "probability": 0.066162109375
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -0.60791015625,
            "text": "drowsiness/sedation, dizziness",
            "probability": 0.0164031982421875
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -0.60791015625,
            "text": "dizziness",
            "probability": 0.0007066726684570312
        },
        {
            "start_logit": -5.51171875,
            "end_logit": 3.416015625,
            "text": ", drowsiness",
            "probability": 8.809566497802734e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -6.640625,
            "text": "drowsiness/",
            "probability": 3.910064697265625e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -6.64453125,
            "text": "drow",
            "probability": 3.910064697265625e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -7.1328125,
            "text": "drowsiness/sedation, dizziness, and malaise/lassitude",
            "probability": 2.4080276489257812e-05
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 3.416015625,
            "text": "siness",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.416015625,
            "text": "ess",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": -6.984375,
            "end_logit": 3.416015625,
            "text": "adverse events reported during the first month of treatment, drowsiness",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -7.37890625,
            "text": "drowsiness/sedation, dizziness, and malaise/lassit",
            "probability": 1.8715858459472656e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -7.39453125,
            "text": "drowsiness/sedation, dizziness, and malaise/lassitude, also were",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -7.41015625,
            "text": "drowsiness/sedation, dizziness, and malaise/lassitude, also",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": 3.73828125,
            "end_logit": -7.41796875,
            "text": "drowsiness/sedation, dizziness, and malaise/",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 3.416015625,
            "text": "first month of treatment, drowsiness",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -7.421875,
            "end_logit": 3.416015625,
            "text": "most frequently reported adverse events reported during the first month of treatment, drowsiness",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -5.51171875,
            "end_logit": 0.7900390625,
            "text": ", drowsiness/sedation",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -5.6875,
            "text": "dizziness, and malaise/lassitude, also were the commonest reasons for discontinuing GBP and reported as suspected adverse drug reactions",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 0.7900390625,
            "text": "sedation",
            "probability": 2.7418136596679688e-06
        }
    ],
    "515db70c298dcd4e51000017_3": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.26171875,
            "text": "headache",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.80078125,
            "text": "headache. However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.86328125,
            "text": "headache. However, their incidence was low and intensity mild.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 7.26171875,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 7.26171875,
            "text": "and headache",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.24609375,
            "text": "headache. However, their incidence was low and intensity mild. There was no clear relationship between the dose given",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 7.26171875,
            "text": "antiepileptic drugs. The commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.38671875,
            "text": "headache. However, their incidence was low and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 7.26171875,
            "text": ". The commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.26171875,
            "text": "adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.26171875,
            "text": "commonest adverse effects seen were somnolence, fainting, ataxia, nystagmus, tremor and headache",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -6.234375,
            "text": "somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -6.80078125,
            "text": "However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects",
            "probability": 0.0
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -6.86328125,
            "text": "However, their incidence was low and intensity mild.",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -6.234375,
            "text": "antiepileptic drugs. The commonest adverse effects seen were somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -6.82421875,
            "end_logit": -6.234375,
            "text": ". The commonest adverse effects seen were somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -7.24609375,
            "text": "However, their incidence was low and intensity mild. There was no clear relationship between the dose given",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -6.86328125,
            "text": "somnolence, fainting, ataxia, nystagmus, tremor and headache. However, their incidence was low and intensity mild.",
            "probability": 0.0
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -7.328125,
            "text": "However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects, except for fainting",
            "probability": 0.0
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -7.33984375,
            "text": "However, their incidence was low and intensity mild. There was no clear relationship between the dose given and appearance of side effects, except for fainting and",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_4": [
        {
            "start_logit": 8.0546875,
            "end_logit": 6.7109375,
            "text": "dizziness",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.69873046875,
            "text": "dizziness, ataxia, fatigue), only one, dizziness",
            "probability": 0.0006046295166015625
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 6.7109375,
            "text": "somnolence, dizziness",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.796875,
            "text": "dizziness, ataxia, fatigue",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.24609375,
            "text": "dizziness, ataxia, fatigue)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.3046875,
            "text": "dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.33203125,
            "text": "dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.42578125,
            "text": "dizziness, ataxia, fatigue), only one, dizziness, occurred",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.43359375,
            "text": "dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation) group than in the titrated (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.4453125,
            "text": "dizziness, ataxia, fatigue), only one, dizziness, occurred more often in the nontitrated (Rapid initiation) group",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.4453125,
            "text": "dizziness, ataxia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.7109375,
            "text": "adverse events (somnolence, dizziness",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.7109375,
            "text": ", dizziness",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 6.7109375,
            "text": "nolence, dizziness",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.7109375,
            "text": "most common adverse events (somnolence, dizziness",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.7109375,
            "text": "Of the four most common adverse events (somnolence, dizziness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.37890625,
            "end_logit": -0.69873046875,
            "text": "dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -0.69873046875,
            "text": "somnolence, dizziness, ataxia, fatigue), only one, dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -0.69873046875,
            "text": ", dizziness",
            "probability": 0.0
        },
        {
            "start_logit": -6.50390625,
            "end_logit": -0.69873046875,
            "text": "fatigue), only one, dizziness",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_5": [
        {
            "start_logit": 8.0859375,
            "end_logit": 7.4296875,
            "text": "dizziness",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.9765625,
            "text": "dizziness were the only adverse events",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 7.4296875,
            "text": "Somnolence and dizziness",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.13671875,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or other safety parameters were observed.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.13671875,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.37109375,
            "text": "dizziness were the only adverse events reported",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.41796875,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or other safety parameters",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.4296875,
            "text": "and dizziness",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.53515625,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or other safety parameters were",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.54296875,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.54296875,
            "text": "dizziness were",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.55078125,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.5546875,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments or other safety parameters were observed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.58203125,
            "text": "dizziness were the only adverse events reported by at least two patients during gabapentin treatment. No clinically important changes in laboratory assessments",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6328125,
            "text": "dizziness were the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.63671875,
            "text": "dizziness were the only adverse events reported by at least two",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.63671875,
            "text": "dizziness were the only adverse events reported by at",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": -6.01171875,
            "text": "Somnolence",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": -6.9765625,
            "text": "Somnolence and dizziness were the only adverse events",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": -7.109375,
            "text": "Somnolen",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_6": [
        {
            "start_logit": 8.0390625,
            "end_logit": 6.14453125,
            "text": "hyperactivity",
            "probability": 1.0
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -3.203125,
            "text": "hyperactivity, irritability",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -5.66796875,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.734375,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention deficit.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.29296875,
            "text": "hyperactivity, irritability, and agitation that occurred",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.31640625,
            "text": "hyperactivity, irritability, and agitation",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.45703125,
            "text": "hyperactivity, irritability, and agitation that occurred in patients with baseline mental retardation with attention",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.57421875,
            "text": "hyperactivity, irritability, and",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.609375,
            "text": "hyperactivity, irritability, and agitation that",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.78125,
            "end_logit": 6.14453125,
            "text": "of hyperactivity",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.14453125,
            "text": "behavioral. These consisted of hyperactivity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 6.14453125,
            "text": "side effects were behavioral. These consisted of hyperactivity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 6.14453125,
            "text": ". These consisted of hyperactivity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 6.14453125,
            "text": "consisted of hyperactivity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 6.14453125,
            "text": "These consisted of hyperactivity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.4921875,
            "end_logit": -3.203125,
            "text": "irritability",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": -3.203125,
            "text": "of hyperactivity, irritability",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -3.203125,
            "text": ", irritability",
            "probability": 0.0
        },
        {
            "start_logit": -6.84375,
            "end_logit": -3.203125,
            "text": "behavioral. These consisted of hyperactivity, irritability",
            "probability": 0.0
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -3.203125,
            "text": "side effects were behavioral. These consisted of hyperactivity, irritability",
            "probability": 0.0
        }
    ],
    "515db70c298dcd4e51000017_7": [
        {
            "start_logit": 4.44921875,
            "end_logit": 5.76171875,
            "text": "attention deficit hyperactivity disorder",
            "probability": 0.63134765625
        },
        {
            "start_logit": 4.4453125,
            "end_logit": 5.2265625,
            "text": "behavioral side effects",
            "probability": 0.368408203125
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -2.341796875,
            "text": "behavioral",
            "probability": 0.00018978118896484375
        },
        {
            "start_logit": 4.44921875,
            "end_logit": -3.353515625,
            "text": "attention deficit hyperactivity",
            "probability": 6.93202018737793e-05
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 5.76171875,
            "text": "disorder",
            "probability": 4.106760025024414e-05
        },
        {
            "start_logit": 4.44921875,
            "end_logit": -4.109375,
            "text": "attention deficit",
            "probability": 3.248453140258789e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 5.2265625,
            "text": "effects",
            "probability": 2.09808349609375e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 5.76171875,
            "text": ". All behavioral changes were reversible and were managed by dose reduction or discontinuation of GBP. All children had baseline attention deficit hyperactivity disorder",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -6.015625,
            "end_logit": 5.76171875,
            "text": ". All children had baseline attention deficit hyperactivity disorder",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": 4.44921875,
            "end_logit": -4.84765625,
            "text": "attention deficit hyperactivity disorder and developmental delays",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 5.2265625,
            "text": "developed behavioral side effects",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 5.2265625,
            "text": "side effects",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 5.76171875,
            "text": "children had baseline attention deficit hyperactivity disorder",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 5.76171875,
            "text": "had baseline attention deficit hyperactivity disorder",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 5.76171875,
            "text": "All children had baseline attention deficit hyperactivity disorder",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 4.44921875,
            "end_logit": -6.2578125,
            "text": "attention deficit hyperactivity disorder and developmental delays.",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 4.44921875,
            "end_logit": -6.26171875,
            "text": "attention",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -6.26953125,
            "text": "behavioral side effects.",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -6.28125,
            "text": "behavioral side effects. These behavioral changes",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -6.5,
            "text": "behavioral side effects. These behavioral changes consisted of intensification of baseline behaviors as well as new behavioral problems",
            "probability": 2.9802322387695312e-06
        }
    ],
    "515db70c298dcd4e51000017_8": [
        {
            "start_logit": 4.1484375,
            "end_logit": 6.27734375,
            "text": "behavioral problems",
            "probability": 0.9921875
        },
        {
            "start_logit": 4.1484375,
            "end_logit": 1.365234375,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 0.007343292236328125
        },
        {
            "start_logit": -3.78125,
            "end_logit": 6.27734375,
            "text": "problems",
            "probability": 0.00035834312438964844
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 6.27734375,
            "text": "partial seizures who developed severe behavioral problems",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 6.27734375,
            "text": "severe behavioral problems",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": 1.365234375,
            "text": "hyperactive",
            "probability": 6.35385513305664e-05
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 6.27734375,
            "text": "learning disabled children, 1 aged 7 and 2 aged 10 years, with intractable partial seizures who developed severe behavioral problems",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 6.27734375,
            "text": "seizures who developed severe behavioral problems",
            "probability": 1.7821788787841797e-05
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 6.27734375,
            "text": "3 learning disabled children, 1 aged 7 and 2 aged 10 years, with intractable partial seizures who developed severe behavioral problems",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 6.27734375,
            "text": "with intractable partial seizures who developed severe behavioral problems",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 6.27734375,
            "text": ", 1 aged 7 and 2 aged 10 years, with intractable partial seizures who developed severe behavioral problems",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -5.62890625,
            "text": "behavioral",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -5.92578125,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive and had explosive outburst consisting of aggressive and oppositional behavior",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -6.55078125,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive and",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.78125,
            "end_logit": 1.365234375,
            "text": "problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -6.65625,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive and had explosive outburst consisting of aggressive and oppositional behavior.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -6.65625,
            "text": "behavioral problems while receiving modest doses of GBP.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 4.1484375,
            "end_logit": -6.66796875,
            "text": "behavioral problems while receiving modest doses of GBP. The children became hyperactive and had explosive outburst",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 1.365234375,
            "text": "partial seizures who developed severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 1.365234375,
            "text": "severe behavioral problems while receiving modest doses of GBP. The children became hyperactive",
            "probability": 7.152557373046875e-07
        }
    ],
    "57090784cf1c325851000011_1": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.1875,
            "text": "myelodysplastic syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.89013671875,
            "text": "myelodysplastic",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": -1.482421875,
            "end_logit": 9.1875,
            "text": "syndrome",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.03515625,
            "text": "myelodysplastic syndrome (MDS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 9.1875,
            "text": "with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.16796875,
            "text": "myelodysplastic syndrome (MDS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.28515625,
            "text": "myelodysplastic syndrome (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.51171875,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.52734375,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.53515625,
            "text": "myelodysplastic syndrome (MDS), but are rare",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5625,
            "text": "myelodysplastic syndrome (MDS), but are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.57421875,
            "text": "myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.58984375,
            "text": "myelodysplastic syndrome (MDS),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.60546875,
            "text": "myelodysplastic syndrome (MDS), but",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.1875,
            "text": "patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.1875,
            "text": "of patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.1875,
            "text": "~\\n10% of patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.1875,
            "text": "in ~\\n10% of patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.1875,
            "text": "complex 2 (PRC2), are observed in ~\\n10% of patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.1875,
            "text": "polycomb repressive complex 2 (PRC2), are observed in ~\\n10% of patients with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        }
    ],
    "57090784cf1c325851000011_2": [
        {
            "start_logit": 9.453125,
            "end_logit": 9.140625,
            "text": "myelodysplastic syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -0.630859375,
            "text": "myelodysplastic",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": -1.646484375,
            "end_logit": 9.140625,
            "text": "syndrome",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.53125,
            "text": "myelodysplastic syndrome (MDS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.20703125,
            "text": "myelodysplastic syndrome (MDS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.31640625,
            "text": "myelodysplastic syndrome (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.46484375,
            "text": "myelodysplastic syndrome (MDS) presenting with normal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.5,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype and FISH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.515625,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.51953125,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype and FISH result",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.53515625,
            "text": "myelodysplastic syndrome (MDS) presenting with normal karyotype and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.54296875,
            "text": "myelodysplastic syndrome (MDS) presenting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.140625,
            "text": "with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.140625,
            "text": "aCNA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.140625,
            "text": "cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.140625,
            "text": "NA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.140625,
            "text": "genomic profiling of aCNA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.140625,
            "text": "patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.140625,
            "text": "with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.140625,
            "text": "of aCNA and cnLOH, together with sequence analysis of recurrently mutated genes, in a patient with myelodysplastic syndrome",
            "probability": 5.960464477539063e-08
        }
    ],
    "57090784cf1c325851000011_3": [
        {
            "start_logit": 8.7421875,
            "end_logit": 5.6796875,
            "text": "Acquired aplastic anemia",
            "probability": 0.93017578125
        },
        {
            "start_logit": 8.7421875,
            "end_logit": 3.087890625,
            "text": "Acquired aplastic anemia (AA)",
            "probability": 0.06951904296875
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -2.044921875,
            "text": "Acquired",
            "probability": 0.00041031837463378906
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -4.8828125,
            "text": "Acquired aplastic anemia (",
            "probability": 2.4080276489257812e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -5.15234375,
            "text": "Acquired aplastic anemia (AA) is",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -5.62890625,
            "text": "Acquired aplastic anemia (AA",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.79296875,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow (BM) failure syndrome",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.8046875,
            "text": "Acquired aplastic anemia (AA) is a",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.9375,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow (BM) failure",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.05859375,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.09375,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow (BM",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.21875,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow (BM)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.23046875,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.30859375,
            "text": "Acquired aplastic anemia (AA) is a potentially fatal bone marrow (",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 5.6796875,
            "text": "aplastic anemia",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.44921875,
            "end_logit": 5.6796875,
            "text": "anemia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 3.087890625,
            "text": "aplastic anemia (AA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.44921875,
            "end_logit": 3.087890625,
            "text": "anemia (AA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 3.087890625,
            "text": ")",
            "probability": 0.0
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -4.8828125,
            "text": "aplastic anemia (",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_4": [
        {
            "start_logit": 9.125,
            "end_logit": 9.0703125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.5107421875,
            "text": "We",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -1.93359375,
            "end_logit": 9.0703125,
            "text": "syndrome",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.5546875,
            "text": "Weaver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 9.0703125,
            "text": "aver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.171875,
            "text": "Weaver syndrome are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.0703125,
            "text": "cause Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.44921875,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.46484375,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.47265625,
            "text": "Weaver syndrome are primarily missense variants and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.47265625,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.5,
            "text": "Weaver syndrome are primarily missense variants and the rare truncating mutations reported to date",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 9.0703125,
            "text": "EZH2 mutations that cause Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -1.5107421875,
            "text": "cause We",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -7.171875,
            "text": "syndrome are",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -1.5107421875,
            "text": "EZH2 mutations that cause We",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -7.44921875,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported to date are",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -7.46484375,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported to",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -7.47265625,
            "text": "syndrome are primarily missense variants and",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -7.47265625,
            "text": "syndrome are primarily missense variants and the rare truncating mutations reported",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_5": [
        {
            "start_logit": 8.4375,
            "end_logit": 8.0078125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.4375,
            "end_logit": -2.818359375,
            "text": "We",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -3.560546875,
            "end_logit": 8.0078125,
            "text": "syndrome",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": 8.4375,
            "end_logit": -4.48046875,
            "text": "Weaver",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.2890625,
            "text": "Weaver syndrome and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.34375,
            "text": "Weaver syndrome and EZH2 mutations",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.53125,
            "text": "Weaver syndrome and EZH2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.5859375,
            "text": "Weaver syndrome and EZ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -7.2890625,
            "text": "syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -7.34375,
            "text": "syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -7.53125,
            "text": "syndrome and EZH2",
            "probability": 0.0
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -7.5859375,
            "text": "syndrome and EZ",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_6": [
        {
            "start_logit": 8.6953125,
            "end_logit": 8.203125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -2.33203125,
            "text": "We",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -3.35546875,
            "end_logit": 8.203125,
            "text": "syndrome",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -5.3828125,
            "text": "Weaver",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 8.203125,
            "text": "cause Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.203125,
            "text": "aver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -2.33203125,
            "text": "cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -5.3828125,
            "text": "cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -5.3828125,
            "text": "aver",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_7": [
        {
            "start_logit": 7.765625,
            "end_logit": 1.888671875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 0.8017578125
        },
        {
            "start_logit": 7.765625,
            "end_logit": 0.444091796875,
            "text": "Weaver",
            "probability": 0.18896484375
        },
        {
            "start_logit": 7.765625,
            "end_logit": -3.12890625,
            "text": "Weaver syndrome",
            "probability": 0.005298614501953125
        },
        {
            "start_logit": 7.765625,
            "end_logit": -3.78125,
            "text": "We",
            "probability": 0.0027599334716796875
        },
        {
            "start_logit": 0.51318359375,
            "end_logit": 1.888671875,
            "text": "Sotos",
            "probability": 0.0005674362182617188
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.87890625,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes.",
            "probability": 0.0001251697540283203
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.9296875,
            "text": "Weaver syndrome and/or distinguishing Weaver",
            "probability": 0.00011843442916870117
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.97265625,
            "text": "Weaver syndrome and/or distinguishing We",
            "probability": 0.00011396408081054688
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.98046875,
            "text": "Weaver syndrome and/or",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.9921875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.16015625,
            "text": "Weaver syndrome and",
            "probability": 9.447336196899414e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.1875,
            "text": "Weaver syndrome and/",
            "probability": 9.1552734375e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.296875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Soto",
            "probability": 8.20159912109375e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 1.888671875,
            "text": "s",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 1.888671875,
            "text": "tos",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 1.888671875,
            "text": "of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 1.888671875,
            "text": "subtle presentation of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 1.888671875,
            "text": "distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 1.888671875,
            "text": "Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 1.888671875,
            "text": "presentation of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 1.7881393432617188e-07
        }
    ],
    "57090784cf1c325851000011_8": [
        {
            "start_logit": 8.7890625,
            "end_logit": 8.59375,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.1796875,
            "text": "We",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -2.802734375,
            "end_logit": 8.59375,
            "text": "syndrome",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -5.7265625,
            "text": "Weaver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 8.59375,
            "text": "cause Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.59375,
            "text": "aver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": -2.1796875,
            "text": "cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.15234375,
            "end_logit": -5.7265625,
            "text": "cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -5.7265625,
            "text": "aver",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_9": [
        {
            "start_logit": 8.3203125,
            "end_logit": 7.66015625,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -3.01171875,
            "text": "We",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -4.67578125,
            "text": "Weaver",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -4.0625,
            "end_logit": 7.66015625,
            "text": "syndrome",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 7.66015625,
            "text": "cause Weaver syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.66015625,
            "text": "that mutations in EZH2 cause Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": -3.01171875,
            "text": "cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -3.01171875,
            "text": "that mutations in EZH2 cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -4.67578125,
            "text": "cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -4.67578125,
            "text": "that mutations in EZH2 cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.48828125,
            "text": "that mutations",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.52734375,
            "text": "that mutations in",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_10": [
        {
            "start_logit": 8.421875,
            "end_logit": 8.1328125,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.421875,
            "end_logit": -2.837890625,
            "text": "We",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": -3.478515625,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 8.421875,
            "end_logit": -5.234375,
            "text": "Weaver",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.57421875,
            "text": "Weaver syndrome shows",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.23046875,
            "text": "Weaver syndrome shows considerable overlap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.390625,
            "text": "Weaver syndrome shows considerable overlap with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.49609375,
            "text": "Weaver syndrome shows considerable",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.53125,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.5390625,
            "text": "Weaver syndrome shows considerable overlap with the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.55859375,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.1328125,
            "text": "in Weaver syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.5859375,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in myeloid malignancies",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.58984375,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in myeloid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.6171875,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.64453125,
            "text": "Weaver syndrome shows considerable overlap with the inactivating somatic EZH2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.1328125,
            "text": "The EZH2 mutation spectrum in Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1328125,
            "text": "EZH2 mutation spectrum in Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.1328125,
            "text": "spectrum in Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.478515625,
            "end_logit": -6.57421875,
            "text": "syndrome shows",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_11": [
        {
            "start_logit": 8.9609375,
            "end_logit": 8.796875,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.884765625,
            "text": "We",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -2.4296875,
            "end_logit": 8.796875,
            "text": "syndrome",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -5.97265625,
            "text": "Weaver",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.16015625,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of human growth.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.26171875,
            "text": "Weaver syndrome and provide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.796875,
            "text": "aver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.42578125,
            "text": "Weaver syndrome and provide further",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.4453125,
            "text": "Weaver syndrome and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.4609375,
            "text": "Weaver syndrome and provide further links between histone modifications and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.46875,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of human growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.796875,
            "text": "as the cause of Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.50390625,
            "text": "Weaver syndrome and provide further links between histone modifications",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.51953125,
            "text": "Weaver syndrome and provide further links between",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.5390625,
            "text": "Weaver syndrome and provide further links between histone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.796875,
            "text": "of Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.5625,
            "text": "Weaver syndrome and provide further links between histone modifications and regulation of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.796875,
            "text": "cause of Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.796875,
            "text": "EZH2 mutations as the cause of Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -1.884765625,
            "text": "as the cause of We",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_12": [
        {
            "start_logit": 5.83984375,
            "end_logit": 1.85546875,
            "text": "non-Hodgkin lymphoma (NHL)",
            "probability": 0.72216796875
        },
        {
            "start_logit": 5.83984375,
            "end_logit": 0.8076171875,
            "text": "non-Hodgkin lymphoma",
            "probability": 0.25341796875
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -1.5947265625,
            "text": "non-Hodgkin lymphoma (NHL",
            "probability": 0.02294921875
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -5.515625,
            "text": "non",
            "probability": 0.00045418739318847656
        },
        {
            "start_logit": -1.7265625,
            "end_logit": 1.85546875,
            "text": "subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 0.00037360191345214844
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -6.06640625,
            "text": "non-Hodgkin lymphoma (",
            "probability": 0.0002617835998535156
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -6.7265625,
            "text": "non-Hodgkin",
            "probability": 0.00013589859008789062
        },
        {
            "start_logit": -1.7265625,
            "end_logit": 0.8076171875,
            "text": "subtypes of non-Hodgkin lymphoma",
            "probability": 0.00013065338134765625
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 1.85546875,
            "text": "certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 1.4126300811767578e-05
        },
        {
            "start_logit": -1.7265625,
            "end_logit": -1.5947265625,
            "text": "subtypes of non-Hodgkin lymphoma (NHL",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -5.53125,
            "end_logit": 1.85546875,
            "text": "NHL)",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 0.8076171875,
            "text": "certain subtypes of non-Hodgkin lymphoma",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 1.85546875,
            "text": "with certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 1.85546875,
            "text": "S and Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 1.85546875,
            "text": "and Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 1.85546875,
            "text": "in patients with certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 1.85546875,
            "text": "patients with certain subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.875,
            "end_logit": 1.85546875,
            "text": "-Hodgkin lymphoma (NHL)",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 0.8076171875,
            "text": "with certain subtypes of non-Hodgkin lymphoma",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 0.8076171875,
            "text": "S and Y641H) in the SET domain of EZH2 have been identified in patients with certain subtypes of non-Hodgkin lymphoma",
            "probability": 1.1920928955078125e-06
        }
    ],
    "57090784cf1c325851000011_13": [
        {
            "start_logit": 8.9375,
            "end_logit": 8.75,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.9375,
            "end_logit": -1.9228515625,
            "text": "We",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -2.501953125,
            "end_logit": 8.75,
            "text": "syndrome",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -5.1796875,
            "text": "Weaver",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 8.75,
            "text": "cause Weaver syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -7.26171875,
            "text": "Weaver syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.75,
            "text": "aver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.75,
            "text": ", mutations in the histone methyltransferase, EZH2, were shown to cause Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.75,
            "text": ", EZH2, were shown to cause Weaver syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -1.9228515625,
            "text": "cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -1.9228515625,
            "text": ", mutations in the histone methyltransferase, EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.9228515625,
            "text": ", EZH2, were shown to cause We",
            "probability": 0.0
        },
        {
            "start_logit": -2.501953125,
            "end_logit": -7.26171875,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -5.1796875,
            "text": "cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -5.1796875,
            "text": "aver",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -5.1796875,
            "text": ", mutations in the histone methyltransferase, EZH2, were shown to cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -5.1796875,
            "text": ", EZH2, were shown to cause Weaver",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -7.26171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -7.26171875,
            "text": "cause Weaver syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.26171875,
            "text": "aver syndrome.",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_14": [
        {
            "start_logit": 8.7890625,
            "end_logit": 8.640625,
            "text": "Weaver syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.263671875,
            "text": "We",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": -2.623046875,
            "end_logit": 8.640625,
            "text": "syndrome",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -3.521484375,
            "text": "Weaver",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.203125,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.40234375,
            "text": "Weaver syndrome and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.4140625,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.51953125,
            "text": "Weaver syndrome and EZH2 mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.6015625,
            "text": "Weaver syndrome and EZH2 mutations: Clarifying the clinical",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.623046875,
            "end_logit": -7.203125,
            "text": "syndrome and EZH2 mutations: Clarifying the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -2.623046875,
            "end_logit": -7.40234375,
            "text": "syndrome and",
            "probability": 0.0
        },
        {
            "start_logit": -2.623046875,
            "end_logit": -7.4140625,
            "text": "syndrome and EZH2 mutations: Clarifying the clinical phenotype",
            "probability": 0.0
        },
        {
            "start_logit": -2.623046875,
            "end_logit": -7.51953125,
            "text": "syndrome and EZH2 mutations",
            "probability": 0.0
        },
        {
            "start_logit": -2.623046875,
            "end_logit": -7.6015625,
            "text": "syndrome and EZH2 mutations: Clarifying the clinical",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -7.203125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.203125,
            "text": "Clarifying the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.203125,
            "text": "the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.203125,
            "text": "EZH2 mutations: Clarifying the clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -7.203125,
            "text": "clinical phenotype.",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.4140625,
            "text": "Clarifying the clinical phenotype",
            "probability": 0.0
        }
    ],
    "57090784cf1c325851000011_15": [
        {
            "start_logit": 7.765625,
            "end_logit": 1.888671875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 0.8017578125
        },
        {
            "start_logit": 7.765625,
            "end_logit": 0.444091796875,
            "text": "Weaver",
            "probability": 0.18896484375
        },
        {
            "start_logit": 7.765625,
            "end_logit": -3.12890625,
            "text": "Weaver syndrome",
            "probability": 0.005298614501953125
        },
        {
            "start_logit": 7.765625,
            "end_logit": -3.78125,
            "text": "We",
            "probability": 0.0027599334716796875
        },
        {
            "start_logit": 0.51318359375,
            "end_logit": 1.888671875,
            "text": "Sotos",
            "probability": 0.0005674362182617188
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.87890625,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes.",
            "probability": 0.0001251697540283203
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.9296875,
            "text": "Weaver syndrome and/or distinguishing Weaver",
            "probability": 0.00011843442916870117
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.97265625,
            "text": "Weaver syndrome and/or distinguishing We",
            "probability": 0.00011396408081054688
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.98046875,
            "text": "Weaver syndrome and/or",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.9921875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Sotos syndromes",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.16015625,
            "text": "Weaver syndrome and",
            "probability": 9.447336196899414e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.1875,
            "text": "Weaver syndrome and/",
            "probability": 9.1552734375e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.296875,
            "text": "Weaver syndrome and/or distinguishing Weaver and Soto",
            "probability": 8.20159912109375e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 1.888671875,
            "text": "s",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 1.888671875,
            "text": "tos",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 1.888671875,
            "text": "of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 1.888671875,
            "text": "subtle presentation of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 1.888671875,
            "text": "distinguishing Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 1.888671875,
            "text": "Weaver and Sotos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 1.888671875,
            "text": "presentation of Weaver syndrome and/or distinguishing Weaver and Sotos",
            "probability": 1.7881393432617188e-07
        }
    ],
    "57090784cf1c325851000011_16": [
        {
            "start_logit": 7.90234375,
            "end_logit": 6.18359375,
            "text": "Weaver",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.064453125,
            "end_logit": 6.18359375,
            "text": "Sotos and Weaver",
            "probability": 0.0010738372802734375
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -3.462890625,
            "text": "We",
            "probability": 6.449222564697266e-05
        },
        {
            "start_logit": 1.064453125,
            "end_logit": 2.623046875,
            "text": "Sotos",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.83203125,
            "text": "Weaver syndromes is also evident.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.84765625,
            "text": "Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of Weaver",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.0546875,
            "text": "Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of Weaver syndrome",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.1015625,
            "text": "Weaver syndromes",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.13671875,
            "text": "Weaver syndromes is also evident",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.1640625,
            "text": "Weaver syndromes is also evident. The identification of an EZH2 mutation can therefore provide an objective means of confirming a subtle presentation of We",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.19921875,
            "text": "Weaver syndromes is",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 6.18359375,
            "text": "aver",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.078125,
            "end_logit": 6.18359375,
            "text": "tos and Weaver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.18359375,
            "text": "phenotypic overlap between Sotos and Weaver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.18359375,
            "text": "s and Weaver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.18359375,
            "text": "Considerable phenotypic overlap between Sotos and Weaver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 6.18359375,
            "text": "overlap between Sotos and Weaver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.18359375,
            "text": "and Weaver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.18359375,
            "text": "between Sotos and Weaver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.064453125,
            "end_logit": -3.462890625,
            "text": "Sotos and We",
            "probability": 5.960464477539063e-08
        }
    ],
    "5547a7e9f35db75526000006_1": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.4296875,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": -0.90673828125,
            "end_logit": 9.4296875,
            "text": "A",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.6513671875,
            "text": "uvr",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 9.4296875,
            "text": "and mutants for uvrA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.4375,
            "text": "uvrA, uvrB, uvrC or uvrAC genes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.125,
            "end_logit": 9.4296875,
            "text": "Cultures of wild-type E. coli K12 and mutants for uvrA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 9.4296875,
            "text": "mutants for uvrA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.42578125,
            "text": "uvrA, uvrB, uvrC or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 9.4296875,
            "text": ". Cultures of wild-type E. coli K12 and mutants for uvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.59375,
            "text": "uvrA, uvrB, uvrC or uvrAC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.67578125,
            "text": "uvrA, uvrB, uvrC or uvrAC genes were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.72265625,
            "text": "uvrA, uvrB, uvrC or uvrAC genes were treated with PUVA and cell survival was determined.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.95703125,
            "text": "uvrA, uvrB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.0,
            "text": "uvrA, uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.07421875,
            "text": "uvrA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.4296875,
            "text": "of wild-type E. coli K12 and mutants for uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.12109375,
            "text": "uvrA, uvrB, uvrC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.90673828125,
            "end_logit": -5.4375,
            "text": "A, uvrB, uvrC or uvrAC genes",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -1.6513671875,
            "text": "and mutants for uvr",
            "probability": 0.0
        },
        {
            "start_logit": -0.90673828125,
            "end_logit": -6.42578125,
            "text": "A, uvrB, uvrC or",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_2": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.359375,
            "text": "UvrA",
            "probability": 1.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": 9.359375,
            "text": "A",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.681640625,
            "text": "Uvr",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.64453125,
            "text": "UvrA, UvrB, UvrC, the UvrD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.2578125,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5625,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 9.359375,
            "text": ". In eubacteria, the NER system typically consists of UvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 9.359375,
            "text": "DNA damage. In eubacteria, the NER system typically consists of UvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.359375,
            "text": "of UvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.359375,
            "text": "types of DNA damage. In eubacteria, the NER system typically consists of UvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.18359375,
            "text": "UvrA, UvrB, UvrC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1953125,
            "text": "UvrA, UvrB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1953125,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.33203125,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.421875,
            "text": "UvrA, UvrB, Uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.44140625,
            "text": "UvrA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -5.64453125,
            "text": "A, UvrB, UvrC, the UvrD",
            "probability": 0.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -6.2578125,
            "text": "A, UvrB, UvrC, the UvrD helicase",
            "probability": 0.0
        },
        {
            "start_logit": -1.1748046875,
            "end_logit": -6.5625,
            "text": "A, UvrB, UvrC, the UvrD helicase, DNA polymerase I",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_3": [
        {
            "start_logit": 7.49609375,
            "end_logit": 7.2421875,
            "text": "UvrD",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": 7.2421875,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 0.0004856586456298828
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -2.671875,
            "text": "UvrD, a superfamily 1A helicase",
            "probability": 4.982948303222656e-05
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -3.701171875,
            "text": "Uvr",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -4.109375,
            "end_logit": 7.2421875,
            "text": "D",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -6.91796875,
            "text": "UvrD, a superfamily 1A helicase.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.2421875,
            "text": "by UvrD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -7.2890625,
            "text": "UvrD, a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -7.390625,
            "text": "UvrD,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.49609375,
            "end_logit": -7.4140625,
            "text": "UvrD, a superfamily 1A",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.2421875,
            "text": "the UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.2421875,
            "text": "DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.2421875,
            "text": "short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -2.04296875,
            "text": "UvrC nuclease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -2.671875,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD, a superfamily 1A helicase",
            "probability": 0.0
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -3.107421875,
            "text": "UvrC",
            "probability": 0.0
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -3.701171875,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by Uvr",
            "probability": 0.0
        },
        {
            "start_logit": -4.109375,
            "end_logit": -2.671875,
            "text": "D, a superfamily 1A helicase",
            "probability": 0.0
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -6.7734375,
            "text": "UvrC nuclease and",
            "probability": 0.0
        },
        {
            "start_logit": -0.1368408203125,
            "end_logit": -6.91796875,
            "text": "UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD, a superfamily 1A helicase.",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_4": [
        {
            "start_logit": 4.35546875,
            "end_logit": 5.640625,
            "text": "UvrD",
            "probability": 0.81982421875
        },
        {
            "start_logit": 4.35546875,
            "end_logit": 3.87109375,
            "text": "UvrD interacts with UvrB",
            "probability": 0.13916015625
        },
        {
            "start_logit": 3.138671875,
            "end_logit": 3.87109375,
            "text": "UvrB",
            "probability": 0.0411376953125
        },
        {
            "start_logit": -5.90625,
            "end_logit": 5.640625,
            "text": "D",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -5.875,
            "text": "UvrD interacts",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -5.90625,
            "end_logit": 3.87109375,
            "text": "D interacts with UvrB",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -6.5390625,
            "text": "Uvr",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -6.84765625,
            "text": "UvrD interacts with UvrB, a component of the post-incision complex.",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -6.9921875,
            "text": "UvrD interacts with UvrB, a component of the post-incision",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.04296875,
            "text": "UvrD interacts with UvrB,",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.16015625,
            "text": "UvrD interacts with Uvr",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.16796875,
            "text": "UvrD interacts with UvrB, a",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.2265625,
            "text": "UvrD interacts with UvrB, a component of the post-incision complex",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 3.87109375,
            "text": "B",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.3515625,
            "text": "UvrD interacts with UvrB, a component of the",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.40625,
            "text": "UvrD interacts with UvrB, a component of the post-",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.421875,
            "text": "UvrD interacts with UvrB, a component of",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 4.35546875,
            "end_logit": -7.44921875,
            "text": "UvrD interacts with UvrB, a component",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 3.87109375,
            "text": "with UvrB",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 3.138671875,
            "end_logit": -6.84765625,
            "text": "UvrB, a component of the post-incision complex.",
            "probability": 9.5367431640625e-07
        }
    ],
    "5547a7e9f35db75526000006_5": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.4921875,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": -0.724609375,
            "end_logit": 9.4921875,
            "text": "A",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.5830078125,
            "text": "uvr",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.796875,
            "text": "uvrA and uvrB mutants",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.125,
            "text": "uvrA and uvrB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 9.4921875,
            "text": "that uvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.4921875,
            "text": "mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.765625,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.796875,
            "text": "uvrA and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.4921875,
            "text": "Escherichia coli K12 mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.4921875,
            "text": "increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.95703125,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.4921875,
            "text": "results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.4921875,
            "text": "K12 mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.0078125,
            "text": "uvrA and uvrB mutants are sensitive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.01953125,
            "text": "uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain as the wild type strain.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.4921875,
            "text": "to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.4921875,
            "text": "concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.4921875,
            "text": "nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.4921875,
            "text": "submitted to increasing concentrations of cisplatin, and the results revealed that uvrA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5547a7e9f35db75526000006_6": [
        {
            "start_logit": 8.875,
            "end_logit": 9.4921875,
            "text": "uvrA",
            "probability": 1.0
        },
        {
            "start_logit": -0.72705078125,
            "end_logit": 9.4921875,
            "text": "A",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": 8.875,
            "end_logit": -2.052734375,
            "text": "uvr",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -3.51953125,
            "end_logit": 9.4921875,
            "text": "uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -4.6875,
            "end_logit": 9.4921875,
            "text": "Inactivation of uvrA",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.875,
            "end_logit": -5.58984375,
            "text": "uvrA and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 9.4921875,
            "text": ". Inactivation of uvrA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.4921875,
            "text": "of uvrA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 9.4921875,
            "text": "Inactivation of any of the four uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.359375,
            "text": "uvrA and uvrB",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 9.4921875,
            "text": "four uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.90234375,
            "text": "uvrA and uvr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.00390625,
            "text": "uvrA and uvrB significantly decreased mutation frequencies whereas only the uvrA deficient",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.046875,
            "text": "uvrA and uvrB significantly decreased mutation frequencies whereas only the uvrA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.51953125,
            "end_logit": -0.0278778076171875,
            "text": "uvr genes",
            "probability": 0.0
        },
        {
            "start_logit": -3.51953125,
            "end_logit": -2.052734375,
            "text": "uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvr",
            "probability": 0.0
        },
        {
            "start_logit": -0.72705078125,
            "end_logit": -5.58984375,
            "text": "A and",
            "probability": 0.0
        },
        {
            "start_logit": -4.6875,
            "end_logit": -2.052734375,
            "text": "Inactivation of uvr",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -0.0278778076171875,
            "text": "Inactivation of any of the four uvr genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -0.0278778076171875,
            "text": "roles of nucleotide excision repair (NER) pathway components in H. pylori mutation and recombination. RESULTS: Inactivation of any of the four uvr genes",
            "probability": 0.0
        }
    ],
    "5547a7e9f35db75526000006_7": [
        {
            "start_logit": 8.7421875,
            "end_logit": 9.4375,
            "text": "UvrA",
            "probability": 1.0
        },
        {
            "start_logit": -0.87890625,
            "end_logit": 9.4375,
            "text": "A",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -2.19921875,
            "text": "Uvr",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 9.4375,
            "text": "upon UvrA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 9.4375,
            "text": "depends upon UvrA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 9.4375,
            "text": ". Damage recognition during bacterial NER depends upon UvrA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 9.4375,
            "text": "NER depends upon UvrA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.09375,
            "text": "UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.4375,
            "text": "Damage recognition during bacterial NER depends upon UvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.4375,
            "text": "but the mechanism underlying this rate enhancement is not understood. Damage recognition during bacterial NER depends upon UvrA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.66796875,
            "text": "UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.87109375,
            "text": "UvrA, which binds to the damage and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.06640625,
            "text": "UvrA, which binds to the damage and loads UvrB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.87890625,
            "end_logit": -6.09375,
            "text": "A, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd",
            "probability": 0.0
        },
        {
            "start_logit": -0.87890625,
            "end_logit": -6.66796875,
            "text": "A, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein",
            "probability": 0.0
        },
        {
            "start_logit": -0.87890625,
            "end_logit": -6.87109375,
            "text": "A, which binds to the damage and",
            "probability": 0.0
        },
        {
            "start_logit": -0.87890625,
            "end_logit": -7.06640625,
            "text": "A, which binds to the damage and loads UvrB",
            "probability": 0.0
        },
        {
            "start_logit": -6.30078125,
            "end_logit": -2.19921875,
            "text": "upon Uvr",
            "probability": 0.0
        },
        {
            "start_logit": -6.59375,
            "end_logit": -2.19921875,
            "text": "depends upon Uvr",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -2.19921875,
            "text": ". Damage recognition during bacterial NER depends upon Uvr",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_1": [
        {
            "start_logit": 7.0546875,
            "end_logit": 2.625,
            "text": "Increased serum ferritin",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -4.1328125,
            "text": "Increased",
            "probability": 0.00115966796875
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -5.38671875,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR",
            "probability": 0.0003294944763183594
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.7265625,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein",
            "probability": 8.666515350341797e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.8671875,
            "text": "Increased serum ferritin (74.2%)",
            "probability": 7.534027099609375e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.90625,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR)",
            "probability": 7.241964340209961e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.92578125,
            "text": "Increased serum ferritin (74.2",
            "probability": 7.128715515136719e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.98046875,
            "text": "Increased serum ferritin (",
            "probability": 6.699562072753906e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.18359375,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3",
            "probability": 5.46574592590332e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.23046875,
            "text": "Increased serum ferritin (74",
            "probability": 5.21540641784668e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.25,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73.3%)",
            "probability": 5.131959915161133e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.26953125,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (73",
            "probability": 5.054473876953125e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.32421875,
            "text": "Increased serum ferritin (74.2%), high C-reactive protein (",
            "probability": 4.744529724121094e-05
        },
        {
            "start_logit": -4.07421875,
            "end_logit": 2.625,
            "text": "serum ferritin",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -6.796875,
            "end_logit": 2.625,
            "text": "ferritin",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -5.38671875,
            "text": "serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR",
            "probability": 0.0
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -6.7265625,
            "text": "serum ferritin (74.2%), high C-reactive protein",
            "probability": 0.0
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -6.8671875,
            "text": "serum ferritin (74.2%)",
            "probability": 0.0
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -6.90625,
            "text": "serum ferritin (74.2%), high C-reactive protein (73.3%), and high erythrocyte sedimentation rate (ESR)",
            "probability": 0.0
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -6.92578125,
            "text": "serum ferritin (74.2",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_2": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.2578125,
            "text": "leucocytosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.1064453125,
            "text": "leuc",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.3955078125,
            "end_logit": 9.2578125,
            "text": "ocytosis",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.09765625,
            "text": "leucocytosis, lymphopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 9.2578125,
            "text": "as leucocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.30078125,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.36328125,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.42578125,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, creatinine, creatine kinase (CK)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.4375,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.2578125,
            "text": "deterioration of disease, such as leucocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 9.2578125,
            "text": "Some specific laboratory indicators implied the deterioration of disease, such as leucocytosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.50390625,
            "text": "leucocytosis, lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5234375,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, creatinine, creatine kinase (CK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5390625,
            "text": "leucocytosis, lymphopenia, platelet, alanine aminotransferase (ALT), aspartate aminotransferase (AST)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3955078125,
            "end_logit": -6.09765625,
            "text": "ocytosis, lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -1.1064453125,
            "text": "as leuc",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -1.1064453125,
            "text": "deterioration of disease, such as leuc",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -1.1064453125,
            "text": "Some specific laboratory indicators implied the deterioration of disease, such as leuc",
            "probability": 0.0
        },
        {
            "start_logit": -1.3955078125,
            "end_logit": -7.30078125,
            "text": "ocytosis, lymphopenia, platelet, alanine aminotransferase (ALT)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3955078125,
            "end_logit": -7.36328125,
            "text": "ocytosis, lymphopenia, platelet, alanine aminotransferase (ALT",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_3": [
        {
            "start_logit": 8.609375,
            "end_logit": 6.8046875,
            "text": "fever",
            "probability": 1.0
        },
        {
            "start_logit": 8.609375,
            "end_logit": -5.67578125,
            "text": "fever and cough with lymphopenia",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.1796875,
            "text": "fever and cough with lymphopenia and increased inflammatory indices",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.64453125,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved bilateral lung",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.86328125,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.99609375,
            "text": "fever and cough with lymphopenia and increased inflammatory",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.1953125,
            "text": "fever and cough with lymphopenia and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.2109375,
            "text": "fever and cough",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.3125,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.390625,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved bilateral lung.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.5,
            "text": "fever and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.55078125,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT feature is GGO involved bilateral",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.5703125,
            "text": "fever and cough with lymphope",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.5859375,
            "text": "fever and cough with lymphopenia and increased inflammatory indices, and the main CT",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 6.8046875,
            "text": "have fever",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 6.8046875,
            "text": "patients have fever",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.8046875,
            "text": "Most COVID-19 patients have fever",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": -5.67578125,
            "text": "lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -5.67578125,
            "text": "have fever and cough with lymphopenia",
            "probability": 0.0
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -6.1796875,
            "text": "increased inflammatory indices",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_4": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.625,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": -0.341552734375,
            "end_logit": 9.625,
            "text": "nia",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.8603515625,
            "text": "lympho",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 9.625,
            "text": "penia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.625,
            "text": "that lymphopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.59765625,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.83984375,
            "text": "lymphopenia, elevated level of d-dimer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -6.99609375,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.1328125,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.26953125,
            "text": "lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.37890625,
            "text": "lymphopenia, elevated level of d",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.43359375,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.48046875,
            "text": "lymphopenia, elevated level of d-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.50390625,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.5234375,
            "text": "lymphopenia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.53515625,
            "text": "lymphopenia, elevated level of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.341552734375,
            "end_logit": -6.59765625,
            "text": "nia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI)",
            "probability": 0.0
        },
        {
            "start_logit": -0.341552734375,
            "end_logit": -6.83984375,
            "text": "nia, elevated level of d-dimer",
            "probability": 0.0
        },
        {
            "start_logit": -0.341552734375,
            "end_logit": -6.99609375,
            "text": "nia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI",
            "probability": 0.0
        },
        {
            "start_logit": -0.341552734375,
            "end_logit": -7.1015625,
            "text": "nia, elevated level of d-dimer, hypersensitive cardiac troponin I (hs-CTnI) and high sensitivity C-reactive protein (hs-CRP",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_5": [
        {
            "start_logit": 9.3671875,
            "end_logit": 9.59375,
            "text": "Lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": -0.384033203125,
            "end_logit": 9.59375,
            "text": "nia",
            "probability": 5.7816505432128906e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -0.8203125,
            "text": "Lympho",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -5.1328125,
            "text": "Lymphopenia, elevated level of d-dimer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.265625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.59375,
            "text": "penia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.6484375,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.078125,
            "text": "Lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.390625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.453125,
            "text": "Lymphopenia, elevated level of d-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.46484375,
            "text": "Lymphopenia, elevated level of d",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.57421875,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.578125,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.58203125,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.59765625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults with severe COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.640625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults with severe COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.65625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults with severe COV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.6640625,
            "text": "Lymphopenia, elevated level of d-dimer, hs-CTnI and hs-CRP predicted clinical outcomes of young adults with severe COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.384033203125,
            "end_logit": -5.1328125,
            "text": "nia, elevated level of d-dimer",
            "probability": 0.0
        },
        {
            "start_logit": -0.384033203125,
            "end_logit": -6.265625,
            "text": "nia, elevated level of d-dimer, hs-CTnI and hs-CRP",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_6": [
        {
            "start_logit": 8.234375,
            "end_logit": 7.24609375,
            "text": "Hyponatremia",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.2734375,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.21484375,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.3359375,
            "text": "Hyponatremia (50%)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.359375,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.3828125,
            "text": "Hyponatremia (50%), elevated C-reactive protein",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.39453125,
            "text": "Hyponatremia (50%), elevated C-reactive",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4765625,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48828125,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP;",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.54296875,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "Hyponatremia (50%), elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.58203125,
            "text": "Hyponatremia (50",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.58984375,
            "text": "Hyponatremia (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -6.2734375,
            "text": "elevated C-reactive protein (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -6.5,
            "text": "elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -6.5234375,
            "text": "elevated C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -6.2734375,
            "text": "C-reactive protein (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -6.5,
            "text": "C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -6.5234375,
            "text": "C-reactive protein (CRP; 100%), and lactate dehydrogenase (LDH; 80%) were common. Acute renal",
            "probability": 0.0
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -6.2734375,
            "text": ", elevated C-reactive protein (CRP",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_7": [
        {
            "start_logit": 8.296875,
            "end_logit": 7.1953125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 7.1953125,
            "text": ", thrombocytopenia",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.36328125,
            "text": "thrombocytopenia (17%-36",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.390625,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4140625,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93%)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.41796875,
            "text": "thrombocytopenia (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.421875,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.44140625,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4453125,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93%), lactate dehydrogenase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 7.1953125,
            "text": "decreased lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.46875,
            "text": "thrombocytopenia (17%-36.2%)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.46875,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia (17%-36.2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.1953125,
            "text": "lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.1953125,
            "text": "include decreased lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.1953125,
            "text": "COVID\u201119 include decreased lymphocyte count (35%-82.1%), thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -7.36328125,
            "text": ", thrombocytopenia (17%-36",
            "probability": 0.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -7.390625,
            "text": ", thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7",
            "probability": 0.0
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -7.4140625,
            "text": ", thrombocytopenia (17%-36.2%), elevated serum C\u2011reactive protein (60.7%-93%)",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_8": [
        {
            "start_logit": 8.4453125,
            "end_logit": 7.04296875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -4.12890625,
            "text": "thrombocytopenia, and prolonged prothrombin time",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -3.564453125,
            "end_logit": 7.04296875,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -7.1953125,
            "text": "thrombocytopenia, and prolonged prothrombin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -7.25390625,
            "text": "thrombocytopenia, and prolonged prothrombin time.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -7.52734375,
            "text": "thrombocytopenia,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -7.72265625,
            "text": "thrombocytopenia, and prolonged",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.04296875,
            "text": "lymphopenia, thrombocytopenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.04296875,
            "text": "coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.04296875,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.04296875,
            "text": "that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.04296875,
            "text": "related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.04296875,
            "text": "hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.04296875,
            "text": "by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.04296875,
            "text": "including lymphopenia, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.564453125,
            "end_logit": -2.234375,
            "text": "pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": -3.564453125,
            "end_logit": -4.12890625,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -2.234375,
            "text": "that COVID-19 related pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -2.234375,
            "text": "related pneumonia",
            "probability": 0.0
        },
        {
            "start_logit": -3.564453125,
            "end_logit": -5.94921875,
            "text": "pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_9": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.375,
            "text": "Lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.900390625,
            "text": "Lympho",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": -1.1201171875,
            "end_logit": 9.375,
            "text": "nia",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 9.375,
            "text": "penia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.1875,
            "text": "Lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.203125,
            "text": "Lymphopenia is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.3046875,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.31640625,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50% of COVID-19 patients.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.3984375,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.4140625,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.43359375,
            "text": "Lymphopenia is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.44921875,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.5234375,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50%",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.52734375,
            "text": "Lymphopenia is the mostly commonly reported",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.578125,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.6171875,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.62890625,
            "text": "Lymphopenia is the mostly commonly reported laboratory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.640625,
            "text": "Lymphopenia is the mostly commonly reported laboratory abnormality and occurs in over 50% of COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1201171875,
            "end_logit": -7.203125,
            "text": "nia is",
            "probability": 0.0
        },
        {
            "start_logit": -1.1201171875,
            "end_logit": -7.3046875,
            "text": "nia is the mostly commonly reported laboratory abnormality",
            "probability": 0.0
        }
    ],
    "627a70e656bf9aee6f000021_10": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.328125,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": -1.091796875,
            "end_logit": 9.328125,
            "text": "nia",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.4248046875,
            "text": "lympho",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 9.328125,
            "text": "include lymphopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 9.328125,
            "text": "penia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.4765625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.4921875,
            "text": "lymphopenia, elevated of LDH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.96875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte sedimentation rate.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.328125,
            "text": "; laboratory abnormalities include lymphopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.07421875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.1015625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.30859375,
            "text": "lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.3125,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.328125,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte sedimentation rate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.359375,
            "text": "lymphopenia, elevated of LDH, CPK and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.44140625,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte sedimentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.48046875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.57421875,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.62109375,
            "text": "lymphopenia, elevated of LDH,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.62109375,
            "text": "lymphopenia, elevated of LDH, CPK and the inflammatory markers, such as C reactive protein, ferritinemia and the erythrocyte",
            "probability": 5.960464477539063e-08
        }
    ],
    "627a70e656bf9aee6f000021_11": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.4609375,
            "text": "lymphopenia",
            "probability": 1.0
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 9.4609375,
            "text": "nia",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.1044921875,
            "text": "lympho",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 9.4609375,
            "text": "penia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.0625,
            "text": "lymphopenia, elevated levels of C-reactive proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.1484375,
            "text": "lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 9.4609375,
            "text": "include lymphopenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.17578125,
            "text": "lymphopenia, elevated levels of C-reactive proteins and lactate dehydrogenase.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.42578125,
            "text": "lymphopenia, elevated levels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.546875,
            "text": "lymphopenia, elevated levels of C-reactive proteins and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.546875,
            "text": "lymphopenia, elevated levels of C-reactive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.57421875,
            "text": "lymphopenia, elevated levels of C-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.609375,
            "text": "lymphopenia, elevated levels of C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.6171875,
            "text": "lymphopenia, elevated levels of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.66015625,
            "text": "lymphope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.69140625,
            "text": "lymphopenia, elevated levels of C-reactive proteins and lactate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": -6.0625,
            "text": "nia, elevated levels of C-reactive proteins",
            "probability": 0.0
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": -6.1484375,
            "text": "nia, elevated levels of C-reactive proteins and lactate dehydrogenase",
            "probability": 0.0
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": -7.17578125,
            "text": "nia, elevated levels of C-reactive proteins and lactate dehydrogenase.",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -1.1044921875,
            "text": "include lympho",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_1": [
        {
            "start_logit": 9.3515625,
            "end_logit": 9.40625,
            "text": "Lichen sclerosus",
            "probability": 1.0
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -0.9453125,
            "text": "Lichen",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": 9.40625,
            "text": "osus",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 9.40625,
            "text": "sclerosus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -6.765625,
            "text": "Lichen scler",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -6.8671875,
            "text": "Lichen sclerosus has been reported at sites of injury",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.2421875,
            "text": "Lichen sclerosus has been reported",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.26953125,
            "text": "Lichen sclerosus has been reported at sites of injury as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.29296875,
            "text": "Lichen sclerosus has been reported at sites of injury as a Koebner phenomenon.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.34765625,
            "text": "Lichen sclerosus has been reported at sites of injury as a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.3828125,
            "text": "Lichen sclerosus has been reported at sites of injury as a Koebner phenomenon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.421875,
            "text": "Lichen sclerosus has been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.42578125,
            "text": "Lichen sclerosus has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.4765625,
            "text": "Lichen sclerosus has been reported at sites of injury as a Koebner",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.515625,
            "text": "Lichen sclerosus has been reported at sites of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": -6.8671875,
            "text": "osus has been reported at sites of injury",
            "probability": 0.0
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": -7.2421875,
            "text": "osus has been reported",
            "probability": 0.0
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": -7.26953125,
            "text": "osus has been reported at sites of injury as",
            "probability": 0.0
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": -7.29296875,
            "text": "osus has been reported at sites of injury as a Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": -1.0146484375,
            "end_logit": -7.34765625,
            "text": "osus has been reported at sites of injury as a",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_2": [
        {
            "start_logit": 8.8984375,
            "end_logit": 9.453125,
            "text": "physical trauma",
            "probability": 1.0
        },
        {
            "start_logit": -0.270751953125,
            "end_logit": 9.453125,
            "text": "trauma",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -1.556640625,
            "text": "physical",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 9.453125,
            "text": "apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.9296875,
            "end_logit": 9.453125,
            "text": "following physical trauma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.453125,
            "text": "Deprivation of survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 9.453125,
            "text": ". Vitiligo often develops following physical trauma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 9.453125,
            "text": "survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.88671875,
            "text": "physical trauma, even if this is minor. The exact mechanism of the Koebner phenomenon in vitiligo is unclear.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.890625,
            "text": "physical trauma, even if this is minor.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.453125,
            "text": "of survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.453125,
            "text": "Vitiligo often develops following physical trauma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.453125,
            "text": "the apoptosis of melanocytes. Vitiligo often develops following physical trauma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.1328125,
            "text": "physical trauma, even if this is minor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.1796875,
            "text": "physical trauma, even if this is minor. The exact mechanism of the Koebner phenomenon in vitiligo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.1796875,
            "text": "physical trauma, even if this is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.27734375,
            "text": "physical trauma, even",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.5390625,
            "end_logit": -1.556640625,
            "text": "apoptosis of melanocytes. Vitiligo often develops following physical",
            "probability": 0.0
        },
        {
            "start_logit": -4.9296875,
            "end_logit": -1.556640625,
            "text": "following physical",
            "probability": 0.0
        },
        {
            "start_logit": -5.53515625,
            "end_logit": -1.556640625,
            "text": "Deprivation of survival factors causes the apoptosis of melanocytes. Vitiligo often develops following physical",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_3": [
        {
            "start_logit": 2.41796875,
            "end_logit": 5.875,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 0.85595703125
        },
        {
            "start_logit": 0.45068359375,
            "end_logit": 5.875,
            "text": "sexual abuse",
            "probability": 0.1190185546875
        },
        {
            "start_logit": 2.41796875,
            "end_logit": 1.72265625,
            "text": "lichen sclerosus",
            "probability": 0.01342010498046875
        },
        {
            "start_logit": -2.103515625,
            "end_logit": 5.875,
            "text": "trauma, injury, and sexual abuse",
            "probability": 0.00928497314453125
        },
        {
            "start_logit": -4.84375,
            "end_logit": 5.875,
            "text": "and sexual abuse",
            "probability": 0.0005984306335449219
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 5.875,
            "text": "abuse",
            "probability": 0.0004699230194091797
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 5.875,
            "text": "(lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 0.00015985965728759766
        },
        {
            "start_logit": 2.41796875,
            "end_logit": -2.74609375,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma",
            "probability": 0.00015366077423095703
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 5.875,
            "text": "so trauma, injury, and sexual abuse",
            "probability": 7.611513137817383e-05
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 5.875,
            "text": "injury, and sexual abuse",
            "probability": 7.039308547973633e-05
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 5.875,
            "text": "sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 5.65648078918457e-05
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 5.875,
            "text": ", injury, and sexual abuse",
            "probability": 4.7266483306884766e-05
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 5.875,
            "text": ", and sexual abuse",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 5.875,
            "text": "occur (lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 4.476308822631836e-05
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 5.875,
            "text": "in skin already scarred or damaged), so trauma, injury, and sexual abuse",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": 2.41796875,
            "end_logit": -6.14453125,
            "text": "lichen sclerosus occurs",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 2.41796875,
            "end_logit": -6.5859375,
            "text": "lichen sclerosus occurs in skin already scarred or damaged",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 1.72265625,
            "text": "(lichen sclerosus",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 2.41796875,
            "end_logit": -7.109375,
            "text": "lichen scler",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.41796875,
            "end_logit": -7.109375,
            "text": "lichen sclerosus occurs in skin already scarred or damaged), so trauma, injury, and sexual abuse have been suggested as possible triggers of symptoms",
            "probability": 1.9669532775878906e-06
        }
    ],
    "58bfcb8702b8c60953000016_4": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.2578125,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": -0.76025390625,
            "end_logit": 9.2578125,
            "text": "stress",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.0068359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.1474609375,
            "text": "physical",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -5.62109375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -5.82421875,
            "text": "physical stress is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 9.2578125,
            "text": "of physical stress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.578125,
            "text": "physical stress is seen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.2578125,
            "text": "triggering role of physical stress",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.2578125,
            "text": "The triggering role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.1328125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.2578125,
            "text": "role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26171875,
            "text": "physical stress is seen in the \"deep Koebner",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26953125,
            "text": "physical stress is seen in the \"deep Ko",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.31640625,
            "text": "physical stress is seen in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.328125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.3359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.3671875,
            "text": "physical stress is seen in the \"deep Koeb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.38671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.39453125,
            "text": "physical stress is seen in the \"deep Koebner\"",
            "probability": 5.960464477539063e-08
        }
    ],
    "58bfcb8702b8c60953000016_5": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.2578125,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": -0.76025390625,
            "end_logit": 9.2578125,
            "text": "stress",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.0068359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.1474609375,
            "text": "physical",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -5.62109375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -5.82421875,
            "text": "physical stress is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 9.2578125,
            "text": "of physical stress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.578125,
            "text": "physical stress is seen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.2578125,
            "text": "triggering role of physical stress",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.2578125,
            "text": "The triggering role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.1328125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.2578125,
            "text": "role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26171875,
            "text": "physical stress is seen in the \"deep Koebner",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26953125,
            "text": "physical stress is seen in the \"deep Ko",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.31640625,
            "text": "physical stress is seen in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.328125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.3359375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.3671875,
            "text": "physical stress is seen in the \"deep Koeb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.38671875,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.39453125,
            "text": "physical stress is seen in the \"deep Koebner\"",
            "probability": 5.960464477539063e-08
        }
    ],
    "58bfcb8702b8c60953000016_6": [
        {
            "start_logit": -0.46484375,
            "end_logit": 5.69921875,
            "text": "psoriasis",
            "probability": 0.52880859375
        },
        {
            "start_logit": -0.697265625,
            "end_logit": 5.69921875,
            "text": "unusual skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 0.418212890625
        },
        {
            "start_logit": -2.939453125,
            "end_logit": 5.69921875,
            "text": "skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 0.04449462890625
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 5.69921875,
            "text": "Two patients with unusual skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 0.00215911865234375
        },
        {
            "start_logit": -6.09375,
            "end_logit": 5.69921875,
            "text": "patients with unusual skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 0.00189971923828125
        },
        {
            "start_logit": -0.697265625,
            "end_logit": 0.2149658203125,
            "text": "unusual skin stimuli",
            "probability": 0.0017366409301757812
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 5.69921875,
            "text": "in psoriasis",
            "probability": 0.0014848709106445312
        },
        {
            "start_logit": -6.78125,
            "end_logit": 5.69921875,
            "text": "with unusual skin stimuli causing koebner phenomenon in psoriasis",
            "probability": 0.0009551048278808594
        },
        {
            "start_logit": -2.939453125,
            "end_logit": 0.2149658203125,
            "text": "skin stimuli",
            "probability": 0.0001844167709350586
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 0.2149658203125,
            "text": "Two patients with unusual skin stimuli",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -6.09375,
            "end_logit": 0.2149658203125,
            "text": "patients with unusual skin stimuli",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -0.46484375,
            "end_logit": -5.84375,
            "text": "psoriasis are",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -0.697265625,
            "end_logit": -5.84375,
            "text": "unusual skin stimuli causing koebner phenomenon in psoriasis are",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.78125,
            "end_logit": 0.2149658203125,
            "text": "with unusual skin stimuli",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -0.46484375,
            "end_logit": -6.12109375,
            "text": "psoriasis are reported",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -0.697265625,
            "end_logit": -6.12109375,
            "text": "unusual skin stimuli causing koebner phenomenon in psoriasis are reported",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -0.46484375,
            "end_logit": -6.83203125,
            "text": "psoriasis are reported.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -0.697265625,
            "end_logit": -6.62890625,
            "text": "unusual skin stimuli causing",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -0.697265625,
            "end_logit": -6.83203125,
            "text": "unusual skin stimuli causing koebner phenomenon in psoriasis are reported.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -0.697265625,
            "end_logit": -7.1875,
            "text": "unusual skin stimuli causing koebner phenomenon",
            "probability": 1.0728836059570312e-06
        }
    ],
    "58bfcb8702b8c60953000016_7": [
        {
            "start_logit": 8.8203125,
            "end_logit": 9.0859375,
            "text": "striae distensae",
            "probability": 1.0
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 9.0859375,
            "text": "ae",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -2.224609375,
            "text": "str",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -5.0546875,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -5.140625,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 9.0859375,
            "text": "iae distensae",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -5.48828125,
            "text": "striae distensae and striae gravidarum",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 9.0859375,
            "text": "of striae distensae",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -5.73046875,
            "text": "striae distens",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.046875,
            "end_logit": 9.0859375,
            "text": "role of striae distensae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.09375,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 9.0859375,
            "text": "distensae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.4453125,
            "text": "striae distensae and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.625,
            "text": "striae distensae and striae gravida",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.63671875,
            "text": "striae distensae and striae grav",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 9.0859375,
            "text": "To document the role of striae distensae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 9.0859375,
            "text": "the role of striae distensae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.9140625,
            "text": "striae dist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.0234375,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.07421875,
            "text": "striae distensae and striae gravidarum in",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58bfcb8702b8c60953000016_8": [
        {
            "start_logit": 6.53125,
            "end_logit": 8.6796875,
            "text": "cutaneus trauma",
            "probability": 1.0
        },
        {
            "start_logit": -1.912109375,
            "end_logit": 8.6796875,
            "text": "local cutaneus trauma",
            "probability": 0.0002149343490600586
        },
        {
            "start_logit": -2.46484375,
            "end_logit": 8.6796875,
            "text": "trauma",
            "probability": 0.0001233816146850586
        },
        {
            "start_logit": -2.775390625,
            "end_logit": 8.6796875,
            "text": "psoriasis can be caused by a local cutaneus trauma",
            "probability": 9.101629257202148e-05
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 8.6796875,
            "text": ", psoriasis can be caused by a local cutaneus trauma",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": 8.6796875,
            "text": "aneus trauma",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 8.6796875,
            "text": "a local cutaneus trauma",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.734375,
            "end_logit": 8.6796875,
            "text": "by a local cutaneus trauma",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 8.6796875,
            "text": "addition, psoriasis can be caused by a local cutaneus trauma",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.8125,
            "end_logit": 8.6796875,
            "text": "us trauma",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.53125,
            "end_logit": -5.00390625,
            "text": "cut",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.6796875,
            "text": "caused by a local cutaneus trauma",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.6796875,
            "text": "In addition, psoriasis can be caused by a local cutaneus trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -6.53515625,
            "text": "cutaneus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -6.78125,
            "text": "cutaneus trauma, known",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -6.7890625,
            "text": "cutaneus trauma, known as Koebner phenomenon.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.2421875,
            "text": "cutaneus trauma, known as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.28125,
            "text": "cutaneus trauma, known as Ko",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.3046875,
            "text": "cutaneus trauma,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.359375,
            "text": "cutaneus trauma, known as Koebner phenomenon",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58bfcb8702b8c60953000016_9": [
        {
            "start_logit": 1.20703125,
            "end_logit": 3.54296875,
            "text": "psoriasis",
            "probability": 0.4658203125
        },
        {
            "start_logit": 1.20703125,
            "end_logit": 3.0859375,
            "text": "psoriasis and lichen planus",
            "probability": 0.294921875
        },
        {
            "start_logit": 0.54541015625,
            "end_logit": 3.0859375,
            "text": "lichen planus",
            "probability": 0.1522216796875
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 3.54296875,
            "text": "vitiligo, psoriasis",
            "probability": 0.04071044921875
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 3.0859375,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 0.0257720947265625
        },
        {
            "start_logit": -2.6015625,
            "end_logit": 3.54296875,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 0.01033782958984375
        },
        {
            "start_logit": -2.6015625,
            "end_logit": 3.0859375,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.006542205810546875
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 3.54296875,
            "text": ", psoriasis",
            "probability": 0.0011110305786132812
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -0.455078125,
            "text": "vitiligo",
            "probability": 0.0007452964782714844
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 3.0859375,
            "text": ", psoriasis and lichen planus",
            "probability": 0.0007033348083496094
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 3.54296875,
            "text": "preexisting vitiligo, psoriasis",
            "probability": 0.00022125244140625
        },
        {
            "start_logit": -2.6015625,
            "end_logit": -0.455078125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0001900196075439453
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 3.54296875,
            "text": "in patients with preexisting vitiligo, psoriasis",
            "probability": 0.00018334388732910156
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 3.0859375,
            "text": "preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.00014007091522216797
        },
        {
            "start_logit": -7.0,
            "end_logit": 3.54296875,
            "text": "patients with preexisting vitiligo, psoriasis",
            "probability": 0.00012755393981933594
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 3.0859375,
            "text": "in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.00011616945266723633
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 3.54296875,
            "text": "with preexisting vitiligo, psoriasis",
            "probability": 0.00010091066360473633
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 3.0859375,
            "text": "and lichen planus",
            "probability": 9.936094284057617e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 3.0859375,
            "text": "us",
            "probability": 8.302927017211914e-05
        },
        {
            "start_logit": -7.0,
            "end_logit": 3.0859375,
            "text": "patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 8.046627044677734e-05
        }
    ],
    "58bfcb8702b8c60953000016_10": [
        {
            "start_logit": 7.64453125,
            "end_logit": 7.86328125,
            "text": "varicella",
            "probability": 1.0
        },
        {
            "start_logit": 7.64453125,
            "end_logit": -5.58203125,
            "text": "varicella and UVB",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 7.86328125,
            "text": "by varicella",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 7.86328125,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.86328125,
            "text": "caused by varicella",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.86328125,
            "text": "psoriasis caused by varicella",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.64453125,
            "end_logit": -7.125,
            "text": "varicella and UVB]",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.64453125,
            "end_logit": -7.1328125,
            "text": "varicella and UVB].",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.64453125,
            "end_logit": -7.30078125,
            "text": "varicella and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.86328125,
            "text": "in psoriasis caused by varicella",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.86328125,
            "text": "Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": -4.63671875,
            "text": "[Unusual Koebner phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -4.63671875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.44140625,
            "end_logit": -5.58203125,
            "text": "by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -4.63671875,
            "text": "in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -4.63671875,
            "text": "Unusual Koebner phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.71484375,
            "end_logit": -5.58203125,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -5.58203125,
            "text": "caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -5.58203125,
            "text": "psoriasis caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -5.58203125,
            "text": "in psoriasis caused by varicella and UVB",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_11": [
        {
            "start_logit": 8.7421875,
            "end_logit": 7.74609375,
            "text": "Borrelia afzelii infection",
            "probability": 1.0
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -0.482177734375,
            "text": "Borrelia afzelii",
            "probability": 0.0002675056457519531
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -1.9892578125,
            "text": "Borrelia",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -2.80078125,
            "text": "Borrelia afzeli",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -3.291015625,
            "text": "Borrelia afze",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -3.3828125,
            "end_logit": 7.74609375,
            "text": "infection",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.3515625,
            "text": "Borrelia af",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.62890625,
            "text": "Borrelia afzelii infection.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.74609375,
            "text": "woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.74609375,
            "text": "by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.74609375,
            "text": "48 year-old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.74609375,
            "text": "old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 7.74609375,
            "text": "afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 7.74609375,
            "text": "exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.74609375,
            "text": "latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.74609375,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.74609375,
            "text": "migrating erythema caused by Borrelia afzelii infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.74609375,
            "text": "an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.74609375,
            "text": "i infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.74609375,
            "text": "in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 5.960464477539063e-08
        }
    ],
    "58bfcb8702b8c60953000016_12": [
        {
            "start_logit": 5.39453125,
            "end_logit": 6.68359375,
            "text": "psoriasis vulgaris",
            "probability": 1.0
        },
        {
            "start_logit": -4.8671875,
            "end_logit": 6.68359375,
            "text": "vulgaris",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 6.68359375,
            "text": "with psoriasis vulgaris",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 5.39453125,
            "end_logit": -4.5703125,
            "text": "psoriasis",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 6.68359375,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 6.68359375,
            "text": "patients with psoriasis vulgaris",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 6.68359375,
            "text": "in patients with psoriasis vulgaris",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.68359375,
            "text": "Characteristics of the Koebner phenomenon in patients with psoriasis vulgaris",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.68359375,
            "text": "of the Koebner phenomenon in patients with psoriasis vulgaris",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 5.39453125,
            "end_logit": -6.765625,
            "text": "psoriasis vulgaris].",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.39453125,
            "end_logit": -7.05078125,
            "text": "psoriasis vulgaris]",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -4.5703125,
            "text": "with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.01953125,
            "end_logit": -4.5703125,
            "text": "[Characteristics of the Koebner phenomenon in patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -4.5703125,
            "text": "patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -4.5703125,
            "text": "in patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -4.8671875,
            "end_logit": -6.765625,
            "text": "vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -4.5703125,
            "text": "Characteristics of the Koebner phenomenon in patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -4.8671875,
            "end_logit": -7.05078125,
            "text": "vulgaris]",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -6.765625,
            "text": "with psoriasis vulgaris].",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -4.5703125,
            "text": "of the Koebner phenomenon in patients with psoriasis",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_13": [
        {
            "start_logit": 8.171875,
            "end_logit": 7.359375,
            "text": "Vitiligo",
            "probability": 1.0
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.828125,
            "text": "Vitiligo appearing in striae distensae as",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.984375,
            "text": "Vitiligo appearing",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.046875,
            "text": "Vitiligo appearing in striae distensae",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.19921875,
            "text": "Vitiligo appearing in striae distensae as a Koebner phenomenon.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.3046875,
            "text": "Vitiligo appearing in striae dist",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.31640625,
            "text": "Vitiligo appearing in striae distens",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.36328125,
            "text": "Vitiligo appearing in striae distensae as a Koebner phenomenon",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.41796875,
            "text": "Vitiligo appearing in striae distensae as a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.51953125,
            "text": "Vitiligo appearing in striae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.5234375,
            "text": "Vitiligo appearing in striae distensae as a Koebner",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -6.828125,
            "text": "striae distensae as",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -6.828125,
            "text": "in striae distensae as",
            "probability": 0.0
        },
        {
            "start_logit": -6.94140625,
            "end_logit": -7.19921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -7.046875,
            "text": "striae distensae",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -7.046875,
            "text": "in striae distensae",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -7.19921875,
            "text": "striae distensae as a Koebner phenomenon.",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -7.3046875,
            "text": "striae dist",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -7.31640625,
            "text": "striae distens",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -7.19921875,
            "text": "in striae distensae as a Koebner phenomenon.",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_14": [
        {
            "start_logit": 7.55078125,
            "end_logit": 7.8203125,
            "text": "vitiligo",
            "probability": 1.0
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -4.890625,
            "text": "vitiligo in striae distensae as",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -5.5390625,
            "text": "vitiligo in striae distensae",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.8203125,
            "text": "of vitiligo",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -6.640625,
            "text": "vitiligo in striae distens",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -6.65625,
            "text": "vitiligo in striae dist",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.8203125,
            "text": "appearance of vitiligo",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -6.90234375,
            "text": "vitiligo in striae distensae as a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.8203125,
            "text": "The appearance of vitiligo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.03515625,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported rarely.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.26171875,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported rarely",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.3046875,
            "text": "vitiligo in striae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.30859375,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been reported",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.3515625,
            "text": "vitiligo in striae distensae as a form of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.3984375,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.41796875,
            "text": "vitiligo in striae distensae as a form",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.44140625,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.54296875,
            "text": "vitiligo in striae distensae as a form of Koebner phenomenon has been",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -4.890625,
            "text": "striae distensae as",
            "probability": 0.0
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -5.5390625,
            "text": "striae distensae",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_15": [
        {
            "start_logit": 6.69921875,
            "end_logit": 8.546875,
            "text": "trauma",
            "probability": 1.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": 8.546875,
            "text": "of trauma",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.546875,
            "text": "consequence of trauma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.546875,
            "text": "psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.546875,
            "text": "uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.546875,
            "text": "with psoriasis as a consequence of trauma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.546875,
            "text": "described the appearance of psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.546875,
            "text": "the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.546875,
            "text": "as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.546875,
            "text": "patients with psoriasis as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.546875,
            "text": "psoriasis as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.546875,
            "text": "of psoriatic lesions in the uninvolved skin of patients with psoriasis as a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.546875,
            "text": "a consequence of trauma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -7.15234375,
            "text": "trauma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": -7.15234375,
            "text": "of trauma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.765625,
            "text": "psoriatic lesions in the uninvolved skin of patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -6.765625,
            "text": "uninvolved skin of patients with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.765625,
            "text": "with psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.05078125,
            "text": "psoriatic lesions in the uninvolved skin of patients with psoriasis as",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_16": [
        {
            "start_logit": 9.0390625,
            "end_logit": 9.1953125,
            "text": "physical stress",
            "probability": 1.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": 0.265380859375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis, resulting in peripheral arthritis",
            "probability": 0.00013244152069091797
        },
        {
            "start_logit": -0.89990234375,
            "end_logit": 9.1953125,
            "text": "stress",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.1943359375,
            "text": "physical",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -5.66796875,
            "text": "physical stress is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -5.86328125,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.609375,
            "end_logit": 9.1953125,
            "text": "of physical stress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.51171875,
            "text": "physical stress is seen",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.1953125,
            "text": "triggering role of physical stress",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.15625,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and in enthesis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.1953125,
            "text": "The triggering role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.1953125,
            "text": "role of physical stress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.29296875,
            "text": "physical stress is seen in the \"deep Koebner",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.30859375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.30859375,
            "text": "physical stress is seen in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.3203125,
            "text": "physical stress is seen in the \"deep Ko",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.34375,
            "text": "physical stress is seen in the \"deep Koebner\" phenomenon, which causes inflammation in the synovial membrane and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.35546875,
            "text": "physical stress is seen in the \"deep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.38671875,
            "text": "physical stress is seen in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.39453125,
            "text": "physical stress is seen in the \"deep Koebner\"",
            "probability": 5.960464477539063e-08
        }
    ],
    "58bfcb8702b8c60953000016_17": [
        {
            "start_logit": 6.984375,
            "end_logit": 6.6484375,
            "text": "striae distensae",
            "probability": 0.986328125
        },
        {
            "start_logit": 3.486328125,
            "end_logit": 5.86328125,
            "text": "blunt trauma",
            "probability": 0.013641357421875
        },
        {
            "start_logit": 6.984375,
            "end_logit": -4.46875,
            "text": "striae dist",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": 6.984375,
            "end_logit": -4.65625,
            "text": "striae distens",
            "probability": 1.2159347534179688e-05
        },
        {
            "start_logit": 6.984375,
            "end_logit": -4.75390625,
            "text": "str",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 6.6484375,
            "text": "ae",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -4.5703125,
            "end_logit": 5.86328125,
            "text": "trauma",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.0546875,
            "text": "striae distensae and striae grav",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -5.765625,
            "end_logit": 6.6484375,
            "text": "role of striae distensae",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.2890625,
            "text": "striae distensae and striae gravida",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.32421875,
            "text": "striae",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 6.6484375,
            "text": "of striae distensae",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.65234375,
            "text": "striae distensae and",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.65625,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus.Striae",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.75390625,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis and lichen planus.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -6.859375,
            "text": "striae distensae and striae gravidarum",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -7.0234375,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo, psoriasis",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.984375,
            "end_logit": -7.046875,
            "text": "striae distensae and striae gravidarum in causing Koebner phenomenon in cases of vitiligo",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 6.6484375,
            "text": "To document the role of striae distensae",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 6.6484375,
            "text": "the role of striae distensae",
            "probability": 8.940696716308594e-07
        }
    ],
    "58bfcb8702b8c60953000016_18": [
        {
            "start_logit": 7.41796875,
            "end_logit": 7.83984375,
            "text": "varicella",
            "probability": 1.0
        },
        {
            "start_logit": 7.41796875,
            "end_logit": -5.875,
            "text": "varicella and UVB",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 7.83984375,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.83984375,
            "text": "by varicella",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.83984375,
            "text": "caused by varicella",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.41796875,
            "end_logit": -6.99609375,
            "text": "varicella and UVB]",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.83984375,
            "text": "psoriasis caused by varicella",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.83984375,
            "text": "Unusual Koebner phenomenon in psoriasis caused by varicella",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.83984375,
            "text": "in psoriasis caused by varicella",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.41796875,
            "end_logit": -7.26171875,
            "text": "varicella and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -4.80859375,
            "text": "[Unusual Koebner phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -4.80859375,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -5.875,
            "text": "[Unusual Koebner phenomenon in psoriasis caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -5.875,
            "text": "by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -4.80859375,
            "text": "Unusual Koebner phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -4.80859375,
            "text": "in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -5.875,
            "text": "caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -5.875,
            "text": "psoriasis caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -5.875,
            "text": "Unusual Koebner phenomenon in psoriasis caused by varicella and UVB",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -5.875,
            "text": "in psoriasis caused by varicella and UVB",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_19": [
        {
            "start_logit": 8.34375,
            "end_logit": 7.10546875,
            "text": "Borrelia afzelii infection",
            "probability": 1.0
        },
        {
            "start_logit": 8.34375,
            "end_logit": -0.92236328125,
            "text": "Borrelia afzelii",
            "probability": 0.00032520294189453125
        },
        {
            "start_logit": 8.34375,
            "end_logit": -2.66015625,
            "text": "Borrelia",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 8.34375,
            "end_logit": -3.4921875,
            "text": "Borrelia afzeli",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 8.34375,
            "end_logit": -3.6328125,
            "text": "Borrelia afze",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -4.13671875,
            "end_logit": 7.10546875,
            "text": "infection",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.42578125,
            "text": "Borrelia af",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.10546875,
            "text": "woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 7.10546875,
            "text": "by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.10546875,
            "text": "48 year-old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.10546875,
            "text": "afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.10546875,
            "text": "old woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.10546875,
            "text": "exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.10546875,
            "text": "latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.10546875,
            "text": "migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.10546875,
            "text": "an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.10546875,
            "text": "psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.10546875,
            "text": "in a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.10546875,
            "text": "a migrating erythema caused by Borrelia afzelii infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -0.92236328125,
            "text": "woman developed an exacerbation of a latent psoriasis as a Koebner phenomenon in a migrating erythema caused by Borrelia afzelii",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_20": [
        {
            "start_logit": 8.515625,
            "end_logit": 7.66796875,
            "text": "Intradermal antigen tests",
            "probability": 0.97607421875
        },
        {
            "start_logit": 8.515625,
            "end_logit": 3.94921875,
            "text": "Intradermal antigen tests and the Koebner phenomenon in psoriasis",
            "probability": 0.023681640625
        },
        {
            "start_logit": 8.515625,
            "end_logit": -2.408203125,
            "text": "Intradermal",
            "probability": 4.094839096069336e-05
        },
        {
            "start_logit": 8.515625,
            "end_logit": -3.330078125,
            "text": "Intradermal antigen",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -3.662109375,
            "end_logit": 7.66796875,
            "text": "tests",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 8.515625,
            "end_logit": -5.2578125,
            "text": "Intradermal antigen tests and",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.515625,
            "end_logit": -6.484375,
            "text": "Intradermal antigen tests and the",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.2421875,
            "text": "Intradermal antigen tests and the Koebner",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.328125,
            "text": "Intradermal antigen tests and the Koebner phenomenon",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.3671875,
            "text": "Intradermal antigen tests and the Koeb",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.515625,
            "end_logit": -7.37890625,
            "text": "Intradermal antigen tests and the Ko",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.66796875,
            "text": "antigen tests",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.662109375,
            "end_logit": 3.94921875,
            "text": "tests and the Koebner phenomenon in psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.265625,
            "end_logit": 3.94921875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 3.94921875,
            "text": "in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 3.94921875,
            "text": "antigen tests and the Koebner phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": 3.94921875,
            "text": "phenomenon in psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.662109375,
            "end_logit": -5.2578125,
            "text": "tests and",
            "probability": 0.0
        },
        {
            "start_logit": -3.662109375,
            "end_logit": -6.484375,
            "text": "tests and the",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -3.330078125,
            "text": "antigen",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_21": [
        {
            "start_logit": 3.845703125,
            "end_logit": 4.41796875,
            "text": "vitiligo",
            "probability": 0.88720703125
        },
        {
            "start_logit": 3.845703125,
            "end_logit": 2.322265625,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 0.10888671875
        },
        {
            "start_logit": -0.357177734375,
            "end_logit": 2.322265625,
            "text": "lichen planus",
            "probability": 0.0016279220581054688
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -2.048828125,
            "text": "vitiligo, psoriasis",
            "probability": 0.001377105712890625
        },
        {
            "start_logit": -5.015625,
            "end_logit": 4.41796875,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.00012612342834472656
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 4.41796875,
            "text": "preexisting vitiligo",
            "probability": 4.0590763092041016e-05
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 2.322265625,
            "text": "psoriasis and lichen planus",
            "probability": 3.212690353393555e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 4.41796875,
            "text": "in patients with preexisting vitiligo",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 4.41796875,
            "text": "patients with preexisting vitiligo",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -5.015625,
            "end_logit": 2.322265625,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 4.41796875,
            "text": "with preexisting vitiligo",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -6.9765625,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 4.41796875,
            "text": "RESULTS: Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.13671875,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Nelder",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.17578125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.23828125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.2421875,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.25,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according to Boyd and Neld",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -5.765625,
            "end_logit": 2.322265625,
            "text": ", psoriasis and lichen planus",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 3.845703125,
            "end_logit": -7.30078125,
            "text": "vitiligo, psoriasis and lichen planus, the three conditions where 'true kobenerisation' has been suggested according",
            "probability": 7.271766662597656e-06
        }
    ],
    "58bfcb8702b8c60953000016_22": [
        {
            "start_logit": 1.162109375,
            "end_logit": 6.14453125,
            "text": "psoriasis",
            "probability": 0.9970703125
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 6.14453125,
            "text": "severe psoriasis",
            "probability": 0.0008711814880371094
        },
        {
            "start_logit": -6.28125,
            "end_logit": 6.14453125,
            "text": ": The Koebner reaction is often thought to be more frequent in actively spreading, severe psoriasis",
            "probability": 0.0005846023559570312
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 6.14453125,
            "text": "in actively spreading, severe psoriasis",
            "probability": 0.0004448890686035156
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 6.14453125,
            "text": ", severe psoriasis",
            "probability": 0.00034236907958984375
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 6.14453125,
            "text": "more frequent in actively spreading, severe psoriasis",
            "probability": 0.0003116130828857422
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.14453125,
            "text": "DISCUSSION: The Koebner reaction is often thought to be more frequent in actively spreading, severe psoriasis",
            "probability": 0.00027298927307128906
        },
        {
            "start_logit": 1.162109375,
            "end_logit": -5.98046875,
            "text": "psoriasis.",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -6.8515625,
            "text": "positive and the other with negative Koebner phenomenon which presented the control group",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -6.91015625,
            "text": "positive and",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -6.98046875,
            "text": "positive and the other with negative Koebner phenomenon",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -6.99609375,
            "text": "positive",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.10546875,
            "text": "positive and the other with negative Koebner phenomenon which",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.17578125,
            "text": "positive and the other with negative Koebner phenomenon which presented the control group at",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.2109375,
            "text": "positive and the other with negative Ko",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.2109375,
            "text": "positive and the other with negative Koebner",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.2109375,
            "text": "positive and the other with negative Koebner phenomenon which presented the control",
            "probability": 0.0
        },
        {
            "start_logit": -4.55859375,
            "end_logit": -7.21875,
            "text": "positive and the other with negative Koebner phenomenon which presented the",
            "probability": 0.0
        },
        {
            "start_logit": -5.82421875,
            "end_logit": -5.98046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.8828125,
            "end_logit": -5.98046875,
            "text": "severe psoriasis.",
            "probability": 0.0
        }
    ],
    "58bfcb8702b8c60953000016_23": [
        {
            "start_logit": 6.15234375,
            "end_logit": 6.64453125,
            "text": "sarcoidosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.8408203125,
            "end_logit": 6.64453125,
            "text": "lichen planus and sarcoidosis",
            "probability": 0.0003380775451660156
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -5.609375,
            "text": "sarcoidosis in the auditory canal",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 6.64453125,
            "text": "case of concurrent lichen planus and sarcoidosis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.64453125,
            "text": "concurrent lichen planus and sarcoidosis",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 6.64453125,
            "text": "planus and sarcoidosis",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.64453125,
            "text": "a case of concurrent lichen planus and sarcoidosis",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.64453125,
            "text": "describe a case of concurrent lichen planus and sarcoidosis",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.06640625,
            "text": "sarcoidosis in the auditory canal, which represents",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.64453125,
            "text": "We describe a case of concurrent lichen planus and sarcoidosis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.64453125,
            "text": "of concurrent lichen planus and sarcoidosis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.26953125,
            "text": "sarcoidosis in the auditory canal, which represents an unusual manifestation of the Koebner phenomenon.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.3046875,
            "text": "sarcoidosis in the auditory canal, which",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.3828125,
            "text": "sarcoidosis in",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.41015625,
            "text": "sarcoidosis in the",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.4375,
            "text": "sarcoidosis in the auditory canal,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.49609375,
            "text": "sarcoidosis in the auditory canal, which represents an",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.5,
            "text": "sarcoidosis in the auditory canal, which represents an unusual manifestation",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.51171875,
            "text": "sarcoidosis in the auditory canal, which represents an unusual manifestation of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -7.53515625,
            "text": "sarcoidosis in the auditory canal, which represents an unusual manifestation of the",
            "probability": 7.152557373046875e-07
        }
    ],
    "58bfcb8702b8c60953000016_24": [
        {
            "start_logit": 1.20703125,
            "end_logit": 3.54296875,
            "text": "psoriasis",
            "probability": 0.4658203125
        },
        {
            "start_logit": 1.20703125,
            "end_logit": 3.0859375,
            "text": "psoriasis and lichen planus",
            "probability": 0.294921875
        },
        {
            "start_logit": 0.54541015625,
            "end_logit": 3.0859375,
            "text": "lichen planus",
            "probability": 0.1522216796875
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 3.54296875,
            "text": "vitiligo, psoriasis",
            "probability": 0.04071044921875
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 3.0859375,
            "text": "vitiligo, psoriasis and lichen planus",
            "probability": 0.0257720947265625
        },
        {
            "start_logit": -2.6015625,
            "end_logit": 3.54296875,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis",
            "probability": 0.01033782958984375
        },
        {
            "start_logit": -2.6015625,
            "end_logit": 3.0859375,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.006542205810546875
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 3.54296875,
            "text": ", psoriasis",
            "probability": 0.0011110305786132812
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -0.455078125,
            "text": "vitiligo",
            "probability": 0.0007452964782714844
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 3.0859375,
            "text": ", psoriasis and lichen planus",
            "probability": 0.0007033348083496094
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 3.54296875,
            "text": "preexisting vitiligo, psoriasis",
            "probability": 0.00022125244140625
        },
        {
            "start_logit": -2.6015625,
            "end_logit": -0.455078125,
            "text": "Striae are documented to cause Koebner phenomenon in patients with preexisting vitiligo",
            "probability": 0.0001900196075439453
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 3.54296875,
            "text": "in patients with preexisting vitiligo, psoriasis",
            "probability": 0.00018334388732910156
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 3.0859375,
            "text": "preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.00014007091522216797
        },
        {
            "start_logit": -7.0,
            "end_logit": 3.54296875,
            "text": "patients with preexisting vitiligo, psoriasis",
            "probability": 0.00012755393981933594
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 3.0859375,
            "text": "in patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 0.00011616945266723633
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 3.54296875,
            "text": "with preexisting vitiligo, psoriasis",
            "probability": 0.00010091066360473633
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 3.0859375,
            "text": "and lichen planus",
            "probability": 9.936094284057617e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 3.0859375,
            "text": "us",
            "probability": 8.302927017211914e-05
        },
        {
            "start_logit": -7.0,
            "end_logit": 3.0859375,
            "text": "patients with preexisting vitiligo, psoriasis and lichen planus",
            "probability": 8.046627044677734e-05
        }
    ],
    "5c73ace67c78d69471000083_1": [
        {
            "start_logit": 8.3203125,
            "end_logit": 7.16796875,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -6.83203125,
            "text": "deafness (sensorineural",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -6.86328125,
            "text": "deafness (sensorineural)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.3203125,
            "text": "deafness (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.41015625,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.453125,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.57421875,
            "text": "deafness (sensorineural), onychodystrophy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.578125,
            "text": "deafness (sensorineural), onychodystrophy, oste",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3203125,
            "end_logit": -7.5859375,
            "text": "deafness (sensorineural), onychodystrophy, osteodystrophy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.16796875,
            "text": "of deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.16796875,
            "text": "multisystem genetic disorder, consisting of deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.16796875,
            "text": "rare multisystem genetic disorder, consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.16796875,
            "text": "consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.16796875,
            "text": "is a rare multisystem genetic disorder, consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.16796875,
            "text": "syndrome is a rare multisystem genetic disorder, consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.16796875,
            "text": "DOOR syndrome is a rare multisystem genetic disorder, consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.16796875,
            "text": "a rare multisystem genetic disorder, consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.16796875,
            "text": ", consisting of deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": -6.83203125,
            "text": "of deafness (sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -7.109375,
            "end_logit": -6.86328125,
            "text": "of deafness (sensorineural)",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_2": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.35546875,
            "text": "epilepsy",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.359375,
            "text": "epilepsy and cerebral palsy",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.75,
            "text": "epilepsy and cerebral palsy who had two dental",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.83984375,
            "text": "epilepsy and cerebral palsy who had two dental procedures under anaesthetic care.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.9296875,
            "text": "epilepsy and cerebral palsy who had two dental procedures",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 7.35546875,
            "text": "Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.01171875,
            "text": "epilepsy and cerebral palsy who had two dental procedures under anaesthetic care",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.33984375,
            "text": "epilepsy and cerebral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.35546875,
            "text": ", epilepsy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.37890625,
            "text": "epilepsy and cerebral palsy who had two dental procedures under anaesthetic",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.421875,
            "text": "epilepsy and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.47265625,
            "text": "epilepsy and cerebral palsy who had two dental procedures under",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.5,
            "text": "epilepsy and cerebral palsy who",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.35546875,
            "text": "with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 7.35546875,
            "text": "Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.35546875,
            "text": "patient with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.35546875,
            "text": "a 48-year-old male patient with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.35546875,
            "text": "syndrome, epilepsy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.35546875,
            "text": "male patient with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.35546875,
            "text": "the anaesthetic management of a 48-year-old male patient with Deafness, Onycho-Osteodystrophy and mental Retardation syndrome, epilepsy",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c73ace67c78d69471000083_3": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.0703125,
            "text": "congenital deafness",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -0.8974609375,
            "text": "congenital",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.5625,
            "end_logit": 9.0703125,
            "text": "deafness",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -4.3671875,
            "end_logit": 9.0703125,
            "text": "delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 9.0703125,
            "text": "life because of a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.8359375,
            "text": "congenital deafness, nail and bone abnormalities, and mild mental retardation.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 9.0703125,
            "text": ". The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.09765625,
            "text": "congenital deafness, nail and bone abnormalities",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.20703125,
            "text": "congenital deafness, nail and bone abnormalities, and mild mental retardation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.0703125,
            "text": "development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.37109375,
            "text": "congenital deafness,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.3828125,
            "text": "congenital deafness, nail and bone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.0703125,
            "text": "with DOOR syndrome recognized in the first year of his life because of a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.48828125,
            "text": "congenital deafness, nail and bone abnormalities, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.328125,
            "end_logit": 9.0703125,
            "text": "including congenital deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.0703125,
            "text": "his life because of a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.0703125,
            "text": "a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.3671875,
            "end_logit": -0.8974609375,
            "text": "delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital",
            "probability": 0.0
        },
        {
            "start_logit": -6.52734375,
            "end_logit": -0.8974609375,
            "text": "life because of a delayed development of speech. The diagnosis was based on characteristic abnormalities, including congenital",
            "probability": 0.0
        },
        {
            "start_logit": -6.82421875,
            "end_logit": -0.8974609375,
            "text": ". The diagnosis was based on characteristic abnormalities, including congenital",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_4": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.49609375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.40234375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.453125,
            "text": "deafness, onychodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.50390625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.51171875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.515625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.53515625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.54296875,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.546875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.578125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.58203125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.625,
            "text": "deafness, onychodystrophy, oste",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.63671875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.49609375,
            "text": "(deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.49609375,
            "text": "syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.49609375,
            "text": "DOOR syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.40234375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_5": [
        {
            "start_logit": 7.9609375,
            "end_logit": 7.6484375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.21484375,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.21484375,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome].",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.26171875,
            "text": "deafness, onychodystrophy, oste",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.29296875,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.3984375,
            "text": "deafness, onychodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.45703125,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation) syndrome]",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.54296875,
            "text": "deafness, onychodystrophy, osteodystrophy, mental retardation)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.546875,
            "text": "deafness, onych",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.6484375,
            "text": "(deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.6484375,
            "text": "[DOOR (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.6484375,
            "text": "DOOR (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": -7.21484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.21484375,
            "text": "osteodystrophy, mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.21484375,
            "text": "osteodystrophy, mental retardation) syndrome].",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.21484375,
            "text": "onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.21484375,
            "text": "onychodystrophy, osteodystrophy, mental retardation) syndrome].",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.26171875,
            "text": "oste",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.26171875,
            "text": "onychodystrophy, oste",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.29296875,
            "text": "osteodystrophy",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_6": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.49609375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.40234375,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.453125,
            "text": "deafness, onychodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.50390625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.51171875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.515625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.53515625,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.54296875,
            "text": "deafness, onychodystrophy, osteodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.546875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.578125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.58203125,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.625,
            "text": "deafness, onychodystrophy, oste",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.63671875,
            "text": "deafness, onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.49609375,
            "text": "(deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.49609375,
            "text": "syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.49609375,
            "text": "DOOR syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation) is a rarely described disorder with less than 35 reports in the literature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.40234375,
            "text": "onychodystrophy, osteodystrophy, and mental retardation)",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_7": [
        {
            "start_logit": 8.4609375,
            "end_logit": 8.6796875,
            "text": "sensorineural hearing loss",
            "probability": 0.998046875
        },
        {
            "start_logit": 2.11328125,
            "end_logit": 8.6796875,
            "text": "hearing loss",
            "probability": 0.0017538070678710938
        },
        {
            "start_logit": -2.46875,
            "end_logit": 8.6796875,
            "text": "loss",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -2.345703125,
            "text": "sensorineural",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 8.6796875,
            "text": "hallmarks of the syndrome, represented in the DOOR acronym, include sensorineural hearing loss",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -6.96484375,
            "text": "sensorineural hearing loss, hypoplastic or absent nails",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.6796875,
            "text": "include sensorineural hearing loss",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.6796875,
            "text": "syndrome, represented in the DOOR acronym, include sensorineural hearing loss",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.6796875,
            "text": "acronym, include sensorineural hearing loss",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.39453125,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and feet",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.47265625,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalange",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.47265625,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.4765625,
            "text": "sensorineural hearing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.49609375,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.53515625,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.578125,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and feet, small or absent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.60546875,
            "text": "sensorineural hearing loss, hypoplastic or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.609375,
            "text": "sensorineural hearing loss, hypoplastic or absent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.62890625,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.63671875,
            "text": "sensorineural hearing loss, hypoplastic or absent nails on the hands and feet, small or absent distal phalanges of the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c73ace67c78d69471000083_8": [
        {
            "start_logit": 9.09375,
            "end_logit": 9.3828125,
            "text": "dystrophic thumbs",
            "probability": 1.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": 0.583984375,
            "text": "dystrophic thumbs, sensorineural deafness",
            "probability": 0.00015234947204589844
        },
        {
            "start_logit": -1.046875,
            "end_logit": 9.3828125,
            "text": "s",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -1.5068359375,
            "text": "dystrophic",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -4.87109375,
            "end_logit": 9.3828125,
            "text": "onycho-osteodystrophy, dystrophic thumbs",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.53125,
            "end_logit": 9.3828125,
            "text": "thumbs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 9.3828125,
            "text": ", dystrophic thumbs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 9.3828125,
            "text": "Four patients from three families with the clinical features of DOOR syndrome (onycho-osteodystrophy, dystrophic thumbs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 9.3828125,
            "text": "(onycho-osteodystrophy, dystrophic thumbs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 9.3828125,
            "text": "patients from three families with the clinical features of DOOR syndrome (onycho-osteodystrophy, dystrophic thumbs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.890625,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the subjects of this report.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.3828125,
            "text": "clinical features of DOOR syndrome (onycho-osteodystrophy, dystrophic thumbs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.28515625,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.33203125,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.41796875,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.4375,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.4453125,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.45703125,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the subjects of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.48828125,
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the subjects of this",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1785888671875,
            "end_logit": 0.583984375,
            "text": "sensorineural deafness",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_9": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.484375,
            "text": "sensorineural deafness",
            "probability": 1.0
        },
        {
            "start_logit": -0.64599609375,
            "end_logit": 9.484375,
            "text": "deafness",
            "probability": 4.506111145019531e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.65380859375,
            "text": "sensorineural",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.32421875,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.484375,
            "text": "acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.484375,
            "text": "comprising sensorineural deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.484375,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.484375,
            "text": "The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.484375,
            "text": "syndrome comprising sensorineural deafness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.56640625,
            "text": "sensorineural deafness, osteodystrophy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.56640625,
            "text": "sensorineural deafness, osteodystrophy, onychodystrophy, and mental retardation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.64599609375,
            "end_logit": -7.32421875,
            "text": "deafness, osteodystrophy, onychodystrophy, and mental retardation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -0.65380859375,
            "text": "acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -0.64599609375,
            "end_logit": -7.484375,
            "text": "deafness, osteodystrophy, onychodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.65380859375,
            "text": "comprising sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -0.64599609375,
            "end_logit": -7.56640625,
            "text": "deafness, osteodystrophy",
            "probability": 0.0
        },
        {
            "start_logit": -0.64599609375,
            "end_logit": -7.56640625,
            "text": "deafness, osteodystrophy, onychodystrophy, and mental retardation",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -0.65380859375,
            "text": "The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -0.65380859375,
            "text": "syndrome comprising sensorineural",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -7.32421875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_10": [
        {
            "start_logit": 8.15625,
            "end_logit": 7.43359375,
            "text": "deafness",
            "probability": 1.0
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.18359375,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.26171875,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive cases",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.28125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive cases.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.37109375,
            "text": "deafness, onycho",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.4296875,
            "text": "deafness, onycho-osteodystrophy, and mental retardation)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.4453125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.48828125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.5,
            "text": "deafness, onycho-oste",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.5390625,
            "text": "deafness, onycho-osteodystrophy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.56640625,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.578125,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability among recessive",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.609375,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.625,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.625,
            "text": "deafness, onycho-osteodystrophy, and mental retardation): a new",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.43359375,
            "text": "(deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.43359375,
            "text": "syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.43359375,
            "text": "DOOR syndrome (deafness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.28125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.18359375,
            "text": "onycho-osteodystrophy, and mental retardation): a new patient and delineation of neurologic variability",
            "probability": 0.0
        }
    ],
    "5c73ace67c78d69471000083_11": [
        {
            "start_logit": 6.37890625,
            "end_logit": 8.546875,
            "text": "sensorineural deafness",
            "probability": 0.67529296875
        },
        {
            "start_logit": 6.94140625,
            "end_logit": 7.25,
            "text": "Congenital heart disease",
            "probability": 0.323974609375
        },
        {
            "start_logit": -0.52099609375,
            "end_logit": 8.546875,
            "text": "deafness",
            "probability": 0.0006814002990722656
        },
        {
            "start_logit": -4.14453125,
            "end_logit": 7.25,
            "text": "disease",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -3.921875,
            "text": "Congenital",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -4.4921875,
            "text": "sensorineural",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 8.546875,
            "text": ".The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.546875,
            "text": "siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.546875,
            "text": "urinary tract abnormalities in two siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.546875,
            "text": "comprising sensorineural deafness",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.546875,
            "text": "two siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.546875,
            "text": "acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.546875,
            "text": "The acronym DOOR was first used by Cantwell in 1975 to describe a syndrome comprising sensorineural deafness",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.25,
            "text": "heart disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.60546875,
            "text": "Congenital heart",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.12109375,
            "text": "Congenital heart disease and urinary tract abnormalities",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.16015625,
            "text": "Congenital heart disease and urinary tract abnormalities in two siblings",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.25390625,
            "text": "Congenital heart disease and urinary tract abnormalities in two siblings with DOOR syndrome.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.40625,
            "text": "Congenital heart disease and urinary tract",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.52734375,
            "text": "Congenital heart disease and urinary tract abnormalities in two siblings with DOOR syndrome.The acronym DOOR was first used by Cantwell",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56be143eef6e394741000009_1": [
        {
            "start_logit": 7.6328125,
            "end_logit": 7.65234375,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": 7.65234375,
            "text": "confusion, oculomotor disturbance and ataxia",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 7.65234375,
            "text": "(confusion, oculomotor disturbance and ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -6.81640625,
            "text": "ataxia)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.65234375,
            "text": "triad (confusion, oculomotor disturbance and ataxia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.04296875,
            "text": "ataxia), however, in the majority of the cases only confusion is present.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.18359375,
            "text": "ataxia), however, in the majority of the cases only confusion",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.65234375,
            "text": "and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.65234375,
            "text": "typical triad (confusion, oculomotor disturbance and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.65234375,
            "text": "characterized by a typical triad (confusion, oculomotor disturbance and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.65234375,
            "text": ", oculomotor disturbance and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.390625,
            "text": "ataxia), however, in the majority of the cases only confusion is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.65234375,
            "text": "by a typical triad (confusion, oculomotor disturbance and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.65234375,
            "text": "oculomotor disturbance and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.48046875,
            "text": "ataxia), however",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.4921875,
            "text": "ataxia), however, in the majority of the cases only confusion is present",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.51953125,
            "text": "ataxia), however, in the majority of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -4.74609375,
            "text": "confusion",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -6.81640625,
            "text": "confusion, oculomotor disturbance and ataxia)",
            "probability": 0.0
        },
        {
            "start_logit": -4.10546875,
            "end_logit": -7.04296875,
            "text": "confusion, oculomotor disturbance and ataxia), however, in the majority of the cases only confusion is present.",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_2": [
        {
            "start_logit": 7.6328125,
            "end_logit": 7.94921875,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.94921875,
            "text": "and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.94921875,
            "text": "acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.94921875,
            "text": "encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.94921875,
            "text": "mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.94921875,
            "text": "neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.36328125,
            "text": "ataxia.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.94921875,
            "text": "is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.94921875,
            "text": "an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.94921875,
            "text": ", and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.94921875,
            "text": "oculomotor dysfunction, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.36328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.36328125,
            "text": "and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.36328125,
            "text": "acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.36328125,
            "text": "encephalopathy is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.36328125,
            "text": "mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.36328125,
            "text": "neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -7.36328125,
            "text": "is an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -7.36328125,
            "text": "an acute neurological disorder characterized by mental confusion, oculomotor dysfunction, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -7.36328125,
            "text": ", and ataxia.",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_3": [
        {
            "start_logit": 3.66796875,
            "end_logit": 7.96484375,
            "text": "ataxia",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.125,
            "end_logit": 7.96484375,
            "text": "gait ataxia",
            "probability": 0.0011205673217773438
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 7.96484375,
            "text": "encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 6.103515625e-05
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 7.96484375,
            "text": ", oculomotor dysfunction and gait ataxia",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.96484375,
            "text": "of encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.96484375,
            "text": "oculomotor dysfunction and gait ataxia",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.96484375,
            "text": "triad consists of encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.96484375,
            "text": "classic triad consists of encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.96484375,
            "text": "dysfunction and gait ataxia",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.96484375,
            "text": "consists of encephalopathy, oculomotor dysfunction and gait ataxia",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.96484375,
            "text": "and gait ataxia",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": 3.66796875,
            "end_logit": -6.515625,
            "text": "ataxia but",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.66796875,
            "end_logit": -6.55078125,
            "text": "ataxia but is not seen in a majority of patients.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 3.66796875,
            "end_logit": -7.375,
            "text": "ataxia but is not seen",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.66796875,
            "end_logit": -7.40625,
            "text": "ataxia but is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.66796875,
            "end_logit": -7.453125,
            "text": "ataxia but is not seen in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.125,
            "end_logit": -6.515625,
            "text": "gait ataxia but",
            "probability": 0.0
        },
        {
            "start_logit": -3.125,
            "end_logit": -6.55078125,
            "text": "gait ataxia but is not seen in a majority of patients.",
            "probability": 0.0
        },
        {
            "start_logit": -3.125,
            "end_logit": -7.375,
            "text": "gait ataxia but is not seen",
            "probability": 0.0
        },
        {
            "start_logit": -3.125,
            "end_logit": -7.40625,
            "text": "gait ataxia but is",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_4": [
        {
            "start_logit": 3.53125,
            "end_logit": 8.2734375,
            "text": "ataxia",
            "probability": 0.99609375
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 8.2734375,
            "text": "truncal ataxia",
            "probability": 0.0032444000244140625
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 8.2734375,
            "text": "vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 0.00010514259338378906
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 8.2734375,
            "text": "al ataxia",
            "probability": 3.987550735473633e-05
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 8.2734375,
            "text": "and truncal ataxia",
            "probability": 3.987550735473633e-05
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.2734375,
            "text": "frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.574920654296875e-05
        },
        {
            "start_logit": -7.21875,
            "end_logit": 8.2734375,
            "text": ", and truncal ataxia",
            "probability": 2.1398067474365234e-05
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.2734375,
            "text": "After frequent vomiting, he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 2.1219253540039062e-05
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.2734375,
            "text": ", he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.2734375,
            "text": "ocular abnormalities, and truncal ataxia",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.2734375,
            "text": "he presented with mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.2734375,
            "text": "abnormalities, and truncal ataxia",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.2734375,
            "text": "mental status changes, ocular abnormalities, and truncal ataxia",
            "probability": 1.5020370483398438e-05
        },
        {
            "start_logit": 3.53125,
            "end_logit": -6.8515625,
            "text": "ataxia (the classic triad).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 3.53125,
            "end_logit": -6.98828125,
            "text": "ataxia (the classic triad)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.53125,
            "end_logit": -7.47265625,
            "text": "ataxia (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.8515625,
            "text": "truncal ataxia (the classic triad).",
            "probability": 0.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.98828125,
            "text": "truncal ataxia (the classic triad)",
            "probability": 0.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -7.47265625,
            "text": "truncal ataxia (",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -6.4609375,
            "text": "vomiting",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_5": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.5,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.71484375,
            "end_logit": 9.5,
            "text": "oplegia",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.4638671875,
            "text": "ophthalm",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -2.982421875,
            "text": "ophthalmoplegia, ataxia",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.65234375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.5,
            "text": "of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.5,
            "text": "triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.23828125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.5,
            "text": "a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.31640625,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.5,
            "text": "is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.32421875,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.5,
            "text": "encephalopathy is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.40234375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.421875,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5078125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5234375,
            "text": "ophthalmoplegia, ataxia and confusion seen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.71484375,
            "end_logit": -2.982421875,
            "text": "oplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -0.71484375,
            "end_logit": -6.65234375,
            "text": "oplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -0.71484375,
            "end_logit": -7.23828125,
            "text": "oplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency.",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_6": [
        {
            "start_logit": 7.3828125,
            "end_logit": 8.1875,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.1875,
            "text": "and ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.1875,
            "text": "triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1875,
            "text": "confusional symptoms, ocular alterations and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.1875,
            "text": "thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.1875,
            "text": "defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.1875,
            "text": ", ocular alterations and ataxia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.1875,
            "text": "by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.1875,
            "text": "caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1875,
            "text": "of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.1875,
            "text": "ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1875,
            "text": "by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1875,
            "text": "central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.1875,
            "text": "encephalopathy is caused by thiamine deficiency in the central nervous system, and is defined by the triad of confusional symptoms, ocular alterations and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.3125,
            "text": "ataxia.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": -6.65625,
            "text": "thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -6.65625,
            "text": "caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -7.3125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -6.65625,
            "text": "by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.65625,
            "text": "encephalopathy is caused by thiamine",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_7": [
        {
            "start_logit": 9.3515625,
            "end_logit": 9.4375,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.96875,
            "end_logit": 9.4375,
            "text": "oplegia",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -0.95263671875,
            "text": "ophthalm",
            "probability": 3.0934810638427734e-05
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.4375,
            "text": ", ophthalmoplegia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 9.4375,
            "text": "clinical symptoms described by Wernicke (gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.4375,
            "text": "triad of clinical symptoms described by Wernicke (gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.4375,
            "text": "gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.39453125,
            "text": "ophthalmoplegia, and confusion) are found in only a third of patients upon initial examination.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.4140625,
            "text": "ophthalmoplegia, and confusion) are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.4375,
            "text": "classical triad of clinical symptoms described by Wernicke (gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.4375,
            "text": "of clinical symptoms described by Wernicke (gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.4375,
            "text": "(gait ataxia, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.53515625,
            "text": "ophthalmoplegia, and confusion)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.57421875,
            "text": "ophthalmoplegia, and confusion) are found in only a third of patients upon",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.6015625,
            "text": "ophthalmoplegia, and confusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.6171875,
            "text": "ophthalmoplegia, and confusion) are found",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.546875,
            "end_logit": -0.95263671875,
            "text": ", ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -0.95263671875,
            "text": "clinical symptoms described by Wernicke (gait ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -0.95263671875,
            "text": "triad of clinical symptoms described by Wernicke (gait ataxia, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -0.95263671875,
            "text": "gait ataxia, ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_8": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.5,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.7578125,
            "end_logit": 9.5,
            "text": "oplegia",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.32421875,
            "text": "ophthalm",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -2.755859375,
            "text": "ophthalmoplegia, and ataxia",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -6.390625,
            "end_logit": 9.5,
            "text": ", ophthalmoplegia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 9.5,
            "text": "confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.5,
            "text": "that only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.21875,
            "text": "ophthalmoplegia, and ataxia.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.5,
            "text": "namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.5,
            "text": "population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.5,
            "text": "only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.5,
            "text": "classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.5,
            "text": "was found that only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.5,
            "text": "the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.5,
            "text": "had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.7578125,
            "end_logit": -2.755859375,
            "text": "oplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -1.32421875,
            "text": ", ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -0.7578125,
            "end_logit": -7.21875,
            "text": "oplegia, and ataxia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -1.32421875,
            "text": "confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -1.32421875,
            "text": "that only 0.4% of the population studied had the classical triad of Wernicke's encephalopathy, namely confusion, ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_9": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.390625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -1.0732421875,
            "end_logit": 9.390625,
            "text": "oplegia",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.1005859375,
            "text": "ophthalm",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -5.90234375,
            "text": "ophthalmoplegia and nystagmus, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.390625,
            "text": ", ophthalmoplegia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.82421875,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.390625,
            "text": "state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.2734375,
            "text": "ophthalmoplegia and nystagmus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 9.390625,
            "text": "triad of Wernicke's encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.40234375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.390625,
            "text": "confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.390625,
            "text": "global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5,
            "text": "ophthalmoplegia and nystagmus, and ataxia--",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.390625,
            "text": "encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.390625,
            "text": "--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.61328125,
            "text": "ophthalmoplegia and nystagmus, and ataxia-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.6171875,
            "text": "ophthalmoplegia and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0732421875,
            "end_logit": -5.90234375,
            "text": "oplegia and nystagmus, and ataxia",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_10": [
        {
            "start_logit": 7.69140625,
            "end_logit": 7.86328125,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 7.86328125,
            "text": "and ataxia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.140625,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.86328125,
            "text": "ocular signs, and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.86328125,
            "text": ", ocular signs, and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.86328125,
            "text": "clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.86328125,
            "text": "with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.86328125,
            "text": "signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.86328125,
            "text": "encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.86328125,
            "text": ", and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.86328125,
            "text": "Only six presented with the Wernicke's encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.86328125,
            "text": "mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.421875,
            "text": "ataxia)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.86328125,
            "text": "changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.46875,
            "text": "ataxia) at neurologic onset; nine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.53125,
            "text": "ataxia) at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.2734375,
            "end_logit": -7.140625,
            "text": "and ataxia) at neurologic onset; nine eventually demonstrated this triad.",
            "probability": 0.0
        },
        {
            "start_logit": -6.2734375,
            "end_logit": -7.421875,
            "text": "and ataxia)",
            "probability": 0.0
        },
        {
            "start_logit": -6.2734375,
            "end_logit": -7.46875,
            "text": "and ataxia) at neurologic onset; nine",
            "probability": 0.0
        },
        {
            "start_logit": -6.2734375,
            "end_logit": -7.53125,
            "text": "and ataxia) at",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_11": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.3828125,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -1.138671875,
            "end_logit": 9.3828125,
            "text": "oplegia",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.083984375,
            "text": "ophthalm",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 9.3828125,
            "text": "ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.015625,
            "end_logit": 9.3828125,
            "text": "and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.3828125,
            "text": ", ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.3828125,
            "text": "confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.35546875,
            "text": "ophthalmoplegia.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.3828125,
            "text": "triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.3828125,
            "text": "classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.3828125,
            "text": "encephalopathy is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.3828125,
            "text": "syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 9.3828125,
            "text": "by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 9.3828125,
            "text": "of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 9.3828125,
            "text": "is a well-described syndrome characterized by the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 9.3828125,
            "text": "the classic triad of confusion, ataxia, and ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -1.083984375,
            "text": "ataxia, and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -1.083984375,
            "text": "and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -1.083984375,
            "text": ", ataxia, and ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -1.083984375,
            "text": "confusion, ataxia, and ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_12": [
        {
            "start_logit": 9.25,
            "end_logit": 9.4765625,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.85009765625,
            "end_logit": 9.4765625,
            "text": "oplegia",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.220703125,
            "text": "ophthalm",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -4.26171875,
            "text": "ophthalmoplegia, ataxia",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.51953125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.4765625,
            "text": "of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.30859375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.359375,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine) deficiency",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.4765625,
            "text": "triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.4765625,
            "text": ";s encephalopathy is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.4765625,
            "text": "encephalopathy is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.421875,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.42578125,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics with dietary vitamin B1 (thiamine)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.4765625,
            "text": "a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.44921875,
            "text": "ophthalmoplegia, ataxia and confusion seen in alcoholics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.4765625,
            "text": "is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.4765625,
            "text": "s encephalopathy is a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.51171875,
            "text": "ophthalmoplegia, ataxia and confusion seen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.55859375,
            "text": "ophthalmoplegia, ataxia and confusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.85009765625,
            "end_logit": -4.26171875,
            "text": "oplegia, ataxia",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_13": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.4609375,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.89306640625,
            "end_logit": 9.4609375,
            "text": "oplegia",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.1044921875,
            "text": "ophthalm",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.109375,
            "text": "ophthalmoplegia, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.4609375,
            "text": "of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.4609375,
            "text": "neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.4609375,
            "text": "triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.4609375,
            "text": "acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.41796875,
            "text": "ophthalmoplegia, ataxia, and mental confusion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.4609375,
            "text": "is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.4609375,
            "text": "WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.4609375,
            "text": "an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.4609375,
            "text": "encephalopathy (WE) is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.4609375,
            "text": ") is an acute neurologic disorder characterized by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.4609375,
            "text": "by a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 9.4609375,
            "text": "a triad of ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.89306640625,
            "end_logit": -6.109375,
            "text": "oplegia, ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -0.89306640625,
            "end_logit": -7.41796875,
            "text": "oplegia, ataxia, and mental confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -1.1044921875,
            "text": "of ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -1.1044921875,
            "text": "neurologic disorder characterized by a triad of ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_14": [
        {
            "start_logit": 4.9453125,
            "end_logit": 4.93359375,
            "text": "ophthalmoplegia",
            "probability": 0.79150390625
        },
        {
            "start_logit": 3.46484375,
            "end_logit": 4.93359375,
            "text": "ataxia, ophthalmoplegia",
            "probability": 0.1807861328125
        },
        {
            "start_logit": 3.46484375,
            "end_logit": 3.05859375,
            "text": "ataxia",
            "probability": 0.0277252197265625
        },
        {
            "start_logit": 4.9453125,
            "end_logit": -5.87109375,
            "text": "ophthalm",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 4.93359375,
            "text": "oplegia",
            "probability": 1.5020370483398438e-05
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 4.93359375,
            "text": ", ophthalmoplegia",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 4.9453125,
            "end_logit": -7.3359375,
            "text": "ophthalmoplegia, and altered mental status",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -5.87109375,
            "text": "ataxia, ophthalm",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 4.93359375,
            "text": "of ataxia, ophthalmoplegia",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 4.93359375,
            "text": "triad of ataxia, ophthalmoplegia",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 4.93359375,
            "text": "metabolic disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 4.93359375,
            "text": "patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 4.93359375,
            "text": "disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia, ophthalmoplegia",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.3359375,
            "text": "ataxia, ophthalmoplegia, and altered mental status",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 3.05859375,
            "text": "of ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 3.05859375,
            "text": "triad of ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 3.05859375,
            "text": "encephalopathy is a metabolic disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 3.05859375,
            "text": "is a metabolic disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 3.05859375,
            "text": "metabolic disorder caused by deficiency of thiamine (vitamin B1) seen in alcoholics and even in nonalcoholic patients, classically presenting with a triad of ataxia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 3.05859375,
            "text": "patients, classically presenting with a triad of ataxia",
            "probability": 4.172325134277344e-07
        }
    ],
    "56be143eef6e394741000009_15": [
        {
            "start_logit": 1.154296875,
            "end_logit": 8.25,
            "text": "ataxia",
            "probability": 0.998046875
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.25,
            "text": "and ataxia",
            "probability": 0.00024890899658203125
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.25,
            "text": "encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.00021958351135253906
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.25,
            "text": "acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.00017368793487548828
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.25,
            "text": ";s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001709461212158203
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.25,
            "text": ", oculomotor dysfunction and ataxia",
            "probability": 0.00016963481903076172
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.25,
            "text": "neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.00016832351684570312
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.25,
            "text": "triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.00015938282012939453
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.25,
            "text": "characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001556873321533203
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.25,
            "text": "an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001556873321533203
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.25,
            "text": "is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001531839370727539
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.25,
            "text": "mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.00014865398406982422
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.25,
            "text": "oculomotor dysfunction and ataxia",
            "probability": 0.0001462697982788086
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.25,
            "text": "s encephalopathy is an acute neurological syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001462697982788086
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.25,
            "text": "syndrome due to thiamine deficiency, which is characterized by a typical triad of mental status changes, oculomotor dysfunction and ataxia",
            "probability": 0.0001418590545654297
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -6.56640625,
            "text": "encephalopathy is an acute neurological syndrome due to thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.56640625,
            "text": "acute neurological syndrome due to thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -6.56640625,
            "text": ";s encephalopathy is an acute neurological syndrome due to thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -6.56640625,
            "text": "neurological syndrome due to thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -6.56640625,
            "text": "an acute neurological syndrome due to thiamine",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_16": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.484375,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.79248046875,
            "end_logit": 9.484375,
            "text": "oplegia",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.083984375,
            "text": "ophthalm",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.484375,
            "text": ", ophthalmoplegia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.77734375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.9765625,
            "text": "ophthalmoplegia and nystagmus, and ataxia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 9.484375,
            "text": "state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.3671875,
            "text": "ophthalmoplegia and nystagmus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.484375,
            "text": "triad of Wernicke&apos;s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.484375,
            "text": "encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.484375,
            "text": "confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.484375,
            "text": ";s encephalopathy--global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.453125,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.4609375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated by immediate thiamine treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.484375,
            "text": "global confusional state, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.52734375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.52734375,
            "text": "ophthalmoplegia and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.625,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and is often attenuated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.6328125,
            "text": "ophthalmoplegia and nystagmus, and ataxia-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.6484375,
            "text": "ophthalmoplegia and nystagmus, and ataxia--is occasionally seen in chronic alcoholics and",
            "probability": 5.960464477539063e-08
        }
    ],
    "56be143eef6e394741000009_17": [
        {
            "start_logit": 7.9609375,
            "end_logit": 7.56640625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -5.984375,
            "end_logit": 7.56640625,
            "text": ", ataxia",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -6.6015625,
            "text": "ataxia and confusion",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 7.56640625,
            "text": "ocular symptoms, ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.27734375,
            "text": "ataxia and confusion, was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.37890625,
            "text": "ataxia and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.38671875,
            "text": "ataxia and confusion, was found",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.56640625,
            "text": "with ocular symptoms, ataxia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.56640625,
            "text": "patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.56640625,
            "text": "classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.56640625,
            "text": ";s encephalopathy with ocular symptoms, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.56640625,
            "text": "In 25/73 (35%) of the patients the classic triad of Wernicke&apos;s encephalopathy with ocular symptoms, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.56640625,
            "text": "symptoms, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.984375,
            "end_logit": -6.6015625,
            "text": ", ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -6.6015625,
            "text": "ocular symptoms, ataxia and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -5.984375,
            "end_logit": -7.27734375,
            "text": ", ataxia and confusion, was",
            "probability": 0.0
        },
        {
            "start_logit": -5.984375,
            "end_logit": -7.37890625,
            "text": ", ataxia and",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -6.88671875,
            "text": "ocular symptoms",
            "probability": 0.0
        },
        {
            "start_logit": -5.984375,
            "end_logit": -7.38671875,
            "text": ", ataxia and confusion, was found",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -6.6015625,
            "text": "with ocular symptoms, ataxia and confusion",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_18": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.4453125,
            "text": "ophthalmoplegia",
            "probability": 1.0
        },
        {
            "start_logit": -0.93115234375,
            "end_logit": 9.4453125,
            "text": "oplegia",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.45703125,
            "text": "ophthalm",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 9.4453125,
            "text": ", ophthalmoplegia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.51953125,
            "text": "ophthalmoplegia, and ataxia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.4453125,
            "text": "confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.4453125,
            "text": "namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.4453125,
            "text": "population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.4453125,
            "text": "only 0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.4453125,
            "text": ";s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.4453125,
            "text": "s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.4453125,
            "text": "classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.4453125,
            "text": "&apos;s encephalopathy, namely confusion, ophthalmoplegia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.93115234375,
            "end_logit": -6.51953125,
            "text": "oplegia, and ataxia",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -1.45703125,
            "text": ", ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -1.45703125,
            "text": "confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -1.45703125,
            "text": "that only 0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -1.45703125,
            "text": "namely confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.45703125,
            "text": "population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalm",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.45703125,
            "text": "only 0.4% of the population studied had the classical triad of Wernicke&apos;s encephalopathy, namely confusion, ophthalm",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_19": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.73828125,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.58203125,
            "text": "ataxia, and confusion",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.40234375,
            "text": "ataxia,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.73828125,
            "text": "neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.73828125,
            "text": ", ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.73828125,
            "text": ", neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.4921875,
            "text": "ataxia, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.73828125,
            "text": ", potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.73828125,
            "text": "potentially fatal, neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.73828125,
            "text": "triad of ocular abnormalities, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.73828125,
            "text": "abnormalities, ataxia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.58203125,
            "text": "neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.58203125,
            "text": ", ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.58203125,
            "text": ", neurologic disorder caused by thiamine deficiency (vitamin B(1)), classically described as presenting with a triad of ocular abnormalities, ataxia, and confusion",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.6328125,
            "text": "neurologic disorder caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.6328125,
            "text": ", neurologic disorder caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -6.6328125,
            "text": "serious, potentially fatal, neurologic disorder caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.6328125,
            "text": "encephalopathy (WE) is a serious, potentially fatal, neurologic disorder caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.6328125,
            "text": ";s encephalopathy (WE) is a serious, potentially fatal, neurologic disorder caused by thiamine",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -6.6328125,
            "text": ", potentially fatal, neurologic disorder caused by thiamine",
            "probability": 0.0
        }
    ],
    "56be143eef6e394741000009_20": [
        {
            "start_logit": 7.81640625,
            "end_logit": 7.72265625,
            "text": "ataxia",
            "probability": 1.0
        },
        {
            "start_logit": -6.609375,
            "end_logit": 7.72265625,
            "text": "and ataxia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -6.94140625,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.171875,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9%) confirms",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.22265625,
            "text": "ataxia)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.3125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.3203125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.72265625,
            "text": "with the Wernicke&apos;s encephalopathy clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.44140625,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.453125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.45703125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.46484375,
            "text": "ataxia) at neurologic onset; nine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.72265625,
            "text": "clinical triad (mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.46875,
            "text": "ataxia) at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.46875,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (41.9%)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.48828125,
            "text": "ataxia) at neurologic onset; nine eventually demonstrated this triad. The high rate of patients diagnosed only at postmortem examination (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.72265625,
            "text": "ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.72265625,
            "text": "mental status changes, ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.72265625,
            "text": ", ocular signs, and ataxia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -6.9375,
            "text": "that Wernicke&apos;s encephalopathy is underdiagnosed in children.",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_1": [
        {
            "start_logit": 7.62109375,
            "end_logit": 8.71875,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 8.71875,
            "text": "6",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -3.74609375,
            "text": "Cdc",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -5.43359375,
            "text": "Cdc6/Cdc18",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.71875,
            "text": "proteins, Cdc6",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 8.71875,
            "text": ", Cdc6",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 8.71875,
            "text": "four proteins, Cdc6",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 8.71875,
            "text": "replication initiation is the assembly of pre-replication complex (pre-RC). Since 1973, four proteins, Cdc6",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -6.1015625,
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -6.171875,
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -6.5234375,
            "text": "Cdc6/Cdc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -6.75,
            "text": "Cdc6/Cdc18, MCM, ORC and Cdt1, have",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -7.02734375,
            "text": "Cdc6/Cdc18, MCM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -5.43359375,
            "text": "6/Cdc18",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -6.1015625,
            "text": "6/Cdc18, MCM, ORC and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -6.171875,
            "text": "6/Cdc18, MCM, ORC and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -6.5234375,
            "text": "6/Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -6.75,
            "text": "6/Cdc18, MCM, ORC and Cdt1, have",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -7.02734375,
            "text": "6/Cdc18, MCM",
            "probability": 0.0
        },
        {
            "start_logit": -6.8828125,
            "end_logit": -3.5,
            "text": ". Recently, a novel pre-RC component called Sap1/Girdin",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_2": [
        {
            "start_logit": 8.0078125,
            "end_logit": 8.0859375,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -2.484375,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -3.26171875,
            "end_logit": 8.0859375,
            "text": "6",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -3.265625,
            "text": "Cdc",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 8.0859375,
            "text": ", Cdc6",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.0859375,
            "text": "Origin Recognition Complex (ORC), Cdc6",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.37890625,
            "text": "Cdc6 and the MCM replicative helicase",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.73046875,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic OR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.796875,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.82421875,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Or",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.86328125,
            "text": "Cdc6 and the MCM replicative helicase in conjunction with Cdt1.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.0859375,
            "text": "ORC), Cdc6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 8.0859375,
            "text": "), Cdc6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.0859375,
            "text": "Complex (ORC), Cdc6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.26171875,
            "end_logit": -2.484375,
            "text": "6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -4.21875,
            "end_logit": -2.484375,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -2.484375,
            "text": ", Cdc6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.546875,
            "end_logit": -2.484375,
            "text": "Origin Recognition Complex (ORC), Cdc6 and the MCM replicative helicase in conjunction with Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -3.265625,
            "text": ", Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -5.546875,
            "end_logit": -3.265625,
            "text": "Origin Recognition Complex (ORC), Cdc",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_3": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.1796875,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": 9.1796875,
            "text": "45",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -1.6572265625,
            "end_logit": 9.1796875,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -1.8505859375,
            "text": "Cdc",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 9.1796875,
            "text": ". Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.73046875,
            "text": "Cdc45)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 9.1796875,
            "text": "and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 9.1796875,
            "text": "sequencing of the Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.84765625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 9.1796875,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.8671875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.921875,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.953125,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.00390625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6572265625,
            "end_logit": -1.8505859375,
            "text": "Cdt1, DDK and Cdc",
            "probability": 0.0
        },
        {
            "start_logit": -1.6572265625,
            "end_logit": -2.462890625,
            "text": "Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -6.73046875,
            "text": "45)",
            "probability": 0.0
        },
        {
            "start_logit": -1.6572265625,
            "end_logit": -6.73046875,
            "text": "Cdt1, DDK and Cdc45)",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -6.84765625,
            "text": "45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC).",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -6.8671875,
            "text": "45) of the eukaryotic cell cycle machinery",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_4": [
        {
            "start_logit": 8.9296875,
            "end_logit": 9.203125,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": -1.4599609375,
            "end_logit": 9.203125,
            "text": "6",
            "probability": 3.0934810638427734e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -1.87109375,
            "text": "Cdc",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.2421875,
            "text": "Cdc6, and Cdt1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 9.203125,
            "text": ", Cdc6",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.58984375,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 9.203125,
            "text": "origin recognition complex (ORC), Cdc6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.734375,
            "text": "Cdc6, and Cdt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.73828125,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 9.203125,
            "text": ", origin recognition complex (ORC), Cdc6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.05859375,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.203125,
            "text": "), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.15234375,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7) complex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.15625,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.1953125,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance (MCM2-7) complex onto DNA.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.203125,
            "text": "formation, origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.26171875,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.28125,
            "text": "Cdc6, and Cdt1 cooperatively load the 6-subunit mini chromosome maintenance",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.203125,
            "text": "During pre-replication complex (pre-RC) formation, origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.31640625,
            "text": "Cdc6, and Cdt1 cooperatively",
            "probability": 5.960464477539063e-08
        }
    ],
    "58dcecf58acda34529000023_5": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.0859375,
            "text": "Cdt1",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.10546875,
            "text": "Cdt",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.9013671875,
            "end_logit": 9.0859375,
            "text": "1",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.83984375,
            "text": "Cdt1 is the major regulator in licensing control for DNA replication",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.0546875,
            "text": "Cdt1 is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.0859375,
            "text": "component Cdt1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34765625,
            "text": "Cdt1 is the major regulator in licensing control for DNA replication.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.37890625,
            "text": "Cdt1 is the major regulator in licensing control",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.44921875,
            "text": "Cdt1 is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5234375,
            "text": "Cdt1 is the major regulator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.55859375,
            "text": "Cdt1 is the major",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.55859375,
            "text": "Cdt1 is the major regulator in licensing control for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5625,
            "text": "Cdt1 is the major regulator in licensing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5625,
            "text": "Cdt1 is the major regulator in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5703125,
            "text": "Cdt1 is the major regulator in licensing control for DNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.0859375,
            "text": ") component Cdt1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.0859375,
            "text": "complex (pre-RC) component Cdt1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.0859375,
            "text": "pre-replication complex (pre-RC) component Cdt1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.0859375,
            "text": "higher eukaryotes, the pre-replication complex (pre-RC) component Cdt1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 9.0859375,
            "text": "-replication complex (pre-RC) component Cdt1",
            "probability": 5.960464477539063e-08
        }
    ],
    "58dcecf58acda34529000023_6": [
        {
            "start_logit": 8.8359375,
            "end_logit": 8.9453125,
            "text": "Cdc45",
            "probability": 1.0
        },
        {
            "start_logit": -1.00390625,
            "end_logit": 8.9453125,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -2.048828125,
            "end_logit": 8.9453125,
            "text": "45",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -2.09375,
            "text": "Cdc",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -6.4375,
            "end_logit": 8.9453125,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -6.5703125,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -6.63671875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 8.9453125,
            "text": ". Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -6.94140625,
            "text": "Cdc45)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.9453125,
            "text": "sequencing of the Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -7.0390625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -7.046875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.9453125,
            "text": "The sequencing of the Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.9453125,
            "text": "apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -7.27734375,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.9453125,
            "text": "key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.9453125,
            "text": "and Cdc45",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.9453125,
            "text": "DDK and Cdc45",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -7.36328125,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.9453125,
            "text": "absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 5.960464477539063e-08
        }
    ],
    "58dcecf58acda34529000023_7": [
        {
            "start_logit": 9.1015625,
            "end_logit": 9.171875,
            "text": "CDC6",
            "probability": 1.0
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 9.171875,
            "text": "6",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.59765625,
            "text": "CDC",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.578125,
            "text": "CDC6, CDT1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 9.171875,
            "text": ", CDC6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.95703125,
            "text": "CDC6, CDT1, and MCM2-7",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.15234375,
            "text": "CDC6, CDT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.234375,
            "text": "CDC6, CDT1, and MCM",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.2421875,
            "text": "CDC6, CDT1, and MCM2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.42578125,
            "text": "CDC6, CDT1, and MCM2-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.171875,
            "text": "mRNA expression of the components of pre-replication complex (Pre-RC), CDC6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.171875,
            "text": "the mRNA expression of the components of pre-replication complex (Pre-RC), CDC6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.171875,
            "text": "complex (Pre-RC), CDC6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.546875,
            "text": "CDC6, CDT1, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.171875,
            "text": "examined the mRNA expression of the components of pre-replication complex (Pre-RC), CDC6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.171875,
            "text": "We examined the mRNA expression of the components of pre-replication complex (Pre-RC), CDC6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.61328125,
            "text": "CDC6, CDT1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -6.578125,
            "text": "6, CDT1",
            "probability": 0.0
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -1.59765625,
            "text": ", CDC",
            "probability": 0.0
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -6.95703125,
            "text": "6, CDT1, and MCM2-7",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_8": [
        {
            "start_logit": 8.7890625,
            "end_logit": 8.96875,
            "text": "Cdc45",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.330078125,
            "end_logit": 8.96875,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0005793571472167969
        },
        {
            "start_logit": -2.025390625,
            "end_logit": 8.96875,
            "text": "45",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.166015625,
            "text": "Cdc",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 8.96875,
            "text": "Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.330078125,
            "end_logit": 1.115234375,
            "text": "Cdt1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.54296875,
            "text": "Cdc45) of the eukaryotic cell cycle",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.66796875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 8.96875,
            "text": ". Cdt1, DDK and Cdc45",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.91796875,
            "text": "Cdc45)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.94921875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 8.96875,
            "text": "sequencing of the Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.0390625,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.1171875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication complex (pre-RC).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.96875,
            "text": "The sequencing of the Plasmodium genome has also revealed the apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.96875,
            "text": "apparent absence of many key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.96875,
            "text": "and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.96875,
            "text": "key components (e.g. Cdt1, DDK and Cdc45",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.96875,
            "text": "DDK and Cdc45",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -7.296875,
            "text": "Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 5.960464477539063e-08
        }
    ],
    "58dcecf58acda34529000023_9": [
        {
            "start_logit": 8.96875,
            "end_logit": 8.9609375,
            "text": "Cdt1",
            "probability": 1.0
        },
        {
            "start_logit": 8.96875,
            "end_logit": -0.18603515625,
            "text": "Cdt1, DDK and Cdc45",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 8.96875,
            "end_logit": -1.7841796875,
            "text": "Cdt",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -2.115234375,
            "end_logit": 8.9609375,
            "text": "1",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 8.96875,
            "end_logit": -6.80078125,
            "text": "Cdt1, DDK",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -6.8203125,
            "text": "Cdt1, DDK and Cdc45)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.0234375,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that are responsible for the formation of the pre-replication",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.18359375,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.1875,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.24609375,
            "text": "Cdt1, DD",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.34375,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.41796875,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that are responsible",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.44921875,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.4921875,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that are responsible for the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.50390625,
            "text": "Cdt1, DDK and Cdc45) of the eukaryotic cell cycle machinery that are responsible for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.54296875,
            "text": "Cdt1, DDK and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2861328125,
            "end_logit": -0.18603515625,
            "text": "Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -2.115234375,
            "end_logit": -0.18603515625,
            "text": "1, DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -6.83203125,
            "end_logit": -0.18603515625,
            "text": "DDK and Cdc45",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -0.18603515625,
            "text": ", DDK and Cdc45",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_10": [
        {
            "start_logit": 7.109375,
            "end_logit": 8.671875,
            "text": "MCM2-7",
            "probability": 1.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 8.671875,
            "text": "7",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 7.109375,
            "end_logit": -4.02734375,
            "text": "MCM",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.046875,
            "end_logit": 8.671875,
            "text": "2-7",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.6875,
            "text": "MCM2-7 is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 8.671875,
            "text": "-7",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.84375,
            "text": "MCM2-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -6.1953125,
            "text": "MCM2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.328125,
            "text": "MCM2-7 is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.484375,
            "text": "MCM2-7 is a key component of the prereplicative",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.5078125,
            "text": "MCM2-7 is a key component of the prereplicative complex (pre-RC), which is loaded onto chromatin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.5546875,
            "text": "MCM2-7 is a key component",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.58984375,
            "text": "MCM2-7 is a key component of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.44921875,
            "end_logit": -2.998046875,
            "text": "Cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -5.6875,
            "text": "7 is",
            "probability": 0.0
        },
        {
            "start_logit": -3.44921875,
            "end_logit": -5.76171875,
            "text": "Cdc6, and Cdt1",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -7.328125,
            "text": "7 is a",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -7.484375,
            "text": "7 is a key component of the prereplicative",
            "probability": 0.0
        },
        {
            "start_logit": -3.44921875,
            "end_logit": -6.43359375,
            "text": "Cdc6, and Cdt",
            "probability": 0.0
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -7.5078125,
            "text": "7 is a key component of the prereplicative complex (pre-RC), which is loaded onto chromatin",
            "probability": 0.0
        }
    ],
    "58dcecf58acda34529000023_11": [
        {
            "start_logit": 9.03125,
            "end_logit": 9.3125,
            "text": "Cdc6",
            "probability": 1.0
        },
        {
            "start_logit": -1.2275390625,
            "end_logit": 9.3125,
            "text": "6",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 9.03125,
            "end_logit": -1.7001953125,
            "text": "Cdc",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.0859375,
            "text": "Cdc6, Cdt1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 9.3125,
            "text": ", Cdc6",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.3359375,
            "text": "Cdc6, Cdt1, and the Mcm2-7 complex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.5078125,
            "text": "Cdc6, Cdt1, and the Mcm2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.64453125,
            "text": "Cdc6, Cdt1, and the Mcm2-7",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.3125,
            "text": "origin recognition complex (ORC), Cdc6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.3125,
            "text": "origins of replication through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.921875,
            "text": "Cdc6, Cdt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.94921875,
            "text": "Cdc6, Cdt1, and the Mcm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.3125,
            "text": "action of the origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -7.0546875,
            "text": "Cdc6, Cdt1, and the Mcm2-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -7.125,
            "text": "Cdc6, Cdt1, and the Mcm2-7 complex.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.3125,
            "text": "at all potential origins of replication through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.3125,
            "text": "through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3125,
            "text": "potential origins of replication through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.3125,
            "text": "formed at all potential origins of replication through the action of the origin recognition complex (ORC), Cdc6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -7.52734375,
            "text": "Cdc6, Cdt1, and",
            "probability": 5.960464477539063e-08
        }
    ],
    "58dd07488acda34529000025_1": [
        {
            "start_logit": 8.1875,
            "end_logit": 7.26953125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -3.212890625,
            "text": "thrombocytopenia, fever",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.5390625,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.0546875,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.1640625,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopidine",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.375,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4140625,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlopi",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.484375,
            "text": "thrombocytopenia, fever, renal failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.49609375,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking ticlo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.546875,
            "text": "thrombocytopenia, fever, renal failure and hemolytic anemia in a patient taking tic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.26953125,
            "text": ", thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 7.26953125,
            "text": "combination of neurological symptoms, thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.26953125,
            "text": "neurological symptoms, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.26953125,
            "text": "The combination of neurological symptoms, thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.26953125,
            "text": "symptoms, thrombocytopenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.279296875,
            "end_logit": -3.212890625,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.279296875,
            "end_logit": -6.5390625,
            "text": "fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": -3.212890625,
            "text": ", fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -3.212890625,
            "text": ", thrombocytopenia, fever",
            "probability": 0.0
        },
        {
            "start_logit": -3.279296875,
            "end_logit": -7.0546875,
            "text": "fever, renal failure and hemolytic anemia in a patient taking ticlopidine points to a diagnosis of TTP.",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_2": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.7109375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.9384765625,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a patient after abdominal surgery",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.625,
            "text": "thrombocytopenia, haemolysis, fever",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.76953125,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.07421875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a patient after abdominal surgery.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.15234375,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.24609375,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a patient after abdominal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.296875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.3515625,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.390625,
            "text": "thrombocytopenia, haemolysis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.4140625,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.4296875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.7109375,
            "text": "like thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.4765625,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.51171875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.53125,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.5546875,
            "text": "thrombocytopenia, haemolysis, fever, coma and renal failure, signs of a beginning DIC could be seen in a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.58984375,
            "text": "thrombocytopenia, haemolysis, fever, coma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.7109375,
            "text": "In addition to the typical manifestations of thrombotic-thrombocytopenic purpura like thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.7109375,
            "text": "manifestations of thrombotic-thrombocytopenic purpura like thrombocytopenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58dd07488acda34529000025_3": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.671875,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.99609375,
            "text": "thrombocytopenia, neurologic symptoms and renal disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.3125,
            "text": "thrombocytopenia, neurologic symptoms and renal disease.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.3203125,
            "text": "thrombocytopenia, neurologic symptoms and renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.671875,
            "text": ". This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.421875,
            "text": "thrombocytopenia, neurologic symptoms",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.5546875,
            "text": "thrombocytopenia, neurologic symptoms and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.671875,
            "text": "microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.671875,
            "text": "with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.671875,
            "text": "hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.671875,
            "text": "poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.671875,
            "text": "rare disorder with a poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.671875,
            "text": "characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.671875,
            "text": "a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.671875,
            "text": "syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.671875,
            "text": "by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.671875,
            "text": "This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.671875,
            "text": "syndrome or thrombotic thrombocytopenic purpura is a rare disorder with a poor prognosis. This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -6.99609375,
            "text": ". This syndrome is characterized by a microangiopathic hemolytic anemia with thrombocytopenia, neurologic symptoms and renal disease",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -7.11328125,
            "text": ". This syndrome is characterized by a microangiopathic hemolytic anemia",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_4": [
        {
            "start_logit": 8.078125,
            "end_logit": 7.5234375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.078125,
            "end_logit": -6.77734375,
            "text": "thrombocytopenia, neurological symptoms and renal",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -6.8671875,
            "text": "thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.2109375,
            "text": "thrombocytopenia, neurological symptoms and renal involvement.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.22265625,
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.5234375,
            "text": ". It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.5234375,
            "text": "haemolytic anaemia associated with thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.5234375,
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.5234375,
            "text": "with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.5234375,
            "text": "a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.5234375,
            "text": "rare condition with poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.5234375,
            "text": "by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.5234375,
            "text": "poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5234375,
            "text": "opathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5234375,
            "text": "syndrome is a rare condition with poor prognosis. It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -6.4140625,
            "text": ". It is characterized by a microangiopathic haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -6.4140625,
            "text": "haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -6.4140625,
            "text": "microangiopathic haemolytic anaemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -6.77734375,
            "text": ". It is characterized by a microangiopathic haemolytic anaemia associated with thrombocytopenia, neurological symptoms and renal",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -6.77734375,
            "text": "haemolytic anaemia associated with thrombocytopenia, neurological symptoms and renal",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_5": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.42578125,
            "text": "thrombocytopenia",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.03125,
            "end_logit": 0.466552734375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0009546279907226562
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.1875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.20703125,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.21875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.453125,
            "text": "thrombocytopenia, Coombs-negative",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.48046875,
            "text": "thrombocytopenia, Coombs",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.54296875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.56640625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5859375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.42578125,
            "text": "with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.42578125,
            "text": "clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.42578125,
            "text": "is a clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.671875,
            "end_logit": 0.466552734375,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 0.466552734375,
            "text": "Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": 0.466552734375,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 0.466552734375,
            "text": "with thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": 0.466552734375,
            "text": "clinically heterogeneous syndrome associated with thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 0.466552734375,
            "text": "ombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 0.466552734375,
            "text": ", Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_6": [
        {
            "start_logit": 7.97265625,
            "end_logit": 7.47265625,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -2.07421875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.2890625,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.29296875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.49609375,
            "text": "thrombocytopenia, Coombs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.5,
            "text": "thrombocytopenia, Coombs-negative",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.546875,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.58984375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.59375,
            "text": "thrombocytopenia, Coombs-negative hemolytic anemia, neurologic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.47265625,
            "text": "clinically heterogeneous syndrome associated with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.47265625,
            "text": "with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": -2.07421875,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -2.07421875,
            "text": "Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -2.07421875,
            "text": "clinically heterogeneous syndrome associated with thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -2.07421875,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -2.07421875,
            "text": "with thrombocytopenia, Coombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -2.07421875,
            "text": "ombs-negative hemolytic anemia, neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -2.07421875,
            "text": ", neurologic changes, renal impairment, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -7.2890625,
            "text": "Coombs-negative hemolytic anemia, neurologic changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -7.29296875,
            "text": "Coombs-negative hemolytic anemia",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_7": [
        {
            "start_logit": -3.703125,
            "end_logit": 0.307861328125,
            "text": "brain",
            "probability": 0.362060546875
        },
        {
            "start_logit": -3.775390625,
            "end_logit": 0.307861328125,
            "text": "thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.3369140625
        },
        {
            "start_logit": -4.87109375,
            "end_logit": 0.307861328125,
            "text": "ischemic dysfunction of various organs including the brain",
            "probability": 0.11260986328125
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 0.307861328125,
            "text": "microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.061492919921875
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 0.307861328125,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.05865478515625
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 0.307861328125,
            "text": "by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.01415252685546875
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 0.307861328125,
            "text": "to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.01019287109375
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 0.307861328125,
            "text": "various organs including the brain",
            "probability": 0.00888824462890625
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 0.307861328125,
            "text": "characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs including the brain",
            "probability": 0.00848388671875
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -3.40625,
            "text": "thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction",
            "probability": 0.0082244873046875
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -3.935546875,
            "text": "thrombotic microangiopathy",
            "probability": 0.004833221435546875
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -4.171875,
            "text": "thrombotic microangiopathy leading to microvascular occlusion",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": -4.87109375,
            "end_logit": -3.40625,
            "text": "ischemic dysfunction",
            "probability": 0.0027313232421875
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -5.0546875,
            "text": "thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction of various organs",
            "probability": 0.0015811920166015625
        },
        {
            "start_logit": -5.4765625,
            "end_logit": -3.40625,
            "text": "microvascular occlusion and ischemic dysfunction",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -3.40625,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion and ischemic dysfunction",
            "probability": 0.0014286041259765625
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -3.935546875,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy",
            "probability": 0.0008397102355957031
        },
        {
            "start_logit": -5.4765625,
            "end_logit": -4.171875,
            "text": "microvascular occlusion",
            "probability": 0.0006961822509765625
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -4.171875,
            "text": "TTP, Moschcowitz disease) is characterized by thrombotic microangiopathy leading to microvascular occlusion",
            "probability": 0.0006642341613769531
        },
        {
            "start_logit": -4.87109375,
            "end_logit": -5.0546875,
            "text": "ischemic dysfunction of various organs",
            "probability": 0.0005297660827636719
        }
    ],
    "58dd07488acda34529000025_8": [
        {
            "start_logit": 7.8984375,
            "end_logit": 7.7734375,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -5.78125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.20703125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.7734375,
            "text": "with thrombocytopenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.4453125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.44921875,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.48046875,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.515625,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.57421875,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.640625,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.64453125,
            "text": "thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.7734375,
            "text": "disorder presenting with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.7734375,
            "text": "protease (ADAMTS-13) activity (<5% of normal) is specific for classical thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.7734375,
            "text": "(ADAMTS-13) activity (<5% of normal) is specific for classical thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.7734375,
            "text": "<5% of normal) is specific for classical thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.7734375,
            "text": ", a disorder presenting with thrombocytopenia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -5.78125,
            "text": "with thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -5.78125,
            "text": "disorder presenting with thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -5.78125,
            "text": "with organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -5.78125,
            "text": "organ dysfunction such as neurological symptoms, renal failure, and fever",
            "probability": 0.0
        }
    ],
    "58dd07488acda34529000025_9": [
        {
            "start_logit": 7.80859375,
            "end_logit": 7.5703125,
            "text": "thrombocytopenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -0.84033203125,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.2890625,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.3984375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.4609375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.46484375,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.5,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.6640625,
            "text": "thrombocytopenia, microangiopathic hemolytic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.66796875,
            "text": "thrombocytopenia, microangiopathic hemolytic anemia, neurologic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.5703125,
            "text": "of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.5703125,
            "text": "syndrome that occurs mainly in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.5703125,
            "text": "with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.5703125,
            "text": "in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.33203125,
            "end_logit": -0.84033203125,
            "text": "fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -0.84033203125,
            "text": "and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -0.84033203125,
            "text": "of thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -0.84033203125,
            "text": ", neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -0.84033203125,
            "text": "syndrome that occurs mainly in adults with multiorgan microvascular thrombosis consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.84033203125,
            "text": "neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -0.84033203125,
            "text": "with multiorgan microvascular thrombosis consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal involvement, and fever",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_1": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.21875,
            "text": "rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.125,
            "text": "ro",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": 9.21875,
            "text": "ib",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -5.4375,
            "end_logit": 9.21875,
            "text": "fecoxib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 9.21875,
            "text": "coxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.8046875,
            "text": "rofecox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.21875,
            "text": "xib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.0546875,
            "text": "rofeco",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.38671875,
            "text": "rofecoxib was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.453125,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.453125,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.46484375,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.4765625,
            "text": "rofecoxib was voluntarily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.53125,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib was also",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.53515625,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdeco",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.57421875,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valdecoxib was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.60546875,
            "text": "rofecoxib was voluntarily removed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.609375,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, val",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.61328125,
            "text": "rofecoxib was voluntarily removed from the market for increased cardiovascular risk and in April 2005, valde",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.61328125,
            "text": "rofecoxib was volunt",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a326da60087bc10a00000e_2": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.40625,
            "text": "clobutinol",
            "probability": 1.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": 9.40625,
            "text": "inol",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0986328125,
            "text": "clo",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 9.40625,
            "text": "butinol",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.40625,
            "text": ", clobutinol",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.8046875,
            "text": "clobutinol, was recently withdrawn from the market due to its potential to induce cardiac arrhythmias",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 9.40625,
            "text": "non-opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.40625,
            "text": "antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.40625,
            "text": "opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.40625,
            "text": "over-the-counter (OTC) non-opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.29296875,
            "text": "clobutinol, was recently withdrawn from the market due to its potential to induce cardiac arrhythmias by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.40625,
            "text": "common over-the-counter (OTC) non-opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.40625,
            "text": "drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.40625,
            "text": "OTC) non-opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.35546875,
            "text": "clobutinol, was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.40625,
            "text": "clobutinol,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.4296875,
            "text": "clobutinol, was recently withdrawn from the market due to its potential to induce cardiac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.4453125,
            "text": "clobutinol, was recently withdrawn from the market due to its potential to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.40625,
            "text": "counter (OTC) non-opioid antitussive drug, clobutinol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.48828125,
            "text": "clobutinol, was recently withdrawn from the market due to its potential to induce",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a326da60087bc10a00000e_3": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.296875,
            "text": "orlistat",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3173828125,
            "text": "or",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.423828125,
            "end_logit": 9.296875,
            "text": "at",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -3.8125,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -5.859375,
            "end_logit": 9.296875,
            "text": "listat",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3515625,
            "text": "orlistat (Europe; USA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.40625,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.42578125,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine having",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.45703125,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.296875,
            "text": "writing orlistat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5,
            "text": "orlistat (Europe; USA) remains",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.55859375,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine having recently been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5625,
            "text": "orlistat (Europe; USA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.296875,
            "text": ". However, despite this, at the time of writing orlistat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.56640625,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine having recently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.58203125,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.296875,
            "text": ", despite this, at the time of writing orlistat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.59375,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.59375,
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.423828125,
            "end_logit": -3.8125,
            "text": "at (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_4": [
        {
            "start_logit": 7.65234375,
            "end_logit": 7.94140625,
            "text": "Diclofenac",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 0.50244140625,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0005884170532226562
        },
        {
            "start_logit": 1.1484375,
            "end_logit": 0.50244140625,
            "text": "rofecoxib",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -6.72265625,
            "text": "Diclofenac has a risk very similar to rofecox",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.20703125,
            "text": "Diclofenac has a risk very similar to rofeco",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.21875,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.23828125,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.25390625,
            "text": "Diclofenac has a risk very",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.30859375,
            "text": "Diclofenac has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.3828125,
            "text": "Diclofenac has a risk very similar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.41015625,
            "text": "Diclofenac has a risk very similar to rofecoxib,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4921875,
            "text": "Diclofenac has a risk",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.49609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.5078125,
            "text": "Diclofenac has a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -6.72265625,
            "text": "rofecox",
            "probability": 0.0
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 0.50244140625,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.20703125,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.21875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.23828125,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_5": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.34375,
            "text": "Sibutramine",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1455078125,
            "text": "Sib",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -1.3173828125,
            "end_logit": 9.34375,
            "text": "amine",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": -5.5703125,
            "end_logit": 9.34375,
            "text": "utramine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.42578125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.46484375,
            "text": "Sibutramine was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.484375,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.52734375,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.54296875,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and it was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.55078125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.56640625,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.56640625,
            "text": "Sibutramine was associated with an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.578125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.578125,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and it was withdrawn",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.58984375,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.609375,
            "text": "Sibutramine was associated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.62109375,
            "text": "Sibutramine was associated with an increase in major adverse cardiovascular events in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3173828125,
            "end_logit": -7.42578125,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3173828125,
            "end_logit": -7.46484375,
            "text": "amine was",
            "probability": 0.0
        },
        {
            "start_logit": -1.3173828125,
            "end_logit": -7.484375,
            "text": "amine was associated with an increase in major adverse cardiovascular events in the Sibutramine Cardiovascular Outcomes (SCOUT) trial and",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_6": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3515625,
            "text": "aprotinin",
            "probability": 1.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 9.3515625,
            "text": "in",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.220703125,
            "text": "apr",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.3515625,
            "text": "otinin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.3515625,
            "text": ", aprotinin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.3515625,
            "text": "safety of the most popular agent, aprotinin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -6.73828125,
            "text": "in, has been challenged, and it was withdrawn from world markets in May 2008 because of concerns that it increased the risk of cardiovascular complications and death.",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -1.220703125,
            "text": ", apr",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.220703125,
            "text": "safety of the most popular agent, apr",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.19140625,
            "text": "MEDLINE",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.60546875,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.73828125,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid SP) 1980 to July 2010.",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.171875,
            "text": "MEDLINE (Ovid SP) 1950",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.1796875,
            "text": "MEDLINE (Ovid",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.24609375,
            "text": "MEDLINE (",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.28125,
            "text": "MEDLINE (Ovid SP)",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.28515625,
            "text": "MEDLINE (Ovid SP) 1950 to",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.2890625,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.296875,
            "text": "MEDLINE (Ovid SP",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.30859375,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid SP) 1980 to",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_7": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3515625,
            "text": "aprotinin",
            "probability": 1.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 9.3515625,
            "text": "in",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.220703125,
            "text": "apr",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.3515625,
            "text": "otinin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.3515625,
            "text": ", aprotinin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.3515625,
            "text": "safety of the most popular agent, aprotinin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -6.73828125,
            "text": "in, has been challenged, and it was withdrawn from world markets in May 2008 because of concerns that it increased the risk of cardiovascular complications and death.",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -1.220703125,
            "text": ", apr",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.220703125,
            "text": "safety of the most popular agent, apr",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.19140625,
            "text": "MEDLINE",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.60546875,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.73828125,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid SP) 1980 to July 2010.",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.171875,
            "text": "MEDLINE (Ovid SP) 1950",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.1796875,
            "text": "MEDLINE (Ovid",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.24609375,
            "text": "MEDLINE (",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.28125,
            "text": "MEDLINE (Ovid SP)",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.28515625,
            "text": "MEDLINE (Ovid SP) 1950 to",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.2890625,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.296875,
            "text": "MEDLINE (Ovid SP",
            "probability": 0.0
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.30859375,
            "text": "MEDLINE (Ovid SP) 1950 to July 2010, EMBASE (Ovid SP) 1980 to",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_8": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.234375,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.39453125,
            "text": "Ro",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": 9.234375,
            "text": "ib",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 9.234375,
            "text": "fecoxib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.58203125,
            "text": "Rofecox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.9140625,
            "text": "Rofecoxib and valdecoxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.9453125,
            "text": "Rofeco",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.234375,
            "text": "coxib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1953125,
            "text": "Rofecoxib and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.2890625,
            "text": "Rofecoxib and val",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 9.234375,
            "text": "xib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.34375,
            "text": "Rofecoxib and valdecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.35546875,
            "text": "Rofecoxib and valdecoxib have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.38671875,
            "text": "Rofecoxib and valdeco",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -6.80078125,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumiraco",
            "probability": 0.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -6.9140625,
            "text": "ib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -7.046875,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumira",
            "probability": 0.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -7.15625,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lum",
            "probability": 0.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -7.1953125,
            "text": "ib and",
            "probability": 0.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -7.2890625,
            "text": "ib and val",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_9": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.2265625,
            "text": "Sibutramine",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.2421875,
            "end_logit": 1.828125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.30078125,
            "text": "Sib",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.599609375,
            "end_logit": 9.2265625,
            "text": "amine",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 3.09765625,
            "end_logit": 1.828125,
            "text": "sibutramine",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 9.2265625,
            "text": "utramine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.06640625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1015625,
            "text": "Sibutramine Cardiovascular OUTcomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.13671875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.39453125,
            "text": "Sibutramine Cardiovascular OUTcomes)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.41796875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.46484375,
            "text": "Sibutramine Cardiovascular OUTcomes) study",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.484375,
            "text": "Sibutramine Cardiovascular",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.51953125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.2265625,
            "text": "(Sibutramine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.599609375,
            "end_logit": 1.828125,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 1.828125,
            "text": "utramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": 3.09765625,
            "end_logit": -7.06640625,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": 3.09765625,
            "end_logit": -7.13671875,
            "text": "sib",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_10": [
        {
            "start_logit": 7.65234375,
            "end_logit": 7.94140625,
            "text": "Diclofenac",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 0.50244140625,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0005884170532226562
        },
        {
            "start_logit": 1.1484375,
            "end_logit": 0.50244140625,
            "text": "rofecoxib",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -6.72265625,
            "text": "Diclofenac has a risk very similar to rofecox",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.20703125,
            "text": "Diclofenac has a risk very similar to rofeco",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.21875,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.23828125,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.25390625,
            "text": "Diclofenac has a risk very",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.30859375,
            "text": "Diclofenac has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.3828125,
            "text": "Diclofenac has a risk very similar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.41015625,
            "text": "Diclofenac has a risk very similar to rofecoxib,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4921875,
            "text": "Diclofenac has a risk",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.49609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.5078125,
            "text": "Diclofenac has a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -6.72265625,
            "text": "rofecox",
            "probability": 0.0
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 0.50244140625,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.20703125,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.21875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.23828125,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_11": [
        {
            "start_logit": 9.25,
            "end_logit": 9.2734375,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.2685546875,
            "text": "Ro",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": 9.2734375,
            "text": "ib",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -6.015625,
            "end_logit": 9.2734375,
            "text": "fecoxib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.57421875,
            "text": "Rofecox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.921875,
            "text": "Rofecoxib and valdecoxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.9296875,
            "text": "Rofeco",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 9.2734375,
            "text": "coxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.2734375,
            "text": "xib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.234375,
            "text": "Rofecoxib and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.2890625,
            "text": "Rofecoxib and val",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.32421875,
            "text": "Rofecoxib and valdecox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.35546875,
            "text": "Rofecoxib and valdecoxib have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.3828125,
            "text": "Rofecoxib and valdeco",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -6.70703125,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumiraco",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -6.921875,
            "text": "ib and valdecoxib",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -7.015625,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lumira",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -7.1171875,
            "text": "ib and valdecoxib have been withdrawn from the market worldwide due to safety concerns (most importantly for cardiovascular adverse events) and lum",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -7.234375,
            "text": "ib and",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -7.2890625,
            "text": "ib and val",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_12": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.25,
            "text": "Sertindole",
            "probability": 1.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": 9.25,
            "text": "indole",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.60546875,
            "text": "Sert",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.296875,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.3203125,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.3203125,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.484375,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.5,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.55078125,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.57421875,
            "text": "Sertindole , first withdrawn from the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.578125,
            "text": "Sertindole ,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.6015625,
            "text": "Sertindole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.296875,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries.",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.3203125,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available in many countries",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.3203125,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.484375,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns,",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.5,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.55078125,
            "text": "indole , first withdrawn from the market for cardiovascular safety concerns, is currently available in",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.57421875,
            "text": "indole , first withdrawn from the",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.578125,
            "text": "indole ,",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_13": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.28125,
            "text": "Sibutramine",
            "probability": 0.89208984375
        },
        {
            "start_logit": 9.2890625,
            "end_logit": 6.7734375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0732421875
        },
        {
            "start_logit": 8.53125,
            "end_logit": 6.7734375,
            "text": "sibutramine",
            "probability": 0.034332275390625
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.150390625,
            "text": "Sib",
            "probability": 2.658367156982422e-05
        },
        {
            "start_logit": -1.4296875,
            "end_logit": 9.28125,
            "text": "amine",
            "probability": 1.990795135498047e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -2.517578125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.517578125,
            "text": "sib",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -1.4296875,
            "end_logit": 6.7734375,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 9.28125,
            "text": "utramine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.9453125,
            "text": "Sibutramine Cardiovascular OUTcomes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.11328125,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 6.7734375,
            "text": "amine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.9140625,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and was consequently withdrawn from the market.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.11328125,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 6.7734375,
            "text": "utramine",
            "probability": 0.0
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 6.7734375,
            "text": "utramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -2.517578125,
            "text": "amine Cardiovascular OUTcomes) study, sib",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -6.9453125,
            "text": "amine Cardiovascular OUTcomes",
            "probability": 0.0
        },
        {
            "start_logit": -6.00390625,
            "end_logit": -2.517578125,
            "text": "utramine Cardiovascular OUTcomes) study, sib",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -7.11328125,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_14": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.1875,
            "text": "rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": -0.389404296875,
            "end_logit": 9.1875,
            "text": "NSAIDs) (e.g., rofecoxib",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.5712890625,
            "end_logit": 9.1875,
            "text": "ib",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.5556640625,
            "text": "ro",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 9.1875,
            "text": "non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 9.1875,
            "text": "fecoxib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.359375,
            "end_logit": 9.1875,
            "text": ", rofecoxib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.85546875,
            "text": "rofeco",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.9140625,
            "text": "rofecox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 9.1875,
            "text": "Certain non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 9.1875,
            "text": "., rofecoxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.1875,
            "text": "coxib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.1484375,
            "text": "rofecoxib [Vioxx",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.1875,
            "text": "drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.1875,
            "text": "xib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.1875,
            "text": "inflammatory drugs (NSAIDs) (e.g., rofecoxib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.328125,
            "text": "rofecoxib [Vioxx])",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.38671875,
            "text": "rofecoxib [Vioxx]) increase the risk of heart attack and stroke",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.390625,
            "text": "rofecoxib [Viox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.1875,
            "text": "e.g., rofecoxib",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a326da60087bc10a00000e_15": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.296875,
            "text": "Sibutramine",
            "probability": 0.986328125
        },
        {
            "start_logit": 9.2734375,
            "end_logit": 4.91015625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 0.012420654296875
        },
        {
            "start_logit": 6.8828125,
            "end_logit": 4.91015625,
            "text": "sibutramine",
            "probability": 0.0011377334594726562
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.2314453125,
            "text": "Sib",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 9.296875,
            "text": "amine",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -4.6640625,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sib",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.734375,
            "end_logit": 9.296875,
            "text": "utramine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 4.91015625,
            "text": "amine Cardiovascular OUTcomes) study, sibutramine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -6.87109375,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.00390625,
            "text": "Sibutramine Cardiovascular OUTcomes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -4.6640625,
            "text": "sib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.25,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.3828125,
            "text": "Sibutramine Cardiovascular OUTcomes)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.45703125,
            "text": "Sibutramine Cardiovascular OUTcomes) study",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.46484375,
            "text": "Sibutramine Cardiovascular",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.48046875,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.5,
            "text": "Sibutramine Cardiovascular OUTcomes) study, sibutramine increased serious cardiovascular events, such as stroke or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.296875,
            "text": "(Sibutramine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -6.87109375,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction",
            "probability": 0.0
        },
        {
            "start_logit": 6.8828125,
            "end_logit": -6.9921875,
            "text": "sibutramine increased serious cardiovascular events, such as stroke or myocardial infarction, compared with placebo, and was consequently withdrawn from the market.",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_16": [
        {
            "start_logit": 7.65234375,
            "end_logit": 7.94140625,
            "text": "Diclofenac",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 0.50244140625,
            "text": "Diclofenac has a risk very similar to rofecoxib",
            "probability": 0.0005884170532226562
        },
        {
            "start_logit": 1.1484375,
            "end_logit": 0.50244140625,
            "text": "rofecoxib",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -6.72265625,
            "text": "Diclofenac has a risk very similar to rofecox",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.20703125,
            "text": "Diclofenac has a risk very similar to rofeco",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.21875,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.23828125,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.25390625,
            "text": "Diclofenac has a risk very",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.30859375,
            "text": "Diclofenac has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.3828125,
            "text": "Diclofenac has a risk very similar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.41015625,
            "text": "Diclofenac has a risk very similar to rofecoxib,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.4921875,
            "text": "Diclofenac has a risk",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.49609375,
            "text": "Diclofenac has a risk very similar to rofecoxib, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -7.5078125,
            "text": "Diclofenac has a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -6.72265625,
            "text": "rofecox",
            "probability": 0.0
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 0.50244140625,
            "text": "fecoxib",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.20703125,
            "text": "rofeco",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.21875,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity",
            "probability": 0.0
        },
        {
            "start_logit": 1.1484375,
            "end_logit": -7.23828125,
            "text": "rofecoxib, which was withdrawn from worldwide markets owing to cardiovascular toxicity.",
            "probability": 0.0
        }
    ],
    "58a326da60087bc10a00000e_17": [
        {
            "start_logit": 9.3359375,
            "end_logit": 9.328125,
            "text": "Rofecoxib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -1.03125,
            "text": "Ro",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": 9.328125,
            "text": "ib",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 9.328125,
            "text": "fecoxib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 9.328125,
            "text": "coxib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.328125,
            "text": "xib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.875,
            "text": "Rofecox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.89453125,
            "text": "Rofeco",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.3359375,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.34765625,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.45703125,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.49609375,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.51953125,
            "text": "Rofecoxib, a selective cyclo-oxygenase (COX)-2 inhibitor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.3359375,
            "text": "ib, a selective cyclo-oxygenase (COX)-2 inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.34765625,
            "text": "ib, a selective cyclo-oxygenase (COX)-2",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.45703125,
            "text": "ib, a selective cyclo-oxygenase (COX",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.49609375,
            "text": "ib, a selective cyclo-oxygenase (COX)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.51953125,
            "text": "ib, a selective cyclo-oxygenase (COX)-2 inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -6.875,
            "text": "fecox",
            "probability": 0.0
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -6.89453125,
            "text": "feco",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_1": [
        {
            "start_logit": 6.58984375,
            "end_logit": 6.03125,
            "text": "neonatal intrahepatic cholestasis",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.58984375,
            "end_logit": 0.117919921875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema",
            "probability": 0.0026836395263671875
        },
        {
            "start_logit": -3.556640625,
            "end_logit": 6.03125,
            "text": "lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis",
            "probability": 3.904104232788086e-05
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -4.4921875,
            "text": "neonatal",
            "probability": 2.664327621459961e-05
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 6.03125,
            "text": "cholestasis",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -5.95703125,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the lower extremities",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -6.125,
            "end_logit": 6.03125,
            "text": "intrahepatic cholestasis",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -0.54736328125,
            "end_logit": 0.117919921875,
            "text": "lymphoedema",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.0625,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.234375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lympho",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.25,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the lower extremities.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.25,
            "text": "neonatal intrahepatic",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 6.03125,
            "text": "by neonatal intrahepatic cholestasis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.41796875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.4921875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.49609375,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.5078125,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema,",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.03125,
            "text": "called lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.03125,
            "text": "characterized by neonatal intrahepatic cholestasis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 6.03125,
            "text": ", also called lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis",
            "probability": 7.152557373046875e-07
        }
    ],
    "5895f9cf78275d0c4a000002_2": [
        {
            "start_logit": 4.38671875,
            "end_logit": 6.796875,
            "text": "lymphedema",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.705078125,
            "end_logit": 6.796875,
            "text": "chronic lymphedema",
            "probability": 0.0022525787353515625
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 6.796875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 6.796875,
            "text": "severe chronic lymphedema",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 6.796875,
            "text": ") severe chronic lymphedema",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 6.796875,
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 6.796875,
            "text": "1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 6.796875,
            "text": ") neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.796875,
            "text": "2) severe chronic lymphedema",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.796875,
            "text": "and 2) severe chronic lymphedema",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.796875,
            "text": "with age, and 2) severe chronic lymphedema",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.796875,
            "text": "rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.796875,
            "text": ", characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.28515625,
            "text": "lymphedema, mainly lower limb",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.6484375,
            "text": "lymphedema, mainly lower",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.66015625,
            "text": "lymphedema,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.12109375,
            "end_logit": -3.06640625,
            "text": "Lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.28515625,
            "text": "chronic lymphedema, mainly lower limb",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.47265625,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.6484375,
            "text": "chronic lymphedema, mainly lower",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_3": [
        {
            "start_logit": 8.6640625,
            "end_logit": 8.78125,
            "text": "lymphoedema",
            "probability": 0.9970703125
        },
        {
            "start_logit": 8.6640625,
            "end_logit": 2.986328125,
            "text": "lymphoedema cholestasis",
            "probability": 0.0030517578125
        },
        {
            "start_logit": -2.23828125,
            "end_logit": 8.78125,
            "text": "edema",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -2.296875,
            "text": "lympho",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": -6.6875,
            "end_logit": 8.78125,
            "text": "Do patients with lymphoedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.63671875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.87890625,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholest",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.97265625,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.28515625,
            "text": "lymphoedema cholestasis syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.78125,
            "text": "with lymphoedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.78125,
            "text": "patients with lymphoedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.41796875,
            "text": "lymphoedema cholestasis syndrome 1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.23828125,
            "end_logit": 2.986328125,
            "text": "edema cholestasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 2.986328125,
            "text": "cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.6875,
            "end_logit": 2.986328125,
            "text": "Do patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 2.986328125,
            "text": "with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 2.986328125,
            "text": "patients with lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -2.23828125,
            "end_logit": -6.63671875,
            "text": "edema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic",
            "probability": 0.0
        },
        {
            "start_logit": -6.6875,
            "end_logit": -2.296875,
            "text": "Do patients with lympho",
            "probability": 0.0
        },
        {
            "start_logit": -2.23828125,
            "end_logit": -6.87890625,
            "text": "edema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholest",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_4": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.4609375,
            "text": "lymphoedema",
            "probability": 1.0
        },
        {
            "start_logit": -0.86572265625,
            "end_logit": 9.4609375,
            "text": "edema",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.4501953125,
            "text": "lympho",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -2.7890625,
            "text": "lymphoedema cholestasis",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.4609375,
            "text": "with lymphoedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.4609375,
            "text": ": Patients with lymphoedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.4609375,
            "text": "Patients with lymphoedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.2578125,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.2734375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.359375,
            "text": "lymphoedema cholestasis syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.37109375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.390625,
            "text": "lymphoedema cholestasis syndrome 1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 9.4609375,
            "text": "BACKGROUND & AIMS: Patients with lymphoedema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.4140625,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholest",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.51171875,
            "text": "lymphoedema cholestasis syndrome 1/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.5546875,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.5859375,
            "text": "lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.86572265625,
            "end_logit": -2.7890625,
            "text": "edema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -0.86572265625,
            "end_logit": -7.2578125,
            "text": "edema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic",
            "probability": 0.0
        },
        {
            "start_logit": -0.86572265625,
            "end_logit": -7.2734375,
            "text": "edema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic.",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_5": [
        {
            "start_logit": 8.4296875,
            "end_logit": 6.65625,
            "text": "lymphedema",
            "probability": 1.0
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -3.73828125,
            "text": "lymphedema of the lower extremities",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -3.587890625,
            "end_logit": 6.65625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.22265625,
            "text": "lymphedema of the",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.24609375,
            "text": "lymphedema of the lower extremities.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.25,
            "text": "lymphedema of the lower",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.33984375,
            "text": "lymphedema of",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 6.65625,
            "text": "with lymphedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.65625,
            "text": "called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.65625,
            "text": "intrahepatic cholestasis associated with lymphedema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.65625,
            "text": "form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.65625,
            "text": "idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.65625,
            "text": ", also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.65625,
            "text": "also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.65625,
            "text": "of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.65625,
            "text": ", is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.65625,
            "text": "syndrome, also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -3.73828125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -4.83203125,
            "text": "Lymphedema Cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -5.265625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_6": [
        {
            "start_logit": 8.4296875,
            "end_logit": 6.65625,
            "text": "lymphedema",
            "probability": 1.0
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -3.73828125,
            "text": "lymphedema of the lower extremities",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -3.587890625,
            "end_logit": 6.65625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.22265625,
            "text": "lymphedema of the",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.24609375,
            "text": "lymphedema of the lower extremities.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.25,
            "text": "lymphedema of the lower",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.33984375,
            "text": "lymphedema of",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 6.65625,
            "text": "with lymphedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.65625,
            "text": "called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.65625,
            "text": "intrahepatic cholestasis associated with lymphedema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.65625,
            "text": "form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.65625,
            "text": "idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.65625,
            "text": ", also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.65625,
            "text": "also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.65625,
            "text": "of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.65625,
            "text": ", is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.65625,
            "text": "syndrome, also called Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -3.73828125,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -4.83203125,
            "text": "Lymphedema Cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.587890625,
            "end_logit": -5.265625,
            "text": "Lymphedema Cholestasis Syndrome (LSC 1), is a form of idiopathic familial intrahepatic cholestasis",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_7": [
        {
            "start_logit": 8.953125,
            "end_logit": 9.3359375,
            "text": "infantile cholestasis",
            "probability": 0.9677734375
        },
        {
            "start_logit": 8.953125,
            "end_logit": 5.90234375,
            "text": "infantile cholestasis with lymphoedema",
            "probability": 0.0316162109375
        },
        {
            "start_logit": 4.8671875,
            "end_logit": 5.90234375,
            "text": "lymphoedema",
            "probability": 0.0005269050598144531
        },
        {
            "start_logit": -0.8681640625,
            "end_logit": 9.3359375,
            "text": "cholestasis",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -1.8388671875,
            "text": "infantile",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -0.8681640625,
            "end_logit": 5.90234375,
            "text": "cholestasis with lymphoedema",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -5.78515625,
            "text": "infantile cholestasis with lympho",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "infantile cholestasis with lymphoedema (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.3359375,
            "text": "Parent-child transmission of infantile cholestasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.16796875,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.3359375,
            "text": "of infantile cholestasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.453125,
            "text": "infantile cholestasis with lymphoedema (Aa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.5,
            "text": "infantile cholestasis with lymphoedema (Aagenae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.5,
            "text": "infantile cholestasis with lymphoedema (Aagen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 5.90234375,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 4.8671875,
            "end_logit": -5.78515625,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 5.90234375,
            "text": "with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 5.90234375,
            "text": "Parent-child transmission of infantile cholestasis with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": 5.90234375,
            "text": "of infantile cholestasis with lymphoedema",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_8": [
        {
            "start_logit": 8.46875,
            "end_logit": 8.4921875,
            "text": "lymphoedema",
            "probability": 1.0
        },
        {
            "start_logit": 8.46875,
            "end_logit": -2.494140625,
            "text": "lympho",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -2.740234375,
            "end_logit": 8.4921875,
            "text": "edema",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 8.4921875,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lymphoedema",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 8.4921875,
            "text": "development of lymphoedema",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -6.8984375,
            "text": "lymphoedema.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 8.4921875,
            "text": "of neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lymphoedema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 8.4921875,
            "text": "intermittent cholestatic episodes in childhood into adulthood and development of lymphoedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 8.4921875,
            "text": "of lymphoedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.4921875,
            "text": "and development of lymphoedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": -2.494140625,
            "text": "neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -2.494140625,
            "text": "development of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -2.494140625,
            "text": "of neonatal cholestasis with intermittent cholestatic episodes in childhood into adulthood and development of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -2.740234375,
            "end_logit": -6.8984375,
            "text": "edema.",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -2.494140625,
            "text": "intermittent cholestatic episodes in childhood into adulthood and development of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -2.494140625,
            "text": "of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -2.494140625,
            "text": "and development of lympho",
            "probability": 0.0
        },
        {
            "start_logit": -5.4453125,
            "end_logit": -6.03515625,
            "text": "neonatal cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.796875,
            "end_logit": -5.8203125,
            "text": "lymphoedema cholestasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.796875,
            "end_logit": -6.03515625,
            "text": "lymphoedema cholestasis syndrome 1 (LCS1)), which is an autosomal recessive inherited syndrome consisting of neonatal cholestasis",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_9": [
        {
            "start_logit": 4.38671875,
            "end_logit": 6.796875,
            "text": "lymphedema",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.705078125,
            "end_logit": 6.796875,
            "text": "chronic lymphedema",
            "probability": 0.0022525787353515625
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 6.796875,
            "text": "neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 6.796875,
            "text": "severe chronic lymphedema",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 6.796875,
            "text": ") severe chronic lymphedema",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 6.796875,
            "text": "intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 6.796875,
            "text": "1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 6.796875,
            "text": ") neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.796875,
            "text": "2) severe chronic lymphedema",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.796875,
            "text": "and 2) severe chronic lymphedema",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.796875,
            "text": "with age, and 2) severe chronic lymphedema",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.796875,
            "text": "rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.796875,
            "text": ", characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.28515625,
            "text": "lymphedema, mainly lower limb",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.6484375,
            "text": "lymphedema, mainly lower",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.38671875,
            "end_logit": -7.66015625,
            "text": "lymphedema,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.12109375,
            "end_logit": -3.06640625,
            "text": "Lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.28515625,
            "text": "chronic lymphedema, mainly lower limb",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.47265625,
            "text": "chronic",
            "probability": 0.0
        },
        {
            "start_logit": -1.705078125,
            "end_logit": -7.6484375,
            "text": "chronic lymphedema, mainly lower",
            "probability": 0.0
        }
    ],
    "5895f9cf78275d0c4a000002_10": [
        {
            "start_logit": 8.953125,
            "end_logit": 9.3359375,
            "text": "infantile cholestasis",
            "probability": 0.9677734375
        },
        {
            "start_logit": 8.953125,
            "end_logit": 5.90234375,
            "text": "infantile cholestasis with lymphoedema",
            "probability": 0.0316162109375
        },
        {
            "start_logit": 4.8671875,
            "end_logit": 5.90234375,
            "text": "lymphoedema",
            "probability": 0.0005269050598144531
        },
        {
            "start_logit": -0.8681640625,
            "end_logit": 9.3359375,
            "text": "cholestasis",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -1.8388671875,
            "text": "infantile",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -0.8681640625,
            "end_logit": 5.90234375,
            "text": "cholestasis with lymphoedema",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -5.78515625,
            "text": "infantile cholestasis with lympho",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "infantile cholestasis with lymphoedema (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.3359375,
            "text": "Parent-child transmission of infantile cholestasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.16796875,
            "text": "infantile cholestasis with lymphoedema (Aagenaes syndrome).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.3359375,
            "text": "of infantile cholestasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.453125,
            "text": "infantile cholestasis with lymphoedema (Aa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.5,
            "text": "infantile cholestasis with lymphoedema (Aagenae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.5,
            "text": "infantile cholestasis with lymphoedema (Aagen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 5.90234375,
            "text": "edema",
            "probability": 0.0
        },
        {
            "start_logit": 4.8671875,
            "end_logit": -5.78515625,
            "text": "lympho",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 5.90234375,
            "text": "with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 5.90234375,
            "text": "Parent-child transmission of infantile cholestasis with lymphoedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": 5.90234375,
            "text": "of infantile cholestasis with lymphoedema",
            "probability": 0.0
        }
    ],
    "5536554abc4f83e828000008_1": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.4296875,
            "text": "D22S1",
            "probability": 1.0
        },
        {
            "start_logit": -1.021484375,
            "end_logit": 9.4296875,
            "text": "1",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.1337890625,
            "text": "D2",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 9.4296875,
            "text": "2S1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.64453125,
            "text": "D22S1 and D22S15",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 9.4296875,
            "text": ", D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 9.4296875,
            "text": "probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.4296875,
            "text": "two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.4296875,
            "text": "localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.4296875,
            "text": "between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.35546875,
            "text": "D22S1 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.4296875,
            "text": "has been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.4296875,
            "text": "been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.43359375,
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.4453125,
            "text": "D22S1 and D22S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.453125,
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.4296875,
            "text": "translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5625,
            "text": "D22S1 and D2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.021484375,
            "end_logit": -6.64453125,
            "text": "1 and D22S15",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -1.1337890625,
            "text": ", D2",
            "probability": 0.0
        }
    ],
    "5536554abc4f83e828000008_2": [
        {
            "start_logit": 9.328125,
            "end_logit": 9.4921875,
            "text": "D22S1",
            "probability": 1.0
        },
        {
            "start_logit": -0.84375,
            "end_logit": 9.4921875,
            "text": "1",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": 9.328125,
            "end_logit": -1.015625,
            "text": "D2",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 9.4921875,
            "text": "2S1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.328125,
            "end_logit": -6.3515625,
            "text": "D22S1 and D22S15",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 9.4921875,
            "text": ", D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.4921875,
            "text": "probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.4921875,
            "text": "two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.171875,
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.4921875,
            "text": "localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.4921875,
            "text": "between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.4921875,
            "text": "has been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.4921875,
            "text": "been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.37109375,
            "text": "D22S1 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.42578125,
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4296875,
            "text": "D22S1 and D22S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.44921875,
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.4921875,
            "text": "translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.57421875,
            "text": "D22S1 and D2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.84375,
            "end_logit": -6.3515625,
            "text": "1 and D22S15",
            "probability": 0.0
        }
    ],
    "535d69177d100faa09000003_1": [
        {
            "start_logit": 4.1953125,
            "end_logit": 2.587890625,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 0.47021484375
        },
        {
            "start_logit": 4.1953125,
            "end_logit": 2.34375,
            "text": "low-frequency modulated electric current",
            "probability": 0.368896484375
        },
        {
            "start_logit": 3.10546875,
            "end_logit": 2.587890625,
            "text": "duodenal ulcer",
            "probability": 0.15869140625
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -3.328125,
            "text": "low-frequency modulated electric current therapy",
            "probability": 0.0012693405151367188
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.59375,
            "text": "low",
            "probability": 4.845857620239258e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.609375,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (DU).",
            "probability": 4.774332046508789e-05
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 2.587890625,
            "text": "modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 4.661083221435547e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.75,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (DU",
            "probability": 4.1484832763671875e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.84375,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (DU)",
            "probability": 3.7729740142822266e-05
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 2.34375,
            "text": "modulated electric current",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.9921875,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": -5.5390625,
            "end_logit": 2.587890625,
            "text": "electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.19921875,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used",
            "probability": 2.658367156982422e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.23828125,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": -5.640625,
            "end_logit": 2.587890625,
            "text": "frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": -5.5390625,
            "end_logit": 2.34375,
            "text": "electric current",
            "probability": 2.187490463256836e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.40625,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer (",
            "probability": 2.1517276763916016e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.42578125,
            "text": "low-frequency modulated electric current therapy, SCENAR therapy, was",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 2.587890625,
            "text": "technique of low-frequency modulated electric current therapy, SCENAR therapy, was used in treatment of 103 patients with duodenal ulcer",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.4921875,
            "text": "low-frequency modulated electric",
            "probability": 1.9729137420654297e-05
        }
    ],
    "535d69177d100faa09000003_2": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.125,
            "text": "nocturnal enuresis",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.2880859375,
            "text": "nocturnal",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -1.6279296875,
            "end_logit": 9.125,
            "text": "uresis",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 9.125,
            "text": "enuresis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.65625,
            "text": "nocturnal enuresis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 9.125,
            "text": "with nocturnal enuresis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 9.125,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.125,
            "text": "children with nocturnal enuresis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 9.125,
            "text": "neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 9.125,
            "text": "in children with nocturnal enuresis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.125,
            "text": "treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.125,
            "text": "in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.125,
            "text": "bladder in children with nocturnal enuresis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.3984375,
            "text": "nocturnal en",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.125,
            "text": "SCENAR) as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.69921875,
            "end_logit": -1.2880859375,
            "text": "with nocturnal",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -1.2880859375,
            "text": "as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -1.2880859375,
            "text": "children with nocturnal",
            "probability": 0.0
        },
        {
            "start_logit": -6.94140625,
            "end_logit": -1.2880859375,
            "text": "neurogenic dysfunction of the bladder in children with nocturnal",
            "probability": 0.0
        },
        {
            "start_logit": -1.6279296875,
            "end_logit": -6.65625,
            "text": "uresis.",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_1": [
        {
            "start_logit": 6.171875,
            "end_logit": 4.83984375,
            "text": "physical activity",
            "probability": 0.99609375
        },
        {
            "start_logit": 0.53662109375,
            "end_logit": 4.83984375,
            "text": "overall physical activity",
            "probability": 0.0035381317138671875
        },
        {
            "start_logit": 6.171875,
            "end_logit": -4.69140625,
            "text": "physical",
            "probability": 7.224082946777344e-05
        },
        {
            "start_logit": 6.171875,
            "end_logit": -4.78125,
            "text": "physical activity (PAL",
            "probability": 6.580352783203125e-05
        },
        {
            "start_logit": 6.171875,
            "end_logit": -5.6640625,
            "text": "physical activity (PAL), constant strain postures",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 4.83984375,
            "text": "activity",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 6.171875,
            "end_logit": -6.56640625,
            "text": "physical activity (PAL), constant strain postures (CSP",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 6.171875,
            "end_logit": -6.69921875,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -6.8203125,
            "text": "physical activity (PAL)",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -6.8828125,
            "text": "physical activity (PAL), constant strain",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -6.8828125,
            "text": "physical activity (PAL), constant strain postures (CSP)",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.09765625,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.1875,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST)",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.2265625,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time (LT)",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.2265625,
            "text": "physical activity (PAL), constant strain postures (",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.234375,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying time (LT",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.23828125,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.23828125,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time (ST) and lying",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 6.171875,
            "end_logit": -7.24609375,
            "text": "physical activity (PAL), constant strain postures (CSP), standing time",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 4.83984375,
            "text": "measuring overall physical activity",
            "probability": 1.9073486328125e-06
        }
    ],
    "533f9df0c45e133714000016_2": [
        {
            "start_logit": 8.7578125,
            "end_logit": 6.64453125,
            "text": "Physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -1.662109375,
            "text": "Physical",
            "probability": 0.0002453327178955078
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -1.9365234375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an RT3 accelerometer",
            "probability": 0.00018668174743652344
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -5.21875,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an RT3",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.515625,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months with an RT",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 6.64453125,
            "text": "activity",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.30859375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3 months",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.4296875,
            "text": "Physical activity was measured for 7 days",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.4609375,
            "text": "Physical activity was",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.46875,
            "text": "Physical activity was measured",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.51953125,
            "text": "Physical activity was measured for 7 days at both baseline and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.58984375,
            "text": "Physical activity was measured for 7 days at both baseline and at 3",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.59375,
            "text": "Physical activity was measured for 7 days at",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.59765625,
            "text": "Physical activity was measured for 7 days at both baseline",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.63671875,
            "text": "Physical activity was measured for 7 days at both baseline and at",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -4.0859375,
            "end_logit": -1.9365234375,
            "text": "RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -4.5390625,
            "end_logit": -1.9365234375,
            "text": "activity was measured for 7 days at both baseline and at 3 months with an RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.4921875,
            "end_logit": -1.9365234375,
            "text": "with an RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.60546875,
            "end_logit": -1.9365234375,
            "text": "an RT3 accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -1.9365234375,
            "text": "3 months with an RT3 accelerometer",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_3": [
        {
            "start_logit": 9.0,
            "end_logit": 8.71875,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.41015625,
            "text": "physical",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -2.21484375,
            "end_logit": 8.71875,
            "text": "activity",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.2109375,
            "text": "physical activity in daily life",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.71875,
            "text": "assess physical activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 8.71875,
            "text": "wearing an accelerometer to assess physical activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 8.71875,
            "text": "accelerometer to assess physical activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.50390625,
            "text": "physical activity in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.71875,
            "text": "to assess physical activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.71875,
            "text": "an accelerometer to assess physical activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.21484375,
            "end_logit": -5.2109375,
            "text": "activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -1.41015625,
            "text": "assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -6.578125,
            "end_logit": -1.41015625,
            "text": "wearing an accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -1.41015625,
            "text": "accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -1.41015625,
            "text": "to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -1.41015625,
            "text": "an accelerometer to assess physical",
            "probability": 0.0
        },
        {
            "start_logit": -2.21484375,
            "end_logit": -7.50390625,
            "text": "activity in",
            "probability": 0.0
        },
        {
            "start_logit": -6.578125,
            "end_logit": -4.4140625,
            "text": "wearing an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -5.2109375,
            "text": "assess physical activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -4.4140625,
            "text": "accelerometer",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_4": [
        {
            "start_logit": 9.1796875,
            "end_logit": 8.7734375,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -0.9609375,
            "text": "physical",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": -2.08984375,
            "end_logit": 8.7734375,
            "text": "activity",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -5.58203125,
            "text": "physical activity in daily life was measured, with both an electronic diary",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -5.76953125,
            "text": "physical activity in daily life was measured, with both an electronic diary and an accelerometer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.23828125,
            "text": "physical activity in daily life",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.85546875,
            "text": "physical activity in daily life was measured, with both an electronic diary and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 8.7734375,
            "text": "days physical activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.29296875,
            "text": "physical activity in daily life was",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 8.7734375,
            "text": "During 14days physical activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.52734375,
            "text": "physical activity in daily life was measured",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.58984375,
            "text": "physical activity in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.6171875,
            "text": "physical activity in daily life was measured, with both an electronic diary and an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.7734375,
            "text": "14days physical activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -0.9609375,
            "text": "days physical",
            "probability": 0.0
        },
        {
            "start_logit": -2.08984375,
            "end_logit": -5.58203125,
            "text": "activity in daily life was measured, with both an electronic diary",
            "probability": 0.0
        },
        {
            "start_logit": -2.08984375,
            "end_logit": -5.76953125,
            "text": "activity in daily life was measured, with both an electronic diary and an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -0.9609375,
            "text": "During 14days physical",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -0.9609375,
            "text": "14days physical",
            "probability": 0.0
        },
        {
            "start_logit": -2.08984375,
            "end_logit": -6.23828125,
            "text": "activity in daily life",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_5": [
        {
            "start_logit": 9.2109375,
            "end_logit": 8.9296875,
            "text": "physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -0.99072265625,
            "text": "physical",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": 8.9296875,
            "text": "activity",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.2890625,
            "text": "physical activity in daily life",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.9296875,
            "text": "physical activity in daily life was measured with an accelerometer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3046875,
            "text": "physical activity in daily life was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.37890625,
            "text": "physical activity in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.515625,
            "text": "physical activity in daily life was measured",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.69140625,
            "text": "physical activity in daily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -6.2890625,
            "text": "activity in daily life",
            "probability": 0.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -6.9296875,
            "text": "activity in daily life was measured with an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -7.3046875,
            "text": "activity in daily life was",
            "probability": 0.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -7.37890625,
            "text": "activity in",
            "probability": 0.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -7.515625,
            "text": "activity in daily life was measured",
            "probability": 0.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": -7.69140625,
            "text": "activity in daily",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -6.2890625,
            "text": "daily life",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -6.9296875,
            "text": "daily life was measured with an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.9296875,
            "text": "an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.9296875,
            "text": "with an accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.3046875,
            "text": "daily life was",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_6": [
        {
            "start_logit": 0.96728515625,
            "end_logit": 4.12109375,
            "text": "step count",
            "probability": 0.94482421875
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -0.08380126953125,
            "text": "activPAL activity monitor",
            "probability": 0.036407470703125
        },
        {
            "start_logit": -3.994140625,
            "end_logit": 4.12109375,
            "text": "and step count",
            "probability": 0.006618499755859375
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 4.12109375,
            "text": "time walking, and step count",
            "probability": 0.0032749176025390625
        },
        {
            "start_logit": -5.234375,
            "end_logit": 4.12109375,
            "text": "time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0019121170043945312
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -3.19921875,
            "text": "activPAL",
            "probability": 0.0016155242919921875
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 4.12109375,
            "text": ". The following parameters of physical activity were recorded: time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0013284683227539062
        },
        {
            "start_logit": -5.85546875,
            "end_logit": 4.12109375,
            "text": "following parameters of physical activity were recorded: time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0010271072387695312
        },
        {
            "start_logit": -6.25,
            "end_logit": 4.12109375,
            "text": "parameters of physical activity were recorded: time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.0006923675537109375
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 4.12109375,
            "text": "count",
            "probability": 0.0005850791931152344
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 4.12109375,
            "text": "physical activity were recorded: time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.00044345855712890625
        },
        {
            "start_logit": -6.71875,
            "end_logit": 4.12109375,
            "text": ": time upright (standing or walking), time standing, time walking, and step count",
            "probability": 0.00043320655822753906
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -4.62109375,
            "text": "activPAL activity monitor) over a one week period.",
            "probability": 0.0003898143768310547
        },
        {
            "start_logit": 0.96728515625,
            "end_logit": -4.6015625,
            "text": "step count.",
            "probability": 0.0001533031463623047
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -5.890625,
            "text": "activPAL activity monitor)",
            "probability": 0.00010949373245239258
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -5.95703125,
            "text": "activPAL activity",
            "probability": 0.00010287761688232422
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.01953125,
            "text": "activPAL activity monitor) over a one week period",
            "probability": 9.66191291809082e-05
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.09765625,
            "text": "activPAL activity monitor) over a one week period. The following parameters of physical activity were recorded: time upright",
            "probability": 8.934736251831055e-05
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.18359375,
            "text": "activPAL activity monitor) over a",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.23828125,
            "text": "activPAL activity monitor) over",
            "probability": 7.766485214233398e-05
        }
    ],
    "533f9df0c45e133714000016_7": [
        {
            "start_logit": 8.3828125,
            "end_logit": 5.94140625,
            "text": "Physical activity",
            "probability": 1.0
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -2.421875,
            "text": "Physical",
            "probability": 0.00023233890533447266
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -4.0390625,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial accelerometer",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -6.640625,
            "text": "Physical activity levels will",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -6.734375,
            "text": "Physical activity levels",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -6.91796875,
            "text": "Physical activity levels will be measured by self report",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -6.9375,
            "text": "Physical activity levels will be measured by self report, RT3",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.421875,
            "text": "Physical activity levels will be measured by self report, RT3 tri",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.4296875,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 5.94140625,
            "text": "activity",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.68359375,
            "text": "Physical activity levels will be measured by self report, RT3 triaxial accelerometer,",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.68359375,
            "text": "Physical activity levels will be measured",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.6875,
            "text": "Physical activity levels will be",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": -4.0390625,
            "text": "activity levels will be measured by self report, RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -5.59375,
            "end_logit": -4.0390625,
            "text": "RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -4.0390625,
            "text": ", RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -6.73046875,
            "end_logit": -4.0390625,
            "text": "self report, RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -4.0390625,
            "text": "by self report, RT3 triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -4.0390625,
            "text": "triaxial accelerometer",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -4.0390625,
            "text": "axial accelerometer",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_8": [
        {
            "start_logit": 8.2578125,
            "end_logit": 6.6796875,
            "text": "physical activity level",
            "probability": 1.0
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -2.666015625,
            "text": "physical",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -3.548828125,
            "text": "physical activity",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.3359375,
            "text": "physical activity level (PAL",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.48828125,
            "text": "physical activity level (PAL)",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.29296875,
            "end_logit": 6.6796875,
            "text": "level",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.7109375,
            "text": "physical activity level (PAL), number of constant postures (CP",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.71484375,
            "text": "physical activity level (PAL), number of constant postures",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.765625,
            "text": "physical activity level (PAL), number of constant postures (CP)",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.76953125,
            "text": "physical activity level (",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.91015625,
            "text": "physical activity level (PAL), number of constant postures (",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.2578125,
            "text": "physical activity level (PAL), number of constant",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.49609375,
            "text": "physical activity level (PAL), number of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 6.6796875,
            "text": "(physical activity level",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 6.6796875,
            "text": "activity level",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 6.6796875,
            "text": "daily life (physical activity level",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.6796875,
            "text": "8-h accelerometer assessment in their daily life (physical activity level",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.6796875,
            "text": "life (physical activity level",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.6796875,
            "text": "their daily life (physical activity level",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.29296875,
            "end_logit": -4.3359375,
            "text": "level (PAL",
            "probability": 0.0
        }
    ],
    "533f9df0c45e133714000016_9": [
        {
            "start_logit": 6.71875,
            "end_logit": 4.83203125,
            "text": "Physical activity",
            "probability": 0.99609375
        },
        {
            "start_logit": 6.71875,
            "end_logit": -1.0673828125,
            "text": "Physical activity in daily life, expressed as whole-body acceleration",
            "probability": 0.002742767333984375
        },
        {
            "start_logit": 6.71875,
            "end_logit": -2.607421875,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmor",
            "probability": 0.0005865097045898438
        },
        {
            "start_logit": 6.71875,
            "end_logit": -4.24609375,
            "text": "Physical",
            "probability": 0.00011372566223144531
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.40234375,
            "text": "Physical activity in daily life",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.65625,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.78515625,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.8359375,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmor)",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.96484375,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmo",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.1953125,
            "text": "Physical activity in daily life, expressed as whole-body",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.3671875,
            "text": "Physical activity in",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.625,
            "text": "Physical activity in daily life, expressed as whole-body acceleration measured with a triaxial accelerometer (Tracmor),",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 4.83203125,
            "text": "activity",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -1.0673828125,
            "text": "whole-body acceleration",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -2.607421875,
            "text": "whole-body acceleration measured with a triaxial accelerometer (Tracmor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.203125,
            "end_logit": -2.607421875,
            "text": "Tracmor",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -1.0673828125,
            "text": "activity in daily life, expressed as whole-body acceleration",
            "probability": 0.0
        },
        {
            "start_logit": -6.20703125,
            "end_logit": -1.0673828125,
            "text": "as whole-body acceleration",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -1.0673828125,
            "text": "body acceleration",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -1.0673828125,
            "text": "expressed as whole-body acceleration",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_1": [
        {
            "start_logit": 4.00390625,
            "end_logit": 6.828125,
            "text": "statins",
            "probability": 0.83544921875
        },
        {
            "start_logit": 2.345703125,
            "end_logit": 6.828125,
            "text": "fibrates and statins",
            "probability": 0.1593017578125
        },
        {
            "start_logit": 2.345703125,
            "end_logit": 3.419921875,
            "text": "fibrates",
            "probability": 0.00528717041015625
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 6.828125,
            "text": "and statins",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": -6.53125,
            "end_logit": 6.828125,
            "text": "ates and statins",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 6.828125,
            "text": ". This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 2.0742416381835938e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 6.828125,
            "text": "This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 1.436471939086914e-05
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 6.828125,
            "text": "(fibrates and statins",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.828125,
            "text": "study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.828125,
            "text": "drugs (fibrates and statins",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.828125,
            "text": "common lipid-lowering drugs (fibrates and statins",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.828125,
            "text": "diseases. This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.828125,
            "text": "2 common lipid-lowering drugs (fibrates and statins",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.828125,
            "text": "(CV) diseases. This study examined which of 2 common lipid-lowering drugs (fibrates and statins",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 4.00390625,
            "end_logit": -6.92578125,
            "text": "statins) is more effective in patients with remnant lipoproteinemia and if lowering remnant lipoprotein levels can reduce CV risk.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 3.419921875,
            "text": "ates",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 3.419921875,
            "text": ". This study examined which of 2 common lipid-lowering drugs (fibrates",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 4.00390625,
            "end_logit": -7.3046875,
            "text": "statins)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.00390625,
            "end_logit": -7.5234375,
            "text": "statins) is more effective in patients with remnant lipoproteinemia and if lowering remnant lipoprotein levels can",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 3.419921875,
            "text": "This study examined which of 2 common lipid-lowering drugs (fibrates",
            "probability": 4.76837158203125e-07
        }
    ],
    "589c42b178275d0c4a00003f_2": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.49609375,
            "text": "Statins",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.78125,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.953125,
            "text": "Statins are",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.43359375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.45703125,
            "text": "Statins are powerful",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.4609375,
            "text": "Statins are powerful lipid-lowering drugs, widely used",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.46484375,
            "text": "Statins are powerful lipid-lowering drugs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.48828125,
            "text": "Statins are powerful lipid-lowering drugs, widely",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.515625,
            "text": "Statins are powerful lipid",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.53515625,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.59375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.63671875,
            "text": "Statins are powerful lipid-lowering",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.640625,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.6640625,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.68359375,
            "text": "Statins are powerful lipid-lowering drugs, widely used in patients with hyperlipidemia and coronary artery",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.68359375,
            "text": "Statins are powerful lipid-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.6953125,
            "text": "Statins are powerful lipid-lowering drugs,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -6.78125,
            "text": "with hyperlipidemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -6.78125,
            "text": "in patients with hyperlipidemia",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -7.43359375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_3": [
        {
            "start_logit": 7.24609375,
            "end_logit": 4.72265625,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -4.71875,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimibe",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -6.55078125,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimi",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -6.859375,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimibe).",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.046875,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezetimibe)",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.10546875,
            "text": "statins and",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -4.89453125,
            "end_logit": 4.72265625,
            "text": "fibrates, niacin, statins",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.44140625,
            "text": "statins and cholesterol absorption-inhibiting drugs (ezeti",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.4765625,
            "text": "statins and cholesterol absorption",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.578125,
            "text": "statins and cholesterol absorption-",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -7.61328125,
            "text": "statins and cholesterol absorption-inhibiting drugs",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -5.140625,
            "end_logit": 4.72265625,
            "text": "niacin, statins",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 4.72265625,
            "text": ", statins",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 4.72265625,
            "text": "resins, fibrates, niacin, statins",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.8125,
            "end_logit": 4.72265625,
            "text": "with lipid-lowering drugs such as resins, fibrates, niacin, statins",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 4.72265625,
            "text": ", fibrates, niacin, statins",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 4.72265625,
            "text": "as resins, fibrates, niacin, statins",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 4.72265625,
            "text": "acin, statins",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 4.72265625,
            "text": ", niacin, statins",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 4.72265625,
            "text": "Patients are frequently treated with lipid-lowering drugs such as resins, fibrates, niacin, statins",
            "probability": 4.76837158203125e-07
        }
    ],
    "589c42b178275d0c4a00003f_4": [
        {
            "start_logit": 6.25,
            "end_logit": 4.4296875,
            "text": "statin",
            "probability": 1.0
        },
        {
            "start_logit": 6.25,
            "end_logit": -5.5859375,
            "text": "statin treatment or &lt;100 mg/dl without statins",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 6.25,
            "end_logit": -6.5234375,
            "text": "statin treatment",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 6.25,
            "end_logit": -6.796875,
            "text": "statin treatment or",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 4.4296875,
            "text": "under statin",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 4.4296875,
            "text": "enrolled 70 consecutive CAD patients who were referred for percutaneous coronary intervention and whose low-density lipoprotein cholesterol level was &lt;120 mg/dl under statin",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.203125,
            "end_logit": -4.7265625,
            "text": "daily glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -6.37109375,
            "end_logit": -4.7265625,
            "text": "glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -6.5,
            "end_logit": -4.7265625,
            "text": "effect of daily glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -5.5859375,
            "text": "statins",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -4.7265625,
            "text": "This study sought to investigate the effect of daily glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -4.7265625,
            "text": "investigate the effect of daily glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -4.7265625,
            "text": "study sought to investigate the effect of daily glucose fluctuation",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -5.5859375,
            "text": "under statin treatment or &lt;100 mg/dl without statins",
            "probability": 0.0
        },
        {
            "start_logit": -6.203125,
            "end_logit": -6.4921875,
            "text": "daily glucose fluctuation on coronary plaque properties in patients with coronary artery disease (CAD) pre-treated with lipid-lowering therapy.",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -6.421875,
            "text": ".There is growing evidence that glucose fluctuation, as a residual risk apart from dyslipidemia",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -6.4921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -6.4921875,
            "text": ".There is growing evidence that glucose fluctuation, as a residual risk apart from dyslipidemia, is an important factor contributing to the development of CAD.",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -6.4921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.33984375,
            "end_logit": -6.5234375,
            "text": "under statin treatment",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_5": [
        {
            "start_logit": 8.09375,
            "end_logit": 7.4296875,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.42578125,
            "text": "statins reduces cardiovascular events",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.56640625,
            "text": "statins reduces",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.6875,
            "text": "statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.4296875,
            "text": "using statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.4296875,
            "text": "that lipid-lowering therapy using statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.4296875,
            "text": "Large clinical trials have elucidated that lipid-lowering therapy using statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.4296875,
            "text": "clinical trials have elucidated that lipid-lowering therapy using statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.4296875,
            "text": "lowering therapy using statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -7.42578125,
            "text": "cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.42578125,
            "text": "using statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.56640625,
            "text": "using statins reduces",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.42578125,
            "text": "that lipid-lowering therapy using statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.42578125,
            "text": "Large clinical trials have elucidated that lipid-lowering therapy using statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.42578125,
            "text": "clinical trials have elucidated that lipid-lowering therapy using statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -7.6875,
            "text": "cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.42578125,
            "text": "lowering therapy using statins reduces cardiovascular events",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.6875,
            "text": "using statins reduces cardiovascular events in patients with coronary artery disease (CAD)",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.515625,
            "text": "Large clinical trials have elucidated",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.515625,
            "text": "clinical trials have elucidated",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_6": [
        {
            "start_logit": 8.1875,
            "end_logit": 7.390625,
            "text": "statins",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.6015625,
            "text": "statins could",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.73828125,
            "text": "statins could attenuate EPC telomere erosion",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4296875,
            "text": "statins could attenuate EPC telomere",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6171875,
            "text": "statins could attenuate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.625,
            "text": "statins could attenuate EPC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6484375,
            "text": "statins could attenuate EPC telomere erosion in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.69140625,
            "text": "statins could attenuate EPC telomere erosion in patients with CAD (coronary artery disease)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 7.390625,
            "text": "with statins",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 7.390625,
            "text": "whether LLT (lipid-lowering therapy) with statins",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.390625,
            "text": "LLT (lipid-lowering therapy) with statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.390625,
            "text": "present study was to investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.390625,
            "text": "aim of the present study was to investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.390625,
            "text": "study was to investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.390625,
            "text": "(lipid-lowering therapy) with statins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.390625,
            "text": "investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.390625,
            "text": "The aim of the present study was to investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.390625,
            "text": "lowering therapy) with statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.390625,
            "text": "to investigate whether LLT (lipid-lowering therapy) with statins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": -6.6015625,
            "text": "with statins could",
            "probability": 0.0
        }
    ],
    "589c42b178275d0c4a00003f_7": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.74609375,
            "text": "pravastatin",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -5.59765625,
            "text": "pravastatin (+/-colestyramine",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.5546875,
            "text": "pravastatin (+/-colestyramine/niacin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 7.74609375,
            "text": "of pravastatin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.74609375,
            "text": "Beneficial effects of pravastatin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.12890625,
            "text": "pravastatin (+/-colestyramine/niacin)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.13671875,
            "text": "pravastatin (+/",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.2109375,
            "text": "pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.35546875,
            "text": "pravastatin (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.3671875,
            "text": "pravastatin (+/-colestyramine/niacin) initiated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.3671875,
            "text": "pravastatin (+/-colestyramine/niacin) initiated immediately",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.37890625,
            "text": "pravastatin (+/-colestyramine/",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.74609375,
            "text": "effects of pravastatin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.46484375,
            "text": "pravastatin (+/-colestyr",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.53515625,
            "text": "pravastatin (+/-colestyramine/niacin) initiated immediately after",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.5546875,
            "text": "pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -5.59765625,
            "text": "colestyramine",
            "probability": 0.0
        },
        {
            "start_logit": -6.6484375,
            "end_logit": -5.59765625,
            "text": "of pravastatin (+/-colestyramine",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -5.59765625,
            "text": "Beneficial effects of pravastatin (+/-colestyramine",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -5.59765625,
            "text": "+/-colestyramine",
            "probability": 0.0
        }
    ],
    "55072c803b8a5dc045000001_1": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.5390625,
            "text": "Notch-1",
            "probability": 1.0
        },
        {
            "start_logit": -0.3388671875,
            "end_logit": 9.5390625,
            "text": "1",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.212890625,
            "text": "Notch",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.68359375,
            "text": "Notch-1 to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 9.5390625,
            "text": "-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.5390625,
            "text": "(Notch-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.1796875,
            "text": "Notch-1 to -4",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 9.5390625,
            "text": ". Four Notch receptors have been identified in man (Notch-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.5390625,
            "text": "Four Notch receptors have been identified in man (Notch-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.64453125,
            "text": "Notch-1 to -4)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.5390625,
            "text": "Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.5390625,
            "text": "receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.5390625,
            "text": "Notch signaling is an evolutionarily conserved mechanism, used to regulate cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.5390625,
            "text": "cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.984375,
            "text": "Notch-1 to -4).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.5390625,
            "text": "signaling is an evolutionarily conserved mechanism, used to regulate cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.5390625,
            "text": "evolutionarily conserved mechanism, used to regulate cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.5390625,
            "text": "regulate cell fate decisions. Four Notch receptors have been identified in man (Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.12890625,
            "text": "Notch-1 to -",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.3388671875,
            "end_logit": -5.68359375,
            "text": "1 to",
            "probability": 0.0
        }
    ],
    "55072c803b8a5dc045000001_2": [
        {
            "start_logit": 9.421875,
            "end_logit": 9.7109375,
            "text": "Notch-1",
            "probability": 1.0
        },
        {
            "start_logit": 0.2015380859375,
            "end_logit": 9.7109375,
            "text": "1",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": 9.421875,
            "end_logit": -0.6640625,
            "text": "Notch",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 9.7109375,
            "text": "-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.421875,
            "end_logit": -5.78125,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.421875,
            "end_logit": -6.4609375,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.7109375,
            "text": "of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 9.7109375,
            "text": "receptors were expressed in the adult liver, with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -6.74609375,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3 expression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.7109375,
            "text": "levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 9.7109375,
            "text": "4 receptors were expressed in the adult liver, with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.7109375,
            "text": "adult liver, with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.7109375,
            "text": "liver, with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.01953125,
            "text": "Notch-1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.7109375,
            "text": "All 4 receptors were expressed in the adult liver, with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.11328125,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.12890625,
            "text": "Notch-1, -2, and -4 messenger RNA (mRNA) between normal and diseased liver. However, Notch-3 expression appeared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.14453125,
            "text": "Notch-1, -2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.7109375,
            "text": "with no significant differences in the levels of Notch-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.421875,
            "end_logit": -7.2890625,
            "text": "Notch-1, -2, and -4",
            "probability": 5.960464477539063e-08
        }
    ],
    "601d6ec61cb411341a000032_1": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.28125,
            "text": "Focal segmental glomerulosclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.1416015625,
            "text": "Focal",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": 9.28125,
            "text": "glomerulosclerosis",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -2.205078125,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 9.28125,
            "text": "segmental glomerulosclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.90625,
            "text": "Focal segmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.97265625,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.125,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.28515625,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.296875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.359375,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating TRIM8 mutation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.36328125,
            "text": "Focal segmental glomerulosclerosis and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.421875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.42578125,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.4921875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.53515625,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5390625,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo truncating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.546875,
            "text": "Focal segmental glomerulosclerosis and mild intellectual disability in a patient with a novel de novo trunc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": -2.205078125,
            "text": "glomerulosclerosis and mild intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -4.83203125,
            "end_logit": -2.205078125,
            "text": "mild intellectual disability",
            "probability": 0.0
        }
    ],
    "601d6ec61cb411341a000032_2": [
        {
            "start_logit": 3.953125,
            "end_logit": 6.0546875,
            "text": "nephrotic syndrome",
            "probability": 0.68896484375
        },
        {
            "start_logit": 4.91015625,
            "end_logit": 4.06640625,
            "text": "severe developmental delay, intellectual disability and epilepsy",
            "probability": 0.24560546875
        },
        {
            "start_logit": 2.974609375,
            "end_logit": 4.06640625,
            "text": "epilepsy",
            "probability": 0.035400390625
        },
        {
            "start_logit": 4.91015625,
            "end_logit": 1.9521484375,
            "text": "severe developmental delay",
            "probability": 0.029693603515625
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 6.0546875,
            "text": "syndrome",
            "probability": 9.709596633911133e-05
        },
        {
            "start_logit": -6.28125,
            "end_logit": 6.0546875,
            "text": "have nephrotic syndrome",
            "probability": 2.47955322265625e-05
        },
        {
            "start_logit": 4.91015625,
            "end_logit": -6.046875,
            "text": "severe developmental delay, intellectual disability",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 4.91015625,
            "end_logit": -6.09765625,
            "text": "severe",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 4.06640625,
            "text": "developmental delay, intellectual disability and epilepsy",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": 3.953125,
            "end_logit": -5.80078125,
            "text": "nephrotic",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 4.06640625,
            "text": "with severe developmental delay, intellectual disability and epilepsy",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 4.06640625,
            "text": "in patients with severe developmental delay, intellectual disability and epilepsy",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 4.06640625,
            "text": "patients with severe developmental delay, intellectual disability and epilepsy",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 1.9521484375,
            "text": "developmental delay",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 1.9521484375,
            "text": "with severe developmental delay",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 1.9521484375,
            "text": "in patients with severe developmental delay",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 1.9521484375,
            "text": "patients with severe developmental delay",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -4.9375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -6.046875,
            "text": "developmental delay, intellectual disability",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -4.9375,
            "text": "need for proteinuria screening in patients with TRIM8 mutations.",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_1": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.2734375,
            "text": "type 2 diabetes",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -0.85009765625,
            "text": "type",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -1.1376953125,
            "end_logit": 9.2734375,
            "text": "diabetes",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -3.951171875,
            "end_logit": 9.2734375,
            "text": "Apolipoprotein E4 (E4) and type 2 diabetes",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 9.2734375,
            "text": "2 diabetes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.02734375,
            "text": "type 2 diabetes are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 9.2734375,
            "text": "and type 2 diabetes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.23046875,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.2734375,
            "text": "E4) and type 2 diabetes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.42578125,
            "text": "type 2 diabetes are major risk factors for cognitive decline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4453125,
            "text": "type 2 diabetes are major risk factors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.44921875,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.46875,
            "text": "type 2 diabetes are major risk factors for cognitive decline and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.2734375,
            "text": "(E4) and type 2 diabetes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5546875,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.578125,
            "text": "type 2 diabetes are major risk factors for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.58203125,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (AD)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.58984375,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.58984375,
            "text": "type 2 diabetes are major risk factors for cognitive decline and late onset Alzheimer's disease (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.951171875,
            "end_logit": -0.85009765625,
            "text": "Apolipoprotein E4 (E4) and type",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_2": [
        {
            "start_logit": 7.57421875,
            "end_logit": 8.0234375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.0234375,
            "text": "Cardiovascular risk factors, especially hypertension",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.0234375,
            "text": "especially hypertension",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.0234375,
            "text": "risk factors, especially hypertension",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.2421875,
            "text": "hypertension, are",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.27734375,
            "text": "hypertension,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.328125,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.62890625,
            "text": "hypertension, are also",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.6640625,
            "text": "hypertension, are also major risk factors for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.671875,
            "text": "hypertension, are also major risk factors for Alzheimer's disease (AD",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": -6.89453125,
            "text": "Cardiovascular",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.0234375,
            "text": "Cardiovascular risk factors",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.2421875,
            "text": "Cardiovascular risk factors, especially hypertension, are",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.27734375,
            "text": "Cardiovascular risk factors, especially hypertension,",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.328125,
            "text": "Cardiovascular risk factors, especially hypertension, are also major risk factors for Alzheimer's disease (AD).",
            "probability": 0.0
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -7.328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.5234375,
            "text": "Cardiovascular risk",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.62890625,
            "text": "Cardiovascular risk factors, especially hypertension, are also",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -7.0234375,
            "text": "risk factors",
            "probability": 0.0
        },
        {
            "start_logit": -6.9375,
            "end_logit": -7.65625,
            "text": "Cardiovascular risk factors,",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_3": [
        {
            "start_logit": 8.5,
            "end_logit": 7.89453125,
            "text": "Clusterin",
            "probability": 1.0
        },
        {
            "start_logit": 8.5,
            "end_logit": -2.818359375,
            "text": "Cluster",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 8.5,
            "end_logit": -3.755859375,
            "text": "Clusterin (Apo J)",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -3.701171875,
            "end_logit": 7.89453125,
            "text": "in",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 8.5,
            "end_logit": -5.8125,
            "text": "Clusterin (",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.5,
            "end_logit": -6.0,
            "text": "Clusterin (Apo J",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -6.40234375,
            "text": "Clusterin (Apo J) is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -6.81640625,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form of AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -6.9453125,
            "text": "Clusterin (Apo J) is one",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.14453125,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form of AD.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.2265625,
            "text": "Clusterin (Apo J) is one of the major risk factors",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.296875,
            "text": "Clusterin (Apo",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.36328125,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.390625,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.40625,
            "text": "Clusterin (Apo J) is one of the major risk factors for sporadic form of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.45703125,
            "text": "Clusterin (Apo J) is one of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.47265625,
            "text": "Clusterin (Apo J) is one of the major risk factors for",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.5,
            "text": "Clusterin (Apo J) is one of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.701171875,
            "end_logit": -3.755859375,
            "text": "in (Apo J)",
            "probability": 0.0
        },
        {
            "start_logit": -3.701171875,
            "end_logit": -5.8125,
            "text": "in (",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_4": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.76953125,
            "text": "Hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.8359375,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.8515625,
            "text": "Hypertension is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1328125,
            "text": "Hypertension is one",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.37890625,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.41796875,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.52734375,
            "text": "Hypertension is one of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.56640625,
            "text": "Hypertension is one of the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.62890625,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.65234375,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.65234375,
            "text": "Hypertension is one of the major risk factors",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.6796875,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.6953125,
            "text": "Hypertension is one of the major risk factors for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.69921875,
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.8359375,
            "text": "risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.8359375,
            "text": "nervous system (CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.37890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -6.8359375,
            "text": "central nervous system (CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -6.8359375,
            "text": "CNS) disorders like stroke",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -7.37890625,
            "text": "risk factors for central nervous system (CNS) disorders like stroke and Alzheimer's disease (AD).",
            "probability": 0.0
        }
    ],
    "5a9d96564e03427e73000001_5": [
        {
            "start_logit": 7.5859375,
            "end_logit": 7.87109375,
            "text": "age",
            "probability": 1.0
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -4.75,
            "text": "age and diabetes. Lately, obesity",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -5.3125,
            "text": "age and diabetes",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 7.87109375,
            "text": "advancing age",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.87109375,
            "text": "are advancing age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.87109375,
            "text": "risk factors for AD are advancing age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.87109375,
            "text": "Major risk factors for AD are advancing age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.87109375,
            "text": "AD are advancing age",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.23828125,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk of dementia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.3203125,
            "text": "age and diabetes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.3203125,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk of dementia.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.4765625,
            "text": "age and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.48828125,
            "text": "age and diabetes. Lately, obesity has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.53515625,
            "text": "age and diabetes. Late",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.5546875,
            "text": "age and diabetes. Lately, obesity has been associated with an increased risk",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.6015625,
            "text": "age and diabetes. Lately",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.63671875,
            "text": "age and diabetes. Lately, obesity has been associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5859375,
            "end_logit": -7.640625,
            "text": "age and diabetes. Lately, obesity has been",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -4.75,
            "text": "advancing age and diabetes. Lately, obesity",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -4.75,
            "text": ". Lately, obesity",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_1": [
        {
            "start_logit": 9.3359375,
            "end_logit": 9.3984375,
            "text": "SCDRHA",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -1.015625,
            "text": "SCD",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -1.166015625,
            "end_logit": 9.3984375,
            "text": "A",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.19921875,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 9.3984375,
            "text": "RHA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.671875,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencode",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.69140625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.0234375,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.03515625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoenc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.046875,
            "text": "SCDRHA:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.25,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality Reduction Algorithm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.2890625,
            "text": "SCDRH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.29296875,
            "text": "SCDRHA: A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.37890625,
            "text": "SCDRHA: A scRNA-Seq Data Dimensionality",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.3984375,
            "text": "SCDRHA: A scRNA-Seq Data",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.166015625,
            "end_logit": -6.19921875,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder",
            "probability": 0.0
        },
        {
            "start_logit": -1.166015625,
            "end_logit": -6.671875,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencode",
            "probability": 0.0
        },
        {
            "start_logit": -1.166015625,
            "end_logit": -6.69140625,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoencoder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.166015625,
            "end_logit": -7.0234375,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction",
            "probability": 0.0
        },
        {
            "start_logit": -1.166015625,
            "end_logit": -7.03515625,
            "text": "A: A scRNA-Seq Data Dimensionality Reduction Algorithm Based on Hierarchical Autoenc",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_2": [
        {
            "start_logit": 8.5859375,
            "end_logit": 8.765625,
            "text": "SCDRHA",
            "probability": 1.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": 8.765625,
            "text": "A",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -2.255859375,
            "text": "SCD",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 4.5859375,
            "end_logit": -1.6904296875,
            "text": "cell clustering",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -5.78515625,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder (DCA)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 8.765625,
            "text": "paper, we propose a scRNA-seq data dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 8.765625,
            "text": "termed SCDRHA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 8.765625,
            "text": "dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.3828125,
            "text": "SCDRHA.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 8.765625,
            "text": "RHA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.765625,
            "text": "data dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.5078125,
            "text": "SCDRHA. The proposed SCDRHA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.59765625,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.6328125,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.6953125,
            "text": "SCDRHA. The proposed SCDRHA consists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.79296875,
            "text": "SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count auto",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.5859375,
            "end_logit": -4.84765625,
            "text": "cell",
            "probability": 0.0
        },
        {
            "start_logit": 4.5859375,
            "end_logit": -6.37890625,
            "text": "cell clustering.",
            "probability": 0.0
        },
        {
            "start_logit": -3.69140625,
            "end_logit": -1.6904296875,
            "text": "data visualization and cell clustering",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -1.6904296875,
            "text": "real scRNA-seq datasets. Besides, SCDRHA can also dramatically improve the performance of data visualization and cell clustering",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_3": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.3359375,
            "text": "CellVGAE",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.2109375,
            "text": "Cell",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": 9.3359375,
            "text": "GAE",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 9.3359375,
            "text": "VGAE",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.5,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1328125,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.16015625,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.33984375,
            "text": "CellVGAE: an unsupervised scRNA-seq",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.41015625,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph attention",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.4296875,
            "text": "CellVGAE: an unsupervised scRNA-seq analysis workflow with graph",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -6.5,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph attention networks",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.1328125,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.16015625,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph attention networks.",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.33984375,
            "text": "GAE: an unsupervised scRNA-seq",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.41015625,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph attention",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.4296875,
            "text": "GAE: an unsupervised scRNA-seq analysis workflow with graph",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -6.5,
            "text": "VGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.1328125,
            "text": "VGAE: an unsupervised scRNA-seq analysis workflow",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.16015625,
            "text": "VGAE: an unsupervised scRNA-seq analysis workflow with graph attention networks.",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.33984375,
            "text": "VGAE: an unsupervised scRNA-seq",
            "probability": 0.0
        }
    ],
    "621e5cf53a8413c65300004e_4": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.1796875,
            "text": "CellVGAE",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.48046875,
            "text": "Cell",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -1.662109375,
            "end_logit": 9.1796875,
            "text": "GAE",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 9.1796875,
            "text": "VGAE",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.91015625,
            "text": "CellVGAE, can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.05078125,
            "text": "CellVGAE,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.1796875,
            "text": "that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.21875,
            "text": "CellVGAE, can be effectively used for exploratory analysis even",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.1796875,
            "text": "With the help of several case studies, we show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.1796875,
            "text": "named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.1796875,
            "text": "case studies, we show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.28515625,
            "text": "CellVGAE, can be effectively used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.2890625,
            "text": "CellVGAE, can be effectively used for exploratory analysis even on challenging datasets, by extracting meaningful features from the data and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.3359375,
            "text": "CellVGAE, can be effectively used for exploratory analysis even on challenging datasets, by extracting meaningful features from the data",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.3671875,
            "text": "CellVGAE, can be effectively used for exploratory analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.1796875,
            "text": "show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.1796875,
            "text": "we show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.1796875,
            "text": "help of several case studies, we show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.1796875,
            "text": "the help of several case studies, we show that our model, named CellVGAE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.662109375,
            "end_logit": -6.91015625,
            "text": "GAE, can",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_1": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.203125,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.3154296875,
            "text": "c",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 9.203125,
            "text": "Abl",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -3.458984375,
            "end_logit": 9.203125,
            "text": "A role for c-Abl",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -5.66015625,
            "end_logit": 9.203125,
            "text": "-Abl",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.1875,
            "end_logit": 9.203125,
            "text": "role for c-Abl",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.42578125,
            "text": "c-Abl in cell senescence and spontaneous immortalization",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.06640625,
            "text": "c-Abl in cell senescence and spontaneous immortal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.13671875,
            "text": "c-Abl in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.2421875,
            "text": "c-Abl in cell senescence and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 9.203125,
            "text": "for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.29296875,
            "text": "c-Abl in cell senescence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -1.3154296875,
            "text": "A role for c",
            "probability": 0.0
        },
        {
            "start_logit": -3.458984375,
            "end_logit": -3.240234375,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -1.3154296875,
            "text": "role for c",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -6.42578125,
            "text": "Abl in cell senescence and spontaneous immortalization",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.06640625,
            "text": "Abl in cell senescence and spontaneous immortal",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -1.3154296875,
            "text": "for c",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.13671875,
            "text": "Abl in",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.2421875,
            "text": "Abl in cell senescence and",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_2": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.328125,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": -1.2177734375,
            "end_logit": 9.328125,
            "text": "Abl",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.416015625,
            "text": "c",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 9.328125,
            "text": "-Abl",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.4375,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 9.328125,
            "text": "role for c-Abl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.328125,
            "text": "important role for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.16796875,
            "text": "c-Abl in replicative senescence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.328125,
            "text": "Here, we report an important role for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.20703125,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.21875,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.23046875,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.328125,
            "text": "report an important role for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.2734375,
            "text": "c-Abl in replicative senescence and immortalization by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.27734375,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.328125,
            "text": "an important role for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.36328125,
            "text": "c-Abl in replicative senescence and immortalization by regulating the expression of two tumor suppressors that induce cellular senescence, p53 and p16(INK4a)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.328125,
            "text": "we report an important role for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.328125,
            "text": "for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.39453125,
            "text": "c-Abl in replicative senescence and",
            "probability": 5.960464477539063e-08
        }
    ],
    "5309f8f5970c65fa6b000001_3": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.015625,
            "text": "c-Abl",
            "probability": 1.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.3349609375,
            "text": "c",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -1.7529296875,
            "end_logit": 9.015625,
            "text": "Abl",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -5.703125,
            "end_logit": 9.015625,
            "text": "-Abl",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 9.015625,
            "text": "role for c-Abl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.8828125,
            "text": "c-Abl in regulating cell senescence and immortalization might",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.0859375,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.11328125,
            "text": "c-Abl in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 9.015625,
            "text": "The role for c-Abl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.23828125,
            "text": "c-Abl in regulating cell senescence and immortalization",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.3359375,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.3515625,
            "text": "c-Abl in regulating cell senescence and immortal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.015625,
            "text": "for c-Abl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.390625,
            "text": "c-Abl in regulating cell senescence and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.3984375,
            "text": "c-Abl in regulating cell senescence and immortalization might explain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.4453125,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.453125,
            "text": "c-Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.49609375,
            "text": "c-Abl in regulating cell senescence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -1.740234375,
            "text": "BCR-ABL",
            "probability": 0.0
        },
        {
            "start_logit": -1.7529296875,
            "end_logit": -1.740234375,
            "text": "Abl in regulating cell senescence and immortalization might explain some of the developmental defects in c-Abl (-/-) mice and how BCR-ABL",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_4": [
        {
            "start_logit": 8.2734375,
            "end_logit": 7.29296875,
            "text": "Ras",
            "probability": 1.0
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.609375,
            "text": "Ras/Raf",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.62890625,
            "text": "Ras/Raf-prototy",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.6328125,
            "text": "Ras/Raf-prototypic",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.8046875,
            "text": "Ras/Raf-prototypic oncogenes",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.03125,
            "text": "Ras/Raf-proto",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.34375,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safeguard program",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.390625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.41015625,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safeguard",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.43359375,
            "text": "Ras/Raf-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.4375,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as a default cellular safegu",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.4375,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest, as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.5859375,
            "text": "Ras/Raf-prototypic oncogenes induce cellular senescence, a terminal cell-cycle arrest,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.59765625,
            "text": "Ras/Raf-prototypic oncogenes induce",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.609375,
            "text": "/Raf",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.62890625,
            "text": "/Raf-prototy",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.6328125,
            "text": "/Raf-prototypic",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.8046875,
            "text": "/Raf-prototypic oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -7.03125,
            "text": "/Raf-proto",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -7.34375,
            "text": "terminal cell-cycle arrest, as a default cellular safeguard program",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_5": [
        {
            "start_logit": 7.78515625,
            "end_logit": 7.83203125,
            "text": "Myc",
            "probability": 1.0
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -5.83984375,
            "text": "Myc style",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 7.83203125,
            "text": ", Myc",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.83203125,
            "text": "senescence, Myc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.83203125,
            "text": "oncogene-induced senescence, Myc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": -5.83984375,
            "text": ", Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -5.83984375,
            "text": "senescence, Myc style",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.83984375,
            "text": "oncogene-induced senescence, Myc style",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_6": [
        {
            "start_logit": 8.4921875,
            "end_logit": 6.953125,
            "text": "Myc",
            "probability": 1.0
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -6.98046875,
            "text": "Myc-induced senescence - which is detectable to a limited degree as",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.0859375,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a cell-autonomous, direct response to Myc",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.19140625,
            "text": "Myc-induced",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.2421875,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a cell-autonomous, direct response to Myc action",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.265625,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a cell-autonomous",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.28515625,
            "text": "Myc-induced senescence - which",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.2890625,
            "text": "Myc-induced senescence - which is detectable to a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.30859375,
            "text": "Myc-induced senescence",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.3828125,
            "text": "Myc-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.46484375,
            "text": "Myc-induced senescence - which is detectable to a limited degree as a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 6.953125,
            "text": "here evidence for Myc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.953125,
            "text": "review and discuss here evidence for Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.953125,
            "text": "evidence for Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.953125,
            "text": "for Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 6.953125,
            "text": "We review and discuss here evidence for Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -6.6875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -6.6875,
            "text": "namely cells of the host immune system, prompting them to release pro-senescent cytokines that strike back onto adjacent proliferating tumor cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -6.98046875,
            "text": "here evidence for Myc-induced senescence - which is detectable to a limited degree as",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.6875,
            "text": "tumor cells.",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_7": [
        {
            "start_logit": 8.484375,
            "end_logit": 8.1015625,
            "text": "Skp2 inactivation",
            "probability": 1.0
        },
        {
            "start_logit": 8.484375,
            "end_logit": -2.5390625,
            "text": "Sk",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 8.484375,
            "end_logit": -2.71484375,
            "text": "Skp2",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -3.248046875,
            "end_logit": 8.1015625,
            "text": "inactivation",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 8.1015625,
            "text": "genetic Skp2 inactivation",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.77734375,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.82421875,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.91015625,
            "text": "Skp2 inactivation evokes cellular senescence even",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -6.95703125,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.0703125,
            "text": "Skp2 inactivation evoke",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.09765625,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.1328125,
            "text": "Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": -2.5390625,
            "text": "genetic Sk",
            "probability": 0.0
        },
        {
            "start_logit": -5.6328125,
            "end_logit": -2.71484375,
            "text": "genetic Skp2",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -6.77734375,
            "text": "inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -6.82421875,
            "text": "inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -6.91015625,
            "text": "inactivation evokes cellular senescence even",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -6.95703125,
            "text": "inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -6.9921875,
            "text": "inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF complex",
            "probability": 0.0
        },
        {
            "start_logit": -3.248046875,
            "end_logit": -7.05078125,
            "text": "inactivation evokes cellular senescence even in oncogenic conditions in which the p19(Arf)-p53 response is impaired, whereas a Skp2-SCF complex inhibitor",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_8": [
        {
            "start_logit": 8.4609375,
            "end_logit": 6.96875,
            "text": "RAS",
            "probability": 1.0
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -1.849609375,
            "text": "RAS/BRAF",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -6.1171875,
            "text": "RAS/BRAF oncogenes",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -6.359375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 6.96875,
            "text": "Activated RAS",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.234375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.31640625,
            "text": "RAS/BRAF oncogenes induce cellular senescence as",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.43359375,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.484375,
            "text": "RAS/BRAF oncogenes induce cellular senescence",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.4921875,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.5,
            "text": "RAS/BRAF oncogenes induce",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.4609375,
            "end_logit": -7.5078125,
            "text": "RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -1.849609375,
            "text": "Activated RAS/BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -1.849609375,
            "text": "/BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -1.849609375,
            "text": "BRAF",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -6.1171875,
            "text": "Activated RAS/BRAF oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -6.359375,
            "text": "Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -7.234375,
            "text": "Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -6.1171875,
            "text": "/BRAF oncogenes",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -7.31640625,
            "text": "Activated RAS/BRAF oncogenes induce cellular senescence as",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_9": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.87109375,
            "text": "Myc",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.44140625,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein Wrn",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.97265625,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein Wrn.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.984375,
            "text": "Myc also causes senescence in cells lacking the DNA repair",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.20703125,
            "text": "Myc also causes senescence",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.27734375,
            "text": "Myc also causes senescence in cells lacking",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.33984375,
            "text": "Myc also",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.40625,
            "text": "Myc also causes senescence in cells lacking the DNA repair protein",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.48828125,
            "text": "Myc also causes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.5,
            "text": "Myc also causes senescence in cells lacking the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.5234375,
            "text": "Myc also causes senescence in cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.53125,
            "text": "Myc also causes senescence in cells lacking the DNA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -6.44140625,
            "text": "DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -6.97265625,
            "text": "DNA repair protein Wrn.",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -6.984375,
            "text": "DNA repair",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.97265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.44140625,
            "text": "Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -6.44140625,
            "text": "in cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -7.40625,
            "text": "DNA repair protein",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.44140625,
            "text": "cells lacking the DNA repair protein Wrn",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_10": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.640625,
            "text": "Akt",
            "probability": 1.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": 7.640625,
            "text": "expression of such an oncogene, Akt",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 7.640625,
            "text": ", Akt",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.4921875,
            "text": "Akt, causes senescence in primary mouse hepatoblasts",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 7.640625,
            "text": "oncogene, Akt",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.890625,
            "text": "Akt,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.9453125,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in vitro.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.0234375,
            "text": "Akt, causes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 7.640625,
            "text": "that expression of such an oncogene, Akt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.17578125,
            "text": "Akt, causes senescence",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.25390625,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in vitro",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.28515625,
            "text": "Akt, causes senescence in primary mouse hepat",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.640625,
            "text": "an oncogene, Akt",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.3984375,
            "text": "Akt, causes senescence in primary mouse hepatoblasts in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.53125,
            "text": "Akt, causes senescence in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.640625,
            "text": "of such an oncogene, Akt",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.640625,
            "text": "found that expression of such an oncogene, Akt",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.640625,
            "text": "have found that expression of such an oncogene, Akt",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.640625,
            "text": "such an oncogene, Akt",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.640625,
            "text": "We have found that expression of such an oncogene, Akt",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5309f8f5970c65fa6b000001_11": [
        {
            "start_logit": 5.81640625,
            "end_logit": 8.0625,
            "text": "AKT",
            "probability": 1.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": 8.0625,
            "text": "hyperproliferative signaling through AKT",
            "probability": 0.0001214742660522461
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 8.0625,
            "text": "through AKT",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -6.921875,
            "end_logit": 8.0625,
            "text": "signaling through AKT",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.0625,
            "text": "roliferative signaling through AKT",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -5.12109375,
            "text": "AKT might",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -5.36328125,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate cells.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -5.8046875,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate cells",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -6.140625,
            "text": "AKT might be",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -6.5390625,
            "text": "AKT might be a driving force of the senescence in activated hepatic stellate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -6.859375,
            "text": "AKT might be a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -7.2421875,
            "text": "AKT might be a driving force",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -7.28515625,
            "text": "AKT might be a driving force of the senescence in activated hepatic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -5.12109375,
            "text": "hyperproliferative signaling through AKT might",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -5.36328125,
            "text": "hyperproliferative signaling through AKT might be a driving force of the senescence in activated hepatic stellate cells.",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -5.8046875,
            "text": "hyperproliferative signaling through AKT might be a driving force of the senescence in activated hepatic stellate cells",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -6.140625,
            "text": "hyperproliferative signaling through AKT might be",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -6.5390625,
            "text": "hyperproliferative signaling through AKT might be a driving force of the senescence in activated hepatic stellate",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -6.859375,
            "text": "hyperproliferative signaling through AKT might be a",
            "probability": 0.0
        },
        {
            "start_logit": -3.205078125,
            "end_logit": -7.1796875,
            "text": "hyperproliferative",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_12": [
        {
            "start_logit": 7.5078125,
            "end_logit": 8.125,
            "text": "RAS",
            "probability": 1.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 8.125,
            "text": "oncogenic RAS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -6.7109375,
            "text": "RAS expression",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -7.421875,
            "text": "RAS expression, which causes genotoxic stress and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -7.46484375,
            "text": "RAS expression, which causes genotoxic stress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -7.4921875,
            "text": "RAS expression, which causes genotoxic stress and senescence",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -7.56640625,
            "text": "RAS expression, which causes genotoxic stress and senescence in normal cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.5078125,
            "end_logit": -7.62109375,
            "text": "RAS expression,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -6.7109375,
            "text": "oncogenic RAS expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.421875,
            "text": "oncogenic RAS expression, which causes genotoxic stress and",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.46484375,
            "text": "oncogenic RAS expression, which causes genotoxic stress",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.4921875,
            "text": "oncogenic RAS expression, which causes genotoxic stress and senescence",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.56640625,
            "text": "oncogenic RAS expression, which causes genotoxic stress and senescence in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.62109375,
            "text": "oncogenic RAS expression,",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.421875,
            "text": "causes genotoxic stress and",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.46484375,
            "text": "causes genotoxic stress",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.421875,
            "text": "genotoxic stress and",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.4921875,
            "text": "causes genotoxic stress and senescence",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.46484375,
            "text": "genotoxic stress",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.4921875,
            "text": "genotoxic stress and senescence",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_13": [
        {
            "start_logit": 9.1171875,
            "end_logit": 8.5625,
            "text": "c-Myc",
            "probability": 1.0
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.4443359375,
            "text": "c",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -2.890625,
            "text": "c-Myc (MYC",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -2.392578125,
            "end_logit": 8.5625,
            "text": "Myc",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -5.484375,
            "text": "c-Myc (MYC)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.0625,
            "text": "c-Myc (MYC) oncogene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.203125,
            "text": "c-Myc (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.75,
            "end_logit": 8.5625,
            "text": "-Myc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.078125,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.0859375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.12890625,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and hepatocellular carcinoma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.27734375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and hepatocellular carcinoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.36328125,
            "text": "c-Myc (MYC) oncogene induces",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.390625,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.484375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.5625,
            "text": "Here we report that the suppression of the c-Myc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.5234375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types including lymphoma, osteosarcoma, and hepatocellular",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.52734375,
            "text": "c-Myc (MYC) oncogene induces cellular senescence in diverse tumor types",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 8.5625,
            "text": "suppression of the c-Myc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.5625,
            "text": "that the suppression of the c-Myc",
            "probability": 5.960464477539063e-08
        }
    ],
    "5309f8f5970c65fa6b000001_14": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.67578125,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 7.984375,
            "end_logit": -6.62109375,
            "text": "MYC inactivation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.26171875,
            "text": "MYC inactivation was associated with prototypic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.27734375,
            "text": "MYC inactivation was",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.37890625,
            "text": "MYC inactivation was associated with prototypical",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.43359375,
            "text": "MYC inactivation was associated with prototy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.4375,
            "text": "MYC inactivation was associated with prototypical markers",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.484375,
            "text": "MYC inactivation was associated with prototypical markers of senescence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.484375,
            "text": "MYC inactivation was associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.515625,
            "text": "MYC inactivation was associated with prototypical markers of",
            "probability": 2.384185791015625e-07
        }
    ],
    "5309f8f5970c65fa6b000001_15": [
        {
            "start_logit": 8.1484375,
            "end_logit": 7.4375,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.5390625,
            "text": "MYC inactivation induce robust senescence and sustained tumor",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.59375,
            "text": "MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.796875,
            "text": "MYC inactivation",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.90234375,
            "text": "MYC inactivation induce robust senescence and sustained tumor regression.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.125,
            "text": "MYC inactivation induce robust senescence",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 7.4375,
            "text": "did MYC",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.31640625,
            "text": "MYC inactivation induce",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 7.4375,
            "text": "only after lymphomas were repaired for p53 expression did MYC",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.55078125,
            "text": "MYC inactivation induce robust senescence and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.5625,
            "text": "MYC inactivation induce robust",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.4375,
            "text": "after lymphomas were repaired for p53 expression did MYC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.4375,
            "text": "lymphomas were repaired for p53 expression did MYC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.4375,
            "text": "for p53 expression did MYC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.4375,
            "text": "repaired for p53 expression did MYC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.4375,
            "text": "were repaired for p53 expression did MYC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": -6.5390625,
            "text": "did MYC inactivation induce robust senescence and sustained tumor",
            "probability": 0.0
        },
        {
            "start_logit": -6.46484375,
            "end_logit": -6.59375,
            "text": "did MYC inactivation induce robust senescence and sustained tumor regression",
            "probability": 0.0
        },
        {
            "start_logit": -6.68359375,
            "end_logit": -6.4765625,
            "text": "only after lymphomas were repaired for p53 expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.68359375,
            "end_logit": -6.48828125,
            "text": "only after lymphomas were repaired for p53",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_16": [
        {
            "start_logit": 7.08984375,
            "end_logit": 7.76953125,
            "text": "ras",
            "probability": 1.0
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -0.6552734375,
            "text": "ras, or p16",
            "probability": 0.0002200603485107422
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 7.76953125,
            "text": "overexpression of oncogenic ras",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -6.234375,
            "end_logit": 7.76953125,
            "text": "oncogenic ras",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 7.76953125,
            "text": "by the overexpression of oncogenic ras",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 7.76953125,
            "text": "Replicative senescence due to telomere shortening can, for example, be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 7.76953125,
            "text": "the overexpression of oncogenic ras",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.76953125,
            "text": "premature senescence by the overexpression of oncogenic ras",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 7.76953125,
            "text": "induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 7.76953125,
            "text": ", premature senescence by the overexpression of oncogenic ras",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -6.6640625,
            "text": "ras, or p16.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.76953125,
            "text": "by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.76953125,
            "text": "dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.76953125,
            "text": ", be induced by a dominant negative version of telomerase, premature senescence by the overexpression of oncogenic ras",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -7.30078125,
            "text": "ras,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -7.50390625,
            "text": "ras, or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -0.6552734375,
            "text": "p16",
            "probability": 0.0
        },
        {
            "start_logit": -5.9609375,
            "end_logit": -0.6552734375,
            "text": "overexpression of oncogenic ras, or p16",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -0.6552734375,
            "text": "oncogenic ras, or p16",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -0.6552734375,
            "text": "by the overexpression of oncogenic ras, or p16",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_17": [
        {
            "start_logit": 8.671875,
            "end_logit": 8.0859375,
            "text": "HDAC2",
            "probability": 1.0
        },
        {
            "start_logit": 8.671875,
            "end_logit": -2.04296875,
            "text": "HDAC",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -1.68359375,
            "end_logit": 8.0859375,
            "text": "knockdown of HDAC2",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -3.466796875,
            "end_logit": 8.0859375,
            "text": "2",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 8.671875,
            "end_logit": -5.50390625,
            "text": "HDAC2 induced cellular senescence.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.671875,
            "end_logit": -6.7578125,
            "text": "HDAC2 induced",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -6.953125,
            "text": "HDAC2 induced cellular senescence",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.0859375,
            "text": "of HDAC2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -2.04296875,
            "text": "knockdown of HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -5.50390625,
            "text": "knockdown of HDAC2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -6.72265625,
            "text": "knockdown",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -6.7578125,
            "text": "knockdown of HDAC2 induced",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -6.953125,
            "text": "knockdown of HDAC2 induced cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -2.04296875,
            "text": "of HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -3.466796875,
            "end_logit": -5.50390625,
            "text": "2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -3.466796875,
            "end_logit": -6.7578125,
            "text": "2 induced",
            "probability": 0.0
        },
        {
            "start_logit": -3.466796875,
            "end_logit": -6.953125,
            "text": "2 induced cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -5.59375,
            "end_logit": -5.50390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -5.50390625,
            "text": "of HDAC2 induced cellular senescence.",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.7578125,
            "text": "of HDAC2 induced",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_18": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.66796875,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 7.984375,
            "end_logit": -6.87890625,
            "text": "MYC overexpression",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -6.9453125,
            "text": "MYC overexpression is thought to initiate tumorigenesis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.39453125,
            "text": "MYC overexpression is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.3984375,
            "text": "MYC overexpression is thought",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.50390625,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.53515625,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.55078125,
            "text": "MYC overexpression is thought to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5546875,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5625,
            "text": "MYC overexpression is thought to initiate tumorigenesis by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5625,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.984375,
            "end_logit": -7.5703125,
            "text": "MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": -7.34765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -6.75390625,
            "text": "initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.75390625,
            "text": "cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -6.75390625,
            "text": "cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.75390625,
            "text": ", and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.75390625,
            "text": "proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.75390625,
            "text": "cellular senescence, and/or apoptosis",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_19": [
        {
            "start_logit": 7.82421875,
            "end_logit": 7.828125,
            "text": "Ras",
            "probability": 1.0
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.0,
            "text": "Ras over-expression",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.109375,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 7.828125,
            "text": "oncogenic Ras",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.89453125,
            "text": "Ras over-expression and inappropriate culture conditions",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.0859375,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.19921875,
            "text": "Ras over",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.26171875,
            "text": "Ras over-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.4375,
            "text": "Ras over-expression and inappropriate culture conditions,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.4453125,
            "text": "Ras over-expression and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.5,
            "text": "Ras over-expression and inappropriate culture conditions, also",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.828125,
            "text": "including oncogenic Ras",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.828125,
            "text": "conditions, including oncogenic Ras",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.5859375,
            "text": "Ras over-expression and inappropriate culture conditions, also induce senescence without telomere",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.828125,
            "text": "Several conditions, including oncogenic Ras",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.12109375,
            "end_logit": -5.0,
            "text": "oncogenic Ras over-expression",
            "probability": 0.0
        },
        {
            "start_logit": -6.12109375,
            "end_logit": -5.109375,
            "text": "oncogenic Ras over-expression and inappropriate culture conditions, also induce senescence without telomere shortening",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -5.109375,
            "text": "telomere shortening",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -5.0,
            "text": "over-expression",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -5.109375,
            "text": "over-expression and inappropriate culture conditions, also induce senescence without telomere shortening",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_20": [
        {
            "start_logit": 8.984375,
            "end_logit": 9.3046875,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": 9.3046875,
            "text": "1",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.7861328125,
            "text": "caveolin",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -2.673828125,
            "end_logit": 9.3046875,
            "text": "Expression of caveolin-1",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -6.15625,
            "end_logit": 9.3046875,
            "text": "-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 9.3046875,
            "text": "of caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.2421875,
            "text": "caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.09765625,
            "text": "caveolin-1 induces",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.14453125,
            "text": "caveolin-1 induces premature cellular senescence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.48828125,
            "text": "caveolin-1 induces premature cellular senescence in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.673828125,
            "end_logit": -1.7861328125,
            "text": "Expression of caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -6.2421875,
            "text": "1 induces premature cellular senescence in primary cultures of murine fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -1.7861328125,
            "text": "of caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.09765625,
            "text": "1 induces",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.14453125,
            "text": "1 induces premature cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -1.3427734375,
            "end_logit": -7.48828125,
            "text": "1 induces premature cellular senescence in",
            "probability": 0.0
        },
        {
            "start_logit": -2.673828125,
            "end_logit": -6.2421875,
            "text": "Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts",
            "probability": 0.0
        },
        {
            "start_logit": -2.673828125,
            "end_logit": -6.6328125,
            "text": "Expression",
            "probability": 0.0
        },
        {
            "start_logit": -2.673828125,
            "end_logit": -7.09765625,
            "text": "Expression of caveolin-1 induces",
            "probability": 0.0
        },
        {
            "start_logit": -2.673828125,
            "end_logit": -7.14453125,
            "text": "Expression of caveolin-1 induces premature cellular senescence",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_21": [
        {
            "start_logit": 8.8046875,
            "end_logit": 9.328125,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.2021484375,
            "end_logit": 9.328125,
            "text": "1",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -2.0390625,
            "text": "caveolin",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 9.328125,
            "text": "that mouse embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.93359375,
            "end_logit": 9.328125,
            "text": "-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 9.328125,
            "text": "overexpressing caveolin-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.08984375,
            "text": "caveolin-1 show: 1) a reduced proliferative lifespan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 9.328125,
            "text": "Here, we demonstrate that mouse embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.328125,
            "text": "embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 9.328125,
            "text": "mouse embryonic fibroblasts transgenically overexpressing caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.65625,
            "text": "caveolin-1 show",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2021484375,
            "end_logit": -6.08984375,
            "text": "1 show: 1) a reduced proliferative lifespan",
            "probability": 0.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": -2.0390625,
            "text": "that mouse embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -1.2021484375,
            "end_logit": -6.65625,
            "text": "1 show",
            "probability": 0.0
        },
        {
            "start_logit": -1.2021484375,
            "end_logit": -6.71484375,
            "text": "1 show: 1) a reduced proliferative lifespan; 2) senescence-like cell morphology; and 3) a senescence-associated increase in beta-galactosidase",
            "probability": 0.0
        },
        {
            "start_logit": -6.3671875,
            "end_logit": -2.0390625,
            "text": "overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -2.0390625,
            "text": "Here, we demonstrate that mouse embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -2.0390625,
            "text": "embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": -2.0390625,
            "text": "mouse embryonic fibroblasts transgenically overexpressing caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": -6.08984375,
            "text": "that mouse embryonic fibroblasts transgenically overexpressing caveolin-1 show: 1) a reduced proliferative lifespan",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_22": [
        {
            "start_logit": 8.671875,
            "end_logit": 8.9921875,
            "text": "caveolin-1",
            "probability": 0.9677734375
        },
        {
            "start_logit": 5.21484375,
            "end_logit": 8.9921875,
            "text": "hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 0.0306243896484375
        },
        {
            "start_logit": 5.21484375,
            "end_logit": 5.703125,
            "text": "hydrogen peroxide",
            "probability": 0.0011510848999023438
        },
        {
            "start_logit": -2.00390625,
            "end_logit": 8.9921875,
            "text": "1",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": 8.671875,
            "end_logit": -2.275390625,
            "text": "caveolin",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 8.9921875,
            "text": "premature senescence induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.71875,
            "end_logit": 8.9921875,
            "text": "antisense caveolin-1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 8.9921875,
            "text": "peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 8.9921875,
            "text": "by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.015625,
            "end_logit": 8.9921875,
            "text": "-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -2.275390625,
            "text": "hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.12890625,
            "end_logit": 8.9921875,
            "text": "Interestingly, premature senescence induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.9921875,
            "text": "NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -6.77734375,
            "text": "caveolin-1. Importantly, induction of premature senescence is recovered when caveolin-1 levels are restored.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -6.78515625,
            "text": "caveolin-1.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 8.9921875,
            "text": ", premature senescence induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.9921875,
            "text": "in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.9921875,
            "text": "harboring antisense caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.9921875,
            "text": "induced by hydrogen peroxide is greatly reduced in NIH 3T3 cells harboring antisense caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.15625,
            "text": "caveolin-1. Importantly, induction of premature senescence",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5309f8f5970c65fa6b000001_23": [
        {
            "start_logit": 8.8125,
            "end_logit": 9.3046875,
            "text": "caveolin-1",
            "probability": 1.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": 9.3046875,
            "text": "1",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.146484375,
            "text": "caveolin",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -5.9375,
            "end_logit": 9.3046875,
            "text": "-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 9.3046875,
            "text": "results clearly indicate a central role for caveolin-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 9.3046875,
            "text": "these results clearly indicate a central role for caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.3046875,
            "text": "central role for caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.3046875,
            "text": "role for caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.609375,
            "text": "caveolin-1 in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.3046875,
            "text": "a central role for caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.3046875,
            "text": "for caveolin-1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.94140625,
            "text": "caveolin-1 in promoting cellular senescence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.42578125,
            "text": "caveolin-1 in promoting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -6.609375,
            "text": "1 in",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -6.94140625,
            "text": "1 in promoting cellular senescence",
            "probability": 0.0
        },
        {
            "start_logit": -1.3330078125,
            "end_logit": -7.42578125,
            "text": "1 in promoting",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -2.146484375,
            "text": "results clearly indicate a central role for caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -2.146484375,
            "text": "these results clearly indicate a central role for caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -2.146484375,
            "text": "central role for caveolin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -2.146484375,
            "text": "role for caveolin",
            "probability": 0.0
        }
    ],
    "5309f8f5970c65fa6b000001_24": [
        {
            "start_logit": 7.6484375,
            "end_logit": 8.0,
            "text": "ras",
            "probability": 1.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.0,
            "text": "oncogenic ras",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.76171875,
            "text": "ras or activated mek1 with p53",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.0,
            "text": "coexpression of oncogenic ras",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.96875,
            "text": "ras or activated mek1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.97265625,
            "text": "ras or",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.0,
            "text": "contrast, coexpression of oncogenic ras",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.0,
            "text": "of oncogenic ras",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.0,
            "text": ", coexpression of oncogenic ras",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.0,
            "text": "In contrast, coexpression of oncogenic ras",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.359375,
            "text": "ras or activated mek",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.37890625,
            "text": "ras or activated mek1 with",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.48046875,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.5234375,
            "text": "ras or activated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.56640625,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.5703125,
            "text": "ras or activated mek1 with p53 enhanced both p53",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.5703125,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.5859375,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest that displayed features",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.58984375,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.59375,
            "text": "ras or activated mek1 with p53 enhanced both p53 levels and activity relative to that observed for p53 alone and produced an irreversible cell cycle arrest that displayed",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5309f8f5970c65fa6b000001_25": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.875,
            "text": "MYC",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.890625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known as oncogene addiction",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.94921875,
            "text": "MYC is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.03125,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.875,
            "text": "of MYC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.21484375,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known as oncogene addiction.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.2265625,
            "text": "MYC is sufficient",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.875,
            "text": "levels of MYC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.875,
            "text": "oncogenic levels of MYC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.875,
            "text": "suppression of oncogenic levels of MYC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.3515625,
            "text": "MYC is sufficient to induce sustained tumor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.359375,
            "text": "MYC is sufficient to induce sustained tumor regression",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.875,
            "text": "The suppression of oncogenic levels of MYC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.47265625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.49609375,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.5078125,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.51953125,
            "text": "MYC is sufficient to induce sustained tumor regression associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.53125,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence, and/or apoptosis, a phenomenon known",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.59765625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.6015625,
            "text": "MYC is sufficient to induce sustained tumor regression associated with proliferative arrest, differentiation, cellular senescence,",
            "probability": 1.7881393432617188e-07
        }
    ],
    "6206b8c2c9dfcb9c0900003c_1": [
        {
            "start_logit": 9.3828125,
            "end_logit": 9.1640625,
            "text": "EC migration",
            "probability": 1.0
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -0.58251953125,
            "text": "EC",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": 9.1640625,
            "text": "migration",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.125,
            "text": "EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -6.875,
            "text": "EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2) PI3K/AKT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.33984375,
            "text": "EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2) PI3K",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.37890625,
            "text": "EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 9.1640625,
            "text": "for EC migration",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.40625,
            "text": "EC migration, with 42/198 genes being",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.46484375,
            "text": "EC migration,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -6.125,
            "text": "migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -0.58251953125,
            "text": "for EC",
            "probability": 0.0
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -6.875,
            "text": "migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2) PI3K/AKT",
            "probability": 0.0
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -7.33984375,
            "text": "migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2) PI3K",
            "probability": 0.0
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -7.37890625,
            "text": "migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK, 2",
            "probability": 0.0
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -7.40625,
            "text": "migration, with 42/198 genes being",
            "probability": 0.0
        },
        {
            "start_logit": -1.4306640625,
            "end_logit": -7.46484375,
            "text": "migration,",
            "probability": 0.0
        },
        {
            "start_logit": -6.93359375,
            "end_logit": -6.125,
            "text": "MEK/ERK",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -6.125,
            "text": ") MEK/ERK",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -6.125,
            "text": "for EC migration, with 42/198 genes being involved in the following EC migration-related pathways: 1) MEK/ERK",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_1": [
        {
            "start_logit": 7.59765625,
            "end_logit": 8.0078125,
            "text": "Mannose 6-phosphate receptors",
            "probability": 0.98828125
        },
        {
            "start_logit": 7.59765625,
            "end_logit": 3.533203125,
            "text": "Mannose 6-phosphate receptors (MPRs)",
            "probability": 0.0112457275390625
        },
        {
            "start_logit": -2.9296875,
            "end_logit": 8.0078125,
            "text": "receptors",
            "probability": 2.6404857635498047e-05
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -3.41796875,
            "text": "Mannose 6-phosphate receptors (MPR",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -3.736328125,
            "text": "Mannose",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -4.359375,
            "text": "Mannose 6-phosphate",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -4.546875,
            "text": "Mannose 6-phosphate receptors (",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -4.73828125,
            "text": "Mannose 6-phosphate receptors (MPRs",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.0078125,
            "text": "6-phosphate receptors",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -6.87890625,
            "text": "Mannose 6-phosphate receptors (MPRs) are",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -6.94921875,
            "text": "Mannose 6-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.9296875,
            "end_logit": 3.533203125,
            "text": "receptors (MPRs)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.37109375,
            "text": "Mannose 6-phosphate receptors (MPRs) are known",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.47265625,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.48828125,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.51953125,
            "end_logit": 3.533203125,
            "text": "MPRs)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 3.533203125,
            "text": ")",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 3.533203125,
            "text": "6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 3.533203125,
            "text": "s)",
            "probability": 0.0
        },
        {
            "start_logit": -2.9296875,
            "end_logit": -3.41796875,
            "text": "receptors (MPR",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_2": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.0,
            "text": "sortilin",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5595703125,
            "text": "sort",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -2.07421875,
            "end_logit": 9.0,
            "text": "ilin",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.0,
            "text": "by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.58203125,
            "text": "sortilin.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.0,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.0,
            "text": ", is sorted and trafficked to the lysosomes by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.0,
            "text": "certain soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.0,
            "text": "hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.0,
            "text": "lysosomal hydrolases, is sorted and trafficked to the lysosomes by sortilin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21875,
            "end_logit": -1.5595703125,
            "text": "by sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -1.5595703125,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -1.5595703125,
            "text": ", is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -1.5595703125,
            "text": "certain soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -1.5595703125,
            "text": "hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.5595703125,
            "text": "lysosomal hydrolases, is sorted and trafficked to the lysosomes by sort",
            "probability": 0.0
        },
        {
            "start_logit": -2.07421875,
            "end_logit": -7.58203125,
            "text": "ilin.",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -7.58203125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.58203125,
            "text": "by sortilin.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.31640625,
            "text": "soluble lysosomal hydrolases, is sorted and trafficked to the lysosomes",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_3": [
        {
            "start_logit": 6.046875,
            "end_logit": 6.11328125,
            "text": "sortilin",
            "probability": 0.87744140625
        },
        {
            "start_logit": 5.1875,
            "end_logit": 5.00390625,
            "text": "Mannose-6-phosphate receptors",
            "probability": 0.12255859375
        },
        {
            "start_logit": 5.1875,
            "end_logit": -1.8779296875,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.0001266002655029297
        },
        {
            "start_logit": -5.34375,
            "end_logit": 6.11328125,
            "text": "receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -5.4140625,
            "end_logit": 6.11328125,
            "text": "ilin",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -5.3828125,
            "text": "sort",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.17578125,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -5.34375,
            "end_logit": 5.00390625,
            "text": "receptors",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -6.53125,
            "end_logit": 6.11328125,
            "text": ". Recently, the multi-ligand receptor sortilin",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.62109375,
            "text": "Mannose",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -6.5,
            "text": "sortilin has",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.93359375,
            "text": "Mannose-6-phosphate",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.96875,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -6.921875,
            "text": "sortilin has also",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 6.11328125,
            "text": "MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes. Recently, the multi-ligand receptor sortilin",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -6.30078125,
            "text": "Mannose-6-phosphate receptors (",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -7.17578125,
            "text": "sortilin has also been implicated",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -7.1953125,
            "text": "sortilin has also been",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 6.11328125,
            "text": "receptor sortilin",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -7.3203125,
            "text": "sortilin has also been implicated in this transport",
            "probability": 1.3113021850585938e-06
        }
    ],
    "554101d0234c5a7c75000002_4": [
        {
            "start_logit": 8.8125,
            "end_logit": 9.0625,
            "text": "sortilin",
            "probability": 1.0
        },
        {
            "start_logit": -1.9013671875,
            "end_logit": 9.0625,
            "text": "ilin",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.23828125,
            "text": "sort",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -5.05859375,
            "end_logit": 9.0625,
            "text": "and sortilin",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.09375,
            "end_logit": 9.0625,
            "text": ", lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 9.0625,
            "text": "lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 9.0625,
            "text": "M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 9.0625,
            "text": ". Among them, the two that are mediated by the M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 9.0625,
            "text": "receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 9.0625,
            "text": "alternative receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.84765625,
            "text": "sortilin, have gained unequivocal support",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.0625,
            "text": "by the M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sortilin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.91015625,
            "text": "sortilin, have",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.0625,
            "text": "integral membrane protein (LIMP-2) and sortilin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.140625,
            "text": "sortilin, have gained unequivocal support.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.171875,
            "text": "sortilin, have gained",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.05859375,
            "end_logit": -2.23828125,
            "text": "and sort",
            "probability": 0.0
        },
        {
            "start_logit": -6.09375,
            "end_logit": -2.23828125,
            "text": ", lysosomal integral membrane protein (LIMP-2) and sort",
            "probability": 0.0
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -2.23828125,
            "text": "lysosomal integral membrane protein (LIMP-2) and sort",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -2.23828125,
            "text": "M6P alternative receptors, lysosomal integral membrane protein (LIMP-2) and sort",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_5": [
        {
            "start_logit": 8.203125,
            "end_logit": 4.6796875,
            "text": "cation-independent mannose 6-phosphate receptor",
            "probability": 0.90771484375
        },
        {
            "start_logit": 8.203125,
            "end_logit": 2.29296875,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR",
            "probability": 0.08380126953125
        },
        {
            "start_logit": 8.203125,
            "end_logit": -0.10870361328125,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR)",
            "probability": 0.007556915283203125
        },
        {
            "start_logit": 8.203125,
            "end_logit": -2.796875,
            "text": "cation",
            "probability": 0.0005140304565429688
        },
        {
            "start_logit": 1.552734375,
            "end_logit": 2.29296875,
            "text": "CI-MPR",
            "probability": 0.00010770559310913086
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.50390625,
            "text": "cation-independent mannose 6-phosphate",
            "probability": 3.415346145629883e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.8046875,
            "text": "cation-independent mannose 6-phosphate receptor (CI",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.015625,
            "text": "cation-independent mannose 6-phosphate receptor (",
            "probability": 2.0563602447509766e-05
        },
        {
            "start_logit": 1.552734375,
            "end_logit": -0.10870361328125,
            "text": "CI-MPR)",
            "probability": 9.775161743164062e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.15625,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors from the TGN to endosomes.",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.29296875,
            "text": "cation-independent mannose 6",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.296875,
            "text": "cation-independent mannose 6-",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.3671875,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.40234375,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors from the TGN to endosomes",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.53125,
            "text": "cation-independent mannose 6-phosphate receptor (CI-MPR) mediates sorting of lysosomal hydrolase precursors from",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5390625,
            "text": "cation-independent mannose 6-phosphate receptor (CI-",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.55078125,
            "text": "cation-independent",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -4.7421875,
            "end_logit": 4.6796875,
            "text": "receptor",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -4.828125,
            "end_logit": 4.6796875,
            "text": "mannose 6-phosphate receptor",
            "probability": 2.0265579223632812e-06
        }
    ],
    "554101d0234c5a7c75000002_6": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.953125,
            "text": "Mannose-6-phosphate receptors",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.95703125,
            "end_logit": 1.4990234375,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.0015726089477539062
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.3427734375,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 9.1552734375e-05
        },
        {
            "start_logit": -2.953125,
            "end_logit": 7.953125,
            "text": "receptors",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -3.31640625,
            "text": "Mannose",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -4.45703125,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.0703125,
            "text": "Mannose-6-phosphate",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.1015625,
            "text": "Mannose-6-phosphate receptors (",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 7.953125,
            "text": "-6-phosphate receptors",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.19140625,
            "text": "Mannose-6-phosphate receptors (MPRs) transport",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.21875,
            "text": "Mannose-6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.234375,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.953125,
            "text": "-phosphate receptors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.3671875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.953125,
            "text": "phosphate receptors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.38671875,
            "text": "Mannose-6-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.953125,
            "text": "6-phosphate receptors",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.546875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.08203125,
            "end_logit": 1.4990234375,
            "text": "MPRs)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.953125,
            "end_logit": 1.4990234375,
            "text": "receptors (MPRs)",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_7": [
        {
            "start_logit": 7.22265625,
            "end_logit": 8.09375,
            "text": "mannose 6-phosphate receptors",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.22265625,
            "end_logit": 0.458740234375,
            "text": "mannose 6-phosphate receptors (MPRs)",
            "probability": 0.0004837512969970703
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -1.6416015625,
            "text": "mannose 6-phosphate receptors (MPRs",
            "probability": 5.91278076171875e-05
        },
        {
            "start_logit": -2.986328125,
            "end_logit": 8.09375,
            "text": "receptors",
            "probability": 3.701448440551758e-05
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -4.11328125,
            "text": "mannose 6-phosphate receptors (MPR",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -4.1640625,
            "text": "mannose",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -4.59765625,
            "text": "mannose 6-phosphate",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.09375,
            "text": "related mannose 6-phosphate receptors",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 8.09375,
            "text": "Two related mannose 6-phosphate receptors",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -5.8046875,
            "text": "mannose 6-phosphate receptors (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 8.09375,
            "text": "6-phosphate receptors",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 8.09375,
            "text": "-phosphate receptors",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.37109375,
            "text": "mannose 6-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.46875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.5625,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.59375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.75390625,
            "end_logit": 0.458740234375,
            "text": "MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -2.986328125,
            "end_logit": 0.458740234375,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -1.6416015625,
            "text": "MPRs",
            "probability": 0.0
        },
        {
            "start_logit": -2.986328125,
            "end_logit": -1.6416015625,
            "text": "receptors (MPRs",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_8": [
        {
            "start_logit": 7.390625,
            "end_logit": 7.32421875,
            "text": "Mannose-6-phosphate receptors",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.390625,
            "end_logit": 0.70654296875,
            "text": "Mannose-6-phosphate receptors (MPRs)",
            "probability": 0.001323699951171875
        },
        {
            "start_logit": 7.390625,
            "end_logit": -1.529296875,
            "text": "Mannose-6-phosphate receptors (MPRs",
            "probability": 0.0001418590545654297
        },
        {
            "start_logit": -3.564453125,
            "end_logit": 7.32421875,
            "text": "receptors",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": 7.390625,
            "end_logit": -3.8828125,
            "text": "Mannose",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 7.390625,
            "end_logit": -4.12890625,
            "text": "Mannose-6-phosphate receptors (MPR",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 7.390625,
            "end_logit": -5.328125,
            "text": "Mannose-6-phosphate receptors (",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.390625,
            "end_logit": -5.5390625,
            "text": "Mannose-6-phosphate",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 7.32421875,
            "text": "-6-phosphate receptors",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.171875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.2578125,
            "text": "Mannose-6",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.32421875,
            "text": "-phosphate receptors",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.3359375,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from the trans Golgi network (TGN) to endosomes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.32421875,
            "text": "phosphate receptors",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.46875,
            "text": "Mannose-6-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.51171875,
            "text": "Mannose-6-phosphate receptors (MPRs) transport lysosomal hydrolases from",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.32421875,
            "text": "6-phosphate receptors",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.36328125,
            "end_logit": 0.70654296875,
            "text": "MPRs)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.564453125,
            "end_logit": 0.70654296875,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -2.36328125,
            "end_logit": -1.529296875,
            "text": "MPRs",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_9": [
        {
            "start_logit": 7.0546875,
            "end_logit": 7.51171875,
            "text": "Mannose 6-phosphate receptors",
            "probability": 0.9931640625
        },
        {
            "start_logit": 7.0546875,
            "end_logit": 2.5078125,
            "text": "Mannose 6-phosphate receptors (MPRs)",
            "probability": 0.00669097900390625
        },
        {
            "start_logit": -3.50390625,
            "end_logit": 7.51171875,
            "text": "receptors",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -3.34765625,
            "text": "Mannose 6-phosphate receptors (MPR",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -4.265625,
            "text": "Mannose",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -4.68359375,
            "text": "Mannose 6-phosphate",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -4.87890625,
            "text": "Mannose 6-phosphate receptors (",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -5.04296875,
            "text": "Mannose 6-phosphate receptors (MPRs",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.51171875,
            "text": "6-phosphate receptors",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.90625,
            "text": "Mannose 6-phosphate receptors (MPRs) are",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.0234375,
            "text": "Mannose 6-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.51171875,
            "text": "-phosphate receptors",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.37890625,
            "text": "Mannose 6-phosphate receptors (MPRs) are known",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.46875,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.49609375,
            "text": "Mannose 6-phosphate receptors (MPRs) are known to be",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.50390625,
            "end_logit": 2.5078125,
            "text": "receptors (MPRs)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 2.5078125,
            "text": "MPRs)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 2.5078125,
            "text": "6-phosphate receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 2.5078125,
            "text": ")",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 2.5078125,
            "text": "s)",
            "probability": 0.0
        }
    ],
    "554101d0234c5a7c75000002_10": [
        {
            "start_logit": 6.6640625,
            "end_logit": 7.91015625,
            "text": "mannose 6-phosphate receptors",
            "probability": 1.0
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -0.9541015625,
            "text": "mannose 6-phosphate receptors (MPRs)",
            "probability": 0.00014090538024902344
        },
        {
            "start_logit": -3.2265625,
            "end_logit": 7.91015625,
            "text": "receptors",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -2.615234375,
            "text": "mannose 6-phosphate receptors (MPRs",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -3.810546875,
            "text": "mannose 6-phosphate receptors (MPR",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -4.64453125,
            "text": "mannose",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -6.125,
            "end_logit": 7.91015625,
            "text": "related mannose 6-phosphate receptors",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -4.98046875,
            "text": "mannose 6-phosphate",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 7.91015625,
            "text": "Two related mannose 6-phosphate receptors",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 7.91015625,
            "text": "6-phosphate receptors",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -5.9140625,
            "text": "mannose 6-phosphate receptors (",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.91015625,
            "text": "-phosphate receptors",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.4375,
            "text": "mannose 6-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.46875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.55859375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.60546875,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.609375,
            "text": "mannose 6-phosphate receptors (MPRs) recognize this feature in the trans Golgi network (TGN) and deliver the hydrolases to the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.2265625,
            "end_logit": -0.9541015625,
            "text": "receptors (MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -3.66015625,
            "end_logit": -0.9541015625,
            "text": "MPRs)",
            "probability": 0.0
        },
        {
            "start_logit": -3.2265625,
            "end_logit": -2.615234375,
            "text": "receptors (MPRs",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_1": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.2109375,
            "text": "Retinochoroiditis",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.298828125,
            "text": "Retin",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.578125,
            "end_logit": 9.2109375,
            "text": "itis",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.21875,
            "end_logit": -5.2578125,
            "text": "Retinochoroiditis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.0390625,
            "text": "Retinochoroiditis is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 9.2109375,
            "text": "ochoroiditis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.53515625,
            "text": "Retinochoroid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.609375,
            "text": "Retinochor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.2109375,
            "text": "oroiditis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.07421875,
            "text": "Retinochoroiditis is the most frequent manifestation of congenital",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.2109375,
            "text": "oiditis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.30859375,
            "text": "Retinochoroiditis is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.40234375,
            "text": "Retinochoroiditis is the most frequent manifestation of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.4609375,
            "text": "Retinochoroiditis is the most frequent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.484375,
            "text": "Retinochoroiditis is the most frequent manifestation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.578125,
            "end_logit": -5.2578125,
            "text": "itis is the most frequent manifestation of congenital toxoplasmosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.578125,
            "end_logit": -6.0390625,
            "text": "itis is",
            "probability": 0.0
        },
        {
            "start_logit": -1.578125,
            "end_logit": -7.07421875,
            "text": "itis is the most frequent manifestation of congenital",
            "probability": 0.0
        },
        {
            "start_logit": -1.578125,
            "end_logit": -7.30859375,
            "text": "itis is the",
            "probability": 0.0
        },
        {
            "start_logit": -1.578125,
            "end_logit": -7.40234375,
            "text": "itis is the most frequent manifestation of",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_2": [
        {
            "start_logit": 3.099609375,
            "end_logit": 1.8349609375,
            "text": "posterior uveitis",
            "probability": 0.96337890625
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -1.884765625,
            "text": "posterior uveitis cases of which toxoplasmosis",
            "probability": 0.02337646484375
        },
        {
            "start_logit": -1.4384765625,
            "end_logit": 1.8349609375,
            "text": "Infectious uveitis accounted for 37% of posterior uveitis",
            "probability": 0.01029205322265625
        },
        {
            "start_logit": -4.40234375,
            "end_logit": 1.8349609375,
            "text": "uveitis accounted for 37% of posterior uveitis",
            "probability": 0.0005326271057128906
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -6.203125,
            "text": "posterior",
            "probability": 0.00031065940856933594
        },
        {
            "start_logit": -1.4384765625,
            "end_logit": -1.7294921875,
            "text": "Infectious uveitis",
            "probability": 0.0002918243408203125
        },
        {
            "start_logit": -1.4384765625,
            "end_logit": -1.884765625,
            "text": "Infectious uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis",
            "probability": 0.00024962425231933594
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -6.50390625,
            "text": "posterior uveitis cases of which toxoplasmosis was",
            "probability": 0.00023090839385986328
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -6.59765625,
            "text": "posterior uveitis cases",
            "probability": 0.00021028518676757812
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -6.796875,
            "text": "posterior uveitis cases of which toxoplasmosis was the most common cause",
            "probability": 0.000171661376953125
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -6.81640625,
            "text": "posterior uveitis cases of which toxoplasmosis was the most common cause.",
            "probability": 0.00016891956329345703
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -7.08984375,
            "text": "posterior uveitis cases of which toxoplasmosis was the",
            "probability": 0.0001285076141357422
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -7.3515625,
            "text": "posterior uveitis cases of",
            "probability": 9.85264778137207e-05
        },
        {
            "start_logit": 3.099609375,
            "end_logit": -7.3671875,
            "text": "posterior uveitis cases of which toxoplasmosis was the most common",
            "probability": 9.703636169433594e-05
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 1.8349609375,
            "text": "uveitis",
            "probability": 8.499622344970703e-05
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 1.8349609375,
            "text": "of posterior uveitis",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 1.8349609375,
            "text": "for 37% of posterior uveitis",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 1.8349609375,
            "text": "% of posterior uveitis",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -4.40234375,
            "end_logit": -1.7294921875,
            "text": "uveitis",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -4.40234375,
            "end_logit": -1.884765625,
            "text": "uveitis accounted for 37% of posterior uveitis cases of which toxoplasmosis",
            "probability": 1.2934207916259766e-05
        }
    ],
    "601d72181cb411341a000034_3": [
        {
            "start_logit": 8.671875,
            "end_logit": 9.2421875,
            "text": "posterior uveitis",
            "probability": 1.0
        },
        {
            "start_logit": -0.50537109375,
            "end_logit": 9.2421875,
            "text": "uveitis",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": 8.671875,
            "end_logit": -1.71875,
            "text": "posterior",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.2421875,
            "text": "cause of posterior uveitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.2421875,
            "text": "most common cause of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.05078125,
            "text": "posterior uveitis (60%)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.2421875,
            "text": "of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.15234375,
            "text": "posterior uveitis (60",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.34765625,
            "text": "posterior uveitis (60%",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.41015625,
            "text": "posterior uveitis (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.50537109375,
            "end_logit": -7.05078125,
            "text": "uveitis (60%)",
            "probability": 0.0
        },
        {
            "start_logit": -0.50537109375,
            "end_logit": -7.15234375,
            "text": "uveitis (60",
            "probability": 0.0
        },
        {
            "start_logit": -0.50537109375,
            "end_logit": -7.34765625,
            "text": "uveitis (60%",
            "probability": 0.0
        },
        {
            "start_logit": -0.50537109375,
            "end_logit": -7.41015625,
            "text": "uveitis (",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -1.71875,
            "text": "cause of posterior",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -1.71875,
            "text": "most common cause of posterior",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.71875,
            "text": "of posterior",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.05078125,
            "text": "cause of posterior uveitis (60%)",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -7.05078125,
            "text": "most common cause of posterior uveitis (60%)",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.15234375,
            "text": "cause of posterior uveitis (60",
            "probability": 0.0
        }
    ],
    "601d72181cb411341a000034_4": [
        {
            "start_logit": 3.642578125,
            "end_logit": 5.48828125,
            "text": "uveitis",
            "probability": 0.86474609375
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": 5.48828125,
            "text": "infectious uveitis",
            "probability": 0.134765625
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -2.740234375,
            "text": "uveitis, herpetic iridocyclitis",
            "probability": 0.0002294778823852539
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -2.740234375,
            "text": "infectious uveitis, herpetic iridocyclitis",
            "probability": 3.606081008911133e-05
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 5.48828125,
            "text": "For infectious uveitis",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -5.5625,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -6.2109375,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis, and bacterial endophthalmitis",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -6.69140625,
            "text": "uveitis, herpetic iridocycl",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -6.79296875,
            "text": "uveitis, herpetic irid",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -7.40234375,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis, and bacterial",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -5.5625,
            "text": "infectious uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -7.42578125,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis, and bacterial endophthalmitis increased",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -7.484375,
            "text": "uveitis, herpetic iridocyclitis,",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -7.49609375,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 3.642578125,
            "end_logit": -7.52734375,
            "text": "uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis,",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -6.2109375,
            "text": "infectious uveitis, herpetic iridocyclitis, ocular toxoplasmosis, ocular syphilis, and bacterial endophthalmitis",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -6.3125,
            "text": "infectious",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -6.69140625,
            "text": "infectious uveitis, herpetic iridocycl",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 1.7861328125,
            "end_logit": -6.79296875,
            "text": "infectious uveitis, herpetic irid",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.61328125,
            "end_logit": -2.740234375,
            "text": "herpetic iridocyclitis",
            "probability": 4.76837158203125e-07
        }
    ],
    "601d72181cb411341a000034_5": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.640625,
            "text": "posterior uveitis",
            "probability": 1.0
        },
        {
            "start_logit": 0.366943359375,
            "end_logit": 9.640625,
            "text": "uveitis",
            "probability": 0.00015974044799804688
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.1337890625,
            "text": "posterior",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.53515625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.640625,
            "text": "cause of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.05078125,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to be linked to human lesions in the eye.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.640625,
            "text": "Toxoplasmosis is the most common cause of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.640625,
            "text": "most common cause of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.640625,
            "text": "of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.640625,
            "text": "common cause of posterior uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.34375,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.40234375,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4140625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.4765625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.5625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to be linked to human lesions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.5703125,
            "text": "posterior uveitis in immunocompetent subjects",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.59375,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.59765625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to be linked to human lesions in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.6015625,
            "text": "posterior uveitis in immunocompetent subjects and congenital toxoplasmosis transmission was the first parasite to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.60546875,
            "text": "posterior uveitis in",
            "probability": 5.960464477539063e-08
        }
    ],
    "601d72181cb411341a000034_6": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.2890625,
            "text": "Retinochoroiditis",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.2412109375,
            "text": "Retin",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.404296875,
            "end_logit": 9.2890625,
            "text": "itis",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.03515625,
            "text": "Retinochoroiditis is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 9.2890625,
            "text": "ochoroiditis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.3203125,
            "text": "Retinochor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.3671875,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.5546875,
            "text": "Retinochoroid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 9.2890625,
            "text": "oroiditis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.02734375,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.06640625,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.06640625,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.2890625,
            "text": "oiditis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.09765625,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1875,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.31640625,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.375,
            "text": "Retinochoroiditis is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.46484375,
            "text": "Retinochoroiditis is the most common ocular manifestation of congenital",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.47265625,
            "text": "Retinochoroiditis is the most common ocular manifestation of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.404296875,
            "end_logit": -6.03515625,
            "text": "itis is",
            "probability": 0.0
        }
    ],
    "5162e44f298dcd4e5100004a_1": [
        {
            "start_logit": 8.578125,
            "end_logit": -0.169921875,
            "text": "Convection-enhanced delivery",
            "probability": 0.80908203125
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.22265625,
            "text": "Conve",
            "probability": 0.10406494140625
        },
        {
            "start_logit": 8.578125,
            "end_logit": -3.0234375,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy.",
            "probability": 0.04669189453125
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.46875,
            "text": "Convection-enhanced",
            "probability": 0.01100921630859375
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.890625,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading",
            "probability": 0.007221221923828125
        },
        {
            "start_logit": 8.578125,
            "end_logit": -5.12109375,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2",
            "probability": 0.005733489990234375
        },
        {
            "start_logit": 8.578125,
            "end_logit": -5.71875,
            "text": "Convection",
            "probability": 0.003154754638671875
        },
        {
            "start_logit": 8.578125,
            "end_logit": -5.91796875,
            "text": "Convection-enhanced delivery of neprilysin",
            "probability": 0.0025844573974609375
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.22265625,
            "text": "Convection-enhanced delivery of",
            "probability": 0.0019054412841796875
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.27734375,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy",
            "probability": 0.0018033981323242188
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.46484375,
            "text": "Convection-enhanced delivery of neprilysin:",
            "probability": 0.001495361328125
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.640625,
            "text": "Convection-enhanced delivery of neprilysin: a",
            "probability": 0.001255035400390625
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.7109375,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-",
            "probability": 0.0011692047119140625
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.8046875,
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic",
            "probability": 0.001064300537109375
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.8984375,
            "text": "Convection-",
            "probability": 0.0009694099426269531
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.98046875,
            "text": "Convection-enhanced delivery of neprilys",
            "probability": 0.0008931159973144531
        },
        {
            "start_logit": -1.5341796875,
            "end_logit": -3.0234375,
            "text": "amyloid-\u03b2-degrading therapeutic strategy.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -1.5341796875,
            "end_logit": -4.890625,
            "text": "amyloid-\u03b2-degrading",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.5341796875,
            "end_logit": -5.12109375,
            "text": "amyloid-\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -0.169921875,
            "text": "ction-enhanced delivery",
            "probability": 1.1920928955078125e-07
        }
    ],
    "6025a1e91cb411341a0000b4_1": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.3828125,
            "text": "tofacitinib",
            "probability": 1.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": 9.3828125,
            "text": "tinib",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.3369140625,
            "text": "tof",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -0.87060546875,
            "text": "methotrexate",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.171875,
            "end_logit": -5.46875,
            "text": "tofacitinib, baricitinib, filgotinib, upadacitinib).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.3828125,
            "text": "acitinib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.3828125,
            "text": "s) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.3828125,
            "text": "(the Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.3828125,
            "text": "Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -6.89453125,
            "text": "methotrexate (",
            "probability": 0.0
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.03125,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids",
            "probability": 0.0
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.10546875,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids (GCs",
            "probability": 0.0
        },
        {
            "start_logit": -1.115234375,
            "end_logit": -5.46875,
            "text": "tinib, baricitinib, filgotinib, upadacitinib).",
            "probability": 0.0
        },
        {
            "start_logit": -6.01953125,
            "end_logit": -0.87060546875,
            "text": "(methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -0.87060546875,
            "text": "s (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.17578125,
            "end_logit": -0.87060546875,
            "text": "recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -0.87060546875,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.87060546875,
            "text": "cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -0.87060546875,
            "text": ") DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -1.3369140625,
            "text": "s) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tof",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_2": [
        {
            "start_logit": 9.1015625,
            "end_logit": 9.390625,
            "text": "tofacitinib",
            "probability": 1.0
        },
        {
            "start_logit": 8.578125,
            "end_logit": 1.2958984375,
            "text": "methotrexate",
            "probability": 0.00017952919006347656
        },
        {
            "start_logit": -1.123046875,
            "end_logit": 9.390625,
            "text": "tinib",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.5244140625,
            "text": "tof",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.71484375,
            "text": "tofacitinib, baricitinib, filgotinib, upadacitinib).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 9.390625,
            "text": "acitinib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.390625,
            "text": "s) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.390625,
            "text": "JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.390625,
            "text": "Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.390625,
            "text": "s (the Janus kinase (JAK) inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.390625,
            "text": "inhibitors tofacitinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.859375,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.859375,
            "text": "methotrexate (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.05078125,
            "text": "methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids (GCs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 1.2958984375,
            "text": "(methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 1.2958984375,
            "text": "s (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 1.2958984375,
            "text": "cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 1.2958984375,
            "text": "task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": 1.2958984375,
            "text": ") DMARDs (methotrexate",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 1.2958984375,
            "text": "recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_3": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.6796875,
            "text": "methotrexate",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.8828125,
            "text": "methotrexate, sulfasalazine",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.50390625,
            "text": "methotrexate, sulfasalazine, leflunomide",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.640625,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.05859375,
            "text": "methotrexate, sulfasalazine, leflunomi",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.07421875,
            "text": "methotrexate, sulfasalazine, lefluno",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.1328125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychlor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.21875,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative period.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.4453125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative period",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.6796875,
            "text": "as methotrexate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.51171875,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxych",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.53125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.55078125,
            "text": "methotrexate, sulfasal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.5703125,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.6796875,
            "text": "Conventional synthetic DMARDs such as methotrexate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.6796875,
            "text": "synthetic DMARDs such as methotrexate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.6796875,
            "text": "DMARDs such as methotrexate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -5.8828125,
            "text": "sulfasalazine",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -6.50390625,
            "text": "sulfasalazine, leflunomide",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -6.640625,
            "text": "sulfasalazine, leflunomide, hydroxychloroquine",
            "probability": 0.0
        }
    ],
    "6025a1e91cb411341a0000b4_4": [
        {
            "start_logit": 6.45703125,
            "end_logit": 6.17578125,
            "text": "methotrexate",
            "probability": 0.99609375
        },
        {
            "start_logit": 2.890625,
            "end_logit": 4.1328125,
            "text": "tofacitinib",
            "probability": 0.003650665283203125
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -6.765625,
            "text": "methotrexate, sulfasalazine, leflunomide, hydroxychloroquine, gold salts and others).",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 6.17578125,
            "text": "while csDMARDs would comprise the traditional drugs (such as methotrexate",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.19140625,
            "text": "methotrexate, sulfasalazine",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.109375,
            "end_logit": 6.17578125,
            "text": "drugs (such as methotrexate",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.17578125,
            "text": "as methotrexate",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.17578125,
            "text": "csDMARDs would comprise the traditional drugs (such as methotrexate",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 6.17578125,
            "text": "Ds would comprise the traditional drugs (such as methotrexate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.17578125,
            "text": "traditional drugs (such as methotrexate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 4.1328125,
            "text": "tinib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 4.1328125,
            "text": "acitinib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 4.1328125,
            "text": "as tofacitinib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 4.1328125,
            "text": "such as tofacitinib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 4.1328125,
            "text": "tsDMARDs would then constitute only those that were specifically developed to target a particular molecular structure (such as tofacitinib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 4.1328125,
            "text": "only those that were specifically developed to target a particular molecular structure (such as tofacitinib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.890625,
            "end_logit": -7.00390625,
            "text": "tof",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.890625,
            "end_logit": -7.20703125,
            "text": "tofacitinib, fostamatinib, baricitinib or apremilast, or agents not focused primarily on rheumatic diseases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.890625,
            "end_logit": -7.23046875,
            "text": "tofacitinib, fostamatinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.890625,
            "end_logit": -7.2421875,
            "text": "tofacitinib, fostamatinib, baricitinib or apremilast, or",
            "probability": 5.960464477539063e-08
        }
    ],
    "54cf43abf693c3b16b000008_1": [
        {
            "start_logit": 7.328125,
            "end_logit": 8.2890625,
            "text": "lambdoid sutures",
            "probability": 1.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": 8.2890625,
            "text": "sagittal and both lambdoid sutures",
            "probability": 0.00014889240264892578
        },
        {
            "start_logit": -2.830078125,
            "end_logit": 8.2890625,
            "text": "sutures",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 7.328125,
            "end_logit": -3.791015625,
            "text": "lamb",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 8.2890625,
            "text": "trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid sutures",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 8.2890625,
            "text": "oid sutures",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.2890625,
            "text": "doid sutures",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -5.72265625,
            "text": "lambdoid",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.2890625,
            "text": "both lambdoid sutures",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.2890625,
            "text": "a trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid sutures",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 8.2890625,
            "text": "are a trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid sutures",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.2890625,
            "text": "the sagittal and both lambdoid sutures",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.2890625,
            "text": "involving the sagittal and both lambdoid sutures",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.2890625,
            "text": "and both lambdoid sutures",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -6.9140625,
            "text": "lambdoid sutures.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.484375,
            "end_logit": -3.791015625,
            "text": "sagittal and both lamb",
            "probability": 0.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": -5.72265625,
            "text": "sagittal and both lambdoid",
            "probability": 0.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": -6.03125,
            "text": "sagittal",
            "probability": 0.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": -6.9140625,
            "text": "sagittal and both lambdoid sutures.",
            "probability": 0.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": -7.25,
            "text": "sagittal and",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_2": [
        {
            "start_logit": 8.3671875,
            "end_logit": 8.96875,
            "text": "sagittal suture",
            "probability": 1.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": 8.96875,
            "text": "suture",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -2.521484375,
            "text": "sagittal",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.96875,
            "text": "Despite fusion of the sagittal suture",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.484375,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.5703125,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.96875,
            "text": ": Despite fusion of the sagittal suture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.96875,
            "text": "CONCLUSIONS: Despite fusion of the sagittal suture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.96875,
            "text": "of the sagittal suture",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.8671875,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.296875,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.4765625,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.5703125,
            "text": "sagittal suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -6.484375,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -6.5703125,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -6.8671875,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not reduction.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.296875,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.4765625,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull lengthening, not",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.5703125,
            "text": "suture, the surgical treatment for Mercedes Benz pattern craniosynostosis should include skull",
            "probability": 0.0
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -2.521484375,
            "text": "Despite fusion of the sagittal",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_3": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.44921875,
            "text": "bilateral lambdoid and sagittal synostosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -3.46484375,
            "text": "bilateral",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -3.37890625,
            "end_logit": 7.44921875,
            "text": "lambdoid and sagittal synostosis",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -3.96875,
            "end_logit": 7.44921875,
            "text": "ostosis",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -4.3203125,
            "text": "bilateral lambdoid",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -5.828125,
            "text": "bilateral lambdoid and sagittal syn",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.27734375,
            "text": "bilateral lambdoid and sagittal",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.3203125,
            "text": "bilateral lambdoid and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.453125,
            "text": "bilateral lambdoid and sagittal synostosis (BL",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.5078125,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.5625,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS) results in a very characteristic head shape with frontal bossing",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.609375,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS) results in a very characteristic head shape with frontal bos",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 7.44921875,
            "text": "craniosynostosis that includes bilateral lambdoid and sagittal synostosis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 7.44921875,
            "text": "sagittal synostosis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.8984375,
            "text": "bilateral lambdoid and sagittal synostosis (BLSS) results in a very characteristic head shape with frontal bossin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.44921875,
            "text": "synostosis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.44921875,
            "text": "includes bilateral lambdoid and sagittal synostosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.44921875,
            "text": "Multisutural craniosynostosis that includes bilateral lambdoid and sagittal synostosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -4.3203125,
            "text": "lambdoid",
            "probability": 0.0
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -5.828125,
            "text": "lambdoid and sagittal syn",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_4": [
        {
            "start_logit": 8.390625,
            "end_logit": 8.25,
            "text": "posterior sagittal",
            "probability": 1.0
        },
        {
            "start_logit": 8.390625,
            "end_logit": -0.384521484375,
            "text": "posterior sagittal synostosis",
            "probability": 0.00017821788787841797
        },
        {
            "start_logit": -2.27734375,
            "end_logit": 8.25,
            "text": "sagittal",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 8.390625,
            "end_logit": -2.83203125,
            "text": "posterior",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -4.40625,
            "end_logit": 8.25,
            "text": "Bilambdoid and posterior sagittal",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -5.140625,
            "text": "posterior sagittal syn",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -6.9296875,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.25,
            "text": "ambdoid and posterior sagittal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.25,
            "text": "and posterior sagittal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -0.384521484375,
            "text": "sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -0.384521484375,
            "text": "Bilambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -2.83203125,
            "text": "Bilambdoid and posterior",
            "probability": 0.0
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -5.140625,
            "text": "sagittal syn",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.384521484375,
            "text": "synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.384521484375,
            "text": "ambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -0.384521484375,
            "text": "and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -6.9296875,
            "text": "sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -5.140625,
            "text": "Bilambdoid and posterior sagittal syn",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -2.83203125,
            "text": "ambdoid and posterior",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -2.83203125,
            "text": "and posterior",
            "probability": 0.0
        }
    ],
    "54cf43abf693c3b16b000008_5": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.828125,
            "text": "lambdoid sutures",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.2958984375,
            "text": "lamb",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -2.00390625,
            "end_logit": 8.828125,
            "text": "sutures",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -2.779296875,
            "text": "lambdoid",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.6640625,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 8.828125,
            "text": "bilateral lambdoid sutures",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.21875,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.2578125,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces a characteristic triradiate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 8.828125,
            "text": "sagittal and bilateral lambdoid sutures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.47265625,
            "text": "lambdoid sutures is described in three patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 8.828125,
            "text": "doid sutures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 8.828125,
            "text": "craniosynostosis in the sagittal and bilateral lambdoid sutures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.66015625,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.796875,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.828125,
            "text": "and bilateral lambdoid sutures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.9921875,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces a characteristic triradi",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1015625,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated with fusion of these sutures produces a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 8.828125,
            "text": "oid sutures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1171875,
            "text": "lambdoid sutures is described in three patients. The external cranial ridging associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.19921875,
            "text": "lambdoid sutures is described in three patients. The external cranial rid",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54cf43abf693c3b16b000008_6": [
        {
            "start_logit": 8.390625,
            "end_logit": 8.25,
            "text": "posterior sagittal",
            "probability": 1.0
        },
        {
            "start_logit": 8.390625,
            "end_logit": -0.384521484375,
            "text": "posterior sagittal synostosis",
            "probability": 0.00017821788787841797
        },
        {
            "start_logit": -2.27734375,
            "end_logit": 8.25,
            "text": "sagittal",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 8.390625,
            "end_logit": -2.83203125,
            "text": "posterior",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -4.40625,
            "end_logit": 8.25,
            "text": "Bilambdoid and posterior sagittal",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -5.140625,
            "text": "posterior sagittal syn",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -6.9296875,
            "text": "posterior sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.25,
            "text": "ambdoid and posterior sagittal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.25,
            "text": "and posterior sagittal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -0.384521484375,
            "text": "sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -0.384521484375,
            "text": "Bilambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -2.83203125,
            "text": "Bilambdoid and posterior",
            "probability": 0.0
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -5.140625,
            "text": "sagittal syn",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.384521484375,
            "text": "synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.384521484375,
            "text": "ambdoid and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -0.384521484375,
            "text": "and posterior sagittal synostosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.27734375,
            "end_logit": -6.9296875,
            "text": "sagittal synostosis: the Mercedes Benz syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -4.40625,
            "end_logit": -5.140625,
            "text": "Bilambdoid and posterior sagittal syn",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -2.83203125,
            "text": "ambdoid and posterior",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -2.83203125,
            "text": "and posterior",
            "probability": 0.0
        }
    ],
    "553f7a71ab98a37113000009_1": [
        {
            "start_logit": 8.609375,
            "end_logit": 8.4375,
            "text": "nucleotide excision repair",
            "probability": 1.0
        },
        {
            "start_logit": 8.609375,
            "end_logit": -1.427734375,
            "text": "nucleotide excision repair (NER",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -2.296875,
            "text": "nucleotide",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -2.701171875,
            "end_logit": 8.4375,
            "text": "repair",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.26171875,
            "text": "nucleotide excision repair (NER)",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -3.728515625,
            "end_logit": 8.4375,
            "text": "Transcription-coupled repair (TCR) is a subpathway of nucleotide excision repair",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.01171875,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed genes",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.1953125,
            "text": "nucleotide excision",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.296875,
            "text": "nucleotide excision repair (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.52734375,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed genes.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 8.4375,
            "text": "excision repair",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.00390625,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of expressed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.1875,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.203125,
            "text": "nucleotide excision repair (NER) that acts specifically on lesions in the transcribed strand",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.4375,
            "text": "of nucleotide excision repair",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.4375,
            "text": "subpathway of nucleotide excision repair",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.4375,
            "text": "TCR) is a subpathway of nucleotide excision repair",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.701171875,
            "end_logit": -1.427734375,
            "text": "repair (NER",
            "probability": 0.0
        },
        {
            "start_logit": -3.728515625,
            "end_logit": -1.427734375,
            "text": "Transcription-coupled repair (TCR) is a subpathway of nucleotide excision repair (NER",
            "probability": 0.0
        },
        {
            "start_logit": -4.4921875,
            "end_logit": -1.427734375,
            "text": "NER",
            "probability": 0.0
        }
    ],
    "553f7a71ab98a37113000009_2": [
        {
            "start_logit": 8.375,
            "end_logit": 7.3515625,
            "text": "nucleotide excision repair",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.375,
            "end_logit": 0.71533203125,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts",
            "probability": 0.0013151168823242188
        },
        {
            "start_logit": 8.375,
            "end_logit": -2.501953125,
            "text": "nucleotide",
            "probability": 5.263090133666992e-05
        },
        {
            "start_logit": 8.375,
            "end_logit": -4.33984375,
            "text": "nucleotide excision repair (NER)",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -4.03125,
            "end_logit": 7.3515625,
            "text": "repair",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -5.203125,
            "text": "nucleotide excision repair (NER",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.37109375,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.6015625,
            "text": "nucleotide excision repair (NER) is",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.7265625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC endonuclease.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.7421875,
            "text": "nucleotide excision",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.84765625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC endonuclease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.9140625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.11328125,
            "text": "nucleotide excision repair (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.13671875,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.25390625,
            "text": "nucleotide excision repair (NER) is responsible",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.265625,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrABC",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.3125,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the UvrAB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.32421875,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.4375,
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 7.3515625,
            "text": "excision repair",
            "probability": 2.980232238769531e-07
        }
    ],
    "550e866271445a662f000005_1": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.3046875,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -0.9462890625,
            "text": "prostate",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -1.2607421875,
            "end_logit": 9.3046875,
            "text": "cancer",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.77734375,
            "text": "prostate cancer.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.3046875,
            "text": "metastatic castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.3046875,
            "text": "with metastatic castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.3046875,
            "text": "patients with metastatic castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.3046875,
            "text": "castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.3046875,
            "text": "with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -0.9462890625,
            "text": "metastatic castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -1.2607421875,
            "end_logit": -6.77734375,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -0.9462890625,
            "text": "with metastatic castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -0.9462890625,
            "text": "patients with metastatic castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -0.9462890625,
            "text": "castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.9462890625,
            "text": "with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -3.890625,
            "end_logit": -5.26171875,
            "text": "monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -3.890625,
            "end_logit": -7.390625,
            "text": "monoclonal antibody to",
            "probability": 0.0
        },
        {
            "start_logit": -3.890625,
            "end_logit": -7.48828125,
            "text": "monoclonal antibody to human \u03b1\u03bd integrins",
            "probability": 0.0
        },
        {
            "start_logit": -3.890625,
            "end_logit": -7.58203125,
            "text": "monoclonal antibody to human \u03b1\u03bd integrins (",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -5.26171875,
            "text": "human monoclonal antibody",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_2": [
        {
            "start_logit": 9.328125,
            "end_logit": 9.3984375,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": 9.3984375,
            "text": "cancer",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 9.328125,
            "end_logit": -0.947265625,
            "text": "prostate",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": 9.328125,
            "end_logit": -6.8125,
            "text": "prostate cancer (CRPC) patients.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.1171875,
            "text": "prostate cancer (CRPC)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.3984375,
            "text": "castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.31640625,
            "text": "prostate cancer (CRPC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.3984375,
            "text": "in castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.484375,
            "text": "prostate cancer (CRPC) patients. PATIENTS AND METHODS: In a phase 2, randomized, double-blind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.3984375,
            "text": "fully human mAb with antiangiogenic, antitumor properties which has shown potential therapeutic effect in castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.3984375,
            "text": ": Intetumumab is a fully human mAb with antiangiogenic, antitumor properties which has shown potential therapeutic effect in castration-resistant prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.5234375,
            "text": "prostate cancer (CRP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.53515625,
            "text": "prostate cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -6.8125,
            "text": "cancer (CRPC) patients.",
            "probability": 0.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -7.1171875,
            "text": "cancer (CRPC)",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -0.947265625,
            "text": "castration-resistant prostate",
            "probability": 0.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -7.31640625,
            "text": "cancer (CRPC",
            "probability": 0.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -7.484375,
            "text": "cancer (CRPC) patients. PATIENTS AND METHODS: In a phase 2, randomized, double-blind",
            "probability": 0.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -7.5234375,
            "text": "cancer (CRP",
            "probability": 0.0
        },
        {
            "start_logit": -0.92529296875,
            "end_logit": -7.53515625,
            "text": "cancer (",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_3": [
        {
            "start_logit": 7.67578125,
            "end_logit": 7.8671875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.8671875,
            "text": "metastatic melanoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.8046875,
            "text": "melanoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.8671875,
            "text": "Stage IV metastatic melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.8671875,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.8671875,
            "text": "from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.48828125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.56640625,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.70703125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.08984375,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.15625,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.16796875,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.1875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.22265625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.2421875,
            "text": "Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.25390625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.28125,
            "text": "Melanoma Subscale",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.29296875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were taken",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.36328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI)",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.3671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_4": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.87890625,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.0859375,
            "text": "melanoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.87890625,
            "text": "stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.87890625,
            "text": "anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.87890625,
            "text": "phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.87890625,
            "text": ", phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.87890625,
            "text": ", an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.87890625,
            "text": "dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.87890625,
            "text": "an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.87890625,
            "text": "with dacarbazine in stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -7.0859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.0859375,
            "text": "stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -7.0859375,
            "text": "anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -7.0859375,
            "text": "phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.0859375,
            "text": ", phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.0859375,
            "text": ", an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -7.0859375,
            "text": "dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.0859375,
            "text": "an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.0859375,
            "text": "with dacarbazine in stage IV melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -7.33984375,
            "text": "anti-\u03b1v-integrin",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_5": [
        {
            "start_logit": 7.71484375,
            "end_logit": 7.91796875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.91796875,
            "text": "advanced melanoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.1484375,
            "text": "melanoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.91796875,
            "text": "CONCLUSION: With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.91796875,
            "text": "With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.91796875,
            "text": "in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.91796875,
            "text": ": With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.91796875,
            "text": ", intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.91796875,
            "text": "intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.91796875,
            "text": "investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.91796875,
            "text": "favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -7.1484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -7.1484375,
            "text": "advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.1484375,
            "text": "CONCLUSION: With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.1484375,
            "text": "With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.1484375,
            "text": "in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.1484375,
            "text": ": With its favourable safety profile and a nonsignificant trend towards improved OS, intetumumab merits further investigation in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -7.1484375,
            "text": ", intetumumab merits further investigation in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -7.1484375,
            "text": "intetumumab merits further investigation in advanced melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.1484375,
            "text": "investigation in advanced melanoma.",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_6": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.69921875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.36328125,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.37890625,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.4140625,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.4453125,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.69921875,
            "text": "stage IV melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.69921875,
            "text": ", stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.69921875,
            "text": "In a multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.69921875,
            "text": ": In a multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.69921875,
            "text": "METHODS: In a multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.69921875,
            "text": "a multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.69921875,
            "text": "multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -6.80078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.36328125,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.4140625,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.4453125,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -7.36328125,
            "text": "to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.36328125,
            "text": ", stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -7.37890625,
            "text": "to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.36328125,
            "text": "1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_7": [
        {
            "start_logit": 7.875,
            "end_logit": 7.77734375,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -3.888671875,
            "text": "melanoma or angiosarcoma",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -6.4296875,
            "text": "melanoma or angiosarcom",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.04296875,
            "text": "melanoma or angiosar",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.265625,
            "text": "melanoma or angiosarcoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.44140625,
            "text": "melanoma or angiosa",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.77734375,
            "text": "with melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.52734375,
            "text": "melanoma or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.77734375,
            "text": "Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.77734375,
            "text": "CNTO 95) in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.77734375,
            "text": "(CNTO 95) in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.77734375,
            "text": "dose levels of intetumumab (CNTO 95) in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -3.888671875,
            "text": "angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -3.888671875,
            "text": "sarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -3.888671875,
            "text": "with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -3.888671875,
            "text": "Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -3.888671875,
            "text": "CNTO 95) in patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -3.888671875,
            "text": "rcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -3.888671875,
            "text": "or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -3.888671875,
            "text": "(CNTO 95) in patients with melanoma or angiosarcoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_8": [
        {
            "start_logit": 7.98046875,
            "end_logit": 7.6796875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -3.92578125,
            "text": "melanoma or angiosarcoma",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -6.09765625,
            "text": "melanoma or angiosarcom",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -6.62890625,
            "text": "melanoma or angiosar",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.046875,
            "text": "melanoma or angiosarcoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.19921875,
            "text": "melanoma or angiosa",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.19921875,
            "text": "melanoma or angio",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.328125,
            "text": "melanoma or",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.51953125,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.5234375,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.5546875,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.55859375,
            "text": "melanoma or angiosarcoma. PATIENTS AND METHODS: Patients with histologically-confirmed inoperable melanoma or angiosarcom",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.6796875,
            "text": "with melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.6796875,
            "text": "monoclonal antibody was evaluated for safety, pharmacokinetics, and pharmacodynamic activity in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.6796875,
            "text": "in patients with melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": -3.92578125,
            "text": "angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -3.92578125,
            "text": "with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -3.92578125,
            "text": "monoclonal antibody was evaluated for safety, pharmacokinetics, and pharmacodynamic activity in patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -3.92578125,
            "text": "in patients with melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.265625,
            "end_logit": -6.09765625,
            "text": "angiosarcom",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_9": [
        {
            "start_logit": 7.44140625,
            "end_logit": 8.203125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -6.09375,
            "text": "melanoma and angiosarcoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.203125,
            "text": "malignant melanoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.203125,
            "text": "metastatic malignant melanoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.203125,
            "text": "with metastatic malignant melanoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.203125,
            "text": "CONCLUSIONS: In patients with metastatic malignant melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.203125,
            "text": ": In patients with metastatic malignant melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.203125,
            "text": "In patients with metastatic malignant melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.203125,
            "text": "patients with metastatic malignant melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -6.87890625,
            "text": "melanoma and angiosarcom",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.22265625,
            "text": "melanoma and angiosar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.37109375,
            "text": "melanoma and angiosarcoma in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.44140625,
            "text": "melanoma and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.47265625,
            "text": "melanoma and angiosa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.54296875,
            "text": "melanoma and angiosarcoma in this",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.5546875,
            "text": "melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity, was well tolerated, and presented approximately dose-proportional",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.58203125,
            "text": "melanoma and angiosarcoma in this study",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.59765625,
            "text": "melanoma and angio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.67578125,
            "text": "melanoma and angiosarcoma in this study, intetumumab demonstrated manageable toxicity, was well tolerated, and presented approximately dose-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -6.09375,
            "text": "angiosarcoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_10": [
        {
            "start_logit": 9.3671875,
            "end_logit": 9.1640625,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -0.6845703125,
            "text": "prostate",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": -1.5302734375,
            "end_logit": 9.1640625,
            "text": "cancer",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.48828125,
            "text": "prostate cancer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.1640625,
            "text": "metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.1640625,
            "text": "with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.1640625,
            "text": "patients with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -0.6845703125,
            "text": "metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -0.6845703125,
            "text": "with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -1.5302734375,
            "end_logit": -6.48828125,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -0.6845703125,
            "text": "patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -6.25390625,
            "text": "monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.359375,
            "text": "monoclonal antibody to",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.40234375,
            "text": "monoclonal antibody to human \u03b1(v) integrins",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.44140625,
            "text": "monoclonal antibody to human \u03b1(v) integrins, intetumumab",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.44140625,
            "text": "monoclonal antibody to human \u03b1(v",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.46875,
            "text": "monoclonal antibody to human \u03b1(v) integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate",
            "probability": 0.0
        },
        {
            "start_logit": -5.3515625,
            "end_logit": -7.47265625,
            "text": "monoclonal antibody to human \u03b1(v) integrins, intetumumab, in combination with docetaxel",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": -6.48828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -6.25390625,
            "text": "phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_11": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.2421875,
            "text": "prostate cancer",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -0.62841796875,
            "text": "prostate",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": -1.3701171875,
            "end_logit": 9.2421875,
            "text": "cancer",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -6.57421875,
            "text": "prostate cancer.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.44140625,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.2421875,
            "text": "metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.484375,
            "text": "prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.2421875,
            "text": "safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.2421875,
            "text": "with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.2421875,
            "text": ": We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.2421875,
            "text": "evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.2421875,
            "text": "castrate-resistant metastatic prostate cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -0.62841796875,
            "text": "metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -1.3701171875,
            "end_logit": -6.57421875,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -0.62841796875,
            "text": "safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -0.62841796875,
            "text": "with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -0.62841796875,
            "text": ": We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -0.62841796875,
            "text": "evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -0.62841796875,
            "text": "castrate-resistant metastatic prostate",
            "probability": 0.0
        },
        {
            "start_logit": -1.3701171875,
            "end_logit": -7.44140625,
            "text": "cancer. Patients and methods In this phase 1, open-label",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_12": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.703125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.34375,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.41796875,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.43359375,
            "text": "melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.703125,
            "text": "stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.703125,
            "text": ", stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.703125,
            "text": "In a multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.703125,
            "text": "multicentre, randomised, phase II study, stage IV melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -6.84765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.34375,
            "text": "to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.34375,
            "text": "1 to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.41796875,
            "text": "to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.43359375,
            "text": "to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.41796875,
            "text": "1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.41796875,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo (n=32",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -7.44921875,
            "text": "to 1000 mg m(-2) dacarbazine+placebo (n=32), 1000 mg m(",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.43359375,
            "text": "1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.43359375,
            "text": "stage IV melanoma patients were randomised 1:1:1:1 to 1000 mg m(-2) dacarbazine+placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.34375,
            "text": ":1 to 1000 mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.34375,
            "text": "mg m(-2) dacarbazine+placebo (n=32)",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_13": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.76171875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -5.9609375,
            "text": "melanoma or angiosarcoma",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.76171875,
            "text": "melanoma or angiosarcom",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.25,
            "text": "melanoma or angiosar",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.38671875,
            "text": "melanoma or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.76171875,
            "text": "with histologically-confirmed inoperable melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.44921875,
            "text": "melanoma or angiosa",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.50390625,
            "text": "melanoma or angiosarcoma refractory",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.76171875,
            "text": "inoperable melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.546875,
            "text": "melanoma or angiosarcoma refractory to standard treatment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.5546875,
            "text": "melanoma or angio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.6015625,
            "text": "melanoma or angiosarcoma refractory to standard treatment were",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.61328125,
            "text": "melanoma or angiosarcoma refractory to standard treatment were allocated to treatment with 10 mg/kg or 20 mg/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.62109375,
            "text": "melanoma or angiosarcoma refractory to standard treatment were allocated to treatment with 10 mg/kg or 20",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.76171875,
            "text": "Patients with histologically-confirmed inoperable melanoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.63671875,
            "text": "melanoma or angiosarcoma refractory to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -5.9609375,
            "text": "angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -5.9609375,
            "text": "with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -5.9609375,
            "text": "inoperable melanoma or angiosarcoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -5.9609375,
            "text": "Patients with histologically-confirmed inoperable melanoma or angiosarcoma",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_14": [
        {
            "start_logit": 7.67578125,
            "end_logit": 7.8671875,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.8671875,
            "text": "metastatic melanoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.8046875,
            "text": "melanoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.8671875,
            "text": "Stage IV metastatic melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.8671875,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.8671875,
            "text": "from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.48828125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.56640625,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -6.70703125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.08984375,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.15625,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.16796875,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.1875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.22265625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.2421875,
            "text": "Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.25390625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.28125,
            "text": "Melanoma Subscale",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.29296875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were taken",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.36328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI)",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -7.3671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_15": [
        {
            "start_logit": 4.515625,
            "end_logit": 7.36328125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.36328125,
            "text": "metastatic melanoma",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.36328125,
            "text": "Stage IV metastatic melanoma",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.36328125,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.36328125,
            "text": "in Stage IV metastatic melanoma",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.41796875,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.453125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.81640625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.015625,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.03515625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.0390625,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.04296875,
            "text": "Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.1171875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.1328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.15625,
            "text": "Melanoma Subscale",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.203125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were taken",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.28125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.31640625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BP",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.3671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of",
            "probability": 0.0
        }
    ],
    "550e866271445a662f000005_16": [
        {
            "start_logit": 4.515625,
            "end_logit": 7.36328125,
            "text": "melanoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.36328125,
            "text": "metastatic melanoma",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.36328125,
            "text": "Stage IV metastatic melanoma",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.36328125,
            "text": "Brief Pain Inventory (BPI) were taken from a clinical trial evaluating intetumumab alone or with dacarbazine in Stage IV metastatic melanoma",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.36328125,
            "text": "in Stage IV metastatic melanoma",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.41796875,
            "text": "Melanoma Subscale (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.453125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.81640625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.015625,
            "text": "Melanoma Subscale (MS",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.03515625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.0390625,
            "text": "Melanoma Subscale (",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.04296875,
            "text": "Melanoma",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.1171875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.1328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.15625,
            "text": "Melanoma Subscale",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.203125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BPI) were taken",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.28125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.31640625,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.328125,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of Cancer Therapy-Melanoma and the worst pain question from the Brief Pain Inventory (BP",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -7.3671875,
            "text": "Melanoma Subscale (MS) of the Functional Assessment of",
            "probability": 0.0
        }
    ],
    "5c34a761da8336e21a000005_1": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.21875,
            "text": "unsaturated fatty acid and amino acid metabolism",
            "probability": 1.0
        },
        {
            "start_logit": -0.9921875,
            "end_logit": 9.21875,
            "text": "metabolism",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.3388671875,
            "text": "unsaturated",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -1.8515625,
            "end_logit": 9.21875,
            "text": "fatty acid and amino acid metabolism",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -2.86328125,
            "text": "unsaturated fatty acid and amino acid metabolism pathway",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -3.984375,
            "text": "unsaturated fatty acid and amino acid",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 9.21875,
            "text": "amino acid metabolism",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 9.21875,
            "text": "acid and amino acid metabolism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 9.21875,
            "text": "and amino acid metabolism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.578125,
            "text": "unsaturated fatty acid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.21875,
            "text": "analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 9.21875,
            "text": "changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.8359375,
            "text": "unsaturated fatty acid and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 9.21875,
            "text": "acid metabolism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 9.21875,
            "text": "in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 9.21875,
            "text": "significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.21875,
            "text": "According to the analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.21875,
            "text": ", SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.21875,
            "text": "could cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.21875,
            "text": "cause significant changes in unsaturated fatty acid and amino acid metabolism",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c34a761da8336e21a000005_2": [
        {
            "start_logit": 7.42578125,
            "end_logit": 6.78515625,
            "text": "glycosphingolipid metabolism",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.42578125,
            "end_logit": 0.378662109375,
            "text": "glycosphingolipid",
            "probability": 0.00164794921875
        },
        {
            "start_logit": 7.42578125,
            "end_logit": -3.8671875,
            "text": "glycos",
            "probability": 2.3484230041503906e-05
        },
        {
            "start_logit": -4.484375,
            "end_logit": 6.78515625,
            "text": "metabolism",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -4.546875,
            "end_logit": 6.78515625,
            "text": "TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 7.42578125,
            "end_logit": -5.40625,
            "text": "glycosphing",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 6.78515625,
            "text": "modulation of glycosphingolipid metabolism",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.42578125,
            "end_logit": -6.41796875,
            "text": "glycosphi",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -5.890625,
            "end_logit": 6.78515625,
            "text": "IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.625,
            "end_logit": 6.78515625,
            "text": "decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 6.78515625,
            "text": "through the modulation of glycosphingolipid metabolism",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.78515625,
            "text": "phingolipid metabolism",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 6.78515625,
            "text": "T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 6.78515625,
            "text": "olipid metabolism",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.78515625,
            "text": "part through the modulation of glycosphingolipid metabolism",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.72607421875,
            "end_logit": -2.400390625,
            "text": "FLI1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.72607421875,
            "end_logit": -3.8671875,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycos",
            "probability": 0.0
        },
        {
            "start_logit": -4.546875,
            "end_logit": 0.378662109375,
            "text": "TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid",
            "probability": 0.0
        },
        {
            "start_logit": 0.72607421875,
            "end_logit": -5.40625,
            "text": "FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphing",
            "probability": 0.0
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 0.378662109375,
            "text": "modulation of glycosphingolipid",
            "probability": 0.0
        }
    ],
    "5c34a761da8336e21a000005_3": [
        {
            "start_logit": 9.3359375,
            "end_logit": 5.12109375,
            "text": "estrogen metabolism",
            "probability": 0.8095703125
        },
        {
            "start_logit": 9.3359375,
            "end_logit": 3.671875,
            "text": "estrogen",
            "probability": 0.1907958984375
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.80859375,
            "text": "estrogen metabolism might",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.19921875,
            "text": "estrogen metabolism might contribute",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.41015625,
            "text": "estrogen metabolism might contribute towards pathophysiology",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.6171875,
            "text": "estrogen metabolism might contribute towards",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.6171875,
            "text": "estrogen metabolism might contribute towards pathophysiology of",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.640625,
            "text": "estrogen metabolism might contribute towards pathophysiology of systemic lupus erythematosus (SLE)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 5.12109375,
            "text": "metabolism",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 5.12109375,
            "text": "genetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 5.12109375,
            "text": "xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 5.12109375,
            "text": "in estrogen metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 5.12109375,
            "text": "metabolic pathway involved in estrogen metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 5.12109375,
            "text": "pathway involved in estrogen metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 5.12109375,
            "text": "polymorphisms of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 5.12109375,
            "text": "of the xenobiotic metabolic pathway involved in estrogen metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.484375,
            "end_logit": 3.671875,
            "text": "genetic polymorphisms of the xenobiotic metabolic pathway involved in estrogen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.890625,
            "end_logit": 3.671875,
            "text": "xenobiotic metabolic pathway involved in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 3.671875,
            "text": "in estrogen",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 3.671875,
            "text": "metabolic pathway involved in estrogen",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_1": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.4140625,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.09375,
            "end_logit": 9.4140625,
            "text": "ib",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.2001953125,
            "text": "Dab",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.9375,
            "end_logit": 9.4140625,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 9.4140625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.4140625,
            "text": "BRAF (Dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.921875,
            "text": "Dabrafenib) and MEK inhibition (Trametinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.94140625,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.4140625,
            "text": "(Dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.0546875,
            "text": "Dabrafenib) and MEK inhibition (Trametini",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.4140625,
            "text": "Combined BRAF (Dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.26171875,
            "text": "Dabrafenib)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.3828125,
            "text": "Dabrafenib) and MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.43359375,
            "text": "Dabrafenib) and MEK inhibition (Tram",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.5546875,
            "text": "Dabrafenib) and MEK inhibition (Trameti",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.58984375,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.6171875,
            "text": "Dabrafenib) and MEK inhibition (Trametinib)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.625,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.63671875,
            "text": "Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.09375,
            "end_logit": -6.921875,
            "text": "ib) and MEK inhibition (Trametinib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_2": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.3125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.193359375,
            "text": "dab",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.375,
            "end_logit": 9.3125,
            "text": "ib",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 9.3125,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 9.3125,
            "text": "fenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.0625,
            "text": "dabrafenib monotherapy (part C; n = 45).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.15625,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.3125,
            "text": "with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.30859375,
            "text": "dabrafenib monotherapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.4296875,
            "text": "dabrafenib monotherapy (part C; n = 45",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.3125,
            "text": "BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.5,
            "text": "dabrafenib monotherapy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.50390625,
            "text": "dabrafenib monotherapy (part C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.3125,
            "text": "inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.58984375,
            "text": "dabrafenib monotherapy (part C; n = 45)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.6015625,
            "text": "dabrafenib monotherapy (part C; n",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -1.193359375,
            "text": "with dab",
            "probability": 0.0
        },
        {
            "start_logit": -1.375,
            "end_logit": -7.0625,
            "text": "ib monotherapy (part C; n = 45).",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.193359375,
            "text": "combination therapy after disease progression with BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.193359375,
            "text": "BRAF inhibitor treatment administered before study enrollment (part B; n = 26) or after cross-over at progression with dab",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_3": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.3046875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.388671875,
            "end_logit": 9.3046875,
            "text": "ib",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.73828125,
            "text": "ve",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 9.3046875,
            "text": "murafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.74609375,
            "text": "vemurafenib and the MEK inhibitor cobimetinib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 9.3046875,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.609375,
            "end_logit": 9.3046875,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.3046875,
            "text": "inhibitor vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 9.3046875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.66796875,
            "text": "vemurafenib and the MEK inhibitor cobimetinib.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.765625,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1875,
            "text": "vemurafenib and the MEK inhibitor cobime",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.3046875,
            "text": "combination of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.3046875,
            "text": "This randomized phase 3 study evaluated the combination of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.3046875,
            "text": "evaluated the combination of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.3046875,
            "text": "phase 3 study evaluated the combination of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.3359375,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.4140625,
            "text": "vemurafenib and the MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.50390625,
            "text": "vemurafenib and the MEK inhibitor cob",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.388671875,
            "end_logit": -5.74609375,
            "text": "ib and the MEK inhibitor cobimetinib",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_4": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.3125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.369140625,
            "end_logit": 9.3125,
            "text": "ib",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.3623046875,
            "text": "ve",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.625,
            "end_logit": 9.3125,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 9.3125,
            "text": "All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 9.3125,
            "text": "inhibitors vemurafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.52734375,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.3125,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.61328125,
            "text": "vemurafenib or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.3125,
            "text": "BRAF inhibitors vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.3125,
            "text": "patients treated with the BRAF inhibitors vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.3125,
            "text": "fenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.3125,
            "text": "with the BRAF inhibitors vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1953125,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.3125,
            "text": "the BRAF inhibitors vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.31640625,
            "text": "vemurafenib or dabrafenib or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.3515625,
            "text": "vemurafenib or dabrafenib or combination BRAF inhibitor and mitogen-activated protein kinase kinase (MEK) inhibitor therapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.3125,
            "text": ": All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.3125,
            "text": "METHODS: All patients treated with the BRAF inhibitors vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.390625,
            "text": "vemurafenib or dabrafenib or combination BRAF inhibitor and mitogen-activated protein kinase kinase (MEK) inhibitor",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_5": [
        {
            "start_logit": 8.8203125,
            "end_logit": 9.109375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": 9.109375,
            "text": "ib",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -2.173828125,
            "text": "ve",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -4.22265625,
            "text": "vemurafenib and MEK inhibition with cobimetinib",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -5.78125,
            "end_logit": 9.109375,
            "text": "murafenib",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.609375,
            "end_logit": 9.109375,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 9.109375,
            "text": "with vemurafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 9.109375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.765625,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF-mutated melanoma.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -6.8046875,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.109375,
            "text": "combined BRAF inhibition with vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.109375,
            "text": "safety and efficacy of combined BRAF inhibition with vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.109375,
            "text": "assessed the safety and efficacy of combined BRAF inhibition with vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.109375,
            "text": "BRAF inhibition with vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.1953125,
            "text": "vemurafenib and MEK inhibition with cobime",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.109375,
            "text": "the safety and efficacy of combined BRAF inhibition with vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.37890625,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.45703125,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF-mutated melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.46875,
            "text": "vemurafenib and MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8203125,
            "end_logit": -7.46875,
            "text": "vemurafenib and MEK inhibition with cobimetinib in patients with advanced BRAF-mutated",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_6": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.21875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.353515625,
            "text": "ve",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": 9.21875,
            "text": "ib",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.21875,
            "text": "murafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 9.21875,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 9.21875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.921875,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.93359375,
            "text": "vemurafenib or never received a BRAF inhibitor.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 9.21875,
            "text": "on vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.16015625,
            "text": "vemurafenib or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.50390625,
            "text": "vemurafenib or never received a BRAF inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.53515625,
            "text": "vemurafenib or never",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.6171875,
            "text": "vemurafenib or never received",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.21875,
            "text": "We included individuals who had either recently progressed on vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.21875,
            "text": "recently progressed on vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -1.353515625,
            "text": "on ve",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.93359375,
            "text": "ib or never received a BRAF inhibitor.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.16015625,
            "text": "ib or",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.353515625,
            "text": "We included individuals who had either recently progressed on ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.353515625,
            "text": "recently progressed on ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_7": [
        {
            "start_logit": 9.09375,
            "end_logit": 9.3203125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.2626953125,
            "end_logit": 9.3203125,
            "text": "ib",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -1.6123046875,
            "text": "ve",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -5.76171875,
            "end_logit": 9.3203125,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.01171875,
            "text": "vemura",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.69921875,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.796875,
            "text": "vemurafenib with ipilimumab (anti-CTLA4), with significant liver toxicities.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.3203125,
            "text": "fenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.3203125,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.3203125,
            "text": "rafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.1640625,
            "text": "vemurafenib with ipilimumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.3203125,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.21484375,
            "text": "vemurafenib with ipilimuma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.34375,
            "text": "vemurafenib with ipilimu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.40625,
            "text": "vemurafenib with ipilimumab (anti-CTLA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.4296875,
            "text": "vemurafenib with ipilimumab (anti-CTLA4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.4296875,
            "text": "vemurafenib with ipili",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.4921875,
            "text": "vemurafenib with ipilimumab (anti-CTLA4), with significant liver toxicities",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2626953125,
            "end_logit": -6.796875,
            "text": "ib with ipilimumab (anti-CTLA4), with significant liver toxicities.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2626953125,
            "end_logit": -7.1640625,
            "text": "ib with ipilimumab",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_8": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.2578125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.107421875,
            "text": "dab",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -1.52734375,
            "end_logit": 9.2578125,
            "text": "ib",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 9.2578125,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 9.2578125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.0,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.1328125,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated metastatic melanoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34765625,
            "text": "dabrafenib recently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.2578125,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3828125,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.2578125,
            "text": "inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.453125,
            "text": "dabrafenib recently was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.45703125,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated metastatic melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.48828125,
            "text": "dabrafenib recently was approved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.58203125,
            "text": "dabrafenib recently was approved for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.5859375,
            "text": "dabrafenib recently was approved for use in patients with BRAF V600-mutated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -1.107421875,
            "text": "BRAF inhibitor dab",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -1.107421875,
            "text": "inhibitor dab",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.1328125,
            "text": "ib recently was approved for use in patients with BRAF V600-mutated metastatic melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.34765625,
            "text": "ib recently",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_9": [
        {
            "start_logit": 9.25,
            "end_logit": 9.3203125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.228515625,
            "text": "ve",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": 9.3203125,
            "text": "ib",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 9.3203125,
            "text": "murafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.4453125,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.58984375,
            "text": "vemura",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.95703125,
            "text": "vemurafenib (PLX-40",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 9.3203125,
            "text": "rafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.3203125,
            "text": "fenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.18359375,
            "text": "vemurafenib (PLX-4032",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.2109375,
            "text": "vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.2421875,
            "text": "vemurafenib (PLX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.3203125,
            "text": "adjuvant radiotherapy, and interferon, metastasectomies, granulocyte-macrophage colony-stimulating factors, a clinical trial with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.33984375,
            "text": "vemurafenib (PLX-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.3203125,
            "text": "clinical trial with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.3203125,
            "text": "and interferon, metastasectomies, granulocyte-macrophage colony-stimulating factors, a clinical trial with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.3984375,
            "text": "vemurafenib (PLX-4032), clinical trial with combination BRAF plus MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.41015625,
            "text": "vemurafenib (PLX-4032)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -1.228515625,
            "text": "surgery, adjuvant radiotherapy, and interferon, metastasectomies, granulocyte-macrophage colony-stimulating factors, a clinical trial with the BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -6.95703125,
            "text": "ib (PLX-40",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_10": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.3359375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.15234375,
            "text": "dab",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -1.337890625,
            "end_logit": 9.3359375,
            "text": "ib",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 9.3359375,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 9.3359375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.9296875,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF-inhibitor treatment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.0078125,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.21875,
            "text": "dabrafenib therapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 9.3359375,
            "text": "commenced dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.3359375,
            "text": "patients commenced dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.42578125,
            "text": "dabrafenib therapy including",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.48046875,
            "text": "dabrafenib therapy including six individuals who had",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.48828125,
            "text": "dabrafenib therapy including six",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.49609375,
            "text": "dabrafenib therapy including six individuals who had progressed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.51953125,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF-inhibitor treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.55078125,
            "text": "dabrafenib therapy including six individuals who",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.578125,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF-inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5859375,
            "text": "dabrafenib therapy including six individuals who had progressed on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.58984375,
            "text": "dabrafenib therapy including six individuals who had progressed on a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.625,
            "text": "dabrafenib therapy including six individuals who had progressed on a prior BRAF",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_11": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.3515625,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.119140625,
            "text": "dab",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.283203125,
            "end_logit": 9.3515625,
            "text": "ib",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 9.3515625,
            "text": "rafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.3515625,
            "text": "fenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.92578125,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.1015625,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 9.3515625,
            "text": "pharmacokinetics of dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.3515625,
            "text": "Population pharmacokinetics of dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.3515625,
            "text": "of dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4921875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.50390625,
            "text": "dabrafenib,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.50390625,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.57421875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.57421875,
            "text": "dabrafenib, a BRAF inhibitor: effect of dose, time, covariates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.58203125,
            "text": "dabrafenib, a BRAF inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.283203125,
            "end_logit": -6.92578125,
            "text": "ib, a BRAF inhibitor: effect of dose, time, covariates, and relationship with its metabolites.",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -1.119140625,
            "text": "pharmacokinetics of dab",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -1.119140625,
            "text": "Population pharmacokinetics of dab",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -1.119140625,
            "text": "of dab",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_12": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.2578125,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0693359375,
            "text": "Dab",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 9.2578125,
            "text": "ib",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.2578125,
            "text": "rafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 9.2578125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.01953125,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.3125,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive melanoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.421875,
            "text": "Dabrafenib is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.46484375,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.46875,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.50390625,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.51171875,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.52734375,
            "text": "Dabrafenib is a BRAF kinase inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.5546875,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.58984375,
            "text": "Dabrafenib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.3125,
            "text": "ib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation-positive melanoma.",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.421875,
            "text": "ib is",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.46484375,
            "text": "ib is a BRAF kinase inhibitor indicated",
            "probability": 0.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.46875,
            "text": "ib is a BRAF kinase inhibitor indicated for the treatment of BRAF V600E mutation",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_13": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.3828125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.1669921875,
            "end_logit": 9.3828125,
            "text": "ib",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.181640625,
            "text": "dab",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -6.484375,
            "end_logit": 9.3828125,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.484375,
            "text": "dabrafenib) or as part of an expanded access program (vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.625,
            "text": "dabrafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.84375,
            "text": "dabrafenib) or as part of an expanded access program (vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.94140625,
            "text": "dabrafenib) or as part of an expanded access program (vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.078125,
            "end_logit": 9.3828125,
            "text": "fenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.10546875,
            "text": "dabrafenib) or as part of an expanded access program (vemurafenib).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.3828125,
            "text": "iBRAF within a clinical trial (dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.328125,
            "end_logit": 9.3828125,
            "text": "with iBRAF within a clinical trial (dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.23828125,
            "text": "dabrafenib) or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.26953125,
            "text": "dabrafenib) or as part of an expanded access program (ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.3828125,
            "text": "(dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.3046875,
            "text": "dabrafenib)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.30859375,
            "text": "dabrafenib) or as part of an expanded access program (vemu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.3828125,
            "text": "study of melanoma patients harboring the BRAF V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.3828125,
            "text": "prospective study of melanoma patients harboring the BRAF V600 mutation and treated with iBRAF within a clinical trial (dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.3828125,
            "text": "trial (dabrafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_14": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.2578125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.3388671875,
            "text": "ve",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.5166015625,
            "end_logit": 9.2578125,
            "text": "ib",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": -5.5625,
            "end_logit": 9.2578125,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.46484375,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain metastases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 9.2578125,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.7890625,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.81640625,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain metastases.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.2578125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.2578125,
            "text": "BRAF kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.2578125,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.38671875,
            "text": "vemurafenib in patients with advanced melanoma with symptomatic brain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.3984375,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.48828125,
            "text": "vemurafenib in patients with advanced melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.2578125,
            "text": "kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.54296875,
            "text": "vemurafenib in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5166015625,
            "end_logit": -6.46484375,
            "text": "ib in patients with advanced melanoma with symptomatic brain metastases",
            "probability": 0.0
        },
        {
            "start_logit": -1.5166015625,
            "end_logit": -6.81640625,
            "text": "ib in patients with advanced melanoma with symptomatic brain metastases.",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -1.3388671875,
            "text": "BRAF kinase inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.3388671875,
            "text": "inhibitor ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_15": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.3046875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": 9.3046875,
            "text": "ib",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.37109375,
            "text": "ve",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 9.3046875,
            "text": "murafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.05078125,
            "text": "vemurafenib and dabrafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 9.3046875,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.56640625,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.640625,
            "text": "vemurafenib and dabrafenib.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.7890625,
            "text": "vemurafenib and dab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.3046875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.94921875,
            "text": "vemurafenib and dabra",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.9609375,
            "text": "vemurafenib and dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1171875,
            "text": "vemurafenib and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.25,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.3046875,
            "text": "development of BRAF kinase inhibitors like vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.3046875,
            "text": "like vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.3046875,
            "text": "BRAF kinase inhibitors like vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.3046875,
            "text": "kinase inhibitors like vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -6.05078125,
            "text": "ib and dabrafenib",
            "probability": 0.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -6.640625,
            "text": "ib and dabrafenib.",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_16": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3046875,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2236328125,
            "text": "Dab",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 9.3046875,
            "text": "ib",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 9.3046875,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 9.3046875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.82421875,
            "text": "Dabrafenib joins vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.921875,
            "text": "Dabrafenib join",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.96875,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1328125,
            "text": "Dabrafenib joins vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarbazine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.22265625,
            "text": "Dabrafenib joins ve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2421875,
            "text": "Dabrafenib joins vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.29296875,
            "text": "Dabrafenib joins vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.484375,
            "text": "Dabrafenib joins vemurafenib to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5078125,
            "text": "Dabrafenib joins vemu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5546875,
            "text": "Dabrafenib joins vemurafenib to confirm the superior clinical outcome of the BRAF inhibitors when compared with dacarb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.3046875,
            "text": "CONCLUSIONS: Dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6171875,
            "text": "Dabrafenib joins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.625,
            "text": "Dabrafenib joins vemurafenib to confirm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": -6.82421875,
            "text": "ib joins vemurafenib",
            "probability": 0.0
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": -6.921875,
            "text": "ib join",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_17": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.34375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -1.009765625,
            "text": "dab",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -1.2861328125,
            "end_logit": 9.34375,
            "text": "ib",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 9.34375,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 9.34375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.8671875,
            "text": "dabrafenib (GSK2118436).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.98828125,
            "text": "dabrafenib (GSK2118436",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.15625,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.17578125,
            "text": "dabrafenib (GSK2118",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.20703125,
            "text": "dabrafenib (GSK211843",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.34375,
            "text": "inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.27734375,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.34375,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.34375,
            "text": "Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.36328125,
            "text": "dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.375,
            "text": "dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.34375,
            "text": "with metastatic melanoma treated with the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.34375,
            "text": "with the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.51953125,
            "text": "dabrafenib (GSK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.34375,
            "text": "patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_18": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.296875,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.1474609375,
            "text": "Dab",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.4228515625,
            "end_logit": 9.296875,
            "text": "ib",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 9.296875,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 9.296875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.984375,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.23828125,
            "text": "Dabrafenib is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.51953125,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.55859375,
            "text": "Dabrafenib is a selective inhibitor of V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.55859375,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.55859375,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS) as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.57421875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.58203125,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.59375,
            "text": "Dabrafenib is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.6171875,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.625,
            "text": "Dabrafenib is a selective inhibitor of V600-mutant BRAF kinase, which recently showed improved progression-free survival (PFS) as compared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.625,
            "text": "Dabrafenib is a selective inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.296875,
            "text": "PURPOSE: Dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4228515625,
            "end_logit": -7.23828125,
            "text": "ib is",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -1.1474609375,
            "text": "PURPOSE: Dab",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_19": [
        {
            "start_logit": 9.3359375,
            "end_logit": 9.3515625,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -1.0400390625,
            "text": "dab",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.2900390625,
            "end_logit": 9.3515625,
            "text": "ib",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.61328125,
            "end_logit": 9.3515625,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 9.3515625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.98046875,
            "text": "dabrafenib (GSK2118436) in patients with metastatic melanoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.1484375,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.203125,
            "text": "dabrafenib (GSK2118436",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.2421875,
            "text": "dabrafenib (GSK2118",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.32421875,
            "text": "dabrafenib (GSK211843",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.4140625,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.44140625,
            "text": "dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.45703125,
            "text": "dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -7.45703125,
            "text": "dabrafenib (GSK2118436) in patients with metastatic melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.3515625,
            "text": "inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.3515625,
            "text": "Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.3515625,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.3515625,
            "text": "BREAK-2) of the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.3515625,
            "text": "the BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2900390625,
            "end_logit": -6.98046875,
            "text": "ib (GSK2118436) in patients with metastatic melanoma.",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_20": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.3828125,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": 9.3828125,
            "text": "ib",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.166015625,
            "text": "Dab",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -5.6171875,
            "end_logit": 9.3828125,
            "text": "rafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.3671875,
            "text": "Dabrafenib (GSK2118436",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.3828125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.78125,
            "text": "Dabrafenib (GSK211843",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.8125,
            "text": "Dabrafenib (GSK2118",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.87890625,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.1328125,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF kinase.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.14453125,
            "text": "Dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.26953125,
            "text": "Dabrafenib (GSK2118436) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.2890625,
            "text": "Dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.32421875,
            "text": "Dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.3984375,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5390625,
            "text": "Dabrafenib (GSK2118436) is a potent inhibitor of mutated BRAF kinase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5546875,
            "text": "Dabrafenib (GSK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": -6.3671875,
            "text": "ib (GSK2118436",
            "probability": 0.0
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": -6.78125,
            "text": "ib (GSK211843",
            "probability": 0.0
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": -6.8125,
            "text": "ib (GSK2118",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_21": [
        {
            "start_logit": 7.30078125,
            "end_logit": 8.25,
            "text": "vemurafenib, and dabrafenib",
            "probability": 0.403076171875
        },
        {
            "start_logit": 7.30078125,
            "end_logit": 8.1171875,
            "text": "vemurafenib",
            "probability": 0.355712890625
        },
        {
            "start_logit": 6.77734375,
            "end_logit": 8.25,
            "text": "dabrafenib",
            "probability": 0.24072265625
        },
        {
            "start_logit": -3.251953125,
            "end_logit": 8.25,
            "text": "ib",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -3.43359375,
            "end_logit": 8.25,
            "text": "ib, and dabrafenib",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -3.43359375,
            "end_logit": 8.1171875,
            "text": "ib",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 8.25,
            "text": "and dabrafenib",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.30078125,
            "end_logit": -4.19921875,
            "text": "ve",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.30078125,
            "end_logit": -4.53125,
            "text": "vemurafenib, and dab",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.77734375,
            "end_logit": -4.53125,
            "text": "dab",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 8.25,
            "text": "murafenib, and dabrafenib",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 8.1171875,
            "text": "murafenib",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 8.25,
            "text": ". While the two drugs shown to improve survival, vemurafenib, and dabrafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 8.25,
            "text": "rafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 8.1171875,
            "text": ". While the two drugs shown to improve survival, vemurafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.25,
            "text": ", and dabrafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.25,
            "text": "rafenib, and dabrafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.1171875,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.25,
            "text": ", vemurafenib, and dabrafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 8.25,
            "text": "fenib, and dabrafenib",
            "probability": 1.7881393432617188e-07
        }
    ],
    "54d8d60d014675820d000007_22": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.203125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.421875,
            "text": "ve",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.587890625,
            "end_logit": 9.203125,
            "text": "ib",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -5.890625,
            "end_logit": 9.203125,
            "text": "murafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 9.203125,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 9.203125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.046875,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 9.203125,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.22265625,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.203125,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.203125,
            "text": "assess pharmacodynamic effects and intrinsic and acquired resistance mechanisms of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.203125,
            "text": "pharmacodynamic effects and intrinsic and acquired resistance mechanisms of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.53125,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma, leading to an understanding of the mechanism of action of vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.203125,
            "text": "effects and intrinsic and acquired resistance mechanisms of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.5546875,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma, leading to an understanding of the mechanism of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.203125,
            "text": "of the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.58203125,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.59765625,
            "text": "vemurafenib in BRAF(V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.6015625,
            "text": "vemurafenib in BRAF(V600)-mutant melanoma, leading to an understanding of the mechanism of action of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.171875,
            "end_logit": -7.60546875,
            "text": "vemurafenib in BRAF(V600)-mutant",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_23": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.0859375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.6005859375,
            "text": "ve",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -1.892578125,
            "end_logit": 9.0859375,
            "text": "ib",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -5.796875,
            "end_logit": 9.0859375,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.390625,
            "text": "vemurafen",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.0859375,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.0859375,
            "text": "fenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.0859375,
            "text": "selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.38671875,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.0859375,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.0859375,
            "text": "with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.0859375,
            "text": "select patients with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.0859375,
            "text": "for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.0859375,
            "text": "CE-marked and FDA-approved in vitro diagnostic assay used to select patients with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.0859375,
            "text": "with metastatic melanoma for treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.0859375,
            "text": "treatment with the selective BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -1.6005859375,
            "text": "selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -1.6005859375,
            "text": "inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -1.6005859375,
            "text": "with the selective BRAF inhibitor ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -1.6005859375,
            "text": "select patients with metastatic melanoma for treatment with the selective BRAF inhibitor ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_24": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.3046875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1142578125,
            "text": "dab",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -1.34765625,
            "end_logit": 9.3046875,
            "text": "ib",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -6.0625,
            "end_logit": 9.3046875,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.3046875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.9453125,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.08984375,
            "text": "dabrafenib (GSK2118436) and the evolving role of dabrafenib in treatment for melanoma patients.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.3046875,
            "text": "with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.26171875,
            "text": "dabrafenib (GSK2118",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.2890625,
            "text": "dabrafenib (GSK2118436",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.3125,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.3203125,
            "text": "dabrafenib (GSK2118436) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.3046875,
            "text": "with emphasis on the trials conducted with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.33203125,
            "text": "dabrafenib (GSK211843",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.41015625,
            "text": "dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.4375,
            "text": "dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.3046875,
            "text": "purpose of this study is to review the development of BRAF inhibitors, with emphasis on the trials conducted with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.48046875,
            "text": "dabrafenib (GSK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.3046875,
            "text": "study is to review the development of BRAF inhibitors, with emphasis on the trials conducted with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.3046875,
            "text": "review the development of BRAF inhibitors, with emphasis on the trials conducted with dabrafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_25": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.265625,
            "text": "Dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.1474609375,
            "text": "Dab",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 9.265625,
            "text": "ib",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -5.76953125,
            "end_logit": 9.265625,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.265625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.11328125,
            "text": "Dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.40625,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.421875,
            "text": "Dabrafenib inhibits",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.48046875,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.48828125,
            "text": "Dabrafenib inhibits the mutant BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.51953125,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V600K",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.54296875,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut))",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.55078125,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.55859375,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5625,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5625,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5625,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5703125,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.57421875,
            "text": "Dabrafenib inhibits the mutant BRAF (BRAF(",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.36328125,
            "text": "ib inhibits the mutant BRAF (BRAF(mut)) protein in melanomas with BRAF(V600E) and BRAF(V600K) genotypes.",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_26": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.2890625,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.232421875,
            "text": "dab",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -1.412109375,
            "end_logit": 9.2890625,
            "text": "ib",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 9.2890625,
            "text": "rafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 9.2890625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.15625,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.16015625,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametini",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23046875,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2578125,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.2890625,
            "text": "with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.33203125,
            "text": "dabrafenib, a selective BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.4375,
            "text": "dabrafenib, a selective BRAF inhibitor, and trameti",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.47265625,
            "text": "dabrafenib, a selective BRAF inhibitor, and tram",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.51953125,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.2890625,
            "text": "combined treatment with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.53515625,
            "text": "dabrafenib, a selective BRAF inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.2890625,
            "text": "conducted a phase 1 and 2 trial of combined treatment with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.2890625,
            "text": "phase 1 and 2 trial of combined treatment with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5625,
            "text": "dabrafenib, a selective BRAF inhibitor, and trametinib, a selective MAPK kinase (MEK) inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.578125,
            "text": "dabrafenib, a",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_27": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.3984375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.169921875,
            "end_logit": 9.3984375,
            "text": "ib",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.119140625,
            "text": "dab",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -5.328125,
            "end_logit": 9.3984375,
            "text": "rafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 9.3984375,
            "text": "fenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.265625,
            "text": "dabrafenib (GSK2118436",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.83203125,
            "text": "dabrafenib (GSK211843",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.03515625,
            "text": "dabrafenib (GSK2118",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.05859375,
            "text": "dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.13671875,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.23828125,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.33203125,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4140625,
            "text": "dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4296875,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4609375,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.3984375,
            "text": "Cutaneous manifestations of dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.3984375,
            "text": "of dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.59765625,
            "text": "dabrafenib (GSK2118436):",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.6171875,
            "text": "dabrafenib (GSK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.62890625,
            "text": "dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_28": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.3359375,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0771484375,
            "text": "dab",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.306640625,
            "end_logit": 9.3359375,
            "text": "ib",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 9.3359375,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.640625,
            "end_logit": 9.3359375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.7890625,
            "text": "dabrafenib (GSK2118436).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.0390625,
            "text": "dabrafenib (GSK2118436",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.046875,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.05078125,
            "text": "dabrafenib (GSK2118",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.2265625,
            "text": "dabrafenib (GSK211843",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.3359375,
            "text": "systematic prospective dermatological review of all patients enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.3046875,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.32421875,
            "text": "dabrafenib (GSK2118436)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.3828125,
            "text": "dabrafenib (GSK21",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.3359375,
            "text": "mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.3359375,
            "text": "all patients enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.3359375,
            "text": "prospective dermatological review of all patients enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.3359375,
            "text": "inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.3359375,
            "text": "a systematic prospective dermatological review of all patients enrolled at a single institution in the phase I/II clinical trial of the mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.306640625,
            "end_logit": -6.7890625,
            "text": "ib (GSK2118436).",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_29": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.21875,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1435546875,
            "text": "dab",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.625,
            "end_logit": 9.21875,
            "text": "ib",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -5.78125,
            "end_logit": 9.21875,
            "text": "rafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 9.21875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.18359375,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low-grade malignancy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.27734375,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.21875,
            "text": "mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.40625,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.43359375,
            "text": "dabrafenib is associated with induction of keratinocytic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.21875,
            "text": "inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.21875,
            "text": "BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.55078125,
            "text": "dabrafenib is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5625,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low-grade malignancy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.60546875,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.6171875,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.62109375,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.62109375,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.63671875,
            "text": "dabrafenib is associated with induction of keratinocytic proliferation, which in some cases develops features of low-grade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.21875,
            "text": "CONCLUSIONS: Administration of the mutant BRAF inhibitor dabrafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_30": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.328125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1396484375,
            "text": "dab",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.3642578125,
            "end_logit": 9.328125,
            "text": "ib",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -5.390625,
            "end_logit": 9.328125,
            "text": "rafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 9.328125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.83984375,
            "text": "dabrafenib (a V600EBRAF inhibitor): a case report.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 9.328125,
            "text": "with dabrafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.87890625,
            "text": "dabrafenib (a V600EBRAF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.91796875,
            "text": "dabrafenib (a V600EB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.91796875,
            "text": "dabrafenib (a V600EBRAF inhibitor): a case report",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.01953125,
            "text": "dabrafenib (a V600EBRA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.06640625,
            "text": "dabrafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.078125,
            "text": "dabrafenib (a V600EBRAF inhibitor)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.10546875,
            "text": "dabrafenib (a V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.18359375,
            "text": "dabrafenib (a V600EBRAF inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.328125,
            "text": "leptomeningitis presenting in a melanoma patient treated with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.328125,
            "text": "Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.390625,
            "text": "dabrafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.328125,
            "text": "a melanoma patient treated with dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5,
            "text": "dabrafenib (a V600EBRAF inhibitor):",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_31": [
        {
            "start_logit": 9.25,
            "end_logit": 9.1953125,
            "text": "dabrafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.2548828125,
            "text": "dab",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.685546875,
            "end_logit": 9.1953125,
            "text": "ib",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 9.1953125,
            "text": "GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 9.1953125,
            "text": "rafenib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.84765625,
            "text": "dabrafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.1953125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.0859375,
            "text": "dabrafenib, as a second line of therapy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.1953125,
            "text": ", dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.1953125,
            "text": "with the GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.1953125,
            "text": "2118436 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.1953125,
            "text": "6 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.40625,
            "text": "dabrafenib, as a second line of therapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.1953125,
            "text": "BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.1953125,
            "text": "the GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.1953125,
            "text": "she was enrolled into another clinical trial with the GSK2118436 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.50390625,
            "text": "dabrafenib,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.52734375,
            "text": "dabrafenib, as a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.53515625,
            "text": "dabrafenib, as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.1953125,
            "text": "436 BRAF inhibitor, dabrafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_32": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.3203125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -1.0146484375,
            "text": "ve",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -1.322265625,
            "end_logit": 9.3203125,
            "text": "ib",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 9.3203125,
            "text": "murafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 9.3203125,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 9.3203125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.3203125,
            "text": "as vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.98046875,
            "text": "vemurafenib.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.05859375,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.1640625,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.3203125,
            "text": "adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.3203125,
            "text": "s) and well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.3203125,
            "text": "squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -1.0146484375,
            "text": "as ve",
            "probability": 0.0
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -6.98046875,
            "text": "ib.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -1.0146484375,
            "text": "oacanthomas (KAs) and well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -1.0146484375,
            "text": "adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -1.0146484375,
            "text": "s) and well-differentiated squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -1.0146484375,
            "text": "squamous cell carcinomas (SCCs) is a known adverse effect of novel BRAF inhibitors such as ve",
            "probability": 0.0
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -6.98046875,
            "text": "murafenib.",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_33": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.265625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.3583984375,
            "text": "ve",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.4453125,
            "end_logit": 9.265625,
            "text": "ib",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.265625,
            "text": "murafenib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.265625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 9.265625,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.20703125,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.26953125,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.265625,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.265625,
            "text": "patient with stage IV melanoma who received the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.265625,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.265625,
            "text": "describe a patient with stage IV melanoma who received the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.265625,
            "text": "received the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.265625,
            "text": "who received the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.265625,
            "text": "a patient with stage IV melanoma who received the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.45703125,
            "text": "vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.45703125,
            "text": "vemurafenib (recently approved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.46875,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration) as part of a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.4921875,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration) as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.52734375,
            "text": "vemurafenib (recently approved by the US Food and Drug Administration) as part of a clinical trial and developed numerous diffuse, pathology-proven",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_34": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.28125,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3583984375,
            "text": "ve",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -1.48046875,
            "end_logit": 9.28125,
            "text": "ib",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -5.125,
            "end_logit": 9.28125,
            "text": "murafenib",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 9.28125,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 9.28125,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.265625,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.28125,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.359375,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report on the effective use of PDT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.421875,
            "text": "vemurafenib'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.4453125,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.4609375,
            "text": "vemurafenib's recent approval",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.50390625,
            "text": "vemurafenib's recent approval by the US Food and Drug Administration, we provide a timely case report on the effective use of PDT in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.28125,
            "text": "CONCLUSIONS: Given vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.52734375,
            "text": "vemurafenib's recent approval by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.28125,
            "text": "Given vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.546875,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5546875,
            "text": "vemurafenib's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.56640625,
            "text": "vemurafenib's recent approval by the US Food and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -7.28125,
            "text": "ib's recent approval by the US Food and Drug Administration, we provide a timely case report",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_35": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.296875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.1875,
            "text": "ve",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": -1.4189453125,
            "end_logit": 9.296875,
            "text": "ib",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 9.296875,
            "text": "murafenib",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.296875,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 9.296875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 9.296875,
            "text": ", vemurafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.1796875,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.296875,
            "text": "BRAF inhibitor, vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.41015625,
            "text": "vemurafenib,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.41796875,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.50390625,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.5078125,
            "text": "vemurafenib, has shown up to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.5078125,
            "text": "vemurafenib, has shown up to 78",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.52734375,
            "text": "vemurafenib, has shown up to 78% objective response rates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.546875,
            "text": "vemurafenib, has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.55859375,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.55859375,
            "text": "vemurafenib, has shown up to 78% objective response rates in melanoma patients harboring the BRAF-V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.56640625,
            "text": "vemurafenib, has shown up to 78% objective response",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.59375,
            "text": "vemurafenib, has shown up to 78%",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_36": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.375,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.2001953125,
            "end_logit": 9.375,
            "text": "ib",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.3955078125,
            "text": "ve",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 9.375,
            "text": "murafenib",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.33984375,
            "text": "vemurafenib (PLX4032",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.375,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 9.375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.765625,
            "text": "vemurafenib (PLX40",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.375,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.0234375,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.15625,
            "text": "vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.1640625,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.375,
            "text": "oral BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.296875,
            "text": "vemurafenib (PLX4032)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.328125,
            "text": "vemurafenib (PLX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.375,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.47265625,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.484375,
            "text": "vemurafenib (PL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.5078125,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600-mutant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.5390625,
            "text": "vemurafenib (PLX4032) frequently produced tumor regressions in patients with BRAF V600-mutant metastatic melanoma",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_37": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.21875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.421875,
            "text": "ve",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -1.5849609375,
            "end_logit": 9.21875,
            "text": "ib",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": -5.69921875,
            "end_logit": 9.21875,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 9.21875,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.80078125,
            "text": "vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.21875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.1015625,
            "text": "vemurafenib.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.3125,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.21875,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.21875,
            "text": "BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.21875,
            "text": "with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.21875,
            "text": "for treatment with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.21875,
            "text": "select patients with BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.21875,
            "text": "treatment with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.21875,
            "text": "with BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.21875,
            "text": "patients with BRAF-mutant metastatic melanoma for treatment with the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.21875,
            "text": "the BRAF inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5849609375,
            "end_logit": -7.1015625,
            "text": "ib.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -1.421875,
            "text": "inhibitor ve",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_38": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3515625,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.2822265625,
            "end_logit": 9.3515625,
            "text": "ib",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.244140625,
            "text": "ve",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 9.3515625,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 9.3515625,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.48046875,
            "text": "vemurafenib (PLX4032",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 9.3515625,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.78125,
            "text": "vemurafenib (PLX40",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.3515625,
            "text": ", vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1171875,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.3515625,
            "text": "However, in the recent clinical trial of the BRAF inhibitor, vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.26953125,
            "text": "vemurafenib (PLX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3125,
            "text": "vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.33203125,
            "text": "vemurafenib (PLX4032)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.3515625,
            "text": "recent clinical trial of the BRAF inhibitor, vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3515625,
            "text": "clinical trial of the BRAF inhibitor, vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.45703125,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.45703125,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E mutant melanoma patients did not meet the RECIST criteria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.46875,
            "text": "vemurafenib (PLX4032), a significant percentage of BRAF V600E mutant melanoma patients did",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_39": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3984375,
            "text": "Vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.154296875,
            "end_logit": 9.3984375,
            "text": "ib",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2001953125,
            "text": "Ve",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 9.3984375,
            "text": "murafenib",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 9.3984375,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.29296875,
            "text": "Vemurafenib (RG7204/PLX4032",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 9.3984375,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.0078125,
            "text": "Vemurafenib (RG7204/PLX4032)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.08984375,
            "text": "Vemurafenib (RG7204/PLX40",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1015625,
            "text": "Vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.125,
            "text": "Vemurafenib (RG7204",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2109375,
            "text": "Vemurafenib (RG720",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.265625,
            "text": "Vemurafenib (RG7204/PLX4032), a small-molecule",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.37109375,
            "text": "Vemurafenib (RG7204/PLX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.37890625,
            "text": "Vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.37890625,
            "text": "Vemurafenib (RG7204/PL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Vemurafenib (RG7204/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.53125,
            "text": "Vemurafenib (RG72",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.53125,
            "text": "Vemurafenib (RG7204/PLX4032), a small-molecule inhibitor of mutant BRAF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.154296875,
            "end_logit": -6.29296875,
            "text": "ib (RG7204/PLX4032",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_40": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.296875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.3935546875,
            "end_logit": 9.296875,
            "text": "ib",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.333984375,
            "text": "ve",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 9.296875,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 9.296875,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 9.296875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.76171875,
            "text": "vemurafenib (PLX4032",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.0859375,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.12109375,
            "text": "vemurafenib (PLX40",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.296875,
            "text": "inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.234375,
            "text": "vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.34375,
            "text": "vemurafenib (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.38671875,
            "text": "vemurafenib (PLX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.4375,
            "text": "vemurafenib (PLX4032)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.51171875,
            "text": "vemurafenib (PL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.296875,
            "text": "Phase 1 and 2 clinical trials of the BRAF kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.296875,
            "text": "kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.55078125,
            "text": "vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.296875,
            "text": "BRAF kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.296875,
            "text": "trials of the BRAF kinase inhibitor vemurafenib",
            "probability": 5.960464477539063e-08
        }
    ],
    "54d8d60d014675820d000007_41": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.3046875,
            "text": "Vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.3818359375,
            "end_logit": 9.3046875,
            "text": "ib",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 9.15625,
            "end_logit": -1.46484375,
            "text": "Ve",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -5.6171875,
            "end_logit": 9.3046875,
            "text": "murafenib",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 9.3046875,
            "text": "rafenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -6.83203125,
            "text": "Vemurafen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 9.3046875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.390625,
            "text": "Vemurafenib is the first molecularly targeted therapy to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.421875,
            "text": "Vemura",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.44140625,
            "text": "Vemurafenib is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.5234375,
            "text": "Vemurafenib is the first molecularly targeted therapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.5234375,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.5546875,
            "text": "Vemurafenib is the first molecularly targeted therapy to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.5546875,
            "text": "Vemurafenib is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.58203125,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.59375,
            "text": "Vemurafenib is the first molecularly targeted",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.59765625,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the US and Europe for treatment of advanced melanoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.61328125,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -7.6171875,
            "text": "Vemurafenib is the first molecularly targeted therapy to be licensed in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3818359375,
            "end_logit": -7.390625,
            "text": "ib is the first molecularly targeted therapy to",
            "probability": 0.0
        }
    ],
    "54d8d60d014675820d000007_42": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.296875,
            "text": "vemurafenib",
            "probability": 1.0
        },
        {
            "start_logit": -1.4072265625,
            "end_logit": 9.296875,
            "text": "ib",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.380859375,
            "text": "ve",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.3828125,
            "end_logit": 9.296875,
            "text": "murafenib",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 9.296875,
            "text": "rafenib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 9.296875,
            "text": "fenib",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.296875,
            "text": "of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.25390625,
            "text": "vemurafen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.296875,
            "text": "efficacy of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.35546875,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.296875,
            "text": "test the efficacy of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.43359375,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.296875,
            "text": "the efficacy of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.296875,
            "text": "Clinical trials to test the efficacy of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.296875,
            "text": "trials to test the efficacy of vemurafenib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.51171875,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimuma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.58984375,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.59765625,
            "text": "vemurafenib in combination with immunomodulatory agents, such as ipilimumab, and MAPK kinase (MEK) inhibitors, such",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -1.380859375,
            "text": "of ve",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -1.380859375,
            "text": "efficacy of ve",
            "probability": 0.0
        }
    ],
    "5314c7afdae131f84700000a_1": [
        {
            "start_logit": 0.3984375,
            "end_logit": 0.436767578125,
            "text": "hypothermia",
            "probability": 0.74951171875
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -0.9931640625,
            "text": "hypothermia and hyperhidrosis",
            "probability": 0.179443359375
        },
        {
            "start_logit": -2.806640625,
            "end_logit": 0.436767578125,
            "text": "periodic hypothermia",
            "probability": 0.0304718017578125
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -3.23828125,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.01898193359375
        },
        {
            "start_logit": -2.732421875,
            "end_logit": -0.9931640625,
            "text": "hyperhidrosis",
            "probability": 0.00782012939453125
        },
        {
            "start_logit": -2.806640625,
            "end_logit": -0.9931640625,
            "text": "periodic hypothermia and hyperhidrosis",
            "probability": 0.00726318359375
        },
        {
            "start_logit": -2.732421875,
            "end_logit": -3.23828125,
            "text": "hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.0008306503295898438
        },
        {
            "start_logit": -2.806640625,
            "end_logit": -3.23828125,
            "text": "periodic hypothermia and hyperhidrosis along with agenesis of the corpus callosum",
            "probability": 0.0007686614990234375
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -6.69921875,
            "text": "hypothermia and hyperhidro",
            "probability": 0.0005960464477539062
        },
        {
            "start_logit": -6.84375,
            "end_logit": 0.436767578125,
            "text": "constellation of periodic hypothermia",
            "probability": 0.0005364418029785156
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -6.94140625,
            "text": "hypothermia and hyperhidrosis along with agenesis",
            "probability": 0.0004680156707763672
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.05078125,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro et al. in 1969.",
            "probability": 0.00041961669921875
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.18359375,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus",
            "probability": 0.0003674030303955078
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.19921875,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro et al",
            "probability": 0.0003616809844970703
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.24609375,
            "text": "hypothermia and hyperhidrosis along with agenesis of the",
            "probability": 0.0003452301025390625
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.34375,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum by Shapiro et al. in 1969",
            "probability": 0.00031304359436035156
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 0.436767578125,
            "text": "defined as the constellation of periodic hypothermia",
            "probability": 0.00030231475830078125
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.39453125,
            "text": "hypothermia and hyperhidrosis along",
            "probability": 0.00029730796813964844
        },
        {
            "start_logit": -7.4375,
            "end_logit": 0.436767578125,
            "text": "as the constellation of periodic hypothermia",
            "probability": 0.0002963542938232422
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -7.421875,
            "text": "hypothermia and hyperhidrosis along with agenesis of the corpus callosum by",
            "probability": 0.0002894401550292969
        }
    ],
    "5314c7afdae131f84700000a_2": [
        {
            "start_logit": 1.4677734375,
            "end_logit": 2.65234375,
            "text": "hyperhidrosis",
            "probability": 0.50439453125
        },
        {
            "start_logit": 3.03125,
            "end_logit": 0.8740234375,
            "text": "congenital agenesis of the corpus callosum",
            "probability": 0.406982421875
        },
        {
            "start_logit": 1.4677734375,
            "end_logit": 0.8740234375,
            "text": "hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.0850830078125
        },
        {
            "start_logit": -5.0,
            "end_logit": 2.65234375,
            "text": "hypothermia, hyperhidrosis",
            "probability": 0.0007824897766113281
        },
        {
            "start_logit": 3.03125,
            "end_logit": -5.82421875,
            "text": "congenital agenesis of the corpus",
            "probability": 0.0005011558532714844
        },
        {
            "start_logit": -6.171875,
            "end_logit": 2.65234375,
            "text": ", hyperhidrosis",
            "probability": 0.00024235248565673828
        },
        {
            "start_logit": 3.03125,
            "end_logit": -6.81640625,
            "text": "congenital agenesis of the corpus callosum.",
            "probability": 0.00018584728240966797
        },
        {
            "start_logit": -4.75,
            "end_logit": 0.8740234375,
            "text": "agenesis of the corpus callosum",
            "probability": 0.00016999244689941406
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 2.65234375,
            "text": "recurrent hypothermia, hyperhidrosis",
            "probability": 0.00016999244689941406
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 2.65234375,
            "text": "hidrosis",
            "probability": 0.0001590251922607422
        },
        {
            "start_logit": 3.03125,
            "end_logit": -7.03125,
            "text": "congenital agenesis of",
            "probability": 0.0001493692398071289
        },
        {
            "start_logit": 3.03125,
            "end_logit": -7.04296875,
            "text": "congenital agenesis",
            "probability": 0.0001481771469116211
        },
        {
            "start_logit": 3.03125,
            "end_logit": -7.05859375,
            "text": "congenital",
            "probability": 0.00014591217041015625
        },
        {
            "start_logit": 3.03125,
            "end_logit": -7.1484375,
            "text": "congenital agenesis of the",
            "probability": 0.00013387203216552734
        },
        {
            "start_logit": -5.0,
            "end_logit": 0.8740234375,
            "text": "hypothermia, hyperhidrosis and congenital agenesis of the corpus callosum",
            "probability": 0.00013184547424316406
        },
        {
            "start_logit": 1.4677734375,
            "end_logit": -5.82421875,
            "text": "hyperhidrosis and congenital agenesis of the corpus",
            "probability": 0.00010502338409423828
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 2.65234375,
            "text": "drosis",
            "probability": 0.00010102987289428711
        },
        {
            "start_logit": -7.09375,
            "end_logit": 2.65234375,
            "text": "sis",
            "probability": 9.638071060180664e-05
        },
        {
            "start_logit": -7.265625,
            "end_logit": 2.65234375,
            "text": "triad of recurrent hypothermia, hyperhidrosis",
            "probability": 8.118152618408203e-05
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 2.65234375,
            "text": "of recurrent hypothermia, hyperhidrosis",
            "probability": 6.41942024230957e-05
        }
    ],
    "5314c7afdae131f84700000a_3": [
        {
            "start_logit": 8.9921875,
            "end_logit": 9.0703125,
            "text": "hyperhidrosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -1.822265625,
            "text": "hyper",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -1.8974609375,
            "end_logit": 9.0703125,
            "text": "sis",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -4.78515625,
            "end_logit": 9.0703125,
            "text": "hypothermia and hyperhidrosis",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 9.0703125,
            "text": "Hypermelatoninemia should be considered in patients with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 9.0703125,
            "text": "hidrosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -6.5625,
            "text": "hyperhidro",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 9.0703125,
            "text": "drosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.04296875,
            "text": "hyperhidrosis, and also in patients with Shapiro's syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 9.0703125,
            "text": "periodic hypothermia and hyperhidrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.0703125,
            "text": "melatoninemia should be considered in patients with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.0703125,
            "text": "patients with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.0703125,
            "text": "and hyperhidrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.0703125,
            "text": "in patients with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.0703125,
            "text": "with spontaneous periodic hypothermia and hyperhidrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.52734375,
            "text": "hyperhidrosis, and also in patients with Shapiro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.78515625,
            "end_logit": -1.822265625,
            "text": "hypothermia and hyper",
            "probability": 0.0
        },
        {
            "start_logit": -5.0078125,
            "end_logit": -1.822265625,
            "text": "Hypermelatoninemia should be considered in patients with spontaneous periodic hypothermia and hyper",
            "probability": 0.0
        },
        {
            "start_logit": -1.8974609375,
            "end_logit": -7.04296875,
            "text": "sis, and also in patients with Shapiro's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -1.822265625,
            "text": "periodic hypothermia and hyper",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_1": [
        {
            "start_logit": 9.0234375,
            "end_logit": 8.671875,
            "text": "non-small cell lung cancer",
            "probability": 1.0
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -1.7802734375,
            "text": "non",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -2.48046875,
            "end_logit": 8.671875,
            "text": "cancer",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -3.52734375,
            "text": "non-small cell lung",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -4.84375,
            "end_logit": 8.671875,
            "text": "Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -5.984375,
            "text": "non-small cell",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.8125,
            "end_logit": 8.671875,
            "text": "-small cell lung cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 8.671875,
            "text": "lung cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.38671875,
            "text": "non-small",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.23046875,
            "text": "non-small cell lung cancer both in vitro and in vivo.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.3359375,
            "text": "non-small cell lung cancer both",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.40234375,
            "text": "non-small cell lung cancer both in vitro and in vivo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.4921875,
            "text": "non-small cell lung cancer both in vitro",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.671875,
            "text": "small cell lung cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.5546875,
            "text": "non-small cell lung cancer both in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.671875,
            "text": "in non-small cell lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.671875,
            "text": "improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.671875,
            "text": "electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.671875,
            "text": "cell lung cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.84375,
            "end_logit": -1.7802734375,
            "text": "Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_2": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.2578125,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": -1.390625,
            "end_logit": 9.2578125,
            "text": "multiforme",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.375,
            "text": "glioblastoma",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.140625,
            "text": "glioblastoma multiforme response",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 9.2578125,
            "text": "The effect of field strength on glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 9.2578125,
            "text": "field strength on glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.2578125,
            "text": "effect of field strength on glioblastoma multiforme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.0234375,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A system.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.16015625,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.328125,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.375,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A system",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.4296875,
            "text": "glioblastoma multiforme response in patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.44921875,
            "text": "glioblastoma multiforme response in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.47265625,
            "text": "glioblastoma multiforme response in patients treated with the NovoTT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.53125,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.2578125,
            "text": "of field strength on glioblastoma multiforme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.55859375,
            "text": "glioblastoma multiforme response in patients treated with the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.6171875,
            "text": "glioblastoma multiforme response in patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.62890625,
            "text": "glioblastoma multiforme response in patients treated with the NovoTTF\u2122-100",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.390625,
            "end_logit": -6.140625,
            "text": "multiforme response",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_3": [
        {
            "start_logit": 5.4609375,
            "end_logit": 3.291015625,
            "text": "glioblastoma multiforme",
            "probability": 0.8984375
        },
        {
            "start_logit": 5.4609375,
            "end_logit": 1.041015625,
            "text": "glioblastoma multiforme (GBM)",
            "probability": 0.09466552734375
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -1.607421875,
            "text": "glioblastoma multiforme (GBM",
            "probability": 0.0066986083984375
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -4.8828125,
            "text": "glioblastoma",
            "probability": 0.0002536773681640625
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -6.921875,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for recurrent GBM.",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.17578125,
            "text": "glioblastoma multiforme (GBM) and",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.3359375,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for recurrent GBM",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.46484375,
            "text": "glioblastoma multiforme (",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.5546875,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved",
            "probability": 1.7583370208740234e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.640625,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 5.4609375,
            "end_logit": -7.65625,
            "text": "glioblastoma multiforme (GBM) and it has been FDA-approved for recurrent",
            "probability": 1.5854835510253906e-05
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 3.291015625,
            "text": "for newly diagnosed glioblastoma multiforme",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 3.291015625,
            "text": "diagnosed glioblastoma multiforme",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 3.291015625,
            "text": "newly diagnosed glioblastoma multiforme",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 3.291015625,
            "text": "efficacy for newly diagnosed glioblastoma multiforme",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 3.291015625,
            "text": "multiforme",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 3.291015625,
            "text": "assessing its efficacy for newly diagnosed glioblastoma multiforme",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 3.291015625,
            "text": "An ongoing trial is assessing its efficacy for newly diagnosed glioblastoma multiforme",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 3.291015625,
            "text": "its efficacy for newly diagnosed glioblastoma multiforme",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 1.041015625,
            "text": "for newly diagnosed glioblastoma multiforme (GBM)",
            "probability": 7.152557373046875e-07
        }
    ],
    "56c1f007ef6e39474100003b_4": [
        {
            "start_logit": 9.171875,
            "end_logit": 9.328125,
            "text": "non-small cell lung",
            "probability": 1.0
        },
        {
            "start_logit": -1.0712890625,
            "end_logit": 9.328125,
            "text": "lung",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.4189453125,
            "text": "non",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.171875,
            "end_logit": -5.75,
            "text": "non-small cell lung cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.328125,
            "text": "-small cell lung",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.5546875,
            "text": "non-small cell",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.328125,
            "text": "cell lung",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.8515625,
            "text": "non-small",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 9.328125,
            "text": "small cell lung",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.90625,
            "text": "non-small cell lung cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.328125,
            "text": "advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.328125,
            "text": "phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.328125,
            "text": "of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.328125,
            "text": "with pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.328125,
            "text": "trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.328125,
            "text": "A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.328125,
            "text": "for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.328125,
            "text": "pemetrexed for advanced non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0712890625,
            "end_logit": -5.75,
            "text": "lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.0712890625,
            "end_logit": -6.90625,
            "text": "lung cancer.",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_5": [
        {
            "start_logit": 8.0,
            "end_logit": 7.5703125,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.2265625,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.30859375,
            "text": "glioblastoma by the U.S",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.5703125,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.59375,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.5703125,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.5703125,
            "text": "treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5703125,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.5703125,
            "text": "recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.5703125,
            "text": ", regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.5703125,
            "text": "treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -6.78515625,
            "text": "TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.125,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.14453125,
            "text": "TTFields) is a noninvasive, regional antimitotic",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.1640625,
            "text": "TTField",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.203125,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.30859375,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.2265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.44140625,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.4609375,
            "text": "TTFields) is",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_6": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.8359375,
            "text": "TTFields",
            "probability": 1.0
        },
        {
            "start_logit": 3.400390625,
            "end_logit": 4.05078125,
            "text": "glioblastoma",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.7822265625,
            "end_logit": 8.8359375,
            "text": "s",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 2.76953125,
            "end_logit": 3.798828125,
            "text": "nonsmall cell lung cancer",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -3.2734375,
            "text": "TT",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.8359375,
            "text": "Fields",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.2734375,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.76171875,
            "text": "TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized. A phase III trial of TTFields",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.0078125,
            "text": "TTFields therapy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.76953125,
            "end_logit": -3.515625,
            "text": "nonsmall cell lung",
            "probability": 0.0
        },
        {
            "start_logit": -5.3125,
            "end_logit": 3.798828125,
            "text": "glioblastoma, solid tumor brain metastases, nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 3.400390625,
            "end_logit": -5.34765625,
            "text": "glioblastoma patients established that TTFields therapy is associated with minimal toxicity",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": 3.798828125,
            "text": ", nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 4.05078125,
            "text": ". A phase III trial of TTFields monotherapy compared to active chemotherapy in recurrent glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 3.798828125,
            "text": ". Ongoing and future trials will evaluate TTFields in newly diagnosed glioblastoma, solid tumor brain metastases, nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 3.798828125,
            "text": "solid tumor brain metastases, nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 3.798828125,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": 3.400390625,
            "end_logit": -6.28125,
            "text": "glioblastoma patients established that TTFields therapy is associated with minimal toxicity, better quality of life, and comparable efficacy to chemotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -6.6875,
            "end_logit": 3.798828125,
            "text": ", solid tumor brain metastases, nonsmall cell lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": 2.76953125,
            "end_logit": -5.91796875,
            "text": "nonsmall cell lung cancer, and ovarian and pancreatic",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_7": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.90625,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": -2.103515625,
            "end_logit": 8.90625,
            "text": "multiforme",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.220703125,
            "text": "glioblastoma",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 8.90625,
            "text": "NovoTTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.0703125,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.06640625,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer types",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.11328125,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.16015625,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer types.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.1640625,
            "text": "glioblastoma multiforme after standard therapies have failed.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.90625,
            "text": "TTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.27734375,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.90625,
            "text": "progressive glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.90625,
            "text": "the NovoTTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.30078125,
            "text": "glioblastoma multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.3984375,
            "text": "glioblastoma multiforme after standard therapies have failed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.4296875,
            "text": "glioblastoma multiforme after standard therapies have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.103515625,
            "end_logit": -6.0703125,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -2.220703125,
            "text": "NovoTTF-100A\u2122, that uses this technology and is indicated for use in progressive glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -2.103515625,
            "end_logit": -7.06640625,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer types",
            "probability": 0.0
        },
        {
            "start_logit": -2.103515625,
            "end_logit": -7.11328125,
            "text": "multiforme after standard therapies have failed. Promising clinical trial results will likely lead to expanded uses in primary brain tumors and other cancer",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_8": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.109375,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.4794921875,
            "text": "glioblastoma",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -1.68359375,
            "end_logit": 9.109375,
            "text": "multiforme",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -6.9375,
            "end_logit": 9.109375,
            "text": "from glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 9.109375,
            "text": "Long-term survival of patients suffering from glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.0234375,
            "text": "glioblastoma multiforme treated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.04296875,
            "text": "glioblastoma multiforme treated with tumor-treating fields.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.109375,
            "text": "patients suffering from glioblastoma multiforme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.546875,
            "text": "glioblastoma multiforme treated with tumor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.55859375,
            "text": "glioblastoma multiforme treated with tumor-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.109375,
            "text": "of patients suffering from glioblastoma multiforme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.59375,
            "text": "glioblastoma multiforme treated with tumor-treating fields",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.609375,
            "text": "glioblastoma multiforme treated with tumor-treating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.109375,
            "text": "survival of patients suffering from glioblastoma multiforme",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9375,
            "end_logit": -1.4794921875,
            "text": "from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -1.4794921875,
            "text": "Long-term survival of patients suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -7.0234375,
            "text": "multiforme treated",
            "probability": 0.0
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -7.04296875,
            "text": "multiforme treated with tumor-treating fields.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -1.4794921875,
            "text": "patients suffering from glioblastoma",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -1.4794921875,
            "text": "of patients suffering from glioblastoma",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_9": [
        {
            "start_logit": 8.546875,
            "end_logit": 8.7890625,
            "text": "glioblastoma multiforme",
            "probability": 1.0
        },
        {
            "start_logit": -2.244140625,
            "end_logit": 8.7890625,
            "text": "multiforme",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 8.546875,
            "end_logit": -2.45703125,
            "text": "glioblastoma",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -3.052734375,
            "end_logit": 8.7890625,
            "text": "TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.7890625,
            "text": "Fields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.546875,
            "end_logit": -6.98828125,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.7890625,
            "text": "in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.7890625,
            "text": "recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.7890625,
            "text": "one in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.7890625,
            "text": "with TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.7890625,
            "text": "clinical experience with TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.7890625,
            "text": "it summarizes the clinical experience with TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.7890625,
            "text": "summarizes the clinical experience with TTFields, mainly in two indications: one in recurrent glioblastoma multiforme",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.37890625,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.42578125,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared with best standard care (including chemotherapy)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.51953125,
            "text": "glioblastoma multiforme: in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.54296875,
            "text": "glioblastoma multiforme: in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.546875,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was compared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.55078125,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III trial TTFields was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -7.55859375,
            "text": "glioblastoma multiforme: in a large prospective randomized Phase III",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c1f007ef6e39474100003b_10": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.1953125,
            "text": "non-small cell lung",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.134765625,
            "text": "non",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -1.2158203125,
            "end_logit": 9.1953125,
            "text": "lung",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -4.68359375,
            "text": "non-small cell lung cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.85546875,
            "end_logit": 9.1953125,
            "text": "-small cell lung",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 9.1953125,
            "text": "small cell lung",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.3828125,
            "text": "non-small cell lung cancer, where TTFields",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 9.1953125,
            "text": "cell lung",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.0,
            "text": "non-small cell",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05078125,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetrexed.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.140625,
            "text": "non-small",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.4296875,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetrexed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.1953125,
            "text": "in second-line non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5078125,
            "text": "non-small cell lung cancer, where TTFields was administered concomitantly with pemetrex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5234375,
            "text": "non-small cell lung cancer, where TTFields was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.1953125,
            "text": "Phase II study in second-line non-small cell lung",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.62109375,
            "text": "non-small cell lung cancer, where TTField",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.625,
            "text": "non-small cell lung cancer,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2158203125,
            "end_logit": -4.68359375,
            "text": "lung cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.2158203125,
            "end_logit": -6.3828125,
            "text": "lung cancer, where TTFields",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_11": [
        {
            "start_logit": 8.515625,
            "end_logit": 6.66796875,
            "text": "pancreatic",
            "probability": 0.994140625
        },
        {
            "start_logit": 8.515625,
            "end_logit": 1.5849609375,
            "text": "pancreatic cancer",
            "probability": 0.0061492919921875
        },
        {
            "start_logit": 8.515625,
            "end_logit": -6.8359375,
            "text": "pancreatic cancer.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 6.66796875,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 6.66796875,
            "text": "present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.66796875,
            "text": ". The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 6.66796875,
            "text": "study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.66796875,
            "text": "efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.66796875,
            "text": "determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.66796875,
            "text": "mechanism of action of TTFields in preclinical models of pancreatic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 1.5849609375,
            "text": "cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 1.5849609375,
            "text": "glioblastoma. The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 1.5849609375,
            "text": "present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": 1.5849609375,
            "text": ". The present study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 1.5849609375,
            "text": "study determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": 1.5849609375,
            "text": "efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 1.5849609375,
            "text": "determined the efficacy and mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 1.5849609375,
            "text": "mechanism of action of TTFields in preclinical models of pancreatic cancer",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -6.8359375,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.16796875,
            "end_logit": -5.328125,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_12": [
        {
            "start_logit": 7.1015625,
            "end_logit": 7.9921875,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 7.9921875,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.28125,
            "end_logit": 7.9921875,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.9921875,
            "text": "recurrent glioblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.9921875,
            "text": "s) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.9921875,
            "text": "Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.9921875,
            "text": "a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.9921875,
            "text": "cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.9921875,
            "text": "treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -6.9453125,
            "text": "glioblastoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.1875,
            "text": "TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.21484375,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -6.21484375,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.7734375,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.83984375,
            "text": "TTField",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.9453125,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -6.9453125,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -7.0390625,
            "text": "TTFields) are a non-invasive cancer treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -7.0390625,
            "text": "non-invasive cancer treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -7.1640625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_13": [
        {
            "start_logit": 8.0,
            "end_logit": 7.5703125,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.2265625,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.30859375,
            "text": "glioblastoma by the U.S",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.5703125,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.59375,
            "text": "glioblastoma by the U.S. FDA and has a CE mark in Europe",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.5703125,
            "text": "noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.5703125,
            "text": "treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.5703125,
            "text": "antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.5703125,
            "text": "recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.5703125,
            "text": ", regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.5703125,
            "text": "treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -6.78515625,
            "text": "TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.125,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.14453125,
            "text": "TTFields) is a noninvasive, regional antimitotic",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.1640625,
            "text": "TTField",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.203125,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.30859375,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.2265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.44140625,
            "text": "TTFields) is a noninvasive, regional antimitotic treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.4609375,
            "text": "TTFields) is",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_14": [
        {
            "start_logit": 7.1484375,
            "end_logit": 7.8828125,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 7.8828125,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 7.8828125,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.8828125,
            "text": "Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.8828125,
            "text": "s) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.8828125,
            "text": "OBJECTIVES: Tumor Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.8828125,
            "text": "recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.8828125,
            "text": "with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.8828125,
            "text": "Treating Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.8828125,
            "text": "cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.8828125,
            "text": "a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1484375,
            "end_logit": -6.96484375,
            "text": "glioblastoma.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -6.09765625,
            "text": "TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -6.35546875,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -6.35546875,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -6.79296875,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -6.96484375,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -6.96484375,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -6.09765625,
            "text": "Fields (TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -7.1015625,
            "text": "non-invasive cancer treatment modality",
            "probability": 0.0
        }
    ],
    "56c1f007ef6e39474100003b_15": [
        {
            "start_logit": 7.1015625,
            "end_logit": 7.9921875,
            "text": "glioblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 7.9921875,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.28125,
            "end_logit": 7.9921875,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.9921875,
            "text": "recurrent glioblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.9921875,
            "text": "s) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.9921875,
            "text": "Fields (TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.9921875,
            "text": "a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.9921875,
            "text": "cancer treatment modality approved for the treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.9921875,
            "text": "treatment of patients with recurrent glioblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -6.9453125,
            "text": "glioblastoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.1875,
            "text": "TTFields)",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.21484375,
            "text": "TTFields) are a non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -6.21484375,
            "text": "non-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.7734375,
            "text": "TTFields",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.83984375,
            "text": "TTField",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -6.9453125,
            "text": "TTFields) are a non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -6.9453125,
            "text": "non-invasive cancer treatment modality approved for the treatment of patients with recurrent glioblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -7.0390625,
            "text": "TTFields) are a non-invasive cancer treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -7.0390625,
            "text": "non-invasive cancer treatment modality",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -7.1640625,
            "text": "TTFields) are a non-invasive cancer treatment modality approved",
            "probability": 0.0
        }
    ],
    "61f81a2d882a024a10000042_1": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.34375,
            "text": "intellectual disability",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.0888671875,
            "text": "intellectual",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": 9.34375,
            "text": "disability",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.7890625,
            "text": "intellectual disability, speech delay, and dysmorphism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.15625,
            "text": "intellectual disability, speech delay",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.40234375,
            "text": "intellectual disability, speech delay, and dysmorphism.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.34375,
            "text": "with intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.34375,
            "text": "cause a syndrome with intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.34375,
            "text": "syndrome with intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.34375,
            "text": "Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.34375,
            "text": "a syndrome with intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": -6.7890625,
            "text": "disability, speech delay, and dysmorphism",
            "probability": 0.0
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": -7.15625,
            "text": "disability, speech delay",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -1.0888671875,
            "text": "with intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": -7.40234375,
            "text": "disability, speech delay, and dysmorphism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.0888671875,
            "text": "cause a syndrome with intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -1.0888671875,
            "text": "syndrome with intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -1.0888671875,
            "text": "Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -1.0888671875,
            "text": "a syndrome with intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.7890625,
            "text": "speech delay, and dysmorphism",
            "probability": 0.0
        }
    ],
    "61f81a2d882a024a10000042_2": [
        {
            "start_logit": 1.0673828125,
            "end_logit": 0.2081298828125,
            "text": "developmental delay/intellectual disability",
            "probability": 0.97802734375
        },
        {
            "start_logit": 1.0673828125,
            "end_logit": -4.28515625,
            "text": "developmental delay",
            "probability": 0.01094818115234375
        },
        {
            "start_logit": 1.0673828125,
            "end_logit": -5.23828125,
            "text": "developmental delay/intellectual disability, particularly affecting speech, while additional features include growth failure, feeding difficulties, non-specific MRI abnormalities, epilepsy",
            "probability": 0.004222869873046875
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 0.2081298828125,
            "text": "cohort is a variable degree of developmental delay/intellectual disability",
            "probability": 0.0011453628540039062
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 0.2081298828125,
            "text": ". The major phenotypic characteristic of our cohort is a variable degree of developmental delay/intellectual disability",
            "probability": 0.0009202957153320312
        },
        {
            "start_logit": -6.015625,
            "end_logit": 0.2081298828125,
            "text": "phenotypic characteristic of our cohort is a variable degree of developmental delay/intellectual disability",
            "probability": 0.0008182525634765625
        },
        {
            "start_logit": 1.0673828125,
            "end_logit": -6.94921875,
            "text": "developmental delay/intellectual disability, particularly affecting speech, while additional features include growth failure",
            "probability": 0.000762939453125
        },
        {
            "start_logit": 1.0673828125,
            "end_logit": -6.953125,
            "text": "developmental delay/intellectual disability, particularly affecting speech",
            "probability": 0.0007567405700683594
        },
        {
            "start_logit": 1.0673828125,
            "end_logit": -6.99609375,
            "text": "developmental delay/",
            "probability": 0.0007281303405761719
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 0.2081298828125,
            "text": "intellectual disability",
            "probability": 0.0006227493286132812
        },
        {
            "start_logit": -6.953125,
            "end_logit": 0.2081298828125,
            "text": "variable degree of developmental delay/intellectual disability",
            "probability": 0.0003204345703125
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 0.2081298828125,
            "text": "characteristic of our cohort is a variable degree of developmental delay/intellectual disability",
            "probability": 0.0002741813659667969
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 0.2081298828125,
            "text": "ankyrin repeats through alteration of core structural residues. The major phenotypic characteristic of our cohort is a variable degree of developmental delay/intellectual disability",
            "probability": 0.00027179718017578125
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 0.2081298828125,
            "text": "degree of developmental delay/intellectual disability",
            "probability": 0.00022554397583007812
        },
        {
            "start_logit": -3.625,
            "end_logit": -5.23828125,
            "text": "epilepsy",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": -5.68359375,
            "end_logit": -4.28515625,
            "text": "cohort is a variable degree of developmental delay",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -5.90234375,
            "end_logit": -4.28515625,
            "text": ". The major phenotypic characteristic of our cohort is a variable degree of developmental delay",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -6.015625,
            "end_logit": -4.28515625,
            "text": "phenotypic characteristic of our cohort is a variable degree of developmental delay",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -4.70703125,
            "end_logit": -5.62890625,
            "text": "neurodevelopmental disorder.",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -3.625,
            "end_logit": -6.984375,
            "text": "epilepsy and/or abnormal EEG, predisposition to recurrent infections (mostly bacterial), ophthalmological abnormalities",
            "probability": 6.735324859619141e-06
        }
    ],
    "620997e9c9dfcb9c09000042_1": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.09375,
            "text": "intellectual disability",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.091796875,
            "text": "intellectual",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.765625,
            "end_logit": 9.09375,
            "text": "disability",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.23828125,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 9.09375,
            "text": "to intellectual disability",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.01171875,
            "text": "intellectual disability, spastic-dystonic cerebral palsy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.109375,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.25,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.625,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.6640625,
            "text": "intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.09375,
            "text": "lead to intellectual disability",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -1.091796875,
            "text": "to intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -6.23828125,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.091796875,
            "text": "lead to intellectual",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -7.01171875,
            "text": "disability, spastic-dystonic cerebral palsy",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -7.109375,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -7.25,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -7.625,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.765625,
            "end_logit": -7.6640625,
            "text": "disability, spastic-dystonic cerebral palsy, epilepsy, and hearing",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -6.23828125,
            "text": "to intellectual disability, spastic-dystonic cerebral palsy, epilepsy",
            "probability": 0.0
        }
    ],
    "620997e9c9dfcb9c09000042_2": [
        {
            "start_logit": 9.3984375,
            "end_logit": 9.28125,
            "text": "sensorineural hearing loss",
            "probability": 1.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -0.48193359375,
            "text": "sensorineural",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": -1.2958984375,
            "end_logit": 9.28125,
            "text": "loss",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -3.2109375,
            "end_logit": 9.28125,
            "text": "hearing loss",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.28125,
            "text": "with sensorineural hearing loss",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.9453125,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.99609375,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.0234375,
            "text": "sensorineural hearing loss in 47 individuals from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.17578125,
            "text": "sensorineural hearing loss in 47 individuals from 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.18359375,
            "text": "sensorineural hearing loss in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.1875,
            "text": "sensorineural hearing loss in 47",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.27734375,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.37109375,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.421875,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.42578125,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.4296875,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.43359375,
            "text": "sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families. In addition, 25/47 affected individuals (53%) presented",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.28125,
            "text": "associated with sensorineural hearing loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.28125,
            "text": "variants in SPATA5L1 associated with sensorineural hearing loss",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.28125,
            "text": "report 28 bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss",
            "probability": 5.960464477539063e-08
        }
    ],
    "51595fb0d24251bc0500009c_1": [
        {
            "start_logit": 7.609375,
            "end_logit": 8.0234375,
            "text": "CD44",
            "probability": 1.0
        },
        {
            "start_logit": 7.609375,
            "end_logit": -5.04296875,
            "text": "CD44 and PARP1",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 8.0234375,
            "text": "biology and clinical management of this disease, such as CD44",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.0234375,
            "text": "as CD44",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.609375,
            "end_logit": -6.93359375,
            "text": "CD44 and PARP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.0234375,
            "text": "of outstanding interest in the biology and clinical management of this disease, such as CD44",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.0234375,
            "text": "such as CD44",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.609375,
            "end_logit": -7.328125,
            "text": "CD44 and PARP1.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.609375,
            "end_logit": -7.453125,
            "text": "CD44 and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -5.04296875,
            "text": "PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -5.04296875,
            "text": "biology and clinical management of this disease, such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -5.04296875,
            "text": "as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -5.04296875,
            "text": "and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -5.04296875,
            "text": "of outstanding interest in the biology and clinical management of this disease, such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -5.04296875,
            "text": "such as CD44 and PARP1",
            "probability": 0.0
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -6.93359375,
            "text": "PARP",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -6.93359375,
            "text": "biology and clinical management of this disease, such as CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -6.93359375,
            "text": "as CD44 and PARP",
            "probability": 0.0
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -7.328125,
            "text": "PARP1.",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -6.93359375,
            "text": "and PARP",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_2": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.46875,
            "text": "Mage-A4",
            "probability": 1.0
        },
        {
            "start_logit": -0.85546875,
            "end_logit": 9.46875,
            "text": "A4",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1416015625,
            "text": "Mage",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 9.46875,
            "text": "-A4",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.46875,
            "text": ", Mage-A4",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 9.46875,
            "text": "identification and validation of one specific protein, Mage-A4",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.03125,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive/ER negative lesions.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.46875,
            "text": "specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.46875,
            "text": "large cumulative database of proteins based on the analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.46875,
            "text": "analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.46875,
            "text": "s, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.46875,
            "text": "database of proteins based on the analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.2109375,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.46875,
            "text": "including a large cumulative database of proteins based on the analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.46875,
            "text": "and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.46875,
            "text": "the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.46875,
            "text": "the analysis of 78 TNBCs, and the identification and validation of one specific protein, Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.25,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive/ER negative",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.2734375,
            "text": "Mage-A4, which was expressed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.375,
            "text": "Mage-A4, which was expressed in a significant fraction of TNBC and Her2-positive",
            "probability": 5.960464477539063e-08
        }
    ],
    "51595fb0d24251bc0500009c_3": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.5078125,
            "text": "Mage-A4",
            "probability": 1.0
        },
        {
            "start_logit": -0.7861328125,
            "end_logit": 9.5078125,
            "text": "A4",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3857421875,
            "text": "Mage",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 9.5078125,
            "text": "-A4",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.69140625,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.5078125,
            "text": "identifies Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.05078125,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.5078125,
            "text": "carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.5078125,
            "text": "with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.5078125,
            "text": "of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.5078125,
            "text": "breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.2890625,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3203125,
            "text": "Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.4609375,
            "text": "Mage-A4 as potential therapeutic target",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5078125,
            "text": "Mage-A4 as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.6328125,
            "text": "Mage-A4 as potential therapeutic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.640625,
            "text": "Mage-A4 as potential therapeutic target in estrogen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.7861328125,
            "end_logit": -6.69140625,
            "text": "A4 as potential therapeutic target in estrogen receptor negative",
            "probability": 0.0
        },
        {
            "start_logit": -0.7861328125,
            "end_logit": -7.05078125,
            "text": "A4 as potential therapeutic target in estrogen receptor",
            "probability": 0.0
        },
        {
            "start_logit": -0.7861328125,
            "end_logit": -7.2890625,
            "text": "A4 as potential therapeutic target in estrogen receptor negative breast cancer",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_4": [
        {
            "start_logit": 7.87109375,
            "end_logit": 8.9140625,
            "text": "S100A14",
            "probability": 1.0
        },
        {
            "start_logit": -1.9384765625,
            "end_logit": 8.9140625,
            "text": "14",
            "probability": 5.519390106201172e-05
        },
        {
            "start_logit": -2.904296875,
            "end_logit": 8.9140625,
            "text": "lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -2.154296875,
            "text": "S100A14 and mucin 1 (MUC1",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -3.263671875,
            "text": "S100A",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.359375,
            "end_logit": 8.9140625,
            "text": "RAB25, S100A14",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 8.9140625,
            "text": "as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.9140625,
            "text": ", S100A14",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.9140625,
            "text": "novel markers of breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 8.9140625,
            "text": "such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.9609375,
            "text": "S100A14 and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.96484375,
            "text": "S100A14 and mucin 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.01171875,
            "text": "S100A14 and mucin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 8.9140625,
            "text": "lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.9140625,
            "text": "markers of breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.9140625,
            "text": "potential novel markers of breast cancer cells with tumor-initiating features, such as lipolysis-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.9140625,
            "text": "-stimulated lipoprotein receptor (LSR), RAB25, S100A14",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.203125,
            "text": "S100A14 and mucin 1 (MUC1), as well as a novel 31-gene signature capable of predicting distant metastasis in cohorts of estrogen receptor-negative",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.43359375,
            "text": "S100A14 and mucin 1 (MUC1)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.43359375,
            "text": "S100A14 and mucin 1 (MUC1), as well as a novel 31-gene signature capable of predicting distant metastasis in cohorts of estrogen receptor",
            "probability": 2.384185791015625e-07
        }
    ],
    "51595fb0d24251bc0500009c_5": [
        {
            "start_logit": 7.75,
            "end_logit": 7.8984375,
            "text": "Hsp90",
            "probability": 1.0
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.65625,
            "text": "Hsp90 as",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.8359375,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8984375,
            "text": "identify Hsp90",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.8984375,
            "text": "he results identify Hsp90",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.33984375,
            "text": "Hsp90 as a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.4375,
            "text": "Hsp90 as a critical and multimodal target",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.46875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor PU-H71",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.48046875,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.5,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.51953125,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.55078125,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.5625,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90 inhibitor PU-H7",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.5703125,
            "text": "Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.57421875,
            "text": "Hsp90 as a critical and multimodal target in this",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.65625,
            "text": "identify Hsp90 as",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.65625,
            "text": "he results identify Hsp90 as",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.8359375,
            "text": "identify Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.8359375,
            "text": "he results identify Hsp90 as a critical and multimodal target in this most difficult to treat breast cancer subtype and support the use of the Hsp90",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -7.328125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_6": [
        {
            "start_logit": 3.0390625,
            "end_logit": 3.123046875,
            "text": "glycolytic enzymes",
            "probability": 0.927734375
        },
        {
            "start_logit": 3.0390625,
            "end_logit": 0.51708984375,
            "text": "glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 0.068359375
        },
        {
            "start_logit": -0.01910400390625,
            "end_logit": 0.51708984375,
            "text": "cytokeratins",
            "probability": 0.003215789794921875
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -4.89453125,
            "text": "glycolytic enzymes (as for example MDH2",
            "probability": 0.0003063678741455078
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -5.59765625,
            "text": "glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1",
            "probability": 0.00015163421630859375
        },
        {
            "start_logit": -5.75,
            "end_logit": 3.123046875,
            "text": "enzymes",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 0.51708984375,
            "text": ", cytokeratins",
            "probability": 0.00011354684829711914
        },
        {
            "start_logit": -3.6171875,
            "end_logit": 0.51708984375,
            "text": "MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 8.7738037109375e-05
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -6.17578125,
            "text": "glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratin",
            "probability": 8.505582809448242e-05
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 3.123046875,
            "text": "several glycolytic enzymes",
            "probability": 6.031990051269531e-05
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -6.6640625,
            "text": "glycolytic",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -7.09375,
            "text": "glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 3.0390625,
            "end_logit": -7.12109375,
            "text": "glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1)",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -5.703125,
            "end_logit": 0.51708984375,
            "text": "Aldolase1), cytokeratins",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": -5.75,
            "end_logit": 0.51708984375,
            "text": "enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -0.01910400390625,
            "end_logit": -5.40625,
            "text": "cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 0.51708984375,
            "text": "several glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -0.01910400390625,
            "end_logit": -6.17578125,
            "text": "cytokeratin",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 0.51708984375,
            "text": "as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 0.51708984375,
            "text": "example MDH2, PGK1, TKT, Aldolase1), cytokeratins",
            "probability": 2.9206275939941406e-06
        }
    ],
    "51595fb0d24251bc0500009c_7": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.015625,
            "text": "CD74",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.6796875,
            "text": "CD",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.96875,
            "end_logit": 9.015625,
            "text": "74",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 9.015625,
            "text": "Stat1, Mx1, and CD74",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 9.015625,
            "text": "and CD74",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 9.015625,
            "text": "Mx1, and CD74",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 9.015625,
            "text": "first is characterized by high expression of Stat1, Mx1, and CD74",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.00390625,
            "text": "CD74.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 9.015625,
            "text": "1, and CD74",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.015625,
            "text": "high expression of Stat1, Mx1, and CD74",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.015625,
            "text": ", and CD74",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.015625,
            "text": "of Stat1, Mx1, and CD74",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.015625,
            "text": "by high expression of Stat1, Mx1, and CD74",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.67578125,
            "end_logit": -1.6796875,
            "text": "Stat1, Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -1.6796875,
            "text": "and CD",
            "probability": 0.0
        },
        {
            "start_logit": -6.53125,
            "end_logit": -1.6796875,
            "text": "Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -1.6796875,
            "text": "first is characterized by high expression of Stat1, Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -1.6796875,
            "text": "1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -1.6796875,
            "text": "high expression of Stat1, Mx1, and CD",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -1.6796875,
            "text": ", and CD",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_8": [
        {
            "start_logit": 4.83984375,
            "end_logit": 7.6796875,
            "text": "Stat1/CD74",
            "probability": 0.97314453125
        },
        {
            "start_logit": 1.119140625,
            "end_logit": 7.6796875,
            "text": "CD74",
            "probability": 0.02362060546875
        },
        {
            "start_logit": 2.826171875,
            "end_logit": 2.91796875,
            "text": "beta-catenin",
            "probability": 0.0011129379272460938
        },
        {
            "start_logit": -2.208984375,
            "end_logit": 7.6796875,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD74",
            "probability": 0.00084686279296875
        },
        {
            "start_logit": 4.83984375,
            "end_logit": 0.0914306640625,
            "text": "Stat1",
            "probability": 0.0004940032958984375
        },
        {
            "start_logit": -3.80078125,
            "end_logit": 7.6796875,
            "text": "74",
            "probability": 0.00017213821411132812
        },
        {
            "start_logit": -4.12109375,
            "end_logit": 7.6796875,
            "text": "integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD74",
            "probability": 0.000125885009765625
        },
        {
            "start_logit": -5.16796875,
            "end_logit": 7.6796875,
            "text": "plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD74",
            "probability": 4.4226646423339844e-05
        },
        {
            "start_logit": -5.69921875,
            "end_logit": 7.6796875,
            "text": "that Stat1/CD74",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 7.6796875,
            "text": "results show that Stat1/CD74",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 7.6796875,
            "text": ". Taken together, our results show that Stat1/CD74",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 7.6796875,
            "text": "show that Stat1/CD74",
            "probability": 1.0013580322265625e-05
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 7.6796875,
            "text": ", integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1/CD74",
            "probability": 1.0013580322265625e-05
        },
        {
            "start_logit": 4.83984375,
            "end_logit": -5.9609375,
            "text": "Stat1/CD74 positive",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 2.826171875,
            "end_logit": -4.171875,
            "text": "beta-catenin, MUC18",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 2.826171875,
            "end_logit": -4.6015625,
            "text": "beta-catenin, MUC18, plexins, integrins",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.83984375,
            "end_logit": -6.69921875,
            "text": "Stat1/CD74 positive triple-negative tumors are more aggressive and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.208984375,
            "end_logit": 0.0914306640625,
            "text": "MUC18, plexins, integrins, and other proteins involved in cell adhesion and cancer metastasis. Taken together, our results show that Stat1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.83984375,
            "end_logit": -6.96875,
            "text": "Stat1/CD74 positive triple-negative tumors are",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.83984375,
            "end_logit": -7.04296875,
            "text": "Stat1/CD74 positive triple-negative tumors are more aggressive and suggest",
            "probability": 4.172325134277344e-07
        }
    ],
    "51595fb0d24251bc0500009c_9": [
        {
            "start_logit": 9.046875,
            "end_logit": 8.8515625,
            "text": "IDH2",
            "probability": 1.0
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.7529296875,
            "text": "ID",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -2.345703125,
            "end_logit": 8.8515625,
            "text": "H2",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -4.15625,
            "text": "IDH2 and CRABP2",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.1171875,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.8828125,
            "text": "IDH2 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.8515625,
            "text": "high levels of IDH2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 8.8515625,
            "text": "of IDH2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.15625,
            "text": "IDH2 and CRAB",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1640625,
            "text": "IDH2 and CRABP2 and low levels of SEC14",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.23046875,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer survival.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 8.8515625,
            "text": "levels of IDH2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.50390625,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.5234375,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer survival",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.8515625,
            "text": "identified high levels of IDH2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.5859375,
            "text": "IDH2 and CRABP2 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.59375,
            "text": "IDH2 and CRABP2 and low levels of SEC14L2 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.345703125,
            "end_logit": -4.15625,
            "text": "H2 and CRABP2",
            "probability": 0.0
        },
        {
            "start_logit": -2.345703125,
            "end_logit": -6.1171875,
            "text": "H2 and CRABP2 and low levels of SEC14L2",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": -1.7529296875,
            "text": "high levels of ID",
            "probability": 0.0
        }
    ],
    "51595fb0d24251bc0500009c_10": [
        {
            "start_logit": 6.87109375,
            "end_logit": 8.3671875,
            "text": "cathepsin D",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.87109375,
            "end_logit": 2.2109375,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 0.002117156982421875
        },
        {
            "start_logit": -2.87890625,
            "end_logit": 8.3671875,
            "text": "D",
            "probability": 5.817413330078125e-05
        },
        {
            "start_logit": -3.234375,
            "end_logit": 8.3671875,
            "text": "thromobospondin 1, galectin-3 binding protein, cathepsin D",
            "probability": 4.094839096069336e-05
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -2.966796875,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 1.35546875,
            "end_logit": 2.2109375,
            "text": "CD44",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -4.44921875,
            "text": "cathepsin",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.0390625,
            "end_logit": 8.3671875,
            "text": "galectin-3 binding protein, cathepsin D",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -6.8125,
            "end_logit": 8.3671875,
            "text": ", cathepsin D",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.3671875,
            "text": ", galectin-3 binding protein, cathepsin D",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.3671875,
            "text": "potential biomarkers including thromobospondin 1, galectin-3 binding protein, cathepsin D",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 8.3671875,
            "text": "biomarkers including thromobospondin 1, galectin-3 binding protein, cathepsin D",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 8.3671875,
            "text": "including thromobospondin 1, galectin-3 binding protein, cathepsin D",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.3671875,
            "text": "1, galectin-3 binding protein, cathepsin D",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.40625,
            "text": "cathepsin D, vimentin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.70703125,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR from the breast cancer cell lines and in their culture media were",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.97265625,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR from the breast cancer cell lines",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -7.0,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR from the breast cancer cell lines and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -7.00390625,
            "text": "cathepsin D, vimentin, zinc-\u03b12-glycoprotein, CD44, and EGFR from the breast cancer cell lines and in their culture media were further validated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.87890625,
            "end_logit": 2.2109375,
            "text": "D, vimentin, zinc-\u03b12-glycoprotein, CD44",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54d77bdf3706e89528000019_1": [
        {
            "start_logit": 7.20703125,
            "end_logit": 8.265625,
            "text": "1",
            "probability": 1.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.265625,
            "text": "Chromosomes 1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.265625,
            "text": "much of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.265625,
            "text": "genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.265625,
            "text": "on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.265625,
            "text": "of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.265625,
            "text": "including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.265625,
            "text": "multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.265625,
            "text": "CMI, much of the PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.265625,
            "text": "PF morphology was found to be heritable and multiple genomic regions were strongly implicated from OSA, including regions on Chromosomes 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.140625,
            "text": "1 (LOD = 3.07",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.2265625,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.23046875,
            "text": "1 (LOD = 3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.34375,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.35546875,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) )",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.38671875,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3) ) and 22 (LOD = 3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.4453125,
            "text": "1 (LOD = 3.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.453125,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10(-3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.48828125,
            "text": "1 (LOD = 3.07, p = 3 \u00d7 10",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.20703125,
            "end_logit": -7.48828125,
            "text": "1 (LOD =",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54d77bdf3706e89528000019_2": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.0703125,
            "text": "Chr8",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.3974609375,
            "text": "Chr",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.60546875,
            "end_logit": 9.0703125,
            "text": "8",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.5625,
            "text": "Chr8, Max LOD = 3",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.78125,
            "text": "Chr8, Max LOD = 3.04",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.6328125,
            "text": "Chr8, Max LOD = 3.04; Chr12",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.0859375,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.0703125,
            "text": "(Chr8",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.34765625,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09) identified",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.35546875,
            "text": "Chr8, Max LOD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4453125,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.46484375,
            "text": "Chr8, Max LOD = 3.04; Chr12, Max LOD = 2.09) identified within the subset of \"CTD-negative",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.0703125,
            "text": "interest were two regions (Chr8",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.0703125,
            "text": "Of particular interest were two regions (Chr8",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.0703125,
            "text": "were two regions (Chr8",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.60546875,
            "end_logit": -5.5625,
            "text": "8, Max LOD = 3",
            "probability": 0.0
        },
        {
            "start_logit": -1.60546875,
            "end_logit": -5.78125,
            "text": "8, Max LOD = 3.04",
            "probability": 0.0
        },
        {
            "start_logit": -1.60546875,
            "end_logit": -6.6328125,
            "text": "8, Max LOD = 3.04; Chr12",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -1.3974609375,
            "text": "(Chr",
            "probability": 0.0
        },
        {
            "start_logit": -1.60546875,
            "end_logit": -7.0859375,
            "text": "8, Max LOD = 3.04; Chr12, Max LOD = 2",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_3": [
        {
            "start_logit": 7.078125,
            "end_logit": 8.3515625,
            "text": "5",
            "probability": 1.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.3515625,
            "text": "chromosome 5",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.3515625,
            "text": "interstitial duplication in chromosome 5",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.3515625,
            "text": "performed DNA analysis showed interstitial duplication in chromosome 5",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.3515625,
            "text": "in chromosome 5",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.3515625,
            "text": "showed interstitial duplication in chromosome 5",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.3515625,
            "text": "duplication in chromosome 5",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.3515625,
            "text": "Moreover, the performed DNA analysis showed interstitial duplication in chromosome 5",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -6.82421875,
            "text": "5 (5q35",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -6.85546875,
            "text": "5 (5q35.1)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.2890625,
            "text": "5 (5q35.1).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.36328125,
            "text": "5 (5q35.1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.37109375,
            "text": "5 (5q",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.375,
            "text": "5 (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.45703125,
            "text": "5 (5",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.078125,
            "end_logit": -7.5546875,
            "text": "5 (5q35.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -6.82421875,
            "text": "chromosome 5 (5q35",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -6.85546875,
            "text": "chromosome 5 (5q35.1)",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.82421875,
            "text": "5q35",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.85546875,
            "text": "5q35.1)",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_4": [
        {
            "start_logit": 6.734375,
            "end_logit": 7.75,
            "text": "3",
            "probability": 1.0
        },
        {
            "start_logit": -5.640625,
            "end_logit": 7.75,
            "text": "16p13.3",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -5.734375,
            "end_logit": 7.75,
            "text": ".3",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 7.75,
            "text": "approximately 520.7 kb microdeletion on 16p13.3",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 7.75,
            "text": "7 kb microdeletion on 16p13.3",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 7.75,
            "text": "on 16p13.3",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 7.75,
            "text": "p13.3",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.125,
            "end_logit": 7.75,
            "text": "kb microdeletion on 16p13.3",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.75,
            "text": "microdeletion on 16p13.3",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.75,
            "text": "a approximately 520.7 kb microdeletion on 16p13.3",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -6.41015625,
            "text": "3 involving CREBBP, ADCY9, and SRL genes",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.75,
            "text": "showed a approximately 520.7 kb microdeletion on 16p13.3",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.75,
            "text": ".7 kb microdeletion on 16p13.3",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -6.63671875,
            "text": "3 involving CREBBP, ADCY9, and SRL genes.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -7.01953125,
            "text": "3 involving CREBBP, ADCY9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -7.2109375,
            "text": "3 involving CREBBP, ADCY9, and SRL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -7.22265625,
            "text": "3 involving CREBBP, ADCY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.734375,
            "end_logit": -7.34375,
            "text": "3 involving CREBBP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.640625,
            "end_logit": -4.453125,
            "text": "16p13",
            "probability": 0.0
        },
        {
            "start_logit": -6.2109375,
            "end_logit": -4.453125,
            "text": "approximately 520.7 kb microdeletion on 16p13",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_5": [
        {
            "start_logit": 8.46875,
            "end_logit": 9.0390625,
            "text": "49,XXXXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": 9.0390625,
            "text": "XY",
            "probability": 4.2319297790527344e-05
        },
        {
            "start_logit": 8.46875,
            "end_logit": -2.583984375,
            "text": "49,XX",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 8.46875,
            "end_logit": -2.703125,
            "text": "49",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -3.908203125,
            "end_logit": 9.0390625,
            "text": "Pentasomy 49,XXXXY",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 9.0390625,
            "text": ",XXXXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -6.015625,
            "text": "49,XXX",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 9.0390625,
            "text": "XXXXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.0390625,
            "text": "my 49,XXXXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -6.5625,
            "text": "49,XXXXY associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.0390625,
            "text": "somy 49,XXXXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.0390625,
            "text": "XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -6.85546875,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and cervical syrinx.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -7.25,
            "text": "49,XXXXY associated with a Chiari type 1 malformation and cervical syrinx",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -2.583984375,
            "text": "Pentasomy 49,XX",
            "probability": 0.0
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -2.703125,
            "text": "Pentasomy 49",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -6.5625,
            "text": "XY associated",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -6.85546875,
            "text": "XY associated with a Chiari type 1 malformation and cervical syrinx.",
            "probability": 0.0
        },
        {
            "start_logit": -6.11328125,
            "end_logit": -2.583984375,
            "text": ",XX",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -7.25,
            "text": "XY associated with a Chiari type 1 malformation and cervical syrinx",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_6": [
        {
            "start_logit": 7.57421875,
            "end_logit": 8.6171875,
            "text": "49,XXXXY",
            "probability": 1.0
        },
        {
            "start_logit": 7.57421875,
            "end_logit": 0.68701171875,
            "text": "49,XX",
            "probability": 0.0003600120544433594
        },
        {
            "start_logit": -1.625,
            "end_logit": 8.6171875,
            "text": "XY",
            "probability": 0.00010150671005249023
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -3.66015625,
            "text": "49",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 8.6171875,
            "text": "pentasomy 49,XXXXY",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 8.6171875,
            "text": ",XXXXY",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 8.6171875,
            "text": "XXXXY",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.6171875,
            "text": "with pentasomy 49,XXXXY",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 8.6171875,
            "text": "XXY",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.6171875,
            "text": "A 13-year-old with pentasomy 49,XXXXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.6171875,
            "text": "my 49,XXXXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.6171875,
            "text": "13-year-old with pentasomy 49,XXXXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.6171875,
            "text": "-year-old with pentasomy 49,XXXXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.6171875,
            "text": "-old with pentasomy 49,XXXXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.66015625,
            "text": "49,XXX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.91015625,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx is presented.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.0,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.19140625,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx is presented",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.31640625,
            "text": "49,XXXXY and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.375,
            "text": "49,XXXXY and a Chiari type 1 malformation with an associated cervical syrinx is",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54d77bdf3706e89528000019_7": [
        {
            "start_logit": 7.09375,
            "end_logit": 8.375,
            "text": "9",
            "probability": 1.0
        },
        {
            "start_logit": 7.09375,
            "end_logit": -4.125,
            "text": "9 and 15",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.375,
            "text": "chromosomes 9",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.375,
            "text": "with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.375,
            "text": "on chromosomes 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.375,
            "text": "Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.375,
            "text": "Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.375,
            "text": "-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.375,
            "text": "high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.375,
            "text": "shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.375,
            "text": "genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.375,
            "text": "coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.1796875,
            "text": "9 and 15.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.390625,
            "text": "9 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -4.125,
            "text": "and 15",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -4.125,
            "text": "chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -4.125,
            "text": "with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -4.125,
            "text": "on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -4.125,
            "text": "Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -4.125,
            "text": "Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_8": [
        {
            "start_logit": 7.10546875,
            "end_logit": 8.3515625,
            "text": "15",
            "probability": 1.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.3515625,
            "text": "chromosome 15",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.3515625,
            "text": "Two-point LOD scores on chromosome 15",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.3515625,
            "text": "on chromosome 15",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.3515625,
            "text": "LOD scores on chromosome 15",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.3515625,
            "text": "point LOD scores on chromosome 15",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -6.9296875,
            "text": "15 reached 3.3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.1875,
            "text": "15 reached 3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.203125,
            "text": "15 reached",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.23046875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21.1-22",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.30078125,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.359375,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21.1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.40625,
            "text": "15 reached 3.3 and multipoint scores in this",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.41796875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15q21.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.4296875,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores over 1 (15",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.4921875,
            "text": "15 reached 3.3 and multipoint scores in this region identified",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.5234375,
            "text": "15 reached 3.3 and multipoint scores in this region",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.52734375,
            "text": "15 reached 3.3 and multipoint scores in this region identified a 13 cM region with LOD scores",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": -7.11328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.9296875,
            "text": "chromosome 15 reached 3.3",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_9": [
        {
            "start_logit": 7.34765625,
            "end_logit": 8.15625,
            "text": "9",
            "probability": 1.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.15625,
            "text": "LOD scores on chromosome 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.15625,
            "text": "chromosome 9",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.15625,
            "text": "Multipoint LOD scores on chromosome 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.15625,
            "text": "on chromosome 9",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.15625,
            "text": "oint LOD scores on chromosome 9",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.29296875,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.296875,
            "text": "9 maximize",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.32421875,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.3515625,
            "text": "9 maximized at 3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.3671875,
            "text": "9 maximized",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.375,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.375,
            "text": "9 maximized at 3.05",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.3828125,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33.1)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.4375,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -7.4765625,
            "text": "9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33.1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -7.12109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.29296875,
            "text": "LOD scores on chromosome 9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33-33",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.296875,
            "text": "LOD scores on chromosome 9 maximize",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.32421875,
            "text": "LOD scores on chromosome 9 maximized at 3.05, identifying a 40 cM region with LOD scores over 1 (9q21.33",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_10": [
        {
            "start_logit": 7.2109375,
            "end_logit": 7.34375,
            "text": "1",
            "probability": 1.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": 7.34375,
            "text": "46, XY, del(1",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -5.84375,
            "text": "1)",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 7.34375,
            "text": "del(1",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 7.34375,
            "text": ", XY, del(1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -6.78515625,
            "text": "1)(q23q31.2)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.34375,
            "text": "XY, del(1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.34375,
            "text": "showed 46, XY, del(1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 7.34375,
            "text": "(1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.109375,
            "text": "1)(q23q31.2).",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.34375,
            "text": ", del(1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.35546875,
            "text": "1)(q23q31",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.36328125,
            "text": "1)(q23q31.2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.37109375,
            "text": "1)(",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.34375,
            "text": "The karyotype showed 46, XY, del(1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.34375,
            "text": "karyotype showed 46, XY, del(1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -2.078125,
            "text": "46, XY",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -5.84375,
            "text": "46, XY, del(1)",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -6.78515625,
            "text": "46, XY, del(1)(q23q31.2)",
            "probability": 0.0
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -2.078125,
            "text": ", XY",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_11": [
        {
            "start_logit": 7.0703125,
            "end_logit": 6.60546875,
            "text": "Y chromosome",
            "probability": 1.0
        },
        {
            "start_logit": 7.0703125,
            "end_logit": -1.9755859375,
            "text": "Y",
            "probability": 0.0001882314682006836
        },
        {
            "start_logit": -4.703125,
            "end_logit": 6.60546875,
            "text": "chromosome",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 6.60546875,
            "text": "inversion of Y chromosome",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 7.0703125,
            "end_logit": -6.39453125,
            "text": "Y chromosome.",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.265625,
            "end_logit": 6.60546875,
            "text": "showed inversion of Y chromosome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.60546875,
            "text": "of Y chromosome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.60546875,
            "text": "Karyotype analysis showed inversion of Y chromosome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.07421875,
            "end_logit": -1.9755859375,
            "text": "inversion of Y",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -1.9755859375,
            "text": "showed inversion of Y",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -1.9755859375,
            "text": "of Y",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.9755859375,
            "text": "Karyotype analysis showed inversion of Y",
            "probability": 0.0
        },
        {
            "start_logit": -4.703125,
            "end_logit": -6.39453125,
            "text": "chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -5.07421875,
            "end_logit": -6.39453125,
            "text": "inversion of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.39453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -6.39453125,
            "text": "showed inversion of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -6.39453125,
            "text": "of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.39453125,
            "text": "Karyotype analysis showed inversion of Y chromosome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.71484375,
            "text": "Karyotype analysis",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -7.2578125,
            "text": "showed",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_12": [
        {
            "start_logit": 6.73828125,
            "end_logit": 8.65625,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 8.65625,
            "text": "trisomy 18",
            "probability": 0.00022518634796142578
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 8.65625,
            "text": "clinical features and morphological findings in 31 Japanese infants with trisomy 18",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.65625,
            "text": "with trisomy 18",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.65625,
            "text": "The clinical features and morphological findings in 31 Japanese infants with trisomy 18",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.65625,
            "text": "infants with trisomy 18",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.73828125,
            "end_logit": -6.9140625,
            "text": "18 are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.73828125,
            "end_logit": -7.2421875,
            "text": "18 are presented.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.73828125,
            "end_logit": -7.2421875,
            "text": "18 are presented. The majority were small-for-date infants.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.73828125,
            "end_logit": -7.27734375,
            "text": "18 are presented",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -6.9140625,
            "text": "trisomy 18 are",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.2421875,
            "text": "trisomy 18 are presented.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.2421875,
            "text": "trisomy 18 are presented. The majority were small-for-date infants.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.27734375,
            "text": "trisomy 18 are presented",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.3671875,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -6.9140625,
            "text": "clinical features and morphological findings in 31 Japanese infants with trisomy 18 are",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.12109375,
            "text": ". The average age at death was greater in females than in males. Cardiovascular anomalies were consistently present; ventricular septar defect and patent ductus arteriosus",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.9140625,
            "text": "with trisomy 18 are",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -7.23828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.2421875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_13": [
        {
            "start_logit": 6.98046875,
            "end_logit": 8.5078125,
            "text": "13",
            "probability": 1.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.5078125,
            "text": "trisomy 13",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.5078125,
            "text": "heterotopia of striated skeletal muscle and glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy 13",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.5078125,
            "text": "unusual heterotopia of striated skeletal muscle and glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy 13",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.5078125,
            "text": "stillborn male showing feature of trisomy 13",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.5078125,
            "text": "glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy 13",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.5078125,
            "text": "skeletal muscle and glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy 13",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.5078125,
            "text": "meninges of a stillborn male showing feature of trisomy 13",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.359375,
            "text": "13 and an Arnold-Chiari malformation.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.40625,
            "text": "13 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.5546875,
            "text": "13 and an Arnold-Chiari malformation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.55859375,
            "text": "13 and an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -6.96875,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -6.93359375,
            "end_logit": -7.359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.96875,
            "text": "heterotopia of striated skeletal muscle and glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.96875,
            "text": "unusual heterotopia of striated skeletal muscle and glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.359375,
            "text": "trisomy 13 and an Arnold-Chiari malformation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.96875,
            "text": "stillborn male showing feature of trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.40625,
            "text": "trisomy 13 and",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -6.96875,
            "text": "glial tissue occurred in the pontine meninges of a stillborn male showing feature of trisomy",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_14": [
        {
            "start_logit": 6.90625,
            "end_logit": 8.5703125,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -5.55078125,
            "end_logit": 8.5703125,
            "text": "trisomy 18",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.5703125,
            "text": "in trisomy 18",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.5703125,
            "text": "Type II Arnold-Chiari malformation with normal spine in trisomy 18",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.5703125,
            "text": "ari malformation with normal spine in trisomy 18",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.90625,
            "end_logit": -7.32421875,
            "text": "18.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.55078125,
            "end_logit": -6.9609375,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -5.55078125,
            "end_logit": -7.32421875,
            "text": "trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -7.32421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -6.9609375,
            "text": "in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -6.9609375,
            "text": "Type II Arnold-Chiari malformation with normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.9609375,
            "text": "ari malformation with normal spine in trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -7.32421875,
            "text": "in trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.3046875,
            "text": "Type II Arnold-Chiari malformation with normal",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.32421875,
            "text": "Type II Arnold-Chiari malformation with normal spine in trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.3046875,
            "text": "ari malformation with normal",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.32421875,
            "text": "ari malformation with normal spine in trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.421875,
            "text": "Type II Arnold-Chiari malformation with normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.421875,
            "text": "ari malformation with normal spine",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.59375,
            "text": "Type II Arnold",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_15": [
        {
            "start_logit": 6.66015625,
            "end_logit": 8.7265625,
            "text": "18",
            "probability": 1.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": 8.7265625,
            "text": "trisomy 18",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.7265625,
            "text": "in trisomy 18",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.7265625,
            "text": "central nervous system are observed in trisomy 18",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -6.66015625,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -6.8984375,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -7.24609375,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -7.25,
            "text": "18.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -7.49609375,
            "text": "18. The present case describes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.66015625,
            "end_logit": -7.51171875,
            "text": "18. The present case describes an infant having a type II Arnold-Chiari malformation without spina",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -6.66015625,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -6.8984375,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifid",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.24609375,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida.",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.25,
            "text": "trisomy 18.",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.31640625,
            "text": "trisomy",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.49609375,
            "text": "trisomy 18. The present case describes",
            "probability": 0.0
        },
        {
            "start_logit": -3.17578125,
            "end_logit": -7.51171875,
            "text": "trisomy 18. The present case describes an infant having a type II Arnold-Chiari malformation without spina",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": -6.46875,
            "text": ". One previous case of an Arnold-Chiari malformation was reported in trisomy 18",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -6.66015625,
            "text": ". The present case describes an infant having a type II Arnold-Chiari malformation without spina bifida",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -6.8984375,
            "text": ". The present case describes an infant having a type II Arnold-Chiari malformation without spina bifid",
            "probability": 0.0
        }
    ],
    "54d77bdf3706e89528000019_16": [
        {
            "start_logit": -2.912109375,
            "end_logit": 0.65625,
            "text": "3p13-14",
            "probability": 0.37890625
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -0.6123046875,
            "text": "FOXP1",
            "probability": 0.36376953125
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -0.6123046875,
            "text": "3p13-14.1 deletion of four genes, including FOXP1",
            "probability": 0.106689453125
        },
        {
            "start_logit": -3.177734375,
            "end_logit": -0.6123046875,
            "text": "1 deletion of four genes, including FOXP1",
            "probability": 0.081787109375
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -2.11328125,
            "text": "3p13-14.1",
            "probability": 0.0238037109375
        },
        {
            "start_logit": -3.177734375,
            "end_logit": -2.11328125,
            "text": "1",
            "probability": 0.01824951171875
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 0.65625,
            "text": "Recently, a child was reported who presented with a 3p13-14",
            "probability": 0.006320953369140625
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 0.65625,
            "text": "with a 3p13-14",
            "probability": 0.006221771240234375
        },
        {
            "start_logit": -6.703125,
            "end_logit": -0.6123046875,
            "text": ".1 deletion of four genes, including FOXP1",
            "probability": 0.0023975372314453125
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -5.8125,
            "text": "FOXP1, and a constellation of deficits that included speech delay",
            "probability": 0.0020046234130859375
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -5.83203125,
            "text": "FOXP1, and a constellation of deficits that included speech delay.",
            "probability": 0.0019741058349609375
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -0.6123046875,
            "text": "Recently, a child was reported who presented with a 3p13-14.1 deletion of four genes, including FOXP1",
            "probability": 0.0017824172973632812
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -0.6123046875,
            "text": "with a 3p13-14.1 deletion of four genes, including FOXP1",
            "probability": 0.0017547607421875
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -6.84375,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study, we report the case of a",
            "probability": 0.0007143020629882812
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -6.90234375,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study, we report the case of a patient with a",
            "probability": 0.0006766319274902344
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -7.015625,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study",
            "probability": 0.0006017684936523438
        },
        {
            "start_logit": -1.68359375,
            "end_logit": -7.0234375,
            "text": "FOXP1, and a constellation of deficits that included speech delay. In this study, we report the case of a patient with a single deletion",
            "probability": 0.0006017684936523438
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -5.8125,
            "text": "3p13-14.1 deletion of four genes, including FOXP1, and a constellation of deficits that included speech delay",
            "probability": 0.0005879402160644531
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -5.83203125,
            "text": "3p13-14.1 deletion of four genes, including FOXP1, and a constellation of deficits that included speech delay.",
            "probability": 0.0005784034729003906
        },
        {
            "start_logit": -6.703125,
            "end_logit": -2.11328125,
            "text": ".1",
            "probability": 0.0005397796630859375
        }
    ],
    "5a67afb7b750ff445500000d_1": [
        {
            "start_logit": 9.1484375,
            "end_logit": 8.9921875,
            "text": "papilledema",
            "probability": 1.0
        },
        {
            "start_logit": 1.3720703125,
            "end_logit": 8.9921875,
            "text": "peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 0.0004208087921142578
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.4169921875,
            "text": "papill",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -1.9345703125,
            "end_logit": 8.9921875,
            "text": "edema",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.32421875,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.9921875,
            "text": ". Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.109375,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocyt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.15234375,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 8.9921875,
            "text": "changes, papilledema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.2109375,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 8.9921875,
            "text": "skin changes, papilledema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.25,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.9921875,
            "text": ", papilledema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.9921875,
            "text": "combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.9921875,
            "text": "opathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.9921875,
            "text": "Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.9921875,
            "text": "of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5,
            "text": "papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5078125,
            "text": "papilledema, extravascular volume overload, sclerotic bone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.9921875,
            "text": ", skin changes, papilledema",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a67afb7b750ff445500000d_2": [
        {
            "start_logit": 8.59375,
            "end_logit": 6.82421875,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.59375,
            "end_logit": -3.76171875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": 8.59375,
            "end_logit": -7.40625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.59375,
            "end_logit": -7.73046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.59375,
            "end_logit": -7.73046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.59375,
            "end_logit": -7.73828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome should be directed",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 6.82421875,
            "text": "of polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.82421875,
            "text": "Treatment of polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -3.76171875,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -3.76171875,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -3.76171875,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -3.76171875,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -3.76171875,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -3.76171875,
            "text": "of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -3.76171875,
            "text": "opathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.76171875,
            "text": "Treatment of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -3.76171875,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -3.76171875,
            "text": "omegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -7.52734375,
            "text": "skin changes (POEMS) syndrome should be directed at the underlying plasma cell clone with risk-adapted therapy based on the extent of the plasma cell disorder",
            "probability": 0.0
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -7.625,
            "text": "skin changes (POEMS) syndrome should be directed at the underlying plasma cell clone with risk-adapted therapy based on the extent of the plasma cell",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_3": [
        {
            "start_logit": 8.6640625,
            "end_logit": 1.556640625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 0.857421875
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -0.24658203125,
            "text": "Polyneuropathy",
            "probability": 0.14111328125
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.1875,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.0003724098205566406
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.50390625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell",
            "probability": 0.0002703666687011719
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -6.91015625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder",
            "probability": 0.0001800060272216797
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.0,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome is a rare paraneoplastic disorder.",
            "probability": 0.0001652240753173828
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.3125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (",
            "probability": 0.0001208186149597168
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.45703125,
            "text": "Polyneuropathy, organomegaly,",
            "probability": 0.00010418891906738281
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.46875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes (POEMS) syndrome is",
            "probability": 0.00010341405868530273
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -7.4765625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin",
            "probability": 0.00010257959365844727
        },
        {
            "start_logit": -3.0546875,
            "end_logit": 1.556640625,
            "text": "skin changes",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 1.556640625,
            "text": "monoclonal plasma cell disorder, skin changes",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 1.556640625,
            "text": ", organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 1.556640625,
            "text": "plasma cell disorder, skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 1.556640625,
            "text": "endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 1.556640625,
            "text": "organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 1.556640625,
            "text": ", skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 1.556640625,
            "text": "changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 1.556640625,
            "text": "opathy, monoclonal plasma cell disorder, skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 1.556640625,
            "text": ", monoclonal plasma cell disorder, skin changes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a67afb7b750ff445500000d_4": [
        {
            "start_logit": 8.9765625,
            "end_logit": 5.9296875,
            "text": "Polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -4.6484375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.1015625,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.24609375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.62109375,
            "text": "Polyneuropathy, Organomegaly, Endocrinopathy, M protein",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.265625,
            "end_logit": 5.9296875,
            "text": ", Polyneuropathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 5.9296875,
            "text": "namely, Polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 5.9296875,
            "text": "syndrome, namely, Polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 5.9296875,
            "text": "clinical features of the syndrome, namely, Polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -4.6484375,
            "text": "Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -6.265625,
            "end_logit": -4.6484375,
            "text": ", Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -4.6484375,
            "text": "Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -4.6484375,
            "text": "and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -4.6484375,
            "text": "namely, Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -4.6484375,
            "text": "Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -4.6484375,
            "text": ", Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -4.6484375,
            "text": "omegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -4.6484375,
            "text": "syndrome, namely, Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -4.6484375,
            "text": "clinical features of the syndrome, namely, Polyneuropathy, Organomegaly, Endocrinopathy, M protein, and Skin abnormalities",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -4.6484375,
            "text": ", and Skin abnormalities",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_5": [
        {
            "start_logit": 7.640625,
            "end_logit": 4.39453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.990234375
        },
        {
            "start_logit": 7.640625,
            "end_logit": -0.27685546875,
            "text": "polyneuropathy",
            "probability": 0.00930023193359375
        },
        {
            "start_logit": -2.083984375,
            "end_logit": 4.39453125,
            "text": "skin changes",
            "probability": 5.9545040130615234e-05
        },
        {
            "start_logit": 7.640625,
            "end_logit": -6.7578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes)",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.0625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.1484375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem disorder with a good long-term prognosis.",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.42578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.45703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) is a multisystem",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.484375,
            "text": "polyneuropathy, organ",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.54296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 4.39453125,
            "text": "changes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 4.39453125,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 4.39453125,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 4.39453125,
            "text": "(polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 4.39453125,
            "text": "opathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 4.39453125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 4.39453125,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 4.39453125,
            "text": "omegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 4.39453125,
            "text": ", monoclonal gammopathy and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 4.39453125,
            "text": "syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a67afb7b750ff445500000d_6": [
        {
            "start_logit": 8.3046875,
            "end_logit": 6.8046875,
            "text": "polyneuropathy",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 0.19091796875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0013360977172851562
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.73828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.12109375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.21484375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.5,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.58984375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.63671875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes forms a characteristic multisystem syndrome, Crow-Fukase syndrome, or",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 6.8046875,
            "text": "association of polyneuropathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.8046875,
            "text": "of polyneuropathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.8046875,
            "text": "The association of polyneuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.48046875,
            "end_logit": 0.19091796875,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": 0.19091796875,
            "text": "association of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 0.19091796875,
            "text": "of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": 0.19091796875,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 0.19091796875,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": 0.19091796875,
            "text": "The association of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 0.19091796875,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 0.19091796875,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 0.19091796875,
            "text": "opathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_7": [
        {
            "start_logit": 9.59375,
            "end_logit": 4.20703125,
            "text": "Polyneuropathy",
            "probability": 0.9951171875
        },
        {
            "start_logit": 9.59375,
            "end_logit": -1.1044921875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.00494384765625
        },
        {
            "start_logit": 9.59375,
            "end_logit": -6.6875,
            "text": "Polyneuropathy, organomegaly",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": 9.59375,
            "end_logit": -6.7265625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.46875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.4765625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.52734375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.53125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.5390625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome is a multisystem",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -1.1044921875,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.51171875,
            "end_logit": -1.1044921875,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -1.1044921875,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -1.1044921875,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -1.1044921875,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -1.1044921875,
            "text": "gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -1.1044921875,
            "text": "opathy, monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -1.1044921875,
            "text": ", monoclonal gammopathy and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.1044921875,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -6.7265625,
            "text": "monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -7.18359375,
            "text": "monoclonal gammopathy and skin changes (POEMS) syndrome is a multisystem disorder arising from underlying plasma cell dyscrasia.",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_8": [
        {
            "start_logit": 7.58984375,
            "end_logit": 1.361328125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.97998046875
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -2.607421875,
            "text": "Polyneuropathy",
            "probability": 0.0185089111328125
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.02734375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.0006046295166015625
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.9765625,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.00023305416107177734
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.09375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 0.00020897388458251953
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.3046875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (",
            "probability": 0.0001678466796875
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.3203125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.0001653432846069336
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.40625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 0.00015294551849365234
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.52734375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and",
            "probability": 0.00013494491577148438
        },
        {
            "start_logit": -4.19921875,
            "end_logit": 1.361328125,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 1.361328125,
            "text": "skin changes",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 1.361328125,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 1.361328125,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 1.361328125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 1.361328125,
            "text": "opathy, monoclonal gammopathy, and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 1.361328125,
            "text": ", monoclonal gammopathy, and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 1.361328125,
            "text": "changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 1.361328125,
            "text": "omegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -6.02734375,
            "text": "monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -4.19921875,
            "end_logit": -7.03515625,
            "text": "monoclonal gammopathy, and skin changes (POEMS) syndrome is an uncommon condition related to a paraneoplastic syndrome secondary to an underlying plasma cell disorder.",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_9": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.4609375,
            "text": "Pulmonary hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": 9.4609375,
            "text": "hypertension",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -1.001953125,
            "text": "Pulmonary",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -5.5703125,
            "text": "Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.58203125,
            "text": "Pulmonary hypertension is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.171875,
            "text": "Pulmonary hypertension is one",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.40625,
            "text": "Pulmonary hypertension is one of the well-known",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.46484375,
            "text": "Pulmonary hypertension is one of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.46484375,
            "text": "Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.5390625,
            "text": "Pulmonary hypertension is one of the well-known clinical manifestations of polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.5703125,
            "text": "Pulmonary hypertension is one of the well",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.59375,
            "text": "Pulmonary hypertension is one of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -5.5703125,
            "text": "hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -6.58203125,
            "text": "hypertension is",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.171875,
            "text": "hypertension is one",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.40625,
            "text": "hypertension is one of the well-known",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.46484375,
            "text": "hypertension is one of",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.46484375,
            "text": "hypertension is one of the well-known clinical manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.5390625,
            "text": "hypertension is one of the well-known clinical manifestations of polyneuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -0.84765625,
            "end_logit": -7.5703125,
            "text": "hypertension is one of the well",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_10": [
        {
            "start_logit": 7.1875,
            "end_logit": 2.58203125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 0.9873046875
        },
        {
            "start_logit": 7.1875,
            "end_logit": -1.8486328125,
            "text": "Polyneuropathy",
            "probability": 0.011810302734375
        },
        {
            "start_logit": 7.1875,
            "end_logit": -6.14453125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.0001614093780517578
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.00390625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare disorder.",
            "probability": 6.830692291259766e-05
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.140625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 5.936622619628906e-05
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.1484375,
            "text": "Polyneuropathy, organomegaly",
            "probability": 5.888938903808594e-05
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.2890625,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (",
            "probability": 5.120038986206055e-05
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.29296875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy,",
            "probability": 5.078315734863281e-05
        },
        {
            "start_logit": -3.5703125,
            "end_logit": 2.58203125,
            "text": "skin changes",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -3.666015625,
            "end_logit": 2.58203125,
            "text": "monoclonal gammopathy, and skin changes",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 2.58203125,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 2.58203125,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 2.58203125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 2.58203125,
            "text": "changes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 2.58203125,
            "text": "opathy, monoclonal gammopathy, and skin changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 2.58203125,
            "text": ", monoclonal gammopathy, and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 2.58203125,
            "text": "omegaly, endocrinopathy, monoclonal gammopathy, and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 2.58203125,
            "text": "and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 2.58203125,
            "text": "gammopathy, and skin changes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.666015625,
            "end_logit": -6.14453125,
            "text": "monoclonal gammopathy",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_11": [
        {
            "start_logit": 9.1875,
            "end_logit": 1.115234375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.71728515625
        },
        {
            "start_logit": 9.1875,
            "end_logit": 0.1348876953125,
            "text": "Polyneuropathy",
            "probability": 0.26806640625
        },
        {
            "start_logit": 9.1875,
            "end_logit": -2.833984375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome, a plasma cell dyscrasia associated with pulmonary hypertension",
            "probability": 0.013763427734375
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.8125,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 0.0002582073211669922
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.93359375,
            "text": "Polyneuropathy, organomegaly",
            "probability": 0.0002295970916748047
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.33984375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (",
            "probability": 0.00015294551849365234
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.35546875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and",
            "probability": 0.00015056133270263672
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.37109375,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome, a plasma cell dyscrasia",
            "probability": 0.0001481771469116211
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.5546875,
            "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 0.0001227855682373047
        },
        {
            "start_logit": -5.0390625,
            "end_logit": 1.115234375,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 1.115234375,
            "text": "skin changes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 1.115234375,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.712890625,
            "end_logit": -2.833984375,
            "text": "pulmonary hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 1.115234375,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 1.115234375,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 1.115234375,
            "text": "opathy, monoclonal gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 1.115234375,
            "text": "gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 1.115234375,
            "text": ", monoclonal gammopathy and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -2.833984375,
            "text": "monoclonal gammopathy and skin changes (POEMS) syndrome, a plasma cell dyscrasia associated with pulmonary hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -5.62109375,
            "end_logit": -2.833984375,
            "text": "skin changes (POEMS) syndrome, a plasma cell dyscrasia associated with pulmonary hypertension",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_12": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.3671875,
            "text": "optic disc edema",
            "probability": 1.0
        },
        {
            "start_logit": -1.083984375,
            "end_logit": 9.3671875,
            "text": "edema",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.0283203125,
            "text": "optic",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -4.01953125,
            "end_logit": 9.3671875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -5.21484375,
            "text": "optic disc edema (ODE)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -5.32421875,
            "text": "optic disc edema (ODE), bilateral cystoid macular edema (CME), anasarca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 9.3671875,
            "text": "disc edema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 9.3671875,
            "text": "bilateral optic disc edema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.58984375,
            "text": "optic disc edema (OD",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.8203125,
            "text": "optic disc edema (ODE), bilateral cystoid macular edema (CME), anasar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 9.3671875,
            "text": "skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.8828125,
            "text": "optic disc edema (ODE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.3671875,
            "text": "with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.3671875,
            "text": "had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.3671875,
            "text": "man with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.14453125,
            "text": "optic disc edema (ODE), bilateral cystoid macular edema (CME)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.3671875,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.1875,
            "text": "optic disc edema (ODE), bilateral cystoid macular edema (CME), anasa",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.3671875,
            "text": "monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.3671875,
            "text": "endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome had bilateral optic disc edema",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a67afb7b750ff445500000d_13": [
        {
            "start_logit": 7.171875,
            "end_logit": 3.337890625,
            "text": "polyneuropathy",
            "probability": 0.9951171875
        },
        {
            "start_logit": 7.171875,
            "end_logit": -2.17578125,
            "text": "polyneuropathy, hepatomegaly",
            "probability": 0.00402069091796875
        },
        {
            "start_logit": 7.171875,
            "end_logit": -4.29296875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes",
            "probability": 0.0004837512969970703
        },
        {
            "start_logit": 7.171875,
            "end_logit": -6.28515625,
            "text": "polyneuropathy, hepatomegaly, splenomegaly",
            "probability": 6.574392318725586e-05
        },
        {
            "start_logit": 7.171875,
            "end_logit": -6.80859375,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features of the recently described POEMS syndrome.",
            "probability": 3.927946090698242e-05
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.47265625,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.484375,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes,",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.484375,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features of the recently described",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.4921875,
            "text": "polyneuropathy, hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several",
            "probability": 1.9729137420654297e-05
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 3.337890625,
            "text": "with polyneuropathy",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 3.337890625,
            "text": "A 39-year-old woman presented with polyneuropathy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 3.337890625,
            "text": "woman presented with polyneuropathy",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 3.337890625,
            "text": "39-year-old woman presented with polyneuropathy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.9970703125,
            "end_logit": -2.17578125,
            "text": "hepatomegaly",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.9970703125,
            "end_logit": -4.29296875,
            "text": "hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9970703125,
            "end_logit": -6.28515625,
            "text": "hepatomegaly, splenomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -6.58203125,
            "end_logit": -2.17578125,
            "text": "with polyneuropathy, hepatomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -1.9970703125,
            "end_logit": -6.80859375,
            "text": "hepatomegaly, splenomegaly, endocrinopathy, monoclonal protein and skin changes, several of the many clinical features of the recently described POEMS syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -2.17578125,
            "text": "A 39-year-old woman presented with polyneuropathy, hepatomegaly",
            "probability": 0.0
        },
        {
            "start_logit": -5.13671875,
            "end_logit": -4.29296875,
            "text": "splenomegaly, endocrinopathy, monoclonal protein and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_14": [
        {
            "start_logit": 8.8046875,
            "end_logit": 6.36328125,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -4.3828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -7.07421875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions'.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -7.25390625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions'",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -7.3125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -7.35546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 6.36328125,
            "text": "'polyneuropathy",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 6.36328125,
            "text": "namely 'polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.36328125,
            "text": "acronym POEMS is derived from main features of the syndrome namely 'polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.36328125,
            "text": "syndrome namely 'polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.3828125,
            "text": "'polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -4.3828125,
            "text": "skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -4.3828125,
            "text": "namely 'polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -4.3828125,
            "text": "endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.17578125,
            "end_logit": -4.3828125,
            "text": "organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -4.3828125,
            "text": "opathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -4.3828125,
            "text": "acronym POEMS is derived from main features of the syndrome namely 'polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -4.3828125,
            "text": "monoclonal gammopathy and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -4.3828125,
            "text": "and skin lesions",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -4.3828125,
            "text": ", monoclonal gammopathy and skin lesions",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_15": [
        {
            "start_logit": 9.4140625,
            "end_logit": 4.71875,
            "text": "polyneuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -3.03515625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0004291534423828125
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.0078125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes.",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.703125,
            "end_logit": 4.71875,
            "text": "by polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 4.71875,
            "text": "multisystem syndrome characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 4.71875,
            "text": "syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 4.71875,
            "text": "rare multisystem syndrome characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 4.71875,
            "text": "syndrome, also known as Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.3828125,
            "end_logit": -3.03515625,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.703125,
            "end_logit": -3.03515625,
            "text": "by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -3.03515625,
            "text": "organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -3.03515625,
            "text": ", organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -3.03515625,
            "text": "multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.03515625,
            "text": "endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -3.03515625,
            "text": "syndrome, represents a rare multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -3.03515625,
            "text": "opathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -3.03515625,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -3.03515625,
            "text": "rare multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -3.03515625,
            "text": "omegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_16": [
        {
            "start_logit": 8.3828125,
            "end_logit": 6.7734375,
            "text": "Polyneuropathy",
            "probability": 0.95703125
        },
        {
            "start_logit": 8.3828125,
            "end_logit": 3.59375,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 0.039794921875
        },
        {
            "start_logit": 5.87109375,
            "end_logit": 3.59375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes",
            "probability": 0.00324249267578125
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -3.412109375,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy",
            "probability": 3.600120544433594e-05
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -3.412109375,
            "text": "polyneuropathy",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.00390625,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.13671875,
            "text": "Polyneuropathy is",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.20703125,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.4453125,
            "text": "Polyneuropathy is often an",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.48046875,
            "text": "Polyneuropathy is often an initial manifestation of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.3828125,
            "end_logit": -7.5625,
            "text": "Polyneuropathy is often",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -6.80859375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed as chronic inflammatory demyelinating polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -7.00390625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -7.20703125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -7.46875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -7.48046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 3.59375,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.87109375,
            "end_logit": -7.578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome and therefore this disorder is frequently misdiagnosed as chronic inflammatory demyelinating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 3.59375,
            "text": "M protein and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 3.59375,
            "text": "changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_17": [
        {
            "start_logit": 7.22265625,
            "end_logit": 8.7265625,
            "text": "distal polyneuropathy",
            "probability": 0.87744140625
        },
        {
            "start_logit": 5.25390625,
            "end_logit": 8.7265625,
            "text": "progressive distal polyneuropathy",
            "probability": 0.12255859375
        },
        {
            "start_logit": -2.322265625,
            "end_logit": 8.7265625,
            "text": "polyneuropathy",
            "probability": 6.264448165893555e-05
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -4.25,
            "text": "distal",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 8.7265625,
            "text": "with progressive distal polyneuropathy",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -5.41015625,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.7265625,
            "text": "manifests with progressive distal polyneuropathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.7265625,
            "text": "rare paraneoplastic condition, commonly associated with Castleman disease, that manifests with progressive distal polyneuropathy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -4.25,
            "text": "progressive distal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.2421875,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.2890625,
            "text": "distal polyneuropathy and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.328125,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.34765625,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -5.41015625,
            "text": "progressive distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.3828125,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites, erythro",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.3828125,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes, sclerotic bone lesions, ascites, erythrocyt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.4375,
            "text": "distal polyneuropathy and a monoclonal plasma cell",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.44921875,
            "text": "distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -5.72265625,
            "text": "progressive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.25390625,
            "end_logit": -7.2421875,
            "text": "progressive distal polyneuropathy and a monoclonal plasma cell disorder, often accompanied by endocrinopathy, organomegaly, skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_18": [
        {
            "start_logit": 9.5625,
            "end_logit": 2.111328125,
            "text": "polyneuropathy",
            "probability": 0.9912109375
        },
        {
            "start_logit": 9.5625,
            "end_logit": -2.677734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.00824737548828125
        },
        {
            "start_logit": 9.5625,
            "end_logit": -6.99609375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin",
            "probability": 0.00010967254638671875
        },
        {
            "start_logit": 9.5625,
            "end_logit": -7.29296875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes.",
            "probability": 8.147954940795898e-05
        },
        {
            "start_logit": 9.5625,
            "end_logit": -7.52734375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins",
            "probability": 6.443262100219727e-05
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 2.111328125,
            "text": "by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 2.111328125,
            "text": "multisystem disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.03125,
            "end_logit": 2.111328125,
            "text": "osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 2.111328125,
            "text": "characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 2.111328125,
            "text": "variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 2.111328125,
            "text": "disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 2.111328125,
            "text": "rare multisystem disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.96484375,
            "end_logit": -2.677734375,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -2.677734375,
            "text": "by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -2.677734375,
            "text": "osteosclerotic myeloma and is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -2.677734375,
            "text": "characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -2.677734375,
            "text": "monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -2.677734375,
            "text": "endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -2.677734375,
            "text": "variant of osteosclerotic myeloma and is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -2.677734375,
            "text": "disease, is a variant of osteosclerotic myeloma and is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal proteins, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_19": [
        {
            "start_logit": 7.921875,
            "end_logit": 4.24609375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.921875,
            "end_logit": -2.107421875,
            "text": "polyneuropathy",
            "probability": 0.0017271041870117188
        },
        {
            "start_logit": 7.921875,
            "end_logit": -4.36328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as systemic sclerosis",
            "probability": 0.00018203258514404297
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.6015625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as systemic sclerosis.",
            "probability": 1.9311904907226562e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.796875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed",
            "probability": 1.5854835510253906e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.16015625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.1796875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously",
            "probability": 1.0848045349121094e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.3203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes)",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.35546875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gamm",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.3828125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.3984375,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had been previously misdiagnosed as",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.42578125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) syndrome that had",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -3.85546875,
            "end_logit": 4.24609375,
            "text": "skin changes",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 4.24609375,
            "text": "monoclonal gammopathy and skin changes",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 4.24609375,
            "text": "changes",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 4.24609375,
            "text": "man with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 4.24609375,
            "text": "(polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 4.24609375,
            "text": "endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 4.24609375,
            "text": "with POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 4.24609375,
            "text": ", organomegaly, endocrinopathy, monoclonal gammopathy and skin changes",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5a67afb7b750ff445500000d_20": [
        {
            "start_logit": 9.0234375,
            "end_logit": 4.70703125,
            "text": "polyneuropathy",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -2.181640625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0010166168212890625
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.75,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.14453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes.",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.453125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, M protein",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 4.70703125,
            "text": "by polyneuropathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 4.70703125,
            "text": "plasma cell dyscrasia characterized by polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 4.70703125,
            "text": "rare plasma cell dyscrasia characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 4.70703125,
            "text": "characterized by polyneuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.53125,
            "end_logit": -2.181640625,
            "text": "skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -2.181640625,
            "text": "by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -2.181640625,
            "text": "plasma cell dyscrasia characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -2.181640625,
            "text": "opathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -2.181640625,
            "text": "organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -2.181640625,
            "text": "endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -2.181640625,
            "text": "rare plasma cell dyscrasia characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -2.181640625,
            "text": ", organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -2.181640625,
            "text": "and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -2.181640625,
            "text": "omegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -2.181640625,
            "text": "characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_21": [
        {
            "start_logit": 8.9765625,
            "end_logit": 4.61328125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy",
            "probability": 0.95068359375
        },
        {
            "start_logit": 8.9765625,
            "end_logit": 1.33203125,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes",
            "probability": 0.03570556640625
        },
        {
            "start_logit": 8.9765625,
            "end_logit": 0.292724609375,
            "text": "polyneuropathy",
            "probability": 0.012542724609375
        },
        {
            "start_logit": 1.609375,
            "end_logit": 4.61328125,
            "text": "monoclonal gammapathy",
            "probability": 0.0005979537963867188
        },
        {
            "start_logit": 1.609375,
            "end_logit": 1.33203125,
            "text": "monoclonal gammapathy, and skin changes",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.3046875,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes)",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.37890625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapath",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.4765625,
            "text": "polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy, and skin changes) syndrome is a rare variant of plasma cell dyscrasia",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 4.61328125,
            "text": "y",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 4.61328125,
            "text": "gammapathy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.61328125,
            "text": "endocrinopathy, monoclonal gammapathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 4.61328125,
            "text": "pathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 4.61328125,
            "text": "organomegaly, endocrinopathy, monoclonal gammapathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 4.61328125,
            "text": "opathy, monoclonal gammapathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 4.61328125,
            "text": ", monoclonal gammapathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 4.61328125,
            "text": ", organomegaly, endocrinopathy, monoclonal gammapathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 4.61328125,
            "text": "(polyneuropathy, organomegaly, endocrinopathy, monoclonal gammapathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.58203125,
            "end_logit": 1.33203125,
            "text": "skin changes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 1.33203125,
            "text": "y, and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 1.33203125,
            "text": "gammapathy, and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_22": [
        {
            "start_logit": 6.84765625,
            "end_logit": 7.58984375,
            "text": "ascites",
            "probability": 1.0
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -2.294921875,
            "text": "ascites was a main presenting feature thus the poems syndrome must be added to the list of rare causes of ascites",
            "probability": 5.1021575927734375e-05
        },
        {
            "start_logit": -5.28515625,
            "end_logit": 7.58984375,
            "text": "case ascites",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -5.61328125,
            "text": "ascites was",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -6.82421875,
            "text": "ascites was a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -6.98828125,
            "text": "ascites was a main presenting feature thus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -7.09375,
            "text": "ascites was a main presenting feature thus the poems syndrome must",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.234375,
            "end_logit": -5.2109375,
            "text": "polyneuropathy hepatomegaly splenomegaly endocrinopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.234375,
            "end_logit": -5.22265625,
            "text": "polyneuropathy hepatomegaly splenomegaly endocrinopathy monoclonal protein and skin changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.234375,
            "end_logit": -5.93359375,
            "text": "polyneuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.234375,
            "end_logit": -6.3046875,
            "text": "polyneuropathy hepatomegaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.234375,
            "end_logit": -6.56640625,
            "text": "polyneuropathy hepatomegaly splenomegaly endocrinopathy monoclonal protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.234375,
            "end_logit": -6.8984375,
            "text": "polyneuropathy hepatomegaly splenomegaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.234375,
            "end_logit": -6.90234375,
            "text": "polyneuropathy hepatomegaly splenomegaly endocrinopathy monoclonal protein and skin changes several",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -2.294921875,
            "text": "case ascites was a main presenting feature thus the poems syndrome must be added to the list of rare causes of ascites",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -2.294921875,
            "text": "ascites",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -2.294921875,
            "text": "thus the poems syndrome must be added to the list of rare causes of ascites",
            "probability": 0.0
        },
        {
            "start_logit": -5.28515625,
            "end_logit": -5.61328125,
            "text": "case ascites was",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -5.2109375,
            "text": "hepatomegaly splenomegaly endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -5.22265625,
            "text": "hepatomegaly splenomegaly endocrinopathy monoclonal protein and skin changes",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_23": [
        {
            "start_logit": 7.4375,
            "end_logit": 7.7890625,
            "text": "ascites",
            "probability": 1.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": 7.7890625,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.7890625,
            "text": "developed ascites",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 7.7890625,
            "text": "with polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.7890625,
            "text": "describe a 46 year old man who developed ascites",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.7890625,
            "text": "skin changes we describe a 46 year old man who developed ascites",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.05859375,
            "text": "ascites one year after",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.13671875,
            "text": "ascites one year after the onset of peripheral neuropathy with accompanying muscle atrophies and increasing weakness extensive evaluation revealed that the patient had no underlying liver disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.14453125,
            "text": "ascites one",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -5.46484375,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -6.0546875,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -6.73046875,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -6.7890625,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -6.8984375,
            "text": "polyneuropathy organomegaly endocrinopathy of",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -7.05859375,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites one year after",
            "probability": 0.0
        },
        {
            "start_logit": -1.970703125,
            "end_logit": -7.14453125,
            "text": "polyneuropathy organomegaly endocrinopathy of various forms production of monoclonal m component and skin changes we describe a 46 year old man who developed ascites one",
            "probability": 0.0
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -4.85546875,
            "text": "refractory ascites",
            "probability": 0.0
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -4.85546875,
            "text": "case ascites was a main presenting feature thus the poems syndrome must be added to the list of rare causes of refractory ascites",
            "probability": 0.0
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -6.0,
            "text": "refractory ascites.",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -4.85546875,
            "text": "ascites",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_24": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.5625,
            "text": "glomeruloid hemangiomas",
            "probability": 1.0
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": 9.5625,
            "text": "hemangiomas",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.90234375,
            "text": "glomerul",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -3.1015625,
            "text": "glomeruloid hemangiomas are",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -5.84375,
            "end_logit": 9.5625,
            "text": "oid hemangiomas",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 9.5625,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomeruloid hemangiomas",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.5625,
            "text": "skin abnormalities glomeruloid hemangiomas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.9296875,
            "text": "glomeruloid hemangiomas are considered to be a specific clinical marker",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.9765625,
            "text": "glomeruloid hemangiomas are considered",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.5625,
            "text": "protein and skin abnormalities glomeruloid hemangiomas",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.20703125,
            "text": "glomeruloid hemangiomas are considered to be a specific clinical marker of poems syndrome however while they are not pathognomonic their",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.23828125,
            "text": "glomeruloid hemangiomas are considered to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": -3.1015625,
            "text": "hemangiomas are",
            "probability": 0.0
        },
        {
            "start_logit": -6.2421875,
            "end_logit": -0.90234375,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin abnormalities glomerul",
            "probability": 0.0
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": -6.9296875,
            "text": "hemangiomas are considered to be a specific clinical marker",
            "probability": 0.0
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": -6.9765625,
            "text": "hemangiomas are considered",
            "probability": 0.0
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": -7.20703125,
            "text": "hemangiomas are considered to be a specific clinical marker of poems syndrome however while they are not pathognomonic their",
            "probability": 0.0
        },
        {
            "start_logit": -0.5615234375,
            "end_logit": -7.23828125,
            "text": "hemangiomas are considered to",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -0.90234375,
            "text": "skin abnormalities glomerul",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -0.90234375,
            "text": "protein and skin abnormalities glomerul",
            "probability": 0.0
        }
    ],
    "5a67afb7b750ff445500000d_25": [
        {
            "start_logit": 1.3203125,
            "end_logit": -2.017578125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions",
            "probability": 0.9111328125
        },
        {
            "start_logit": 1.3203125,
            "end_logit": -5.16796875,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy",
            "probability": 0.039031982421875
        },
        {
            "start_logit": -2.52734375,
            "end_logit": -2.236328125,
            "text": "thrombocytosis",
            "probability": 0.01555633544921875
        },
        {
            "start_logit": 1.3203125,
            "end_logit": -6.37890625,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.01165008544921875
        },
        {
            "start_logit": 1.3203125,
            "end_logit": -6.45703125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease",
            "probability": 0.010772705078125
        },
        {
            "start_logit": -2.66796875,
            "end_logit": -3.697265625,
            "text": "small vessel vasculitis",
            "probability": 0.00313568115234375
        },
        {
            "start_logit": -3.20703125,
            "end_logit": -3.697265625,
            "text": "polyarteritis nodosa although association with small vessel vasculitis",
            "probability": 0.0018281936645507812
        },
        {
            "start_logit": -2.52734375,
            "end_logit": -4.60546875,
            "text": "thrombocytosis myeloma",
            "probability": 0.0014581680297851562
        },
        {
            "start_logit": -5.58984375,
            "end_logit": -2.017578125,
            "text": "namely polyneuropathy organomegaly endocrinopathy monoclonal gammopathy and skin lesions",
            "probability": 0.0009055137634277344
        },
        {
            "start_logit": -5.65625,
            "end_logit": -2.236328125,
            "text": "erythrocytosis and thrombocytosis",
            "probability": 0.0006833076477050781
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -2.236328125,
            "text": "osis and thrombocytosis",
            "probability": 0.0005621910095214844
        },
        {
            "start_logit": -5.65625,
            "end_logit": -2.48828125,
            "text": "erythrocytosis",
            "probability": 0.0005321502685546875
        },
        {
            "start_logit": -3.20703125,
            "end_logit": -4.9453125,
            "text": "polyarteritis nodosa",
            "probability": 0.0005240440368652344
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -2.017578125,
            "text": "skin lesions",
            "probability": 0.00045871734619140625
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -2.48828125,
            "text": "osis",
            "probability": 0.0004343986511230469
        },
        {
            "start_logit": -2.52734375,
            "end_logit": -5.87890625,
            "text": "thrombocytosis myeloma is the most common plasma cell dyscrasia associated with poems syndrome renal",
            "probability": 0.000408172607421875
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -2.236328125,
            "text": "skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease papilledema pleural effusion edema ascites erythrocytosis and thrombocytosis",
            "probability": 0.0003685951232910156
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -2.48828125,
            "text": "skin lesions other clinical features include presence of sclerotic bone lesions castleman s disease papilledema pleural effusion edema ascites erythrocytosis",
            "probability": 0.00028705596923828125
        },
        {
            "start_logit": -2.52734375,
            "end_logit": -6.265625,
            "text": "thrombocytosis myeloma is the most common plasma cell dyscrasia associated with poems syndrome renal involvement",
            "probability": 0.0002760887145996094
        },
        {
            "start_logit": -6.83984375,
            "end_logit": -2.017578125,
            "text": "monoclonal gammopathy and skin lesions",
            "probability": 0.0002593994140625
        }
    ],
    "5a67afb7b750ff445500000d_26": [
        {
            "start_logit": 7.60546875,
            "end_logit": -0.130859375,
            "text": "edema effusions",
            "probability": 0.701171875
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -1.1376953125,
            "text": "edema",
            "probability": 0.256103515625
        },
        {
            "start_logit": 2.6796875,
            "end_logit": 1.2109375,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin changes hypothyroidism",
            "probability": 0.019439697265625
        },
        {
            "start_logit": 2.6796875,
            "end_logit": 0.75,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin changes",
            "probability": 0.0122528076171875
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -5.7265625,
            "text": "edema effusions of the 24 patients with poems syndrome 17 70 8 had a recognized hypothyroidism including 11 clinical hypothyroidism",
            "probability": 0.0025997161865234375
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -5.78125,
            "text": "edema effusions of the 24 patients with poems syndrome 17 70 8 had a recognized hypothyroidism including 11 clinical hypothyroidism and 6 subclinical hypothyroidism",
            "probability": 0.0024623870849609375
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -5.89453125,
            "text": "edema effusions of the 24",
            "probability": 0.002197265625
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -5.9765625,
            "text": "edema effusions of the 24 patients with poems syndrome 17",
            "probability": 0.0020236968994140625
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -6.2421875,
            "text": "edema effusions of the 24 patients with poems syndrome 17 70 8 had a recognized hypothyroidism including 11 clinical hypothyroidism and 6 subclinical",
            "probability": 0.0015516281127929688
        },
        {
            "start_logit": -1.7451171875,
            "end_logit": -0.130859375,
            "text": "hypothyroidism and edema effusions",
            "probability": 6.091594696044922e-05
        },
        {
            "start_logit": -3.314453125,
            "end_logit": 1.2109375,
            "text": "hypothyroidism",
            "probability": 4.851818084716797e-05
        },
        {
            "start_logit": 2.6796875,
            "end_logit": -4.9921875,
            "text": "polyneuropathy organomegaly endocrinopathy m protein",
            "probability": 3.933906555175781e-05
        },
        {
            "start_logit": -3.734375,
            "end_logit": 1.2109375,
            "text": "skin changes hypothyroidism",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": -1.7451171875,
            "end_logit": -1.1376953125,
            "text": "hypothyroidism and edema",
            "probability": 2.2232532501220703e-05
        },
        {
            "start_logit": -3.734375,
            "end_logit": 0.75,
            "text": "skin changes",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": 2.6796875,
            "end_logit": -6.31640625,
            "text": "polyneuropathy organomegaly endocrinopathy m protein and skin changes hypothyroidism is",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 1.2109375,
            "text": "by polyneuropathy organomegaly endocrinopathy m protein and skin changes hypothyroidism",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.59375,
            "end_logit": 1.2109375,
            "text": "protein and skin changes hypothyroidism",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 0.75,
            "text": "by polyneuropathy organomegaly endocrinopathy m protein and skin changes",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.59375,
            "end_logit": 0.75,
            "text": "protein and skin changes",
            "probability": 1.1920928955078125e-06
        }
    ],
    "5a67afb7b750ff445500000d_27": [
        {
            "start_logit": 5.6640625,
            "end_logit": -0.484130859375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes",
            "probability": 0.8671875
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -2.826171875,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 0.0833740234375
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -3.69921875,
            "text": "polyneuropathy organomegaly",
            "probability": 0.034820556640625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.54296875,
            "text": "polyneuropathy organomegaly endocrinopathy",
            "probability": 0.005512237548828125
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.83984375,
            "text": "polyneuropathy",
            "probability": 0.004093170166015625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -6.87109375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein",
            "probability": 0.0014600753784179688
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -7.03125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy was",
            "probability": 0.00124359130859375
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -7.05859375,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association",
            "probability": 0.0012102127075195312
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -7.078125,
            "text": "polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy was described in 1956",
            "probability": 0.001186370849609375
        },
        {
            "start_logit": -5.6484375,
            "end_logit": -0.484130859375,
            "text": "features polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -2.826171875,
            "text": "polyneuropathy",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -2.646484375,
            "end_logit": -4.625,
            "text": "polyneuropathy peripheral oedema",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": -0.484130859375,
            "text": "skin changes",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.6484375,
            "end_logit": -2.826171875,
            "text": "features polyneuropathy organomegaly endocrinopathy monoclonal protein m protein skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -4.546875,
            "end_logit": -4.56640625,
            "text": ".",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.5703125,
            "end_logit": -4.56640625,
            "text": "polyneuropathy and plasma cell dyscrasia this disease should be taken into consideration.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.6484375,
            "end_logit": -3.69921875,
            "text": "features polyneuropathy organomegaly",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.646484375,
            "end_logit": -7.05859375,
            "text": "polyneuropathy peripheral oedema osteosclerotic bone lesions skin changes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": -2.826171875,
            "text": "skin changes association between plasma cell dyscrasia and polyneuropathy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -4.56640625,
            "text": "coexistence polyneuropathy and plasma cell dyscrasia this disease should be taken into consideration.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "571f3b320fd6f91b68000007_1": [
        {
            "start_logit": 8.8671875,
            "end_logit": 8.8984375,
            "text": "hirsutism",
            "probability": 1.0
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -0.343505859375,
            "text": "hirsutism, obesity, striae, acne and hypertension",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -1.1640625,
            "text": "hirsutism, obesity",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -1.8173828125,
            "text": "hirs",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -2.02734375,
            "end_logit": 8.8984375,
            "text": "ism",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -4.484375,
            "text": "hirsutism, obesity, striae, acne",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.49609375,
            "end_logit": 8.8984375,
            "text": ", hirsutism",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 8.8984375,
            "text": "weight gain, growth retardation, hirsutism",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 8.8984375,
            "text": "Presenting features commonly include weight gain, growth retardation, hirsutism",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.8984375,
            "text": "utism",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 8.8984375,
            "text": ". Presenting features commonly include weight gain, growth retardation, hirsutism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 8.8984375,
            "text": "include weight gain, growth retardation, hirsutism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -0.343505859375,
            "text": "ism, obesity, striae, acne and hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -1.1640625,
            "text": "ism, obesity",
            "probability": 0.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": -0.343505859375,
            "text": "obesity, striae, acne and hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -4.39453125,
            "end_logit": -0.343505859375,
            "text": "acne and hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -3.802734375,
            "end_logit": -1.1640625,
            "text": "obesity",
            "probability": 0.0
        },
        {
            "start_logit": -4.74609375,
            "end_logit": -0.343505859375,
            "text": "hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -5.49609375,
            "end_logit": -0.343505859375,
            "text": ", hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -0.343505859375,
            "text": "weight gain, growth retardation, hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.0
        }
    ],
    "571f3b320fd6f91b68000007_2": [
        {
            "start_logit": 7.34765625,
            "end_logit": 4.078125,
            "text": "primary pigmented nodular adrenal disease",
            "probability": 0.96142578125
        },
        {
            "start_logit": 7.34765625,
            "end_logit": 0.8154296875,
            "text": "primary pigmented nodular adrenal disease (PPNAD)",
            "probability": 0.0369873046875
        },
        {
            "start_logit": 0.3779296875,
            "end_logit": 3.517578125,
            "text": "hirsutism",
            "probability": 0.0005178451538085938
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -3.94921875,
            "text": "primary",
            "probability": 0.00031495094299316406
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -5.484375,
            "text": "primary pigmented nodular adrenal",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -5.515625,
            "text": "primary pigmented nodular adrenal disease (PPNA",
            "probability": 6.55055046081543e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -5.60546875,
            "text": "primary pigmented nodular adrenal disease (PPNAD",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 0.3779296875,
            "end_logit": 1.033203125,
            "text": "hirsutism, acne, secondary amenorrhea and facial lentiginosis",
            "probability": 4.3332576751708984e-05
        },
        {
            "start_logit": 0.14111328125,
            "end_logit": 1.033203125,
            "text": "facial lentiginosis",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -6.1953125,
            "text": "primary pigmented nodular",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -6.24609375,
            "text": "primary pigmented nodular adrenal disease (PPNAD), is an uncommon cause of adrenocorticotropic hormone-independent Cushing's syndrome.",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -6.9140625,
            "text": "primary pigmented nodular adrenal disease (PPNAD), is",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -6.9765625,
            "text": "primary pigmented nodular adrenal disease (PP",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 3.517578125,
            "text": "weight gain, hirsutism",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 4.078125,
            "text": "pigmented nodular adrenal disease",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 4.078125,
            "text": "disease",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -2.84765625,
            "end_logit": 1.033203125,
            "text": "acne, secondary amenorrhea and facial lentiginosis",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 4.078125,
            "text": ", primary pigmented nodular adrenal disease",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 0.3779296875,
            "end_logit": -2.75390625,
            "text": "hirsutism, acne",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 3.517578125,
            "text": "case of a 20-year-old patient with a history of weight gain, hirsutism",
            "probability": 8.344650268554688e-07
        }
    ],
    "56be0e4aef6e394741000008_1": [
        {
            "start_logit": 7.53125,
            "end_logit": 7.40234375,
            "text": "bronchiectasis",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.53125,
            "end_logit": 0.08367919921875,
            "text": "bronchiectasis and sinusitis",
            "probability": 0.0006589889526367188
        },
        {
            "start_logit": -5.421875,
            "end_logit": 7.40234375,
            "text": "situs inversus, bronchiectasis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 7.40234375,
            "text": ", bronchiectasis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 7.40234375,
            "text": "triad of situs inversus, bronchiectasis",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 7.40234375,
            "text": "of situs inversus, bronchiectasis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.53125,
            "end_logit": -7.0703125,
            "text": "bronchiectasis and sinusitis is known as Kartagener syndrome.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.53125,
            "end_logit": -7.23828125,
            "text": "bronchiectasis and sinusitis is known",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.53125,
            "end_logit": -7.484375,
            "text": "bronchiectasis and sinusitis is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.40234375,
            "text": "The triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.40234375,
            "text": "s inversus, bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.40234375,
            "text": "us, bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.326171875,
            "end_logit": 0.08367919921875,
            "text": "sinusitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.421875,
            "end_logit": 0.08367919921875,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 0.08367919921875,
            "text": ", bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 0.08367919921875,
            "text": "triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 0.08367919921875,
            "text": "and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 0.08367919921875,
            "text": "of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 0.08367919921875,
            "text": "The triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 0.08367919921875,
            "text": "s inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_2": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.43359375,
            "text": "situs inversus",
            "probability": 0.87890625
        },
        {
            "start_logit": 6.37890625,
            "end_logit": 4.4375,
            "text": "situs inversus, chronic rhinosinusitis",
            "probability": 0.1190185546875
        },
        {
            "start_logit": 2.13671875,
            "end_logit": 4.4375,
            "text": "chronic rhinosinusitis",
            "probability": 0.00171661376953125
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -2.51953125,
            "text": "situs inversus, chronic rhinosinusitis, and bronchiectasis",
            "probability": 0.00011366605758666992
        },
        {
            "start_logit": -2.203125,
            "end_logit": 4.4375,
            "text": "rhinosinusitis",
            "probability": 2.2351741790771484e-05
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -4.828125,
            "text": "situ",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -4.90234375,
            "end_logit": 6.43359375,
            "text": "us",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 6.43359375,
            "text": ": situs inversus",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -6.578125,
            "text": "situs invers",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.13671875,
            "end_logit": -2.51953125,
            "text": "chronic rhinosinusitis, and bronchiectasis",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -6.80859375,
            "text": "situs inversus, chronic rhinosinusitis, and bronchiectasis.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -4.90234375,
            "end_logit": 4.4375,
            "text": "us, chronic rhinosinusitis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.43359375,
            "text": "SYMPTOMS: situs inversus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 6.43359375,
            "text": "s inversus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.43359375,
            "text": "inversus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.43359375,
            "text": "RARE CONGENITAL DISEASE CHARACTERISED BY A CLINICAL TRIAD OF SYMPTOMS: situs inversus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.4453125,
            "text": "situs",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.43359375,
            "text": "TRIAD OF SYMPTOMS: situs inversus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.43359375,
            "text": "CLINICAL TRIAD OF SYMPTOMS: situs inversus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 4.4375,
            "text": ": situs inversus, chronic rhinosinusitis",
            "probability": 3.5762786865234375e-07
        }
    ],
    "56be0e4aef6e394741000008_3": [
        {
            "start_logit": 7.703125,
            "end_logit": 7.82421875,
            "text": "sinusitis",
            "probability": 1.0
        },
        {
            "start_logit": 7.703125,
            "end_logit": -3.734375,
            "text": "sinusitis, situs inversus and bronchiectasis",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.26953125,
            "text": "sinusitis, situs inversus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 7.82421875,
            "text": "of sinusitis",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.8984375,
            "text": "sinusitis, situs invers",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.00390625,
            "text": "sinusitis, situs inversus and bronchiectasis.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.82421875,
            "text": "congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.82421875,
            "text": "triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.82421875,
            "text": "classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.82421875,
            "text": "very rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.82421875,
            "text": "rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.82421875,
            "text": "syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.82421875,
            "text": "a classic triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.82421875,
            "text": "of a classic triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -3.734375,
            "text": "situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -3.734375,
            "text": "of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -3.734375,
            "text": "bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -3.734375,
            "text": ", situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -3.734375,
            "text": "and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -3.734375,
            "text": "congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_4": [
        {
            "start_logit": 4.72265625,
            "end_logit": 9.21875,
            "text": "sinusitis",
            "probability": 0.994140625
        },
        {
            "start_logit": -0.37890625,
            "end_logit": 9.21875,
            "text": "chronic sinusitis",
            "probability": 0.006099700927734375
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.21875,
            "text": "case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.21875,
            "text": "patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.21875,
            "text": "present a case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.21875,
            "text": "a case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.21875,
            "text": "comprising chronic sinusitis",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 9.21875,
            "text": "triad comprising chronic sinusitis",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.21875,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.21875,
            "text": "a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -3.40234375,
            "text": "sinusitis, bronchiectasis",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -6.48828125,
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -6.640625,
            "text": "sinusitis, bronchiectasis, and situs invers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -6.8203125,
            "text": "sinusitis, bronchiectasis, and situs inversus.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.4296875,
            "text": "sinusitis, bronchiectasis, and situs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.37890625,
            "end_logit": -3.40234375,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -0.37890625,
            "end_logit": -6.48828125,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.0
        },
        {
            "start_logit": -0.37890625,
            "end_logit": -6.640625,
            "text": "chronic sinusitis, bronchiectasis, and situs invers",
            "probability": 0.0
        },
        {
            "start_logit": -0.37890625,
            "end_logit": -6.8203125,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": -0.37890625,
            "end_logit": -7.4296875,
            "text": "chronic sinusitis, bronchiectasis, and situs",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_5": [
        {
            "start_logit": 7.45703125,
            "end_logit": 7.703125,
            "text": "bronchiectasis",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.45703125,
            "end_logit": 0.345947265625,
            "text": "bronchiectasis and sinusitis",
            "probability": 0.0006413459777832031
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 7.703125,
            "text": "situs inversus, bronchiectasis",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 7.703125,
            "text": ", bronchiectasis",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 7.703125,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 7.703125,
            "text": "triad of situs inversus, bronchiectasis",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.703125,
            "text": "of situs inversus, bronchiectasis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.03515625,
            "text": "bronchiectasis and sinusitis.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.703125,
            "text": "characterized by the triad of situs inversus, bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.703125,
            "text": "s inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.703125,
            "text": "an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.703125,
            "text": "by the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.703125,
            "text": "the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.703125,
            "text": ", an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.703125,
            "text": "inversus, bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.9375,
            "end_logit": 0.345947265625,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 0.345947265625,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 0.345947265625,
            "text": ", bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 0.345947265625,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 0.345947265625,
            "text": "triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_6": [
        {
            "start_logit": 7.78515625,
            "end_logit": 7.7265625,
            "text": "sinusitis",
            "probability": 1.0
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -3.748046875,
            "text": "sinusitis, bronchiectasis",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -6.25390625,
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -6.71875,
            "text": "sinusitis, bronchiectasis, and situs invers",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -6.79296875,
            "text": "sinusitis, bronchiectasis, and situs inversus.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 7.7265625,
            "text": "of sinusitis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 7.7265625,
            "text": "triad of sinusitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.7265625,
            "text": "Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.7265625,
            "text": "Zurich pulmonary physician, reported four patients with the triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.7265625,
            "text": ", Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.7265625,
            "text": "1933, Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.7265625,
            "text": "with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.7265625,
            "text": "patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.7265625,
            "text": "four patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.54296875,
            "text": "sinusitis, bronchiectasis, and situs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.7265625,
            "text": "reported four patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.7265625,
            "text": "In 1933, Manes Kartagener, a Zurich pulmonary physician, reported four patients with the triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": -3.748046875,
            "text": "bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -3.748046875,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.84375,
            "end_logit": -3.748046875,
            "text": "of sinusitis, bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_7": [
        {
            "start_logit": 7.7734375,
            "end_logit": 8.5625,
            "text": "chronic maxillary sinusitis",
            "probability": 0.9951171875
        },
        {
            "start_logit": 2.4921875,
            "end_logit": 8.5625,
            "text": "maxillary sinusitis",
            "probability": 0.005023956298828125
        },
        {
            "start_logit": -1.478515625,
            "end_logit": 8.5625,
            "text": "sinusitis",
            "probability": 9.489059448242188e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -0.74267578125,
            "text": "chronic maxillary sinusitis, bronchiectasis",
            "probability": 8.988380432128906e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -3.2734375,
            "text": "chronic",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -5.10546875,
            "end_logit": 8.5625,
            "text": ": chronic maxillary sinusitis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.5625,
            "text": "A case of a nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -0.74267578125,
            "text": "maxillary sinusitis, bronchiectasis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 8.5625,
            "text": "case of a nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.5625,
            "text": "described: chronic maxillary sinusitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 8.5625,
            "text": "child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 8.5625,
            "text": "with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 8.5625,
            "text": "a nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.5625,
            "text": "nine year and eight months old child with Kartagener's syndrome (triad) is described: chronic maxillary sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.57421875,
            "text": "chronic maxillary sinusitis, bronchiectasis and \"situs inversus totalis\".",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.5625,
            "text": "triad) is described: chronic maxillary sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.09765625,
            "text": "chronic maxillary sinusitis, bronchiectasis and \"situs inversus total",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.21484375,
            "text": "chronic maxillary sinusitis, bronchiectasis and \"situs inversus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.2421875,
            "text": "chronic maxillary sinusitis, bronchiectasis and \"situs invers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.26171875,
            "text": "chronic maxillary",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56be0e4aef6e394741000008_8": [
        {
            "start_logit": 7.55859375,
            "end_logit": 7.9921875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -5.79296875,
            "text": "bronchiectasis, situs inversus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -5.8046875,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.9921875,
            "text": "triad of symptoms--bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.9921875,
            "text": "-bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -6.9375,
            "text": "bronchiectasis, situs invers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.0859375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia syndrome.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.9921875,
            "text": "inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.9921875,
            "text": "syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.9921875,
            "text": "symptoms--bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.9921875,
            "text": "an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.33984375,
            "text": "bronchiectasis, situs inversus and sinusitis--",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.38671875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.4609375,
            "text": "bronchiectasis, situs inversus and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.47265625,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.51953125,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.52734375,
            "text": "bronchiectasis, situs inversus and sinusitis-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.5546875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immoti",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.5859375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55859375,
            "end_logit": -7.59765625,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56be0e4aef6e394741000008_9": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.84375,
            "text": "bronchitis",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -2.595703125,
            "text": "bronchitis, sinusitis",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 7.84375,
            "text": "of bronchitis",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 7.84375,
            "text": "triad of bronchitis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.53125,
            "text": "bronchitis, sinusitis, and situs inversus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.84375,
            "text": "clinical triad of bronchitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.0625,
            "text": "bronchitis, sinusitis, and situs invers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3125,
            "text": "bronchitis, sinusitis, and situs inversus.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.84375,
            "text": "characterized by the clinical triad of bronchitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.44921875,
            "text": "bronchitis, sinusitis,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.84375,
            "text": "by the clinical triad of bronchitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.84375,
            "text": "syndrome is characterized by the clinical triad of bronchitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.84375,
            "text": "the clinical triad of bronchitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.54296875,
            "end_logit": -2.595703125,
            "text": "of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -2.595703125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -2.595703125,
            "text": "triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -2.595703125,
            "text": ", sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -2.595703125,
            "text": "clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -2.595703125,
            "text": "characterized by the clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -2.595703125,
            "text": "by the clinical triad of bronchitis, sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_10": [
        {
            "start_logit": 6.98828125,
            "end_logit": 7.19921875,
            "text": "sinusitis",
            "probability": 0.958984375
        },
        {
            "start_logit": 3.8359375,
            "end_logit": 7.19921875,
            "text": "bronchiectasis, sinusitis",
            "probability": 0.04083251953125
        },
        {
            "start_logit": 3.8359375,
            "end_logit": 3.208984375,
            "text": "bronchiectasis",
            "probability": 0.0007596015930175781
        },
        {
            "start_logit": -4.09375,
            "end_logit": 7.19921875,
            "text": ", sinusitis",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -5.33984375,
            "text": "sinusitis and situs inversus",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 7.19921875,
            "text": "of bronchiectasis, sinusitis",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -6.33984375,
            "text": "sinusitis and situs invers",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.04296875,
            "text": "sinusitis and situs inversus.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.19921875,
            "text": "presentations consisting of bronchiectasis, sinusitis",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.19921875,
            "text": "syndrome is a well known classical triad of presentations consisting of bronchiectasis, sinusitis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.19921875,
            "text": "triad of presentations consisting of bronchiectasis, sinusitis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.98828125,
            "end_logit": -7.43359375,
            "text": "sinusitis and situs",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.19921875,
            "text": "consisting of bronchiectasis, sinusitis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 3.8359375,
            "end_logit": -5.33984375,
            "text": "bronchiectasis, sinusitis and situs inversus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.8359375,
            "end_logit": -6.33984375,
            "text": "bronchiectasis, sinusitis and situs invers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.8359375,
            "end_logit": -7.04296875,
            "text": "bronchiectasis, sinusitis and situs inversus.",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 3.208984375,
            "text": "of bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": 3.8359375,
            "end_logit": -7.43359375,
            "text": "bronchiectasis, sinusitis and situs",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 3.208984375,
            "text": "presentations consisting of bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 3.208984375,
            "text": "syndrome is a well known classical triad of presentations consisting of bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_11": [
        {
            "start_logit": 7.21484375,
            "end_logit": 7.953125,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -3.7890625,
            "text": "bronchiectasis and paranasal sinusitis",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 7.953125,
            "text": ", bronchiectasis",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 7.953125,
            "text": "situs inversus, including dextrocardia, bronchiectasis",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 7.953125,
            "text": "dextrocardia, bronchiectasis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.953125,
            "text": "ocardia, bronchiectasis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 7.953125,
            "text": "triad of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.953125,
            "text": "rare disorder characterized by the triad of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.953125,
            "text": "of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.953125,
            "text": "including dextrocardia, bronchiectasis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.953125,
            "text": "a, bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.953125,
            "text": "disorder characterized by the triad of situs inversus, including dextrocardia, bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -7.02734375,
            "text": "bronchiectasis and paranasal sinusitis.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -7.2265625,
            "text": "bronchiectasis and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -3.7890625,
            "text": ", bronchiectasis and paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.6328125,
            "end_logit": -3.7890625,
            "text": "situs inversus, including dextrocardia, bronchiectasis and paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.68359375,
            "end_logit": -3.7890625,
            "text": "dextrocardia, bronchiectasis and paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -3.7890625,
            "text": "paranasal sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.6328125,
            "end_logit": -4.81640625,
            "text": "situs inversus, including dextrocardia",
            "probability": 0.0
        },
        {
            "start_logit": -5.68359375,
            "end_logit": -4.81640625,
            "text": "dextrocardia",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_12": [
        {
            "start_logit": 7.73046875,
            "end_logit": 7.68359375,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -4.28125,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -5.3984375,
            "text": "bronchiectasis, situs inversus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.40625,
            "end_logit": 7.68359375,
            "text": ": bronchiectasis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -6.77734375,
            "text": "bronchiectasis, situs invers",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.68359375,
            "text": "triad of symptoms: bronchiectasis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.09375,
            "text": "bronchiectasis, situs inversus and sinusitis resulting from defective cilial motility.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.265625,
            "text": "bronchiectasis, situs inversus and sinusitis resulting from defective cilial motility",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.68359375,
            "text": "symptoms: bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.46484375,
            "text": "bronchiectasis, situs inversus and sinusitis resulting from defective cilia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.484375,
            "text": "bronchiectasis, situs inversus and sinusitis resulting from defective cilial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.515625,
            "text": "bronchiectasis, situs inversus and sinusitis resulting",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.53125,
            "text": "bronchiectasis, situs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.68359375,
            "text": "a triad of symptoms: bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.68359375,
            "text": "inherited disease characterized by a triad of symptoms: bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.68359375,
            "text": "syndrome is an inherited disease characterized by a triad of symptoms: bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.328125,
            "end_logit": -4.28125,
            "text": "situs inversus and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.40625,
            "end_logit": -4.28125,
            "text": ": bronchiectasis, situs inversus and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -4.28125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.328125,
            "end_logit": -5.3984375,
            "text": "situs inversus",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_13": [
        {
            "start_logit": 5.26953125,
            "end_logit": 9.140625,
            "text": "rhinosinusitis",
            "probability": 0.8173828125
        },
        {
            "start_logit": 3.765625,
            "end_logit": 9.140625,
            "text": "chronic rhinosinusitis",
            "probability": 0.182373046875
        },
        {
            "start_logit": -6.890625,
            "end_logit": 9.140625,
            "text": "of chronic rhinosinusitis",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 9.140625,
            "text": "patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.140625,
            "text": "with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.140625,
            "text": "syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.140625,
            "text": "in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.140625,
            "text": ": a triad consisting of chronic rhinosinusitis",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.140625,
            "text": "triad consisting of chronic rhinosinusitis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.140625,
            "text": "a triad consisting of chronic rhinosinusitis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.140625,
            "text": "Ear, nose and throat symptoms and signs were studied in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.140625,
            "text": "studied in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.140625,
            "text": "signs were studied in 15 patients with Kartagener's syndrome: a triad consisting of chronic rhinosinusitis",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -6.03515625,
            "text": "rhinosinusitis, chronic bronchitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -6.48828125,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -7.10546875,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -7.13671875,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs invers",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -7.24609375,
            "text": "rhinosinusitis, chronic bronchitis with bronchiectasis, and situs inversus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.765625,
            "end_logit": -5.7421875,
            "text": "chronic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.765625,
            "end_logit": -6.03515625,
            "text": "chronic rhinosinusitis, chronic bronchitis",
            "probability": 5.960464477539063e-08
        }
    ],
    "56be0e4aef6e394741000008_14": [
        {
            "start_logit": 5.21484375,
            "end_logit": 6.0859375,
            "text": "chronic sinusitis",
            "probability": 0.9951171875
        },
        {
            "start_logit": 5.21484375,
            "end_logit": 0.62255859375,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 0.004230499267578125
        },
        {
            "start_logit": -1.845703125,
            "end_logit": 6.0859375,
            "text": "sinusitis",
            "probability": 0.0008592605590820312
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 6.0859375,
            "text": "primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -5.625,
            "text": "chronic sinusitis, bronchiectasis and situs inversus with dextrocardia",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -5.68359375,
            "text": "chronic",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -6.765625,
            "end_logit": 6.0859375,
            "text": "triad of chronic sinusitis",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 6.0859375,
            "text": "of chronic sinusitis",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -1.54296875,
            "end_logit": 0.62255859375,
            "text": "bronchiectasis",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -6.31640625,
            "text": "chronic sinusitis, bronchiectasis and situs inversus",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 6.0859375,
            "text": "clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -1.845703125,
            "end_logit": 0.62255859375,
            "text": "sinusitis, bronchiectasis",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.0859375,
            "text": "syndrome (a clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.0859375,
            "text": "(a clinical variant of primary ciliary dyskinesia) is a recessive autossomical disease characterized by the triad of chronic sinusitis",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.0859375,
            "text": "by the triad of chronic sinusitis",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -6.74609375,
            "text": "chronic sinusitis, bronchiectasis and situs invers",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -7.38671875,
            "text": "chronic sinusitis, bronchiectasis and situs inversus with dextrocardi",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -7.44921875,
            "text": "chronic sinusitis, bronchiectasis and situs inversus with dextr",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 5.21484375,
            "end_logit": -7.50390625,
            "text": "chronic sinusitis, bronchiectasis and situs",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 0.62255859375,
            "text": ", bronchiectasis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56be0e4aef6e394741000008_15": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.47265625,
            "text": "sinusitis",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -3.169921875,
            "text": "sinusitis, bronchiectasis",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -5.5,
            "text": "sinusitis, bronchiectasis and situs inversus with dextrocardia",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 7.47265625,
            "text": "of sinusitis",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.9375,
            "text": "sinusitis, bronchiectasis and situs inversus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.97265625,
            "text": "sinusitis, bronchiectasis and situs invers",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.47265625,
            "text": "autosomal recessive disorder consisting of triad of sinusitis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.421875,
            "text": "sinusitis, bronchiectasis and situs inversus with dextrocardi",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.50390625,
            "text": "sinusitis, bronchiectasis and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.5078125,
            "text": "sinusitis, bronchiectasis and situs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.47265625,
            "text": "triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.47265625,
            "text": "rare autosomal recessive disorder consisting of triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.47265625,
            "text": "of triad of sinusitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.47265625,
            "text": "a rare autosomal recessive disorder consisting of triad of sinusitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.50390625,
            "end_logit": -3.169921875,
            "text": "bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -5.87890625,
            "end_logit": -3.169921875,
            "text": ", bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.37109375,
            "end_logit": -3.169921875,
            "text": "of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -3.169921875,
            "text": "autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -3.169921875,
            "text": "triad of sinusitis, bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -3.169921875,
            "text": "rare autosomal recessive disorder consisting of triad of sinusitis, bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_16": [
        {
            "start_logit": 7.42578125,
            "end_logit": 7.38671875,
            "text": "bronchiectasis",
            "probability": 0.9970703125
        },
        {
            "start_logit": 7.42578125,
            "end_logit": 1.6181640625,
            "text": "bronchiectasis and sinusitis",
            "probability": 0.003124237060546875
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 7.38671875,
            "text": "situs inversus, bronchiectasis",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -5.70703125,
            "end_logit": 7.38671875,
            "text": ", bronchiectasis",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.38671875,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.38671875,
            "text": "triad of situs inversus, bronchiectasis",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.38671875,
            "text": "of situs inversus, bronchiectasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.38671875,
            "text": "characterized by the triad of situs inversus, bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.38671875,
            "text": "by the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.38671875,
            "text": "an autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.38671875,
            "text": "the triad of situs inversus, bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 1.6181640625,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 1.6181640625,
            "text": "situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.70703125,
            "end_logit": 1.6181640625,
            "text": ", bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": 1.6181640625,
            "text": "autosomal recessively inherited disease, is characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": 1.6181640625,
            "text": "triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 1.6181640625,
            "text": "and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 1.6181640625,
            "text": "of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 1.6181640625,
            "text": "characterized by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 1.6181640625,
            "text": "by the triad of situs inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_17": [
        {
            "start_logit": 7.375,
            "end_logit": 8.0390625,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 7.375,
            "end_logit": -5.0,
            "text": "bronchiectasis, situs inversus and sinusitis",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.375,
            "end_logit": -5.85546875,
            "text": "bronchiectasis, situs inversus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.0390625,
            "text": "-bronchiectasis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.0390625,
            "text": "triad of symptoms--bronchiectasis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -6.84375,
            "text": "bronchiectasis, situs invers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.0390625,
            "text": "inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.0390625,
            "text": "syndrome is an inherited disease characterized by a triad of symptoms--bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.234375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.234375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.30859375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immotile cilia syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.3203125,
            "text": "bronchiectasis, situs inversus and sinusitis--",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.4296875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as an immoti",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.46875,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.47265625,
            "text": "bronchiectasis, situs inversus and sinusitis-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.484375,
            "text": "bronchiectasis, situs inversus and sinusitis--and is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.48828125,
            "text": "bronchiectasis, situs inversus and sinusitis--and is classified",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.51953125,
            "text": "bronchiectasis, situs inversus and sinusitis--and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.375,
            "end_logit": -7.53125,
            "text": "bronchiectasis, situs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.80078125,
            "end_logit": -5.0,
            "text": "situs inversus and sinusitis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_18": [
        {
            "start_logit": 7.57421875,
            "end_logit": 7.94140625,
            "text": "sinusitis",
            "probability": 1.0
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -2.40625,
            "text": "sinusitis, situs inversus and bronchiectasis",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 7.94140625,
            "text": "of sinusitis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.33203125,
            "text": "sinusitis, situs inversus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.94140625,
            "text": "triad of sinusitis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.94140625,
            "text": "very rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.94140625,
            "text": "congenital malformation comprising of a classic triad of sinusitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.94921875,
            "text": "sinusitis, situs invers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.94140625,
            "text": "classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.94140625,
            "text": "rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.94140625,
            "text": "syndrome is a very rare congenital malformation comprising of a classic triad of sinusitis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.94140625,
            "text": "a classic triad of sinusitis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.48046875,
            "text": "sinusitis, situs inversus and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.5078125,
            "text": "sinusitis, situs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -2.40625,
            "text": "situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -2.40625,
            "text": "of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.90234375,
            "end_logit": -2.40625,
            "text": ", situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -2.40625,
            "text": "triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -2.40625,
            "text": "very rare congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -2.40625,
            "text": "congenital malformation comprising of a classic triad of sinusitis, situs inversus and bronchiectasis",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_19": [
        {
            "start_logit": 7.546875,
            "end_logit": 8.0234375,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 8.0234375,
            "text": "(bronchiectasis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.0234375,
            "text": "comprehensive clinicomorphological examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.0234375,
            "text": "A comprehensive clinicomorphological examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.0234375,
            "text": "clinicomorphological examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.0234375,
            "text": "ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.0234375,
            "text": "syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.0234375,
            "text": "of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.0234375,
            "text": "examination of 24 children with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.0234375,
            "text": "with Zivert-Kartagener syndrome ascertained the complete triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.0234375,
            "text": "triad (bronchiectasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.52734375,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscera)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.54296875,
            "text": "bronchiectasis, maldevelopment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.56640625,
            "text": "bronchiectasis, maldevelopment of the sinuses",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.5859375,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscera) in all",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.609375,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the viscera",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.6328125,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.65234375,
            "text": "bronchiectasis, maldevelopment of the sinuses and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.6640625,
            "text": "bronchiectasis, maldevelop",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.546875,
            "end_logit": -7.67578125,
            "text": "bronchiectasis, maldevelopment of the sinuses and transposition of the",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56be0e4aef6e394741000008_20": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.71875,
            "text": "bronchiectasis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -2.30078125,
            "text": "bronchiectasis and sinusitis",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 7.71875,
            "text": ", bronchiectasis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.359375,
            "end_logit": 7.71875,
            "text": "triad situs viscerum inversus, bronchiectasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.046875,
            "text": "bronchiectasis and sinusitis is known",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.43359375,
            "text": "bronchiectasis and sinusitis is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.50390625,
            "text": "bronchiectasis and sinusitis is known as",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.515625,
            "text": "bronchiectasis and sinusitis is known as Kartage",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.5390625,
            "text": "bronchiectasis and sinusitis is known as Kartagener",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.71875,
            "text": "situs viscerum inversus, bronchiectasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.71875,
            "text": "The triad situs viscerum inversus, bronchiectasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.71875,
            "text": "viscerum inversus, bronchiectasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": -2.30078125,
            "text": "sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.8828125,
            "end_logit": -2.30078125,
            "text": ", bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -2.30078125,
            "text": "triad situs viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -2.30078125,
            "text": "and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -2.30078125,
            "text": "situs viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -2.30078125,
            "text": "The triad situs viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -2.30078125,
            "text": "viscerum inversus, bronchiectasis and sinusitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.125,
            "end_logit": -7.046875,
            "text": "sinusitis is known",
            "probability": 0.0
        }
    ],
    "56be0e4aef6e394741000008_21": [
        {
            "start_logit": 6.625,
            "end_logit": 9.5390625,
            "text": "chronic sinusitis",
            "probability": 0.9970703125
        },
        {
            "start_logit": 0.92041015625,
            "end_logit": 9.5390625,
            "text": "sinusitis",
            "probability": 0.0033512115478515625
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 9.5390625,
            "text": "ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -3.8828125,
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 9.5390625,
            "text": "comprising chronic sinusitis",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 9.5390625,
            "text": "triad comprising chronic sinusitis",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.5390625,
            "text": "case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.5390625,
            "text": "patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.5390625,
            "text": "present a case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.5390625,
            "text": "a case of a patient with clinically definite ALS, who had earlier suffered from Kartagener syndrome, which is characterized by the triad comprising chronic sinusitis",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -5.015625,
            "text": "chronic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.50390625,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.5078125,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.66015625,
            "text": "chronic sinusitis, bronchiectasis, and situs invers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.6875,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes that are responsible for Kartagener syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.6875,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.30078125,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.3046875,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes that are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.40625,
            "text": "chronic sinusitis, bronchiectasis, and situs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.41796875,
            "text": "chronic sinusitis, bronchiectasis, and situs inversus. Recent linkage and mutational analyses identified several genes that are responsible",
            "probability": 5.960464477539063e-08
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_1": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.3828125,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -1.2060546875,
            "end_logit": 9.3828125,
            "text": "ozin",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.2861328125,
            "text": "dap",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 9.3828125,
            "text": "agliflozin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 9.3828125,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.81640625,
            "text": "dapaglifl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1484375,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It is marketed under the brand name Qtern.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.15234375,
            "text": "dapagliflozin is a recently approved antidiabetic medication.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1640625,
            "text": "dapagliflozin is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.3828125,
            "text": "and dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.3828125,
            "text": "fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.31640625,
            "text": "dapagliflozin is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.453125,
            "text": "dapagliflozin is a recently approved antidiabetic medication",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.4921875,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It is marketed under the brand name",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5078125,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It is marketed under the brand name Qtern",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.5078125,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It is marketed under the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.51171875,
            "text": "dapagliflozin is a recently approved antidiabetic medication. It is marketed under",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.3828125,
            "text": "saxagliptin and dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 9.3828125,
            "text": "Objectives: The fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.3828125,
            "text": "The fixed dose combination of saxagliptin and dapagliflozin",
            "probability": 5.960464477539063e-08
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_2": [
        {
            "start_logit": 9.3671875,
            "end_logit": 9.5390625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.72314453125,
            "end_logit": 9.5390625,
            "text": "ozin",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -0.92919921875,
            "text": "dap",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 9.5390625,
            "text": "agliflozin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 9.5390625,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.88671875,
            "text": "dapagliflozin/saxagliptin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.10546875,
            "text": "dapagliflozin/saxagliptin) tablets.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.5390625,
            "text": "(dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.35546875,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.5390625,
            "text": "fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.41796875,
            "text": "dapagliflozin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.44140625,
            "text": "dapagliflozin/sax",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.5390625,
            "text": ", QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.4765625,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.5390625,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.5390625,
            "text": "ERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.5390625,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.72314453125,
            "end_logit": -6.88671875,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -0.72314453125,
            "end_logit": -7.10546875,
            "text": "ozin/saxagliptin) tablets.",
            "probability": 0.0
        },
        {
            "start_logit": -0.72314453125,
            "end_logit": -7.41796875,
            "text": "ozin/",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_3": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.390625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -1.125,
            "end_logit": 9.390625,
            "text": "ozin",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0986328125,
            "text": "dap",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.390625,
            "text": "agliflozin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 9.390625,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.390625,
            "text": "Saxagliptin/dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.41796875,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.52734375,
            "text": "dapagliflozin fixed-dose combination tablets (Qtern\u00ae)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.61328125,
            "text": "dapagliflozin fixed-dose combination tablets (Qtern\u00ae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.64453125,
            "text": "dapagliflozin fixed-dose combination tablets (Qtern\u00ae) are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -1.0986328125,
            "text": "Saxagliptin/dap",
            "probability": 0.0
        },
        {
            "start_logit": -1.125,
            "end_logit": -7.52734375,
            "text": "ozin fixed-dose combination tablets (Qtern\u00ae)",
            "probability": 0.0
        },
        {
            "start_logit": -1.125,
            "end_logit": -7.61328125,
            "text": "ozin fixed-dose combination tablets (Qtern\u00ae",
            "probability": 0.0
        },
        {
            "start_logit": -1.125,
            "end_logit": -7.64453125,
            "text": "ozin fixed-dose combination tablets (Qtern\u00ae) are",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -7.41796875,
            "text": "aglifl",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -7.52734375,
            "text": "agliflozin fixed-dose combination tablets (Qtern\u00ae)",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -7.61328125,
            "text": "agliflozin fixed-dose combination tablets (Qtern\u00ae",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -7.64453125,
            "text": "agliflozin fixed-dose combination tablets (Qtern\u00ae) are",
            "probability": 0.0
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -7.41796875,
            "text": "ifl",
            "probability": 0.0
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -7.52734375,
            "text": "iflozin fixed-dose combination tablets (Qtern\u00ae)",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_4": [
        {
            "start_logit": 9.1953125,
            "end_logit": 9.25,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.4033203125,
            "text": "dap",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": 9.25,
            "text": "ozin",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 9.25,
            "text": "brodalumab (Siliq), dapagliflozin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 9.25,
            "text": "agliflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.25,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 9.25,
            "text": "dalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.13671875,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.2109375,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.25,
            "text": ", dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.3359375,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.40625,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline (Rhofade)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.25,
            "text": "article highlights the following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.25,
            "text": "following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.4453125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline (Rhofade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.25,
            "text": ": brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.25,
            "text": "This article highlights the following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -1.4033203125,
            "text": "brodalumab (Siliq), dap",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -1.4033203125,
            "text": "dalumab (Siliq), dap",
            "probability": 0.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -7.2109375,
            "text": "ozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_5": [
        {
            "start_logit": 9.359375,
            "end_logit": 9.5234375,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": 9.5234375,
            "text": "ozin",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 9.359375,
            "end_logit": -0.97216796875,
            "text": "dap",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 9.5234375,
            "text": "agliflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 9.5234375,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.00390625,
            "text": "dapagliflozin/saxagliptin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.30859375,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.5234375,
            "text": "(dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.4140625,
            "text": "dapagliflozin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.5234375,
            "text": "fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.484375,
            "text": "dapagliflozin/sax",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.5234375,
            "text": ", QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.5234375,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.5234375,
            "text": "ERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.5234375,
            "text": "QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.359375,
            "end_logit": -7.54296875,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -7.00390625,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -7.4140625,
            "text": "ozin/",
            "probability": 0.0
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -7.484375,
            "text": "ozin/sax",
            "probability": 0.0
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -7.54296875,
            "text": "ozin/saxagliptin)",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_6": [
        {
            "start_logit": 9.375,
            "end_logit": 9.5546875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.6767578125,
            "end_logit": 9.5546875,
            "text": "ozin",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.927734375,
            "text": "dap",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 9.5546875,
            "text": "agliflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 9.5546875,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.87109375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.2421875,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.5546875,
            "text": "fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.39453125,
            "text": "dapagliflozin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.5546875,
            "text": "(dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.45703125,
            "text": "dapagliflozin/sax",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.48046875,
            "text": "dapagliflozin/saxagliptin)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.5546875,
            "text": "FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.5546875,
            "text": "ERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.5546875,
            "text": ", QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.5546875,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.60546875,
            "text": "dapagliflozin/saxagliptin) tablet",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.6767578125,
            "end_logit": -6.87109375,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -0.6767578125,
            "end_logit": -7.39453125,
            "text": "ozin/",
            "probability": 0.0
        },
        {
            "start_logit": -0.6767578125,
            "end_logit": -7.45703125,
            "text": "ozin/sax",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_7": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.453125,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.97705078125,
            "end_logit": 9.453125,
            "text": "ozin",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.9951171875,
            "text": "dap",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 9.453125,
            "text": "agliflozin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.17578125,
            "text": "dapagliflozin/saxagliptin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 9.453125,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.453125,
            "text": "(dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.38671875,
            "text": "dapagliflozin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.4453125,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.97705078125,
            "end_logit": -6.17578125,
            "text": "ozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -0.97705078125,
            "end_logit": -7.38671875,
            "text": "ozin/",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -0.9951171875,
            "text": "(dap",
            "probability": 0.0
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -6.17578125,
            "text": "agliflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -6.17578125,
            "text": "iflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -6.17578125,
            "text": "saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -7.38671875,
            "text": "agliflozin/",
            "probability": 0.0
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -7.4453125,
            "text": "aglifl",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.38671875,
            "text": "more data regarding its effects on complications of diabetes and cardiovascular outcomes become avail",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.17578125,
            "text": "(dapagliflozin/saxagliptin",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.68359375,
            "text": "more data regarding its effects on complications of diabetes and cardiovascular outcomes",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_8": [
        {
            "start_logit": 8.9609375,
            "end_logit": 8.984375,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.90625,
            "text": "dap",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -2.0625,
            "end_logit": 8.984375,
            "text": "ozin",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -3.8515625,
            "end_logit": 8.984375,
            "text": "brodalumab (Siliq), dapagliflozin",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 8.984375,
            "text": "agliflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.984375,
            "text": "dalumab (Siliq), dapagliflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.984375,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.1953125,
            "text": "dapaglifl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.203125,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.3046875,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.984375,
            "text": ", dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.421875,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline (Rhofade)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.44921875,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymet",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.44921875,
            "text": "dapagliflozin and saxagliptin (Qtern), dupilumab (Dupixent), oxymetazoline (Rhofade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.984375,
            "text": "following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.984375,
            "text": "article highlights the following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.984375,
            "text": ": brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.984375,
            "text": "This article highlights the following new drugs: brodalumab (Siliq), dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.8515625,
            "end_logit": -1.90625,
            "text": "brodalumab (Siliq), dap",
            "probability": 0.0
        },
        {
            "start_logit": -3.8515625,
            "end_logit": -4.015625,
            "text": "brodalumab",
            "probability": 0.0
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_9": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.4765625,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.89208984375,
            "end_logit": 9.4765625,
            "text": "ozin",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1171875,
            "text": "dap",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -6.28125,
            "end_logit": 9.4765625,
            "text": "agliflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 9.4765625,
            "text": "iflozin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.70703125,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.95703125,
            "text": "dapagliflozin/saxagliptin) tablets.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.0546875,
            "text": "dapaglifl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.08984375,
            "text": "dapagliflozin/saxagliptin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.4765625,
            "text": "(dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.26171875,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.4765625,
            "text": "fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.35546875,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946 to July 1, 2017) were conducted",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.37109375,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.375,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.390625,
            "text": "dapagliflozin/sax",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.41015625,
            "text": "dapagliflozin/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.421875,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946 to July 1, 2017) were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.4765625,
            "text": "pharmacokinetics, efficacy, safety, and place in therapy of the fixed-dose combination (FDC) product, QTERN (dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.44140625,
            "text": "dapagliflozin/saxagliptin) tablets.DATA SOURCES: Searches of MEDLINE (1946 to July 1",
            "probability": 5.960464477539063e-08
        }
    ],
    "61fbc3d5c9dfcb9c0900000e_10": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.4921875,
            "text": "dapagliflozin",
            "probability": 1.0
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": 9.4921875,
            "text": "ozin",
            "probability": 4.2319297790527344e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3662109375,
            "text": "dap",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 9.4921875,
            "text": "agliflozin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 9.4921875,
            "text": "iflozin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.4921875,
            "text": "nd dapagliflozin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.390625,
            "text": "dapagliflozin + metformin was -0",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.39453125,
            "text": "dapagliflozin + metformin was -0.27",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.3984375,
            "text": "dapagliflozin + metformin was -0.27 (95% CI = -0.48 to -0",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.44140625,
            "text": "dapagliflozin + metformin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.4453125,
            "text": "dapagliflozin + metformin was -0.27 (95% CI = -0",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.47265625,
            "text": "dapagliflozin + metformin was -0.27 (95% CI = -0.48 to -0.05, P = 0",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.48828125,
            "text": "dapagliflozin + metformin was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5234375,
            "text": "dapagliflozin +",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.5234375,
            "text": "dapagliflozin + metformin was -0.27 (95% CI = -0.48 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": -7.390625,
            "text": "ozin + metformin was -0",
            "probability": 0.0
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": -7.39453125,
            "text": "ozin + metformin was -0.27",
            "probability": 0.0
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": -7.3984375,
            "text": "ozin + metformin was -0.27 (95% CI = -0.48 to -0",
            "probability": 0.0
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": -7.44140625,
            "text": "ozin + metformin",
            "probability": 0.0
        },
        {
            "start_logit": -0.85888671875,
            "end_logit": -7.4453125,
            "text": "ozin + metformin was -0.27 (95% CI = -0",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_1": [
        {
            "start_logit": 8.390625,
            "end_logit": 7.05859375,
            "text": "NSAIDs",
            "probability": 1.0
        },
        {
            "start_logit": 8.390625,
            "end_logit": -6.6484375,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.65625,
            "text": "NSAIDs is generally discouraged because of the increased risk of bleeding",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.66796875,
            "text": "NSAIDs is generally discouraged because of the increased risk of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.66796875,
            "text": "NSAIDs is generally discour",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.671875,
            "text": "NSAIDs is generally discouraged",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.68359375,
            "text": "NSAIDs is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.05859375,
            "text": "and NSAIDs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.05859375,
            "text": "combined use of warfarin and NSAIDs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -6.6484375,
            "text": "NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -6.6484375,
            "text": ". In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -6.6484375,
            "text": "In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -6.6484375,
            "text": "and NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -6.6484375,
            "text": "combined use of warfarin and NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -6.6484375,
            "text": "patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -6.6484375,
            "text": "require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.6484375,
            "text": "increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.6484375,
            "text": "who also require NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.65625,
            "text": "and NSAIDs is generally discouraged because of the increased risk of bleeding",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.65625,
            "text": "combined use of warfarin and NSAIDs is generally discouraged because of the increased risk of bleeding",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_2": [
        {
            "start_logit": 7.1171875,
            "end_logit": 9.2734375,
            "text": "azole antibiotics",
            "probability": 1.0
        },
        {
            "start_logit": -0.5546875,
            "end_logit": 9.2734375,
            "text": "antibiotics",
            "probability": 0.00046563148498535156
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -3.587890625,
            "text": "azo",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -5.80859375,
            "end_logit": 9.2734375,
            "text": "le antibiotics",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -5.8125,
            "end_logit": 9.2734375,
            "text": "with azole antibiotics",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -3.9609375,
            "text": "azole antibiotics, macrolides",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 9.2734375,
            "text": ". While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 9.2734375,
            "text": "the consistency of reports of interactions with azole antibiotics",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.2734375,
            "text": "consistency of reports of interactions with azole antibiotics",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 9.2734375,
            "text": "interactions with azole antibiotics",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.2734375,
            "text": "reports of interactions with azole antibiotics",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.2734375,
            "text": "While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.2734375,
            "text": "expand. While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -6.953125,
            "text": "azole antibiotics, macrolides, quinolone",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.17578125,
            "text": "azole antibiotics, macrolide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.2890625,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors, selective serotonin reuptake inhibitors, omeprazole",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.30859375,
            "text": "azole antibiotics, macrolides, quinolones",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.3984375,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.44921875,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.45703125,
            "text": "azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory",
            "probability": 5.960464477539063e-08
        }
    ],
    "5abce6acfcf4565872000022_3": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.546875,
            "text": "corticosteroids",
            "probability": 1.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": 7.546875,
            "text": "oral corticosteroids",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.25,
            "text": "corticosteroids and warfarin, but there is limited documentation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.26171875,
            "text": "corticosteroids and warfarin, but there is limited documentation.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.2890625,
            "text": "corticosteroids and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5078125,
            "text": "corticosteroids and warfarin, but there is limited",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5546875,
            "text": "corticosteroids and warfarin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.62890625,
            "text": "corticosteroids and warfarin,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.65234375,
            "text": "corticosteroids and warfarin, but there is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.546875,
            "text": "potential drug interaction exists between oral corticosteroids",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.25,
            "text": "oral corticosteroids and warfarin, but there is limited documentation",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.26171875,
            "text": "oral corticosteroids and warfarin, but there is limited documentation.",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.2890625,
            "text": "oral corticosteroids and",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.5078125,
            "text": "oral corticosteroids and warfarin, but there is limited",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.5546875,
            "text": "oral corticosteroids and warfarin",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.62890625,
            "text": "oral corticosteroids and warfarin,",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -7.65234375,
            "text": "oral corticosteroids and warfarin, but there is",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -7.26171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.25,
            "text": "but there is limited documentation",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.26171875,
            "text": "but there is limited documentation.",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_4": [
        {
            "start_logit": 7.61328125,
            "end_logit": 7.9609375,
            "text": "corticosteroids",
            "probability": 1.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 7.9609375,
            "text": "oral corticosteroids",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 7.9609375,
            "text": "Use of oral corticosteroids",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.9609375,
            "text": "of oral corticosteroids",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.19921875,
            "text": "corticosteroids in patients on long-term warfarin therapy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.234375,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.40625,
            "text": "corticosteroids in patients on long-term warfarin therapy may",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.48828125,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.5,
            "text": "corticosteroids in patients on long-term warfarin therapy may result",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.515625,
            "text": "corticosteroids in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.5390625,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.5390625,
            "text": "corticosteroids in patients on long-term",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.65625,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.66015625,
            "text": "corticosteroids in patients on long-term warfarin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.67578125,
            "text": "corticosteroids in patients on",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.69140625,
            "text": "corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -7.19921875,
            "text": "oral corticosteroids in patients on long-term warfarin therapy",
            "probability": 0.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -7.234375,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.",
            "probability": 0.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -7.40625,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may",
            "probability": 0.0
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -7.48828125,
            "text": "oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_5": [
        {
            "start_logit": 9.3359375,
            "end_logit": 8.75,
            "text": "protease inhibitors",
            "probability": 1.0
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -0.1676025390625,
            "text": "protease",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": 8.75,
            "text": "inhibitors",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": 8.75,
            "text": "other protease inhibitors",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3359375,
            "end_logit": -6.8203125,
            "text": "protease inhibitors.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.75,
            "text": "and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.75,
            "text": "We review the possible mechanisms of this interaction and the reported interactions between warfarin and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.75,
            "text": "possible mechanisms of this interaction and the reported interactions between warfarin and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.75,
            "text": "review the possible mechanisms of this interaction and the reported interactions between warfarin and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.75,
            "text": "interactions between warfarin and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.75,
            "text": "the reported interactions between warfarin and other protease inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.09375,
            "end_logit": -0.1676025390625,
            "text": "other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -0.1676025390625,
            "text": "and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -0.1676025390625,
            "text": "We review the possible mechanisms of this interaction and the reported interactions between warfarin and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -0.1676025390625,
            "text": "possible mechanisms of this interaction and the reported interactions between warfarin and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -0.1676025390625,
            "text": "review the possible mechanisms of this interaction and the reported interactions between warfarin and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -0.1676025390625,
            "text": "interactions between warfarin and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -0.1676025390625,
            "text": "the reported interactions between warfarin and other protease",
            "probability": 0.0
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": -6.8203125,
            "text": "inhibitors.",
            "probability": 0.0
        },
        {
            "start_logit": -6.09375,
            "end_logit": -6.8203125,
            "text": "other protease inhibitors.",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_6": [
        {
            "start_logit": 7.88671875,
            "end_logit": 7.67578125,
            "text": "antibiotics",
            "probability": 1.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 7.67578125,
            "text": "as antibiotics",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.1015625,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.44140625,
            "text": "antibiotics, may",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.5078125,
            "text": "antibiotics,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.52734375,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.67578125,
            "text": "classes of drugs, such as antibiotics",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.58984375,
            "text": "antibiotics, may interact",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.59375,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults is not clear",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.61328125,
            "text": "antibiotics, may interact with warfarin to cause an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.6328125,
            "text": "antibiotics, may interact with warfarin to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.640625,
            "text": "antibiotics, may interact with warfarin to cause an increase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.65234375,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.65625,
            "text": "antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.1015625,
            "text": "as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.44140625,
            "text": "as antibiotics, may",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.5078125,
            "text": "as antibiotics,",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.52734375,
            "text": "as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.58984375,
            "text": "as antibiotics, may interact",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.61328125,
            "text": "as antibiotics, may interact with warfarin to cause an",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_7": [
        {
            "start_logit": 9.125,
            "end_logit": 9.4296875,
            "text": "psychotropics",
            "probability": 1.0
        },
        {
            "start_logit": -0.479248046875,
            "end_logit": 9.4296875,
            "text": "s",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.08203125,
            "text": "psychotropic",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 9.4296875,
            "text": "As the number of psychotropics",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.31640625,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 9.4296875,
            "text": "number of psychotropics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 9.4296875,
            "text": "of psychotropics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.671875,
            "text": "psychotropics on the market expands",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 9.4296875,
            "text": "the number of psychotropics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.83984375,
            "text": "psychotropics on the market",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.85546875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.2265625,
            "text": "psychotropics on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.3515625,
            "text": "psychotropics on the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.38671875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.40234375,
            "text": "psychotropics on the market expands, the likelihood increases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.44921875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.46484375,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.48046875,
            "text": "psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -1.08203125,
            "text": "As the number of psychotropic",
            "probability": 0.0
        },
        {
            "start_logit": -0.479248046875,
            "end_logit": -6.31640625,
            "text": "s on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_8": [
        {
            "start_logit": 7.54296875,
            "end_logit": 6.18359375,
            "text": "amiodarone",
            "probability": 1.0
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -3.318359375,
            "text": "amiodarone, and omeprazole",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -4.77734375,
            "end_logit": 6.18359375,
            "text": "fluconazole, amiodarone",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.4375,
            "text": "amiodarone, and omeprazole were",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.46875,
            "text": "amiodarone, and omeprazole were associated with the requirement for 45.8, 16.7, and 16.7",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.4921875,
            "text": "amiodarone, and omeprazole were associated with the requirement for 45.8, 16.7, and 16",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.515625,
            "text": "amiodarone, and omeprazole were associated with the requirement for 45.8",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.1875,
            "end_logit": 6.18359375,
            "text": ", fluconazole, amiodarone",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.55078125,
            "text": "amiodarone, and omeprazole were associated with the requirement for 45",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 6.18359375,
            "text": ", amiodarone",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.18359375,
            "text": "drugs that may interact with warfarin, fluconazole, amiodarone",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.18359375,
            "text": "Among 36 drugs that may interact with warfarin, fluconazole, amiodarone",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -3.318359375,
            "text": "fluconazole, amiodarone, and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -3.603515625,
            "text": "fluconazole",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -3.318359375,
            "text": ", fluconazole, amiodarone, and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -6.22265625,
            "end_logit": -3.318359375,
            "text": ", amiodarone, and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -3.603515625,
            "text": ", fluconazole",
            "probability": 0.0
        },
        {
            "start_logit": -6.60546875,
            "end_logit": -3.318359375,
            "text": "and omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -3.318359375,
            "text": "omeprazole",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -3.318359375,
            "text": "drugs that may interact with warfarin, fluconazole, amiodarone, and omeprazole",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_9": [
        {
            "start_logit": 2.35546875,
            "end_logit": 2.64453125,
            "text": "acetylsalicylic acid",
            "probability": 0.599609375
        },
        {
            "start_logit": 2.35546875,
            "end_logit": 2.236328125,
            "text": "acetylsalicylic acid and amiodarone",
            "probability": 0.3994140625
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 2.64453125,
            "text": "being acetylsalicylic acid",
            "probability": 0.0002244710922241211
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 2.236328125,
            "text": "and amiodarone",
            "probability": 0.00017750263214111328
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 2.236328125,
            "text": "being acetylsalicylic acid and amiodarone",
            "probability": 0.0001494884490966797
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 2.64453125,
            "text": "alicylic acid",
            "probability": 0.00010764598846435547
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 2.236328125,
            "text": "amiodarone",
            "probability": 9.72747802734375e-05
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 2.64453125,
            "text": "ylic acid",
            "probability": 9.202957153320312e-05
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 2.64453125,
            "text": "acid",
            "probability": 7.68899917602539e-05
        },
        {
            "start_logit": -6.609375,
            "end_logit": 2.64453125,
            "text": "results demonstrate a high prevalence of concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid",
            "probability": 7.635354995727539e-05
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 2.236328125,
            "text": "alicylic acid and amiodarone",
            "probability": 7.170438766479492e-05
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 2.236328125,
            "text": "ylic acid and amiodarone",
            "probability": 6.085634231567383e-05
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 2.236328125,
            "text": "acid and amiodarone",
            "probability": 5.125999450683594e-05
        },
        {
            "start_logit": -6.609375,
            "end_logit": 2.236328125,
            "text": "results demonstrate a high prevalence of concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid and amiodarone",
            "probability": 5.08427619934082e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 2.64453125,
            "text": "concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid",
            "probability": 4.929304122924805e-05
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 2.64453125,
            "text": "The results demonstrate a high prevalence of concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid",
            "probability": 4.416704177856445e-05
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 2.64453125,
            "text": "potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 2.64453125,
            "text": "high prevalence of concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid",
            "probability": 3.74913215637207e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 2.236328125,
            "text": "concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid and amiodarone",
            "probability": 3.260374069213867e-05
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 2.236328125,
            "text": "potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid and amiodarone",
            "probability": 2.5391578674316406e-05
        }
    ],
    "5abce6acfcf4565872000022_10": [
        {
            "start_logit": 7.8984375,
            "end_logit": 6.75390625,
            "text": "amiodarone",
            "probability": 1.0
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -5.90625,
            "text": "amiodarone, propafenone",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.39453125,
            "text": "amiodarone, propafenone and fibrates",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.55078125,
            "text": "amiodarone, propafenone and fibrates.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.80078125,
            "text": "amiodarone, propafeno",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.05859375,
            "text": "amiodarone, propafenone and fibrates. Cardiovascular drugs which are obviously devoid or proven to be devoid of an interaction are angiotensin converting enzyme (ACE",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.07421875,
            "text": "amiodarone, propafenone and fibrates. Cardiovascular drugs which are obviously devoid or proven to be devoid of an interaction are angiotensin converting",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 6.75390625,
            "text": ": amiodarone",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.75390625,
            "text": "interactions with cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 6.75390625,
            "text": "antilipidaemic drugs which are often coadministered with coumarins: amiodarone",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 6.75390625,
            "text": "with cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.40234375,
            "end_logit": -5.49609375,
            "text": "ACE) inhibitors",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -5.49609375,
            "text": "angiotensin converting enzyme (ACE) inhibitors",
            "probability": 0.0
        },
        {
            "start_logit": -5.40234375,
            "end_logit": -5.97265625,
            "text": "ACE) inhibitors, calcium antagonists, beta-blockers and cardiac glycosides",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -5.97265625,
            "text": "angiotensin converting enzyme (ACE) inhibitors, calcium antagonists, beta-blockers and cardiac glycosides",
            "probability": 0.0
        },
        {
            "start_logit": -5.40234375,
            "end_logit": -6.265625,
            "text": "ACE) inhibitors, calcium antagonists, beta-blockers",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -6.265625,
            "text": "angiotensin converting enzyme (ACE) inhibitors, calcium antagonists, beta-blockers",
            "probability": 0.0
        },
        {
            "start_logit": -5.40234375,
            "end_logit": -6.3046875,
            "text": "ACE) inhibitors, calcium antagonists, beta-blockers and",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -6.3046875,
            "text": "angiotensin converting enzyme (ACE) inhibitors, calcium antagonists, beta-blockers and",
            "probability": 0.0
        },
        {
            "start_logit": -6.37109375,
            "end_logit": -5.49609375,
            "text": "are angiotensin converting enzyme (ACE) inhibitors",
            "probability": 0.0
        }
    ],
    "5abce6acfcf4565872000022_11": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.2265625,
            "text": "trazodone",
            "probability": 1.0
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -1.064453125,
            "text": "tra",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": -1.5751953125,
            "end_logit": 9.2265625,
            "text": "one",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 9.2265625,
            "text": "zodone",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.53515625,
            "text": "trazod",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.62109375,
            "text": "trazodone (2.2%) and carbamazepine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.828125,
            "text": "trazodone (2.2%) and carbamazepine (1.1%).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.00390625,
            "text": "trazodone (2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.03515625,
            "text": "trazodone (2.2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 9.2265625,
            "text": "done",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.1328125,
            "text": "trazodone (2.2%)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.19140625,
            "text": "trazodone (2.2%) and carbamazepine (1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.20703125,
            "text": "trazodone (2.2%) and carbamazepine (1.1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.21484375,
            "text": "trazodone (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.22265625,
            "text": "trazodone (2.2%) and carbamazepine (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.34375,
            "text": "trazodone (2.2%) and carbamazepine (1.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5751953125,
            "end_logit": -6.62109375,
            "text": "one (2.2%) and carbamazepine",
            "probability": 0.0
        },
        {
            "start_logit": -1.5751953125,
            "end_logit": -6.828125,
            "text": "one (2.2%) and carbamazepine (1.1%).",
            "probability": 0.0
        },
        {
            "start_logit": -1.5751953125,
            "end_logit": -7.00390625,
            "text": "one (2",
            "probability": 0.0
        },
        {
            "start_logit": -1.5751953125,
            "end_logit": -7.03515625,
            "text": "one (2.2",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_1": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.4296875,
            "text": "CNVRanger",
            "probability": 1.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": 9.4296875,
            "text": "ger",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.408203125,
            "text": "CNV",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 9.4296875,
            "text": "Ranger",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.12890625,
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.23046875,
            "text": "CNVRanger: association analysis of CNVs with gene expression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.31640625,
            "text": "CNVRanger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.37109375,
            "text": "CNVRanger: association analysis of CNVs with gene expression and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.40625,
            "text": "CNVRanger: association analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.546875,
            "text": "CNVRanger:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.12890625,
            "text": "ger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.23046875,
            "text": "ger: association analysis of CNVs with gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.31640625,
            "text": "ger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.37109375,
            "text": "ger: association analysis of CNVs with gene expression and",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.40625,
            "text": "ger: association analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -7.546875,
            "text": "ger:",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -7.12890625,
            "text": "Ranger: association analysis of CNVs with gene expression and quantitative phenotypes.",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -7.23046875,
            "text": "Ranger: association analysis of CNVs with gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -7.31640625,
            "text": "Ranger: association analysis of CNVs with gene expression and quantitative phenotypes",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -7.37109375,
            "text": "Ranger: association analysis of CNVs with gene expression and",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_2": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.15625,
            "text": "CNVRanger",
            "probability": 1.0
        },
        {
            "start_logit": -1.70703125,
            "end_logit": 9.15625,
            "text": "ger",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -1.80859375,
            "text": "CNV",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.125,
            "text": "CNVRanger R/Bioconductor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 9.15625,
            "text": "Ranger",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.5078125,
            "text": "CNVRanger R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 9.15625,
            "text": ". We present the CNVRanger",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.62890625,
            "text": "CNVRanger R/Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.15625,
            "text": "present the CNVRanger",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.12109375,
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.19140625,
            "text": "CNVRanger R/Bioconductor package which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.70703125,
            "end_logit": -6.125,
            "text": "ger R/Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -1.70703125,
            "end_logit": -6.5078125,
            "text": "ger R",
            "probability": 0.0
        },
        {
            "start_logit": -1.70703125,
            "end_logit": -6.62890625,
            "text": "ger R/Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -1.80859375,
            "text": ". We present the CNV",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -1.80859375,
            "text": "production traits. Established protocols for experimental detection and computational inference of CNVs from SNP array and next-generation sequencing data are available. We present the CNV",
            "probability": 0.0
        },
        {
            "start_logit": -1.70703125,
            "end_logit": -7.12109375,
            "text": "ger R/Bioconductor package which implements a comprehensive toolbox",
            "probability": 0.0
        },
        {
            "start_logit": -1.70703125,
            "end_logit": -7.19140625,
            "text": "ger R/Bioconductor package which",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -1.80859375,
            "text": "present the CNV",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -5.41796875,
            "text": "production traits. Established protocols for experimental detection and computational inference of CNVs from SNP array and next-generation sequencing data",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_3": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.3359375,
            "text": "seqCNA",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.1337890625,
            "text": "seq",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": 9.3359375,
            "text": "A",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 9.3359375,
            "text": "CNA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.15625,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.2578125,
            "text": "seqCNA: an R package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.35546875,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.42578125,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.48046875,
            "text": "seqCNA: an R package for DNA copy number analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.484375,
            "text": "seqCNA: an R package for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.484375,
            "text": "seqCNA: an R package for DNA copy number analysis in cancer using high-throughput",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.15625,
            "text": "A: an R package for DNA copy number analysis in cancer using high-throughput sequencing.",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.2578125,
            "text": "A: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.35546875,
            "text": "A: an R package for DNA copy number analysis in cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.42578125,
            "text": "A: an R package for DNA copy number analysis in cancer using high-throughput sequencing",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.48046875,
            "text": "A: an R package for DNA copy number analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.484375,
            "text": "A: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": -1.3193359375,
            "end_logit": -7.484375,
            "text": "A: an R package for DNA copy number analysis in cancer using high-throughput",
            "probability": 0.0
        },
        {
            "start_logit": -6.0703125,
            "end_logit": -7.15625,
            "text": "CNA: an R package for DNA copy number analysis in cancer using high-throughput sequencing.",
            "probability": 0.0
        },
        {
            "start_logit": -6.0703125,
            "end_logit": -7.2578125,
            "text": "CNA: an R package",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_4": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.34375,
            "text": "seqCNA",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.09765625,
            "text": "seq",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.2451171875,
            "end_logit": 9.34375,
            "text": "A",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.34375,
            "text": "CNA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.109375,
            "text": "seqCNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.19140625,
            "text": "seqCNA, a parallelized R package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.41796875,
            "text": "seqCNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package includes novel methodology on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4765625,
            "text": "seqCNA, a parallelized R package for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.34375,
            "text": "introduce seqCNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2451171875,
            "end_logit": -7.109375,
            "text": "A, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2451171875,
            "end_logit": -7.19140625,
            "text": "A, a parallelized R package",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -1.09765625,
            "text": "introduce seq",
            "probability": 0.0
        },
        {
            "start_logit": -1.2451171875,
            "end_logit": -7.41796875,
            "text": "A, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package includes novel methodology on",
            "probability": 0.0
        },
        {
            "start_logit": -1.2451171875,
            "end_logit": -7.4765625,
            "text": "A, a parallelized R package for",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -7.109375,
            "text": "CNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data.",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -7.19140625,
            "text": "CNA, a parallelized R package",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -7.41796875,
            "text": "CNA, a parallelized R package for an integral copy number analysis of high-throughput sequencing cancer data. The package includes novel methodology on",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -7.4765625,
            "text": "CNA, a parallelized R package for",
            "probability": 0.0
        },
        {
            "start_logit": -6.8046875,
            "end_logit": -7.10546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": -7.109375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_5": [
        {
            "start_logit": 0.311279296875,
            "end_logit": 8.6875,
            "text": "iGC",
            "probability": 0.92236328125
        },
        {
            "start_logit": -2.486328125,
            "end_logit": 8.6875,
            "text": "C",
            "probability": 0.0562744140625
        },
        {
            "start_logit": -3.525390625,
            "end_logit": 8.6875,
            "text": "(iGC",
            "probability": 0.0198974609375
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 8.6875,
            "text": "package (iGC",
            "probability": 0.0010509490966796875
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.6875,
            "text": "developed an open-source R/Bioconductor package (iGC",
            "probability": 0.0006375312805175781
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -4.828125,
            "text": "iGC)",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -6.55859375,
            "text": "iG",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -7.1015625,
            "text": "iGC). Multiple input formats",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -7.11328125,
            "text": "iGC). Multiple input formats are supported",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -7.19921875,
            "text": "iGC). Multiple input formats are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.311279296875,
            "end_logit": -7.22265625,
            "text": "iGC). Multiple input formats are supported and users can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.486328125,
            "end_logit": -4.828125,
            "text": "C)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.525390625,
            "end_logit": -4.828125,
            "text": "(iGC)",
            "probability": 0.0
        },
        {
            "start_logit": -2.486328125,
            "end_logit": -7.1015625,
            "text": "C). Multiple input formats",
            "probability": 0.0
        },
        {
            "start_logit": -2.486328125,
            "end_logit": -7.11328125,
            "text": "C). Multiple input formats are supported",
            "probability": 0.0
        },
        {
            "start_logit": -2.486328125,
            "end_logit": -7.19921875,
            "text": "C). Multiple input formats are",
            "probability": 0.0
        },
        {
            "start_logit": -2.486328125,
            "end_logit": -7.22265625,
            "text": "C). Multiple input formats are supported and users can",
            "probability": 0.0
        },
        {
            "start_logit": -3.525390625,
            "end_logit": -6.55859375,
            "text": "(iG",
            "probability": 0.0
        },
        {
            "start_logit": -3.525390625,
            "end_logit": -7.1015625,
            "text": "(iGC). Multiple input formats",
            "probability": 0.0
        },
        {
            "start_logit": -3.525390625,
            "end_logit": -7.11328125,
            "text": "(iGC). Multiple input formats are supported",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_6": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.1796875,
            "text": "PLRS",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.12890625,
            "text": "PLR",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -1.689453125,
            "end_logit": 9.1796875,
            "text": "S",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.09375,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.15625,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression data",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.328125,
            "text": "PLRS: a flexible tool",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.328125,
            "text": "PLRS: a flexible tool for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.33984375,
            "text": "PLRS: a flexible tool for the joint analysis of DNA copy number and mRNA expression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.359375,
            "text": "PLRS: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.39453125,
            "text": "PLRS: a flexible tool for the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.42578125,
            "text": "PLRS:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.09375,
            "text": "S: a flexible tool for the joint analysis of DNA copy number and mRNA expression data.",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.15625,
            "text": "S: a flexible tool for the joint analysis of DNA copy number and mRNA expression data",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.328125,
            "text": "S: a flexible tool",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.328125,
            "text": "S: a flexible tool for",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.33984375,
            "text": "S: a flexible tool for the joint analysis of DNA copy number and mRNA expression",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.359375,
            "text": "S: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.39453125,
            "text": "S: a flexible tool for the",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -7.42578125,
            "text": "S:",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_7": [
        {
            "start_logit": 8.9765625,
            "end_logit": 9.078125,
            "text": "PLRS",
            "probability": 1.0
        },
        {
            "start_logit": -1.5166015625,
            "end_logit": 9.078125,
            "text": "S",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -1.4296875,
            "text": "PLR",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 9.078125,
            "text": ". PLRS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.24609375,
            "text": "PLRS uses a wide class of interpretable models including popular ones and incorporates prior biological knowledge",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 9.078125,
            "text": ". We present a new tool for flexible modelling of this association. PLRS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.49609375,
            "text": "PLRS uses a wide class of interpretable models",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.5078125,
            "text": "PLRS uses a wide class of interpretable models including popular ones",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.53125,
            "text": "PLRS uses",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.078125,
            "text": "association. PLRS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.8671875,
            "text": "PLRS uses a wide class of interpretable models including",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.91943359375,
            "end_logit": 1.1494140625,
            "text": "PLRS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.92578125,
            "text": "PLRS uses a wide class of interpretable models including popular ones and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 9.078125,
            "text": "new tool for flexible modelling of this association. PLRS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 1.1494140625,
            "text": "glioblastoma data from The Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 1.1494140625,
            "text": "using glioblastoma data from The Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": 1.1494140625,
            "text": ". We illustrate PLRS using glioblastoma data from The Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        },
        {
            "start_logit": 0.91943359375,
            "end_logit": -6.5625,
            "text": "PLRS is implemented as an R package and available from Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 1.1494140625,
            "text": "association and provides confidence intervals. We illustrate PLRS using glioblastoma data from The Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": 1.1494140625,
            "text": "Cancer Genome Atlas.AVAILABILITY AND IMPLEMENTATION: PLRS",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_8": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.1953125,
            "text": "SomatiCA",
            "probability": 1.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": 9.1953125,
            "text": "A",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -1.9541015625,
            "text": "SomatiC",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.8984375,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.06640625,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.2109375,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.28515625,
            "text": "SomatiCA: identifying, characterizing and quantifying somatic copy number aberrations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.41015625,
            "text": "SomatiCA:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.5078125,
            "text": "SomatiCA: identifying, characterizing and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.8984375,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.06640625,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.2109375,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations from cancer genome sequencing",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.28515625,
            "text": "A: identifying, characterizing and quantifying somatic copy number aberrations",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.41015625,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -7.5078125,
            "text": "A: identifying, characterizing and",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.06640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -6.8984375,
            "text": "cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.8984375,
            "text": "copy number aberrations from cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -6.8984375,
            "text": "from cancer genome sequencing data",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -6.8984375,
            "text": "characterizing and quantifying somatic copy number aberrations from cancer genome sequencing data",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_9": [
        {
            "start_logit": 8.7734375,
            "end_logit": 8.5625,
            "text": "SomatiCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -2.056640625,
            "text": "SomatiC",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -2.6640625,
            "end_logit": 8.5625,
            "text": "A",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 8.5625,
            "text": ". Here we describe a computational framework, named SomatiCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.15625,
            "end_logit": 8.5625,
            "text": "Here we describe a computational framework, named SomatiCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.5625,
            "text": "named SomatiCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.5625,
            "text": "insufficient sequencing coverage, unknown tumor sample purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 8.5625,
            "text": "sequencing coverage, unknown tumor sample purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 8.5625,
            "text": "computational framework, named SomatiCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.1484375,
            "text": "SomatiCA, which explicitly accounts for tumor purity and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.1953125,
            "text": "SomatiCA, which explicitly accounts for tumor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.1953125,
            "text": "SomatiCA, which explicitly accounts",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": -2.056640625,
            "text": ". Here we describe a computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -2.056640625,
            "text": "Here we describe a computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -2.056640625,
            "text": "named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -2.056640625,
            "text": "insufficient sequencing coverage, unknown tumor sample purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -2.056640625,
            "text": "sequencing coverage, unknown tumor sample purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -2.056640625,
            "text": "computational framework, named SomatiC",
            "probability": 0.0
        },
        {
            "start_logit": -2.6640625,
            "end_logit": -7.1484375,
            "text": "A, which explicitly accounts for tumor purity and",
            "probability": 0.0
        },
        {
            "start_logit": -2.6640625,
            "end_logit": -7.1953125,
            "text": "A, which explicitly accounts for tumor",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_10": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.234375,
            "text": "Copynumber",
            "probability": 1.0
        },
        {
            "start_logit": -1.61328125,
            "end_logit": 9.234375,
            "text": "er",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.560546875,
            "text": "Copy",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 9.234375,
            "text": "number",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 9.234375,
            "text": "mber",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.0234375,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number segmentation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.171875,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number segmentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.28125,
            "text": "Copynumb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.35546875,
            "text": "Copynumber: Efficient algorithms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.3828125,
            "text": "Copynumber: Efficient algorithms for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.4375,
            "text": "Copynumber: Efficient algorithms for single- and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.4765625,
            "text": "Copynumber: Efficient algorithms for single- and multi-track copy number",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.4921875,
            "text": "Copynumber: Efficient algorithms for single- and multi-track",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.5,
            "text": "Copynumber: Efficient algorithms for single-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.51953125,
            "text": "Copynumber: Efficient algorithms for single- and multi-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.61328125,
            "end_logit": -7.0234375,
            "text": "er: Efficient algorithms for single- and multi-track copy number segmentation.",
            "probability": 0.0
        },
        {
            "start_logit": -1.61328125,
            "end_logit": -7.171875,
            "text": "er: Efficient algorithms for single- and multi-track copy number segmentation",
            "probability": 0.0
        },
        {
            "start_logit": -1.61328125,
            "end_logit": -7.35546875,
            "text": "er: Efficient algorithms",
            "probability": 0.0
        },
        {
            "start_logit": -1.61328125,
            "end_logit": -7.3828125,
            "text": "er: Efficient algorithms for",
            "probability": 0.0
        },
        {
            "start_logit": -1.61328125,
            "end_logit": -7.4375,
            "text": "er: Efficient algorithms for single- and",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_11": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.3828125,
            "text": "copynumber",
            "probability": 1.0
        },
        {
            "start_logit": -1.1337890625,
            "end_logit": 9.3828125,
            "text": "er",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.419921875,
            "text": "copy",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.20703125,
            "text": "copynumber is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 9.3828125,
            "text": "number",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 9.3828125,
            "text": "mber",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.3828125,
            "text": "package copynumber",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.94140625,
            "text": "copynumb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.06640625,
            "text": "copynumber is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.2890625,
            "text": "copynumber is a software suite",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1337890625,
            "end_logit": -6.20703125,
            "text": "er is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 0.0
        },
        {
            "start_logit": -1.1337890625,
            "end_logit": -7.06640625,
            "text": "er is",
            "probability": 0.0
        },
        {
            "start_logit": -1.1337890625,
            "end_logit": -7.2890625,
            "text": "er is a software suite",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -1.419921875,
            "text": "package copy",
            "probability": 0.0
        },
        {
            "start_logit": -6.2734375,
            "end_logit": -6.20703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -6.20703125,
            "text": "number is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 0.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -6.20703125,
            "text": "mber is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -6.20703125,
            "text": "package copynumber is a software suite for segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -6.20703125,
            "text": "segmentation of single- and multi-track copy number data using algorithms based on coherent least squares principles.",
            "probability": 0.0
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -7.16796875,
            "text": "Cancer progression",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_12": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.3203125,
            "text": "crlmm",
            "probability": 1.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": 9.3203125,
            "text": "m",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.3759765625,
            "text": "cr",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 9.3203125,
            "text": "lmm",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.171875,
            "text": "crlmm for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.23828125,
            "text": "crlmm for Genotyping and Copy Number Estimation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.23828125,
            "text": "crlmm for Genotyping and Copy Number Estimation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.3203125,
            "text": "Package crlmm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.375,
            "text": "crlmm for Genotyping and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.3203125,
            "text": "Using the R Package crlmm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.40234375,
            "text": "crlmm for Genotyping",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.4375,
            "text": "crlmm for Genotyping and Copy Number",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 9.3203125,
            "text": "R Package crlmm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.171875,
            "text": "m for",
            "probability": 0.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.23828125,
            "text": "m for Genotyping and Copy Number Estimation.",
            "probability": 0.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.23828125,
            "text": "m for Genotyping and Copy Number Estimation",
            "probability": 0.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.375,
            "text": "m for Genotyping and",
            "probability": 0.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.40234375,
            "text": "m for Genotyping",
            "probability": 0.0
        },
        {
            "start_logit": -1.3623046875,
            "end_logit": -7.4375,
            "text": "m for Genotyping and Copy Number",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -1.3759765625,
            "text": "Package cr",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_13": [
        {
            "start_logit": 9.03125,
            "end_logit": 9.3515625,
            "text": "crlmm",
            "probability": 1.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 9.3515625,
            "text": "m",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 9.03125,
            "end_logit": -1.619140625,
            "text": "cr",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 9.3515625,
            "text": "lmm",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.3515625,
            "text": "package crlmm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 9.3515625,
            "text": "R package crlmm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.3515625,
            "text": ". The R package crlmm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.3515625,
            "text": "Analysis algorithms that do not adjust for batch effects are prone to spurious measures of association. The R package crlmm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -7.11328125,
            "text": "crlmm implement",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.03125,
            "end_logit": -7.234375,
            "text": "crlmm implements a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.236328125,
            "end_logit": -7.11328125,
            "text": "m implement",
            "probability": 0.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": -7.234375,
            "text": "m implements a",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -1.619140625,
            "text": "package cr",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -1.619140625,
            "text": "R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -1.619140625,
            "text": ". The R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -1.619140625,
            "text": "Analysis algorithms that do not adjust for batch effects are prone to spurious measures of association. The R package cr",
            "probability": 0.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": -6.3984375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": -6.40625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.0859375,
            "end_logit": -7.11328125,
            "text": "lmm implement",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -6.0703125,
            "text": "Affymetrix",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_14": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.21875,
            "text": "KC-SMARTR",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.123046875,
            "text": "KC",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": 9.21875,
            "text": "R",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -6.34375,
            "end_logit": 9.21875,
            "text": "-SMARTR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.578125,
            "text": "KC-SMART",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.81640625,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.85546875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.21875,
            "text": "SMARTR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.11328125,
            "text": "KC-SMARTR: An R package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3359375,
            "text": "KC-SMARTR: An R package for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3359375,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4375,
            "text": "KC-SMARTR:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.48828125,
            "text": "KC-SMARTR: An",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.4921875,
            "text": "KC-SMARTR: An R package for detection of statistically significant aberrations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.515625,
            "text": "KC-SMARTR: An R",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -6.81640625,
            "text": "R: An R package for detection of statistically significant aberrations in multi-experiment aCGH data.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -6.85546875,
            "text": "R: An R package for detection of statistically significant aberrations in multi-experiment aCGH data",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.11328125,
            "text": "R: An R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.3359375,
            "text": "R: An R package for",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.3359375,
            "text": "R: An R package for detection of statistically significant aberrations in multi-experiment aCGH",
            "probability": 0.0
        }
    ],
    "601ec0c91cb411341a00005f_15": [
        {
            "start_logit": 7.359375,
            "end_logit": 8.6953125,
            "text": "KC-SMART",
            "probability": 1.0
        },
        {
            "start_logit": -2.26953125,
            "end_logit": 8.6953125,
            "text": "SMART",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 8.6953125,
            "text": "algorithm, KC-SMART",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 7.359375,
            "end_logit": -3.833984375,
            "text": "KC",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -5.34375,
            "end_logit": 8.6953125,
            "text": ", KC-SMART",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": 8.6953125,
            "text": "an algorithm, KC-SMART",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 8.6953125,
            "text": "-SMART",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.6953125,
            "text": "developed an algorithm, KC-SMART",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.359375,
            "end_logit": -6.71484375,
            "text": "KC-SMART, that bases its estimate of the magnitude of the CNA at a given genomic location",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.359375,
            "end_logit": -6.8203125,
            "text": "KC-SMART, that bases its estimate of the magnitude of the CNA at a given genomic location on kernel convolution",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.421875,
            "end_logit": -5.03125,
            "text": "KC-SMARTR",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -3.833984375,
            "text": "algorithm, KC",
            "probability": 0.0
        },
        {
            "start_logit": -2.26953125,
            "end_logit": -6.71484375,
            "text": "SMART, that bases its estimate of the magnitude of the CNA at a given genomic location",
            "probability": 0.0
        },
        {
            "start_logit": -2.26953125,
            "end_logit": -6.8203125,
            "text": "SMART, that bases its estimate of the magnitude of the CNA at a given genomic location on kernel convolution",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": -3.833984375,
            "text": ", KC",
            "probability": 0.0
        },
        {
            "start_logit": -3.421875,
            "end_logit": -6.1953125,
            "text": "KC-SMART",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -4.625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.546875,
            "end_logit": -3.833984375,
            "text": "an algorithm, KC",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": -3.833984375,
            "text": "developed an algorithm, KC",
            "probability": 0.0
        },
        {
            "start_logit": -4.66796875,
            "end_logit": -6.71484375,
            "text": "algorithm, KC-SMART, that bases its estimate of the magnitude of the CNA at a given genomic location",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_1": [
        {
            "start_logit": 7.640625,
            "end_logit": 7.86328125,
            "text": "Ccl4",
            "probability": 1.0
        },
        {
            "start_logit": 7.640625,
            "end_logit": -3.853515625,
            "text": "Ccl4 and neurotensin",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -5.53125,
            "text": "Ccl4 and neurotensin (Nts",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.640625,
            "end_logit": -6.9140625,
            "text": "Ccl4 and neurotensin (Nts)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.20703125,
            "text": "Ccl4 and neurotensin (Nts) (angiocrine factors)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.33203125,
            "text": "Ccl4 and neurotensin (Nts) (angio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.375,
            "text": "Ccl4 and neurotensin (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.43359375,
            "text": "Ccl4 and neurotensin (Nts) (angiocr",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.4453125,
            "text": "Ccl4 and neurotensin (Nts) (angiocrine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.4921875,
            "text": "Ccl4 and neurotensin (Nts) (angiocrine factors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.640625,
            "end_logit": -7.49609375,
            "text": "Ccl4 and neurotensin (Nts) (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -3.853515625,
            "text": "neurotensin",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -5.53125,
            "text": "neurotensin (Nts",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -3.853515625,
            "text": "and neurotensin",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -6.9140625,
            "text": "neurotensin (Nts)",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -7.20703125,
            "text": "neurotensin (Nts) (angiocrine factors)",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -7.33203125,
            "text": "neurotensin (Nts) (angio",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -7.375,
            "text": "neurotensin (",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -7.43359375,
            "text": "neurotensin (Nts) (angiocr",
            "probability": 0.0
        },
        {
            "start_logit": -4.68359375,
            "end_logit": -7.4453125,
            "text": "neurotensin (Nts) (angiocrine",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_2": [
        {
            "start_logit": 9.09375,
            "end_logit": 9.296875,
            "text": "vascular endothelial growth factor",
            "probability": 1.0
        },
        {
            "start_logit": -1.2138671875,
            "end_logit": 9.296875,
            "text": "factor",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -1.4462890625,
            "text": "vascular",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -5.60546875,
            "end_logit": 9.296875,
            "text": "endothelial growth factor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.17578125,
            "text": "vascular endothelial growth factor (VEGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 9.296875,
            "text": "growth factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.81640625,
            "text": "vascular endothelial growth factor (VEGF)-A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.90234375,
            "text": "vascular endothelial growth factor (VEGF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.0,
            "text": "vascular endothelial growth factor (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.26171875,
            "text": "vascular endothelial growth factor (VEGF)-A was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.28125,
            "text": "vascular endothelial growth factor (VEGF)-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.29296875,
            "text": "vascular endothelial growth factor (VEGF)-A was identified",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.39453125,
            "text": "vascular endothelial growth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.3984375,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.43359375,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed factor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.43359375,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.48828125,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly expressed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.5,
            "text": "vascular endothelial growth factor (VEGF)-A was identified as the most abundantly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2138671875,
            "end_logit": -6.17578125,
            "text": "factor (VEGF",
            "probability": 0.0
        },
        {
            "start_logit": -1.2138671875,
            "end_logit": -6.81640625,
            "text": "factor (VEGF)-A",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_3": [
        {
            "start_logit": 7.40625,
            "end_logit": -1.5908203125,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1)",
            "probability": 0.6435546875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -2.61328125,
            "text": "tissue inhibitor of metalloproteinases-1",
            "probability": 0.2313232421875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -4.17578125,
            "text": "tissue",
            "probability": 0.0484619140625
        },
        {
            "start_logit": 7.40625,
            "end_logit": -5.2265625,
            "text": "tissue inhibitor of metalloproteinases",
            "probability": 0.0169525146484375
        },
        {
            "start_logit": 7.40625,
            "end_logit": -5.70703125,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1",
            "probability": 0.01049041748046875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -5.85546875,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3",
            "probability": 0.00904083251953125
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.265625,
            "text": "tissue inhibitor of metalloproteinases-1 (",
            "probability": 0.0059967041015625
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.390625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3)",
            "probability": 0.0052947998046875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.6796875,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3",
            "probability": 0.003963470458984375
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.8203125,
            "text": "tissue inhibitor of",
            "probability": 0.003444671630859375
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.9375,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and",
            "probability": 0.003063201904296875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.953125,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospond",
            "probability": 0.0030155181884765625
        },
        {
            "start_logit": 7.40625,
            "end_logit": -6.98828125,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin",
            "probability": 0.0029125213623046875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -7.0859375,
            "text": "tissue inhibitor of metalloproteinases-",
            "probability": 0.0026416778564453125
        },
        {
            "start_logit": 7.40625,
            "end_logit": -7.109375,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS",
            "probability": 0.0025806427001953125
        },
        {
            "start_logit": 7.40625,
            "end_logit": -7.171875,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp",
            "probability": 0.0024242401123046875
        },
        {
            "start_logit": 7.40625,
            "end_logit": -7.21484375,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-",
            "probability": 0.0023212432861328125
        },
        {
            "start_logit": 7.40625,
            "end_logit": -7.22265625,
            "text": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (TH",
            "probability": 0.0023021697998046875
        },
        {
            "start_logit": -5.703125,
            "end_logit": -1.5908203125,
            "text": "factors tissue inhibitor of metalloproteinases-1 (Timp-1)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.796875,
            "end_logit": -1.5908203125,
            "text": "Timp-1)",
            "probability": 1.1920928955078125e-06
        }
    ],
    "56e46ad951531f7e3300001a_4": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.0703125,
            "text": "Slit2",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -0.80029296875,
            "text": "Slit",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": -1.62109375,
            "end_logit": 9.0703125,
            "text": "2",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -4.453125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.44921875,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.0703125,
            "text": "that Slit2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.7265625,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.7734375,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.80078125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.0859375,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.19140625,
            "text": "Slit2, which is negatively regulated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.21875,
            "text": "Slit2,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.23828125,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angiocrine factor.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.33203125,
            "text": "Slit2, which is negatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.34765625,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.375,
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3828125,
            "text": "Slit2, which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.0703125,
            "text": "found that Slit2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.0703125,
            "text": "We found that Slit2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.62109375,
            "end_logit": -4.453125,
            "text": "2, which is negatively regulated by endothelial EphA2",
            "probability": 0.0
        }
    ],
    "56e46ad951531f7e3300001a_5": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.0546875,
            "text": "hepatocyte growth factor",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -0.68896484375,
            "text": "hepatocyte growth factor (HGF",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.072265625,
            "text": "hepatocyte",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -1.822265625,
            "end_logit": 9.0546875,
            "text": "factor",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -5.86328125,
            "text": "hepatocyte growth factor (HGF) and Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -5.95703125,
            "text": "hepatocyte growth factor (HGF)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.0703125,
            "text": "hepatocyte growth factor (HGF) and Wnt2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 9.0546875,
            "text": "growth factor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.015625,
            "text": "hepatocyte growth factor (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.2109375,
            "text": "hepatocyte growth factor (HGF) and Wnt2.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.3671875,
            "text": "hepatocyte growth factor (HGF) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.0546875,
            "text": "including hepatocyte growth factor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.0546875,
            "text": "factors, including hepatocyte growth factor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -0.68896484375,
            "text": "HGF",
            "probability": 0.0
        },
        {
            "start_logit": -1.822265625,
            "end_logit": -0.68896484375,
            "text": "factor (HGF",
            "probability": 0.0
        },
        {
            "start_logit": -6.01171875,
            "end_logit": -0.68896484375,
            "text": "growth factor (HGF",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -5.86328125,
            "text": "HGF) and Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -5.95703125,
            "text": "HGF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -6.0703125,
            "text": "HGF) and Wnt2",
            "probability": 0.0
        },
        {
            "start_logit": -1.822265625,
            "end_logit": -5.86328125,
            "text": "factor (HGF) and Wnt",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_1": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.203125,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.96533203125
        },
        {
            "start_logit": 8.578125,
            "end_logit": 4.65234375,
            "text": "excessive daytime sleepiness",
            "probability": 0.027801513671875
        },
        {
            "start_logit": 8.578125,
            "end_logit": 3.3359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.007427215576171875
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 8.203125,
            "text": "EDS)",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.548828125,
            "text": "excessive",
            "probability": 2.0682811737060547e-05
        },
        {
            "start_logit": -2.64453125,
            "end_logit": 8.203125,
            "text": ")",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -4.7265625,
            "end_logit": 8.203125,
            "text": "sleepiness (EDS)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.21484375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 8.203125,
            "text": "daytime sleepiness (EDS)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.828125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 3.3359375,
            "text": "EDS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.203125,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.1796875,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.2734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.46875,
            "text": "excessive daytime sleepiness (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.52734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.546875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.203125,
            "text": "of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_2": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.265625,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": -1.150390625,
            "end_logit": 9.265625,
            "text": "sleepiness",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.5126953125,
            "text": "excessive",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -4.13671875,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 9.265625,
            "text": "daytime sleepiness",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.42578125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.265625,
            "text": "of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.265625,
            "text": "symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.21875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.265625,
            "text": "by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.265625,
            "text": "pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.265625,
            "text": "disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.3203125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and catapl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.265625,
            "text": ": Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.38671875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.50390625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.55078125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.65625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.65625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.150390625,
            "end_logit": -4.13671875,
            "text": "sleepiness, sleep paralysis",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_3": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.203125,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.96533203125
        },
        {
            "start_logit": 8.578125,
            "end_logit": 4.65234375,
            "text": "excessive daytime sleepiness",
            "probability": 0.027801513671875
        },
        {
            "start_logit": 8.578125,
            "end_logit": 3.3359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.007427215576171875
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 8.203125,
            "text": "EDS)",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.548828125,
            "text": "excessive",
            "probability": 2.0682811737060547e-05
        },
        {
            "start_logit": -2.64453125,
            "end_logit": 8.203125,
            "text": ")",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -4.7265625,
            "end_logit": 8.203125,
            "text": "sleepiness (EDS)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.21484375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 8.203125,
            "text": "daytime sleepiness (EDS)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.828125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 3.3359375,
            "text": "EDS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.203125,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.1796875,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.2734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.46875,
            "text": "excessive daytime sleepiness (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.52734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.546875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.203125,
            "text": "of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_4": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.453125,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": -0.6552734375,
            "end_logit": 9.453125,
            "text": "sleepiness",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.1591796875,
            "text": "excessive",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -5.640625,
            "end_logit": 9.453125,
            "text": "daytime sleepiness",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -5.4609375,
            "text": "excessive daytime sleepiness, cataplexy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.12109375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted nighttime sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1796875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.20703125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted nighttime sleep.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.453125,
            "text": "symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.453125,
            "text": "STUDY OBJECTIVES: Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.453125,
            "text": "chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.359375,
            "text": "excessive daytime sleepiness, catapl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.453125,
            "text": "includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.453125,
            "text": ": Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.453125,
            "text": ", a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.62109375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.63671875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopomp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.64453125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.65234375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagog",
            "probability": 5.960464477539063e-08
        }
    ],
    "60274a2a1cb411341a0000e2_5": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.265625,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": -1.150390625,
            "end_logit": 9.265625,
            "text": "sleepiness",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.5126953125,
            "text": "excessive",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -4.13671875,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 9.265625,
            "text": "daytime sleepiness",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.42578125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.265625,
            "text": "of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.265625,
            "text": "symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.21875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.265625,
            "text": "by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.265625,
            "text": "pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.265625,
            "text": "disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.3203125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and catapl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.265625,
            "text": ": Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.38671875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.50390625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.55078125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.65625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.65625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.150390625,
            "end_logit": -4.13671875,
            "text": "sleepiness, sleep paralysis",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_6": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.203125,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.96533203125
        },
        {
            "start_logit": 8.578125,
            "end_logit": 4.65234375,
            "text": "excessive daytime sleepiness",
            "probability": 0.027801513671875
        },
        {
            "start_logit": 8.578125,
            "end_logit": 3.3359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.007427215576171875
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 8.203125,
            "text": "EDS)",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.548828125,
            "text": "excessive",
            "probability": 2.0682811737060547e-05
        },
        {
            "start_logit": -2.64453125,
            "end_logit": 8.203125,
            "text": ")",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -4.7265625,
            "end_logit": 8.203125,
            "text": "sleepiness (EDS)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.21484375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 8.203125,
            "text": "daytime sleepiness (EDS)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.828125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 3.3359375,
            "text": "EDS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.203125,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.1796875,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.2734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.46875,
            "text": "excessive daytime sleepiness (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.52734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.546875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.203125,
            "text": "of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_7": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.203125,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.96533203125
        },
        {
            "start_logit": 8.578125,
            "end_logit": 4.65234375,
            "text": "excessive daytime sleepiness",
            "probability": 0.027801513671875
        },
        {
            "start_logit": 8.578125,
            "end_logit": 3.3359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.007427215576171875
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 8.203125,
            "text": "EDS)",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.548828125,
            "text": "excessive",
            "probability": 2.0682811737060547e-05
        },
        {
            "start_logit": -2.64453125,
            "end_logit": 8.203125,
            "text": ")",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -4.7265625,
            "end_logit": 8.203125,
            "text": "sleepiness (EDS)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.21484375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 8.203125,
            "text": "daytime sleepiness (EDS)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.828125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": 3.3359375,
            "text": "EDS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.203125,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.1796875,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.2734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.46875,
            "text": "excessive daytime sleepiness (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.52734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.546875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.203125,
            "text": "of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_8": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.359375,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": -0.79052734375,
            "end_logit": 9.359375,
            "text": "sleepiness",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.2919921875,
            "text": "excessive",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -4.6640625,
            "text": "excessive daytime sleepiness, cataplexy",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": 9.359375,
            "text": "daytime sleepiness",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.0859375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.48046875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.25,
            "text": "excessive daytime sleepiness, catapl",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.40625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.359375,
            "text": "STUDY OBJECTIVES: Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.359375,
            "text": "includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.359375,
            "text": "chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.4375,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopomp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.359375,
            "text": "symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.44921875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.44921875,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations, and disrupted",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.359375,
            "text": ": Narcolepsy, a chronic disorder of the central nervous system, is clinically characterized by a symptom pentad that includes excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.48828125,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.5,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagog",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.53515625,
            "text": "excessive daytime sleepiness, cataplexy, sleep paralysis, hypnopompic/hypnagogic hallucinations,",
            "probability": 5.960464477539063e-08
        }
    ],
    "60274a2a1cb411341a0000e2_9": [
        {
            "start_logit": 8.6875,
            "end_logit": 8.359375,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.97265625
        },
        {
            "start_logit": 8.6875,
            "end_logit": 4.66015625,
            "text": "excessive daytime sleepiness",
            "probability": 0.0239715576171875
        },
        {
            "start_logit": 8.6875,
            "end_logit": 2.828125,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.0038509368896484375
        },
        {
            "start_logit": 8.6875,
            "end_logit": -2.36328125,
            "text": "excessive",
            "probability": 2.1517276763916016e-05
        },
        {
            "start_logit": -2.279296875,
            "end_logit": 8.359375,
            "text": "EDS)",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -2.41015625,
            "end_logit": 8.359375,
            "text": ")",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": 8.6875,
            "end_logit": -4.7734375,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -4.68359375,
            "end_logit": 8.359375,
            "text": "sleepiness (EDS)",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.0390625,
            "end_logit": 8.359375,
            "text": "daytime sleepiness (EDS)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 8.359375,
            "text": "(EDS)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -6.93359375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.16015625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed noctur",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.21484375,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.40625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.546875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.58984375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.359375,
            "text": "of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.62890625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed noct",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -7.6328125,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.359375,
            "text": "pentad of excessive daytime sleepiness (EDS)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_10": [
        {
            "start_logit": 9.125,
            "end_logit": 9.328125,
            "text": "excessive daytime sleepiness",
            "probability": 1.0
        },
        {
            "start_logit": -0.99609375,
            "end_logit": 9.328125,
            "text": "sleepiness",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.4384765625,
            "text": "excessive",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -2.8203125,
            "text": "excessive daytime sleepiness, sleep paralysis",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 9.328125,
            "text": "daytime sleepiness",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.328125,
            "text": "of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.28125,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.328125,
            "text": "symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.328125,
            "text": "by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.328125,
            "text": "disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.328125,
            "text": "pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.328125,
            "text": "BACKGROUND: Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.328125,
            "text": "characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.328125,
            "text": ": Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.43359375,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.6015625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.63671875,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.640625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.65625,
            "text": "excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.99609375,
            "end_logit": -2.8203125,
            "text": "sleepiness, sleep paralysis",
            "probability": 0.0
        }
    ],
    "60274a2a1cb411341a0000e2_11": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.140625,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.89990234375
        },
        {
            "start_logit": 8.703125,
            "end_logit": 5.86328125,
            "text": "excessive daytime sleepiness",
            "probability": 0.0919189453125
        },
        {
            "start_logit": 8.703125,
            "end_logit": 3.43359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.00815582275390625
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.3359375,
            "text": "excessive",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 8.140625,
            "text": "EDS)",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": -2.75,
            "end_logit": 8.140625,
            "text": ")",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -4.16796875,
            "end_logit": 8.140625,
            "text": "sleepiness (EDS)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -4.88671875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.49609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.140625,
            "text": "daytime sleepiness (EDS)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 8.140625,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.16796875,
            "end_logit": 5.86328125,
            "text": "sleepiness",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.17578125,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.19140625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 3.43359375,
            "text": "EDS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.44921875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed no",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.4921875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.5859375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.59375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.59765625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopomp",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60274a2a1cb411341a0000e2_12": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.140625,
            "text": "excessive daytime sleepiness (EDS)",
            "probability": 0.89990234375
        },
        {
            "start_logit": 8.703125,
            "end_logit": 5.86328125,
            "text": "excessive daytime sleepiness",
            "probability": 0.0919189453125
        },
        {
            "start_logit": 8.703125,
            "end_logit": 3.43359375,
            "text": "excessive daytime sleepiness (EDS",
            "probability": 0.00815582275390625
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.3359375,
            "text": "excessive",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 8.140625,
            "text": "EDS)",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": -2.75,
            "end_logit": 8.140625,
            "text": ")",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -4.16796875,
            "end_logit": 8.140625,
            "text": "sleepiness (EDS)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -4.88671875,
            "text": "excessive daytime sleepiness (EDS), cataplexy",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.49609375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.140625,
            "text": "daytime sleepiness (EDS)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 8.140625,
            "text": "(EDS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.16796875,
            "end_logit": 5.86328125,
            "text": "sleepiness",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.17578125,
            "text": "excessive daytime sleepiness (EDS), catapl",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.19140625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": 3.43359375,
            "text": "EDS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.44921875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed no",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.4921875,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.5859375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.59375,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.59765625,
            "text": "excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopomp",
            "probability": 1.1920928955078125e-07
        }
    ],
    "515bd543298dcd4e51000001_1": [
        {
            "start_logit": 7.48828125,
            "end_logit": 7.8203125,
            "text": "H2",
            "probability": 1.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": 7.8203125,
            "text": "GC, but attains a maximum in H2",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -3.318359375,
            "text": "H2 isochores",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.8203125,
            "text": "increasing GC, but attains a maximum in H2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 7.8203125,
            "text": "in H2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.8203125,
            "text": "but attains a maximum in H2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.8203125,
            "text": "with increasing GC, but attains a maximum in H2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.0859375,
            "text": "H2 isocho",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.8203125,
            "text": "frequency of Alu sequences also increases with increasing GC, but attains a maximum in H2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.2421875,
            "text": "H2 isochores, in agreement with previous experimental data",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.8203125,
            "text": "increases with increasing GC, but attains a maximum in H2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.8203125,
            "text": "Alu sequences also increases with increasing GC, but attains a maximum in H2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.328125,
            "text": "H2 isoc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.8203125,
            "text": "The frequency of Alu sequences also increases with increasing GC, but attains a maximum in H2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.4609375,
            "text": "H2 isochores,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.49609375,
            "text": "H2 isochores, in agreement with previous experimental",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.5703125,
            "text": "H2 isochores, in agreement with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.5859375,
            "text": "H2 isochores, in agreement with previous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.265625,
            "end_logit": -3.318359375,
            "text": "GC, but attains a maximum in H2 isochores",
            "probability": 0.0
        },
        {
            "start_logit": -3.265625,
            "end_logit": -3.7890625,
            "text": "GC",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_1": [
        {
            "start_logit": 8.359375,
            "end_logit": 8.25,
            "text": "antisocial personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 8.359375,
            "end_logit": -2.14453125,
            "text": "antisocial",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -2.6875,
            "end_logit": 8.25,
            "text": "disorder",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 8.359375,
            "end_logit": -4.4140625,
            "text": "antisocial personality disorder and high psychopathic",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 8.359375,
            "end_logit": -5.2265625,
            "text": "antisocial personality disorder and high psychopathic traits",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.359375,
            "end_logit": -5.9296875,
            "text": "antisocial personality",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 8.25,
            "text": "with antisocial personality disorder",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 8.25,
            "text": "amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -6.75390625,
            "text": "antisocial personality disorder and high psychopathic traits.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 8.25,
            "text": "Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.03515625,
            "text": "antisocial personality disorder and high psychopath",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.25,
            "text": "violent offenders with antisocial personality disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.30078125,
            "text": "antisocial personality disorder and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.25,
            "text": "personality disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.25,
            "text": "genetic variants and amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.25,
            "text": "variants and amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.25,
            "text": "of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.25,
            "text": "in violent offenders with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.6875,
            "end_logit": -4.4140625,
            "text": "disorder and high psychopathic",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -5.2265625,
            "text": "disorder and high psychopathic traits",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_2": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.34375,
            "text": "Impulsiveness",
            "probability": 1.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 9.34375,
            "text": "ness",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.3330078125,
            "text": "Impulsive",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.34375,
            "text": "Childhood Abuse Predict Impulsiveness",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.90234375,
            "text": "Impulsiveness in Borderline Personality Disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.9296875,
            "text": "Impulsiveness in Borderline Personality Disorder.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.25,
            "text": "Impulsiveness in Borderline Personality",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.34375,
            "text": "Predict Impulsiveness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.29296875,
            "text": "Impulsiveness in Borderline",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.34375,
            "text": "Genetic Variants and Childhood Abuse Predict Impulsiveness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.4140625,
            "text": "Impulsiveness in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.34375,
            "text": "Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.34375,
            "text": "Variants and Childhood Abuse Predict Impulsiveness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 9.34375,
            "text": "-A Genetic Variants and Childhood Abuse Predict Impulsiveness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -1.3330078125,
            "text": "Childhood Abuse Predict Impulsive",
            "probability": 0.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": -6.90234375,
            "text": "ness in Borderline Personality Disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": -6.9296875,
            "text": "ness in Borderline Personality Disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": -7.25,
            "text": "ness in Borderline Personality",
            "probability": 0.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": -7.29296875,
            "text": "ness in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": -7.4140625,
            "text": "ness in",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_3": [
        {
            "start_logit": 4.73828125,
            "end_logit": 3.787109375,
            "text": "Borderline Personality Disorder",
            "probability": 1.0
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -5.15625,
            "text": "Borderline",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -5.53515625,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -6.1796875,
            "text": "Borderline Personality",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -6.63671875,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.296875,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.33203125,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.35546875,
            "text": "Borderline Personality Disorder Is",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.48828125,
            "text": "Borderline Personality Disorder Is Associated With Severity Across",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.49609375,
            "text": "Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality,",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 3.787109375,
            "text": "Disorder",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -6.84375,
            "end_logit": 3.787109375,
            "text": "Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 3.787109375,
            "text": "in Borderline Personality Disorder",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 3.787109375,
            "text": "Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 3.787109375,
            "text": "Distribution Volume in Borderline Personality Disorder",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -5.53515625,
            "text": "Suicidality",
            "probability": 0.0
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -6.63671875,
            "text": "Suicidality, and Cognition.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84375,
            "end_logit": -5.15625,
            "text": "Elevated Monoamine Oxidase-A Distribution Volume in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -5.15625,
            "text": "in Borderline",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -5.53515625,
            "text": "Disorder Is Associated With Severity Across Mood Symptoms, Suicidality",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_4": [
        {
            "start_logit": 7.33984375,
            "end_logit": 7.8828125,
            "text": "borderline personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": -3.447265625,
            "end_logit": 7.8828125,
            "text": "disorder",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -3.2734375,
            "text": "borderline",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.17578125,
            "text": "borderline personality",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.8828125,
            "text": "with borderline personality disorder",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.8828125,
            "text": "personality disorder",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.88671875,
            "text": "borderline personality disorder.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.8828125,
            "text": "associated with borderline personality disorder",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.8828125,
            "text": "Monoamine oxidase a gene is associated with borderline personality disorder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -3.2734375,
            "text": "with borderline",
            "probability": 0.0
        },
        {
            "start_logit": -3.447265625,
            "end_logit": -6.88671875,
            "text": "disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -3.2734375,
            "text": "associated with borderline",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -3.2734375,
            "text": "Monoamine oxidase a gene is associated with borderline",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -6.17578125,
            "text": "with borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.17578125,
            "text": "personality",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.17578125,
            "text": "associated with borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -6.88671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -6.17578125,
            "text": "Monoamine oxidase a gene is associated with borderline personality",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -6.88671875,
            "text": "with borderline personality disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.88671875,
            "text": "personality disorder.",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_5": [
        {
            "start_logit": 8.734375,
            "end_logit": 6.265625,
            "text": "aggression",
            "probability": 1.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -2.724609375,
            "text": "aggression, impulsivity",
            "probability": 0.00012433528900146484
        },
        {
            "start_logit": 8.734375,
            "end_logit": -5.796875,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -6.6875,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -6.859375,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline personality disorder.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -6.87109375,
            "text": "aggression, impulsivity, suicide and mood liability",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.109375,
            "text": "aggression, impulsivity, suicide",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.1953125,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate in borderline",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.28515625,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.390625,
            "text": "aggression, impulsivity, suicide and mood",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.421875,
            "text": "aggression, impulsivity, suicide and",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.47265625,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered a functional candidate",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.53515625,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.546875,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.546875,
            "text": "aggression, impulsivity, suicide and mood liability, monoamine oxidase A can be considered",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 6.265625,
            "text": "As for its role in aggression",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 6.265625,
            "text": "in aggression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.265625,
            "text": "role in aggression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.265625,
            "text": "its role in aggression",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6982421875,
            "end_logit": -2.724609375,
            "text": "impulsivity",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_6": [
        {
            "start_logit": 6.30859375,
            "end_logit": 0.9384765625,
            "text": "borderline personality disorder",
            "probability": 0.98828125
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -3.830078125,
            "text": "borderline",
            "probability": 0.00841522216796875
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -4.953125,
            "text": "borderline personality",
            "probability": 0.0027332305908203125
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.39453125,
            "text": "borderline personality disorder.",
            "probability": 0.0006465911865234375
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 0.9384765625,
            "text": "that the monoamine oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 0.9384765625,
            "text": "play an important role in the etiological development of the borderline personality disorder",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 0.9384765625,
            "text": "role in the etiological development of the borderline personality disorder",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 0.9384765625,
            "text": "may play an important role in the etiological development of the borderline personality disorder",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 0.9384765625,
            "text": "results show that the monoamine oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 0.9384765625,
            "text": "important role in the etiological development of the borderline personality disorder",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 0.9384765625,
            "text": "These results show that the monoamine oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 0.9384765625,
            "text": "in the etiological development of the borderline personality disorder",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 0.9384765625,
            "text": "the borderline personality disorder",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 0.9384765625,
            "text": "etiological development of the borderline personality disorder",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 0.9384765625,
            "text": "development of the borderline personality disorder",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 0.9384765625,
            "text": "an important role in the etiological development of the borderline personality disorder",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 0.9384765625,
            "text": "show that the monoamine oxidase A gene may play an important role in the etiological development of the borderline personality disorder",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -3.830078125,
            "text": "that the monoamine oxidase A gene may play an important role in the etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -3.830078125,
            "text": "play an important role in the etiological development of the borderline",
            "probability": 0.0
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -3.830078125,
            "text": "role in the etiological development of the borderline",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_7": [
        {
            "start_logit": 9.2421875,
            "end_logit": 5.8125,
            "text": "antisocial personality disorder",
            "probability": 0.994140625
        },
        {
            "start_logit": 9.2421875,
            "end_logit": 0.73583984375,
            "text": "antisocial",
            "probability": 0.006195068359375
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -5.9296875,
            "text": "antisocial personality",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.75390625,
            "text": "antisocial personality disorder.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -5.28125,
            "end_logit": 5.8125,
            "text": "disorder",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 5.8125,
            "text": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 5.8125,
            "text": "with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 5.8125,
            "text": "personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 5.8125,
            "text": "associated with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 5.8125,
            "text": "variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 5.8125,
            "text": "are associated with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 5.8125,
            "text": "Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 0.73583984375,
            "text": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -6.703125,
            "end_logit": 0.73583984375,
            "text": "with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 0.73583984375,
            "text": "associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 0.73583984375,
            "text": "variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 0.73583984375,
            "text": "are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": 0.73583984375,
            "text": "Monoamine Oxidase A transcriptional enhancer are associated with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -5.28125,
            "end_logit": -6.75390625,
            "text": "disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -5.9296875,
            "text": "Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality",
            "probability": 0.0
        }
    ],
    "5a99566e1d1251d03b00000f_8": [
        {
            "start_logit": 8.6796875,
            "end_logit": 7.58203125,
            "text": "antisocial personality disorder",
            "probability": 1.0
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -1.1875,
            "text": "antisocial",
            "probability": 0.00015473365783691406
        },
        {
            "start_logit": -3.71875,
            "end_logit": 7.58203125,
            "text": "disorder",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -5.1015625,
            "text": "antisocial personality",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.1796875,
            "text": "antisocial personality disorder.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.265625,
            "end_logit": 7.58203125,
            "text": "an offender population with antisocial personality disorder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.58203125,
            "text": "with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.58203125,
            "text": "gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.58203125,
            "text": "in an offender population with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.58203125,
            "text": "personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.58203125,
            "text": "promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.58203125,
            "text": "offender population with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.58203125,
            "text": "Monoamine oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.58203125,
            "text": "population with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.58203125,
            "text": "A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.58203125,
            "text": "transcriptional downregulation in an offender population with antisocial personality disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.265625,
            "end_logit": -1.1875,
            "text": "an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -1.1875,
            "text": "with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -1.1875,
            "text": "gene promoter methylation and transcriptional downregulation in an offender population with antisocial",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -1.1875,
            "text": "in an offender population with antisocial",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_1": [
        {
            "start_logit": 9.0078125,
            "end_logit": 9.0625,
            "text": "BETAWARE",
            "probability": 1.0
        },
        {
            "start_logit": -1.89453125,
            "end_logit": 9.0625,
            "text": "WARE",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.8486328125,
            "text": "BETA",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -4.046875,
            "text": "BETAWARE: a machine-learning",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -5.7890625,
            "text": "BETAWARE: a machine-learning tool",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.265625,
            "text": "BETAWARE: a machine-learning tool to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.2890625,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins in prokaryotes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.34765625,
            "text": "BETAWARE: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.36328125,
            "text": "BETAWARE: a machine-learning tool to detect and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.3671875,
            "text": "BETAWARE: a machine-learning tool to detect",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.3828125,
            "text": "BETAWARE:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.41015625,
            "text": "BETAWARE: a machine-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.47265625,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.50390625,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta-barrel proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.51171875,
            "text": "BETAWARE: a machine-learning tool to detect and predict",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.54296875,
            "text": "BETAWARE: a machine-learning tool to detect and predict transmembrane beta",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.89453125,
            "end_logit": -4.046875,
            "text": "WARE: a machine-learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.89453125,
            "end_logit": -5.7890625,
            "text": "WARE: a machine-learning tool",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -4.046875,
            "text": "machine-learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.89453125,
            "end_logit": -7.265625,
            "text": "WARE: a machine-learning tool to",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_2": [
        {
            "start_logit": 6.76953125,
            "end_logit": 6.80859375,
            "text": "BETAWARE",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.45556640625,
            "end_logit": 5.50390625,
            "text": "machine-learning approaches",
            "probability": 0.0004916191101074219
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -3.08203125,
            "text": "BETA",
            "probability": 5.060434341430664e-05
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 6.80859375,
            "text": "WARE",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -4.80859375,
            "end_logit": 6.80859375,
            "text": "approaches to tackle both the detection of TMBBs in sets of proteins and the prediction of their topology. Here, we present our BETAWARE",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -4.80859375,
            "end_logit": 5.50390625,
            "text": "approaches",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -6.17578125,
            "text": "BETAWARE program",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -6.328125,
            "text": "BETAWARE program that includes both approaches and",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -6.5078125,
            "text": "BETAWARE program that includes both approaches",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 6.80859375,
            "text": "present our BETAWARE",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.43359375,
            "end_logit": 5.50390625,
            "text": "methods based on machine-learning approaches",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 6.80859375,
            "text": "TMBBs in sets of proteins and the prediction of their topology. Here, we present our BETAWARE",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 6.80859375,
            "text": ". Here, we present our BETAWARE",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.046875,
            "end_logit": 6.80859375,
            "text": "our BETAWARE",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.76171875,
            "end_logit": 5.50390625,
            "text": "on machine-learning approaches",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.80859375,
            "text": "Here, we present our BETAWARE",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.06640625,
            "text": "BETAWARE program that includes both approaches and can",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.18359375,
            "text": "BETAWARE program that includes both",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.21484375,
            "text": "BETAWARE program that includes",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.80859375,
            "text": "detection of TMBBs in sets of proteins and the prediction of their topology. Here, we present our BETAWARE",
            "probability": 6.556510925292969e-07
        }
    ],
    "5149a61ed24251bc05000044_3": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.2890625,
            "text": "BOCTOPUS",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.158203125,
            "text": "BOC",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": 9.2890625,
            "text": "US",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -5.703125,
            "end_logit": 9.2890625,
            "text": "TOPUS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 9.2890625,
            "text": "PUS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.07421875,
            "text": "BOCTOPUS: improved topology",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.30859375,
            "text": "BOCTOPUS: improved topology prediction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.43359375,
            "text": "BOCTOP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.4453125,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2 barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.48828125,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2 barrel proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.5234375,
            "text": "BOCTOPUS:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.546875,
            "text": "BOCTOPUS: improved topology prediction of transmembrane \u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.546875,
            "text": "BOCTOPUS: improved topology prediction of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.07421875,
            "text": "US: improved topology",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.30859375,
            "text": "US: improved topology prediction",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.4453125,
            "text": "US: improved topology prediction of transmembrane \u03b2 barrel",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.48828125,
            "text": "US: improved topology prediction of transmembrane \u03b2 barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.5234375,
            "text": "US:",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.546875,
            "text": "US: improved topology prediction of transmembrane \u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -1.4755859375,
            "end_logit": -7.546875,
            "text": "US: improved topology prediction of",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_4": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.0859375,
            "text": "TMBHMM",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1708984375,
            "text": "TM",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -1.8740234375,
            "end_logit": 9.0859375,
            "text": "MM",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.25,
            "text": "TMBHMM: a frequency profile based HMM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 9.0859375,
            "text": "BHMM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 9.0859375,
            "text": "HMM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.15234375,
            "text": "TMBHMM: a frequency profile based HMM for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.33984375,
            "text": "TMBHMM: a frequency profile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.4453125,
            "text": "TMBHMM: a frequency profile based",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.453125,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.48046875,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.50390625,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.53515625,
            "text": "TMBH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5390625,
            "text": "TMBHMM: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.54296875,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5546875,
            "text": "TMBHMM:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.5703125,
            "text": "TMBHMM: a frequency profile based HMM for predicting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.57421875,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.57421875,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.578125,
            "text": "TMBHMM: a frequency profile based HMM for predicting the topology of transmembrane beta barrel proteins and the exposure status of transmembrane residues",
            "probability": 5.960464477539063e-08
        }
    ],
    "5149a61ed24251bc05000044_5": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.2421875,
            "text": "TMBHMM",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.2158203125,
            "text": "TM",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": 9.2421875,
            "text": "MM",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -4.74609375,
            "text": "TMBHMM, a computational method based on a hidden Markov model",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 9.2421875,
            "text": "BHMM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 9.2421875,
            "text": "HMM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.2421875,
            "text": "here TMBHMM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.27734375,
            "text": "TMBHMM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.29296875,
            "text": "TMBHMM, a computational method based on a hidden Markov",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.3046875,
            "text": "TMBHMM, a computational method based on a hidden Markov model for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.4140625,
            "text": "TMBHMM, a computational method based",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.42578125,
            "text": "TMBHMM, a computational method",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.453125,
            "text": "TMBHMM, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -4.74609375,
            "text": "MM, a computational method based on a hidden Markov model",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -1.2158203125,
            "text": "here TM",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.2109375,
            "text": "MM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence. In addition to predicting transmembrane strands",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.27734375,
            "text": "MM, a computational method based on a hidden Markov model for predicting the structural topology of putative TMBs from sequence.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.29296875,
            "text": "MM, a computational method based on a hidden Markov",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.3046875,
            "text": "MM, a computational method based on a hidden Markov model for",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.4140625,
            "text": "MM, a computational method based",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_6": [
        {
            "start_logit": 9.28125,
            "end_logit": 9.328125,
            "text": "BTMX",
            "probability": 1.0
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.19140625,
            "text": "BT",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.34375,
            "end_logit": 9.328125,
            "text": "X",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -6.15625,
            "end_logit": 9.328125,
            "text": "MX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.40625,
            "text": "BTMX (Beta barrel TransMembrane eXposure)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.95703125,
            "text": "BTMX (Beta barrel TransMembrane eXposure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.39453125,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 9.328125,
            "text": "present BTMX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.43359375,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.46875,
            "text": "BTMX (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.48046875,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.5078125,
            "text": "BTMX (Beta barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.52734375,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.53125,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer or hidden",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.28125,
            "end_logit": -7.54296875,
            "text": "BTMX (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.34375,
            "end_logit": -6.40625,
            "text": "X (Beta barrel TransMembrane eXposure)",
            "probability": 0.0
        },
        {
            "start_logit": -1.34375,
            "end_logit": -6.95703125,
            "text": "X (Beta barrel TransMembrane eXposure",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -1.19140625,
            "text": "present BT",
            "probability": 0.0
        },
        {
            "start_logit": -1.34375,
            "end_logit": -7.39453125,
            "text": "X (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e",
            "probability": 0.0
        },
        {
            "start_logit": -1.34375,
            "end_logit": -7.43359375,
            "text": "X (Beta barrel TransMembrane eXposure), a computational method to predict the exposure status (i.e. exposed to the bilayer or",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_7": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.0546875,
            "text": "TMBETAPRED-RBF",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.2998046875,
            "text": "TM",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": 9.0546875,
            "text": "RBF",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -6.375,
            "end_logit": 9.0546875,
            "text": "BETAPRED-RBF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 9.0546875,
            "text": "PRED-RBF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 9.0546875,
            "text": "-RBF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 9.0546875,
            "text": "D-RBF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.24609375,
            "text": "TMBETAPRED-RBF for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 9.0546875,
            "text": ", TMBETAPRED-RBF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.42578125,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.5,
            "text": "TMBETAPRE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.515625,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.51953125,
            "text": "TMBETAPRED-RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -1.2998046875,
            "text": ", TM",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -7.24609375,
            "text": "RBF for",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -7.42578125,
            "text": "RBF for predicting the transmembrane beta-strands",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -7.51171875,
            "text": "RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http://rbf.bioinfo",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -7.515625,
            "text": "RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -7.51953125,
            "text": "RBF for predicting the transmembrane beta-strands from amino acid sequence and it is available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -6.375,
            "end_logit": -7.24609375,
            "text": "BETAPRED-RBF for",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_8": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.2734375,
            "text": "TMBpro",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.2109375,
            "text": "TM",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": 9.2734375,
            "text": "ro",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 9.2734375,
            "text": "Bpro",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.24609375,
            "text": "TMBpro: secondary structure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.42578125,
            "text": "TMBpro: secondary structure, beta-contact",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.46875,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.51171875,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.515625,
            "text": "TMBpro: secondary structure, beta-contact and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.59375,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.59765625,
            "text": "TMBpro:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.61328125,
            "text": "TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.62109375,
            "text": "TMBpro: secondary structure, beta-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.24609375,
            "text": "ro: secondary structure",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.42578125,
            "text": "ro: secondary structure, beta-contact",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.46875,
            "text": "ro: secondary structure, beta-contact and tertiary structure prediction",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.51171875,
            "text": "ro: secondary structure, beta-contact and tertiary structure",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.515625,
            "text": "ro: secondary structure, beta-contact and",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.59375,
            "text": "ro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.4833984375,
            "end_logit": -7.59765625,
            "text": "ro:",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_9": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.34375,
            "text": "TMBpro",
            "probability": 1.0
        },
        {
            "start_logit": -1.3056640625,
            "end_logit": 9.34375,
            "text": "ro",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.5078125,
            "text": "TM",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 9.34375,
            "text": "Bpro",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.57421875,
            "text": "TMBpro) of specialized predictors",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.91796875,
            "text": "TMBpro)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.34375,
            "text": "(TMBpro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.02734375,
            "text": "TMBpro) of specialized predictors for predicting secondary structure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.34375,
            "text": "suite (TMBpro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.34375,
            "text": "develop a suite (TMBpro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.44140625,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.48828125,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4921875,
            "text": "TMBpro) of specialized predictors for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4921875,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.50390625,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro-CON)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.57421875,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS), beta-contacts (TMBpro-CON",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.578125,
            "text": "TMBpro) of specialized predictors for predicting secondary structure (TMBpro-SS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3056640625,
            "end_logit": -6.57421875,
            "text": "ro) of specialized predictors",
            "probability": 0.0
        },
        {
            "start_logit": -1.3056640625,
            "end_logit": -6.91796875,
            "text": "ro)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3056640625,
            "end_logit": -7.02734375,
            "text": "ro) of specialized predictors for predicting secondary structure",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_10": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.3359375,
            "text": "BOCTOPUS",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2421875,
            "text": "BOC",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -1.337890625,
            "end_logit": 9.3359375,
            "text": "US",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -5.82421875,
            "end_logit": 9.3359375,
            "text": "TOPUS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.91015625,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.07421875,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 9.3359375,
            "text": "PUS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.51171875,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.84765625,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05859375,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.15234375,
            "text": "BOCTOPUS; an improved method for the topology prediction of TMBs by employing a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1875,
            "text": "BOCTOPUS;",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.28125,
            "text": "BOCTOPUS; an improved method for the topology prediction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.3359375,
            "text": "present BOCTOPUS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -5.91015625,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines",
            "probability": 0.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -6.07421875,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs)",
            "probability": 0.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -6.375,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and Hidden Markov Models",
            "probability": 0.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -6.51171875,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVM",
            "probability": 0.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -6.84765625,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs",
            "probability": 0.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": -7.05859375,
            "text": "US; an improved method for the topology prediction of TMBs by employing a combination of support vector machines (SVMs) and",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_11": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.1484375,
            "text": "PRED-TMBB",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.1962890625,
            "text": "PRED",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -1.80078125,
            "end_logit": 9.1484375,
            "text": "BB",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 9.1484375,
            "text": "-TMBB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 9.1484375,
            "text": "TMBB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.03125,
            "text": "PRED-TMBB: a web server",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.25390625,
            "text": "PRED-TMBB: a web server for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.296875,
            "text": "PRED-TMBB: a web server for predicting the topology",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.38671875,
            "text": "PRED-TMBB:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.41015625,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.4296875,
            "text": "PRED-TM",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.43359375,
            "text": "PRED-TMBB: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.453125,
            "text": "PRED-TMBB: a web server for predicting the topology of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.46484375,
            "text": "PRED-TMBB: a web server for predicting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.49609375,
            "text": "PRED-TMBB: a web server for predicting the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.51171875,
            "text": "PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.03125,
            "text": "BB: a web server",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.25390625,
            "text": "BB: a web server for",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.296875,
            "text": "BB: a web server for predicting the topology",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.38671875,
            "text": "BB:",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_12": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.0859375,
            "text": "PRED-TMBB",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.208984375,
            "text": "PRED",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -1.916015625,
            "end_logit": 9.0859375,
            "text": "BB",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 9.0859375,
            "text": "-TMBB",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 9.0859375,
            "text": "TMBB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.25,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa.gr/PRED-TMBB)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3515625,
            "text": "PRED-TMBB, http://bioinformatics.biol.uoa.gr/PRED-TMBB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.0859375,
            "text": "here a web server (PRED-TMBB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.0859375,
            "text": "(PRED-TMBB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.208984375,
            "text": "here a web server (PRED",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -1.208984375,
            "text": "(PRED",
            "probability": 0.0
        },
        {
            "start_logit": -1.916015625,
            "end_logit": -7.25,
            "text": "BB, http://bioinformatics.biol.uoa.gr/PRED-TMBB)",
            "probability": 0.0
        },
        {
            "start_logit": -1.916015625,
            "end_logit": -7.3515625,
            "text": "BB, http://bioinformatics.biol.uoa.gr/PRED-TMBB",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -5.35546875,
            "text": "Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -6.34765625,
            "text": "Hidden Markov Model, trained according to the Conditional Maximum Likelihood",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -5.35546875,
            "text": ". The method is based on a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -5.35546875,
            "text": "a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -5.35546875,
            "text": "transmembrane strands and the topology of beta-barrel outer membrane proteins of Gram-negative bacteria. The method is based on a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -5.35546875,
            "text": "method is based on a Hidden Markov Model",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -5.35546875,
            "text": "on a Hidden Markov Model",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_13": [
        {
            "start_logit": 9.1953125,
            "end_logit": 9.0703125,
            "text": "TBBPred",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.4150390625,
            "text": "TB",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": 9.0703125,
            "text": "red",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -5.875,
            "end_logit": 9.0703125,
            "text": "BPred",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.3046875,
            "text": "TBBPred,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.0703125,
            "text": ", TBBPred",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.484375,
            "text": "TBBPred, for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.4921875,
            "text": "TBBPred, for predicting transmembrane beta-barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.578125,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.58984375,
            "text": "TBBPred, for predicting transmembrane beta",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.59765625,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": -1.4150390625,
            "text": ", TB",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.3046875,
            "text": "red,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.484375,
            "text": "red, for",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.4921875,
            "text": "red, for predicting transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.578125,
            "text": "red, for predicting transmembrane beta-barrel regions",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.58984375,
            "text": "red, for predicting transmembrane beta",
            "probability": 0.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": -7.59765625,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -7.3046875,
            "text": "BPred,",
            "probability": 0.0
        },
        {
            "start_logit": -5.875,
            "end_logit": -7.484375,
            "text": "BPred, for",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_14": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.28125,
            "text": "PROFtmb",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.248046875,
            "text": "PROF",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.48046875,
            "end_logit": 9.28125,
            "text": "mb",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -5.609375,
            "end_logit": 9.28125,
            "text": "tmb",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.91796875,
            "text": "PROFtmb prediction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.94140625,
            "text": "PROFtmb prediction method",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1796875,
            "text": "PROFtmb prediction method are available",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.19140625,
            "text": "PROFtmb prediction method are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.28125,
            "text": "the PROFtmb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 9.28125,
            "text": "and the PROFtmb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -6.91796875,
            "text": "mb prediction",
            "probability": 0.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -6.94140625,
            "text": "mb prediction method",
            "probability": 0.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -7.1796875,
            "text": "mb prediction method are available",
            "probability": 0.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -7.19140625,
            "text": "mb prediction method are",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -1.248046875,
            "text": "the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -1.248046875,
            "text": "and the PROF",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": -6.91796875,
            "text": "tmb prediction",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": -6.94140625,
            "text": "tmb prediction method",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": -7.1796875,
            "text": "tmb prediction method are available",
            "probability": 0.0
        },
        {
            "start_logit": -5.609375,
            "end_logit": -7.19140625,
            "text": "tmb prediction method are",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_15": [
        {
            "start_logit": 8.0546875,
            "end_logit": 6.25,
            "text": "beta-barrel finder",
            "probability": 1.0
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -2.6328125,
            "text": "beta-barrel finder (BBF",
            "probability": 0.00013875961303710938
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -3.021484375,
            "text": "beta",
            "probability": 9.387731552124023e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -4.87890625,
            "text": "beta-barrel finder (BB",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -4.4375,
            "end_logit": 6.25,
            "text": "er",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.40234375,
            "text": "beta-barrel finder (BBF) program",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.49609375,
            "text": "beta-barrel finder (BBF)",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.1015625,
            "text": "beta-barrel",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.16015625,
            "text": "beta-barrel finder (",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.27734375,
            "text": "beta-barrel finder (BBF) program,",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.33203125,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.36328125,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta-barrel proteins encoded within prokaryotic genomes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.37109375,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.38671875,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta-barrel proteins encoded within prokaryotic",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.41015625,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta-barrel proteins encoded",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.42578125,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta-barrel",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.44921875,
            "text": "beta-barrel finder (BBF) program, allowing",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.45703125,
            "text": "beta-barrel finder (BBF) program, allowing identification of outer membrane beta-",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 6.25,
            "text": "finder",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 6.25,
            "text": "The beta-barrel finder",
            "probability": 5.364418029785156e-07
        }
    ],
    "5149a61ed24251bc05000044_16": [
        {
            "start_logit": 5.375,
            "end_logit": 5.2734375,
            "text": "beta-barrel finder",
            "probability": 0.998046875
        },
        {
            "start_logit": 5.375,
            "end_logit": -1.6689453125,
            "text": "beta-barrel finder (BB",
            "probability": 0.000965118408203125
        },
        {
            "start_logit": 5.375,
            "end_logit": -2.56640625,
            "text": "beta-barrel finder (BBF",
            "probability": 0.000392913818359375
        },
        {
            "start_logit": -4.8828125,
            "end_logit": 5.2734375,
            "text": "er",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": 5.375,
            "end_logit": -5.296875,
            "text": "beta",
            "probability": 2.562999725341797e-05
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 5.2734375,
            "text": "program, termed the beta-barrel finder",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": 5.375,
            "end_logit": -5.90234375,
            "text": "beta-barrel finder (BBF)",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -5.91796875,
            "end_logit": 5.2734375,
            "text": "finder",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.50390625,
            "text": "beta-barrel",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.5390625,
            "text": "beta-barrel finder (BBF) program, was used to analyze the proteins encoded within the Escherichia coli genome.",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 5.2734375,
            "text": "the beta-barrel finder",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 5.2734375,
            "text": "termed the beta-barrel finder",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.74609375,
            "text": "beta-barrel finder (BBF) program",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 5.2734375,
            "text": ". This program, termed the beta-barrel finder",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 5.2734375,
            "text": "program was developed allowing prediction of integral membrane beta-barrel proteins encoded within any completely sequenced prokaryotic genome. This program, termed the beta-barrel finder",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 5.2734375,
            "text": "This program, termed the beta-barrel finder",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -1.376953125,
            "end_logit": -1.6689453125,
            "text": "BB",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -2.150390625,
            "end_logit": -1.5263671875,
            "text": "hydropathy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.376953125,
            "end_logit": -2.56640625,
            "text": "BBF",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.8828125,
            "end_logit": -1.6689453125,
            "text": "er (BB",
            "probability": 5.960464477539063e-08
        }
    ],
    "5149a61ed24251bc05000044_17": [
        {
            "start_logit": 2.298828125,
            "end_logit": 8.296875,
            "text": "algorithm transFold",
            "probability": 0.50634765625
        },
        {
            "start_logit": 2.265625,
            "end_logit": 8.296875,
            "text": "transFold",
            "probability": 0.490966796875
        },
        {
            "start_logit": -2.923828125,
            "end_logit": 8.296875,
            "text": "old",
            "probability": 0.0027408599853515625
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.296875,
            "text": "The algorithm transFold",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 8.296875,
            "text": ". The algorithm transFold",
            "probability": 5.221366882324219e-05
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.296875,
            "text": "supersecondary structure of transmembrane beta-barrel proteins. The algorithm transFold",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -4.14453125,
            "text": "algorithm transFold employs a generalized hidden Markov model",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 2.265625,
            "end_logit": -4.14453125,
            "text": "transFold employs a generalized hidden Markov model",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -5.65625,
            "text": "algorithm transFold employs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 2.265625,
            "end_logit": -5.65625,
            "text": "transFold employs",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -6.28515625,
            "text": "algorithm transFold employs a generalized hidden Markov model (i.e., multitape S-attribute grammar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.265625,
            "end_logit": -6.28515625,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S-attribute grammar",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -6.70703125,
            "text": "algorithm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -6.82421875,
            "text": "algorithm transFold employs a generalized hidden Markov",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.265625,
            "end_logit": -6.82421875,
            "text": "transFold employs a generalized hidden Markov",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -7.1171875,
            "text": "algorithm transFold employs a generalized hidden Markov model (i.e., multitape S-attribute grammar)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.265625,
            "end_logit": -7.1171875,
            "text": "transFold employs a generalized hidden Markov model (i.e., multitape S-attribute grammar)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -7.1875,
            "text": "algorithm transFold employs a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.265625,
            "end_logit": -7.1875,
            "text": "transFold employs a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.298828125,
            "end_logit": -7.23046875,
            "text": "algorithm transFold employs a generalized hidden Markov model (i.e., multitape S-attribute gramm",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5149a61ed24251bc05000044_18": [
        {
            "start_logit": 9.328125,
            "end_logit": 9.03125,
            "text": "BOMP",
            "probability": 1.0
        },
        {
            "start_logit": 9.328125,
            "end_logit": -1.04296875,
            "text": "BOM",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": -2.009765625,
            "end_logit": 9.03125,
            "text": "P",
            "probability": 1.1920928955078125e-05
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.33984375,
            "text": "BOMP:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.34375,
            "text": "BOMP: a program to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.35546875,
            "text": "BOMP: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.37890625,
            "text": "BOMP: a program",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.41796875,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4375,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.47265625,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4765625,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4765625,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.48828125,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.4921875,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.50390625,
            "text": "BOMP: a program to predict integral beta-barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.51171875,
            "text": "BOMP: a program to predict",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.51171875,
            "text": "BOMP: a program to predict integral beta-barrel outer membrane proteins encoded",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.009765625,
            "end_logit": -7.33984375,
            "text": "P:",
            "probability": 0.0
        },
        {
            "start_logit": -2.009765625,
            "end_logit": -7.34375,
            "text": "P: a program to",
            "probability": 0.0
        },
        {
            "start_logit": -2.009765625,
            "end_logit": -7.35546875,
            "text": "P: a",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_19": [
        {
            "start_logit": 9.4375,
            "end_logit": 9.15625,
            "text": "BOMP",
            "probability": 1.0
        },
        {
            "start_logit": 9.4375,
            "end_logit": -0.478271484375,
            "text": "BOM",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -1.59765625,
            "end_logit": 9.15625,
            "text": "P",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 9.4375,
            "end_logit": -5.71484375,
            "text": "BOMP)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.140625,
            "text": "BOMP), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal pattern typical",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.15625,
            "text": ". The program, called the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.17578125,
            "text": "BOMP), is based on two separate components to recognize integral beta-barrel proteins. The first component is a C-terminal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.1875,
            "text": "BOMP), is based on two",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.203125,
            "text": "BOMP), is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0625,
            "end_logit": 9.15625,
            "text": "beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.15625,
            "text": "Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.15625,
            "text": "program, called the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.15625,
            "text": "called the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.15625,
            "text": "protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.15625,
            "text": ", called the beta-barrel Outer Membrane protein Predictor (BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.15625,
            "text": "(BOMP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -5.71484375,
            "text": "P)",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -0.478271484375,
            "text": ". The program, called the beta-barrel Outer Membrane protein Predictor (BOM",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -0.478271484375,
            "text": "beta-barrel Outer Membrane protein Predictor (BOM",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -0.478271484375,
            "text": "Predictor (BOM",
            "probability": 0.0
        }
    ],
    "5149a61ed24251bc05000044_20": [
        {
            "start_logit": 8.9921875,
            "end_logit": 9.015625,
            "text": "OMBBpred",
            "probability": 1.0
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -1.87890625,
            "text": "OM",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -2.0078125,
            "end_logit": 9.015625,
            "text": "d",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -6.30078125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -6.33203125,
            "text": "OMBBpred, which utilizes a Support Vector Machine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 9.015625,
            "text": "pred",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -6.83984375,
            "text": "OMBB",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -6.92578125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors derived from predicted secondary structures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.015625,
            "text": "called OMBBpred",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 9.015625,
            "text": "OMBBs, called OMBBpred",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.1640625,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.21484375,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.2734375,
            "text": "OMBBpred, which utilizes a Support Vector",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.30078125,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.34765625,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors derived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.40625,
            "text": "OMBBpred, which utilizes a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -7.4375,
            "text": "OMBBpred, which utilizes a Support Vector Machine classifier and a custom-designed set of 34 novel numerical descriptors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.015625,
            "text": "BBpred",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.015625,
            "text": "sequence-based predictor of OMBBs, called OMBBpred",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.015625,
            "text": "accurate sequence-based predictor of OMBBs, called OMBBpred",
            "probability": 5.960464477539063e-08
        }
    ],
    "5149a61ed24251bc05000044_21": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.171875,
            "text": "TBBPred",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.4267578125,
            "text": "TB",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.736328125,
            "end_logit": 9.171875,
            "text": "red",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 9.171875,
            "text": "BPred",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 9.171875,
            "text": ", TBBPred",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.3515625,
            "text": "TBBPred,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.55078125,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.5546875,
            "text": "TBBPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.56640625,
            "text": "TBBPred, for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.578125,
            "text": "TBBPred, for predicting transmembrane beta-barrel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -1.4267578125,
            "text": ", TB",
            "probability": 0.0
        },
        {
            "start_logit": -1.736328125,
            "end_logit": -7.3515625,
            "text": "red,",
            "probability": 0.0
        },
        {
            "start_logit": -1.736328125,
            "end_logit": -7.55078125,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -1.736328125,
            "end_logit": -7.5546875,
            "text": "red, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res",
            "probability": 0.0
        },
        {
            "start_logit": -1.736328125,
            "end_logit": -7.56640625,
            "text": "red, for",
            "probability": 0.0
        },
        {
            "start_logit": -1.736328125,
            "end_logit": -7.578125,
            "text": "red, for predicting transmembrane beta-barrel",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -7.3515625,
            "text": "BPred,",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -7.55078125,
            "text": "BPred, for predicting transmembrane beta-barrel regions in proteins (available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -7.5546875,
            "text": "BPred, for predicting transmembrane beta-barrel regions in proteins (available at http://www.imtech.res",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -7.56640625,
            "text": "BPred, for",
            "probability": 0.0
        }
    ],
    "6027fcd31cb411341a0000ef_1": [
        {
            "start_logit": 8.6484375,
            "end_logit": 9.1171875,
            "text": "EFMEvolver",
            "probability": 1.0
        },
        {
            "start_logit": -1.7236328125,
            "end_logit": 9.1171875,
            "text": "er",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -2.501953125,
            "text": "EF",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -3.46875,
            "text": "EFMEvo",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 9.1171875,
            "text": "compared with the EFMEvolver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.1171875,
            "text": "MEvolver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.546875,
            "text": "EFMEvolver approach, demonstrating a significant improvement in computation time.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.5546875,
            "text": "EFMEvolv",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.1171875,
            "text": "with the EFMEvolver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.1171875,
            "text": "approach is compared with the EFMEvolver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.7265625,
            "text": "EFMEvolver approach, demonstrating a significant improvement in computation time",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.1171875,
            "text": "tree search and efficiently enumerates a subset of EFMs in GSMNs.RESULTS: Our approach is compared with the EFMEvolver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.8984375,
            "text": "EFMEvolver approach",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.97265625,
            "text": "EFME",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -7.0546875,
            "text": "EFMEvolver approach, demonstrating a significant improvement in computation time. We also validate the usefulness of our new approach by studying the acetate overflow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.853515625,
            "end_logit": -0.67919921875,
            "text": "TreeEFM",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -0.67919921875,
            "text": "software TreeEFM",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -0.67919921875,
            "text": "performance of our approach when applied to large GSMNs.AVAILABILITY AND IMPLEMENTATION: The stand-alone software TreeEFM",
            "probability": 0.0
        },
        {
            "start_logit": -1.7236328125,
            "end_logit": -6.546875,
            "text": "er approach, demonstrating a significant improvement in computation time.",
            "probability": 0.0
        },
        {
            "start_logit": -1.853515625,
            "end_logit": -6.53515625,
            "text": "TreeEFM is implemented in C++ and interacts with the open-source linear solver COIN-OR Linear program Solver (CLP).",
            "probability": 0.0
        }
    ],
    "6027fcd31cb411341a0000ef_2": [
        {
            "start_logit": 9.4375,
            "end_logit": 7.9375,
            "text": "simplex method",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.4375,
            "end_logit": 1.8173828125,
            "text": "simplex",
            "probability": 0.002201080322265625
        },
        {
            "start_logit": -3.041015625,
            "end_logit": 7.9375,
            "text": "method",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 9.4375,
            "end_logit": -6.796875,
            "text": "simplex method. By performing additional elementary steps and avoiding trivial solutions consisting of two cycles, we obtain many more EFMs for each LP problem posed",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 7.9375,
            "text": "the simplex method",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 7.9375,
            "text": ". We base our method on a further study of the final tableau of the simplex method",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 7.9375,
            "text": "of the simplex method",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.19921875,
            "end_logit": -0.9990234375,
            "text": "EFM-Ta",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 1.8173828125,
            "text": "the simplex",
            "probability": 0.0
        },
        {
            "start_logit": -6.3125,
            "end_logit": 1.8173828125,
            "text": ". We base our method on a further study of the final tableau of the simplex",
            "probability": 0.0
        },
        {
            "start_logit": 1.19921875,
            "end_logit": -6.0234375,
            "text": "EFM",
            "probability": 0.0
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 1.8173828125,
            "text": "of the simplex",
            "probability": 0.0
        },
        {
            "start_logit": 1.19921875,
            "end_logit": -6.4453125,
            "text": "EFM-Ta that boosts the efficiency rate by analyzing the information provided by the LP solver.",
            "probability": 0.0
        },
        {
            "start_logit": -4.73046875,
            "end_logit": -1.5390625,
            "text": "those based on solving linear programming (LP) problems",
            "probability": 0.0
        },
        {
            "start_logit": -5.69140625,
            "end_logit": -0.9990234375,
            "text": "method called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -5.44921875,
            "end_logit": -1.5390625,
            "text": "based on solving linear programming (LP) problems",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -0.9990234375,
            "text": "new method called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -0.9990234375,
            "text": "called EFM-Ta",
            "probability": 0.0
        },
        {
            "start_logit": -5.578125,
            "end_logit": -1.5390625,
            "text": ", those based on solving linear programming (LP) problems",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -1.5390625,
            "text": "solving linear programming (LP) problems",
            "probability": 0.0
        }
    ]
}
